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1. Introduction 
 
The isolation of complex natural products with interesting biological activities poses 
many challenges, like accessibility and amount. The chemical synthesis of natural products is 
the alternative, but a large number of steps, selectivity, time and financial efforts are 
frequently limiting factors. Nevertheless a synthetic access is often more practical then 
isolation, since larger amounts can be produced and also more simplified analogs can be 
obtained using the same strategy. Therefore it is necessary to improve existing synthetic 
methodologies, and to design new ones. Since most of the natural products are chiral, 
asymmetric versions of these methodologies must also be developed.  
Enolates are important intermediates in the total synthesis of natural products and in 
organic chemistry in general.1 They react as carbon-centred nucleophiles in aldol additions, 
Claisen condensations or alkylations. Asymmetric variants of these reactions are today 
established synthetic methods.2 They are also versatile precursors for the α-
heterofunctionalisation of carbonyl compounds.3 Besides reactions with electrophiles, 
oxidative reactions of enolate gained significant importance in the synthesis of different 
classes of compounds. The oxidative generation of α-carbonyl radicals from enolates via 
single electron transfer (SET) was also intensively investigated. They can thus serve as the 
first intermediates in complex redox reaction sequences.4  
Single electron transfer (SET) is the generation of a highly reactive intermediate via 
taking or giving one electron from or to a substrate.5 SET with a neutral organic molecule 
generates initially radical ions, while carbanions, radicals and carbocations are linked to each 
other directly via SET.5a, c, e SET at carbonyl compounds can occur either reductively or 
oxidatively. While reductive SET generates ketyl radical anions at the carbonyl group, 
oxidative SET acts at the α-position, affording either enol radical cations from neutral 
substrates or α-carbonyl radicals from enolates. Both are adequately suited to achieve α-
functionalisation. Some of the most common SET oxidants6 used in preparative organic 
chemistry and especially for carbonyl compounds are CuCl2, Cu(OAc)2, FeCl3,7 Fe(acac)3, 
Mn(OAc)3,8 CAN9 or ferrocenium hexafluorophosphate. The latter was established as an 
appropriate SET oxidant for the generation of α-carbonyl radicals from enolates,10 which is 
functional group tolerant and recyclable. 
The α-heterofunctionalisation of carbonyl compounds gives access to a multitude of 
building blocks.3a Among them, α-hydroxy carbonyl units are prominent motifs, which are 
common in biologically active natural compounds.11 Thanks to its coordinating properties, the 
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hydroxy group located proximal to the carbonyl functionality features the attribute of a 
directing functional group. Therefore an α-hydroxy carbonyl moiety can be considered as a 
“privileged synthon”.12 Currently a large number of oxidising reagents for the synthesis of α-
hydroxy carbonyl compounds from enolates and silyl enol ethers exist:13 Oxygen, peroxy 
reagents, hypervalent iodine reagents,14 metal oxides, N-sulfonyloxaziridines,13, 15 iodine, 
ferrocenium hexafluorophosphate or electrochemical oxidation. A large number of methods 
were developed for the enantioselective synthesis of α-hydroxy carbonyl compounds.3a, 15, 16 
The α-hydroxylation of β-dicarbonyl compounds with oxygen in the presence of catalytic 
amounts of CeIII-salts was described as an efficient method.17  Biocatalytic α-
oxyfunctionalisation reactions of carbonyl compounds by enzymatic methods were devised.18 
Enol ether and ketene acetal derivatives are adequate prochiral substrates for the synthesis of 
optically active α-hydroxy carbonyl compounds via the Sharpless dihydroxylation, the 
enantioselective oxidation by (salen)Mn(III) complexes19 or by Oxone® 
(2KHSO5·KHSO4·K2SO4) in the presence of fructose derivatives.20 The asymmetric oxidation 
of acyclic (Z)-enol phosphates with Jacobsen’s (salen)Mn(III) catalyst afforded α-hydroxy 
ketones with high enantioselectivity.21 Another new method is the enantioselective O-nitroso 
aldol reaction of silyl enol ethers.22 
 
Scheme 1.1 α-Oxygenation of esters with TEMPO 
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TEMPO-based α-oxygenation reactions of carbonyl compounds. The stable free radical 
TEMPO 1-2, which is one of the most common radical scavengers, is a convenient reagent to 
introduce oxygen in organic molecules.23 Jahn and Braslau developed the earliest method for 
the α-oxygenation of esters 1-1 with TEMPO 1-2 almost at the same time (Scheme 1.1).10a, 24 
This consists of generation of the enolate followed by SET oxidation triggered by 
ferrocenium hexafluorophosphate 1-310a or by CuCl224 to an α-carbonyl radical, which 
couples with 1-2. Hartmann and Jahn applied the method also to some amides, ketones and 
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nitriles.25 Products 1-4 were reductively deprotected with Zn/AcOH affording hydroxy esters 
1-5.10a, 26 Alternatively, catecholboron ketone enolates liberate α-carbonyl radicals upon 
homolytic substitution with 1-2 at boron giving tetramethylpiperidinyloxy-substituted borates. 
Trapping of the resulting free radical with 1-2 affords aromatic and cyclic α-
tetramethylpiperidinyloxy ketones.27 
 
Scheme 1.2 α-Oxygenation of ketones and malonates with oxoiminium salts 1-8 or 1-15 
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A different oxygenation of enolisable ketones like 1-6 or 1-7 was accomplished by 
stirring them with 2,2,6,6-tetramethyl-1-oxopiperidinium chloride 1-8a in acetonitrile 
(Scheme 1.2).28 The oxoammonium ion induced probably a single electron oxidation of the 
enol 1-11 to an enol radical cation, which was trapped by TEMPO 1-2 providing products 1-9 
or 1-12 via a free radical mechanism. Compound 1-9 underwent a thermal elimination of 
tetramethylpiperidine to 1,2-cyclohexanedione 1-10 in 75% yield. Similar α-oxygenations of 
1-6 or unsubstituted malonates 1-13 were accomplished by treatment of their enolates, such as 
1-14, with 2,2,6,6-tetramethyl-1-oxopiperidinium tetrafluoroborate 1-15.29a Enaminoesters 
were oxidised with 1-15 and the mechanism was studied by cyclovoltammetry.29b 
Organocatalytic oxygenations or aminations in the α-position of aldehydes and ketones 
are currently a tremendously fast developing methodology in organic synthesis.30 Both can be 
performed via the nucleophilic addition of an enol(ate) or enamine 1-17 to electrophilic 
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amination or oxygenation reagents (Scheme 1.3). Azodicarboxylate 1-18 is used widely as a 
nitrogen source, while nitrosobenzene 1-20 acts either as a nitrogen or as an oxygen source 
depending on the chosen catalyst affording products 1-21 or 1-22.16 These reactions can also 
be performed in a catalytic and enantioselective manner using Lewis acid or Lewis base 
catalysis.  
 
Scheme 1.3 Catalytic enantioselective α-amination and α-oxygenation of aldehydes and 
ketones 
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Organocatalytic α-hydroxylations of ketones using oxidants, such as iodosobenzene and 
trans-2-(p-methylphenylsulfonyl)-3-phenyloxaziridine, in the presence of L-proline or proline 
amines as catalysts were developed.31 The oxidation of 2-alkoxycarbonylindanone and other 
β-keto esters with cumyl hydroperoxide catalysed by chiral dihydroquinines is suitable for the 
direct introduction of hydroxy groups.32 Aldehydes and cyclic ketones were also hydroxylated 
with singlet molecular oxygen and excitation by UV light in the presence of 
tetraphenylporphyrin or L-proline in the presence of α-methylproline.33 Another 
organocatalytic oxygenation method is the asymmetric benzoyloxylation of aldehydes.34  
New organocatalytic approaches to the enantioselective α-oxygenation of aldehydes 1-
23 using TEMPO 1-2 as the oxygen source were developed by Sibi’s group (Scheme 1.4).35 
They used MacMillan’s imidazolidinone catalyst 1-24 and different iron-based SET reagents 
to generate the crucial radical 1-28. Based on the evidence, a radical-catalytic cycle (Single-
Occupied Molecular Orbital (SOMO)-catalysis) was proposed to operate. Initially formed 
enamine 1-26 was oxidised to radical cation intermediate 1-28, which was trapped by 1-2. 
The resulting iminium ion 1-29 was hydrolysed to product 1-25, releasing catalyst 1-24. A 
later study concluded that this transformation should proceed predominately via a closed shell 
addition of TEMPO-Fe+Cl2(dmf)3 complex 1-27 to the enamine 1-26.36 At present, the 
experimental evidence provided is not sufficient to distinguish closed shell and SOMO-
enamine activation mechanisms conclusively. 
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Scheme 1.4 Enantioselective α-oxygenation of aldehydes 1-23 with 1-2 
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Sibi’s methodology flourished recently and a number of asymmetric α-oxygenations of 
aldehydes by 1-2 using chiral pyrrolidine catalysts and anodic oxidation37 or resin-supported 
peptide catalysts in aqueous media and chemical oxidation were published.38 Maruoka et al. 
replaced the metal SET oxidant by benzoyl peroxide, which oxidises TEMPO 1-2 in situ to 
oxoammonium ion 1-15.39 Using different chiral pyrrolidines or binaphthyl-based secondary 
amines as catalysts, compounds of type 1-25 were synthesised with high enantioselectivities. 
Another new catalytic method for the synthesis of α-(2,2,6,6-tetramethylpiperidinyloxy) 
carbonyl compounds is the photocatalysed α-oxygenation of aromatic β-keto esters or 
aldehydes with TEMPO via irradiation with visible light in the presence of organic dyes.40  
Oxygenation by TEMPO 1-2 as a termination step in reaction sequences. Highly 
valuable and relatively new applications of TEMPO 1-2 are reaction sequences, which 
combine a free radical 5-exo cyclisation followed by trapping of the cyclised radical with 
TEMPO. Recently, syntheses of substituted pyrrolidines via an oxidative tandem anionic-
radical methodology were reported,4e, 41 which consists of conjugate addition of lithium N-
allylic amides to α,β-unsaturated esters, SET oxidation of the resulting enolate by 1-3, radical 
5-exo cyclisation and finally trapping of resulting cyclic radical with 1-2. N-Protected 4-
oxymethylpyrrolidine-3-carboxylates were obtained in moderate to good yields with exclusive 
2,3-trans selectivity and variable 3,4-diastereoselectivity. Aryl radicals generated from aryl 
iodides with Bu3SnH add intramolecularly in a 5-exo cyclisation mode to a double bond with 
 6 
subsequent TEMPO trapping. This method was used in the total synthesis of natural 
products.26a, 42 The carboaminohydroxylation of olefins with aryl diazonium salts, FeSO4 and 
TEMPO gave access to aromatic α-(2,2,6,6-tetramethylpiperidinyloxy) carboxylic acid 
derivatives by an aryl radical addition/oxygenation sequence.43 Recently, a highly 
stereoselective synthesis of 1,2,3-substituted indanes from 3-substituted indenes via a 
palladium-catalysed carboaminoxylation with arylboronic acids and TEMPO was 
developed.44 Cyclisations of α-substituted 4-pentenyl sulfonamides, which are catalysed by 
Cu(ET)2 or Cu(OTf)2 in the presence of Cs2CO3, followed by oxygenation with TEMPO 
afforded cyclised aminoxylated sulfonamides in good yields and high cis-
diastereoselectivity.45  
Several alkoxyamines, such as 1-16, served as precursors for thermal radical addition or 
cyclisation reactions, in which oxygenation by TEMPO 1-2 serves as the termination step. 
These methods are based on the persistent radical effect (PRE).23b, 46 This explains the 
selective formation of the radical cross-coupling product, when both a transient C-centred 
radical and a persistent radical are generated via a C-O bond homolysis from alkoxyamines at 
equal rates. The persistent radical TEMPO does not dimerise, while the transient C-centred 
undergoes in the very beginning some homocoupling or disproportionation reactions to a 
small extent, which led to a slightly increased concentration of the nitroxyl radical. Based on 
this concentration imbalance, the cross-coupling of the persistent and transient radical will 
occur selectively and any further self-termination of transient radicals does not compete 
anymore in the further course. The PRE was applied in thermal radical carboaminoxylation of 
alkenes, PRE-controlled malonate alkoxyamine additions and addition/cyclisation reactions of 
alkoxyamines with alkenes.23, 46a-c Alkoxyamines were also used as initiators and mediators 
for controlled (or living) radical polymerisations.23, 46d, 47 Nitroxide-mediated polymerisations 
(NMP) allow the preparation of polymers with defined molecular weight using the PRE. The 
reversible C-O bond homolysis generates a nitroxide persistent radical and a chain-growing 
polymer radical, which will be extended by monomer insertion and reversible trapping by the 
persistent nitroxide. 
TEMPO as an oxidant. Catalytic oxidations using the organocatalyst TEMPO and its 
derivatives alone or together with metal salts found numerous applications.48 Hydrogen atom 
abstraction by TEMPO 1-2 in allylic positions is difficult, it occurs only at high temperatures 
and using the substrate as the solvent.49 Allylic oxidations of substituted olefins with in situ 
from 1-2 generated oxoammonium salt 1-15 (TEMPO+BF4–) in aqueous acetonitrile giving 
α,β-unsaturated ketones was reported to be more efficient.50 The reaction occurred probably 
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via hydride abstraction and trapping of the generated allylic cation with water. Subsequent 
oxidation of the resulting allylic alcohol by the oxoammonium salt afforded the α,β-
unsaturated ketone. TEMPO 1-2 is able to abstract hydrogen atoms from phenols.51a-c The 
antioxidant properties of phenols were analysed using a chromophore-conjugated TEMPO 
derivative, which is nonfluorescent. The TEMPO-derivative becomes fluorescent upon 
reduction to the TEMPO-H derivative, allowing to determine the kinetics of the H-transfer 
process. Hydrogen abstraction from hydroxylamines51d or silanes51e also succeeds. A peculiar 
carbene-catalysed oxidation of aldehydes by TEMPO leading to 1-(Acyloxy)-2,2,6,6-
tetramethylpiperidines was reported by Studer.52  
TEMPO 1-2 oxidises organometallic compounds to carbon-centred radicals, which are 
subsequently trapped by a second equivalent of TEMPO affording alkyl alkoxyamines. 
Different alkyl metal compounds (lithium, magnesium, zirconium, copper, zinc) were 
oxidised with 2 equivalents of TEMPO giving the corresponding alkoxyamines.23, 53 Alkyl 
catecholboranes afforded alkoxyamines upon reaction with 1-2 similarly.54, 55 TEMPO was 
also employed as a terminal oxidant in transition metal-catalysed polar coupling reactions, 
such as copper-catalysed cross-coupling reactions of amines or phenols with arylboronic 
acids,56 rhodium-catalysed homocouplings of various alkenyl and arylboronic acids,57 
rhodium-catalysed cross-couplings of arylboronic acids with arenes and heteroarenes,58 or 
palladium-catalysed C-H arylations of 2-phenylpyridine with various boronic acids.59  
 
1,4-Dicarbonyl compounds are versatile building blocks for the synthesis of natural 
products, heterocycles and 1,4-diols. The nucleophilic substitution of α-halo ketones by 
enolates has been so far the most common synthetic approach to 1,4-diketones. This method 
had, however, a very limited scope. Recently C-C bond formation between the α-positions of 
two carbonyl compounds gained more interest. New efficient methods for the synthesis of 
unsymmetrical 1,4-diketones by such methods are the coupling of α-chloro ketones with tin 
ketone enolates catalysed by ZnCl260 or palladium-catalysed cross-couplings of substituted α-
chloro ketones with zinc ketone enolates for the construction of 2,3-diaryl-1,4-diketones.61 
Dimerisations of enolates allow the fastest assembly of 1,4-dicarbonyl compounds.62 
This process usually involves the oxidation of the enolate to α-carbonyl radicals via SET 
using salts of Cu(II), Ti(IV) and Fe(III), iodonium salts, molecular iodine as oxidants or 
electrolysis, followed by the coupling of these radicals (Scheme 1.5). The earliest experiments 
included oxidative dimerisations of t-butyl acetate and ketone enolates induced by Cu(II) 
salts, affording di-tert-butyl succinate and 1,4-diketones.63 The enolates of some cyclic 
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ketones underwent oxidative dimerisation with FeCl3 in 23-69% yield with low 
diastereoselectivity.64 p-Tolylbiphenyl-2,2’-ylenebismuth bis(trifluoromethanesulfonate) was 
used as an alternative oxidant for the oxidative dimerisations of ketones, esters and 
thioesters.65 The diastereoselectivity was not discussed. Recently a two-step one-pot method 
for the preparation of 1,4-dicarbonyl compounds was reported, which consist of a cerium-
catalysed C-C radical addition of styrene with 1,3-dicarbonyl compounds followed by 
Kornblum-De La Mare fragmentation.17b 
 
Scheme 1.5 Oxidative homocoupling of enolates 
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Simple diastereoselectivity was observed only sporadically in oxidative dimerisations. 
Titanium enolates of phenylacetate were oxidatively coupled in the presence of TiCl4 and 
Et3N. The highly selective formation of d,l-2,3-diphenylsuccinic acid dimethyl ester was 
attributed to the oxidation of Ti-bridged enolate dimers.66 This method is however limited to 
this substrate. Carboxylic acid dianions dimerised with a low meso/d,l diastereoselectivity on 
oxidation with iodine.67 The coupling of fatty acid methyl ester enolates induced by CuBr2 
occurred mostly unselectively.68 The oxidative coupling of the enolate of (1R)-(+)-verbenone 
was studied with CuCl2 and FeCl3.69 The regioselectivity was examined in this case. 
Asymmetric dimerisations were accomplished only for carboxylic acid derivatives, which 
were bound to chiral auxiliaries.70 A dimerisation of the enolate of Seebach’s proline-derived 
oxazolidinones with vicinal dihalides, and subsequent hydrolysis of the oxazolidine ring 
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afforded (R,R)-α,α’-biproline and meso-α,α’-biproline.71 Silyl ketene acetals were dimerised 
to substituted succinates using TiCl4 (61%) or FeCl3 (14%).72 A high d,l diastereoselectivity 
was achieved by Schmittel et al. for the intramolecular dimerisation of silicon bisenolates of 
propiophenone.73 The oxidative coupling was induced by [Fe(phen)3](PF6)3 or CAN. 
In the last decade, intermolecular couplings of different types of carbonyl compounds 
gained much interest. Thomson et al. employed the cross-coupling of unsymmetrical silyl bis-
enol ethers, induced by CAN, for the synthesis of 1,4-diketones derived from tetralone, 
indanone and cyclohexanone.74 Baran and coworkers studied the oxidative coupling of 
ketones with N-acyl oxazolidinones and oxindoles, using Fe(III) and Cu(II) salts.75 The 
enantioselective synthesis of α-substituted γ-keto aldehydes from α-substituted aldehydes and 
enol silanes was developed using an organocatalytic SOMO activation protocol.35b, 76 
Applications in total syntheses of natural products emerged both for homo- and hetero-
couplings of enolates. Some intramolecular oxidative dimerisations of ketone enolates with 
CuCl2 were applied in total syntheses of C16-Hexaquinacene and cerorubenic acid-III.77 The 
syntheses of the central ring of Lomaiviticin A78 and of (–)-Bursehernin79 were recently 
reported. 
The mechanism of oxidative homocouplings and heterocouplings was so far not 
elucidated in depth (Scheme 1.5, only homocouplings shown).62 Rathke proposed a radical-
radical coupling mechanism of 1-32 resulting from oxidation of enolate 1-31 (Path A) to the 
products d,l- and meso-1-34.63a Schmittel considered the stability of the M-O bond of high 
importance.73 The non-diastereoselective dimerisation of titanium bisenolates was depicted as 
an intermolecular process, which occurred via addition of the titanium radical cation 1-33 to 
the enolate 1-31 after Ti-O bond cleavage (Path B). A third possibility (Path C) is the 
interaction of the SOMO of the radical 1-32 with the HOMO of the enolate 1-31 in a formal 
radical addition.  
An important aspect is that the exact role of the metal oxidant in dimerisations is most 
often not known. Inner-sphere or outer-sphere oxidants may react differently and can lead to 
different diastereoselectivities.25 Jahn et al. introduced ferrocenium hexafluorophosphate 1-3 
as a versatile recyclable SET oxidant for the generation of α-carbonyl radicals from enolates 
(Scheme 1.6).10a, 25 They developed an efficient method for oxidative dimerisations of esters 
and propiophenone enolates, induced by 1-3. Moderate diastereoselectivity meso/d,l = 2:1 
were obtained for some esters. Propiophenone displayed high d,l/meso-diastereoselectivities 
of 10:1. The results were rationalised from a new perspective. On one hand a correlation 
between the enolate geometry80 and the stereochemistry of the major diastereomer was 
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observed. On the other, it was postulated that the reaction outcome was strongly determined 
by the mechanism of oxidation and enolate aggregation.81 Deprotonation of carbonyl 
compound 1-30 under different conditions generates enolate aggregates 1-35, in which the 
enolate unit may have (E)- or (Z)-geometry. The oxidation with ferrocenium 
hexafluorophosphate 1-3 occurred probably via outer-sphere electron transfer, leading to an 
α-carbonyl radical, which remains bound in the aggregate 1-36. Radical addition giving 1-37, 
followed by a second SET, leads to the products 1-34 with different diastereoselectivities. The 
oxidation of 1-35 with CuCl2 occurred in contrast probably via an inner-sphere electron 
transfer. Transmetallation of Li with Cu lead to the monomeric enolate 1-38, which 
homolysed to α-carbonyl radical 1-32. Radical coupling of two 1-32 units afforded 
compounds 1-34 in a 1:1 meso:d,l ratio. 
 
Scheme 1.6 Dimerisation of carbonyl compounds 
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5-exo Radical cyclisations based on SET oxidations of enolates 
 
Radical cyclisations are intramolecular kinetically controlled radical additions to 
multiple bonds.5a, 6, 82 They are a fundamental method for the synthesis of cyclic organic 
compounds. Their advantages consist of high predictability and functional group tolerance. 
The most popular are 5-hexenyl radical cyclisations. The stereoselectivity of 5-exo radical 
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cyclisations can be predicted and rationalised by means of the Beckwith-Houk transition state 
model.83 
 
Scheme 1.7 Oxidative 5-exo-cyclisation of substituted malonates 1-39 
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Oxidative 5-exo cyclisation of substituted malonate enolates10b, c, 84 marked the 
beginning of a new methodology, which combines anionic and radical processes in reaction 
sequences with intermediates of different oxidation states (Scheme 1.7). Enolates 1-40, 
generated from 1-39 by deprotonation with LDA, proved to be adequate precursors for 
radicals 1-41. SET oxidation of 1-40 using ferrocenium hexafluorophosphate 1-3 afforded α-
carbonyl radicals 1-41, which underwent a 5-exo radical cyclisation. The cyclic radicals 1-42 
were further oxidised to carbocations 1-43 if R = Ph (Path A), which lactonised, giving 
products 1-44 in 64% yield. In the presence of TEMPO 1-2 (Path B), radicals 1-42 (R = H) 
were trapped to oxygenated product 1-45 in 87% yield. Thus malonate enolates are 
convenient starting materials for radical reactions and reaction sequences, which are induced 
by the SET oxidant 1-3. 
 
Total syntheses of lipid metabolites 
 
Based on the oxidative cyclisation of substituted malonates, model studies were 
performed on oxidative radical cyclisations of 1-46 (Scheme 1.8).85 Hydroxy ester 1-46 was 
twofold deprotonated and the resulting dianion underwent an oxidative radical cyclisation 
induced by 1-3, which was terminated by trapping with 1-2. This cascade reaction afforded 
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cyclopentanes 1-47 and 1-48 as main products, accompanied by small amounts of 1-49 and 
other diastereomers. The advantage is on one hand that it allowed access to the cyclopentane 
core structures 1-47 with isoprostane relative ring configuration (2,6-cis) and 1-48 with 
prostaglandin ring configuration (2,6-trans), respectively. On the other hand, trapping by 1-2 
allowed the introduction of a protected oxygen functionality in the distal 8-position in both 
ring diastereomers. 
 
Scheme 1.8 5-exo-Radical cyclisation of hydroxy ester 1-46 
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The further development of similar radical cyclisations would provide the basis for the 
total synthesis of functionalised cyclopentanes, such as prostaglandins, isoprostanes and 
neuroprostanes, which are significant metabolites formed in vivo in humans from 
polyunsaturated fatty acids.86 Similar metabolites found in plants are the phytoprostanes or 
jasmonic acid. 
Arachidonic acid 1-50 is one of the most important polyunsaturated fatty acid. It occurs 
to a large extent as a component of the cell membrane and is the substrate for a variety of 
biologically active natural products.87 The enzymatic transformation of free 1-50 gives 
prostaglandins, thromboxanes and leukotrienes (Figure 1.1).88 They are local hormones, 
which are biosynthesised on demand and quickly metabolised after fulfilling their functions. 
The biosynthesis of enantiomerically pure prostaglandins (PG) 1-51 consists of exclusive 
hydrogen abstraction at 13-position, followed by a free radical cascade of peroxidation, 
double 5-exo cyclisation, oxygenation and final reduction inside the cyclooxygenase enzymes. 
The non-enzymatic autoxidative metabolism of membrane- or low-density lipoprotein (LDL)-
bound arachidonic acid 1-52 leads to the formation of a large number of regioisomeric 
oxygenated metabolites including the isoprostanes (IsoP) 1-53, which are diastereomers of 
PG.86, 89 The IsoP biosynthesis starts also with hydrogen abstraction, this time at any one of 
the three bisallylic positions induced by reactive oxygen species (ROS). A similar free radical 
cascade follows, leading to formation of a racemic mixture of IsoP regioisomers 1-53. 
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Figure 1.1 Schematic depiction of the formation of PGF2α 1-51 from free arachidonic acid 1-
50, and of 15-F2t-IsoP 1-53 from membrane-bound arachidonic acid 1-52 within the cell (only 
one regio- and stereoisomer of IsoP shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
The most significant structural difference between PG and IsoP is the spatial 
arrangement of the alkyl side chains. In PG the alkyl chains at the cyclopentane ring are 
oriented trans to each other, enforced by the spatial constraints of the enzyme. The 
cyclopentane ring of IsoP is formed by a free radical 5-exo cyclisation, which proceeds 
kinetically controlled via a Beckwith-Houk transition state. Therefore the alkyl chains in 
isoprostanes are oriented cis to each other. 
 
Figure 1.2 The 15-series of different ring-substituted isoprostanes 
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Initial hydrogen abstraction at 7-position gives the 5-IsoP series, at 10-position the 8-
IsoP and 12-IsoP series, while hydrogen abstraction at the 13-position leads to the 15-IsoP 
series. The ring substitution patterns can be different within each series (Figure 1.2). For 
example in the presence of high levels of reducing agents in the cell, the formation of 15-F2t-
IsoP 1-54 is preferred. However, formation of 15-E2-IsoP 1-55, 15-D2-IsoP 1-56, 15-A2-IsoP 
1-57 and 15-J2-IsoP 1-58 dominates when the cell lacks sufficient amounts of reducing 
equivalents. 
Prostaglandins regulate a multitude of functions: They stimulate inflammatory reactions 
and are pain mediators, regulate the blood pressure, control the transportation of ions through 
the cell membrane, modulate the synaptic transmission or induce sleep. Isoprostanes caught 
the attention as Robert and Morrow discovered in 1990 that these compounds were produced 
in vivo in considerably larger amounts than prostaglandins. Since then an intense research 
effort was made to unravel the biological functions of these metabolites.86, 89b A large variety 
of health disorders like cardiovascular, renal, pulmonary, liver and neurological diseases are 
correlated with oxidative stress, which increases the levels of F2-IsoP. Oxidative stress occurs 
when the concentration of ROS increases due to imbalances of the redox state of cells or 
tissues. This induces a cascade of oxidative and free radical damage of all susceptible 
molecules, especially lipids. Thanks to their stability F2t-IsoP are used today as the gold 
standard for quantifying oxidative stress. There is a confirmed relationship between F2-IsoP 
levels and the severity of heart failure. Oxidative stress is involved in the early development 
of atherosclerosis. Different exogenous factors like smoking, drug treatment, alcohol 
consumption, and dietary antioxidant supplementation increase the F2-IsoP concentrations in 
blood. F2-IsoP levels are positively correlated to these factors and therefore quantification of 
F2-IsoP represents a physiological marker of oxidative stress. They represent a tool for the 
assessment of oxidative stress in antioxidant therapies. The quantification of F2-IsoP 
metabolites in urine is a non-invasive method to assess the oxidative stress in vivo.  
To study their biological functions and to further develop new methods for diagnostic 
applications, IsoP must be available in sufficient amounts. A large number of total syntheses 
of cyclic PUFA metabolites was published, but they concern only a few members from the 
vast number of IsoP, such as 15-F2t-IsoP. The known total syntheses were recently 
comprehensively reviewed by Jahn et al.86a and classified in three categories based on the 
employed strategies: Biomimetic approaches (cyclisation of full-chain precursors), chain 
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attachments to cyclopentane cores and cyclisation reactions followed by chain attachment. A 
few total syntheses published more recently are highlighted here. 
Taber et al. prepared four enantiomerically pure 13-F4t-NeuroP diastereomers by a new 
biomimetic methodology, based on a highly diastereoselective thermal intramolecular ene 
cyclisation, which gives potentially access to any isoprostane or neuroprostane.90 
Starting with an enantioselective pure diol derived from Corey’s lactone, Rokach et al. 
synthesised 5-epi-8,12-iso-IsoP F3α and 8,12-iso-IsoP F3α, derived either from autoxidation of 
eicosapentaenoic acid or from β-oxidation of DHA-derived neuroprostanes.91 Using synthetic 
probes, they discovered both molecules in human urine. The quantification of these IsoPs may 
be useful to assess the oxidative damage of EPA- and DHA-containing phospholipids. A 
similar strategy was used by Helmchen et al. who employed a diol derived from Corey’s 
lactone, enantiomeric to Rokach’s diol as starting material for total syntheses of ent-5-F2c-
IsoP and 5-epi-ent-5-F2c-IsoP.92 5-F2c-IsoP belongs to the most often found IsoP in human 
urine. The key step consists of introduction of the side chains by an (E)-selective Horner-
Wadsworth-Emmons reaction. 
Jung et al. prepared 1-palmitoyl-2-(5,6)-epoxyisoprostane E2-sn-glycero-3-
phosphocholine (PEIPC) efficiently from 2-bromo-4-(arylmethoxy)cyclopentenone.93 This 
E2-IsoP derivative is especially active in inflammatory responses connected to atherosclerosis.  
Applying regioselective intermolecular Pauson-Khand reactions of silyloxymethyl 
alkynes, Riera and coworkers synthesised protected (hydroxymethyl)cyclopentenones with 
the attached α-chain, which were transformed to the corresponding aldehydes.94 Subsequent 
Julia olefinations with the chiral ω-chains provided phytoprostane B1 type I and prostaglandin 
B1. A new short synthesis of enantiopure phytoprostanes B1 commencing with a 
(dimethoxyphosphoryl)methyl-substituted cyclopentenone was accomplished by 
Mikolajczyk.95 The side chains were attached by an alkylation and a Horner reaction. Durand 
et al. accomplished recently syntheses of the enantiopure diastereomers of phytoprostanes E1 
type II and 15-E2-isoprostanes.96 The enantiopure precursor 4-hydroxy-2-cyclopentenone was 
obtained by regioselective fragmentation of a furan derivative, followed by subsequent 
cyclisation and enzymatic kinetic resolution. The side chains were attached by Horner-
Wadsworth-Emmons and Wittig reactions, respectively. 
Eight enantiomerically pure 5-F2-IsoPs were prepared in 10 steps using a 
stereodivergent route from a functionalised bicyclo[3.2.0]heptene by Snapper et al.97 The key 
feature of the strategy was its ring-opening cross-metathesis with ethylene, followed by a 
cross-metathesis of the resulting diene with an enone. 
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Galano and Durand developed a conceptually new stereocontrolled strategy, which is 
based on a α,β-epoxy ketone prepared from a hydroxy bicyclo[3.3.0]octene by stereoselective 
epoxidation.98 The side chains were introduced via ozonolysis. New total syntheses of 15-F2t-
IsoP, 15-epi-15-F2t-IsoP, 15-epi-15-E2-IsoP and [D4]-labelled F4t-neuroprostane as well as the 
first synthesis of 15-D2t-IsoP were accomplished. 
 
Figure 1.3 Potential metabolites of 15-E2-IsoP 1-55 
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Although a large number of total syntheses of 15-F2t-IsoP 1-54 and a few of 15-E2-IsoP 
1-55 exist, a need for more efficient strategies offering shorter and higher-yielding syntheses 
to deliver sufficient amounts of isoprostanes is obvious. The metabolism of most IsoPs except 
15-F2t-IsoP 1-54 is not known. Approaches to potential metabolites like racemic 1-59 and 1-
60 will help to unravel the metabolic pathways of 15-E2-IsoP 1-55 (Figure 1.3). Syntheses of 
1-59 and 1-60 were so far not reported. 
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2. Objectives 
 
This work provides a significant contribution concerning both the development of 
useful synthetic methodologies and their application to new total syntheses of three natural 
products, 15-F2t-IsoP 1-54, 13,14-dihydro-15-oxo-E2-IsoP 1-59 and its 8-epimer 1-60. 
 
Scheme 2.1 Radical α-aminooxygenation and α-amination of carbonyl compounds 2-1 
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New methodology for the synthesis of α-hydroxy carbonyl compounds, 
monoprotected 1,2-diols, protected β-amino alcohols and 1,4-dicarbonyl compounds will be 
developed based on oxidative reactions of enolates 2-2 generated by deprotonation of 
carbonyl compounds 2-1 (Scheme 2.1). The generation of α-carbonyl radicals 2-3 from 
enolates 2-2 by single electron oxidation induced by 1-3 will be central. The feasibility of 
heterocouplings of 2-3 with persistent radicals, their homocouplings, and radical cyclisations 
in the presence of persistent radicals will be explored. 
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Radical α-heterofunctionalisation of carbonyl compounds 2-1 will be studied as 
follows:  
A) α-Aminooxygenation by coupling of 2-3 with the persistent radical TEMPO 1-2 will 
afford compounds of type 2-4. This reaction should become a general method for the 
synthesis of α-aminoxy carbonyl compounds. 
B) α-Aminooxygenation of α,β-unsaturated carbonyl compounds will be investigated to learn 
about the regioselectivity of radical coupling providing α-aminooxygenation products 2-5 
and/or γ-aminoxy derivatives 2-6. 
C) Compounds of type 2-4 can be seen as protected alcohols. Scope and limitations of 
reductive deprotection to α-hydroxy carbonyl compounds 2-7 will be studied. 
D) Direct oxygenation of enolates 2-2 or α-carbonyl radicals 2-3 with O2 will be investigated. 
E) Reductions of α-aminoxy carbonyl compounds 2-4 by hydride reagents should enable the 
access to monoprotected diols 2-8.  
F) New radical amination reactions, such as heterocoupling reactions of α-carbonyl radical 2-
3 with nitrogen-centred persistent radicals like 1,3,5-verdazyl 2-9, will be explored. Moreover 
the reactivity of 2-9 towards organometallic compounds will be studied. 
 
Scheme 2.2 Oxidative dimerisations of carbonyl compounds 2-1 
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α-Carbonyl radicals 2-3 can also undergo homocoupling reactions giving a direct access 
to 1,4-dicarbonyl compounds d,l-2-12 and/or meso-2-12 (Scheme 2.2). Since dimerisation 
reactions reported so far were applied only to a few types of substrates and lack generality, it 
is necessary to develop new, efficient and widely applicable methodologies, which facilitate 
access to 1,4-dicarbonyl compounds 2-12 from a large number of precursors containing a 
carbonyl group. There is a wide field of exploration for different classes of carbonyl 
derivatives. Not only the scope, but also the mechanism deserves detailed investigations.  
Since aggregates 2-11 and the enolate geometry should influence the course of the 
dimerisation, mechanistic studies should reveal whether the reactions occur by radical 
addition or homocoupling pathways. The insights gained should be utilised to achieve 
diastereoselective dimerisations without attaching chiral or bulky auxiliary groups. 
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Total syntheses of 15-F2t-isoprostane 1-54 and 13,14-dihydro-15-oxo-E2-isoprostane 1-59 
From the multitude of existing isoprostanes, 15-F2t-isoprostane 1-54 is the isomer 
most often synthesised and biologically most thoroughly studied. The development of a new 
synthetic strategy, which is shorter, more efficient and also applicable to other isoprostanes 
would be useful for further biological investigations. By virtue of its stability 15-F2t-IsoP 1-54 
is a basic target for testing new methodology.  
 
Figure 2.1 IsoP target molecules 1-54, 1-59 and 1-60 
O
HO
COOH
O
13,14-Dihydro-15-oxo-PG E2 1-60
HO
HO
COOH
OH
O
HO
COOH
O
15-F2t-IsoP 1-54 13,14-Dihydro-15-oxo-E2-IsoP 1-59
8
12
 
 
In contrast, the metabolism of most isoprostanes except F2-IsoP is unknown. This 
applies also to 15-E2-IsoP 1-55. The metabolism of PGE2 is in the first step an oxidation of 
the hydroxy group in 15-position to an enone, and the second step is the reduction of the 
13,14-double bond to a single bond. Assuming that E2-IsoP undergoes possibly similar 
processes, derivative 1-59 and 1-60 maybe important metabolites and their preparation will 
help to identify its key secondary metabolites and allow the study of their biological activities. 
Since nature is offering only minute amounts, there is a great need to find ways to produce 
reference compounds. 
The objective of this work is the development of new, short and efficient total 
syntheses of 15-F2t-IsoP 1-54 and of 13,14-dihydro-15-oxo-E2-IsoP 1-59, and respectively 
13,14-dihydro-15-oxo-PG E2 1-60. The investigations will concentrate on diastereoselective 
syntheses, since the natural products are racemic. However, studies on the synthesis of 
asymmetric cyclisation precursors will also be performed. The IsoP (8,12-cis-) and PG (8,12-
trans-) cyclopentane cores should be synthesised by a biomimetic radical cyclisation. The 
control of diastereoselectivity in the radical cyclisation must be accurately investigated. The 
total synthesis aims at high modularity to facilitate the adjustment of the desired substitution 
pattern of the ring and side chains. The synthetic steps and their order need to be optimised to 
achieve short and efficient syntheses. This total synthesis is intended as a blueprint, which can 
be used later for the synthesis of other IsoP, PG, phyto- or neuroprostanes. 
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3. Oxidative hetero- and homocoupling reactions of enolates: A new method for the 
synthesis of α-hydroxy carbonyl compounds, 1,2-diols, β-amino alcohols, derivatives of 
unnatural α-amino acids and 1,4-dicarbonyl compounds 
 
3.1 α-Oxygenations of carbonyl compounds by free radical TEMPO 
 
3.1.1 α-Oxygenation of esters 
Linear ethyl pentanoate 3-1a was chosen for a more detailed investigation of the 
competing coupling of radicals 2-3 with 1-2 versus homocoupling leading to dimers 2-12 (cf. 
Schemes 2.1, 2.2).  
 
Scheme 3.1 α-Oxygenation of esters 3-1a-c 
LDA, TEMPO 1-2,
FeCp2PF6 1-3
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Table 3.1 α-Oxygenation of esters  
Entry Substrate Product LDA 
(equiv.) 
Additive 
(equiv.) 
3-2 (%) 3-3 (%) 
(meso/d,l)  
1  3-1a 1.3 HMPA (6) 3-2a 64 20 (1:1.5) 
2  3-1a OEt
O
Pr
OTMP  
1.3 LiCl (6) 3-2a 87 4 (1:0) 
3  3-1ba 2.3 LiCl (4.7) 3-2b 77b - 
4 3-1b 2.15 HMPA (6) 3-2b 66c - 
5  3-1b 2.15 - 3-2b 65d - 
6  3-1b 
COOMe
MeOOC
OH
OTMP  
2.5 - 3-2b 94e - 
7 3-1c 
O O
OTMP
 
1.3 LiCl (6) 3-2c 75 - 
a) Deprotonation with 2.3 equiv. LDA. b) syn:anti 1:1.4. c) syn:anti 1:2; d) syn:anti 1:1.8. e) 
Deprotonation 1 h at –78 - –50 °C. syn:anti 1:2.2. 
 
Deprotonation of 3-1a with LDA, followed by oxidation with 1-3 and trapping with 1-2 
in the presence of 6 equivalents of HMPA gave 3-2a in 64% yield (Scheme 3.1, Table 3.1, 
entry 1). Dimer 3-3a formed in 20% yield with a 1:1.5 meso:d,l diastereoselectivity. In 
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contrast, the α-oxygenation was very efficient in the presence of LiCl giving 3-2a in 87% 
yield and only 4% of meso-3-3a (entry 2). The α-oxygenation of ester 3-1b with a chiral 
centre in β-position occurred also efficiently in 65-77% yields (entries 3-5). Dimer formation 
was not observed. Product 3-2b was isolated in excellent yields of 94%, when a somewhat 
larger excess of LDA was used and the deprotonation was performed for longer time (entry 
6). The α-oxygenation of 3-1b proceeded with low diastereoselectivity. The configuration of 
the syn- and anti-diastereomers was assigned by comparison of the NMR data with those of 
the derived known tartrates (vide infra). Butyrolactone 3-1c gave the trapping product 3-2c in 
75% yield (entry 7). No dimer 3-3c was detected. 
 
Table 3.2 Significant NMR data of compounds 3-2a-c 
 3-2a syn-3-2b anti-3-2b 3-2c 
 δ (ppm), multiplicity 
CHON 4.14, dd 4.65, s 4.81, s 4.71, dd 
CHON 85.5, d 83.6, d 85.8, d 80.3 d 
 
The structural assignment of 3-2a-c is based on their NMR data (Table 3.2). The α-
proton absorbs at 4.14-4.81 ppm in the 1H NMR spectra. The α-carbon appears as a doublet at 
80.3-85.8 ppm in the 13C NMR spectra. 
 
3.1.2 α-Oxygenation of nitriles and amides 
Nitriles and amides proved to be suitable substrates for α-oxygenation with TEMPO 
1-2 (Scheme 3.2, Table 3.3). Phenylacetonitrile 3-4a, octonitrile 3-4b and 3-methyl-3-
hydroxy butyronitrile 3-4c formed the corresponding α-(tetramethylpiperidinyloxy)nitriles 3-
5a-c in high yields (entries 1-5). The additive LiCl had no influence on the efficiency (entries 
1, 3 versus 2, 4, 5). Generally, dimerisation did not take place. The linear tertiary amides 3-4d 
and 3-4e underwent α-oxygenation with TEMPO in high yields in the presence or absence of 
LiCl (entries 6, 7). In some experiments, besides 3-4d small amounts (maximal 5%) of the 
dimer of 3-4d were isolated. Branched amides like N,N-dimethylisobutyramide 3-4f or N,N-
diisopropylisobutyramide 3-4g are hindered at the α-carbonyl position. The α-carbonyl 
radical was probably generated  since 1-3 was consumed while it was added to the enolate 
solution, indicating oxidation of the enolate. Nonetheless, 3-4f gave the α-
(tetramethylpiperidinyloxy)amide 3-5f in low 5-13% yield (entries 8, 9), while the more 
sterically hindered 3-4g did not react at all and the substrate was recovered in 70% yield. 
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N,N,N’,N’-tetramethylglutardiamide 3-4h was subjected to twofold deprotonation and 
oxidation/trapping with TEMPO 1-2 under similar conditions. Product 3-5h was isolated in 
low yields (entries 11, 12). The diastereoselectivity amounted to a 4:1 d,l/meso ratio. The 
isomer meso-3-5h has a plane of symmetry, which is reflected in its NMR spectra and 
allowed the assignment of the diastereomers. 
 
Scheme 3.2 α-Oxygenation of amides and nitriles 
Et2NOC CONEt2LDA, TEMPO 1-2, 
FeCp2PF6 1-3
 THF (LiCl), !78 °C
EWG
3-4a-h
EWG = CN, CONR2
R
1
R
2
R
1
EWG
O
N
R
2
3-5a-h
+
C3H7H7C3
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Table 3.3 α-Oxygenation of amides and nitriles 
Entry Substrate Product 3-5a-h LiCl (equiv.) 3-5 (%) 
1 - 3-5a 93 
2 
3-4a Ph CN
OTMP  4.7 3-5a 73 
3 - 3-5b 78 
4 
3-4b H13C6 CN
OTMP  4.7 3-5b 92 
5a 3-4c 
CN
OH
OTMP  
6 3-5c 99 
6b 3-4d 
OTMP
CONEt2
 
- 3-5d 94 
7 3-4e CONBn2
OTMP  
6 3-5e 74 
8c 4.7 3-5f 5 
9 
3-4f CONMe2
OTMP  - 3-5f 13 
10d 3-4g CONiPr2
OTMP  
6 - 
11e,f 4.7 3-5h 34 
12e,f 
3-4h 
Me2NOC
TMPO
CONMe2
OTMP
 6 3-5h 28 
a) Deprotonation with 2.3 equiv. LDA at –78 - –50 °C for 35 min. b) In some experiments small 
amounts (maximum 5%) of the dimer A were isolated. c) Deprotonation time 1 h 15 min. A very polar 
material, not assignable, which contained an isobutyramide unit, was the major product. d) 3-4g was 
recovered in 70% yield. e) Double deprotonation with 2.3 equiv. LDA at –78 - –65 °C for 0.5 h. f) 
d,l/meso 4:1. 
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Optically pure N-Boc-pyroglutamate 3-4i was an interesting substrate whose 
stereocentre may induce a diastereoselective α-oxygenation (Scheme 3.3). An important issue 
was the retention of configuration at the chiral centre without loss of enantiopurity.99 In earlier 
experiments,25 deprotonation of 3-4i with 1.3 equivalents of LiHMDS followed by oxidation 
with 1-3 in the presence of 1-2 gave (2S,4R)-3-5i with 78% ee and (2S,4S)-3-5i with 81% ee 
in 61% combined yield as a separable 1:1.5 diastereomeric mixture. To improve this result, 
the amount of base was reduced. Experiments with 1.05 equivalents of LiHMDS furnished 
(2S,4R)-3-5i and (2S,4S)-3-5i in 70% yield with a 1:1.2 diastereomeric ratio. The products 
were enantiopure as shown by HPLC measurements using a chiral DAICEL-OD column. 
 
Scheme 3.3 Oxygenation of Boc-protected ethyl (S)-2-pyrrolidone-5-carboxylate 
1) 1.05 equiv. LiHMDS
2) TEMPO 1-2
3) FeCp2PF6 1-3
THF (LiCl), !78 °C
N
Boc
O CO2Et
N
Boc
O CO2Et N
Boc
O CO2Et
O O
N N
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Table 3.4 Significant NMR data of α-(tetramethylpiperidinyloxy) nitriles 3-5a-c 
 3-5a 3-5b 3-5c 
 δ (ppm), multiplicity 
CHON 5.50, s 4.52, dd 4.59, s 
CHON 76.7, d 74.3, d 80.0, d 
 
In compounds 3-5a-c the carbon atom bearing the TMP-group displays a doublet at 
74.3-80.0 ppm (Table 3.4). The corresponding proton gives a singlet at 5.50 and 4.59 ppm in 
3-5a and 3-5c, respectively. In 3-5b the same proton gives a dd at 4.52 ppm. 
 
Table 3.5 Significant NMR data of products 3-5d-i 
 3-5d 3-5e 3-5f d,l-3-5h meso-3-5h (2S,4R)-3-5i (2S,4S)-3-5i 
 δ (ppm), multiplicity 
CHON 4.41, dd 4.59, m - 4.72, dd 4.32, dd 4.69, dd 4.55, dd 
CHON 81.3, d 81.4, d 83.5, d 79.3, d 79.1, d 81.4, d 81.9, d 
 
The characteristic signals of the carbon atom bearing the TMP-group are presented in 
Table 3.5, together with the corresponding proton resonance. 
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3.1.3 α-Oxygenation of acid 3-6 
The double deprotonation of heptanoic acid 3-6 with 2.5 equivalents of LDA generated 
the enediolate, which was subsequently oxidised and trapped by 1-2 (Scheme 3.4, Table 3.6, 
entry 1). Product 3-7 was obtained in a low yield of 33%. It was accompanied by 27% of 
dimer 3-8 as a 1:1 diastereomeric mixture, 6% of disproportionation product 3-9 and 25% of 
unchanged substrate 3-6. The yield did not improve, when the carboxylic acid was 
deprotonated by 1.5 equivalents LDA followed by addition of another equivalent of BuLi. 
Oxygenation product 3-7 was isolated in 37% yield. Dimer 3-8 was not detected, but the 
overall mass balance was low (entry 2). Experiments in the presence of additives as well as 
longer deprotonation time at higher temperature gave similar results (entries 3, 4). The α-
oxygenation of the enediolate generated by deprotonation with LiNEt2100 proved to be more 
efficient affording product 3-7 in an improved 51% yield (entry 5). Formation of dimer 3-8 
and disproportionation product 3-9 could not be further suppressed. 
 
Scheme 3.4 α-Oxygenation of heptanoic acid 3-6 
1) 2.5 equiv. base
2) TEMPO 1-2
3) FeCp2PF6 1-3
THF, !78 °C
H11C5 COOH
H11C5 COOH
O
N
H11C5
COOH
C5H11
HOOC
+ +
COOH
H9C4
3-6 3-7 meso-3-8 and d,l-3-8 3-9  
 
Table 3.6 Conditions of α-oxygenation of heptanoic acid 3-6 
Entry Base (equiv.)a Additives 
(equiv.) 
3-7 3-8 
(meso/d,l) 
3-9 3-6 
1 LDA (2.5) - 33 27 (1:1) 6 25 
2 LDA (1.5) 
BuLi (1.0) 
- 37 - trace trace 
3 LDA (2.5) LiCl (4.7) 
HMPA (6) 
38 17 (1:1) 8 19 
4b LDA (2.5) LiCl (4.7) 32 7 (1:0) 4 8 
5c LiNEt2 (2.5) LiCl (4.7) 51 14 (1:0) 9 22 
6b LiNEt2 (2.5) LiCl (4.7) 33 7 (1:0) 6 13 
7 LiNEt2 (2.5) LiCl (4.7) 
HMPA (6) 
24 
(impure) 
- trace trace 
a) If not specified, the deprotonation was performed at −78 - −35 °C for 1 h. b) Deprotonation at −78 
°C for 10 min, then at r.t. for 2.5 h. c) Deprotonation for 10 min at −78 °C, then at 0 °C for 1 h. 
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Longer deprotonation time at higher temperature had a negative influence on the 
efficiency of the oxygenation (entry 6), while the use of HMPA as an additive led to the 
formation of complex mixtures (entry 7). 
 
3.1.4 α-Oxygenation of ketones 
Various ketones were investigated in α-oxygenation reactions with TEMPO 1-2 
(Scheme 3.5). Aromatic ketones behaved similarly as esters. Dimers 3-12 were formed to a 
rather large extent in competition to desired 3-11 (Table 3.7). Propiophenone 3-10a yielded 3-
11a in only 30% yield (entry 1). Major product was dimer 3-12a, which was isolated in 59% 
yield with a high 10.5:1 d,l/meso diastereoselectivity. The competing dimerisation was very 
unusual in the presence of excess 1-2. The cross-coupling of 2-3 with radical 1-2 should 
prevail (cf. Scheme 2.1).46 The high diastereoselectivity of the formation of dimers 3-12a was 
very surprising. The selectivity for formation of 3-11a improved to 52% yield in the presence 
of HMPA (entry 2). Nonetheless dimerisation occurred in 47% yield. The d,l/meso ratio of 
6:1 was however lower. When LiCl was used as additive, α-oxygenation product 3-11a was 
obtained in 78% yield (entry 3), while dimer 3-12a was isolated in 21% yield with a 5:1 
d,l/meso ratio. The same pattern was observed for butyrophenone 3-10b, which afforded 3-
11b in 38% yield in the absence of additives (entry 4). Dimer 3-12b was isolated in 55% yield 
with a 45:1 d,l/meso ratio. In the presence of LiCl, the oxygenated product 3-11b and dimer 
d,l-3-12b were isolated in 70% and 30% yield, respectively (entry 5). The α-oxygenated 
product 3-11c resulting from isobutyrophenone 3-10c was obtained in low yield probably due 
to steric hindrance, similar to isobutyramides 3-4f or 3-4g (entry 6). The oxygenation method 
is on the other hand well suited for aliphatic acyclic and cyclic ketones, which gave 
oxygenated products 3-11d-3-11g in high yields (entries 7-12). LiCl did not modify the 
reaction course significantly. Dimers 3-12 were rarely isolated and if so only in small 
amounts (entry 9). 
 
Scheme 3.5 α-Oxygenation of ketones 
1) 1.3 equiv. LDA
2) TEMPO 1-2
3) FeCp2PF6 1-3
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Table 3.7 α-Oxygenation of ketones 3-10 
Entry Substrate Product Additive 
(equiv.) 
3-11a-h (%) 3-12a-h (%) 
(d,l/meso) 
1 - 3-11a 30 3-12a 59 (10.5:1) 
2 HMPA (6) 3-11a 52 3-12a 47 (6:1) 
3 
3-10a 
Ph
O
OTMP  LiCl (4.7) 3-11a 78 3-12a 21 (5:1) 
4 - 3-11b 38 3-12b 55 (45:1) 
5 
3-10b 
Ph
O
OTMP  
LiCl (4.7) 3-11b 70 3-12b 30 (1:0) 
6a 3-10c 
Ph
O
OTMP  
- 3-11c 18 - 
7 3-10d O
OTMP  
- 3-11d 79 - 
8 3-10e 
tBu
O
OTMP  
- 3-11e 94 - 
9 - 3-11f 85 3-12f 9 (1:2.5) 
10 LiCl (4.7) 3-11f 77 - 
11 
3-10f 
O
OTMP  
HMPA (6) 3-11f 49  
12 3-10g 
O
OTMP  
LiCl (4.7) 3-11g 87 - 
13 - 3-11h 85b  3-12h 2 (exo,exo) 
14 
3-10h 
O
OTMP
 
LiCl (4.7) 3-11h 95c  - 
a) 62% of substrate was recovered. b) exo/endo 1:1.1. c) exo/endo 1.1:1. 
 
The α-oxygenation of chiral (R)-camphor 3-10h proceeded in high yields (entries 13, 
14). Surprisingly and in contrast to polar oxygenations,101 oxygenation by TEMPO occurred 
from both of the radical faces yielding diastereomers exo-3-11h and endo-3-11h in a 1:1 ratio. 
The yields were also excellent in the presence of LiCl (entry 14). 
Aliphatic linear unsymmetrical ketones 3-10i-k were an interesting substrate class, since 
both α-carbonyl positions can be deprotonated and subsequently oxygenated (Scheme 3.6). 
Deprotonation of cyclopropyl methyl ketone 3-10i for 20 minutes followed by oxidation in 
the presence of TEMPO 1-2 gave only 4% of pure TEMPO trapping product 3-11i with 
complete regioselectivity (Table 3.8, entry 1). Oxygenated 3-13i formed by an aldol addition 
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of the TEMPO adduct 3-11i with unreacted enolate of 3-10i. The major product was 3-13i 
isolated in 50% yield. Dimers 3-12i and 3-12’i were isolated in 20% and 22% yield, 
respectively. The product distribution changed when the deprotonation time was reduced to 
10 minutes and LiCl was used as an additive (entry 2). The yields of products 3-11i and 3-13i 
improved to 23% and 68% respectively. Only small amounts of dimers 3-12i and 3-12’i were 
detected. 
 
Scheme 3.6 α-Oxygenation of methyl ketones 
1.3 equiv. LDA, TEMPO 1-2,
FeCp2PF6 1-3
THF, !78 °C
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Table 3.8 α-Oxygenation of unsymmetrical ketones 3-10i-k 
Entry Substrate Additive 
(equiv.) 
3-11+3-11’ 
(%) 
3-12+3-12’ 
(%) 
3-13 (+3-13’) 
(%) 
3-14 
(%) 
1a - 4 (1:0) 42 (1:1) 50 - 
2b 
O
          3-10i LiCl (6) 23 (1:0) traces 68 - 
3c - 16 (1.9:1) 14d (1.3:1) 26 (+traces) - 
4c 
O
3-10j LiCl (6) 43 (7.4:1) - 19 (+traces) 9 
5c LiCl (6) 29 (12:1) - 30 (+traces) - 
6e 
O
H11C5    3-10k LiCl (6) 37 (8.8:1) traces 24 (+traces) 14 
a) Deprotonation 20 min. b) Deprotonation 10 min. c) Deprotonation 5 min. d) Product 3-12’j was 
isolated as an inseparable mixture with a not assignable dimer, which contained the unit 
tetramethylpiperidinyloxy. e) Deprotonation 30 min. 
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For 6-methyl-5-hepten-2-one 3-10j deprotonation was performed for 5 minutes in the 
presence or absence of LiCl (Table 3.8, entries 3 and 4). In the absence of LiCl, α-oxygenated 
products 3-11j and 3-11’j were obtained in 16% with a low terminal versus internal 
selectivity of 1.9:1. The oxidation/TEMPO trapping/aldol addition product 3-13j was isolated 
in 26% yield, while products 3-12 and 3-12’ were also formed in 14% yield. In the presence 
of LiCl, the yield of 3-11j and 3-11’j improved to 43%, and the selectivity for the formation 
of 3-11j to 7.4:1 (entry 4). Product 3-13j was isolated in 19% yield, while aldol product 3-14j 
was formed in 9% yield. The enolate of 2-octanone 3-10k was oxidised in the presence of 
LiCl, testing short and long deprotonation times of 5 and 30 minutes, respectively (entries 5 
and 6). Products 3-11k and 3-11’k were obtained in low to moderate yields of 29% and 37%, 
respectively, with high regioselectivities of 12:1 and 8.8:1. Compound 3-13k was formed in 
30 and 24% yields. Products 3-14k and 3-12’k were also detected. The low yields of targeted 
3-11 were due to a multitude of competing reactions leading to formation of byproducts 3-12, 
3-13 and 3-14. Their formation was suppressed partially by the presence of LiCl, which 
affected the outcome of these experiments positively. 
 
Table 3.9 Significant NMR data of compounds 3-11i-y and 3-13i-y  
 3-11i 3-11j 3-11k 3-13i 3-13j 3-13k 
 δ (ppm), multiplicity 
CH2ON 4.51, s 4.38, s 4.39, s 3.73, 3.79a 3.75a 3.74a 
CH2ON 83.4, t 83.1, t 83.0, t 81.8, t 80.8, t 81.2, t 
a) AB system. 
 
The structures of compounds 3-11i-k and 3-13i-k were unambiguously assigned by 1H 
and 13C NMR spectroscopy. The most characteristic signals are those of the methylene group 
bearing the TMP-group (Table 3.9).  
 
Key results: 
1. The synthesis of α-tetramethylpiperidinyloxy carbonyl compounds can be efficiently 
accomplished via deprotonation/oxidation with ferrocenium hexafluorophosphate 1-
3/coupling of the resulting α-carbonyl radical by TEMPO 1-2 in high yields for substrates 
which are not hindered at the α-position. α-Branched carbonyl compounds 3-4f, 3-4g, 3-10c 
underwent this reaction in poor yields. 
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2. Oxidative dimerisation competed with the α-oxygenation for aromatic esters and ketones, 
whose enolates aggregate strongly in solution. The yields were considerably improved by 
using LiCl as an additive. 
3. Aliphatic unsymmetrical methyl ketones 3-10 having two enolisable α-positions gave the 
α-oxygenated products in low to moderate yields, but good regioselectivity since compounds 
3-11’ and 3-13’ were formed in low yields. Competing oxidative dimerisations and aldol 
additions limited the yields leading to the formation of products 3-12-3-14. The presence of 
LiCl suppressed the formation of products 3-12 and improved the overall mass balance. 
 
3.2. Reactions of α-tetramethylpiperidinyloxy carbonyl compounds and nitriles 
 
α-Tetramethylpiperidinyloxy carbonyl compounds and nitriles 3-2, 3-5, 3-7 and 3-11 
can be considered protected α-hydroxy carbonyl compounds. The carbonyl function may be 
reduced to an alcohol, the N-O bond can be reductively cleaved to liberate the hydroxy group 
and the α-hydrogen to the carbonyl could be deprotonated giving an enolate, which may 
undergo anionic reactions. Similar reactivity can be envisaged for α-
tetramethylpiperidinyloxy nitriles. 
 
Figure 3.1 Possible reactions of compounds of type 3-2, 3-5, 3-7 and 3-11 
 
R
1
EWG
O
N
Deprotonation and alkylation or aldol reaction
Reduction to an alcohol or an amineReductive removal
of the TMP-functionality
EWG = carbonyl group, nitrile
 
 
3.2.1. Synthesis of α-hydroxy carbonyl compounds via reductive deprotection of the 
tetramethylpiperidine functionality 
The 2,2,6,6-tetramethylpiperidine functionality of α-TMPoxy esters 3-2 was 
previously removed reductively by treatment with Zn/AcOH in THF/H2O affording α-
hydroxy esters 3-15.10a, 26a,b This method was now optimised for a large number of substrates 
such as α-TMPoxy ketones, esters, nitriles, lactones and amides (Scheme 3.7, Table 3.10). 
Most of the reactions provided α-hydroxy carbonyl compounds 3-15-3-17 in high yields 
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(entries 1, 3-7). The procedure was also adapted for the synthesis of the water-soluble 
hydroxy butyrolactone 3-15c, which was obtained in a moderate 54% yield (entry 2).  
 
Scheme 3.7 Reductive deprotection of the TMP functionality 
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Table 3.10 Yields and significant NMR data of α-hydroxy carbonyl derivatives 
Method δ (ppm), multiplicity Entry Substrate 
(mmol)  
Product Yield (%) 
CHOH CHOH 
1 
 
3-2b A 3-15b 75 4.68, sa 
4.62, sb 
73.1, da 
72.3, db 
2 3-2c D 3-15c 54 4.50, dd 67.3, d 
3 3-5b C 3-16b 94 4.47, t 61.2, d 
4 3-5d A 3-16d 83 4.35, m 67.8, d 
5 3-11e B’ 3-17e 71  4.57, q 68.4, d 
  B  55   
6 3-11f B 3-17f 90 4.08, dd 75.3, d 
3-11h A 3-17h 71 exo 3.72, s 76.9, d 7 
3-11hc C 3-17h 87 endo 4.18, d 74.1, d 
a) (2S,3R)-isomer. b) (2S,3S)-isomer. c) 0.55 mmol 3-11h were heated with 1.35 g Zn (38 equiv.) and 3 mL 
AcOH (95 equiv.) in 4 mL THF/H2O 1:1 at 50 °C for 1.5 h. The reaction was not complete by TLC, thus another 
1.3 g Zn and 3 mL AcOH were added and heating was continued for 1 h. 
 
Scheme 3.8 Mechanism of reduction with Zn/AcOH 
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A possible mechanism for the reduction consists of oxidation of Zn0 by acetic acid to 
produce hydrogen atoms. The O-N bond is reduced by 2 hydrogen atoms, and the desired α-
hydroxy carbonyl compounds 3-15, 3-16 and 3-17 and 2,2,6,6-tetramethylpiperidine are 
formed. 
However, a different course was observed with α-TEMPOxy propiophenone 3-11a 
(Scheme 3.9). Here the carbonyl oxygen was more easily attacked by the electron poor 
hydrogen atom because of the lower reduction potential of the aromatic carbonyl group and a 
ketyl radical 3-18 is formed (Scheme 3.9).102 Alternatively, also protonation of the Lewis-
basic carbonyl oxygen is viable, which increases the electron-accepting power of the carbonyl 
group. Direct reduction by Zn0 gives the same ketyl radical. Subsequent β-fragmentation of 
TEMPO leads to the Zn enolate of propiophenone 3-19, which is hydrolysed to 3-10a. 
 
Scheme 3.9 Mechanism of reduction of propiophenone 3-11a 
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Optimisation experiments were performed in order to reduce the large excess (40 
equiv.) of zinc and replace acetic acid (Table 3.11). Amide 3-5d was reduced to 3-16d in low 
yields in the presence of 3.5 equiv. Zn and 8.7 equiv. HCl (entry 1). The reduction of 3-5d 
with 20 equiv. Zn and 50 equiv. AcOH gave the α-hydroxy amide 3-16d in 44% yield (entry 
2). The reagent excess described in the original procedure seems to be necessary for achieving 
good yields. (R)-Camphor derivative 3-11h was recovered quantitatively when it was heated 
with 12 equivalents Zn and 30 equivalents HCl (entry 3). Thus, the replacement of acetic acid 
by the easier removable HCl and reduction of the amount of Zn dust are not tolerated.  
 
Table 3.11 Optimisation experiments of reductive deprotection 
Entry Substrate Conditions Product Yield (%) 
1a 3-5d 3.5 equiv. Zn/ 8.7 equiv. HCl  3-16d 37 
2 3-5d 20 equiv. Zn/ 50 equiv. AcOH 3-16d 44 
3b 3-11h 12 equiv. Zn/ 30 equiv. HCl 3-17h 0 
a) 21% 3-5d was recovered. b) Substrate 3-11h was recovered. 
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Synthesis of α-hydroxy carbonyl compounds from carbonyl compounds in one pot 
The combination of enolate aminoxylation and the reductive cleavage of the TMP-
functionality to a one-pot 2 step process is attractive for the more direct preparation of α-
hydroxy carbonyl compounds (Scheme 3.10). The α-tetramethylpiperidinyloxy carbonyl 
compounds 3-2, 3-5 and 3-11 were synthesised as described before, but the crude product 
containing ferrocene and some TEMPO was immediately treated with Zn/AcOH in THF/H2O 
at 50 °C. Conditions needed to be adjusted partly by increasing the solvent or reagent amount 
(Table 3.12). Ethyl valerate 3-1a yielded product 3-15a efficiently (entry 1). 
 
Scheme 3.10 Synthesis of α-hydroxy carbonyl compound 3-15, 3-16, and 3-17 in one pot 
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Table 3.12 Conditions and yields of the one pot hydroxylation 
Entry Substratea Product Isolation method 3-15, 3-16, 3-17 (%) 
1 
 
3-1a 
H7C3
OEt
O
OH  
G 3-15a 76 
2 3-4bb C 3-16b 85 
3 3-4bc 
H11C5
CN
OH  C 3-16b 54 
4 3-10c O
OH  
B’ 3-17c 31 
5 
 
3-10f O
OH
 
B 3-17f 46 
6 
 
3-10gd 
 
B 3-17g 59 
7 3-10g 
O
OH
 B 3-17g 38 
a) Unless otherwise noted scale 2 mmol, 0.25M in THF/H2O 1:1, 5.2 g Zn, 12 mL AcOH. b) After 1.5 h 25 
equiv. AcOH and 11 equiv. Zn were added. c) Scale 15 mmol; 0.071M in THF/H2O 3:1. The product contained 
traces of heptanol. d) 50 equiv. Zn. 
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Octonitrile 3-4b afforded product 3-16b in high yields on a 2 mmol scale (entry 2) and 
in moderate yields on a 15 mmol scale (entry 3). For smaller molecules the efficiency 
decreased, α-hydroxy tert-butyl ethyl ketone 3-17c and α-hydroxy cyclohexanone 3-17f were 
obtained in moderate yields (entries 4 and 5). Cycloheptanone 3-10g gave 59% of hydroxy 
ketone 3-17g with 50 equiv. Zn (entry 6), while the product was isolated in only 38% yield 
with 40 equiv. Zn (entry 7).  
 
Key results: The reductive deprotection of α-tetramethylpiperidinyloxy carbonyl 
derivatives to α-hydroxy carbonyl compounds 3-15, 3-16 and 3-17 was applied for a large 
number of representative examples. A one pot synthesis of 3-15, 3-16 and 3-17 works for all 
investigated substrates, however, this sequence is only in some cases, mostly for small setups 
and non volatile products, as efficient as the stepwise procedure. 
 
3.2.2. A new efficient access to monoprotected 1,2-diols and O-protected amino alcohols via 
reduction of α-tetramethylpiperidinyloxy carbonyl compounds with hydride reagents 
 
Typical hydride reagents such as NaBH4 or LiAlH4 reduced the carbonyl 
functionality selectively in the presence of the α-tetramethylpiperidinyloxy unit (Scheme 
3.11, Table 3.13). The reduction of different substrates was tested with respect to the syn/anti-
diastereoselectivity. α-(Tetramethylpiperidinyloxy)propiophenone 3-11a was reduced to the 
monoprotected diol 3-20a in high yields with good syn:anti diastereoselectivity of 6.5:1 using 
NaBH4 (Scheme 3.11, Table 3.13, entry 1). Reduction of α-(tetramethylpiperidinyloxy) 
butyrophenone 3-11b occurred also in excellent yields and good to high diastereoselectivities 
applying both NaBH4 and LiAlH4 (entries 2, 3, and 4). 
 
Scheme 3.11 Reduction of ketones 3-11 with hydride reagents (relative stereochemistry 
shown) 
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Table 3.13 Reduction of α-tetramethylpiperidinyloxy ketones 3-11 
Entry Substrate Method Product 3-20 3-20 (%) Diastereomeric ratioa 
1 3-11a A OH
Ph
OTMP  
3-20a 89 6.5 :1 
2 3-11b A 3-20b 95 8:1 
3 3-11b A 3-20b 99 9.2:1 
4 3-11b B 
OH
Ph
OTMP  
3-20b 85 11.2:1 
5 3-11f A 3-20f 100 2.7:1 
6 3-11f B 
OH
OTMP
 3-20f 90 1:1.1 
7 3-11g A 3-20g 75 cis/trans 4:1 
8 3-11g B 
OH
OTMP
 3-20g 92 cis/trans 2.9:1 
9 exo-3-11hb A 3-20h 0 - 
10 exo-3-11h B 3-20h 91 4.3:1 
11 exo-3-11h B 
OTMP
H
H
OH
 3-20h 75 >20:1 
12 endo-3-11h B 
OH
H
OTMP
 
3-20h 100 4.6:1 
a) syn:anti for 3-11a and 3-11b. cis/trans for 3-11f and 3-11g. 2-exo,3-exo:2-endo,3-endo for exo-3-11h. 
2-endo,3-endo:2-exo,3-endo for endo-3-11h. b) 16 equiv. NaBH4, MeOH, 0 °C, 30 min; the impure 
substrate was recovered.  
 
The unequivocal configuration assignment of syn-1-phenyl-2-
(tetramethylpiperidinyloxy)-1-propanol syn-3-20a was accomplished by X-ray 
crystallography. The compound is arranged in an antiperiplanar conformation of the large 
phenyl and tetramethylpiperidinyloxy units, which is stabilised by a hydrogen bond between 
the hydrogen of the hydroxy group and the nitrogen atom of the tetramethylpiperidinyl unit. 
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Figure 3.2 X-Ray crystal structure of syn-1-hydroxy-1-phenyl-2-(tetramethylpiperidinyloxy) 
propane syn-3-20a 
 
 
Significant NMR data for the syn- and anti-isomers of 3-20a and 3-20b are 
presented in the Table 3.14. The assignment of the diastereomers is in agreement with 
literature known data of 1-phenyl-1,2-dihydroxy propane.103 
 
Table 3.14 Chemical shifts of compounds 3-20a,b 
δ (ppm), (m, J (Hz)) Entry Isomer 
H1/C1 H2/C2 OH 
1 syn-3-20a (major) 4.76 (d, 8.6)/80.9 (d) 4.16 (dq, 8.6, 6.3)/80.8 (d) 1.25 (br. s) 
2 anti-3-20a 5.07 (t, 2.5)/74.8 (d) 4.12 (m, 6.6, 3.2)/82.8 (d) 2.43 (d, 2.6) 
3 syn-3-20b (major) 4.80 (d, 8.8)/79.6 (d) 3.94 (dt, 8.5, 3.1)/84.9 (d) 1.07-1.23 (br.s) 
4 anti-3-20b 5.10 (br s)/73.3 (d) 3.94 (m)/87.5 (d) 2.44 (d, 4.4) 
 
 
Scheme 3.12 Rationalisation of formation of syn- and anti-3-20a and 3-20b respectively 
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Addition of a nucleophile to a carbonyl compound with an electron withdrawing 
group in the α-position occurs usually with high syn-selectivity.104 Thus a Felkin-Anh 
transition state A explains the selective formation of syn-3-20a and syn-3-20b (Scheme 3.12). 
On the other hand, minor anti-3-20a and anti-3-20b maybe formed via a Cram-chelate 
transition state B.  
The reduction of 2-tetramethylpiperidinyloxy cyclohexanone 3-11f with NaBH4 and 
LiAlH4 afforded monoprotected cyclohexanone-1,2-diol cis-3-20f and trans-3-20f in excellent 
yields (Table 3.11, entries 5 and 6). The cis/trans diastereoselectivity amounted to 2.7:1 with 
NaBH4, while LiAlH4 gave no selectivity. The structurally similar cycloheptanone derivative 
3-11g was reduced in high yields, however, higher cis/trans diastereoselectivities of 4:1 with 
NaBH4 and 2.9:1 with LiAlH4 were found (entries 7 and 8). 
The configuration of the cis and trans isomers of 3-20f (both oils) was assigned by 
analysing the coupling constants of the CHOH and CHOTMP groups (Table 3.15).  
 
Table 3.15 Significant NMR data of compounds 3-20f and 3-20g 
δ (ppm), multiplicity (J (Hz)) 
Cyclohexanone 3-20f Cycloheptanone 3-20g 
Entry Isomer 
CHOH CHOTMP CHOH CHOTMP 
1 cis-3-20 4.18, br d (1.9) 
68.1, d 
3.65, ddd (11.5, 4.4, 2.7) 
83.5, d 
4.18, m 
70.2, d 
3.65, ddd (10.3, 3.2, 2.4) 
86.7, d 
2 trans-3-20 3.76, m 
75.5, d 
3.76, m 
83.8, d 
3.91, m 
77.0, d 
3.91, m 
86.2, d 
 
The hydrogen atom in CHOTMP in compound cis-3-20f appeared as a ddd with 
coupling constants 11.5, 4.4, 2.7 Hz, which means that the tetramethylpiperinyloxy unit is 
oriented in an equatorial position, since the axial hydrogen atom displays a 3Jaa coupling 
constant of 11.5 Hz and 2 small 3Jae of 4.4 and 2.7 Hz only in this arrangement. For the 
CHOH group only one small coupling constant 3Jae or 3Jee of 1.9 Hz was determined 
unequivocally. However, the line width at half height is only about 10 Hz. This speaks in 
favour of 3 small coupling constants, thus the hydrogen atom in CHOH must be oriented 
equatorially. Consequently this compound has a cis-configuration. The line width at half 
height of the CHOH and CHOTMP groups in trans-3-20f is 18 Hz. This supports a trans-
arrangement in trans-3-20f. 
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Scheme 3.13 Formation of the favoured cis-diastereomer 
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The more stable conformation A of α-(tetramethylpiperidinyloxy) cyclohexanone 3-
11f should be chair-like with the TMP-group oriented in the equatorial position (Scheme 
3.13). The tetramethylpiperidinyl group rotates freely around the N-O bond. The less reactive 
reagent NaBH4, approached the cyclohexane ring more selectively with a trajectory anti-
orientated to the tetramethylpiperidinyloxy group giving cis-3-20f. The attack from the other 
side is however also possible, giving a moderate 2.7:1 cis/trans ratio. The more reactive 
LiAlH4 does not differentiate both faces of the carbonyl group leading to a 1:1.1 cis/trans 
mixture. The cycloheptane ring induced better selectivities in the reduction of α-
(tetramethylpiperidinyloxy)cycloheptanone 3-11g by both reagents. NaBH4 gave a better 
diastereoselectivity than LiAlH4. 
The reduction of (R)-Camphor 3-10h by hydrides occurs normally from the endo-face 
and provides isoborneol as the major product.105 Chiral α-(tetramethylpiperidinyloxy) (R)-
camphor 3-exo-3-11h and 3-endo-3-11h were interesting substrates to study the course of the 
reduction under sterically more constrained conditions. 
The substrate 3-exo-3-11h was completely recovered after treatment with NaBH4 at 0 
°C (Table 3.13, entry 9). In contrast 3-exo-3-11h, containing small amounts of 3-endo-3-11h, 
was reduced by LiAlH4 with complete diastereoselectivity, providing 2-exo,3-exo-3-20h in 
high yields (entries 10 and 11). Reduction of 3-endo-3-11h at 0 °C to room temperature gave 
2-endo,3-endo-3-20h and 2-exo,3-endo-3-20h in 100% yield with a 4.6:1 d.r. (entry 12). 
The configuration of 2-exo,3-exo-3-20h was unequivocally proved by X-ray 
crystallography (Figure 3.3). Both substituents are located on the exo-face of the bicyclus. No 
hydrogen bonds were observed. The elementary cell contains two molecules. 
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Figure 3.3 X-Ray crystal structure of 2-exo,3-exo-3-20h. 
 
 
The configuration of 2-endo,3-endo-3-20h was also confirmed by an X-ray crystal 
structure (Figure 3.4). Both the hydroxy group and the tetramethylpiperidinyloxy group are 
found on the endo-side of the ring system. The tetramethylpiperidine ring having a chair 
conformation is oriented away from the bridged bicycle.  
 
Figure 3.4 X-Ray crystal structure of 2-endo,3-endo-3-20h 
 
 
Additionally the isomers 2-exo,3-exo-3-20h, 2-endo,3-endo-3-20h and 2-exo,3-
endo-3-20h were compared with respect to their 1H and 13C NMR chemical shifts of positions 
2, 3 and 4 and their coupling constants with 2-exo,3-exo-camphane-2,3-diol 3-21 and 2-
endo,3-endo-camphane-2,3 diol 3-22, respectively (Table 3.16 and 3.17).106 The chemical 
shifts, multiplicities and coupling constants of H2 and H3 are similar for the pairs of 
compounds 2-exo,3-exo-3-20h/2-exo,3-exo-3-21 (Table 3.16, entries 1 versus 2) and 2-
endo,3-endo-3-20h/2-endo,3-endo-3-22 (entries 3 versus 4). The shifts of H4 are less similar. 
The 1H NMR data of 2-exo,3-endo-3-20h differ strongly from the exo,exo and endo,endo 
isomers. 
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Table 3.16 Comparison of 1H NMR data of 3-20h, 3-21 and 3-22 
δ (m, J (Hz)) Entry Compound 
H2 OH H3 H4 
1 2-exo,3-exo-3-20h 3.58 (dd, 7.4, 3.7) 3.12 (d, 3.9) 3.92 (d, 7.4) 2.14 (d, 5.1) 
2 2-exo,3-exo-3-21106 3.51 (d, 7.0) - 3.84 (d, 7.0) 1.70 (d, 4.7) 
3 2-endo,3-endo-3-20h 3.77 (ddd, 9.3, 
5.0, 1.8) 
2.84 (d, 5.0) 
 
4.20 (ddd, 9.4, 
4.4, 2.0) 
1.97 (t, 4.5) 
4 2-endo,3-endo-3-22106 3.80 (dd, 8.8, 1.9) - 4.21 (m, 8.8, 
4.6, 1.5) 
1.85 (m, 4.6, 
4.6) 
5 2-exo,3-endo-3-20h 4.28 (dt, 4.5, 2.3) 1.69 (s) 3.53 (s) 2.06 (t, 4.3) 
 
A striking similarity of the 13C chemical shifts for C1 and C2 was observed for the 
pairs 2-exo,3-exo-3-20h/2-exo,3-exo-3-21 (Table 3.17 entries 1 versus 2) and 2-endo,3-endo-
3-20h/2-endo,3-endo-3-22 (entries 3 versus 4). The presence of the tetramethylpiperidinyloxy 
group induced more significant differences for C3 and C4.  
 
Table 3.17 Comparison of 13C NMR data of 3-20h, 3-21 and 3-22 
δ (ppm, multiplicity) Entry Compound 
C1 C2 C3 C4 
1 2-exo,3-exo-3-20h 46.28 (s) 79.93 (d) 90.81 (d) 48.69 (d) 
2 2-exo,3-exo-diol 3-21 46.43 (s) 79.93 (d) 79.19 (d) 51.47 (d) 
3 2-endo,3-endo-3-20h 43.63 (s) 73.74 (d) 82.95 (d) 49.32 (d) 
4 2-endo,3-endo-diol 3-22 44.37 (s) 73.71 (d) 84.58 (d) 52.46 (d) 
5 2-exo,3-endo-3-20h 46.49 (s) 86.27 (d) 94.88 (d) 49.80 (d) 
 
The reduction of (R)-camphor occurs from the endo-face yielding isoborneol. 
Similarly compound 2-exo,3-exo-3-20h was obtained as the only diastereomer. The 
tetramethylpiperidinyloxy and bridge methyl groups blocked the exo-side completely, 
allowing hydride attack only from the endo-face (Scheme 3.14). In 3-endo-3-11h the 
approach from the endo-face is hindered by the neighbouring tetramethylpiperidinyloxy group 
to a high extent, therefore the hydride attack proceeded mainly from the exo-face, but the face 
selection is less pronounced, since some 2-exo,3-endo-3-20h was also isolated. 
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Scheme 3.14 Formation of preferred cis-diastereomers 
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Terminal monoprotected 1,2-diol 3-23 was obtained by reduction of α-
(tetramethylpiperidinyloxy)ester 3-2a with LiAlH4 in dry THF at 0 °C in high yield (Scheme 
3.15). 
 
Scheme 3.15 Reduction of ester 3-2a 
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Scheme 3.16 Reductions of nitriles 3-5b and 3-5a with hydrides 
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Reduction of α-tetramethylpiperidinyloxy nitriles 3-5a and 3-5b with LiAlH4 
proceeded efficiently forming α-tetramethylpiperidinyloxy amines 3-24 and 3-25, which can 
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be potentially reductively deprotected to the free amino alcohols 3-26 and 3-27 (Scheme 
3.16). 
The structures of α-tetramethylpiperidinyloxy alcohol 3-23 and amines 3-24 and 3-
25 were elucidated based on their NMR data. The positions bearing the 
tetramethylpiperidinyloxy group, the alcohol and respectively amine functionalities are 
characteristic for these compounds (Table 3.18). 
 
Table 3.18 Significant chemical shifts of products 3-23, 3-24 and 3-25 
δ (ppm, multiplicity) Entry Compound 
CHOTMP CH2OH or CH2NH2 
1 3-23 4.20 (dddd), 79.8 (d) 3.89 (dd), 68.6 (t) 
2 3-24 4.69 (t), 87.9 (d) 3.11 (d), 46.6 (t) 
3 3-25 3.76 (m), 83.2 (d) 2.82 (m), 44.8 (t) 
 
Key results: α-Tetramethylpiperidinyloxy ketones, esters and nitriles 3-2, 3-5 and 3-11 can 
be efficiently reduced to monoprotected diols like 3-20 and 3-23 and protected amino alcohols 
like 3-24 and 3-25 by hydrides. Reduction of aromatic, bicyclic chiral and racemic α-
tetramethylpiperidinyloxy ketones occurred with good to high diastereoselectivities.  
 
3.3. Reactivity of α,β-unsaturated carbonyl compounds with LDA, TEMPO and 
ferrocenium hexafluorophosphate 
 
An interesting class of compounds eligible to the oxygenation with TEMPO were α,β-
unsaturated carbonyl compounds, since potentially both α- and γ-TEMPO trapping can occur 
(Scheme 3.17). Reaction of methyl trans-2-pentenoate 3-28a with LDA and subsequent 
oxygenation by TEMPO afforded surprisingly β-amino-α-TMPoxy ester 3-29a in 33% yield 
and γ-coupling product 3-30a in only 10% yield. Product 3-29a was obtained with good 5.1:1 
anti/syn diastereoselectivity. The regioselectivity switched in the presence of HMPA 
completely, affording only γ-oxygenated product 3-30a, but the yield of 31% was low. N,N-
Dimethyl crotonamide 3-28b provided product 3-29b in 54% yield with 36:1 anti/syn 
diastereoselectivity. Oxygenation product 3-30b was isolated only in maximal 5% yield with 
low purity. Reactions in the presence of HMPA gave complex mixtures, from which no 
defined products were isolated. Deprotonation and oxidation of 2-cyclohexenone and 2-
pentenenitrile with ferrocenium hexafluorophosphate 1-3 in the presence of TEMPO 1-2 
afforded complex mixtures under the same conditions. 
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Scheme 3.17 Tandem conjugate addition/oxygenation versus oxygenation of 3-28a and 3-28b 
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The major anti-diastereomer of 3-29a was unambiguously assigned by X-ray 
crystallography (Figure 3.5). The compound crystallised having an (R,R)- and (S,S)-
configurated molecule in the unit cell. Both enantiomers are arranged in a staggered 
conformation, in which the bulky diisopropylamino and tetramethylpiperidinyloxy groups are 
arranged antiperiplanar.  
 
Figure 3.5 X-Ray crystal structure of anti-3-29a  
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The configuration of the major diastereomer of 3-29b was assigned to be anti by 
comparison of the NMR data with anti-3-29a. The 1H NMR chemical shift of  the CHOTMP 
group is shifted to the lower field for anti-3-29b compared to syn-3-29b. Significant NMR 
data of the products are presented in Table 3.19. 
 
Table 3.19 1H and 13C NMR chemical shifts of compounds 3-29a and 3-29b 
δ (ppm), multiplicity (J (Hz)) Entry Isomer 
CHOTMP CHNiPr2 
1 anti-3-29a  4.42 (d, 10.0), 86.7 (d) 3.07 (m), 59.2 (d) 
2 syn-3-29a 4.19 (d, 5.2), 88.1 (d) 3.26 (ddd, 9.0, 5.1, 3.8), 58.2 (d) 
3 anti-3-29b 4.57 (d, 9.9), 78.9 (d) 3.62 (dq, 9.1, 7.0), 52.5 (d) 
4 syn-3-29b 4.47 (d, 8.1) Not detectable. 
 
The structure of byproducts 3-30a and 3-30b was assigned based on their NMR data. 
The position bearing the TMPOxy-functionality and the double bond were characteristic for 
these compounds. 
 
Table 3.20 Significant chemical shifts of products 3-30a and 3-30b 
δ (ppm), multiplicity Entry Isomer 
CHxOTMP (x =1 or 2) CH=CHCOO CHCOO 
1 3-30a/1H NMR 4.44 (quint) 6.98 (dd) 5.91 (d) 
2 3-30a/13C NMR 78.4 (d) 150.6 (d) 118.6 (d) 
3 3-30b/1H NMR 4.47 (dd) 6.84 (dt) 6.54 (dt) 
4 3-30b/13C NMR 76.2 (t) 140.8 (d) 119.2 (d) 
 
Competing deprotonation in γ-position giving enolate 3-31-A and conjugate addition of 
the amide anion leading to 3-31-B occurred (Scheme 3.18). Oxidation and regioselective 
trapping by TEMPO at the more electron rich γ-position gave 3-30 from 3-31-A. Although 
LDA is a bulky base, Michael addition107 to the double bond competed significantly giving 
enolate 3-31-B. Subsequent SET oxidation and trapping by TEMPO afforded products 3-29. 
The presence of HMPA suppressed the Michael addition of LDA to methyl trans-2-
pentenoate 3-28a affording only product 3-30a, although the yields remained low. For N,N-
Dimethyl crotonamide 3-28b Michael addition prevailed almost completely over 
deprotonation, affording the Michael addition/oxidation/TEMPO trapping product 3-29b. 
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Scheme 3.18 Mechanism of product formation with α,β-unsaturated substrates 3-28 
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The anti-diastereoselectivity of the TEMPO trapping can be rationalised as follows. 
The enolate resulting after conjugate addition forms a six-membered chelate. On SET 
oxidation this chelate remains largely intact and gives radical 3-33-A, which exists because of 
the planar geometry of the α-carbonyl radical probably in a cyclohexene-like conformation 3-
33-A (Scheme 3.19). 
 The approach of TEMPO from the α-face is more favourable, leading to the 
formation of the major anti-diastereomer. Breaking of the chelate on oxidation and relaxation 
of the radical as in 3-33-B would probably lead to almost equal formation of both 
diastereomers. 
 
Scheme 3.19 Formation of preferred anti-diastereomer 
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Key results: This reaction has a methodic potential. Detailed investigations are 
necessary to improve the control over the switch between sequential Michael addition/SET 
oxidation/TEMPO trapping and deprotonation in γ-position/SET oxidation/TEMPO trapping 
leading either to β-amino-α-tempoxy carbonyl compounds 3-29 or to γ-tempoxy α,β-
unsaturated carbonyl compounds 3-30. 
 
3.4. Attempted α-oxygenations of carbonyl compounds with oxygen 
 
A more direct method to introduce oxygen in the α-position of carbonyl compounds is 
oxidative coupling of enolates with oxygen (Scheme 3.20).13, 108 The enolate of ethyl 
heptanoate 3-1d generated by deprotonation with LDA in THF was treated with O2 by 
bubbling a dry oxygen stream into the enolate solution for a given time. The substrate was 
recovered to 65%. No other products were detected (Table 3.21, entry 1). This indicates that 
lithium enolates are rather insensitive to oxygen. To promote oxygenation, LiCl was added to 
modify the enolate aggregates and the time of oxygen bubbling was reduced to 30 minutes. 
 
Scheme 3.20 Oxygenation of the enolate of 3-1d with O2 
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Table 3.21 Oxygenation of 3-1d by bubbling dry oxygen at −78 °C 
Entry Deprotonation (min)/ 
O2 bubbling (min) 
Additive 3-1d (%) 3-15d (%) 
 
3-34d (%) 3-35d (%) 
1 30/60  - 65 - - - 
2a 30/30 LiCl 8 12 19 11 
3 90/30 LiCl 3 - 46 14 
4 90/30 LiCl 3 - 53 13 
a) 1% 3-3d detected. 
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Under these conditions ethyl α-hydroxy heptanoate 3-15d was indeed isolated in 12% 
yield. It was, however, accompanied by products 3-34d and 3-35d formed via anionic 
pathways (entry 2). Longer deprotonation times favoured the formation of  3-34d and 3-35d 
derived from anionic processes in moderate yields, however, no 3-15d was formed (entries 3 
and 4). 
Formation of 3-15d showed that the enolate was oxidised by O2, nonetheless the 
reaction was very inefficient (Table 3.21, entry 2). Therefore the product distribution was 
investigated at different oxygenation times (Table 3.22). To promote radical coupling and the 
complete disappearance of the enolate, ferrocenium hexafluorophosphate 1-3 was added, after 
bubbling a pre-dried oxygen stream. In its presence ester enolates underwent instantaneous 
oxidative coupling to dimers 3-3d (vide infra).  
 
Table 3.22 Oxygenation of enolate of 3-1d by bubbling dry O2, followed by addition of 
FeCp2PF6. 
Entry O2 bubbling  
Time/T 
3-1d 
(%) 
3-3d 
(%, meso/d,l) 
3-15d 
(%) 
3-34d 
(%) 
3-35d 
(%) 
3-36d 
(%) 
1 10 min/−78 °C - 26 (1:1) 5 4 2 - 
2 30 min/−78 °C 14 - 29 5 4 - 
3 60 min /−78 °C 3 2 (1:0) 14 - - - 
4a 60 min /−30 °C - - 14 38 - 2 
5 60 min /−30 °C 4 10 (1:1) 11 26  4 
6b 60 min /−40 °C 51 - 14 22  2 
a) Deprotonation at −30 °C. b) In the presence of PPh3. 
 
In this way all enolate units that did not react with oxygen and did not undergo anionic 
reactions to 3-34d and 3-35d dimerised. In experiments with short oxygen bubbling time of 
10 minutes the α-hydroxy ester 3-15d was isolated in 5% yield while the dimer was formed in 
26% yield (entry 1). Oxygen bubbling for 30 min yielded 3-15d in 29% yield (entry 2). 
Oxygen bubbling for one hour at −78 °C afforded 3-15d in only 14% yield, while 3-34d or 3-
35d were not detected (entry 3). The low temperature of −78 °C suppressed Claisen 
condensation reactions leading to 3-34d and 3-35d. Oxygen bubbling at higher temperatures 
favoured anionic pathways giving 3-34d in 22 to 38% yield and 3-15d in low yields of 11-
14% (entries 4-6). Even when PPh3 was used for reduction of the first formed peroxide, 
compound 3-15d was obtained only in 14% yield (entry 6). 
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The direct oxygenation of ethyl heptanoate 3-1d with oxygen was inefficient and the 
product distribution was not reproducible. The low mass balance is difficult to explain, since 
ethyl heptanoate has a high boiling point. To narrow the problem, benzaldehyde was added 
after bubbling oxygen for a given time to check whether any enolate was left in the solution 
(Scheme 3.21). Aldol additions of ester enolates to aldehydes are fast reactions. Thus, reaction 
of enolate of 3-1d with benzaldehyde under aldol conditions in the presence of HMPA 
afforded 3-38d and 3-35d in 49% and 13% yield, respectively. HMPA was used to reduce 
anionic Claisen condensation to 3-35d and further trimerisation to 3-34d. The oxygenation 
reactions using varying deprotonation times of 30-45 min and oxygen bubbling times of 10-
120 min gave similar results as above. The oxygenated product 3-15d was formed in 0-29% 
yield, while 3-34d was obtained in 0-36% and 3-35d was isolated in 4-29% yield. In no case, 
aldol product 3-38d could be isolated. This leads to the conclusion that the enolate was 
consumed by oxygen, before the addition of benzaldehyde and apparently this system is not 
suitable to monitor the process. 
 
Scheme 3.21 Oxygenation of ester 3-1d with O2 
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Table 3.23 Conditions for oxygenation of ester 3-1d with O2 
Entry Deprotonation/ 
O2 bubbling time 
Additive 3-1d 3-15d 
 
3-34d 3-35d 3-38d 
1 30 min/ 0 min HMPA - - - 13 49 
2 30 min/ 120 min HMPA 3 6 trace 19 - 
3 30 min/ 10 min HMPA 9 29 - 4 - 
4 45 min/ 10 min HMPA 3 - - 12 - 
5 >30 min/ 10 min HMPA 7 - 36 29 - 
 
Key results: The oxygenation of ester enolates with oxygen occurred inefficiently, 
accompanied by a multitude of Claisen condensation processes. 
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3.5. Coupling of organometallic compounds with the free radical 1,3,5-triphenylverdazyl 
 
A simple introduction of amine functionalities in the α-position of carbonyl 
compounds would give access to α-amino acids and other α-amino carbonyl compounds. To 
investigate the applicability of stable nitrogen radicals in coupling reactions, 1,3,5-
triphenylverdazyl 3-39 was chosen.109 1,3,5-Triphenylverdazyl is a deep green solid. The 
delocalisation of the unpaired electron in the tetrazine system as well as conjugation with the 
benzene rings are the reasons for its stability (Figure 3.6). Generation of the enolate of a 
carbonyl compound and its oxidation by 1-3 in the presence of 3-39 should give compounds 
of type 2-10 (cf. Scheme 2.1). In contrast to TEMPO 1-2, 3-39 has a lower oxidation potential 
than ferrocene (–0.22 V versus Fc/Fc+),110 which makes it susceptible to oxidation by 1-3. 
 
Figure 3.6 Electronic structure of 1,3,5-Triphenylverdazyl 3-39 
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3.5.1. Synthesis of 1,3,5-triphenylverdazyl 3-39 
1,3,5-Triphenylverdazyl was synthesised according to the literature procedure from 
triphenylformazane 3-40111 by treatment with methyl iodide in basic DMF under aerobic 
conditions (Scheme 3.22).112 The synthesis was optimised as summarised in Table 3.24. To 
promote the first alkylation step the reaction mixture was stirred under nitrogen atmosphere in 
nitrogen-saturated DMF by bubbling a slight nitrogen stream for 6 h, followed by bubbling of 
an O2 stream for 16 h or 68 h (entries 1, 2). The yields of 47% and respectively 58% were low 
to moderate. When the reagents where mixed and the reaction mixture was stirred open to the 
air for 64 h, 1,3,5-triphenylverdazyl 3-39 was isolated in a much improved 76% yield. The 
radical was purified by crystallisation, and the purity was checked by the melting point (136-
139 °C) and combustion analysis. The mechanism can be formulated as follows: 
Triphenylformazane 3-40 is deprotonated by Ba(OH)2 and the resulting anion is alkylated by 
methyl iodide. Oxidation of the tertiary amine 3-41 by oxygen to radical cation 3-42, followed 
by a deprotonation to a terminal aminomethyl radical 3-43, and subsequent radical 6-endo 
cyclisation to the azo group gives the persistent radical 3-39. 
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Scheme 3.22 Synthesis of 1,3,5-trephenylverdazyl 3-39 
NN
N N
Ph
Ph
Ph
NHN
N N
Ph
Ph
Ph
DMF, O2, 16 h, r.t.
MeI
NN
N N
Ph
Ph
Ph
excess MeI, BaO, Ba(OH)2  8H2O
NN
N N
Ph
Ph
Ph
NN
N N
Ph
CH2Ph
Ph
O2 ! H
3-40 3-39
3-423-41 3-43   
 
Table 3.24 Optimisation of 1,3,5-triphenylverdazyl 3-39 synthesis 
Entry Conditions 3-39 (%) 
1 N2 bubbling 6 h, O2 bubbling 16 h 47 
2 N2 bubbling 6 h, O2 bubbling 68 h 58 
3 Stirring open to the air for 64 h 76 
 
3.5.2. Enolate oxidation and trapping with 1,3,5-triphenylverdazyl 3-39 
Ethyl heptanoate 3-1d was chosen for the investigations of radical amination 
reactions. Generation of the enolate by deprotonation with LDA, followed by oxidation with 
ferrocenium hexafluorophosphate 1-3 in the presence of 3-39 afforded product 3-44 in 64% 
yield based on 3-39 (Scheme 3.23, Table 3.25, entry 1). To avoid paramagnetic species in the 
product mixture, which would complicate NMR analysis, experiments were performed with 2 
equivalents of enolate based on 3-39. Interestingly two very similar sets of NMR signals were 
detected for compound 3-44, indicating that compound 3-44 was isolated as mixture together 
with an unknown compound, which had a very similar structure. The striking similarity by 
NMR was confirmed by a successful combustion analysis from this mixture, which confirmed 
the chemical formula of 3-44 and of the unknown isomer being C29H34N4O2. A further 
structure elucidation failed. The dimer 3-3d was isolated in 23% yield with a good 5:1 
meso/d,l-diastereoselectivity. Small amounts of trimer 3-34d were also detected. The coupling 
of the enolate of 3-1d with verdazyl 3-39 in the presence of LiCl gave 3-44 and 3-3d in 
similar yield, however, no diastereoselectivity was found for dimers 3-3d (entry 2). 
Additionally compounds 3-34d, 3-45 as well as disproportionation product 3-46 were 
detected by NMR spectroscopy in small amounts. The total efficiency of heterocoupling and 
homocoupling decreased when the SET oxidation was performed with CuCl2 (entry 3).
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Scheme 3.23 α-Amination of ethyl heptanoate 3-1d 
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Table 3.25 α-Amination of ethyl heptanoate 3-1d 
Entry Oxidant Additive 3-44a (%) 3-3db (%) 
(meso/d,l) 
Other (%) 
1c FeCp2PF6 - 64 23 (5:1) 3-34d 3 
2 FeCp2PF6 LiCl 60 22 (1:1) 3-34d trace, 3-45 12, 3-46 4 
3 CuCl2 - 54 3 (1:0) 3-34d trace, 3-35d 3 
a) Yields based on verdazyl 3-39. b) Yields based on 3-1d. c) Deprotonation at −50 °C. 
 
The α-amination of diethyl methylmalonate 3-47 proceeded efficiently affording 3-48 
in 86% yield as the only product (Scheme 3.24). This substrate is more hindered at the α-
position and therefore much more resistant to anionic side reactions or dimerisation. 
 
Scheme 3.24 α-Amination of diethyl methylmalonate 3-47 
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The structure of 3-44-I and of 3-48 was elucidated based on their NMR data. In 3-44-I 
and 3-44-II (unknown isomer) there is only one hydrogen atom in the α-carbonyl position. 
The corresponding carbon is a doublet. In 3-48, there is no hydrogen left in the α-carbonyl 
position and the carbon is a singlet. The complete verdazyl ring was unambiguously assigned 
for all three products.  
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Table 3.26 Significant NMR data of compounds 3-44-I, 3-44-II (unknown) and 3-48 
δ (multiplicity) Entry Compound 
CHNNPh or C(CH3)NNPh PhC=N PhNCH2NPh 
1 3-44-I 4.15 (t), 64.2 (d) 150.3 (s) 4.34 (d), 5.28 (d), 63.2 (t) 
2 3-44-II 4.33 (m), 64.4 (d) 149.4 (s) 4.37 (d), 5.49 (d), 64.8 (t) 
3 3-48 - , 75.3 (s) 148.8 (s) 4.83 (d), 5.61 (d), 59.3 (t) 
 
The reaction of verdazyl with methyl acetoacetate 3-49 under similar conditions 
provided a main product in high yield, whose analytical data do not correspond to the 
expected product 3-50 (Scheme 3.25).  
 
Scheme 3.25 Radical amination of acetoacetate 3-49 with verdazyl 
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 The most likely structure assigned to the product was triazole 3-51 based on the 
following arguments. The NMR spectra revealed that the verdazyl ring was not present by 
comparison to 3-48. The ring methylene group NCH2N, well recognisable in the 1H NMR 
spectra by an AB system in the range of 4.3-5.5 ppm and in 13C NMR by a triplet around 60 
ppm was missing.  
The 1H NMR spectra gave the following signals: a singlet at 3.95 ppm, a multiplet at 
7.45 ppm, a singlet at 7.53 ppm and a multiplet at 8.22 ppm. The integral ratio was 3:5:3:2 
speaking for a methoxy group and 10 aromatic protons. 13C NMR gave a doublet or quartet at 
53.2 ppm, which is an agreement with a methoxy group. Six doublets and two singlets at 
129.6 and 137.9 ppm spoke for two phenyl rings. There are three more singlets at 145.0, 
157.8 and 162.0 ppm. The resonances at 145.0 and 157.8 ppm were assigned to PhC=N and 
N=CCOOMe carbon atoms, respectively, while the resonance at 162.0 ppm was assigned to 
the carboxyl group. A strong intensity band at 1728 cm-1 in the IR spectrum also suggested the 
presence of an ester group in the molecule. In the MS (EI) spectrum peaks at 279 (100%) and 
280 (15.6%), 281 (2.1%) were found. If one assigned peak 279 as the molecular ion, the ratio 
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of peak heights [M+]/[M++1] gave the number of carbon atoms, which had to be 15.6. This 
information ascertained a compound with 16 carbon atoms. Based on these data, the reaction 
product has a 1,2,4-triazol structure like 3-51. Other possible structures such as 3-52 or 3-53 
are not likely based on the spectral data (Figure 3.7).  
 
Figure 3.7 Potential alternative structures of the product triazoles 3-52 and 3-53113 
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Scheme 3.26 Mechanism for the formation of 3-51114 
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A possible mechanism can be proposed as depicted in Scheme 3.26, considering two 
possible pathways. Path A proceeds over 3 steps via less strained intermediates than path B 
that needs 4 steps. Therefore Path A seems more likely. It would be possible to distinguish 
these alternatives by 15N labelling.  
To extend the scope to other carbonyl derivates, α-amination of the ketene iminate 3-
55 of octonitrile 3-4b was investigated (Scheme 3.27). A sudden colour change from pale 
yellow of the solution to dark red at the addition of verdazyl (and not to deep green as 
usually) indicated a fast reaction. Workup at this stage afforded a mixture of two main 
compounds, which were not separable. In a second experiment the sequence was continued by 
addition of ferrocenium fluorophosphate, and the colour changed to dark blue. The same 
products were isolated. Thus no oxidation with ferrocenium hexafluorophosphate took place, 
but the mass balance was lower.  
 
Scheme 3.27 Radical amination of octonitrile 3-4b 
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The ring methylene group NCH2N was completely missing in the 1H and 13C NMR 
spectra indicating a ring rearrangement reaction. The major product must be cyclic. Based on 
the NMR data, structures 3-56a-d presented in Scheme 3.27 are possible. The minor 
component of the mixture was assigned to acyclic aminonitrile 3-57.  
Significant NMR data of the major product were assigned: a triplet at 0.85 for CH3, 
two multiplets at 1.21-1.41 ppm for CH3(CH2)4 and at 1.78 ppm for N=CCH2CH2. The 
integrals in the alkyl range are not accurate enough to determine the number of protons 
unambiguously. A multiplet at 2.82 ppm for N=CCH2, and two multiplets at 7.34-7.57 ppm 
(8H) and at 8.15 ppm (2H) were assigned to the aromatic CHs. In the alkyl range of the 13C 
NMR spectrum, the quartet was assigned to the terminal methyl group and 5 triplets to the 
saturated alkyl chain. In the aromatic range, 6 doublets were assigned to two phenyl rings. 
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The singlets of the phenyl ring could not be unambiguously detected. Two singlets at 157.0 
and 161.3 ppm were assigned to the two carbon atoms of the tetrazine ring. Since NH or NH2 
groups were not conclusively detected in the spectrum, a distinction of 3-56a-d is difficult. 
Since 3-56 and 3-57 are not separable, it is assumed, that based on the similar polarity only 
one NH group is present in the molecule. This aspect speaks rather in favour of 3-56a-b, 
while 3-56c-d should be much more polar. Based on these data, compound 3-56a is the most 
probable product. 
Compound 3-57 was unambiguously assigned: a multiplet (2H) at 3.38 ppm for 
CHCH2NHPh, a broad singlet at 4.02 for NHPh, a doublet (2H) at 6.60 ppm for aromatic CH, 
a triplet at 6.75 ppm for aromatic p-CH, and finally a dd (2H) at 7.20 ppm were the key 
resonances. Resonances in the alkyl range indicated a longer chain, while in 13C NMR a 
singlet at 118.2 ppm was assigned to the cyano group. 
 
3.5.3. Reactions of 1,3,5-triphenylverdazyl with organolithium, organozinc and Grignard 
reagents 
In early studies alkyltetrazines were synthesised by coupling of 1,3,5-
triphenylverdazyl with Grignard reagents or organolithium compounds.115 
Butyltetrahydrotetrazine 3-58a was synthesised in 45% yield by treating 1,3,5-
triphenylverdazyl 3-39 with 1 equivalent of BuLi (Scheme 3.28),116 and the result proved to 
be reproducible (Table 3.27, entry 1). The complete consumption of verdazyl 3-39 was 
accompanied by a colour change from deep green to brown. It was noteworthy that the deep 
green colour of verdazyl reappeared during workup and some of it was recovered. Lowering 
the amount of BuLi to 0.5 equiv. did not lead to formation of 3-58a (entry 2). The reaction 
was, however, improved by regenerating free 3-39 in situ from lithiumverdazyl 3-39-Li by 
reoxidising it with dry air or dry oxygen. After reappearance of the green colour, the reaction 
mixture was purged with nitrogen and treated with additional BuLi at −78 °C. When the green 
colour of verdazyl turned to brown signalling its consumption, dry air was again bubbled 
through the solution until the colour changed to deep green. This procedure was repeated until 
the reaction mixture remained dark brown for at least 15 minutes of air bubbling. The yields 
increased to 86% (entry 3). This experiment was repeated also using dry oxygen for 
reoxidation of the verdazyl lithium species. The consumed amounts of BuLi were somewhat 
different giving 3-58a in 92 and 85% yields, respectively (entry 4). This is probably due to 
exactness of addition and decomposition of excess BuLi by oxygen. The method was also 
applied to other organometallic reagents. The reactivity of tBuLi towards 3-39 proved to be 
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lower. Higher temperatures (−15 °C) and longer times were necessary to obtain a persistent 
colour change to brown of the verdazyl solution (entry 5). A total of 5.4 equivalents of tBuLi 
was used to reach the modest yield of 48% of 3-58b. 
 
Scheme 3.28 Reaction of verdazyl 3-39 with BuLi 
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Table 3.27 Reaction of verdazyl with organometallic compounds 
Entry Reagent (equiv.) Product Method/T (°C) Yield (%) 
1 BuLi (1) A/−30 45 
2 BuLi (0.5) A/20 0 
3 BuLi (2.7) B/−78 86 
4 BuLi (1.8/3.9) 
N
NN
N
Ph Ph
Ph
 
3-58a 
C/−78 92/85 
5 tBuLi (5.4) 
N
NN
N
Ph Ph
Ph
 
3-58b C/−78 48 
6 EtMgBr (1.83) C/−78 47 
7 Et2Zn (5.05) 
N
NN
N
Ph Ph
Ph
 
3-58c 
C/0 47 
8 MgBr2·Et2O - - C/0 - 20 - 
Method A: The organometallic reagent was added at once. Method B: 3-39 was alternatively titrated 
with the organometallic reagent and regenerated by bubbling dry air. Method C: 3-39 was alternatively 
titrated with the organometallic reagent and regenerated by bubbling dry oxygen.  
 
EtMgBr was more reactive, but the reoxidation of organometallic species 3-39-MgBr 
was not proceeding. After initial addition of 1.8 equivalents of EtMgBr, dry oxygen was 
bubbled through the solution but the reaction mixture did not change the colour back to green 
(entry 6). The yield of 47% was slightly higher than previously reported. The reaction with 
diethylzinc proceeded similarly, giving the product in 47% yield (entry 7).  
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The structures of the products were assigned based on their NMR data (Table 3.28). 
 
Table 3.28 Significant NMR data of compounds 3-58a-c 
δ (multiplicity) Entry Compound 
CH2NNPh or CNNPh PhC=N PhNCH2NPh 
1 3-58a 3.22 (m), 55.1 (t) 149.0 (s) 4.24 (d), 5.54 (d), 57.7 (t) 
2 3-58b - , 60.7 (s) 150.0 (s) 4.73 (d), 5.78 (d), 62.0 (t) 
3 3-58c 2.76 (br. s), 3.35 (br. s), 49.8 (t) 149.5 (s) 4.26 (d), 5.56 (d), 57.8 (t) 
 
A plausible mechanism for the formation of alkyl verdazyl adducts 3-58a-c is 
presented in Scheme 3.29. The verdazyl radical 3-39 oxidises the organometallic species 
giving 3-39-Li and a butyl radical, which combines with the excess of 3-39 affording product 
3-58a. This explains the low yield of 45% obtained earlier in the reaction of equimolar 
amounts of verdazyl with BuLi. The reoxidation of 3-39-Li to radical 3-39 by oxygen allowed 
the optimisation of the synthesis of 3-58a up to 92% yield. Unfortunately BuLi was so far 
rather an exception, since either the coupling was slow, as in the case of tBuLi, or the 
reoxidation method was not as efficient for other organometallic reagents like EtMgBr or 
Et2Zn. 
 
Scheme 3.29 Mechanism of oxidation of organolithiums with verdazyl 3-39 
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To determine whether stable verdazyl magnesium species can be generated individually, 
3-39 was treated with two equiv. of Br2Mg·OEt2 at 0-20 °C (Scheme 3.30). A colour change 
would indicate the reduction of the verdazyl. However, no colour change was observed and 3-
39 was recovered, which indicated that it did not react with magnesium bromide. 
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Scheme 3.30 Treatment of 3-39 with MgBr2. 
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Key results:  
Investigations of the general reactivity of verdazyl 3-39 uncovered a multitude of 
reaction channels, which depend on the enolate structure (Scheme 3.31). The heterocoupling 
of verdazyl 3-39 with α-carbonyl radicals 3-59 was efficient and presented a new short access 
to α-amino carbonyl compounds 3-44 and 3-48 with nitrogen containing groups in α-position. 
With octonitrile 3-4b and methyl acetoacetate 3-49 verdazyl underwent new rearrangement 
reactions. In the presence of the enolate of methyl acetoacetate 3-49, the verdazyl ring 
contracted to triazole 3-51, while 3-39 rearranged in the presence of a ketene iminate probably 
to tetrazine 3-56a. These reactions are very interesting and deserve further investigation.  
On the other hand 3-39 played the role of the oxidising agent in the reaction with 
organometallic reagents affording products of type 3-58a. The reaction of 3-39 with BuLi was 
improved by reoxidising the coformed organometallic verdazyl species with oxygen, while 
for other organometallic reagents it proceeded rather with moderate yields. Further 
investigations are necessary to develop this reaction. 
 
Scheme 3.31 Reactions of persistent radical verdazyl 3-39 
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3.6. Dimerisations of carbonyl compounds 
 
The radical dimerisation of carbonyl compounds competes surprisingly successfully to 
the trapping of α-carbonyl radicals 2-3 (cf. Scheme 2.1) with TEMPO for some ketones and 
esters although the latter was present in high concentration in the solution during oxidation, 
like for example ethyl heptanoate 3-1d (Scheme 3.32).10a Due to the persistent radical effect,46 
dimerisation should not occur in these experiments under ordinary conditions. Moreover a 
diastereoselectivity was observed in the dimerisation of aromatic ketones and esters, which is 
surprising for enolates, which are not hindered or auxiliary bound.62  
 
Scheme 3.32 α-Oxygenation of ethyl heptanoate 3-1 according to ref.10a 
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The impact of enolate aggregation and additives on yield and diastereoselectivity of 
radical dimerisations will be studied under following aspects:  
1. Investigation of different dimerisation conditions. 
2. Applicability of the method for a large variety of carbonyl compounds. 
3. Mechanistic investigations: a) Correlation of enolate geometry and diastereoselectivity. b) 
Influence of aggregation on diastereoselectivity to achieve better diastereoselectivity using 
supramolecular structures. c) Mechanism of the oxidation and coupling of enolates. 
 
3.6.1 Investigation of different dimerisation conditions 
The established dimerisation procedure developed for esters implies generation of the 
enolate by deprotonation with LDA in THF at −78 °C, followed by oxidation with 
ferrocenium hexafluorophosphate 1-3.10a, 25 Esters give often a moderate excess of the meso-
dimer under these conditions. It is known that ester enolates form supramolecular structures in 
THF and that their enolates have (E)-geometry.80, 81 However the enolate configuration can be 
changed to a (Z)-geometry by using HMPA as an additive. 
The dimerisation diastereoselectivity of ethyl valerate 3-1a was influenced by the 
addition mode of the oxidant 1-3 (Scheme 3.33). The dimer 3-3a was obtained in 60% yield 
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in a 1.5:1 meso/d,l-ratio when two equivalents of ferrocenium hexafluorophosphate 1-3 were 
added at once to the enolate solution. When 1.8 equivalents of the oxidant 1-3 were added in 
small portions, the dimer 3-3a was isolated in an improved 89% yield with a better 2.5:1 
meso/d,l-ratio. The significance of these results for the mechanism is discussed in chapter 
3.6.3 (vide infra). 
 
Scheme 3.33 Dimerisation of 3-1a 
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b
2%
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+
  
a) The oxidant 1-3 (2 equiv.) was added at once to the enolate solution. b) The oxidant 1-3 (1.8 equiv.) 
was added in portions as it was consumed. 
 
At higher temperature the diastereoselectivity of dimerisation decreased (Table 3.29, 
entry 1). Moreover trimerisation to 3-34a competed. Interestingly, dimerisations in DME 
provided 3-3a with reversed diastereoselectivity in moderate yields (entries 2 and 4). HMPA 
proved to be an additive of choice for breaking enolate aggregation in TEMPO trapping 
reactions. In an experiment in DME/HMPA 5.7:1 it displayed a detrimental effect, since only 
16% of the desired dimer 3-3a was isolated (entry 3). 
 
Table 3.29 Dimerisation of 3-1a under different conditionsa 
Entry Solvent, additive, oxidation temperature 3-3a (%) Meso:d,l 3-34a (%) 
1 THF, −20 °C 53 1.2:1 25 
2 DME, −78 °C 54 1:1.8 2 
3 85% DME, 15% HMPA, −78 °C 16 - - 
4b DME, 0.4 equiv. TEMPO, −78 °C 40 1:1.5 23 
a) Deprotonation time 30 min, 1-3 was added in small portions. b) TEMPO trapping product 3-2a was 
isolated in 29% yield; small amounts of Claisen condensation product were detected. 
 
Other conditions were less suitable. Dimerisations in toluene afforded complex 
mixtures. Resonances of the dimers could not be detected by NMR spectroscopy. Attempted 
oxidative couplings of ethyl valerate enolate with PdCl2 in THF in the absence or presence of 
1 equivalent HMPA afforded also complex mixtures. Small amounts of products formed via 
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anionic pathways such as Claisen condensation product 3-35a and trimer 3-34a were detected. 
The transmetallation of the Li counter ion to a stronger chelating metal ion using MgBr2 was 
tried, however, the magnesium enolate of ethyl valerate 3-1a did not dimerise, but gave 
complex mixtures and a bad mass balance. 
 
3.6.2. Substrate scope and correlation of the enolate geometry with the diastereoselectivity 
The observation that esters enolates, which have an (E)-geometry in THF,80 underwent 
oxidative couplings with meso selectivity,10a while propiophenone enolates with (Z)-
geometry1b gave preferentially the d,l-dimer in high excess,25 suggested the importance of the 
enolate geometry for the diastereoselectivity of dimerisations. The enolates of cyclohexanone 
3-10f, (R)-camphor 3-10h and butyrolactone 3-1c have a “frozen” (E)-geometry constrained 
by the ring (Scheme 3.34, Table 3.30). The dimerisation of cyclohexanone occurred in 86% 
yield but without diastereoselectivity (Table 3.30, entry 1). HMPA and LiCl as additives 
breaking aggregates decreased the yield somewhat, while the diastereoselectivity remained 
unchanged (entries 2 and 3). 
 
Scheme 3.34 Dimerisation of cyclohexanone 3-10f and (R)-camphor 3-10h 
2) FeCp2PF6 1-3
1) LDA
THF, !78 °C
O OO OO 1) LDA
THF, !78 °C
+
O
meso-3-12f dl-3-12f
exo,endo-3-12h endo,endo-3-12h exo,exo-3-12h
2) FeCp2PF6 1-3
+ +
O O
HH
O O
HH
O O
HH
3-10h
3-10f
 
 
Table 3.30 Dimerisation of enolates with a “frozen” (E)-geometry. 
Entry Substrate Additive (equiv.) 3-12 (%) Diastereoselectivitya 
1 - 3-12f 86 1:1.1b 
2 LiCl (4.7) 3-12f 56c 1.2:1b 
3 
3-10f 
HMPA (6) 3-12f 67 1:1b 
4 - 3-12h 66 2.2:1.8:1d 
5 
3-10h 
- 3-12h 66 1.7:1:1.8d 
a) The diastereomeric ratio was determined by NMR. b) meso/d,l. c) Additionally, 5% cyclohexenone 
was isolated. d) exo,endo:endo,endo:exo,exo. 
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 The dimers of (R)-camphor 3-10h were synthesised in good yields (entries 4 and 5).117 
The diastereoselectivity was modest and variable. Butyrolactone 3-1c did not dimerise. The 
isolated complex mixtures may be attributed to ring-opening reactions. 
The structures of the dimers were assigned by means of their NMR data. The 
characteristic resonances of the α-carbonyl positions are given in Table 3.31.  
 
Table 3.31 Significant NMR data of dimers 3-12f and 3-12h 
δ (ppm, multiplicity) Entry Dimer 
CHCO CH2CHCHCO 
1 d,l-3-12f 2.83 (m), 48.9 (d) - 
2 meso-3-12f 2.63 (m), 50.1 (d) - 
3 3,3’-endo,endo-3-12h 2.43 (m), 49.1 (d) 1.96 (m), 49.0 (d) 
4 3,3’-endo,exo-3-12h 2.35 (t), 46.6 (d), exo-part 
2.42 (m), 51.6 (d), endo-part 
2.67 (d), 46.5 (d), exo-part 
1.87 (m), 51.7 (d), endo-part 
5 3,3’-exo,exo-3-12h 2.00 (s), 54.2 (d) 2.08 (d), 46.8 (d) 
 
The configuration of the isomer d,l-3-12f was established by X-ray crystal structure 
analysis (Figure 3.8). The stereochemistry of camphor dimers 3-12h was assigned by NOE 
and NOESY experiments, and were in accordance with the NMR data known from the 
literature.117 
 
Figure 3.8 X-Ray crystal structure of d,l-3-12f 
 
 
It is known that the (E)-enolate geometry of esters in THF can be changed to the (Z)-
enolate by using cosolvents such as HMPA or DMPU.81 Dimerisations performed in 77% 
THF/23% HMPA as a classical solvent to reverse the ester enolate geometry and using 
LiHMDS as a base afforded complex mixtures (not shown). The oxidative coupling of the 
(Z)-enolate of 3-1a in 55% THF/45% DMPU gave no dimer, instead complex mixtures were 
isolated (not shown). 
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Scheme 3.35 Dimerisation of (Z)-enolates 
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Table 3.32 Dimerisation of (Z)-enolatesa 
Entry Substrate R X Dimer (%) d,l/meso Other products (%) 
1 3-1a C3H7 OEt   3-3a 41 1.4:1  
2 3-4d C3H7 NEt2 3-60 40 2.5:1 3-61 (7), 3-4d (17) 
3 3-4d C3H7 NEt2 3-60 30 2.1:1 3-61 (6), 3-4d (15) 
4c 3-4d C3H7 NEt2 3-60 21    5:1 3-62 (15), 3-4d (9) 
5d 3-4d C3H7 NEt2 3-60 19    1:0 3-62 (12), 3-4d (6) 
6 3-6 C5H11 OH   3-8 33    4:1 3-9 (15), 3-6 (51) 
725 3-10a CH3 Ph 3-12a 52  10:1 - 
8e 3-10a CH3 Ph 3-12a 73  5.5:1 - 
9f 3-10a CH3 Ph 3-12a 98  4.1:1 - 
10g 3-10a CH3 Ph 3-12a 36   11:1 3-63a (12) 
11 3-10b CH2CH3 Ph 3-12b 84 > 13:1 - 
a) If not otherwise stated, deprotonation was performed with 1.3 equiv. LDA, and oxidation was performed with 
1-3. b) Additive HMPA (6 equiv.). c) Deprotonation was performed with 2.3 equiv. LDA for 15 min. d) 
Deprotonation was performed with 2.3 equiv. LDA for 15 min, followed by 1 equiv. BuLi for 0.5 h. e) Additive 
LiCl (4.7 equiv.). f) Additive HMPA (6 equiv.). g) The oxidation was performed with CuCl2. 
 
Dimerisation of the enolate of 3-1a generated by deprotonation with LDA in the 
presence of 6 equivalents of HMPA gave the dimer 3-3a in 41% yield with a slight excess of 
the d,l-isomer (Scheme 3.35, Table 3.32, entry 1). The (Z)-enolate of N,N-diethyl pentanoic 
amide 3-4d dimerised with moderate diastereoselectivity (Table 3.32, entries 2-3). The low 
yields of 3-60 are attributed to the formation of byproducts such as N,N-diethyl 2-pentenoic 
amide 3-61. In both experiments, some substrate 3-4d (15-17%) was recovered. Therefore the 
deprotonation was examined under different conditions. A shorter deprotonation time of 15 
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min instead of 30 min with larger amounts of LDA afforded 3-60 in only 21% yield (entry 4). 
Although the amount of recovered 3-4d was smaller (9%) and N,N-diethyl 2-
(diisopropylamino)pentanoic amide 3-62 was isolated in 15% yield, and the overall mass 
balance decreased. In another experiment the amide was deprotonated with 2.3 equiv. LDA 
for 15 min, followed by 1 equiv. BuLi for 30 min (entry 5). The dimer 3-60 was isolated in 
only 19% yield, while 12% of amino ester 3-62 was formed. Interestingly, an increased 
amount of LDA to 2.3 equivalents and 3.3 equivalents afforded 3-60 and 3-62 in similar 
yields, but the diastereoselectivity of 3-60 increased significantly to 5:1 and 1:0, respectively 
(entry 4 versus entry 5). Unfortunately, neither the yield of the dimerisation, nor the yield of 
the potential useful transformation to 3-62d could be increased. 
The enediolate of heptanoic acid 3-6 underwent oxidative dimerisation in 33% yield 
with a reasonable 4:1 diastereoselectivity (entry 6). The deprotonation of this acid with LDE 
gave good results in TEMPO trapping experiments. A similar deprotonation could potentially 
improve the dimerisation yields. 
The low yields in dimerisations of amide 3-4d and acid 3-6 can probably be attributed 
to a parallel orientation of the α-carbonyl radicals to the enolate units in aggregates like 3-64 
(Scheme 3.36). This favours a hydrogen transfer from the enolate unit in a disproportionation 
reaction or from the solvent re-forming the substrate and the α,β-unsaturated acid or amide.  
 
Scheme 3.36 Formation of product 3-67 
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In the reaction of 3-4d a larger excess of LDA promoted formation of 2-
(diisopropylamino)pentanoic amide 3-62. Formation of mixed aggregates 3-68 containing 
enolate and LDA units is the likely reason for the surprising formation of 3-62 (Scheme 3.37). 
Ferrocenium hexafluorophosphate 1-3 oxidised coordinated LDA to a diisopropylaminyl 
radical 3-69 which added to the neighbouring enolate. The resulting stabilised radical 3-70 is 
oxidised by another equiv. 1-3 to amino amide 3-62. Unfortunately the yield of this 
potentially useful transformation could not be increased. 
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Scheme 3.37 Formation of product 3-62 
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Propiophenone 3-10a underwent dimerisation in good yields and high d,l/meso 
diastereoselectivity of 10:1 (Table 3.32, entry 7).25 This reaction proceeded in high yields of 
73% and 98% respectively in the presence of LiCl and HMPA (entries 8 and 9). The 
diastereoselectivity dropped however to 5.5:1 and 4.1:1, respectively. Oxidative coupling with 
CuCl2 occurred in low yield, but also with diastereoselectivity (entry 10). The major isomer 
was confirmed to have d,l-configuration by its X-ray crystal structure, which shows that the 
carbon atoms in the α-position of the carbonyl group have opposite configurations (Figure 
3.9). The methyl and benzoyl groups are in gauche conformations to each other.  
 
Figure 3.9 X-Ray crystal structure of d,l-3-12a 
 
 
Butyrophenone dimerised also in high yields and with high d,l-diastereoselectivity 
(entry 11). The stereochemistry of the dimers was assigned by comparison with 3-12a. 
Substrates with a sterically hindered radical centre like isobutyrophenone 3-10c or 
tert-butyl ethyl ketone 3-10e did not dimerise. Octonitrile 3-4b was also a substrate, which 
did not undergo oxidative dimerisations. Complex mixtures were isolated. 
The resonances of the hydrogen and carbon atoms in the α-carbonyl position are 
characteristic for dimers 3-12a, 3-8 and 3-60 (Table 3.33). 
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Table 3.33 Significant NMR data of dimers 3-12a, 3-60 and 3-8 
δ (ppm, multiplicity) Entry Dimer 
CHCO CH2CHCO 
1 d,l-3-12a 3.92 (m), 43.5 (d) - 
2 d,l-3-60 2.86 (m), 43.8 (d) 1.56 (m), 33.5 (t) 
3 meso-3-60 2.95 (m), 44.9 (d) 1.54 (m), 34.6 (t) 
3 d,l-3-8 2.71 (m), 46.0 (d) 1.28-1.62 (m), 31.6 (t) 
4 meso-3-8 2.66 (m), 48.0 (d) 1.28-1.62 (m), 31.5 (t) 
 
3.6.3. Influence of the aggregation on the diastereoselectivity 
 
Dimerisations in the presence of substoichiometric amounts of TEMPO 
The oxidative heterocouplings with TEMPO and earlier cross-coupling experiments of 
two different ester enolates25 indicated that the dimerisations occurred intramolecularly via 
enolate superstructures. The dynamics of aggregation, i.e. aggregation and deaggregation, 
may play an important role during dimerisation. It was therefore interesting to find out, to 
which extent free enolates 3-71 and aggregate-bound enolates 3-72 dimerised (Scheme 3.38). 
Free radicals 3-73 and aggregate-bound radicals 3-74 should be differentially trapped by 
TEMPO. It is expected that free radicals 3-73 couple considerably faster with TEMPO than 
aggregate-bound radicals 3-74. Therefore, dimerisations of ethyl valerate 3-1a, N,N-diethyl 
pentanoic amide 3-4d and cyclohexanone 3-10f were performed in the presence of 
substoichiometric amounts of TEMPO. 
In a first set of experiments (Method A) defined amounts of 0.1-0.5 equiv. of TEMPO 
were added to the enolate of ethyl valerate 3-1a solution before oxidation (Table 3.34). The 
oxidation was performed by addition of ferrocenium hexafluorophosphate 1-3 in portions at 
−78 °C over a period of 10 min. To achieve identical conditions, the experiments were 
performed in parallel. As expected, the yields of the TEMPO adduct 3-2a increased with 
higher amount of TEMPO, however, not as much as theoretically expected. The yields of the 
dimer 3-3a decreased as expected. The overall mass balance was good to excellent. Compared 
to the original 2.5:1 meso/d,l ratio (see Scheme 3.33), the diastereoselectivities increased in 
these experiments considerably in a range from 3.1:1 (entry 1) to exceptional 12.6:1 (entry 6). 
The diastereomeric ratios, obtained in the experiments with 0.3 and especially 0.5 equivalents 
of TEMPO, were lying outside the trend. These experiments were therefore repeated. Both 
were not reproduced. While the result in entry 4 did not differ strongly from the experiment in 
entry 3, the 12.6:1 meso/d,l-ratio in entry 6 seems to be an experimental error (compared to 
 66 
entry 7). These results are nonetheless very positive. The diastereoselectivity was improved 
significantly to a 3.1-5.4:1 meso/d,l ratio. These results support the supposition that TEMPO 
reacts faster with free α-carbonyl radicals. The aggregate-bound radicals homocoupled more 
selectively, giving dimers meso-3-3a in higher excess.  
 
Scheme 3.38 Oxidative coupling of enolates 3-71 in the presence of substoichiometric 
amounts of TEMPO  
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Table 3.34 Dimerisations of ethyl valerate 3-1a with substoichiometric amounts of TEMPO 
(Method A: TEMPO 1-2 was added before oxidation with 1-3) 
Entry Equiv. TEMPO 3-2a (%) 3-3a (%) meso/d,l 
1 0.1 11 (49 mg) 73 (140 mg) 3.1:1 
2 0.2 18 (79 mg) 66 (128 mg) 3.6:1 
3 0.3 29 (123 mg) 50 (98 mg) 2.6:1 
4a 0.3 27 (115 mg) 46 (90 mg) 4:1 
5 0.4 31 (132 mg) 57 (111 mg) 5.1:1 
6 0.5 32 (139 mg) 34 (68 mg) 12.6:1 
7a 0.5 37 (158 mg) 33 (64 mg) 5.4:1 
a) These experiments were repetitions of those in entries 3 and 6 respectively. 
 
In the first set, TEMPO was present from the beginning in the enolate solution and it 
probably reacted primarily with monomer species. The aggregation dynamics is an 
equilibrium and it depends on the time and concentration since TEMPO reacted not only with 
free radicals but also with aggregate bound species. This means that the substoichiometric 
TEMPO amount was probably consumed before oxidation and dimerisation were finished, 
since the oxidant was added over a period of ten minutes.  
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Therefore in a second set of experiments (Method B), TEMPO was homogeneously 
mixed with ferrocenium hexafluorophosphate and added in portions to the enolate solution 
(Table 3.35). Compared to method A, the yields of TEMPO adducts 3-2a were lower (entries 
1-5). The dimer 3-3a was isolated in moderate to good yields of 46-66%. With 0.2 equiv. of 
TEMPO 1-2 the diastereomeric ratio was with 6.8:1 high (entry 1), while with 0.3 equiv. of 
TEMPO 1-2 a modest 1.3:1 and 3.6:1 ratio was obtained (entries 2 and 3). Reactions with 0.4 
and 0.5 equivalents of 1-2 gave similar diastereoselectivities as method A. The diastereomeric 
ratio was with 5.0-5.4:1 good. A significant improvement of diastereoselectivity was achieved 
also in this case.  
 
Table 3.35 Dimerisations of ethyl valerate 3-1a with substoichiometric amounts of TEMPOa  
Entry Equiv. TEMPO 3-2a (%) 3-3a (%) meso/d,l 
1 0.2 11 (48 mg) 53 (103 mg) 6.8:1 
2 0.3 14 (61 mg) 46 (89 mg) 1.3:1 
3b 0.3 16 (69 mg) 51 (108 mg) 3.6:1 
4 0.4 14 (62 mg) 66 (129 mg) 5.4:1 
5 0.5 7 (29 mg) 51 (82 mg) 5.0:1 
6b 0.5 32 (92 mg) 48 (93 mg) 5.2:1 
a) Method B: TEMPO 1-2 was homogeneously mixed with 1-3. b) These experiments were a 
repetition of the experiments in entries 2 and 5, respectively. 
 
In a third set of experiments, 0.1 equivalents of TEMPO were added prior to oxidation 
(Table 3.36). The remaining TEMPO was homogeneously mixed with ferrocenium 
hexafluorophosphate 1-3 and added in portions (Method C). The TEMPO adduct 3-2a was 
isolated in 19-28% yields, while the dimer 3-3a was obtained in good yields of 56-69%. The 
diastereoselectivity was better than in the absence of 1-2 (compared to scheme 3.32) and 
relatively constant in the range 3.0-3.7:1 for all experiments.  
 
Table 3.36 Dimerisations of 3-1a with substoichiometric amounts of TEMPOa  
Entry Equiv. 1-2 3-2a (%) 3-3a (%) 3-3a meso/d,l 
1 0.2 19 (80 mg) 66 (128 mg) 3.3:1 
2 0.3 22 (93 mg) 69 (133 mg) 3.7:1 
3 0.4 21 (88 mg) 65 (126 mg) 3.6:1 
4 0.5 28 (119 mg) 56 (108 mg) 3.0:1 
a) Method C: 0.1 equiv. of TEMPO 1-2 was added before oxidation; the remaining amount was 
homogeneously mixed with ferrocenium hexafluorophosphate 1-3. 
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The presence of a persistent radical (TEMPO) in substoichiometric amounts in the 
enolate solution during the oxidation consumed a part of the free radicals present in solution 
and allowed the dimerisation in aggregates to a larger extent. The diastereoselectivity of 
oxidative dimerisations was improved significantly. The deaggregation of 3-72 to 3-71 is 
possible, while the deaggregation of the radical anion 3-74 to radical 3-73 and enolate 3-71 is 
rather unlikely as earlier computational calculations have shown.118 All three methods with 
substoichiometric amounts of TEMPO showed a similar trend of increasing 
diastereoselectivity. The results were, however, different since the initial concentration and 
the concentration profile of TEMPO throughout the reaction influenced the reaction 
significantly. Qualitatively it seems logic why rather constant diastereoselectivity is observed 
with method C, since TEMPO traps free radicals constantly. In method A and though less also 
in method B TEMPO is consumed competitively - fast by free radicals and slower by 
aggregate-bound radicals. The lower the TEMPO concentration in the beginning the faster it 
is consumed and for the most part of the reaction TEMPO is not present. The higher the initial 
concentration, the longer the trapping can last increasing the diastereoselectivity. These 
results indicate that aggregation plays an important role in this reaction. Further investigations 
must prove this hypothesis. 
Dimerisation of cyclohexanone 3-10f according to method A afforded the dimer 3-12f 
in a moderate yield of 41%, while the diastereoselectivity did not change significantly (Table 
3.37, entry 1). Dimerisations of N,N-diethyl pentanoic amide 3-4d according to methods A 
and B gave dimers 3-60 in very low yields, but with complete d,l-selectivity (entries 2 and 3).  
 
Table 3.37 Dimerisations in the presence of 0.3 equiv. TEMPO 1-2 
Entry Substrate Enolate 
config. 
Method 3-11f or 3-5d 
(%) 
dimer (%) d,l/meso d,l/meso 
without 1-2 
1 3-10f E A 3-11f 24 3-12f 41 1:1.3 1.1:1c 
2a 3-4d Z A 3-5d 30 3-60 11 d,l 2.5:1d 
3b 3-4d Z B 3-5d 21 3-60 16 d,l 2.5:1d 
a) 2% of 3-61 and 19% of 3-4d were isolated. b) 8% of 3-61, 6% of 3-62 and 20% 3-4d were isolated. c) See 
Table 3.30, entry 1. d) See Table 3.32, entry 2.  
 
 
3.6.4 Dimerisations of silyl ketene acetals 
To gain more information on the importance of enolate geometry, dimerisations of 
enolates with “fixed” geometry in the form of the (E)-silyl ketene acetals or (Z)-silyl ketene 
acetals of 3-1a, were investigated (Scheme 3.39). An interesting feature was to examine the 
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role of diisopropylamine from LDA. The (E)-silyl ketene acetal E-3-75 and (Z)-silyl ketene 
acetal Z-3-76 of ethyl valerate were synthesised using adapted literature procedures in ratios 
4-7:1.119 
Since the oxidation potential of E-3-75 is higher than that of the corresponding lithium 
enolate,120 the oxidation times (2.5-36 h) were much longer, but the dimerisation of (E)-silyl 
ketene acetal E-3-75 in the presence or absence of iPr2NH remained inefficient giving the 
dimer 3-3a in low yields of 10-28% (Table 3.38). The diastereoselectivities were also low.  
 
Scheme 3.39 Dimerisation of silyl ketene acetals 
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Table 3.38 Dimerisation of (E)-silyl ketene acetal E-3-75 
Entry (E/Z)-ratioa Additives (equiv.) Time (h) 3-3a (%) meso/d,l 
1a 4:1 iPr2NH (1.0) 2.5 10 - 
2a 4:1 - 10.5 28 1.3:1 
3b 6.4:1 - 36 15 1.2:1 
a) 0.3M in CH2Cl2. b) 0.3M in DME. 
 
The dimer 3-3a was obtained in low to moderate yields of 15-56% when E-3-75 or Z-
3-76 was transmetallated with MeLi to the amine-free (E)-enolate E-3-77 or (Z)-enolate Z-3-
78 (Scheme 3.40, Table 3.39, entries 1-8). Long transmetallation times (90 min) at higher 
temperatures of −30 to 20 °C triggered anionic competing processes leading to the formation 
of trimer 3-34a in yields from 10 to 30%. Enolate E-3-77 gave meso-3-3a preferentially, but 
only in a slight excess (entries 1, 2, 4 and 5) while Z-3-78 furnished 3-3a with a slight excess 
of the d,l-diastereomer (entry 8). Generally the obtained diastereoselectivities were very low 
and also not reproducible. A significant influence of the E-3-77:Z-3-78 ratio on the reaction 
outcome could not be established. The meso/d,l ratios did not reflect the initial E:Z enolate 
ratio, therefore a clear correlation between the (E/Z)-geometry of the enolate and 
diastereoselectivity of dimerisations was not established from these experiments. The 
oxidation of the lithium enolates E-3-77 or Z-3-78 prepared from E-3-75 or Z-3-76 in the 
presence of iPr2NH induced neither significant changes nor reproducible diastereoselectivities 
(entries 9-11). Experiments in the presence of substoichiometric amounts of TEMPO afforded 
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low yields of 3-3a with variable diastereoselectivities (entries 12-14). Consequently no new 
information or mechanistic insights on correlation between (E/Z)-enolate geometry and 
diastereoselectivity was gathered from these experiments.  
 
Scheme 3.40 Transmetallation of silyl ketene acetals with MeLi and their oxidative 
dimerisation 
OEt
OSiMe3
FeCp2PF6 1-3
C3H7
COOEt
C3H7
EtOOC
C3H7
COOEt
C3H7
EtOOC
+
E-3-75 meso-3-3a
d,l-3-3a
C3H7
OEt
OSiMe3
Z-3-76
H7C3
or
(iPr2NH)
THF, !78 °C
1.3 equiv. MeLi
OEt
OLi
H7C3
Z-3-78
or
OEt
OLi
E-3-77
C3H7
+3-34a
THF, !30 - 20 °C
90 min
 
 
Table 3.39 Dimerisation of (E)- and (Z)-silyl ketene acetals E-3-75 and Z-3-76  
Entrya E:Z Additives (equiv.) 3-2a (%) 3-3a (%) meso/d,l 3-34a (%) 
1b 4:1 - - 56 1.8:1 10 
2c 6.4:1 - - 23 1.9:1 29 
3c 4.5:1 - - 43 1:1.2 30 
4 4.5:1 - - 40 1.5:1 26 
5 7:1 - - 45 1.6:1 28 
6 7:1 - - 15 1:1 26 
7d 1:7 - - 31 - - 
8e 1:7 - - 56 1:1.4 16 
9  5.5:1  iPr2NH (1.3) - 58 3.2:1 20 
10 7:1  iPr2NH (1.3) - 50 1.1:1 22 
11 6.7:1  iPr2NH (1.3) - 41 1:1 41 
12 4.5:1 TEMPO (0.3) 27 16 4.6:1 32 
13 7:1 TEMPO (0.3) 27 29 1.3:1 12 
14 6.7:1 TEMPO (0.3) 30 5 1:0 52 
a) Unless otherwise specified, the general conditions were: Transmetallation with 1.3 equiv. of MeLi at −30 °C 
for 5 min and at r.t. for 90 min in 0.1M solution of the substrate in THF; oxidation with 1-2 equiv. of 1-3 at −78 
°C for 15-30 min. b) 1 equiv. MeLi. c) 1.15equiv. MeLi. d) Transmetallation at −30 - −15 °C for 40 min. e) 
Transmetallation at −40 - −30 °C for 30 min.  
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3.7. Mechanistic rationalisation of oxidative coupling reactions of enolates 
 
The α-oxygenation of carbonyl compounds via SET oxidation of their enolates to an 
α-carbonyl radical induced by ferrocenium hexafluorophosphate 1-3, followed by trapping 
with TEMPO 1-2 is generally applicable. All substrates gave the α-oxygenated carbonyl 
compounds in high yields, with the exception of α,α-dialkyl amides and ketones. Carbonyl 
compounds bearing adjacent chiral centres react with low to moderate diastereoselectivities. 
The oxygenation of ester 3-1b occurs probably via trapping of the chelated alkoxide radical A 
(Figure 3.10). The approach of TEMPO takes place at the β-face affording the anti-isomer, 
similarly to the Frater-Seebach alkylation.121 However, the more hindered α-face is also 
accessible for radical trapping leading to relatively low anti/syn selectivity. Unexpectedly, 
steric effects do not play a role in the radical oxygenation of (R)-camphor 3-10h. 1-2 couples 
with the α-carbonyl radical equally from both faces, although the exo-face is more hindered. 
Similarly ethyl (S)-2-pyrrolidone-5-carboxylate 3-4i gives a low diastereoselectivity. This 
speaks for an early transition state of the radical coupling. 
 
Figure 3.10 Radical coupling of 3-1b with TEMPO 
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Figure 3.11 Model for the preferred formation of d,l-3-5h 
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The diastereoselectivity of radical coupling with glutaric diamide 3-4h can be 
rationalised by assuming that the α-carbonyl radical of amide 3-4h has to be flat and in the 
same plane with the neighbouring amide group (Figure 3.11). Considering a 7-membered ring 
chelated transition state like A, TEMPO 1-2 approaches from the β-face forming d,l-3-5h in 
excess. The residing tetramethylpiperidin-1-yl unit apparently blocks the α-face relatively 
efficiently. The minor isomer may result from an open transition state. 
Unhindered aliphatic esters, carboxylic acids, aromatic ketones and in part amides 
form unexpectedly large amounts of dimers via homocoupling of the α-carbonyl radicals. 
Oxidative dimerisations compete, although TEMPO trapping with α-carbonyl radicals is a 
very fast process (k = 107-109 M–1s–1).122 Moreover, the persistent radical effect of TEMPO 
should inhibit the homocoupling of transient α-carbonyl radicals 3-82 (Scheme 3.41). The 
surprising formation of dimers is ascribed to the aggregation effects of enolate solutions.25 As 
most other organolithium compounds, the enolates of esters and amides aggregate as dimers, 
while ketone enolates assemble in tetrameric superstructures.1, 81 Different degrees of 
diastereoselectivity in dimerisations of esters, amides and ketones, respectively, reflect that, 
while classical radical homocouplings should take place without diastereoselectivity. 
Diastereoselective radical dimerisations were reported rarely, usually for chiral auxiliaries 
bound radicals.62,70  
The diastereoselectivity seems to be correlated to some extent with the enolate 
geometry. It was observed that acyclic (E)-enolates form preferentially meso-dimers, while 
(Z)-enolates give an excess of d,l-isomers. Yet the meso:d,l ratio of dimers does not reflect the 
selectivity of enolate formation. Hence the diastereoselectivity of dimerisation must be a 
result of combined aggregation effects and enolate geometry. 
Ester 3-79 is deprotonated to aggregate E-3-80A in THF (Scheme 3.41, path A). 
Single electron oxidation with ferrocenium hexafluorophosphate leads to formation of radical 
cation 3-80B-1. Elimination of tetracoordinated Li+ generates radical 3-80C-1, composed of 
an α-carbonyl radical unit 3-82 and an enolate unit E-3-81. 3-80C-1 undergoes a 7-endo 
cyclisation to radical 3-80D-1 through a radical addition of the α-carbonyl radical to the 
enolate unit with preferential meso-diastereoselectivity. This is the key step, which determines 
the diastereoselectivity of the products. Another SET step gives dimer meso-3-84. Structures 
like 3-80B-1, 3-80C-1, and 3-80D-1 were approximated by DFT calculations for methyl 
propionate in Me2O.118 The calculations supported the theory that formation of meso-dimer 
from the (E)-enolate is energetically favoured for this case.  
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Scheme 3.41 Rationalisation of the dimerisation diastereoselectivity of esters and amides  
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In THF/HMPA the (Z)-enolate aggregates to Z-3-80A (Path B). SET oxidation by 
ferrocenium hexafluorophosphate gives 3-80B-2, which forms radical 3-80C-2 by elimination 
of a lithium cation. 7-endo-Cyclisation to 3-80D-2 followed by SET oxidation affords d,l-3-
84. Similarly, amide enolates, which have a (Z)-geometry, form the d,l-isomer with high 
selectivity. Monomeric enolates 3-81 are in equilibrium with E-3-80A or Z-3-80A (Path C). 
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They are oxidised to free radicals 3-82, which undergo unselective radical homocoupling to 
both meso- and d,l-3-84. The investigations on the role of aggregates and enolate geometry 
can be outlined as follows: 
1) Hartmann performed crossover oxidative dimerisations of ethyl butyrate and ethyl 
valerate with different mixing time of their enolate solutions.25 The ratio of formed 
homodimers and heterodimers and the constant diastereoselectivity of 2:1 meso:d,l for all 
formed dimers substantiated that aggregation plays an important role in the mechanism of this 
reaction.  
2) The addition of the oxidant has an impact on diastereoselectivity. Addition of the 
oxidant at once to the enolate solution of ethyl valerate gave a 1.5:1 meso:d,l ratio, while 
addition in portions gave a 2.5:1 ratio (Scheme 3.33). Addition at once generates a high 
concentration of α-carbonyl radicals, and the dimerisation occurs mostly via radical coupling. 
When the oxidant is added in portions, a small concentration of α-carbonyl radicals is 
generated stepwise and the radical addition to the enolate units inside of an aggregate dimer 
like 3-80C-1 and 3-80C-2 prevails.  
3) The dimerisation experiments with substoichiometric amounts of TEMPO 
improved the diastereoselectivity of meso-3-3a significantly (Tables 3.34, 3.35 and 3.36). 
TEMPO traps preferentially the free α-carbonyl radicals 3-82 giving product 3-83. These 
results support the theory that aggregation induces diastereoselectivity. The bound α-carbonyl 
radicals in 3-80C-1 undergo a radical addition to the neighbouring enolate unit, leading to 
meso-3-3a. The α-carbonyl radical features a high rotation barrier, and therefore its partial 
allylic character makes a conformational rotation slow.123 In this way the orientation of 
substituents in the enolate will be retained in the α-carbonyl radical. The facts speak for the 
retention of the enolate configuration in the conformation of the radical. 
4) The diastereoselectivity of dimerisation does not reflect the selectivity of enolate 
formation. The preparation of silyl ketene acetals via quenching of the enolate with TMSCl 
allows the accurate determination of the (E/Z)-enolate ratio present in solution (see Tables 
3.38 and 3.39). This ratio can be variable. Their transmetallation with MeLi generates the 
corresponding lithium enolate with retention of the (E/Z)-ratio, allowing in principle the 
investigation of the correlation between the (E/Z)-enolate ratio and the meso/d,l-dimer ratio, 
in the absence of iPr2NH, HMPA or other lithium-coordinating agents. Unfortunately, the 
dimerisation experiments of silyl ketene acetals provided inconsistent results. 
5) The nature of the oxidant and the mechanism of oxidation play also an important 
role. The meso:d,l dimer ratio amounted to 2.5:1 with ferrocenium hexafluorophosphate, 
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which is an outer sphere oxidant (Scheme 3.33). In contrast no diastereoselectivity was 
observed with CuCl2, which is an inner sphere oxidant.25 CuCl2 transmetallates Li+ in E-3-
80A or Z-3-80A, giving covalent copper enolate Cu-3-81 (Scheme 3.41, path D). Inner sphere 
oxidation forms a free α-carbonyl radical 3-82, which couples unselectively to both meso-3-
84 and d,l-3-84. 
 
Scheme 3.42 Dimerisation of propiophenone  
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Similar arguments explain the highly selective formation of d,l-3-12a (Scheme 3.42). 
Propiophenone enolates aggregate in tetrameric superstructures like 3-85A. The addition of 1-
3 in portions oxidises the enolate to an α-carbonyl radical, which is surrounded by three 
enolate units in aggregates like 3-85B. Radical addition to a neighbouring unit followed by a 
second oxidation gives d,l-3-12a. In competition dissociation generates 3-86A whose 
oxidation leads via 3-86B to radical 3-86C, which is further oxidised to d,l-3-12a. The 
concentration of monomer 3-87 gives both dimers d,l-3-12a and meso-3-12a unselectively. 
Aggregate-bound radicals preferentially undergo radical addition to a neighbouring enolate 
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unit. This explains the high yield of the dimer d,l-3-12a formed in the presence of TEMPO 
(Scheme 3.5, table 3.7, entry 1). In the presence of lithium-coordinating additives like HMPA 
or aggregate-breaking additives like LiCl, the concentration of free enolate units 3-87 
increases giving more of 3-11a.  
 
Scheme 3.43 Formation of main products in the α-oxygenation of methyl ketones 3-10i-k 
O
R
1
OTMP
OH O
3-11i-k 3-13i-k
R
1
R
1
OTMP
1-3 O
R
1
Li
S
S
O
R
1
O
R
1
Li
S
S
O
R
1
1-3
1-2
O
R
1
Li
S
S S
n n
1-3
O
R
1
Li
S
S
O
R
1
n
OTMP
1-2
O
R
1
Li
S
S S PF6
1-2
3-89A 3-89B
3-90A 3-90B 3-90C
3-89A
 
 
Methyl ketones 3-10i-k were deprotonated kinetically and oxygenated with high 
regioselectivity at the methyl position. Nonetheless a number of byproducts were isolated. 
The enolate 3-89A is in equilibrium with the aggregate 3-90A (Scheme 3.43). SET oxidation 
of 3-89A to 3-89B and trapping by 1-2 gives product 3-11i-k. SET oxidation of 3-90A forms 
the aggregate bound radical 3-90B, which couples with 1-2 affording intermediate 3-90C. 
Formation of 3-90C is possible because 1-3 is added in portions and a small amount of α-
carbonyl radicals is generated at a time. An aldol addition of the enolate to the trapping 
product follows giving hydroxy ketone 3-13i-k. Small amounts of byproducts resulting from 
the internal deprotonation of methyl ketones 3-10i-k were also observed. They form by 
similar pathways. Addition of the oxidant 1-3 at once would generate a high concentration of 
α-carbonyl radicals, which may be trapped by 1-2 and increase the yield of 3-11i-k. Dimers 
resulting from homocoupling, which were isolated in small amounts, may also form in higher 
yields.  
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4. Oxidative radical cyclisations of enolates and application to new efficient total 
syntheses of 15-F2t-isoprostane, 13,14-dihydro-15-oxo-E2-isoprostane and 13,14-dihydro-
15-oxoprostaglandin E2 
 
4.1. Retrosynthesis 
 
Scheme 4.1 Retrosynthetic disconnection of 4-1, 4-2 and 4-3 
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This chapter presents the development of an oxidative cyclisation method and its 
application to the total synthesis of the methyl ester of racemic 15-F2t-IsoP 4-1. Moreover the 
complete carbon skeleton of 15-A2-IsoP 4-2 was assembled. This method was also applied to 
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the total synthesis of potential metabolites of 15-E2-IsoP 1-55, namely the racemates of 13,14-
dihydro-15-oxo-E2-IsoP 1-59 and 13,14-dihydro-15-oxo-PG E2 1-60 in the form of their 
methyl esters 4-3 and 4-4. 
The retrosynthetic analysis of 15-F2t-IsoP methyl ester 4-1, 15-A2-IsoP methyl ester 4-
2 and 13,14-dihydro-15-oxo-15-E2-IsoP methyl ester 4-3 calls for the crucial C-C bond 
forming steps early in the synthetic strategy and an adjustment of the functional groups in 
derivatives 4-5 and 4-6 in the final part of the synthesis (Scheme 4.1). The disconnection of 
the C6-C7 bond leads to derivatives of hex-5-ynoate 4-9 or 4-10 and 
hydroxycyclopentanecarboxylates 4-7a,b or 4-8a,b. This disconnection is new in isoprostane 
chemistry. The cyclopentane ring systems 4-7a,b and 4-8a,b will be approached by oxidative 
radical 5-exo-cyclisations of 3-alkoxido enolates of 4-11a,b and 4-12a,b respectively. The 
oxygen functionality in the 15-position will be introduced using TEMPO 1-2.124 
 
4.2. Synthesis of starting materials for the oxidative radical cyclisations 
 
4.2.1. Cyclisation precursors for 15-A2-IsoP 4-2 
The impact of different structural features like ester size and geometry of the double 
bond on the radical cyclisation outcome had to be studied in the course of the total synthesis. 
Therefore two isomeric pairs of compounds 4-11 were synthesised (Figure 4.1). 
 
Figure 4.1 Cyclisation precursors for A2-isoprostane synthesis 
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4.2.1.1. An efficient synthesis of 15-A2-IsoP precursors (6E,8Z)-4-11a and (6E,8E)-4-11a,b 
Radical isomerisation of the (Z)-double bond of commercially available (2E,4Z)-ethyl 
2,4-decadienoate (2E,4Z)-4-13 gave (2E,4E)-4-14 in 88% yield by irradiation in benzene in 
the presence of catalytic amounts of Ph2S2 for 4 h (Scheme 4.2). Subsequent reduction of 
(2E,4E)-4-14 with DIBAL-H afforded dienol (2E,4E)-4-15 in an excellent 94% yield.125 The 
double bond geometry ratios (2E,4E)-4-15:(2E,4Z)-4-15 varied in the range 6-14:1. The 
reduction of ester (2E,4Z)-4-14 was conducted with LiAlH4, affording dienol (2E,4Z)-4-15 in 
75 and 71% yields respectively.126 Small amounts of dienol (2E,4E)-4-15 were often observed 
in the NMR spectra. 
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Scheme 4.2 Synthesis of bromide (2E,4E)-4-16  
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Table 4.1 Bromination experiments of (2E,4Z)-4-15 and (2E,4E)-4-15 
Entry Substrate Bromide Solvent Product distribution 
4-16: 4-17: 4-18 
Yield (%)a 
4-16+4-17+4-18 
1  (2E,4Z)-4-15 (2E,4Z)-4-16 Et2O 3.4:1:0 61%b  
2  (2E,4E)-4-15 (2E,4E)-4-16 Et2O 3.8:1:0 90%c 
3  (2E,4E)-4-15 (2E,4E)-4-16 CH2Cl2 4.3:1:1.8 99%d 
4  
 
(2E,4E)-4-15 (2E,4E)-4-16 CH2Cl2 1.7:1:0 crude 
8.7:1:2.6 purified 
90% 
85%e 
a) Determined from the 1H NMR spectrum of the crude product. b) Detectable amounts of (2E,4E)-4-16 and of a 
third isomer, which is probably (2Z,4E)-4-16 (doublet at 4.12 ppm, J = 8.8 Hz, q at 2.37 ppm, J = 13.4, 6.7 Hz) 
were observed in the 1H NMR spectrum. c) (2E,4E)-4-16:(2E,4Z)-4-16 10:1. d) (2E,4E)-4-16:(2E,4Z)-4-16 9:1. 
e) Isolated yield of products after flash chromatography; (2E,4E)-4-16:(2E,4Z)-4-16 18:1. 
 
The conversion of 4-15 to bromide 4-16 represented a challenge (Scheme 4.2). The 
bromination with Br2/Ph3P or CBr4/Ph3P afforded complex mixtures containing large amounts 
of Ph3P=O, although the preparation with Br2 was previously reported.125b, 127 Purification of 
the very labile bromide by kugelrohr distillation allowed separation from Ph3P=O, but the 
mass balance was low due to thermal decomposition and the bromide was obtained as a 
component of a complex mixture. In contrast, the bromination with PBr3125c, 128 furnished a 
mixture of the labile desired terminal bromide 4-16 and undesired internal bromide 4-17 in 
ratios of 1.7-4.3:1 (Table 4.1). 
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The formation of terminal bromides 4-16 was favoured in dry diethyl ether in a ratio 
of (2E,4Z)-4-16:(3Z)-4-17 3.4:1 and (2E,4E)-4-16:(3E)-4-17 3.8:1, respectively (Entries 1 and 
2). A different outcome was observed in the bromination in dry CH2Cl2. The internal bromide 
(3E)-4-17 was partially hydrolysed during workup to the internal dienol (3E)-4-18 (entry 3). 
The ratio of (2E,4E)-4-16:(3E)-4-17:(3E)-4-18 was determined to 4.3:1:1.8 by 1H NMR 
spectroscopy, which means that the ratio terminal bromide (2E,4E)-4-16:internal products 4-
17+4-18 amounted to only 1.5:1. A second experiment performed in dry CH2Cl2 gave a 
mixture of bromides (2E,4E)-4-16:(3E)-4-17 1.7:1 (entry 4). This crude 1.7:1 mixture was 
purified by flash chromatography. The slightly more polar internal bromide 4-17 underwent 
partial isomerisation and hydrolysis resulting in a final terminal:internal bromide ratio of 
8.7:1 in 67% yield and 18% of internal dienol 4-18. Compounds 4-16, 4-17 and 4-18 were 
characterised on the basis of their NMR spectra. The purified bromides gave better yields in 
the following alkylation step. 
 
Scheme 4.3 Alkylation experiments 
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+
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R = Me  (6Z)-4-21a
R = Me  (6E)-4-21a
R = tBu  (6E)-4-21b
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Table 4.2 Alkylation experiments 
Entry Bromide used 
4-16:4-17:4-18 
Product 4-20 (%) 4-21a (%) 
1 4.3:1:0 crude (6E,8Z)-4-20a 34 6 
2 2.3:0.5:1 crude (6E,8E)-4-20b 31 not determined 
3 3.8:1:0 crude (6E,8E)-4-20b 37 not determined 
4 8.7:1:0 purified (6E,8E)-4-20a 40 3 
a) Isolated yield based on dienol 4-15.  
 
The C7-C20 precursors of 15-A2-IsoP, 3-oxotetradeca-6,8-dienoates (6E,8Z)-4-20a 
and (6E,8E)-4-20a,b were synthesised by alkylation of the dienolate of methyl or tert-butyl 
acetoacetates 4-19a,b with bromide 4-16 (Scheme 4.3).127, 129 When the alkylation was 
performed with the crude mixture of bromides 4-16 and 4-17, the desired linear 3-oxoesters 
(6E,8Z)-4-20a and (6E,8E)-4-20a,b were obtained in 34%, 31% and 37% isolated yield, 
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respectively, based on dienol 4-15 (Entries 1, 2, 3). They were accompanied by small amounts 
of branched regioisomers 4-21, unreacted acetoacetate 4-19 and further unknown byproducts. 
Their separation from the product mixtures was often impossible. Keto ester (6E,8E)-4-20a 
was synthesised from the purified 8.7:1 mixture of bromides (2E,4E)-4-16 and (3E)-4-17 in 
40% overall yield based on dienol (6E,8E)-4-15 accompanied by 3% of (6E)-4-21a (entry 4). 
Based on the bromides (2E,4E)-4-16  and (3E)-4-17 the yield of (6E,8E)-4-20a and (6E)-4-
21a amounted to 66% and 42% yield, respectively. 
Keto esters (6E,8E)-4-20a,b and (6E,8Z)-4-20a were reduced in good yields with 
NaBH4 in dry MeOH to cyclisation precursors 3-hydroxytetradeca-6,8-dienoate (6E,8E)- and 
(6E,8Z)-4-11a,b (Scheme 4.4). Small amounts of the reduced keto ester (6Z)-4-21a or (6E)-4-
21a,b were rarely isolated. 
 
Scheme 4.4 Preparation of 4-11a,b from 4-20a,b 
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Keto esters (6E,8E)-4-20a,b and (6E,8Z)-4-20a displayed a singlet for H2 in the range 
3.30-3.45 ppm in the 1H NMR spectra. The double bond resonances exhibited the following 
trends, depending on their geometry (Table 6.2, Experimental part): For compounds (6E,8E)-
4-20a,b, signals of  H8 and H7 as well as H6 and H9 were very close or overlapping. The 13C 
NMR signals shifted downfield in the order: C6, C8, C7, C9, in the range of 129.0-133.5 
ppm. For compounds (6E,8Z)-4-20a,b the signals of the double bond hydrogen atoms were 
well separated. The 1H and 13C signals shifted upfield in the order: H9, H6, H8, H7 and C7, 
C8, C9, C6 in the range 5.29-6.33 ppm and 126.7-131.6 ppm respectively. The coupling 
constants J = 15.0 Hz for H6-H7 in (6E,8Z)-4-20a and J = 15.1 Hz in (6E,8Z)-4-20b attested 
an (E)-geometry. Coupling constants of smaller then 11 Hz for H8-H9 in (6E,8Z)-4-20a,b 
accounted for a (Z)-double bond. The carbonyl group appeared in the range 201.6-202.4 ppm. 
Hydroxy esters (6E,8E)-4-11a,b and (6E,8Z)-4-11a,b showed similar NMR patterns at the 
double bonds, but C6 and C7 in (6E,8E)-4-11a,b could not be unambiguously assigned. The 
1H NMR signals in the range of 3.96-4.01 ppm and the doublets at 67.2-67.7 ppm were 
assigned to H3 and C3, respectively.  
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Key results: Cyclisation precursors 3-hydroxytetradeca-6,8-dienoates  (6E,8E)-4-11a,b and 
(6E,8Z)-4-11a,b were synthesised in 30% and 32% yield in 5 and 4 steps respectively. This 
approach was efficient enough to provide the necessary material for the development of the 
oxidative cyclisations. 
 
4.2.1.2. A very short synthesis of (6E,8Z)-4-11b and (6E,8E)-4-11b 
White’s three component coupling methodology was adapted to synthesise 3-oxo ester 
(6E,8Z)-4-20b (Scheme 4.5).130 4-Bromo-2-butenylphosphonium bromide 4-22 was 
eliminated by LDA to butadienylphosphonium salt 4-23, which was added to the dienediolate 
4-19b-Li. The resulting allylic phosphonium ylide 4-24 was treated with hexanal 4-25 to 
provide the oxo ester 4-20b in 27% yield as a 3.6:1 (E,Z)/(E,E) mixture, which was lower 
than the reported diastereoselectivity.130 Extensive optimisation attempts varying the amounts 
of reagents, reaction times and additives did not improve the reaction outcome (Method A, 
Experimental Part, Table 6.2). Scaling up to gram amounts was, however, accomplished 
without problems with a yield of 28% (Experimental part, Table 6.2, entry 5). 
 
Scheme 4.5 Synthesis of (6E,8Z)-4-11b and (6E,8E)-4-11b 
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A very polar compound was isolated in significant amounts to which the structure of 
N,N’-diisopropyl-2,4-decadienylamine 4-26 was assigned (Scheme 4.6). The 
diisopropylamine unit showed a doublet at 3.09 ppm (2H), a septet at 2.97 ppm (2H) and 
another doublet at 0.93 ppm (12H) in the 1H NMR spectrum. Two double bonds were also 
identified. The formation of compound 4-26 occurred probably via a competitive nucleophilic 
addition of LDA or diisopropylamine to butadienyl phosphonium salt 4-23 and a subsequent 
Wittig reaction with hexanal 4-25. Sometimes small amounts of the aldol addition product of 
hexanal and acetoacetate were also detected. 
 
Scheme 4.6 Formation of byproduct 4-26 
Ph3P
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4-23
N
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O
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C5H11
4-264-25  
 
To reduce the amount of diisopropylamine deprotonation of the phosphonium salt 4-
22 and acetoacetate 4-19b was performed in one pot (Method B). The iPr2NH generated by 
deprotonation of 4-19b with LDA was re-deprotonated with BuLi, followed by addition of 
salt 4-22. Only 5% of product (6E,8Z)-4-20b was isolated in a single experiment, besides 
complex mixtures. 
The β-keto ester (6E,8Z)-4-20b was reduced to β-hydroxy ester (6E,8Z)-4-11b with 
NaBH4 in methanol in 78% yield with a d.r. of (6E,8Z):(6E,8E) 3.9:1 (Scheme 4.5). The 
double bond isomer (6E,8E)-4-11b was synthesised by radical isomerisation of (6E,8Z)-4-11b 
in the presence of catalytic amounts of Ph2S2 in high yield. β-Hydroxy esters (6E,8Z)-4-11b 
and (6E,8E)-4-11b were synthesised by this approach in two steps with an overall yield of  
22% and 21%, respectively, over three steps. However this was not acceptable on larger scale. 
 
4.2.2. Synthesis of 15-F2t-IsoP 4-1 precursors 
The oxidative radical cyclisation methodology developed for (6E,8Z)-4-11a,b and 
(6E,8E)-4-11a,b showed that the (E,E)-geometry of the double bonds gives better cyclisation 
results (vide infra). 5-Hydroxy-3-oxoesters 4-28a,b (cf. Scheme 4.7) cannot serve as 
substrates, because their cyclisation is known to be too slow.85 In contrast 3,5-dihydroxy ester 
derivatives 4-12a and 4-12b with (6E,8E)-geometry should be good substrates (Figure 4.2). 
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Figure 4.2 Cyclisation precursors for the synthesis of 15-F2t-IsoP 
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4.2.2.1. An efficient synthesis of (6E,8E)-4-12a,b in 3 steps 
The sequence started with the vinylogous aldol addition131 of 2,4-decadienal 4-27 and 
the acetoacetate-derived lithium sodium dienediolate 4-19a,b-Li in THF affording products 4-
28a and 4-28b in 94% and 81% yields, respectively (Scheme 4.7). HMPA proved to be a 
necessary additive, since the additions afforded 4-28a in only 30% yield in its absence. The 
formation of a colourless solid was often observed during the deprotonation of 4-19a.  
 
Scheme 4.7 Three-step synthesis of cyclisation precursors 4-12a and 4-12b 
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This indicated that the dienediolate 4-19a,b formed aggregates, which crystallised 
from the solution. HMPA, as the best complexation ligand for lithium, breaks the strong 
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aggregates of the lithium, sodium dienediolates partly and allows the addition to decadienal 4-
27. The immediate reduction of the somewhat labile β-keto esters 4-28a,b with NaBH4, in the 
presence of Et2BOMe furnished syn-diols 4-30a,b in good yields via the boronates 4-29a,b.132 
The reaction proceeds via initial formation of a boronate chelate 4-A with release of ethane 
(Scheme 4.8). This intermediate controls the attack of the hydride ion from the more 
accessible β-face via transition state 4-A, thus avoiding the interaction with the axial 
hydrogen atom on the α-face. This leads to the formation of syn-boronates 4-29a,b. Boronates 
4-29a,b were successfully deprotected with hydrogen peroxide in the presence of NaOAc.133 
Other boronate-hydrolysing methods proved not to be powerful enough for this substrate. 
 
Scheme 4.8 Formation of boronate 4-29a,b 
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(6E,8E)-3,5-Dihydroxy-6,8-tetradecadienoate 4-30a underwent a regioselective 
silylation with TBSOTf in the presence of 3 equivalents of 2,6-lutidine in CH2Cl2 at –78 °C 
(Table 4.3).134 This reaction proved to be unique, since other protective groups did not lead to 
any selectivity.135  
 
Table 4.3 Silylation condition for 4-30a and 4-30b 
Entry Substrate Equiv. 
TBSOTf 
Setup and conditions 4-12 (%) 4-31 (%) 
1 4-30a 2 0.8 mmol, −78 °C 71 29 
2 4-30a 1.5 0.8 mmol, 1.2 equiv TBSOTf, −78 °C, 4 h, 
then 0.3 equiv. TBSOTf, −78 °C, 10 min  
90 10 
3 4-30a 1.25 1.33 mmol, −78 °C 82 6 
4 4-30a 1.05 8.3 mmol, −78 °C, 1.5 h; −78 - −60 °C, 2 h  79a trace 
5 4-30a 1.05 8 mmol, −78 °C, 1.5 h; −78 - −40 °C, 2.5 h  54 18 
6 4-30b 1.2 3.4 mmol, –78 °C, 2.5 h  65 22 
7 4-30b 1.05 9.5 mmol, 1 h –78 °C 63 7 
8 4-30b 1.05 10.7 mmol, 2.5 h –78 °C 56 23 
a 19% substrate was recovered. 
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Methyl (6E,8E)-5-silyloxy-3-hydroxy-6,8-tetradecadienoate 4-12a was obtained in 54-
90% yield, while the disilylated (6E,8E)-3,5-bis(silyloxy)-6,8-dienoate 4-31a formed only in 
yields of 6-29%. The amount of TBSOTf as well as the temperature influenced the silylation 
yield and selectivity. An experiment performed with 2 equivalents of TBSOTf at −80 °C led 
to 71% of monosilylated product 4-12a and 29% yield of disilylated product 4-31a (entry 1). 
The silylation with 1.5 equiv. of TBSOTf added in two portions was the most successful 
(entry 2). Product 4-12a was obtained in 90% yield and the byproduct 4-31a in 10% yield. 
High yields were also obtained with 1.25 and 1.05 equiv. of TBSOTf (entries 3 and 4), where 
the formation of disilylated 4-31a was minimal. It proved to be important, however, to keep 
the temperature low all time to avoid increased formation of 4-31a (entry 5). The selectivity 
was generally lower for 4-30b (entries 6-8). Monosilylated 4-12b was isolated in 56-65% 
yields, while the byproduct 4-31b formed in 7-23% yield. The reaction at the α-dienyl 
hydroxy group was kinetically favoured due to electronic effects induced by the diene unit. 
The cyclisation substrates 4-12a and 4-12b were thus efficiently synthesised in 3 steps 
from 2,4-(E,E)-decadienal 4-27 in overall yields of 72% and 41%, respectively. 
 
4.2.2.2. A synthesis of (6E,8E)-4-12b in 4 steps 
The synthesis of the 15-F2t-IsoP starting materials was alternatively approached by a 
vinylogous aldol addition of 2,2,6-trimethyl-4H-1,3-dioxin-4-one 4-32 with (2E,4E)-deca-2,4-
dienal 4-27 (Scheme 4.9).136  
 
Scheme 4.9 Aldol addition of dioxinone 4-32 and decadienal 4-27  
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Table 4.4 Optimisation of the aldol reaction of 4-32 to 4-27 on a 2 mmol scale 
Entry Reaction time T (°C) Solvent 4-33 (%) 4-29 (%) 
1 45 min −78 THF 43 30 
2 45 min −78 THF/HMPA 53 - 
3 25 min −78 THF 56 31 
4 15 min −90 THF 63 - 
5 120 min −78 - −30 THF 53 - 
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The aldol adduct 4-33 was obtained under basic conditions at –78 °C in a moderate 
43% yield (Table 4.4, entry 1). It was accompanied by a Michael addition product 4-34 
resulting from the attack of the lithium enolate of dioxinone 4-32 to the 3-position of the 
decadienal 4-27 which was isolated in 30% yield. Addition of HMPA suppressed the 
formation of 4-34, but the yield of 4-33 was only slightly improved (entry 2).  
Since the aldol reaction is reversible and kinetically favoured over the Michael 
addition, which is slow and forms the thermodynamically more stable product,107c-f the 
reaction was optimised with respect to reaction time and temperature (entries 3-5). The best 
yield of 4-33 (63%) was obtained at the shortest reaction time of 15 min and the lowest 
temperature of −90 °C (entry 4). Michael adduct 4-34 was not formed under these conditions. 
However 4-34 was not always isolated despite longer reaction time and higher temperatures, 
but the mass balance was low (entry 5).  
 
Table 4.5 Significant NMR chemical shifts and multiplicities of compounds 4-33 and 4-34. 
 CHOH 
or CHO 
CHCOO CH2C(O)=CH CH=CHCH 
or CH2CHO 
CH=CHCH2 
4-33 4.39 (dt) 
69.6 (d) 
5.28 (s) 
95.2 (t) 
2.42, AB part of 
ABX, 41.5 (t) 
6.19 (dd), 5.52 (dd) 
132.3 (d), 130.9 (d) 
5.97 (dd), 5.70 (dt) 
128.8 (d), 137.0 (d) 
4-34 9.64 (t) 
200.8 (d) 
5.15 (s) 
94.7 (d) 
2.29, 2.17, AB part 
of ABX, 39.0 (t) 
2.42 (dd) 
48.3 (t) 
5.45 (dt), 5.18 (ddt) 
133.2 (d), 129.9 (d) 
 
The structure of 4-33 was assigned by means of its NMR data (Table 4.5). The diene 
resonances were found in the range 5.52-6.19 ppm (1H NMR) and 128.8-137.0 ppm (13C 
NMR), respectively. A singlet at 5.28 ppm (1H NMR) corresponding to a doublet at 95.2 ppm 
(13C NMR), and a singlet at 168.5 ppm (13C NMR) accounted for the double bond of the 
dioxinone unit, whose presence was proved also by the signal of the lactone unit =CHCO2 at 
161.2 ppm (s) and the quaternary carbon of the acetal at 106.7 ppm (s). The allylic CH 
bearing the hydroxy group appeared as a doublet of triplets at 4.39 ppm (1H NMR) and a 
doublet at 69.6 ppm (13C NMR), respectively. The Michael addition product 4-34 was 
characterised by the presence of the dioxinone unit and the resonances of only one double 
bond. In addition, a triplet at 9.64 ppm (1H NMR) corresponding to a doublet at 200.8 ppm 
(13C NMR) proved the presence of the aldehyde. 
The Mukaiyama aldol addition of the trimethylsilyl ketene acetal 4-35 and decadienal 
4-27 in CH2Cl2 in the presence of TiCl4 was chosen as an alternative approach to 4-33 
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(Scheme 4.10).137 The trimethylsilyl ketene acetal 4-35 was synthesised according to a 
literature procedure, but was obtained as an inseparable mixture with 4-32.138 The reaction 
with 4-27 was performed by adding excess of this mixture until 4-27 was consumed. 
Hydroxydioxinone 4-33 was obtained in 94% yield based on 4-27.  
 
Scheme 4.10 Mukaiyama aldol addition for the synthesis of 4-33 
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Scheme 4.11 Synthesis of cyclisation precursor 4-12b 
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The protection of pure 4-33 with TBSCl in the presence of imidazole and a catalytic 
amount of DMAP afforded product 4-36 in 72% yield (Scheme 4.11). A similar protection of 
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crude 4-33, which contained small amounts of 4-27, gave product 4-36 in 72% yield. 
Moreover, a Baylis-Hillman-type reaction occurred competitively under the reaction 
conditions giving 10% of 4-37, which was, however, easily separated by flash 
chromatography. 
The structures of 4-36 and 4-37 were unambiguously assigned by means of their 
NMR data (Table 4.6). Characteristic signals of the dioxinone unit and of the diene unit were 
identified. The doublet of triplets at 4.31 ppm (1H NMR), corresponding to its doublet in 13C 
NMR at 70.5 ppm was assigned to the CH unit bearing the silyl ether group. The 
neighbouring methylene group corresponds to the AB part of an ABM system. The byproduct 
4-37 exhibited clearly signals of two diene groups, two silyl ether groups and a dioxinone 
unit. The fifth double bond belonging to the dioxinone showed two quaternary carbon atoms 
in the 13C NMR spectrum, which indicated substitution at the C5-position. 
 
Table 4.6 Significant NMR chemical shifts and multiplicities of 4-36 and 4-37. 
Product CHOTBS CH2CHOTBS CHCOO 
or CCOO 
CH=CHCH2 CH=CHCHOTBS 
4-36 4.31 (dt) 
70.5 (d) 
2.30 (AB part of 
ABM), 43.1 (t) 
5.16 (s) 
95.3 (d) 
5.88 (dd), 5.59 (dt) 
136.6 (s), 129.0 (s) 
6.02 (dd), 5.39 (dd) 
131.9 (d), 131.1 (d) 
4-37 5.34 (d), 
4.37 (m) 
67.5 (d), 
70.5 (d) 
3.01, 2.32 (AB part 
of ABM), 40.3 (t) 
- 
109.6 (s) 
5.90 (dd), 5.57 (m) 
135.5 (d), 134.7 (d) 
129.6 (d), 129.3 (d) 
6.06 (dd), 5.40 (dd) 
133.1 (d), 132.4 (d) 
130.8 (d), 129.5 (d) 
 
tert-Butyl β-keto ester 4-38 was obtained by transesterification of 4-36 with tBuOH 
at high temperature (Scheme 4.11).139 The reaction proceeds probably by a retro-Diels-Alder 
reaction forming the acyl ketene 4-41, followed by the addition of tert-butanol (Scheme 4.12). 
 
Scheme 4.12 Conversion of dioxinone in a 3-oxo-ester 
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An attempted reduction of β-keto ester 4-38 with LiAlH4/LiI proceeded in low yield 
and with a moderate 2.5:1 syn:anti selectivity (Scheme 4.11).140 The attack of LiAlH4 
occurred preferentially at the least hindered face of a six-membered cyclic transition state like 
4-B leading to the formation of an excess of syn-12b. Moreover, the triol 4-40 was also 
formed by reduction of the ester function. The syn-4-12b and anti-4-39 isomers were not 
separable by flash chromatography. The reduction of 4-38 with NaBH4 did not occur with any 
selectivity. Since oxidative radical cyclisations with mixtures of syn-4-12b and anti-4-39 as 
precursors would have doubled the number of products (vide infra), this approach via 4-38 
was given up. To improve the reduction one could deprotect 4-38 to 4-28b, but that would 
result in a larger number of steps.141 
The structures of products 4-38, 4-12b and 4-39 were assigned based on their NMR 
data (Table 4.7). The connectivity was approved by COSY and HSQC measurements. For 
keto ester 4-38 the methylene group adjacent to the ester group displays a singlet at 3.34 ppm 
(1H NMR) and a triplet at 52.1 ppm (13C NMR). The ketone appeared as a singlet at 201.5 
ppm. A doublet of triplets at 4.60 ppm and a 13C NMR resonance at 70.1 ppm was assigned to 
the CH group bearing the TBS-oxy group. Alcohols syn-4-12b and anti-4-39 had only slightly 
different spectra. 
 
Table 4.7 Significant NMR chemical shifts and multiplicities of δ-silyloxy-β-keto ester 4-38, 
syn-4-12b and anti-4-39 
Product CHOTBS CH2CHOTBS CH2COCH2 or 
CHOH 
CH2COOtBu 
4-38 4.60 (dt), 70.1 (d) 2.75, 2.55 (AB part of 
ABX), 51.2 (t) 
-, 201.5 (s) 3.34 (s), 52.1 (t) 
4-12b 4.30 (dt), 72.8 (d) 1.67 (ddd), 1.51 (ddd), 44.5 
(t) 
4.01 (m), 66.6 (d) 2.30 (AB part of 
ABM), 42.7 (t) 
4-39 4.45 (m), 71.1 (d) 1.62 (m), 1.54 (m), 43.9 (t) 4.17 (m), 65.2 (d) 2.33 (m), 43.1 (t) 
 
4.2.3. Attempts toward an asymmetric synthesis of 15-F2t-IsoP precursors 
The isoprostanes are biosynthesised as racemates. Nonetheless it is interesting to 
attempt their synthesis enantioselectively, since the individual enantiomers may display 
significant differential biological activity. This requires to secure their absolute configuration 
early in the synthesis, best already in the initial aldol addition, from which all other 
stereocentres can be introduced subsequently in a controlled manner as shown before. 
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4.2.3.1. Studies on enantioselective aldol additions to control the stereocentre in 11-position 
Literature precedent on asymmetric vinylogous aldol additions142 indicated that 
enantioselective Mukaiyama-aldol additions of the silyl ketene acetal 4-35 and decadienal 4-
27 are promising (Scheme 4.13, Table 4.8). The aldol addition was performed using a 
Ti(IV)/(R)-BINOL complex as the catalyst under conditions similar to those employed by De 
Rosa et al.143 The chemical yield was good in all cases, the enantiomeric excess remained 
however moderate at best. The best enantiomeric excess of 71% was obtained by using 
powdered molecular sieves (entry 3 vs. 1,2). The ee of product 4-33 was determined by HPLC 
with a DAICEL-OD chiral column.  
 
Scheme 4.13 Enantioselective Aldol Addition applying De Rosa’s method 
O
O O
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+
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2) TFA, !78 °C
H11C5 H
O
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Table 4.8 Optimisation of enantioselective aldol addition 
Entry 4-35:4-27:Catalyst Molecular sieves 4Å 
(g/mmol cat.) 
Time (min) 
cat. + 4-27 
Yield (%) %ee 
1 0.94 : 0.47 : 0.08 spheric; 0.6/0.08 45 68 40 
2 2 : 1 : 0.08 spheric; 0.6/0.08 40 74 19 
3 2 : 1 : 0.08 powder; 0.35/0.08 20 72 71 
 
Since 71% ee was not good enough to continue the synthesis on larger scale, the aldol 
reaction was also performed using Carreira’s catalyst 4-42.138, 139, 144 The catalyst was 
generated in situ. The substrates 4-27 and 4-35 were stirred in the presence of 1-3 mol% of 4-
42 at 0 °C for 4 h. The product 4-33 was isolated in a good 73% yield, but the enantiomeric 
excess amounted to only 11%. To optimise this reaction, more detailed investigations on this 
as well as on other catalysts or chiral Lewis acids142a are necessary.  
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Scheme 4.14 Carreira’s asymmetric Mukaiyama aldol additions 
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4.2.3.2. Studies on asymmetric hydrogenations to control the stereocentre in 9-position 
The 5-silyloxy-3-keto ester 4-38a precursor was synthesised by a standard silylation 
of 4-28a in 60% yield (Scheme 4.15). Noyori’s catalyst was generated according to literature 
procedures.145 Hydrogenation of the methyl ester 4-38a afforded complex mixtures. Catalytic 
hydrogenations of 5-silyloxy-3-oxo ester 4-38b were investigated under conditions described 
in Scheme 4.16. No hydrogenation was observed. The starting material accompanied by some 
undefined compounds was recovered and small amounts of the methyl ester 4-38a were 
sometimes isolated as a result of a transesterification reaction. The investigations were not 
continued. 
 
Scheme 4.15 Silylation of 4-28a 
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CH2Cl2
C5H11
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Scheme 4.16 Noyori hydrogenation of 4-38b 
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Alternatives might consist in biocatalytic reduction of 4-38 with baker’s yeast, which 
would give the product with (S)-configuration.146 
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4.3. Development of oxidative radical cyclisations for the synthesis of 2-hydroxy 
cyclopentane carboxylates 
 
To develop an efficient approach to the synthesis of cyclopentanes 4-7a,b and 4-8a,b 
with isoprostane configuration (cf. Scheme 4.1) the diastereoselectivity of the cyclisation has 
to be controlled. The investigations were concentrated on the following aspects:  
A. The influence of structural factors of cyclisation substrates like double bond geometry, the 
substituent in the 11-position and the ester group on the yields and diastereoselectivity of the 
oxidative radical cyclisations.  
B. The coordination strength of the metal counterion and the properties of the enolate 
intermediate should play an important role in the control of diastereoselectivity by influencing 
the transition state of the radical cyclisation.  
 
4.3.1. Development of cyclisations with A2-isoprostane precursors (6E,8Z)-4-11a,b and 
(6E,8E)-4-11b 
Esters 4-11a,b were subjected to dideprotonation with excess LDA followed by 
treatment with TEMPO 1-2 and ferrocenium hexafluorophosphate 1-3 (Scheme 4.17). HMPA 
was known to improve conversion of similar radical cyclisations,25 therefore it was employed 
constantly as an additive. Cyclopentane carboxylates with isoprostane configuration 4-7a,b 
and prostaglandin configuration 4-45a,b were isolated as the main products of the radical 
cyclisation of 3-hydroxy esters (6E,8Z)- and (6E,8E)-4-11a,b. Four other cyclopentane 
isomers 4-46a,b were isolated in small amounts, however, their ring configuration could not 
be established. The TEMPO trapping occurred highly regioselectively in the 15-position. 
Small quantities of acyclic 4-48a,b were also isolated and small amounts of substrate were 
recovered. 
Substrates 4-11a,b with (6E,8Z)-configuration were converted into 4-7a,b and 4-45a,b 
in moderate yields of 51-60% in a roughly 1:1 ratio (Table 4.9, entries 1-3). The size of the 
ester functionality did not influence the outcome.  
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Scheme 4.17 Oxidative radical cyclisations of 4-11a,b 
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Table 4.9 Cyclisation experiments – Investigation on the influence of the ester group R and 
the double bond geometry 
Entry Substrate Equiv. base/ 
equiv. additives  
4-7+4-45+4-46 
(%) 
4-7(α/β)a:4-45(α/β): 
4-46 
4-48 
(%) 
1b (E,Z)-4-11b 2.5 LDA/ 
2.6 HMPA 
51 6.5(1:5.4):5.2(1:1.1):1 - 
2c (E,Z)-4-11a 2.5 LDA/ 
2.5 HMPA 
60 1.7(1:3):2.2(1:1):1 5 
3d (E,Z)-4-11a 2.5 LDA/ 
6 HMPA 
58 3.6(1:2.5):3.7(1.2:1):1 2 
4e (E,E)-4-11b 2.5 LDA/ 
2.5 HMPA, 7 LiCl 
66 2.7(2.4:1):1.8(1:2.3):1 2 
5f (E,E)-4-11a 2.5 LDA/ 
6 HMPA 
75 2.6(3.1:1):1.8(1:2.3):1 10 
6g (E,E)-4-11a 2.5 LDA/ 
6 HMPA, 12 LiCl 
70 2.9(3.8:1):1.45(1:2.3):1 19 
a) α/β refers to the orientation of the tetramethylpiperidinyloxy group in the 15-position. b) Setup 2.34 
mmol, 31% of 4-11 recovered, 4-46b-I3-1,2. c) Setup 0.79 mmol, 4% of 4-11 recovered, 4-46a-I5, I7, 
and I8. d) Setup 0.79 mmol, 4-46a-I7 and I8. e) Scale up 3.37 mmol, 10% of 4-11 recovered, 4-46b-
I3-1,2 and I4-1,2; 4-47 6%. f) Setup 1 mmol, 3% of 4-11 recovered, 4-46a-I5, I6 and I7. g) Setup 1 
mmol, 10% of 4-11 recovered, 4-46a-I6, I7 and I8. 
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Cyclisations of (6E,8E)-4-11a,b afforded cyclopentanes 4-7a,b, 4-45a,b and 4-46a,b 
in improved yields of 66, 75 and 70%, respectively (Table 4.9, entries 4, 5 and 6). The main 
products 4-7a,b and 4-45a,b were formed with slightly improved diastereoselectivity. The 
desired isoprostane-configurated products 4-7a,b were the major diastereomers. The ring 
diastereomers 4-46a,b were isolated in small amounts. Small quantities of regioisomeric 
trapping products 4-47b were detected on scale-up of the reaction (entry 4). The highest 
conversion was realised with methyl ester (6E,8E)-4-11a in the presence of 6 equivalents of 
HMPA, which gave the cyclisation products in 75% yield (entry 5). Acyclic 4-48a was 
formed in 10% yield. In the presence of 12 equivalents of LiCl, a 2:1 diastereoselectivity of 4-
7a:4-45a was achieved, although the cyclisation was apparently slightly slowed down, since 
acyclic 4-48a was isolated in increased 19% yield (entry 6). The 15α/15β-diastereoselectivity 
was variable. Two trends were observed depending on the 6,8-double bond geometry. The 
isomer 15β-4-7a,b was preferentially obtained from (6E,8Z)-4-11a,b, while (6E,8E)-4-11a,b 
furnished mainly 15α-4-7a,b. No selectivity was found for 15α- and 15β-4-45a,b when 
(6E,8Z)-4-11a,b was the precursor, while (6E,8E)-4-11a,b provided 15β-4-45a,b as the major 
diastereomer. The formation of both, the 15α- and 15β-isomers, does not matter at this stage, 
since this stereocentre will be destroyed later by oxidative deprotection of the 2,2,6,6-
tetramethylpiperidinyl unit. 
 
Table 4.10 Cyclisations experiments – investigation of different metal ions 
Entry Substrate Equiv. base/ 
additives  
4-7+4-45 
+4-46 (%) 
4-7(α/β):4-45(α/β):4-46 4-48 
(%) 
1a (E,Z)-4-11b 4 LDA/2.6 HMPA 53 4.8(1:6.9):4.8(2.3:1):1 - 
2b (E,Z)-4-11b 1.5 MeMgCl, 1.3 
LDA/2.7 HMPA 
28 1(1:0):10.5(1:2.1):2.5 22 
3c (E,Z)-4-11a 1.2 tBuMgCl, 1.3 
LDA/6.3 HMPA 
49 1(1:2):8.5(1.7:1):2.7 15 
4d (E,E)-4-11a 1.5 tBuMgCl, 1.5 
LDA/6.3 HMPA 
45 1(2.5:1):5.8(1:1.3):0.7 4 
5e (E,E)-4-11b 1.2 tBuMgCl, 1.3 
LDA/6.3 HMPA 
52 1(3.3:1):5.8(1:2.2):1.8 10 
6f (E,E)-4-11b 1.5 tBuMgCl, 2.2 
LDA/6.3 HMPA 
49 1:19.5(1:1.9):4 4 
a) Setup 0.34 mmol, 4-11 13%, 4-46b-I3-1,2 and I4-1,2. b) Setup 0.57 mmol, 4-11 19%, 4-46b-I4-1,2, 4-47 3%. 
c) Setup 0.79 mmol, 4-11 17%, 4-46-I5 and I6. d) Setup 0.79 mmol, 4-11 7%, 4-46-I5 and I6. e) Setup 1 mmol, 
4-11 24%, 4-46b-I4-1,2, 4-47 6%. f) Setup 1 mmol, 4-11 9%, 4-46b-I3-1,2 and I4-1,2, 4-47 9%. 
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The cyclisation outcome depended significantly on the applied deprotonation 
conditions. An excess of LDA (4 equivalents) in deprotonation of (6E,8Z)-4-11b led to a 
decrease in diastereoselectivity 4-7a,b/4-45a,b to 1:1 (Table 4.10, entry 1 versus Table 4.9, 
entry 1). Sequential deprotonation of 4-11a,b with a slight excess of Grignard reagent and 
then LDA switched the 4-7a,b:4-45a,b diastereoselectivity to 1:5.8-19.5, hence 4-45a,b was 
by far the major diastereomer (Table 4.10, entries 2-6). Cyclopentanes 4-46 were formed in 
similar yields as before. However, the overall conversion was lower and larger amounts of 
substrate 4-11 were recovered. Acyclic 4-48 also formed to a relatively large extent (entries 2, 
3 and 5). When deprotonation of 4-11b was conducted with Et2Zn followed by LDA, no 
cyclisation occurred and the substrate was recovered. 
The structure of 4-7a,b and 4-45a,b-4-48a,b was established by 1H and 13C NMR 
spectroscopy, especially by COSY and HSQC experiments. The chemical shifts of positions 
8, 9, 10, 12, 13 and 14 were significant for the assignment of the ring diastereomers (Figure 
4.3, Experimental part, Table 6.4). The proton at C8 of IsoP isomers 4-7a,b was downfield-
shifted by 0.24-0.33 ppm compared to the PG isomers 4-45a,b. Similarly C8 of 4-7a,b was 
downfield shifted by 1.7-2.5 ppm compared to C8 of 4-45a,b. The same trend, but less 
pronounced, was ascertained for the 9-position. Chemical shifts of H10 were also relevant for 
the assignment of ring diastereomers. While the differences between H10α and H10β of IsoP 
4-7a,b amounted 0.54-0.55 ppm, these protons absorbed much closer to each other in PG 
isomers 4-45a,b, with a difference of only 0.22 ppm. The chemical shift difference of the 
vinyl carbon atoms C13 and C14 were also crucial to distinguish between the ring 
diastereomers. IsoP isomers 4-7a,b exhibited larger differences Δ(δC14-δC13) of 2.9-3.7 ppm 
than PG isomers 4-45a,b, which displayed differences of only 0.3-1.0 ppm.  
 
Figure 4.3 Significant NMR data of compounds 4-7a,b and 4-45a,b 
COOR
HO
OTMP
COOR
HO
OTMP
4-45a,b4-7a,b
5.28-5.40
130.5-131.1
2.65-2.82 
57.0-58.1
4.46-4.57 
74.4-74.8
5.38-5.42
133.8-134.6
5.37-5.47
132.1-133.1
2.33-2.55 
55.3-55.9
4.38-4.46 
74.1-74.3
5.37-5.42 
133.1-133.7
9
8
12 14
9
8
12 14
1.76-1.77
1.95-1.98
1.66-1.67 
2.20-2.22
H
H
H
H
 
 97 
 
The relative ring configuration of 15β-4-45a and 15β-4-7b was confirmed by NOE 
measurements. Common patterns of the NMR data for diastereomers with the same ring 
configuration but different relative configuration in 15-position were ascertained. The α- and 
β-diastereomers in 15-position were assigned by comparison of the 13C NMR data with those 
of model compounds.85 
 
Key results: 
• A new cyclisation method for the synthesis of A2-isoprostane and PG A2 ring systems 4-
7a,b and 4-45a,b was developed. The best yields of cyclic products amounted to 70-75%. 
• The double bond geometry of substrates 4-11a,b had an influence on the 
diastereoselectivity of the radical cyclisation of the dilithium dianion 4-44a,b. (6E,8Z)-4-
11a,b cyclised less selectively than (6E,8E)-4-11a,b, which gave 4-7a,b with isoprostane 
configuration in excess. 
• Modification of the deprotonation conditions to RMgCl/LDA led to a switch of 
diastereoselectivity 4-7a,b:4-45a,b from 2:1 to 1:6-19 in favour of cyclopentanes with 
prostaglandin configuration. The yield of the reactions were however, lower. 
• The reaction was scaled up to gram amounts without problems. The tert-butyl esters 4-7b 
and 4-45b were more easily separable than the methyl esters 4-7a and 4-45b. 
 
4.3.2. Cyclisations with F2t-isoprostane substrates 4-12a,b 
The cyclisation conditions developed for the synthesis of the A2-isoprostane skeleton 
4-7a,b were adapted to assemble the F2t-IsoP ring system 4-8a,b with substrates (6E,8E)-4-
12a and (6E,8E)-4-12b (Scheme 4.18). The oxidative cyclisations of the dilithium alkoxido-
enolate 4-49a,b generated by deprotonation of 4-12a and 4-12b with LDA furnished 
cyclopentanes 4-8a,b and 4-50a,b in yields of 71% and 58%, respectively, accompanied by 
minute amounts of another isomer 4-51a,b (Table 4.11, entries 1-2). From the methyl ester 4-
12a, the 15α/β-isoprostane isomers 4-8a were formed in a slight excess over 4-50a. The 
cyclic proximal products 4-52a,b were also detected in noticeable yields of 1-8%.  
The generation of lithium-magnesium alkoxido-enolates 4-49a,b induced a switch of 
diastereoselectivity in favour of products 4-50a,b with prostaglandin configuration. The 
yields were moderate, but the PG:IsoP ratio (4-50:4-8) amounted to 4-6:1 (entries 3-4). The 
stronger chelation by Mg2+ decreased the cyclisation rate, hence higher amounts of 4-12a,b 
were recovered and the acyclic TEMPO trapping product 4-53 was isolated in 17-19% yield. 
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These results confirmed that the cyclisation conditions developed for substrates 4-11a,b were 
generally applicable to more complex substrates 4-12a,b containing the additional 
stereocentre in 5-position. 
 
Scheme 4.18 Oxidative radical cyclisations of 4-12a,b 
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Table 4.11 Cyclisations with different metal ions and 1-2 added after deprotonation 
Entry Substrate Setup (mmol)/ Equiv. 
Base/ Additives  
4-12a 4-8+4-50 4-8 (α/β): 
4-50 (α/β) 
4-52b 
(%) 
4-53 
(%) 
1  4-12a 0.65/ 2.5 LDA/ 
7 LiCl/ 6 HMPA 
1 71 1.4(1:1.1): 1(2:1) 1c 8 
2 4-12b 0.7/ 2.5 LDA/ 
7 LiCl/ 6 HMPA 
13 58 1.1 (1.8:1): 1(1:1.4) 8d - 
3  4-12a 0.65/ 1.5 tBuMgCl/ 
2.2 LDA/ 6 HMPA 
12 41 1(1:1.1): 4.1(2.1:1) 7e 19 
4 4-12b 0.7/ 1.5 tBuMgCl/ 
2.2 LDA/ 6 HMPA 
23 46 1(1.7:1): 6(1.7:1) 8f 17 
a) Recovered. b) Four cyclic proximal products isolated; the d.r. is given with increasing polarity. c) d.r. 0:0:1:0; 
additionally 4-51 was detected in 3% yield. d) d.r. 3:1:3.25:0; additionally 4-51 was detected as trace. e) 
2.2:1:0:0; additionally 4-51 was detected in 1% yield. f) d.r. 1.4:1:0:0. 
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In the cyclisations of the mixed Li/Ti and Li/B alkoxido-enolates generated by 
deprotonation of 4-12b with LDA/ClTi(OiPr)3 or of 4-12a with Et2BOMe/LDA the substrate 
was recovered. It was not certain whether the deprotonation of 4-12a,b occurred (not shown). 
The formation of acyclic trapping products 4-53a,b occurs via a bimolecular coupling 
reaction of the α-carbonyl radical with TEMPO 1-2 before the radical cyclisation, and it is 
dependent on the concentration of 1-2. A series of experiments was designed to assay the 
impact of TEMPO concentration on the product distribution in the radical cyclisations of 4-
12b (Table 4.12). When TEMPO 1-2 was well mixed with ferrocenium hexafluorophosphate 
1-3 and added in portions at –78 °C (Method A, entry 1), the major isomers 4-8b and 4-50b 
were isolated in 57% yield, similar to results in Table 4.11 (vide supra). Cyclic products 4-
52b were detected in minute amounts (2% yield). Moreover no acyclic tempo adduct 4-53b 
was formed and 4-12b was recovered in 17% yield. In method B 0.2 equiv. of 1-2 was added 
before cyclisation and the oxidation was performed using a mixture of 0.8 equiv. 1-2 and 1 
equiv. of 1-3, providing 4-8b and 4-50b in lower yield of 45% yield (entry 2). The yield of 
the cyclic proximal products 4-52b increased to 13%. A larger amount of 4-12b (24%) was 
recovered. When method B was applied at higher oxidation temperatures of –30 °C (Method 
C, entry 3) 56% of the substrate was recovered and complex mixtures containing 4-8b and 4-
52b were obtained. 
 
Table 4.12 Oxidative cyclisations of 4-12b with low concentration of TEMPO 
Entry Method Setup (mmol)/Equiv. 
Base/Additives 
4-12b 
(%) 
4-8+4-50 
(%) 
4-8 (α/β):4-50 (α/β) 4-52 
(%) 
1 Aa 0.7/ 2.5 LDA/ 7 LiCl/ 
6 HMPA 
17 57 1(2:1): 1(1.05:1) 2b 
2 Bc 0.59/ 2.5 LDA/ 8.7 
LiCl/ 6 HMPA 
24 45 1(2.6:1): 1(1:1.4) 13d 
3 Ce 0.59/ 2.5 LDA/ 8.7 
LiCl/ 6 HMPA 
56 A complex mixture was obtained, 
containing 15α-IsoP 4-8 and 4-52. 
a) Method A: 1-2 (1 equiv.) and 1-3 (1 equiv.) were well mixed and added in portions at –78 °C, followed by 
addition of 1-3 until the reaction remained dark blue. b) d.r. 0:0:1.2:1, the d.r. is given with increasing polarity; 
additionally 4-51 was detected in 1% yield. c) Method B: A portion of TEMPO (0.2 equiv.) was added before 
oxidation, and then a mixture of TEMPO (0.9 equiv.) and FeCp2PF6 (1 equiv.) was added in portions at –78 °C. 
d) d.r. 3.9:trace:1:1, the d.r. is given with increasing polarity; additionally 4-51 was detected in 3% yield. e) 
Method C: A portion of TEMPO (0.2 equiv.) was added before oxidation, followed by addition of a mixture of 
TEMPO (0.8 equiv.) and FeCp2PF6 (1 equiv.) in portions at –30 °C.  
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The modified procedures using low concentrations of TEMPO during the 
oxidation/radical cyclisation did not improve the yields or product distribution for setups 
below 1 mmol. But method B boosted the efficiency of the cyclisations on scale up (Table 
4.13). Deprotonation with 2.5 equiv. of LDA for 1.5 h in the presence of 7 to 15 equiv. of 
LiCl, subsequent addition of 6 equivalents of HMPA and 0.2 equiv. of TEMPO followed by 
oxidation with a mixture of 1 equiv. 1-3 and 0.8 equiv. 1-2 afforded 61 to 77% yield of the 
cyclic products 4-8a,b and 4-50a,b (Entries 1, 2, 4 and 5). IsoP 4-8a,b was produced from 4-
12a,b often in a slight excess over 4-50a,b (entries 2, 3, 5). Products 4-51 and 4-52 were 
generally detected in smaller amounts. Deprotonation with only 2.3 equiv. LDA decreased the 
yield of 4-8b, 4-50b and 4-51b to 52%, while 25% of substrate 4-12b was recovered (entry 
6). A larger excess of LiCl (15 or 25 equiv.) favoured the formation of the acyclic TEMPO 
adduct 4-53a (Entries 2 and 3). The diastereoselectivity of the side chain stereocentre in 15-
position 4-8 and 4-50 was variable. There was no recognisable correlation pattern between 
15α/β-ratios and the ester substitution pattern in 12a,b or the reaction conditions. 
 
Table 4.13 Scale up experimentsa 
Entry 4-12 Setup (mmol)/ 
Equiv. Base/ 
Additives 
4-12 
(%) 
4-8+ 
4-50 
4-8 (α/β):4-50 (α/β) 4-51 
(%) 
4-52b 
(%) 
4-53 
(%) 
1 4-12a 2.9/ 2.5 LDA/ 
7 LiCl/6 HMPA 
2 66 - 4 2 1 
2 4-12a 3.1/ 2.5 LDA/ 
15 LiCl/6 HMPA 
5 62 1.7(1:1.7):1(3:1) 1 8c 7 
3 4-12a 3.1/ 2.5 LDA/ 
25 LiCl/6 HMPA 
3 55 1.3(1.4:1):1(1:2.3):1 - 14d 10 
4 4-12b 1.76/2.5 LDA/ 
7 LiCl/6HMPA 
4 77 1(2.1:1):1.2(1.2:1) - 14e - 
5 4-12b 2.4/ 2.5 LDA/ 
7 LiCl/6HMPA 
1 61 1.3(2.2:1):1(1.2:1) 4 9f - 
6 4-12b 3.5/2.3 LDA/ 
7 LiCl/6 HMPA 
25 52 1(1:1.1):1(1:1) 4 6g - 
a) A portion of 0.2 equiv. of TEMPO was added before oxidation, and then a mixture of TEMPO (0.9 equiv.) 
and FeCp2PF6 (1 equiv.) was added in portions at –78 °C. b) The d.r. is given with increasing polarity. c) d.r. 
4.2:1:3.4:2.7. d) d.r. 4.4:1.6:1.8:1. e) d.r. 3.8:1:1.1:trace. f) d.r. 6.7:1:1.5:1. g) d.r. 8.1:1:1:2.2.  
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The structure of the cyclisation products was established on the basis of their 1H and 
13C NMR, COSY and HSQC NMR spectra (Table 6.5, Figure 4.4).  
 
Figure 4.4 Significant chemical shifts of compounds 4-8a,b and 4-50a,b 
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• The ring protons H8 (dd at 3.06-3.18 ppm) in IsoP isomers 4-8a,b are downfield shifted 
by 0.55-0.59 ppm compared to the corresponding PG isomers 4-50a,b (dd at 2.47-2.65 ppm). 
• The ring protons H9 are in IsoP isomers 4-8a,b (m at 4.44-4.52 ppm) downfield shifted by 
0.11-0.18 ppm compared to those of the corresponding PG isomers 4-50a,b (m at 4.32-4.39 
ppm). The resonances of the corresponding carbon atoms of IsoP isomers are upfield shifted 
by 0.7-1.2 ppm compared to the PG isomers 4-50a,b. 
• The protons in the 10-position of IsoP isomers 4-8a,b displayed two well separated 
signals at 1.64-1.68 and 2.28-2.36 ppm, respectively, while the H10 signals in PG isomers 4-
50a,b are very close to each other or even overlap at 1.78-1.88 ppm. 
• The chemical shift difference of the allylic protons Δ(δH13-δH14) is larger for IsoP-
isomers (0.25-0.42 ppm), while Δ(δH13-δH14) of PG-isomers has values in the range 0.13-
0.16 ppm. The chemical shift difference δC13-δC14 accounts for 8.0-9.4 ppm in IsoP-isomers 
4-8a,b. In PG-isomers Δ(δC13-δC14) amounts to 2.2-3.1 ppm.  
The relative ring configuration of the isoprostane isomers 4-8b and prostaglandin 
isomers 4-50b was proven on the basis of NOE and NOESY experiments. The relative 
configuration of 4-8a and 4-50a was strengthened by comparison with 4-8b and 4-50b. The 
configuration at the exocyclic stereocentre was assigned by comparison with cyclisation 
products 4-7a,b and 4-45a,b and with model compounds.85 
 
Key results: 
• A cyclisation method for the synthesis of cyclopentane carboxylates 4-8a,b and 4-50a,b 
was developed. The 4-8a,b/4-50a,b diastereoselectivity could be switched by using lithium or 
magnesium as the counter ions in enolates 4-49a,b.  
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• The formation of the cyclic proximal products 4-52a,b and the acyclic adduct 4-53a,b as 
well as the recovery of large amounts of the cyclisation substrates 4-12a,b in the cyclisations 
of the mixed Li, Mg-alkoxido enolates were yield limiting processes. 
• The reaction was successfully scaled up to gain the material necessary for the 
accomplishment of the total synthesis. The tert-butyl esters 4-8b and 4-50b were easier to 
separate then the methyl esters 4-8a and 4-50a. 
 
4.4. Mechanistic rationalisation 
 
The control of diastereoselectivity was the decisive point in the investigations of 
oxidative cyclisations of 4-11a,b and 4-12a,b (Scheme 4.19, only 4-12a,b shown). Dienolates 
4-49a,b generated from hydroxy esters 4-12a,b were oxidised by ferrocenium 
hexafluorophosphate 1-3. Since 1-3 is an outer sphere oxidant the oxidation may occur by 
initial SET leading to 4-C, followed by elimination of a metal of MPF6. Cyclisation of 
resulting radicals 4-D and 4-D’, followed by trapping of allylic radicals 4-E and 4-E’ with 
TEMPO furnished a mixture of diastereomers 4-8a,b and 4-50a,b, accompanied by small 
amounts of the regioisomeric products 4-52a,b, which result from TEMPO trapping at 13-
position. Premature coupling of radicals 4-D and 4-D’ with TEMPO provided acyclic product 
4-53a,b.  
The results point to a partial chelation in the transition state of the oxidative 
cyclisation of enolate 4-49a,b. The applied metal ion played a significant role. To assemble 
the isoprostane configurated isomer 4-8a,b, the cyclisation occurred preferentially via non-
chelated transition state 4-D. Coupling of the resulting radical 4-E with TEMPO led to 4-8a,b 
as the major diastereomer. On the other hand, the isomer 4-50a,b with prostaglandin 
configuration was predominetly formed via the chelated six membered ring radical anion 4-D’ 
and subsequent coupling of TEMPO with allylic radical 4-E’.  
This model is supported by the results. With lithium as metal counterion, the 
isoprostane isomer 4-8a,b was obtained via Beckwith-Houk type transition state 4-D as the 
major diastereomer in moderate excess. The best diastereomeric ratio amounted to 1.7:1 for 4-
8a,b/4-50a,b and 2:1 for 4-7a,b/4-45a,b. From Mg/Li mixed alkoxido enolates 4-49a,b 
prostaglandin skeleton 4-50a,b was formed as the main product of the cyclisation in moderate 
yields but good diastereoselectivity. The magnesium counterion stabilised the chelated form 
of radical cation 4-C and the cyclisation proceeded via transition state 4-D’. 
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4.5 Reduction of the ester at the C7-position 
 
Reductions of cyclopentanes 4-7b and 4-45b occurred in excellent yields (Scheme 
4.20, Table 4.14, entries 1 and 2). When the reaction was scaled up to 350 mg, diol 4-54 was 
obtained in a moderate yield of 58% (entry 3). 
 
Scheme 4.20 Reduction of esters 4-7b and 4-45b 
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Table 4.14 Reduction of 4-7b and 4-45b 
Entry Substrate Setup mmol d.r. Yield (%), d.r. 
1 4-7ba 0.18 (80 mg) β:α 4.1:1 100 (β-4-54:α-4-54 4.8:1) 
2 4-45b 0.15 (70 mg) α:β 2.25:1 87 (α-4-55:β-4-55 2.2:1) 
3 4-7b 0.77 (350 mg) β:α:4-46b-I3-2 
4.9:1.1:1 
58 (β-4-54:α-4-54:4-56-I3-2b 4.1:1.7:1) 
a) This sample contains traces of 4-46b-I3-1. b) The ring configuration was not unambiguously 
assigned. 
 
The relative ring configuration of diastereomers 15α-4-54, 15β-4-54, 15α-4-55 and 
15β-4-55 as well as the configuration of the exocyclic stereocentre was assigned based on the 
known configuration of the reduction precursors 4-7b and 4-45b. The characteristic proton 
signal of the methylene group at 3.59-3.86 ppm denoted the presence of the hydroxy group 
(Table 4.15). The corresponding carbon atoms at the same position gave triplets at 61.5-62.7 
ppm. The NMR data were similar to those of F2t-diols 4-57 and 4-58.  
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Table 4.15 Significant NMR data for structure elucidation of 4-54 and 4-55 
α-4-54 β-4-54 α-4-55 β-4-55 Position 
δ (ppm), multiplicity 
CH2OH 3.59, 3.68 (AB of 
ABX), 62.7 (t) 
3.76 (m), 61.5 (t) 3.86 (AB of 
ABX), 62.2 (t) 
3.86 (m), 61.5 (t) 
CHCH2OH 2.15 (m), 53.2 (d) 2.15 (m), 54.0 (d) 2.03 (m), 52.8 (d) 2.03 (m), 51.6 (d)  
CH=CHCHOTMP 5.60 (dd), 133.5 (d) 5.49 (dd), 135.5 
(d) 
5.48 (dd), 135.2 
(d) 
5.34 (m), 134.5 
(d) 
=CHCHOTMP 5.38 (ddd), 132.4 
(d) 
5.43 (m), 133.0 
(d) 
5.34 (dd), 133.1 
(d) 
5.34 (m), 133.3 
(d) 
 
The ester functionality of sterically more hindered cyclopentanes 4-8a,b was also 
transformed to the diols 4-57 via reduction with LiAlH4 (Scheme 4.21). This reaction 
occurred in yields of 60-89% for the methyl ester 4-8a (Table 4.16, entries 1, 2, 4, 5 and 7). 
The reduction of the tert-butyl ester 4-8b was much slower (entries 3 and 6). It was important 
especially for scale up to use a large excess of LiAlH4, otherwise the reactions were very 
sluggish. The yields and mass balances were however lower in reactions at larger scales. With 
milder reagents like DIBAL-H no reaction was observed and the starting material was 
completely recovered. 
IsoP-isomers 4-8a,b were reduced in better yields than cyclopentanes with PG-
configuration 4-50a,b. This was especially noticeable when the reaction was performed on a 
mixture of IsoP- and PG-isomers, because an enrichment in the IsoP isomers 4-57 was 
constantly observed (entries 2, 4, 5 and 7).  
The lower yields of tert-butyl esters 4-8b of 20-59% (Table 4.16, only the best results 
shown) can be traced to their steric hindrance. However, the substrates were recovered only 
rarely, thus the yield limiting process must be a different one. Often the aldehyde 4-59 and the 
in 11-position deprotected cyclopentane ester 4-60 were isolated in low yields. Maybe an 
aluminium salt of the free acid was formed and got lost during the workup. The use of 
different workup procedures did not change the outcome much.  
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Scheme 4.21 Reduction of esters 4-8a,b 
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Table 4.16 Reduction of esters 4-8a,b and 4-50a,b 
Entry Substrate  d.r.a Setup (mmol) Workupb  4-57+4-58  (d.r.)c 
1 4-8a 0:1:0:0 0.11 A 89% (0:1:0:0) 
2 4-8a/4-50a  2.8:10:14:1 0.24 A 65% (0:1.5:1:0) 
3 4-8b 5.5:1:0:0 0.48 B 53% (5:1:0:0)d 
4 4-8a/4-50a 6.1:3.3:3.6:1 0.39 C 60% (2.5:1.4:1:0) 
5 4-8a/4-50a 6.1:3.3:3.6:1 0.37 C 79% (3.8:1.5:1:0) 
6 4-8b/4-50a 7:4:2:0 0.40 C 59% (1.5:1:0:0) 
7 4-8a/4-50a 3.9:2.4:2.4:1 0.25 D 62% (6.2:5:1:0) 
a) d.r. at the 15-position = 15α-4-8:15β-4-8:15α-4-50:15β-4-50. b) The methods are described in the 
experimental part. c) d.r. at the 15-position = 15α-4-57:15β-4-57:15α-4-58:15β-4-58. d) Additionally 
4-59 16%, 4-60 8% were isolated. 
 
The relative ring configuration of diastereomers 15α-4-57, 15β-4-57 and 15α-4-58 as 
well as the configuration of the exocyclic stereocentre was assigned based on the known 
configuration of the reduction precursors. The IsoP ring configuration of 15α-4-57 and 15β-4-
57 was additionally confirmed by NOESY experiments.  
The following NMR data were significant for the assignment of the structure of diols 
4-57 and 4-58 (Table 4.17): The protons of the methylene group bearing the hydroxy function 
appeared as the AB part of an ABX system at 3.61-3.80 ppm; the resonances of the ring 
protons in 8-position of 15α-4-57 and 15β-4-57 appeared at 2.36 ppm and at 2.44 ppm, 
respectively. The shifts of the same proton in 15α-4-58 differed significantly, being upfield 
shifted by 0.52 ppm. In the 13C NMR spectra, the methine carbon bearing the hydroxymethyl 
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group gave a characteristic doublet at 52.0-53.6 ppm. The vinylic carbon atoms absorbed in 
the range 129.8-135.3 ppm. The difference of the chemical shifts Δ(δC14-δC13) was larger 
for the IsoP-isomers 4-57 (3-4.9 ppm) than for the PG-isomer 15α-4-58 (1.4 ppm). 
 
Table 4.17 Significant NMR data of 4-57 and 4-58 
Position 15α-4-57 15β-4-57 15α-4-58 
 δ (ppm), multiplicity 
CH2OH 3.61 (AB of ABX), 62.9 (t) 3.69,a 3.76,a 61.4 (t) 3.80 (m), 62.4 (t) 
CHCH2OH 2.36 (m), 52.6 (d) 2.44 (m), 53.6 (d) 1.82 (m), 52.0 (d) 
CH=CHCHOTMP 5.27 (dd), 129.8 (d) 5.28 (dd), 132.5 (d) 5.23 (dd), 132.8 (d) 
=CHCHOTMP 5.44 (ddd), 134.7 (d) 5.51 (m), 135.3 (d) 5.41 (dd), 134.2 (d) 
a) A and B parts of ABX. 
Key results: Cyclopentane carboxylates 4-7b and 4-45b were reduced in high yields at small 
scales. Introduction of the additional silyloxy group in 4-8a,b and 4-50a,b apparently changes 
the conformation of the ring, so that reduction became significantly more difficult, especially 
for PG isomers 4-50a,b. With all substrates the yield dropped on scale up. 
 
4.6. Transformation of the primary hydroxy group in diols 4-54 and 4-57 to a leaving group 
 
The introduction of different leaving groups in 7-position leading to compounds 4-61-
4-64 was studied next (Scheme 4.22). 
 
Scheme 4.22 Introduction of leaving groups in 7-position of diols 4-54 and 4-57 
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Orienting bromination experiments with alcohol 4-54 using CBr4 and PPh3 in CH2Cl2 
led mainly to decomposition.147 A similar experiment with the PG-configurated alcohol 4-55 
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afforded bromide 4-65 in moderate yield of 51% (Scheme 4.23). In addition, dibromide 4-66 
was obtained in 30% yield. It was thus necessary to find more efficient transformations of the 
primary alcohol into a leaving group, which is also applicable for 4-54 with IsoP-
configuration. 
 
Scheme 4.23 Bromination of 4-55 
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The monosulfonylation of diols 4-57 appeared to be a promising alternative. The 
mesylation of the diol 4-57 with 1.1 equiv. MsCl and 2 equivalents of NEt3 afforded 48% of 
4-67a, 35% of the dimesylated product 4-68a, and even some product 4-69a mesylated in 9-
position (Scheme 4.24, Table 4.18, entry 1). An attempt to optimise this reaction by using 
only 0.95 equivalents of MsCl at lower temperature showed that the primary as well as the 
secondary alcohol groups were reactive in this sulfonylation reaction (entry 2). The selectivity 
for 4-67a over 4-68a was higher, but the overall conversion decreased and more of the 
secondary monosulfonate 4-69a was isolated.  
A sterically more demanding sulfonyl group was expected to differentiate better 
between the secondary and the primary alcohol functions in 4-57. A set of experiments with 
TsCl148 under different conditions afforded product 4-67b, however, in poor yields, 
accompanied by variable amounts of 4-68b and 4-69b (entries 3, 4 and 5).  
The sulfonylation of 4-57 with triflic anhydride provided 4-67c in a moderate yield of 
40% (Table 4.18, entry 6). Products 4-68c or 4-69c were not detected. Although the yield was 
not satisfactory, the more reactive sulfonylating group reacted more selectively with the 
primary hydroxy group.  
 
Scheme 4.24 Sulfonylation of diol 4-57 
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Table 4.18 Sulfonylation Reactions 
Entry X 15-Pos. Config. 4-67 (%) 4-68 (%) 4-69 (%) 4-57 (%) 
1a Ms α:β 3.07:1 48 (α:β 3.8:1) 35 (α:β 5.3:1) 7 (α:β 1:1) 7 (α:β 1:2) 
2b Ms α 34 9 17 34 
3c Ts α 25 - 5 67 
4d Ts α 15 10 3 28 
5e Ts α 19 47 - 12 
6f Tf α 40 0 - 28 
a) 1.1 equiv. MsCl, 2 equiv. Et3N/–20 °C. b) 0.94 equiv. MsCl, 2 equiv. Et3N/–50 °C. c) 1.06 equiv. 
TsCl, 4.2 equiv. Et3N/–80 - 0 °C. d) 1.06 equiv. TsCl, 2 equiv. Et3N/0 °C. e) 1.3 equiv. TsCl, 1.8 
equiv. Et3N/ r.t., after 28 h another 0.8 equiv. TsCl and 1.8 equiv. Et3N were added. f) 1 equiv. Tf2O, 
3.2 equiv. 2,6-lutidine/–78 °C. 
 
The mesylate 4-67a was converted into the more reactive iodide 4-70 in 86% yield, 
via a Finkelstein reaction employing NaI and K2CO3 in the presence of molecular sieves 4Å 
in ethyl methyl ketone (Scheme 4.25). 
 
Scheme 4.25 Finkelstein reaction of mesylate 4-67a 
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The protons of the methylene group bearing the sulfonyl group and the ring proton in 
2-position in compounds 4-67a-c are downfield shifted compared to the diol precursors 
(Table 4.19). Similar trends were observed for the chemical shifts of the carbon atoms bearing 
the sulfonyl group. In contrast, the same position in the iodide 4-70 was upfield shifted to 
2.91 ppm (1H NMR) and 6.2 ppm (13C NMR), respectively. 
 
Table 4.19 Significant NMR data for structure assignment of 4-67a-c and 4-70 
 4-67a 4-70 4-67b 4-67c 
 δ (ppm), multiplicity 
CH2X 4.08, 4.16 (AB of 
ABX), 69.8 (t) 
2.91 (t), 6.2 (t) 3.88-4.06 (m), 70.4 
(t) 
4.44 (d), 77.0 (t) 
CHCH2X 2.59 (m), 50.0 (d) 2.63 (m), 53.7 (d) 2.49 (m), 49.9 (d) 2.67 (dq), 50.3 (d) 
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Since the sulfonylation with triflic anhydride proceeded selectively and subsequent 
investigations of the alkylation reactions showed that the protection of the hydroxy group in 
9-position is very important (vide infra), a simultaneous activation/protection sequence was 
developed. Therefore diols 4-54 and 4-57 were treated successively with fresh triflic 
anhydride and triethylsilyl triflate in the presence of 2,6-lutidine (Scheme 4.26).149 Compound 
4-71 was isolated in 47% yield in an inseparable mixture with 15% yield of the bis-
triethylsilylated diol 4-71TES2 (see Experimental part). Triflate 4-73 was obtained in 81% 
yield. This reaction proceeded selectively only with fresh triflic anhydride, otherwise 
inseparable mixtures 4-73 and 4-73TES2 (not shown) were isolated. 
 
Scheme 4.26 Selective sulfonylation of diols 4-54 and 4-57 
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The assignment of the structures was performed by their NMR data (Table 4.20). The 
protons in 7-position displayed downfield-shifted signals compared to their precursors, due to 
the strong electron withdrawing substituent (entry 1). The proton at the 8-position absorbed at 
2.22 ppm in 15α-71, at 2.62 in 15α-73 and at 2.70 ppm in 15β-73 (entry 2). In 13C NMR, the 
chemical shift of the carbon atoms bearing the triflate unit appeared at 77.1-77.3 ppm, i.e. 
downfield-shifted compared to precursors 4-54 and 4-57. 
 
Table 4.20 Significant NMR data of compounds 4-71 and 4-73  
Entry  15α-4-71 15α-4-73 15β-4-73 
  δ (ppm), multiplicity 
1 CH2OTf 4.27 (m), 4.49 (dd), 77.3 
(t) 
4.51, 4.60 (AB of ABX), 
77.3 (t) 
4.44 (m), 77.1 (t) 
2 CHCH2OTf 2.22 (m), 52.0 (d) 2.62 (dq), 50.4 (d) 2.70 (quint), 50.1 
(d) 
3 CHOTES 3.98 (dd), 74.7 (d) 4.01 (dt), 72.9 (d) 3.91 (m), 73.1 (d) 
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Key results: The hydroxy group at 7-position of 4-57 is apparently sterically hindered and 
therefore sulfonylation at the 9-position competed with sterically more demanding sulfonyl 
groups like the tosyl group. A reasonable selectivity was achieved with small, highly reactive 
sulfonylation reagents like triflic anhydride.  
 
4.7. Completion of the full carbon atom skeleton of 15-A2-IsoP and 15-F2t-IsoP via 
alkylation reactions 
 
The assembly of the full carbon atom skeleton was designed via acetylide alkylation 
between C6 and C7 - a new strategy in IsoP synthesis. When triflate 4-71 was treated with 2 
equivalents of the lithium acetylide 4-9Li in THF/HMPA at –78 °C, compound 4-5 with the 
complete 20 carbon atom chain was formed in 29% yield (Scheme 4.27). The derivative 4-6a 
(15α/β 1:1.6) was similarly synthesised by alkylation of the triflate 4-73 (15α/β 1:2.1) with 4-
9Li in 71% yield. Some migration of the triethylsilyl group affording triethylsilylalkyne 4-74 
was observed. Both main products 4-5 and 4-6a could not be separated from excess 4-9 and 
4-74. Thus, at this stage both and 4-5 and 4-6a were further used as a mixture in the following 
reaction step. 
 
Scheme 4.27 C6-C7 connection via acetylide alkylation of triflates 4-71 and 4-73 with 4-9 
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Table 4.21 Significant NMR data of compounds 4-5 and 4-6a 
 α-4-5 α-4-6a β-4-6b 
 δ (ppm), multiplicity 
CHCH2C≡ 2.14-2.41 (m), 19.1 (t) 2.20-2.48 (m), 19.0 (t) 2.02 (m), 19.1 (t) 
C≡C -, 79.8 (s), 80.8 (s) -, 79.7 (s), 80.8 (s) -, 80.1 (s), 81.1 (s) 
CHOTMP 4.26 (m), 85.9 (d) 4.17 (m), 85.8 (d) 4.17 (m), 85.4 (d) 
CH=CH 5.55 (m), 132.9 (d) 
5.55 (m), 134.4 (d) 
5.30 (dd), 129.8 (d) 
5.58 (m), 136.3 (d) 
5.49 (m), 131.6 (d) 
5.49 (m), 136.0 (d) 
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The structure elucidation was accomplished by means of NMR data (Table 4.21). Two 
singlets at 79.7-81.1 ppm in the 13C NMR spectra for each of the products attested the 
formation of an internal alkyne. 
Assembly of the carboxylate function early in the synthesis was worthwhile. 
Accordingly, protection of 5-hexynoic acid as an orthoester 4-10 was carried out (Scheme 
4.28).150 Compound 4-6b was obtained in 50 to 59% yield in three alkylation experiments of  
4-73 with 4-10Li under slightly different conditions (Table 4.22, entries 1-3). The migration 
of the triethylsilyl group was also a yield limiting process. Byproduct 4-75 with a free 
hydroxy group in 9-position was isolated in 26% yield (entry 1). When the reaction time was 
reduced, product 4-6b was formed in 54% and 59% yield respectively, but 4-75 was not 
isolated (entries 2, 3). To avoid losses by hydrolysis of the very acid sensitive OBO ester, the 
eluent for chromatography had to be slightly basic containing Et3N. 
 
Scheme 4.28 Alkylation of triflate 4-73 with OBO ester 4-10 
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Table 4.22 Alkylation experiments of triflate 4-73 with 4-10 
Entry Conditions 4-6b (%, d.r.) 4-75 (%) 
1a 2 h 40 min, –78 °C - –15 °C 50 (15α/β 1:1.6) 26 (15α/β 1:1.2) 
2b 2 h, –78 °C - –15 °C 54 (15α/β 1.2:1) - 
3a 35 min, –78 °C - –55 °C 59 (15α/β 1:1.1) - 
4a 2 h 40 min –78 °C - –15 °C, 
then 2.5 equiv. TESCl 
30 (15α/β 1:1)  - 
a) From 4-73 15α/β 1:1.2. b) From 4-73 15α/β 1:1. 
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It was assumed that the triethylsilyloxy group in the 9-position exchanged the TES-
group with 4-10Li and that the so formed lithium alkoxide could be reprotected in situ with 
TESCl. Hence triethylsilyl chloride was added after the alkylation was complete by TLC 
(entry 4). Unfortunately there was no improvement of the reaction, since 4-6b was obtained in 
only 30% yield. 
The structures of the products were elucidated based on NMR experiments. The 
methylene group in 7-position absorbed at 2.18 ppm for 4-6b and at 2.05 ppm for 4-75, 
respectively, in 1H NMR (Table 4.23, entry 1). In 13C NMR this position gave a triplet at 
19.0-19.7 ppm. For each isomer two singlets at 79.7-81.6 ppm attested the alkyne. 
Characteristic chemical shifts of the OBO ester were present in all 4 isomers (Figure 4.5). 
 
Figure 4.5 Significant chemical shifts of the OBO ester units 
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Table 4.23 Significant NMR data of compounds 4-6b and 4-75 
 4-6b-Isomer 1 4-6b-Isomer 2 4-75-Isomer 1 4-75-Isomer 2 
 δ (ppm), multiplicity 
CHCH2C≡ 2.18 (m), 19.1 (t) 2.18 (m), 19.0 (t) 2.05 (m), 19.6 (t) 2.05 (m), 19.7 (t) 
C≡C 80.1 (s), 81.4 (s) 79.7 (s), 81.0 (s) 79.9 (s), 81.3 (s) 80.2 (s), 81.6 (s) 
CHOTMP 4.18 (m), 85.3 (d) 4.18 (m), 85.9 (d) 4.09 (m), 85.8 (d) 4.14 (m), 85.2 (d) 
 
Scheme 4.29 Alkyation experiments with different substrates 
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Structural elements of the alkylation substrates were varied. The alkylation of 4-70 
having a free hydroxy group with excess of lithium acetylide of 5-hexynoic acid 4-77 and 
subsequent treatment with TMSCHN2 afforded a complex mixture based on the NMR spectra 
(Scheme 4.29). An attempt to introduce the C1-C6 unit as 4-9 in triflate 4-67c also furnished a 
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complex mixture. When protected 4-73 was treated with the dianion of hexynoic acid 4-77, 
followed by esterification with trimethylsilyldiazomethane, traces of compound 4-80 were 
detected in the NMR spectra of the isolated complex mixture. 
Alkylation of bromide 4-65 with an excess of the dianion of 5-hexynoic acid 4-77 
afforded surprisingly the oxetane 4-81 in 82% yield (Scheme 4.30). The chemical shifts of the 
ABX system at 4.13 ppm and 4.78 ppm in the 1H NMR spectrum, as well as the triplet at 74.4 
ppm in the 13C NMR spectrum, which were clearly different from the substrate, were assigned 
to the CH2O group. Deprotonation of the hydroxy group in 4-65 by the excess of lithium 
acetylide and subsequent intramolecular etherification explains the formation of 4-81. 
Oxetane 4-81 was treated with the dianion of 4-77 in the presence of boron trifluoride 
BF3⋅OEt2, followed by acidic workup and esterification with trimethylsilyldiazomethane. The 
NMR spectra showed that decomposition occurred, and contained the resonances of 4-82. 
 
Scheme 4.30 Formation and attempted alkylation of oxetane 4-81 
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Key results: The completion of the 20-carbon atom skeletons 4-5 and 4-6a,b was achieved 
via a SN2 alkylation reaction. This connection of the C6-C7 carbon atoms is a new strategy in 
IsoP-synthesis. The protection of the carboxyl function in 5-hexynoic acid 4-77 as well as of 
the hydroxy group in 9-position in 4-71 and 4-73 were essential for the success of the 
alkylation reaction. 
 
4.8. Completion of the total synthesis 15-F2t-isoprostane 
 
The final steps in the total synthesis of 15-F2t-Isoprostane required the adjustment of 
functional groups (Figure 4.6). The order of transformations had to be optimised. The 
selective hydrogenation of the alkyne was planned as the last step, to avoid possible 
isomerisation of the 5,6-(Z)-double bond. 
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Figure 4.6 Necessary steps for the completion of the total syntheses 
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4.8.1. Studies towards the oxidative deprotection of the TMP group 
Precedence for the oxidative cleavage of (2,2,6,6-tetramethylpiperidinyloxy)alkanes 
with mCPBA exists to obtain aldehydes and ketones.151 This method was first adapted for the 
oxidative deprotection of the tetramethylpiperidine unit in cyclopentanes 4-8a,b and 4-50b 
(Scheme 4.31). An important aspect to consider was the susceptibility to epimerisation at the 
12-position. Treatment of mixtures of 4-8a,b with IsoP-configuration and 4-50a,b with PG-
configuration afforded ketones 4-83 and 4-84 in high yields (Table 4.24, entries 1,2). A new 
isomer 4-85 (12-epi-4-83) was isolated, interestingly only from IsoP/PG mixtures (entries 1 
and 2). The change of diastereomers ratio of products indicated that 4-8a,b with IsoP-
configuration epimerised in 12-position. When the reaction was performed with pure 4-50b, 
only traces of a new ketone were detected in the NMR spectrum. Therefore the relative 
configuration for 4-85 (12-epi-4-83) in the 8-position was assigned S*, since this compound 
originated from 4-8a,b.  In one experiment the product 4-86 resulting from dehydration in 
11,12-positions was also detected in 5% yield (entry 2). 
 
Scheme 4.31 Oxidative removal of the TMP-group 
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Table 4.24 Oxidative removal of the TMP-group in cyclopentane derivatives 4-8 and 4-50 
Entry Substrate Time (min) Product (IsoP:PG:12-epi-IsoP) Yield (%) 
1 4-8a:4-50a:4-51a (13.3:8.3:1) 30 4-83a:4-84a:4:85a (4.3:4.5:1) 73 
2 4-8b:4-50b:4-52b (20:26:1) 55 4-83b:4-84b:4:85b (3.5:9.6:1) 73a 
3 4-50b 50 4-84b 94b 
a) 4-86 and another unknown isomer were isolated in 5% and 15 % yield, respectively. b) The product 
contains traces of an unknown isomer. 
 
4.8.2. Oxidative deprotection of the TMP group of compounds 4-6a,b and removal of the 
silyl groups 
The tetramethylpiperidine group of 4-6a was oxidatively removed with mCPBA in 
high yield (Scheme 4.32). The reaction time was kept short (20 min). Under these conditions 
only trace amounts of two other isomers were detected based on the signals of an α,β-
unsaturated ketone unit in the 1H NMR spectra. Thus 4-87 displayed more resistance to 
epimerisation. The reaction time proved also to be important. It has to be kept as short as 
possible. 
 
Scheme 4.32 Oxidative removal of the TMP-group in derivative 4-6a 
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The deprotection of the silyl group in compound 4-75 (15α/β 1:1.2) with TBAF in dry 
THF afforded diol 4-88 in 87% yield (Scheme 4.33). Treatment of 4-88 with mCPBA 
provided a crude mixture containing three major components. One of them was the desired 
product 4-89, which was unambiguously assigned based on its NMR data (Figure 4.7). The 
second product displayed a dd at 6.74 ppm and a doublet at 6.12 ppm in the 1H NMR, and is 
thus also an enone whose structure could not be established. The third also unknown 
compound had a triplet at 6.87 ppm and a doublet at 8.30 ppm in the 1H NMR spectra. 
Moreover two other unknown isomers were detected in very small amounts, each of them 
displayed a doublet at 6.27 and 6.32 ppm respectively in the 1H NMR spectra. Resonances at 
173.6 and 171.6 ppm in the 13C NMR spectra indicated that two of these products are (2,2-
bis(hydroxymethyl))propyl esters resulting from premature hydrolysis of the OBO-ester 
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induced by the acidic deprotection conditions (not shown). Product 4-89 decomposed during 
purification on silica gel.  
 
Scheme 4.33 Synthesis of enone 4-89 from 4-75 
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Initial deprotection of the TMP-group in 4-6b (15α/β 1:1.6) furnished the 15-enone 4-
90 in 61% yield. Epimerisation at the 12-position of 4-90 occurred during workup and 
purification affording 4-90 and 12-epi-4-90 in a 4:1 ratio.  
 
Scheme 4.34 Synthesis of enone 4-89 form 4-6b 
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Deprotection of the silyl groups in 4-90 and 12-epi-4-90 with TBAF occurred 
quantitatively, but epimerisation of 4-89 to 12-epi-4-89 as well as dehydration in 11,12-
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position afforded a mixture of three products 4-89, 12-epi-4-89 and 4-91 in a ratio 5:4:1. A 
fourth unassigned component was detected in trace amounts. Since epimerisation of the 12-
position and competing ring opening of the OBO ester were facile, the oxidative deprotection 
step in 15-position had to be postponed to one of the last steps. 
The enone 4-89 displayed a doublet of doublets at 6.63 ppm and a doublet at 6.12 ppm 
in the 1H NMR spectrum. 12-epi-4-89 displayed a similar pattern, but H12 appeared 
significantly downfield-shifted (Figure 4.7). 
 
Figure 4.7 Significant 1H and 13C chemical shifts of compounds 4-89 and 12-epi-4-89 
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In compound 4-90 the protons of the double bond absorb at 6.93 and 6.26 ppm, 
respectively (Figure 4.8). The carbon atoms of the double bond gave two doublets at 144.2 
and 132.6 ppm in 13C NMR, and the ketone appeared as a singlet at 198.5 ppm. 
 
Figure 4.8 Significant 1H and 13C NMR chemical shifts of 4-90 and 12-epi-4-90 
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Further characteristic NMR resonances of compounds 4-90, 12-epi-4-90, 4-89, 12-epi-
4-89 and 4-91 are presented in Table 6.8. 
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4.8.3. Synthesis of methyl ester 4-92 from alkylation product 4-6b 
Synthetic approaches to methyl ester 4-92 starting from the alkylation product 4-6b 
are presented in Scheme 4.35.  
Path I. Diol 4-88 (15α/β 1:1) was synthesised quantitatively from 4-6b by treating 
pure 4-6b (15α/β 1.2:1) with TBAF. To synthesise the acid, compound 4-88 was treated with 
NaHSO4, followed by immediate saponification. The NMR spectrum of the crude acid was 
showing broad signals and its solubility in ethyl acetate was very low. The crude acid was 
therefore immediately esterified in the same flask.  
 
Scheme 4.35 Synthesis of methyl ester 4-92 
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Methyl ester 4-92 (15α/β 1:1) was obtained in 98% yield from 4-88. The 
stereochemistry of the 15-position in 4-92 could however not be determined. 
Path II. Deprotection of the silyl groups in crude 4-6b with TBAF afforded diol 4-88 
(15α/β 1:1) in 53% yield from the triflate 4-73 (15α/β 1:1.2). Treatment of 4-88 with aqueous 
NaHSO4 solution, followed by saponification with LiOH and finally esterification with 
trimethylsilyldiazomethane provided the methyl ester 4-92 in 45% yield from 4-88.152 The 
isomer ratio was 1.2:1. 
Path III. The transformation of OBO-ester 4-6b (15α/β 1.2:1) to methyl ester 4-78 
(15α/β 1:1) was performed before deprotection of the silyl groups. Methyl ester 4-78 was 
synthesised similarly from 4-6b in 62% yield, accompanied by 6% of 4-92. The conditions 
were mild enough for survival of TES-group until the acidic workup after esterification. The 
advantage of this approach is that the methyl ester 4-78 as well as its carboxylic acid 
precursor are much better soluble in organic solvents than 4-92 and its acid precursor, 
therefore this alternative was easier to monitor by NMR spectroscopy. The yield loss (total 
yield only 43% of 4-92 from 4-6b) may be due to partial deprotection of the silyl groups 
during the sequence. Methyl ester 4-92 (15α/β 1:1) was isolated in 70% after deprotection of 
the TBS-group with TBAF. 
 
Table 4.25 Significant NMR data of compounds 4-88, 4-78 and 4-92 
Product H8 H9 H11 H12 H13 H14 H15 
4-88 I1 2.42 (m) 4.08 (dt) 4.00 (dd) 2.89 (m) 5.31 (dd) 5.57 (dd) 4.22 (m) 
4-88 I2 2.50 (m) 4.18 (dt) 3.96 (ddd) 2.89 (m) 5.28 (dd) 5.60 (dd) 4.22 (m) 
4-92 I1 2.40 (m) 4.07 (dt) 3.85 (dt) 2.78 (m) 5.25 (dd) 5.53 (dd) 4.22 (m) 
4-92 I2 2.34 (m) 3.97 (dt) 3.91 (m) 2.78 (m) 5.24 (dd) 5.56 (dd) 4.22 (m) 
4-78 I1 2.39 (m) 4.00 (m) 3.92 (dt) 2.89 (m) 5.22 (dd) 5.48 (dd) 4.17 (m) 
4-78 I2 2.37-2.47 (m) 3.85 (m) 4.00 (m) 2.89 (m) 5.06 (dd) 5.49 (dd) 4.12 (dt) 
 C8 C9 C11 C12 C13 C14 C15 
4-88 I1 50.4 (d) 76.28 (d) 76.0 (d) 54.5 (d) 130.4 (d) 136.3 (d) 85.8 (d) 
4-88 I2 50.8 (d) 76.34 (d) 76.41 (d) 53.9 (d) 130.9 (d) 135.9 (d) 85.3 (d) 
4-92 I1 50.4 (d) 76.4 (d) 76.3 (d) 53.9 (d) 130.6 (d) 136.1 (d) 85.3 (d) 
4-92 I2 50.1 (d) 76.3 (d) 75.9 (d) 54.4 (d) 130.1 (d) 136.5 (d) 85.6 (d) 
4-78 I1 50.2 (d) 76.5 (d) 77.3 (d) 54.4 (d) 129.4 (d) 136.1 (d) 85.2 (d) 
4-78 I2 50.3 (d) 76.7 (d) 77.2 (d) 55.0 (d) 128.7 (d) 136.6 (d) 85.7 (d) 
 
The characteristic chemical shifts of the 15α,β-4-88 isomers resembled those of their 
precursors 4-6b. The silyl group resonances disappeared, however, from the 1H and 13C NMR 
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spectra. Similar trends of the NMR data were observed for derivatives 4-78 and 4-92 (Table 
4.25). The methyl ester function in compounds 15α,β-4-78 and 15α,β-4-92 gave in the 1H 
NMR spectra singlets at 3.31, 3.32 ppm and at 3.23, 3.24 ppm, respectively. In 13C NMR 
spectra the methyl ester was characterised by a quartet at 51.0-51.1 ppm for the methyl and a 
singlet at 172.9-173.1 ppm for the carbonyl group.  
Further attempts to optimise the synthesis of methyl ester 4-92 from the alkylation 
product 4-6b are presented in Scheme 4.36. 
 
Scheme 4.36 Further attempts to synthesise methyl ester 4-92 
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Path IV. The orthoester group in compound 4-6b (15α/β approx. 1:1.3) was 
hydrolysed with PPTS in acetone/water.153 The NMR spectra revealed that the TES-group 
was simultaneous deprotected while the signals of the TBS-group were still present. The 
crude compound 4-93 was treated with TBAF to remove the TBS-groups. The resulting 
tetraol 4-94 was subjected to LiOH in MeOH/water to affect transesterification to 4-92.153 A 
mixture containing 4-92 and free acid 4-95 was obtained, which could not be well separated. 
Therefore this path was not pursued further. It was thus necessary to conduct saponification 
and esterification in separate steps. 
Path V. Treatment of 4-6b (15α/β approx. 1:1.3) with pTsOH in MeOH/water 
afforded crude diol ester 4-93. The remaining silyl groups in 4-93 were deprotected with 
TBAF. Treatment with LiOH in THF/water furnished the free acid 4-95. Esterification of the 
latter was carried out with trimethylsilyldiazomethane in THF/MeOH. Methyl ester 4-92 was 
obtained in 47% yield over 4 steps from 4-6b (d.r. in 15-position 1.3:1). 
 
Key results: The synthesis of methyl ester 4-92 from OBO-ester 4-6b was best accomplished 
via path I (in Scheme 4.35) in excellent yields. Path III was also a productive alternative, and 
also easier to monitor. 
 
4.8.4. Oxidative deprotection of the TMP functionality in 15-position of 4-92 
The synthesis of 15-enone 4-96 was achieved by oxidative deprotection of the 2,2,6,6-
tetramethylpiperidinyloxy unit in methyl ester 4-92 employing mCPBA (Scheme 4.37, Table 
4.26). When compound 4-92 was treated with excess of mCPBA at 0 °C for 30 min, ketone 4-
96 was obtained in 53% yield as a pure diastereomer (entry 1). Epimerisation in 12-position 
occurred during storage giving 4-96 and its 12-epimer in a ratio of >10:1.  
 
Scheme 4.37 Oxidative removal of the TMP-functionality in ester 4-92 
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Table 4.26 Optimisation of the oxidative deprotection of the TMP unit 
Entry Conditions Yield (%) 
1 3.8 equiv. mCPBA, 30 min 53 (4-96:12-epi-4-96 >10:1) 
2 1.4 equiv. mCPBA, 10 min 93 
3 2 equiv. mCPBA, 8 min 73 
 
The treatment of 4-92 with 1.4 equivalents of mCPBA at 0 °C for 10 min furnished 4-
96 in 93% yield as a single diastereomer, as evidenced by the 200 MHz NMR spectrum (entry 
2). To avoid epimerisation 4-96 was reduced immediately. Similar results were obtained with 
2 equivalents of mCPBA (entry 3). 
The disappearance of the resonances of the CH group in 15-position (4.22 ppm in the 
1H NMR spectrum, and the doublets at 85.3 and 85.6 ppm in the 13C NMR spectrum), and the 
2,2,6,6-tetramethylpiperidinyl resonances indicated the formation of 4-96. The proton and 
carbon atoms of the double bond shifted downfield at 13-position from 5.24/5.25 ppm and 
130.6/130.1 ppm to 6.64 ppm and 143.4 ppm, respectively. The proton in 14-position 
similarly shifted from 5.53/5.56 to 6.10 ppm. The doublet of doublets with 15.6 and 0.7 Hz 
coupling constants evidenced that the hydrogen atom in 14-position has only the hydrogen 
atom in the 13-position as a neighbour. NOESY experiments confirmed the relative 
isoprostane configuration at the ring. 
 
4.8.5. Reduction of the ketone 4-96 in 15-position 
Reductions of the ketone in 15-position were performed previously either racemic 
with NaBH4 or enantioselectively.86 Until now no diastereoselective reduction of the carbonyl 
group in 15-position in a racemic isoprostane was reported. 
Yamamoto used a diastereoselective reduction in a racemic synthesis of prostaglandin 
F2α.
154 The reagent diisobutylaluminum 2,6-di-tert-butyl-4-methyl phenoxide 4-97 was 
generated in situ from 2,5-di-tert-butyl-4-methylphenol and DIBAL-H. This method was 
adapted for the reduction of 4-96 (Scheme 4.38, Table 4.28).  
At 0.08M reagent concentration the conversion reached 50% during a reaction time of 
3 h. Triolesters 15α- and 15β-4-98 were isolated with a ratio of 1.4:1 (entry 1). By applying 
Yamamoto’s original conditions (0.2M reagent solution), the 15α:15β diastereomeric ratio 
improved to 1.7:1, while the yield increased to 92% (entry 2). When the temperature was 
raised slower over a prolonged reaction time of totally 9 h, 4-98 was obtained in 92% with 
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15α:β 1.8:1 (entry 3). The two diastereomers 15α-4-98 and 15β-4-98 were separated by flash 
chromatography. 
 
Scheme 4.38 Reduction of ketone 4-96 
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Table 4.28 Optimisation of the reduction conditions 
Entry 4-97 (equiv./conc.) Conditions 4-98 (%, 15α:15β) 
1 10/0.08M –80 - –40 °C/3 h 50 (1.4:1) 
2 12/0.20M –95 - –40 °C/5 h, then –50 - –10 °C/80 min 92 (1.7:1) 
3 10/0.20M –80 °C/3 h, –80 - –50 °C/1 h, –50 °C/2.5 h,  
–50 - –15 °C 2.5 h 
92 (1.8:1) 
 
The assignment of the ring configuration was established by NOESY experiments. 
The proton in 15-position gave a quartet at 4.06 ppm in 15α-4-98 and at 4.08 ppm in 15β-4-
98, respectively. The OH-bearing carbon at the same position gave a doublet at 72.6 and 72.9 
ppm, respectively, in the 13C NMR spectrum. The configuration of the alcohol in 15-position 
was assigned by comparison with the data reported by Durand, who have synthesised the 
same compounds enantiomerically pure.124c The more polar diastereomer was 15α-4-98. 
Other significant NMR data are presented in Table 4.28. 
 
Table 4.28 Chemical shifts and multiplicities of compounds 15α-4-98 and 15β-4-98 
Substrate H8 H9 H11 H12 H13 H14 H15 
15α-4-98  2.32 (m) 4.14 (dt) 4.03 (q) 2.78 (dt) 5.42 (dd) 5.59 (dd) 4.06 (q) 
15β-4-98  2.34 (m) 4.15 (dt) 4.03 (dd) 2.80 (dt) 5.44 (dd) 5.62 (dd) 4.08 (q) 
Substrate C8 C9 C11 C12 C13 C14 C15 
15α-4-98  49.69 (d) 76.23 (d) 76.08 (d) 53.4 (d) 128.3 (d) 136.62 (d) 72.61 (d) 
15β-4-98  49.71 (d) 76.21 (d) 76.06 (d) 53.6 (d) 127.7 (d) 136.7 (d) 72.9 (d) 
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4.8.6. Hydrogenation of the alkyne 
The hydrogenation of the alkyne group in compound 4-98 to the 5,6-(Z)-double bond 
was explored with two catalysts (Scheme 4.39, Table 4.29). Employment of P-2 Ni124c as the 
catalyst was not effective with 4-98, which was recovered unchanged (entry 1). Lindlar’s 
catalyst exhibited under classical conditions (in ethyl acetate, in the presence of pyridine) also 
no activity with this substrate (entry 2). The employment of ethanol as cosolvent made the 
difference. Performing the hydrogenation reaction with the pure alkyne 15α-4-98 in a mixture 
of ethyl acetate/ethanol gave the methyl ester of 15α-F2t-IsoP 15α-4-1 in 96% yield. 
Similarly, 15β-4-98 provided the methyl ester of 15β-F2t-IsoP 15β-4-1 in 99% yield under the 
same conditions. 
 
Scheme 4.39 Selective hydrogenation of the alkyne unit in 4-98 
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Table 4.29 Optimisation of hydrogenation conditions 
Entry Condition Yield 
1 Ni(OAc)2, NaBH4, (CH2NH2)2, H2, Ethanol, 20 °C No reaction 
2 Lindlar’s Catalyst, EtOAc/Py No reaction 
3 Lindlar’s Catalyst, EtOAc/EtOH/Py 2:1:0.2 15α-4-1 15-F2t-IsoP 96%  
4 Lindlar’s Catalyst, EtOAc/EtOH/Py 2:1:0.2 15β-4-1 15-F2t-IsoP  99%  
 
The characteristic alkyne resonances were absent in the 13C NMR spectra of products 
15α-4-1 and 15β-4-1. Instead, four doublets in the range 128.4-136.3 ppm pointed to the 
presence of two double bonds. This was supported by signals in the 1H NMR at 5.43-5.45 
ppm (three protons) and at 5.59-5.60 ppm (one proton). Further NMR data are presented in 
Table 4.30. The relative ring configuration in 15α-4-1 and 15β-4-1 was established by 
comparison to the substrates  15α-4-98 and 15β-4-98. For 15α-4-1 it was additionally 
confirmed via NOESY experiments.  
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Table 4.30 Chemical shifts and multiplicities of 15-F2t-IsoP 15α-4-1 and 15β-4-1 
Compound H8 H9 H11 H12 H13 H14 H15 
15α-4-1 2.18 (m) 3.98 (dt) 4.05 (dt) 2.78 (dt) 5.43 (m) 5.59 (dd) 4.08 (q) 
15β-4-1 2.20 (m) 4.00 (m) 4.04 (ddd) 2.79 (ddd) 5.45 (m) 5.60 (dd) 4.09 (q) 
Compound C8 C9 C11 C12 C13 C14 C15 
15α-4-1 50.80 (d) 74.46 (d), 76.47 (d) 53.66 (d) 128.81 136.20 72.78 (d) 
15β-4-1 50.72 (d) 76.54 (d), 76.62 (d) 53.71 (d) 128.43 (d) 136.29 (d) 72.70 (d) 
 
4.9. The first total synthesis of 13,14-dihydro-15-oxo-15-E2-isoprostane methyl ester 4-3 
and of 13,14-dihydro-15-oxoprostaglandin E2 methyl ester 4-4 
 
Scheme 4.40 Synthesis of enones 4-100a,b 
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Compound 4-6a served as the starting material (Scheme 4.40). The triethylsilyloxy 
functionalities were oxidised under Swern conditions.155, 156 The resulting crude keto aldehyde 
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was oxidised further to the acid,157 which was immediately esterified with 
trimethylsilyldiazomethane providing methyl ester 4-99 in 72% yield. The TBS-ether in the 
11-position of 4-99 was deprotected with pyridine-HF in CH3CN, affording compounds 
15α,β-4-100a in 63% yield and a 1:1 ratio. The stereochemistry in 15-position could not be 
assigned. Some epimerisation of 8-position occurred under these conditions giving a 9:1 
mixture of 4-100a/4-100b. Compound 4-100b was found as a single diastereomer, however 
its configuration at 15-position could not be elucidated. The alkoxyamine in 4-100a and 4-
100b was oxidatively removed with mCPBA in CH2Cl2.151 Extensive epimerisation occurred 
in 8-position,158 affording an inseparable mixture of 4-101a and 4-101b 2.25:1 in 75% yield. 
Small amounts of 4-101c were detected, revealing some epimerisation in 12-position as well.  
The mixture of 4-101a, 4-101b and 4-101c was subjected to Lindlar hydrogenation 
(Scheme 4.41). Under the conditions developed for alkyne reduction in the synthesis of F2t-
IsoP, the alkyne and the enone were reduced successfully. A partially separable mixture of 
diastereomers 4-3 and 4-4 was obtained in excellent yields in a ratio of 1.5:1. Hence, under 
the slightly basic conditions further epimerisation at the 8-position occurred. The structure of 
4-3 was established by means of its NMR data. The structure and configuration of PGE2 
derivative 4-4 was assigned by comparison of its NMR data with those of authentic 13,14-
dihydro-15-oxo-PGE2 methyl ester, which was synthesised by esterification of commercially 
available 13,14-dihydro-15-oxo-PGE2.159 
 
Scheme 4.41 Lindlar hydrogenation of 4-101a,b,c 
90% (4-3 : 4-4 1.5 : 1)
4-3
4-4
Lindlar cat., 1 bar H2
4-101a:b:c 9 : 4 : 1
O
C5H11
OOH
COOMe
O
C5H11
OOH
+
4-101b
+ 4-101a
O
HO
CO2Me
O
O
HO
CO2Me
O
8
8 COOMe
EtOH/EtOAc/pyridine, 
            r.t., 24 h
 
 
The structure assignment of compounds 4-99, 4-100a,b, 4-101a,b,c, 4-3 and 4-4 was 
performed based on NMR experiments.  
The NMR spectra confirmed the successful transformation of 4-6a to 4-99 (Figure 
4.9). The silyloxy group in 9-position disappeared. Instead the carbonyl group at 9-position 
appeared as a singlet at 213.9 and at 216.6 ppm, respectively, for isomers 15α,β-4-99. The 
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methyl ester protons gave a singlet at 3.33 ppm in the 1H NMR spectrum for both 15α-4-99 
and 15β-4-99. The ester carbon was a singlet at 172.9 and 172.8 ppm, respectively.  
 
Figure 4.9 Significant chemical shifts of derivatives 15α-4-99 and 15β-4-99. 
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The t-butyldimethylsilyloxy group in 11-position disappeared in isomers 15α,β-4-
100a and 4-100b. In IsoP-isomers 15α,β-4-100a protons at the 8-position absorbed at 2.79-
2.87 ppm (Figure 4.10). The carbon atoms of the same position gave a doublet at 49.9 ppm 
and 50.7 ppm, respectively. In contrast the proton at the 8-position of PG-isomer 4-100b was 
upfield-shifted by 1.16 ppm absorbing at 1.63 ppm. The carbon atom at this position was 
slightly downfield shifted absorbing at 53.6 ppm. Another distinguishing difference between 
IsoP and PG-isomers was the difference of the C13 and C14 chemical shifts. For 15α-4-100a 
and 15β-4-100b this difference amounts 9.2 ppm and 10.1 ppm, respectively. For 4-100b it 
was much smaller with a value of 6.2 ppm. Further significant NMR data of these compounds 
are presented in Figure 4.10 and Table 6.9. 
 
Figure 4.10 Significant 1H and 13C NMR data of compounds 4-100a and 4-100b 
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The carbonyl group in 15-position of 4-101a and 4-101b absorbed at 198.4 ppm 
(Figure 4.11). The enone proton at 13-position of 4-101a and 4-101b was more downfield-
shifted than in substrates 4-100a,b, giving a doublet of doublets at 6.54 and 6.63 ppm, 
respectively. A similar downfield shift was observed for the protons in 14-position. The 
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carbon atoms in 13-position were also downfield-shifted at 140.8 ppm for 4-101a and at 144.2 
ppm for 4-101b. Further significant NMR data are presented in Figure 4.11 and Table 6.9. 
 
Figure 4.11 Significant NMR data of compounds 4-101a and 4-101b 
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The structure of 13,14-dihydro-15-oxo-15-E2-IsoP 4-3 and of 4-4 was elucidated by 
means of their NMR data (Figure 4.12). The connectivity was established by COSY and 
HSQC experiments. The enone resonances disappeared in the NMR spectra. In compound 4-3 
the protons and carbon atoms of the 13- and 14-positions absorbed in the alkyl range. The 
protons of the new C5-C6 double bond absorbed at 5.43 and 5.32 ppm, while the carbon 
atoms appeared as a doublet at 128.4 and 130.4 ppm, respectively. Similar resonances were 
observed for 4-4. Its structure was additionally confirmed by comparison with the methyl 
ester synthesised from commercially available 13,14-dihydro-15-oxo-PGE2. The most 
significant difference between 4-3 and 4-4 was the chemical shift of H8. 
 
Figure 4.12  Significant NMR data of compounds 4-3 and 4-4 
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Key results: The first synthesis of the potential 15-E2-IsoP metabolite 4-3 and of racemic 
13,14-dihydro-15-oxo-PGE2 4-4 was accomplished in 11 steps and 1.4% overall yield. The 
availability of synthetic material facilitates the study of 15-E2-IsoP metabolism. 
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5. Conclusions and outlook 
 
With this work significant contributions concerning oxidative reactions of enolates 
were achieved. Based on the convenient generation of α-carbonyl radicals 5-2 from 5-1 by 
outer sphere single electron transfer with ferrocenium hexafluorophosphate, new 
methodologies were developed: 1) Radical α-functionalisation; 2) Radical dimerisations and 
3) Selective radical cyclisations and their application to the total synthesis of natural products. 
 
Scheme 5.1 α-Oxygenation of carbonyl compounds 
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1) An efficient α-oxygenation method for the synthesis of carbonyl compounds of type 5-3 
was established (Scheme 5.1, Path A). The scope covers most classes of carbonyl compounds 
and nitriles. This method, adapted for unsaturated carbonyl compounds, gave access to 
products of type 5-6 and 5-7 in low yield (Path B). Amide conjugate addition/oxygenation 
prevailed. The chemoselectivity was partially controlled by using HMPA as cosolvent.  
Compounds 5-3 are valuable building blocks, which were successfully transformed to 
α-hydroxy carbonyl compounds 5-4 by reductive deprotection of the tetramethylpiperidinyl 
group (Path C). The direct oxidation of the enolate 5-1 with oxygen gave only small amounts 
of product 5-4 and could not be further developed to a reliable method (Path D). 
Chemoselective reduction of the carbonyl group allows the efficient synthesis of TMP-
monoprotected diols 5-5.  
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A new radical α-amination of carbonyl compounds by oxidative coupling of their 
enolates with the persistent verdazyl radical 2-9 was developed (Scheme 5.2). 
 
Scheme 5.2 α-Amination of carbonyl compounds 
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Compounds of type 5-8 can be synthesised from esters in high yields. However the 
same conditions applied to 3-oxo esters and nitriles gave rearrangement reactions forming 
new triazoles and tetrazoles. The radical α-amination needs on one hand further 
investigations to establish the scope. On the other hand a detailed mechanistic study of the 
rearrangement reactions is necessary. 
 
2) The oxidative coupling of enolates induced by the outer sphere oxidant ferrocenium 
hexafluorophosphate was established for the synthesis of 1,4-dicarbonyl compounds d,l-5-11 
and meso-5-11 from ketones, esters, acids and amides (Scheme 5.3). While ketones and esters 
react efficiently, the formation of dimers derived from acids and amides is accompanied by 
competing disproportionation reactions. However the method does not work for selected 
lactones or nitriles. 
 
Scheme 5.3 Oxidative coupling of enolates 
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A large body of knowledge was accumulated on the mechanism of radical 
dimerisations. Aggregation of enolates in superstructures like 5-10, conservation of enolate 
geometry in the α-carbonyl radical, the mechanism of the electron transfer (inner or outer
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sphere), and the presence of additives significantly influenced the yields and the 
diastereoselectivity of the dimerisation.  
Exceptionally high diastereoselectivity was achieved in the dimerisations of 
aromatic ketones. Esters, acids and amides dimerised with low to moderate 
diastereoselectivities. 
Oxidative dimerisations should be further studied especially for improving 
diastereoselectivity. Chiral or achiral ligands at the metal counterion, or a different generation 
of the enolate may be promising in this sense. 
 
3) A conceptually new synthesis of the methyl ester of F2t-isoprostane 15α-4-1 and its 15-
epimer 15β-4-1 was achieved in 12 steps and 14% overall yield, which makes it one of the 
most efficient of the existing syntheses (Scheme 5.4). 
 
Scheme 5.4 Schematic representation of the total synthesis of 15α- and 15β-F2t-IsoP 4-1 
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• The assembly of the C7-C20 chain (6E,8E)-4-12a,b was achieved via a short 3 step 
synthesis, consisting of a vinylogous aldol addition, a syn-selective reduction of a 5-hydroxy 
keto ester and a highly regioselective silylation of the resulting diol.  
• A new oxidative radical anion cyclisation/oxygenation methodology gave access to the 
preparation of both IsoP- and PG-skeletons 4-8a,b and 4-50a,b from the same substrate, as 
well as the introduction of the oxygen source, the TMPO-group, in the 15-position. The 
developed cyclisation model proved to be generally applicable for similar precursors, and 
facilitated the stereodivergent synthesis of the central cyclopentane systems of F2t-IsoP, A2-
IsoP, PG F2α, PG A2 and E2-IsoP. This was achieved by controlled manipulation of the 
chelating properties of different metal counterions of the enolate anion A, as well as the 
oxidatively generated radical anion intermediates.  
• The introduction of the C1-C7 chain was accomplished by linking C6 and C7 via an 
alkylation with an alkynyllithium. This completion of C20 skeleton 4-6b is completely new in 
the synthesis of isoprostanes, and was only rarely used in the synthesis of prostaglandins. 
• The total synthesis is an archetype for the preparation of other isoprostanes, many of 
which could not be studied simply because of material deficiency.  
• The approach was adapted to the first synthesis of potential central metabolites of 15-
E2-isoprostane 4-3 and 4-4 (Figure 5.1). The completion of the C20 skeleton was conducted 
similarly to the F2t-IsoP synthesis. Further steps of the total synthesis were particularly 
adapted for the preparation of E2-IsoP metabolites, which was accomplished in 11 steps and 
an overall 1.4% yield. The access facilitates the in vivo study of E2-IsoP metabolism, as well 
as production of enough material, to investigate its biological activities. The high 
epimerisation sensitivity of the 9-position suggests that autoxidatively formed E2-IsoP 
exhibits to some extent a common pathway with the metabolism of PGE2. 
 
Figure 5.1 Structures of 4-3 and 4-4 
 
13,14-Dihydro-15-oxo-E2-IsoP  4-3
C5H11
OOH
COOMe
C5H11
OOH
COOMe
13,14-Dihydro-15-oxo-PGE2  4-4
O O
 
 
• This methodology was also applied to the synthesis of the complete C20 skeleton of 
A2-isoprostane and can be applied to the synthesis of other, less studied oxidative stress 
metabolites in humans or plants like neuroprostanes or phytoprostanes.  
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6. Experimental Part 
 
General: All reactions were conducted in flame-dried glassware under an atmosphere of dry 
nitrogen. THF, CH2Cl2, MeOH, toluene, NEt3, 2,6-lutidine, HMPA, pyridine and ferrocenium 
hexafluorophosphate were dried following standard methods under nitrogen atmosphere. TLC 
plates POLYGRAM SIL G/UV254 (Macherey-Nagel) were used for monitoring reactions. 
Flash column chromatographic separations were performed on silica gel 60 (Fluka, 230-400 
mesh). IR spectra were taken on a Bruker Tensor 27 spectrometer (Dura Sample Diamant-
ATR, 1 Reflexion). 1H and 13C NMR spectra were recorded, unless otherwise noted, in CDCl3 
on Bruker AV II 600, DRX 400, AV 300 or AC 200 spectrometers at 600, 400, 300 or 200 
MHz for 1H NMR, and 150, 100, 75 or 50 MHz for 13C NMR, respectively. Chemical shifts 
are provided in ppm vs. TMS as the internal standard. Connectivity was determined by 1H-1H 
COSY experiments. Stereochemical assignments are based on NOE-Diff and NOESY 
experiments. 13C NMR assignments were obtained from DEPT and HSQC experiments. X-
Ray crystallographic analyses were performed on a Bruker SMART 1000 CCD diffractometer  
using Mo Kα radiation. EI-mass spectra were recorded on Finnigan MAT 95 spectrometers at 
70 eV. ESI-mass spectra were obtained on a Finnigan MAT 95XLT or QSTAR Elite system, 
sample concentration approx. 50 µg/mL in MeOH, spray voltage pos. mode: 1.3 - 1.8 kV, 
spray voltage neg. mode: 1.1 - 2.3 kV, HRMS resolution: 10000 (10% valley definition), or a 
Thermo Fisher Scientific LCQ Fleet spectrometer, sample concentration approx. 1 µg/mL. 
HRMS spectra were measured on a LTQ Orbitrap XL spectrometer, resolution: 100000. 
Combustion analyses were performed at the Microanalytical Laboratories of the Technical 
University of Braunschweig.  
 
The syntheses of silyl ketene acetals E-3-75 and Z-3-76 were performed according to the 
literature.119 The E:Z ratios were in the range 4-7.6:1, and the Z:E ratios were in the range 7-
8.6:1, respectively. 
 
6.1. α-(2,2,6,6-Tetramethylpiperidin-1-yl-1-oxy) carbonyl compounds 3-2, 3-5 and 3-11 
(General procedure): 
General: nBuLi (1.625 mL, 2.6 mmol, 1.6M solution in hexane) was added dropwise via 
syringe to a solution of dry iPr2NH (0.367 mL, 2.6 mmol) in dry THF (19 mL, 0.1M) at –78 
°C. After stirring at –78 °C for 0.5 h, the substrate 3-1, 3-4 or 3-10a-h (2.0 mmol) dissolved 
in THF (1 mL) was added dropwise at –78 °C. For compounds 3-1b and 3-4c,h the 
deprotonation was performed with 4-4.6 mmol of LDA (for exact amounts see Tables 3.1 and 
3.3). The mixture was stirred at –78 °C for 30 min.  
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With LiCl: Anhydrous LiCl (399.5 mg or 510 mg, 9.4 mmol or 12 mmol) was flame-dried 
under high vacuum in a Schenk flask five times for ca. 2 min. Dry THF (19 mL, 0.1M 
solution) followed by dry iPr2NH (0.367 mL, 2.6 mmol) were added. nBuLi (1.625 mL, 2.6 
mmol, 1.6M solution in hexane) was added dropwise via syringe at –78 °C. After stirring at –
78 °C for 0.5 h, the substrate 3-1, 3-4 or 3-10a-h (2.0 mmol) dissolved in THF (1 mL) was 
added dropwise at –78 °C. For compounds 3-1b and 3-4c,h the deprotonation was performed 
with 4-4.6 mmol of LDA (for exact amounts see Tables 3.1 and 3.3). The mixture was stirred 
at –78 °C for 5-30 min (Tables 3.1-3.3). 
With HMPA: nBuLi (1.625 mL, 2.6 mmol, 1.6M solution in hexane) was added dropwise via 
syringe to a solution of dry iPr2NH (0.367 mL, 2.6 mmol) in dry THF (19 mL, 0.1M) at –78 
°C. After stirring at –78 °C for 0.5 h, the substrate 3-1, 3-4 or 3-10a-h (2.0 mmol) dissolved 
in THF (1 mL) was added dropwise at –78 °C. For compounds 3-1b and 3-4c,h the 
deprotonation was performed with 4-4.6 mmol of LDA (for exact amounts see Tables 3.1 and 
3.3). The mixture was stirred at –78 °C for 30 min. Dry HMPA (2.09 mL, 12 mmol) was 
added via syringe. 
TEMPO 1-2 (343 mg, 2.2 mmol) was added in one portion at –78 °C and the mixture was 
stirred until it dissolved (ca. 5 min). For 3-4h, 4.2 mmol of TEMPO was used.  Ferrocenium 
hexafluorophosphate 1-3 was added in small portions at –78 °C as it was consumed (the blue 
colour of the oxidant disappears when added to the enolate solution). Addition was continued 
until the reaction mixture remained dark blue (0.993 g - 1.32 g, 3.0-3.7 mmol; for 3-4h a 
minimum 4 mmol of 1-3 was added). Stirring was continued at –78 °C for 15 min to 1 h and 
the reaction was monitored by TLC (Ferrocene Rf = 0.9 (hexane/EtOAc, 10:1) and TEMPO Rf 
= 0.4 (hexane/EtOAc, 10:1)). The reaction was quenched with 3 to 10 drops of water, diluted 
with 20 mL diethyl ether, warmed to room temperature and filtered through a pad of silica 
gel, which was washed with diethyl ether. The solvent was evaporated in vacuum, the 
inhomogeneous mixture was preadsorbed on silica gel, added to a filled column and purified 
by flash chromatography with hexane/ethyl acetate. 
 
Ethyl 2-(2,2,6,6-tetramethylpiperidin-1-yloxy)pentanoate 3-2a 
OEt
O
Pr
O
N
 
Flash chromatography (hexane/ethyl acetate 80:1, gradient to 10:1) gave ferrocene, followed 
by 3-2a and dimer 3-3a as pale yellow oils. Yield (7 mmol setup, 6 equiv. LiCl): 3-2a 1.74 g 
(87%) and meso-3-3a 36 mg (4%). Yield (1.5 mmol setup, 6 equiv. HMPA) 3-2a 275 mg 
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(64%) and 3-3a 40 mg (20%, meso/d,l 1:1.5). Rf = 0.5 (hexane/EtOAc 10:1). - 1H NMR (400 
MHz): δ = 0.85 (t, J = 7.3 Hz, 3H, CH2CH2CH3), 0.96 (s, 3H, NCCH3), 1.04 (s, 3H, NCCH3), 
1.05 (s, 3H, NCCH3), 1.11 (s, 3H, NCCH3), 1.21 (t, J = 7.1 Hz, 3H, OCH2CH3), 1.14-1.29 (m, 
2H, CH2CH2CH3), 1.31-1.57 (m, 6H, NCCH2CH2CH2CN), 1.73 (m, 2H, CHCH2), 4.09 (q, J = 
7.1 Hz, 2H, OCH2), 4.14 (dd, J = 7.4, 6.8 Hz, 1H, CHON). - 13C NMR (100 MHz): δ = 14.0 
(q, CH2CH2CH3), 14.2 (q, OCH2CH3), 17.1 (t, NCCH2CH2CH2CN), 17.9 (t, CH2CH2CH3), 
20.0 (q, NCCH3), 20.2 (q, NCCH3), 33.0 (q, NCCH3), 33.5 (q, NCCH3), 34.2 (t, 
CH2CH2CH3), 40.2 (t, NCCH2CH2CH2CN), 40.3 (t, NCCH2CH2CH2CN), 59.3 (s, NCCH3), 
60.1 (t, CH2O), 85.5 (d, CHON), 173.6 (s, CO2). - IR (film): v~  = 2964, 2935, 2874, 1748, 
1467, 1376, 1362, 1261, 1245, 1181, 1133, 1031 cm-1. - MS (+CI): m/z (%) = 286 (100) 
[M+H+], 164 (12), 142 (22) [TMPH2+], 126 (13), 116 (12). - Combustion analysis: C16H31NO2 
(285.42): calc. C 67.33, H 10.95, N 4.91; found C 67.24, H 11.06, N 5.06. 
 
syn- and anti-(2S)-Dimethyl 2-hydroxy-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)succinates 3-2b 
COOMe
MeOOC
OH
O
N
 
Flash chromatography (hexane/ethyl acetate 20:1, gradient to 1:1) gave ferrocene, followed 
by anti-3-2b and a mixture of syn- and anti-3-2b as pale yellow oils. Yield (2 mmol setup, 
2.15 equiv. LDA): 410 mg (65%, syn/anti-3-2b 1:1.8). Yield (2 mmol setup, 2.5 equiv. LDA, 
deprotonation 1 h at –78 - –50 °C): 600 mg (94%, syn/anti-3-2b 1:2.2). With 4.7 equiv. LiCl 
(2 mmol setup, 2.3 equiv. LDA): 410 mg (77%, syn/anti-3-2b 1:1.4). With 6 equiv. HMPA (2 
mmol setup, 2.15 equiv. LDA): 420 mg (66%, syn/anti-3-2b 1:2). The analyses were 
performed on a mixture of syn- and anti-isomers. 
 
IR (film): v~  = 3493 (w), 2933 (w), 1739 (s), 1438 (m), 1363 (w), 1257 (m), 1241 (m), 1200 
(s), 1171 (s), 1129 (s), 1080 (s), 1022 (m), 990 (w), 959 (w), 878 (w), 792 (w), 710 (w) cm-1. - 
MS (ESI) m/z (%): 657 (21) [2M+Na+], 340 (100) [M+Na+], 184 (9) [M–TEMPO+Na+]. - 
Combustion analysis: C15H27NO6 (317.38): calc. C 56.77, H 8.57, N 4.41; found C 56.98, H 
8.71, N 4.22. - Major isomer (2S,3R)-3-2b: Rf(hexane/EtOAc 2:1) = 0.38. - 1H NMR (200 
MHz): δ = 1.15 (br. s, 6H, NCCH3), 1.23 (m, 1H, NCCH2CH2CH2CN), 1.25 (s, 6H, NCCH3),    
1.48 (br. s, 5H, NCCH2CH2CH2CN), 3.32 (br. s, 1H, OH), 3.74 (s, 3H, OCH3), 3.83 (s, 3H, 
OCH3), 4.81 (s, 2H, CHON, CHOH). - 13C NMR (50 MHz): δ = 16.9 (t, NCCH2CH2CH2CN), 
20.1 (q, NCCH3), 20.3 (q, NCCH3), 33.0 (q, NCCH3), 33.9 (q, NCCH3), 40.2 (t, 
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NCCH2CH2CH2CN), 51.83 (q, OCH3), 52.6 (q, OCH3), 59.8 (s, NCCH3), 60.7 (s, NCCH3), 
70.9 (d, CHOH), 85.8 (d, CHON), 169.7 (s, CO), 172.3 (s, CO). - Minor isomer (2S,3S)-3-2b: 
Rf(hexane/EtOAc 2:1) = 0.35. -  1H NMR (200 MHz): δ = 1.04-1.48 (m, 18H, 
NCCCH2CH2CH2CN, NCCH3), 3.74 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 4.40 (br. s, OH), 
4.65 (s, 2H, CHON, CHOH). - 13C NMR (50 MHz): δ = 16.8 (t, NCCH2CH2CH2CN), 20.1 (q, 
NCCH3), 20.3 (q, NCCH3), 33.0 (q, NCCH3), 33.9 (q, NCCH3), 40.1 (t, NCCH2CH2CH2CN), 
51.79 (q, OCH3), 52.4 (q, OCH3), 59.8 (s, NCCH3), 60.7 (s, NCCH3), 71.1 (d, CHOH), 83.6 
(d, CHON), 170.2 (s, CO), 171.8 (s, CO).  
 
2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)butyrolactone 3-2c 
O
O
O
N
 
Flash chromatography (hexane/ethyl acetate 20:1, gradient to 2:1) gave ferrocene, followed 
by 3-2c. Colourless solid. Yield (4 mmol setup, 6 equiv. LiCl): 3-2c 725 mg (75%). 
Rf(hexane/EtOAc 5:1) = 0.28, Rf(hexane/EtOAc 2:1) = 0.60. - m.p. 21-22 °C. - 1H NMR (200 
MHz): δ = 1.11 (s, 3H, NCCH3), 1.17 (s, 3H, NCCH3), 1.23 (m+s, 4H, NCCH3, 
NCCH2CH2CH2CN), 1.33 (s, 3H, NCCH3), 1.48 (br. s, 5H, NCCH2CH2CH2CN), 2.29 (m, 
1H, CH2CHO), 2.67 (m, 1H, CH2CHO), 4.08 (ddd, J = 10.8, 9.2, 5.7 Hz, 1H, CH2O), 4.33 (dt, 
J = 8.8, 1.7 Hz, 1H, CH2O), 4.71 (dd, J = 10.8, 7.9 Hz, 1H, CHOTMP). - 13C NMR (50 
MHz): δ = 17.0 (t, NCCH2CH2CH2CN), 20.2 (q, NCCH3), 31.5 (t, CH2CHOTMP), 32.3 (q, 
NCCH3), 34.2 (q, NCCH3), 40.2 (t, NCCH2CH2CH2CN), 59.4 (s, NCCH3), 61.0 (s, NCCH3), 
64.0 (t, CH2O), 80.3 (d, CHOTMP), 174.2 (s, CO). - IR (ATR): v~  = 2972 (w), 2930 (w), 
1781 (s), 1450 (w), 1375 (w), 1361 (w), 1261 (w), 1216 (m), 1180 (w), 1157 (s), 1132 (w), 
1102 (s), 1020 (s), 992 (s), 974 (w), 951 (m), 919 (w), 711 (w), 543 (w) cm-1. - MS (CI, pos.) 
m/z (%): 242 (72) [M+H+], 226 (22) [M+H+−CH3], 156 (100) [TEMPO+]. - Combustion 
analysis: C13H23NO3 (241.33): calc. C 64.70, H 9.61, N 5.80; found: C 64.35, H 10.02, N 
5.88. 
 
2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)phenylacetonitrile 3-5a 
Ph CN
O
N
 
Flash chromatography (hexane/ethyl acetate 80:1, gradient to 50:1) gave ferrocene, followed 
by 3-5a. Yellow oily solid, which turns to dark yellow or orange during a few hours at room 
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temperature, unstable to light and heat. Yield (5 mmol setup): 0.94 g (69%). Yield (3 mmol 
setup): 0.76 g (93%). Yield (5 mmol setup, 4.7 equiv. LiCl): 1 g (73%). Rf = 0.5 
(hexane/EtOAc 10:1). - 1H NMR (200 MHz): δ = 0.94 (s, 3H, NCCH3), 1.02 (s, 3H, NCCH3), 
1.11 (s, 3H, NCCH3), 1.21-1.59 (m, 6H, NCCH2CH2CH2CN), 1.41 (s, 3H, NCCH3), 5.50 (s, 
1H, CHON), 7.29-7.44 (m, 5H, Ph). - 13C NMR (50 MHz): δ = 17.0 (t, NCCH2CH2CH2CN), 
20.4 (q, NCCH3), 20.5 (q, NCCH3), 33.8 (q, NCCH3), 34.6 (q, NCCH3), 40.0 (t, 
NCCH2CH2CH2CN), 60.3 (s, NCCH3), 60.9 (s, NCCH3), 76.7 (d, CHON), 118.9 (s, CN), 
127.2 (d, Ph), 128.9 (d, Ph), 129.4 (d, Ph), 134.9 (s, Ph). - IR (film): v~  = 3070, 2971, 2942, 
2874, 2214, 1687, 1602, 1583, 1548, 1451, 1382, 1315, 1271, 1175, 1120, 1070, 1025, 935, 
793, 710 cm-1. - MS (+ESI): m/z (%) = 295 (100) [M+Na+], 273 (40) [M+H+], 179 (41) 
[TEMPO+Na+], 158 (21) [TEMPOH2+], 142 (3) [TMPH2+]. - Combustion analysis: 
C17H24N2O (272.39): calc. C 74.96, H 8.88, N 10.28; found C 75.16, H 8.88, N 10.21. 
 
2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)capronitrile 3-5b 
CN
O
N
 
Flash chromatography (hexane/EtOAc 100:1, gradient to 2:1) gave ferrocene, followed by a 
mixture of ferrocene and 3-5b, which was further purified. Yield (3 mmol setup): 661 mg 
(78%). Yield (5 mmol setup, 4.7 equiv. LiCl): 1.43 g (92%). The NMR data were in 
agreement with those from literature.25 Pale yellow oil. Rf = 0.64 (hexane/EtOAc 10:1). - 1H 
NMR (200 MHz): δ = 0.83 (t, J = 6.4 Hz, 3H, CH3CH2), 1.02 (s, 3H, NCCH3), 1.04 (s, 3H, 
NCCH3), 1.10 (s, 3H, NCCH3), 1.16-1.66 (m, 17H, NCCH2CH2CH2CN, CH3(CH2)4, 
NCCH3), 1.77 (m, 2H, CH2CH), 4.52 (t, J = 6.5 Hz, 1H, CHOTMP). - 13C NMR (50 MHz): δ 
= 14.0 (q, CH3CH2), 17.0 (t, NCCH2CH2CH2CN), 20.2 (q, NCCH3), 20.4 (q, NCCH3), 22.4 
(t), 24.7 (t, CH2), 28.8 (t, CH2), 31.5 (t, CH2), 32.9 (t, CH2), 33.6 (q, NCCH3), 34.0 (q, 
NCCH3), 39.9 (t, NCCH2CH2CH2CN), 59.8 (s, NCCH3), 60.8 (s, NCCH3), 74.3 (d, 
CHOTMP), 119.7 (CN). 
 
3-Hydroxy-3-methyl-2-(2,2,6,6-tetramethylpiperidin-1-yloxy)butyronitrile 3-5c 
CN
OH
O
N
 
Deprotonation with 2.3 equiv. LDA at –78 - –50 °C for 35 min. Flash chromatography 
(hexane/EtOAc 20:1, gradient to 2:1) gave ferrocene, followed by 3-5c. Yield 530 mg (99%) 
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as a colourless solid. m.p. 22-23 °C. - Rf = 0.34 (hexane/EtOAc 5:1). - 1H NMR (200 MHz): δ 
= 1.11 (s, 3H, NCCH3), 1.17 (s, 3H, NCCH3), 1.24 (s, 3H, NCCH3), 1.34 (s, 3H, NCCH3), 
1.41 (s, 6H, HOC(CH3)2), 1.16-1.60 (m, 6H, NCCH2CH2CH2CN), 2.25 (br. s, 1H, OH), 4.59 
(s, 1H, CHON). - 13C NMR (50 MHz): δ = 16.1 (t, NCCH2CH2CH2CN), 19.9 (q, NCCH3), 
24.8 (q, (CH3)2COH), 24.9 (q, (CH3)2COH), 33.0 (q, NCCH3), 33.3 (q, NCCH3), 39.2 (t, 
NCCH2CH2CH2CN), 39.5 (t, NCCH2CH2CH2CN), 59.6 (s, NCCH3), 71.6 (s, (CH3)2COH), 
80.0 (d, CHON), 117.7 (s, CN). - IR (film): v~  = 3431, 3338, 3011, 2976, 2938, 2871, 2250, 
1465, 1382, 1363, 1259, 1235, 1182, 1133, 1070, 1003, 953, 913, 895, 808, 708 cm-1. - MS 
(ESI): m/z (%) = 531 (37) [2M+Na+], 277 (100) [M+Na+], 179 (43) [TEMPO+Na+]. - 
Combustion analysis: C14H26N2O2 (254.37): calc. C 66.10, H 10.30, N 11.01; found C 65.99, 
H 10.33, N 11.15. 
 
N,N-Diethyl-2-(2,2,6,6-tetramethylpiperidin-1-yloxy)pentanoic amide 3-5d 
NEt2
O
O
N
 
Flash chromatography (hexane/EtOAc 20:1, gradient to 2:1) gave ferrocene, followed by 3-
5d. Yield 589 mg (94%) as a pale yellow oil. Rf = 0.66 (hexane/EtOAc 2:1). - 1H NMR (400 
MHz): δ = 0.88 (t, J = 7.3 Hz, 3H, CH2CH2CH3), 0.98 (s, 3H, NCCH3), 1.02 (s, 3H, NCCH3), 
1.06 (t, J = 7.1 Hz, 3H, NCH2CH3), 1.09 (s, 3H, NCCH3), 1.16 (s, 3H, NCCH3), 1.17 (t, J = 
7.1 Hz, 3H, NCH2CH3), 1.19 (m, 2H, CH2CH2CH3), 1.13-1.49 (m, 6H, NCCH2CH2CH2CN), 
1.67-1.85 (m, 2H, CHCH2), 3.26 (m, 2H, NCH2), 3.35 (dq, J = 13.7, 6.9 Hz, 1H, NCH2), 3.81 
(dq, J = 14.6, 7.3 Hz, 1H, NCH2), 4.41 (dd, J = 10.0, 4.7 Hz, 1H, CHON). - 13C NMR (100 
MHz): δ = 12.4 (q, CH2CH2CH3), 14.3 (q, NCH2CH3), 14.6 (q, NCH2CH3), 17.0 (t, 
NCCH2CH2CH2CN), 18.6 (t, CH3CH2CH2), 19.9 (q, NCCH3), 20.2 (q, NCCH3), 32.9 (q, 
NCCH3), 33.3 (q, NCCH3), 34.4 (t, CH2CHON), 40.2 (t, NCCH2CH2CH2CN), 40.3 (t, CH2N), 
40.4 (t, NCCH2CH2CH2CN), 41.5 (t, CH2N), 59.0 (s, NCCH3), 60.4 (s, NCCH3), 81.4 (d, 
CHON), 172.3 (s, CO). - IR (film): v~  = 2964, 2933, 2874, 1652, 1463, 1455, 1432, 1377, 
1362, 1259, 1133, 1123, 1023 cm-1. - MS (+CI): m/z (%) = 313 (100) [M+H+], 189 (6), 158 
(17) [TEMPOH2+], 142 (38) [TMPH2+], 126 (18), 116 (9). - Combustion analysis: 
C18H36N2O2 (312.49): calc. C 69.18, H 11.61, N 8.96; found C 69.44, H 11.80, N 9.17. 
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N,N-Dibenzyl-2-(2,2,6,6-tetramethylpiperidin-1-yloxy)hexanoic amide 3-5e 
 
NBn2
O
O
N
 
Flash chromatography (hexane/EtOAc 80:1, gradient to 5:1) gave ferrocene, followed by 3-
5e. Yield 667 mg (74 %) as a pale yellow solid. m.p. 49-52 °C. - Rf = 0.42 (hexane/EtOAc 
10:1). - 1H NMR (400 MHz): δ = 0.87 (t, J = 6.9 Hz, 3H, CH3CH2), 0.91 (s, 3H, NCCH3), 
1.05 (s, 3H, NCCH3), 1.09 (s, 6H, NCCH3), 1.13-1.30 (m, 5H, CH3CH2CH2, 
NCCH2CH2CH2CN), 1.32-1.51 (m, 5H, NCCH2CH2CH2CN), 1.88 (m, 2H, CH2CHO), 4.49 
(d, J = 14.1 Hz, 1H, CH2N), 4.59 (m, 3H, CH2N, CHON), 4.96 (d, J = 17.0 Hz, 1H, CH2N), 
7.29 (m, 10H, Ph). - 13C NMR (100 MHz): δ = 13.2 (q, CH3CH2), 16.3 (t, 
NCCH2CH2CH2CN), 19.3 (q, NCCH3), 19.6 (q, NCCH3), 22.1 (t, CH3CH2), 26.8 (t, 
CH2CH2CHO), 31.2 (t, CH2CHO), 32.4 (q, NCCH3), 32.8 (q, NCCH3), 39.6 (t, 
NCCH2CH2CH2CN), 47.6 (t, NCH2), 48.6 (t, NCH2), 58.7 (s, NCCH3), 59.5 (s, NCCH3), 81.4 
(d, CHON), 126.1 (d, Ph), 126.64 (d, Ph), 126.65 (d, Ph), 127.5 (d, Ph), 127.9 (d, Ph), 128.8 
(d, Ph), 136.0 (s, Ph), 136.1 (s, Ph), 172.4 (s, CO). - IR (film): v~  = 2928, 2871, 1651, 1495, 
1453, 1426, 1376, 1361, 1241, 1203, 1182, 1132, 1079, 1028, 1008, 988, 974, 956, 916, 732, 
698 cm-1. - MS (+ESI): m/z (%) = 451 (100) [M+H+], 317 (5). - HRMS: C29H43N2O2+: calc. 
451.3325; found 451.3319. - Combustion analysis: C29H42N2O2 (450.66): calc. C 77.29, H 
9.39, N 6.22; found C 77.33, H 9.48, N 6.00. 
 
N,N-Dimethyl-2-(2,2,6,6-tetramethylpiperidin-1-yloxy)isobutyramide 3-5f 
NMe2
O
O
N
  
Flash chromatography (hexane/EtOAc 40:1, gradient to 2:1) afforded ferrocene, followed by 
residual TEMPO and 3-5f. Yield 70 mg (13%) as a pale yellow oil. Yield (4.7 equiv. LiCl, 
deprotonation at –78 - –50 °C for 75 min): 30 mg (5%):  Rf = 0.59 (hexane/EtOAc 2:1). - 1H 
NMR (400 MHz): δ = 1.04 (s, 6H, NCCH3), 1.10 (s, 6H, NCCH3), 1.13-1.55 (m, 6H, 
NCCH2CH2CH2CN), 1.52 (s, 6H, (CH3)2CON), 2.94 (s, 3H, N(CH3)2), 3.39 (s, 3H, N(CH3)2). 
- 13C NMR (100 MHz): δ = 17.1 (t, NCCH2CH2CH2CN), 21.5 (q, NCCH3), 25.5 (q, 
(CH3)2CON), 33.3 (q, NCCH3), 37.2 (q, N(CH3)2), 38.2 (q, N(CH3)2), 40.3 (t, 
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NCCH2CH2CH2CN), 59.4 (s, NCCH3), 83.5 (s, (CH3)2CON), 174.8 (s, CO). - IR (film): v~  = 
2974, 2934, 2932, 1643, 1472, 1382, 1362, 1260, 1184, 1182, 1145, 1119, 923, 827 cm-1. - 
MS (+ESI): m/z (%) = 833 (93) [3M+Na+], 563 (83) [2M+Na+], 412 (27) [M+TMPH2+], 271 
(100) [M+H+]. - Combustion analysis: C15H30N2O2 (270.41): calc. C 66.62, H 11.18, N 10.36; 
found C 66.58, H 10.78, N 9.56. 
 
2,4-Bis(2,2,6,6-tetramethylpiperidin-1-yloxy)-N,N,N’N’-tetramethylglutardiamide 3-5h 
Me2N
O O
NMe2
O O
NN
 
Flash chromatography (hexane/EtOAc 30:1, gradient to 1:2) afforded ferrocene, followed by 
residual TEMPO, and finally 3-5h. Yield (using 2.0 equiv. TEMPO, 4.7 equiv. LiCl) 230 mg 
(23%, d,l:meso 4:1); yield (using 2.1 equiv. TEMPO, 6 equiv. LiCl) 280 mg (28%, d,l:meso 
4:1) as a colourless solid. m.p. 21-22 °C. - Rf = 0.20 (hexane/EtOAc 2:1). - IR (film): v~  = 
2932, 2873, 1644, 1499, 1466, 1398, 1377, 1361, 1334, 1261, 1132, 1106, 1017, 982, 956, 
910, 877, 793, 708, 656 cm-1. - MS (+ESI): m/z (%) = 1015 (10) [2M+Na+], 519 (100) 
[M+Na+], 223 (23). - C27H52N4O4 (496.73): calc. C 65.29, H 10.55, N 11.28; found C 65.19, 
H 10.66, N 10.81. - d,l-3-5h: 1H NMR (400 MHz): δ = 0.97 (s, 6H, NCCH3), 1.04 (s, 6H, 
NCCH3), 1.09 (s, 6H, NCCH3), 1.20 (s, 6H, NCCH3), 1.21-1.54 (m, 12H, 
NCCH2CH2CH2CN), 2.22 (dt, J = 13.6, 3.4 Hz, 1H, CHCH2CH), 2.68 (dt, J = 13.6, 9.5 Hz, 
1H, CHCH2CH), 2.84 (s, 6H, N(CH3)2), 3.21 (s, 6H, N(CH3)2), 4.72 (dd, J = 9.5, 3.4 Hz, 2H, 
CHCH2CH). - 13C NMR (100 MHz): δ = 17.1 (t, NCCH2CH2CH2CN), 20.1 (q, NCCH3), 20.3 
(q, NCCH3), 32.6 (q, NCCH3), 33.3 (q, NCCH3), 33.7 (t, CHCH2CH), 35.7 (q, N(CH3)2), 37.4 
(q, N(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 40.5 (t, NCCH2CH2CH2CN), 59.3 (s, NCCH3), 
60.4 (s, NCCH3), 79.3 (d, CHON), 171.9 (s, CO). - meso-3-5h: 1H NMR (400 MHz): δ = 0.94 
(s, 6H, NCCH3), 1.04 (s, 6H, NCCH3), 1.09 (s, 6H, NCCH3), 1.19 (s, 6H, NCCH3), 1.21-1.54 
(m, 12H, NCCH2CH2CH2CN), 2.43 (dd, J = 9.1, 6.4 Hz, 2H, CHCH2CH), 2.88 (s, 6H, 
N(CH3)2), 3.19 (s, 6H, N(CH3)2), 4.32 (dd, J = 9.0, 6.5 Hz, 2H, CHCH2CH). - 13C NMR (100 
MHz): δ = 17.1 (t, NCCH2CH2CH2CN), 19.9 (q, NCCH3), 20.3 (q, NCCH3), 32.3 (q, 
NCCH3), 33.1 (q, NCCH3), 34.1 (t, CHCH2CH), 35.8 (q, N(CH3)2), 37.4 (q, N(CH3)2), 40.2 (t, 
NCCH2CH2CH2CN), 40.5 (t, NCCH2CH2CH2CN), 59.2 (s, NCCH3), 60.4 (s, NCCH3), 79.1 
(d, CHON), 172.0 (s, CO). 
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(2S,4R)- and (2S,4S)-Ethyl 1-(tert-butyloxycarbonyl)-5-oxo-4-(2,2,6,6-
tetramethylpiperidinyl-1-yloxy)pyrrolidin-2-carboxylate 3-5i: 
NO
COOtBu
COOEt
H
ON
 
To a solution of (S)-3-4i (257 mg, 1 mmol) in dry THF (10 mL) was added a LiHMDS 
solution (1.05 mL, 1.05 mmol, 1.0M in THF) at –78 °C. After stirring for 0.5 h, 1-2 (172 mg, 
1.1 mmol) was added to the reaction mixture. Stirring was continued for 5 min until it 
dissolved. Ferrocenium hexafluorophosphate 1-3 was added in portions at –78 °C until the 
solution remained dark blue for at least 5 min. Workup was performed according to the 
general procedure (vide supra). Flash chromatography (hexane/ethyl acetate 40:1, gradient to 
1:1) afforded starting from a polarity 10:1 110 mg of (2S,4R)-3-5i, followed by 80 mg of a 
mixture of (2S,4R)-3-5i and (2S,4S)-3-5i, and finally 100 mg of (2S,4S)-3-5i as colourless 
solids. Yield 290 mg (70%), (2S,4R)-3-5i:(2S,4S)-3-5i 1:1.2. HPLC investigations on a 
DAICEL-OD chiral column showed that (2S,4R)-3-5i and (2S,4S)-3-5i are enantiomerically 
pure. (2S,4R)-3-5i: [α]20D = +4.5 ° (c = 0.353, CHCl3), Rf = 0.44 (hexane/EtOAc 5:1); 
(2S,4S)-3-5i: [α]20D = –24.4 ° (c = 0.468, CHCl3), Rf = 0.32 (hexane/EtOAc 5:1). The NMR 
data are in agreement with those reported earlier.25 Combustion analysis: C21H36N2O6 
(412.52): calc. C 61.14, H 8.80, N 6.79; found C 60.92, H 8.90, N 6.54. 
 
2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)heptanoic acid 3-7 
H11C5 COOH
O
N
 
A solution of nBuLi (2.75 mL, 4.4 mmol, 1.6 M in hexane) was added at −78 °C to a solution 
of anhydrous LiCl (400 mg, 9.4 mmol) and dry diethyl amine (0.455 mL, 321 mg, 4.4 mmol) 
in dry THF (20 mL). The reaction mixture was stirred at −78 °C for 10 min and at 0 °C for 20 
min. The acid (0.284 mL, 2 mmol) was added via syringe at −78 °C. After stirring at the same 
temperature for 10 min and at 0 °C for 1 h, the reaction was cooled to −78 °C and TEMPO 
(374 mg, 2.4 mmol) was added. Stirring was continued for 5 min, and ferrocenium 
hexafluorophosphate (0.99 g, 3 mmol) was added in portions at −78 °C during 10 min until a 
blue colour persisted in the mixture. The reaction mixture was stirred at −78 °C for 10 min 
and quenched with 30 mL water. The organic layer was extracted twice with water. The 
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combined aqueous layers were acidified with conc. HCl (3.5 mL) and extracted with diethyl 
ether. The combined ethereal layers were washed with water and brine, dried over Na2SO4 
and the solvent was removed in vacuum. Flash chromatography (hexane/EtOAc 10:1, gradient 
to 2:1) afforded ferrocene, followed by residual 1-2, 80 mg of a mixture of 3-6 and 3-9, and 
360 mg of a mixture of products 3-7 and meso-3-8 at polarity 2:1. Yield based on the NMR 
spectra: 57 mg (22%) of recovered 3-6, 23 mg (9%) of 3-9, 291 mg (51%) of 3-7, and 36 mg 
(14%) of meso-3-8. Further purification of the product allowed the analytical characterisation. 
 
3-7: Rf = 0.35 (hexane/EtOAc 2:1). - 1H NMR (400 MHz): δ = 0.84 (t, J = 7.0 Hz, 3H, 
CH2CH2CH3), 1.19 (s, 3H, NCCH3), 1.21 (s, 3H, NCCH3), 1.24 (s, 3H, NCCH3), 1.28 (m, 4H, 
CH3CH2CH2), 1.29 (s, 3H, NCCH3), 1.44 (m, 3H, CHCH2CH2, NCCH2CH2CH2CN), 1.61 (m, 
5H, NCCH2CH2CH2CN), 1.74 (m, 1H, CHCH2), 2.03 (m, 1H, CHCH2), 4.37 (dd, J = 8.5, 4.0 
Hz, 1H, CHON), 14.58 (br. s, 1H, COOH). - 13C NMR (100 MHz): δ = 13.7 (q, CH2CH3), 
16.1 (t, NCCH2CH2CH2CN), 20.7 (q, NCCH3), 22.1 (t, CH2CH3), 25.0 (t, CHCH2CH2), 30.0 
(q, NCCH3), 30.9 (q, NCCH3), 31.2 (t, CH3CH2CH2), 31.6 (t, CHCH2), 38.9 (t, 
NCCH2CH2CH2CN), 39.0 (t, NCCH2CH2CH2CN), 62.4 (s, NCCH3), 62.7 (s, NCCH3), 80.0 
(d, CHON), 174.0 (s, COOH). - IR (film): v~  = 3350-2450 (br. w), 2930, 2870, 1718, 1464, 
1376, 1362, 1239, 1211, 1180, 1132, 1039, 957, 793, 712 cm-1. - MS (+CI): m/z (%) = 286 
(23) [M+H+], 158 (9) [TEMPOH2+], 142 (100) [TMPH2+], 126 (10), 111 (11), 98 (9), 75 (9), 
69 (20), 61 (28). - HRMS (+ESI): C16H31NO3Na+: calc. 308.2202; found 308.2199. - 
Combustion analysis: C16H31NO3 (285.42): calc. C 67.33, H 10.95, N 4.91; found C 67.04, H 
11.10, N 4.90. 
 
meso/d,l-Dodecan-6,7-dicarboxylic acids 3-8 
COOH
H11C5
HOOC
C5H11
COOH
H11C5
HOOC
C5H11  
The dimers 3-8 were isolated as a mixture together with residual 3-6 and the 
disproportionation product 3-9. 
meso-3-8: 1H NMR (200 MHz): δ = 0.89 (m, 6H, CH2CH3), 1.28-1.62 (m, 16H, 
CH2CH2CH2CH2CH3), 2.66 (m, 2H, CHCOOH), 11.92 (br. s, 2H, COOH). - 13C NMR (50 
MHz): δ = 14.1 (q, CH2CH3), 22.1 (t, CH3CH2), 27.0 (t, CH2), 30.6 (t, CH2), 31.5 (t, CHCH2), 
48.0 (d, CHCOOH), 178.1 (s, COOH). - d,l-3-8: Detectable resonances: 1H NMR (200 MHz): 
δ = 0.89 (m, 6H, CH2CH3), 1.28-1.62 (m, 16H, CH2CH2CH2CH2CH3), 2.71 (m, 2H, 
CHCOOH), 11.92 (br. s, 2H, COOH). - 13C NMR (50 MHz): δ = 22.4 (t, CH3CH2), 26.3 (t, 
CH2), 28.7 (t, CH2), 31.6 (t, CHCH2), 46.0 (d, CHCOOH), 180.7 (s, COOH).  
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 (E)-2-Heptenoic acid 3-9 
COOH
H9C4  
Rf = 0.57 (hexane/EtOAc 2:1). - 1H NMR (200 MHz): δ = 0.90 (m, 3H, CH2CH3), 1.29-1.53 
(m, 4H, CH3CH2CH2), 2.23 (q, J = 6.7 Hz, 2H, CH2CH), 5.82 (d, J = 15.6 Hz, 1H, 
CHCOOH), 7.12 (dt, J = 15.6, 7.0 Hz, 1H, CH=CHCOOH), 11.40 (br. s, 1H, COOH). - 13C 
NMR (50 MHz): δ = 13.7 (q, CH2CH3), 22.2 (t, CH2CH3), 29.9 (t, CHCH2CH2), 31.9 (t, 
=CHCH2), 120.6 (d, =CHCOOH), 152.5 (d, =CHCH2), 172.3 (s, COOH). 
 
1-Phenyl-2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)propan-1-one 3-11a 
Ph
O
OTMP  
Flash chromatography (hexane/ethyl acetate 80:1, gradient to 1:2) afforded ferrocene, 
followed by 3-11a, residual 1-2, and d,l/meso-3-10a. Further purification provided pure 3-
11a. Yield Method A (2 mmol setup): 3-11a 175 mg (30%), d,l/meso-3-10a 158 mg (59%) 
10.5:1; Method B-2 (2 mmol setup): 3-11a 457 mg (78%), d,l/meso-3-10a  60 mg (21%) 5:1; 
Method C (2 mmol setup): 3-11a 307 mg (52%), d,l/meso-3-10a 129 mg (49%) 6:1. 
Colourless solid. m.p. 69-71 °C. - Rf = 0.63 (hexane/EtOAc 10:1). - The NMR data are in 
agreement with those reported in the literature.25 
 
1-Phenyl-2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)butan-1-one 3-11b 
O
Ph
O
N
 
Flash chromatography (hexane/EtOAc 80:1, gradient to 5:1) afforded ferrocene, followed by 
3-11b and d,l/meso-dimer 3-12b. Yields (2 mmol setup): 3-11b 230 mg (38%), d,l/meso-3-
12b 161.5 mg (55%) 45:1. Yields (5 mmol setup, 6 equiv. LiCl): 3-11b 1.03 g (70%), d,l-3-
12b 242 mg (30%). Colourless solid. m.p. 63-65 °C. - Rf = 0.50 (hexane/EtOAc 10:1). - 1H 
NMR (200 MHz): δ = 0.79 (t, J = 7.5 Hz, 3H, CH2CH3), 0.87 (s, 3H, NCCH3), 1.05 (s, 3H, 
NCCH3), 1.15-1.49 (m, 6H, NCCH2CH2CH2CN), 1.20 (s, 3H, NCCH3), 1.30 (s, 3H, NCCH3), 
2.02 (m, 2H, CH2CHON), 4.86 (dd, J = 8.4, 5.4 Hz, 1H, CHCH2), 7.50 (m, 3H, m,p-Ph), 8.10 
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(dd, J = 8.3, 1.7 Hz, 2H, o-Ph). - 13C NMR (50 MHz): δ = 9.1 (q, CH2CH3), 17.1 (t, 
NCCH2CH2CH2CN), 20.2 (q, NCCH3), 25.8 (t, CH2CH3), 33.6 (q, NCCH3), 33.8 (q, NCCH3), 
40.3 (t, NCCH2CH2CH2CN), 59.7 (s, NCCH3), 90.8 (d, CHON), 128.4 (d, Ph), 129.1 (d, Ph), 
132.8 (d, Ph), 136.0 (s, Ph), 201.2 (s, CO). - IR (film): v~  = 2971, 2933, 2875, 1679, 1597, 
1448, 1375, 1361, 1265, 1241, 1213, 1182, 1133, 1045, 1015, 988, 962, 914, 850, 794, 777, 
698 cm-1.- MS (+CI): m/z (%) = 304 (100) [M+H+], 157 (9) [TEMPO+H+], 156 (62) 
[TEMPO+], 142 (7) [TMPH2+], 105 (12) [PhC=O+]. - HRMS (ESI): C19H29NO2Na+: calc. 
326.2096; found 326.2090. - Combustion analysis: C19H29NO2 (303.44): calc. C 75.21, H 
9.63, N 4.62; found C 75.27, H 9.77, N 4.67. 
 
2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)isobutyrophenone 3-11c 
O
Ph
O
N
 
Flash chromatography (hexane/EtOAc 80:1, gradient to 20:1) afforded a mixture of ferrocene, 
3-11c and isobutyrophenone 3-10c, followed by an inseparable mixture of 3-11c, 3-10c, and 
1-2 with Rf = 0.3 (hexane/EtOAc 10:1). Yield: 111 mg (18%), recovered 3-10c 184 mg 
(62%). Pale yellow oil. Rf = 0.54 (hexane/EtOAc 10:1). - 1H NMR (400 MHz): δ = 0.988 (s, 
6H, NCCH3), 0.990 (s, 6H, NCCH3), 1.25-1.59 (m, 6H, NCCH2CH2CH2CN), 1.62 (s, 6H, 
OC(CH3)2), 7.41-7.56 (m, 3H, m,p-Ph), 8.30 (d, J = 7.1 Hz, 2H, o-Ph). - 13C NMR (100 
MHz): δ = 16.7 (t, NCCH2CH2CH2CN), 20.8 (q, NCCH3), 25.4 (q, OC(CH3)2), 33.1 (q, 
NCCH3), 40.1 (t, NCCH2CH2CH2CN), 59.1 (s, NCCH3), 86.9 (s, CON), 127.6 (d, Ph), 130.6 
(d, Ph), 131.9 (d, Ph), 134.7 (s, Ph), 201.8 (s, C=O). - MS (+ESI) (mixture of 3-11c/3-10c 
3.3:1): m/z (%) = 629 (34) [2M+Na+], 482 (26), 473 (26), 326 (100) [M+Na+], 284 (57), 179 
(44) [TEMPO+Na+], 158 (39) [TEMPOH2+], 142 (19) [TMPH+H+]. - HRMS: C19H29NO2Na+: 
calc. 326.2096; found 326.2094. 
 
2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)pentan-3-one 3-11d 
O
O
N
 
Flash chromatography (hexane/EtOAc 40:1, gradient to 2:1) gave ferrocene, followed by 3-
11d. Yield 380 mg (79%) as a pale yellow oil. Rf = 0.40 (hexane/EtOAc 5:1). - 1H NMR (400 
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MHz): δ = 0.92 (br. s, 3H, NCCH3), 0.99 (t, J = 7.3 Hz, 3H, CH3CH2CO), 1.04 (br. s, 3H, 
NCCH3), 1.09 (br. s, 6H, NCCH3), 1.18-1.52 (m, 6H, NCCH2CH2CH2CN), 1.25 (d, J = 7.0 
Hz, 3H, CH3CHCO), 2.48 (dq, J = 18.5, 7.2 Hz, 1H, OCCH2CH3), 2.65 (dq, J = 18.5, 7.3 Hz, 
1H, OCCH2CH3), 4.22 (q, J = 7.0 Hz, 1H, CHON). - 13C NMR (100 MHz): δ = 7.1 (q, 
CH2CH3), 17.0 (t, NCCH2CH2CH2CN), 18.0 (q, CHCH3), 20.2 (q, NCCH3), 31.3 (t, 
CH3CH2CO), 33.7 (q, NCCH3), 34.2 (q, NCCH3), 40.2 (t, NCCH2CH2CH2CN), 59.4 (s, 
NCCH3), 59.9 (s, NCCH3), 87.1 (d, CHON), 213.4 (s, CO). - IR (film): v~  = 2975, 2933, 
2874, 1717, 1456, 1375, 1361, 1260, 1242, 1209, 1184, 1133, 1093, 1045, 1018, 992, 958, 
926, 881, 789, 713 cm-1.  - MS (+ESI): m/z (%) = 748 (6) [3M+Na++H], 704 (8), 660 (8), 615 
(8), 505 (25) [2M+Na+], 443 (7), 270 (6), 264 (68) [M+Na+], 242 (7), 186 (29), 142 (100) 
[TMPH2+], 126 (26). - Combustion analysis: C14H27NO2 (241.20): calc. C 69.66, H 11.27, N 
5.80; found C 69.55, H 11.47, N 5.90.  
 
2,2-Dimethyl-4-(2,2,6,6-tetramethylpiperidin-1-yloxy)pentan-3-one 3-11e 
O
O
N
 
Flash chromatography (hexane/EtOAc 100:1, gradient to 20:1) afforded ferrocene, followed 
by 3-11e and residual 1-2. Yield 506 mg (94%) as a pale yellow oil. Rf = 0.54 (hexane/EtOAc 
10:1). - 1H NMR (400 MHz): δ = 0.97 (br. s, 3H, NCCH3), 1.12 (br. s, 6H, NCCH3), 1.18 (s, 
9H, C(CH3)3), 1.19 (br. s, 3H, NCCH3), 1.25-1.62 (m, 6H, NCCH2CH2CH2CN), 1.30 (d, J = 
6.7 Hz, 3H, CHCH3), 4.81 (q, J = 6.8 Hz, 1H, CHON). - 13C NMR (100 MHz): δ = 17.1 (t, 
NCCH2CH2CH2CN), 18.4 (q, CHCH3), 20.3 (q, NCCH3), 26.8 (q, C(CH3)3), 33.9 (q, NCCH3), 
40.3 (t, NCCH2CH2CH2CN), 43.3 (s, OCC(CH3)3), 59.7 (s, NCCH3), 80.2 (d, CHON), 216.3 
(s, CO). - IR (film): v~ = 2971 (s), 2933 (s), 2872 (m), 1718 (s), 1477 (m), 1363 (s), 1133 (m), 
1047 (m), 983 (s), 938 (m) cm-1.  - MS (+CI): m/z (%) = 270 (100) [M+H+]. - HRMS (ESI): 
C16H32NO2+: calc. 270.2427; found 270.2428; C16H31NO2Na+: calc. 292.2247; found 292.2248. 
- Combustion analysis: C16H31NO2 (269.42): calc. C 71.33, H 11.60, N 5.20; found C 71.61, H 
11.77, N 5.46. 
 
2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)cyclohexanone 3-11f25 
O
N
O
 
Flash chromatography (hexane/ethyl acetate 50:1, gradient to 3:1) afforded ferrocene, 
followed by 3-11f, and finally dimer 3-12f. If necessary, a second purification was performed. 
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Yields: 3-11f 430 mg (85%) and d,l/meso-3-12f 20 mg (9%, d.r. 2.5:1). With LiCl: 3-11f 0.97 
g (77%). With HMPA: 3-11f 0.25 g (49%) impure, contains small amounts of unknown 
products. Pale yellow oil.  Rf = 0.29 (hexane/EtOAc 10:1). - C15H27NO2 (253.38): calc. C 
71.10, H 10.74, N 5.53; found C 70.89, H 10.65, N 5.36. 
 
2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)cycloheptanone 3-11g  
O
N
O
 
Flash chromatography (hexane/EtOAc 80:1, gradient to 10:1) gave ferrocene, followed by 3-
11g. Yield (5 mmol setup): 1.16 g (87%) as a pale yellow oil. m.p. 23-24 °C. - Rf = 0.48 
(hexane/EtOAc 10:1). - 1H-NMR (400 MHz): δ = 0.98 (s, 3H, NCCH3), 1.15 (s, 9H, NCCH3), 
1.22-1.53 (m, 8H, CH2CH2CH2C=O, CH2CH2CHO, NCCH2CH2CH2CN), 1.63-1.81 (m, 4H, 
CH2CH2CH2CH2CHON), 1.96 (m, 2H, CH2CH2C=O, CH2CHON), 2.34 (ddd, J = 15.0, 9.2, 
5.2 Hz, 1H, CH2C=O), 2.79 (ddt, J = 15.1, 6.0, 1.3 Hz, 1H, CH2C=O), 4.31 (dd, J = 8.1, 3.2 
Hz, 1H, CHON). - 13C-NMR (100 MHz): δ = 17.0 (t, NCCH2CH2CH2CN), 20.3 (q, NCCH3), 
23.4 (t, CH2CH2C=O), 24.5 (t, CH2CH2CHON), 28.3 (t, CH2CH2CH2C=O), 30.4 (t, 
CH2CHON), 33.7 (q, NCCH3), 40.1 (t, NCCH2CH2CH2CN), 41.4 (t, CH2C=O), 59.5 (s, 
NCCH3), 92.4 (d, CHON), 213.8 (s, C=O). - IR: v~  = 2999 (w), 2970 (m), 2929 (s), 2869 (w), 
2679 (w), 1705 (s), 1452 (m), 1411 (w), 1376 (w), 1359 (m), 1262 (w), 1241 (w), 1208 (w), 
1184 (w), 1134 (m), 1101 (w), 1083 (w), 1048 (m), 1018 (m), 990 (w), 957 (m), 932 (s), 854 
(w), 831 (w), 790 (w) cm-1. - MS (+CI): m/z (%) = 268 (100) [M+H+], 156 (5) [TEMPO+], 
142 (3) [TMPH2+]. - HRMS (ESI): for C16H29NO2+ calc. 267.2192; found 267.2192. - 
Combustion analysis: C16H29NO2 (267.41): calc. C 71.86, H 10.93, N 5.24; found C 71.61, H 
11.16, N 5.46. 
 
(R)-2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)camphor 3-11h:  
Flash chromatography (hexane/ethyl acetate 100:1, gradient to 5:1) afforded ferrocene, 
followed by a mixture of endo-3-11h, exo-3-11h, and sometimes exo,exo-dimer 3-12h as 
colourless solids. Yield (1 mmol setup): 3-11h 263 mg (85%, 2-exo/endo 1:1.1) and 2,2’-
exo,exo-dimer 3-12h 5 mg (2%). With LiCl (5 mmol setup): 3-11h 1.49 g (95%, exo/endo 
1.1:1). The following analyses were performed on diastereomeric mixture prior to further 
purification. IR (KBr): v~  = 3010 (s), 2991 (s), 2965 (s), 2939 (s), 2890 (s), 2871 (s), 2848 (s), 
1750 (s), 1470 (m), 1453 (m), 1391 (w), 1375 (s), 1360 (w), 1259 (w), 1181 (w), 1131 (m), 
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1063 (w), 1010 (s), 994 (s), 958 (w), 945 (m), 840 (w) cm-1. - MS (EI) m/z (%): 307 (48) 
[M+], 292 (42) [M+–CH3], 156 (100) [TEMPO+], 142 (14) [TMPH2+], 123 (53) [M+–
TEMPO–CH2=CH2], 81 (14) [M+–TEMPO–CH2=CH2–iPr], 69 (11), 55 (19), 41 (18). - 
Combustion analysis: C19H33NO2 (307.47): calc. C 74.22, H 10.82, N 4.56; found C 74.15, H 
10.90, N 4.33.  
9
H3C CH3
8
H
3
O
H
5
H
5'
H
6
H
6'
H
4
O
N
1.7
6.7
 Significant NOE contacts 
 
(R)-2-exo-3-11h: Rf = 0.43 (hexane/EtOAc 10:1). - 1H NMR (400 MHz): δ = 0.86 (s, 3H, 
CH2CCH3), 0.88 (s, 3H, CHCCH3), 0.95 (s, 3H, CHCCH3), 1.06 (br. s, 3H, NCCH3), 1.16 (br. 
s, 6H, NCCH3), 1.23-1.42 (m, 6H, NCCH2CH2CH2CN, CCH2CH2CH, NCCH3), 1.42 (br. s, 
4H, NCCH2CH2CH2CN), 1.52 (m, 2H, CH2CC=O, NCCH2CH2CH2CN), 1.90 (m, 1H, 
CH2CH2CH), 2.43 (d, J = 4.9 Hz, 1H, CHCHON), 4.02 (s, 1H, CHON). - 13C NMR (100 
MHz): δ = 9.1 (q, CH3CC=O), 17.1 (t, NCCH2CH2CH2CN), 19.8 (q, CHCCH3), 20.2 (q, 
NCCH3), 20.8 (q, CHCCH3), 25.0 (t, CH2CHCH), 28.8 (t, CH2CH2CH), 32.1 (q, NCCH3), 
35.0 (q, NCCH3), 40.4 (NCCH2CH2CH2CN), 46.2 (s, CHC(CH3)2), 48.3 (d, CHCHON), 56.8 
(s, CH3CCO), 59.5 (s, NCCH3), 61.5 (s, NCCH3), 90.7 (d, CHON), 217.5 (s, C=O). 
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H3C CH3
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Significant NOE contacts 
(R)-2-endo-3-11h: m.p. 25-26 °C. - Rf = 0.51 (hexane/EtOAc 10:1). - 1H NMR (400 MHz): δ 
= 0.81 (s, 3H, CHC(CH3)2), 0.85 (s, 3H, CH2CCH3), 0.93 (s, 3H, CHCCH3), 1.06 (br. s, 3H, 
NCCH3), 1.09 (br. s, 3H, NCCH3), 1.17 (br. s, 3H, NCCH3), 1.20-1.59 (m, 10H, 
NCCH2CH2CH2CN, CCH2CH2CH, NCCH3), 1.64 (m, 2H, CCH2CH2CH), 1.87 (m, 1H, 
CCH2CH2CH), 2.37 (t, J = 4.3 Hz, 1H, CHCHON), 4.46 (dd, J = 4.7, 1.1 Hz, 1H, CHON). - 
13C NMR (100 MHz): δ = 9.5 (q, CH3CC=O), 17.0 (t, NCCH2CH2CH2CN), 18.8 (q, 
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CHCCH3), 18.8 (t, CH2CH2CH), 19.8 (q, CHCCH3), 20.0 (q, NCCH3), 20.1 (q, NCCH3), 32.1 
(t, CCH2CH2), 32.1 (q, NCCH3), 34.2 (q, NCCH3), 40.5 (t, NCCH2CH2CH2CN), 42.1 (s, 
CHC(CH3)2), 48.4 (d, CHCHON), 58.4 (s, CH3CCO), 59.0 (s, NCCH3), 62.0 (s, NCCH3), 
88.5 (d, CHON), 216.7 (s, C=O). 
 
Oxygenation of alkyl methyl ketones 3-10i-k (general procedure) 
Ketone 3-10i-k (2 mmol) was added via syringe to a solution of 2.6 mmol of LDA prepared 
from diisopropylamine (0.366 mL, 2.6 mmol) and BuLi (1.6M in hexane, 1.625 mL, 2.6 
mmol) in 20 mL dry THF at −78 °C, and the mixture was stirred for the given time (Table 
3.8). TEMPO 1-2 (343.2 mg, 2.2 mmol, 1.1 equiv.) was added. Subsequently, ferrocenium 
hexafluorophosphate (minimum 2 equiv.) was added in portions at −78 °C until a dark blue 
colour persisted in the reaction mixture for 15 to 20 minutes. The reaction mixture was 
quenched with 10 drops of water, diluted with diethyl ether and filtered through a pad of silica 
gel. The solvent was removed in vacuum and the crude product preadsorbed on silica gel was 
purified by column chromatography. 
 
Cyclopropyl (2,2,6,6-tetramethylpiperidin-1-yloxy)methyl ketone 3-11i 
O
O
N
 
Flash chromatography (hexane/ethyl acetate 80:1, gradient to 5:1) afforded ferrocene, 
followed by 3-11i, aldol addition/TEMPO trapping product 3-13i, and an inseparable mixture 
of dimers 3-12i and 3-12’i in a 1:1 ratio. Yield deprotonation 20 min: 3-11i 20 mg (4%), 3-13i 
159 mg (50%), 3-12i 35 mg (20%), 3-12’i 35 mg (22%). Yield with LiCl, deprotonation 10 
min: 3-11i 110 mg (23%) and 3-13i 220 mg (68%). Pale yellow oils. Rf = 0.48 
(hexane/EtOAc 10:1). - IR (film): v~  = 3012, 2978, 2935, 2915, 2877, 2849, 1708, 1471, 
1448, 1392, 1374, 1360, 1340, 1264, 1188, 1132, 1050, 1017, 995, 955, 928, 907, 858, 820, 
774, 716 cm-1. - 1H NMR (200 MHz): δ = 0.93 (m, 2H, CH2CHCO), 1.09 (m, 2H, 
CH2CHCO), 1.17 (s, 12H, NCCH3), 1.25-1.63 (m, 6H, NCCH2CH2CH2CN), 2.30 (m, 1H, 
CH2CHCO), 4.51 (s, 2H, CH2ON). - 13C NMR (50 MHz): δ = 11.2 (t, CHCH2), 17.0 (d, 
CHCO), 17.2 (t, NCCH2CH2CH2CN), 20.2 (q, NCCH3), 32.8 (q, NCCH3), 39.6 (t, 
NCCH2CH2CH2CN), 60.0 (s, NCCH3), 83.4 (t, CH2ON), 208.6 (s, CO). - MS (+ESI): m/z (%) 
= 501 (39) [2M+Na+], 262 (100) [M+Na+], 179 (4) [TEMPO+Na+]. - Combustion analysis: 
C14H25NO2 (239.35): calc. C 70.25, H 10.53, N 5.85; found C 70.29, H 10.66, N 5.83. 
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2,4-Bis(cyclopropyl)-2-hydroxy-1-(2,2,6,6-tetramethylpiperidin-1-yloxy)butan-4-one 3-
13i 
O
HO
O
N
 
Rf = 0.34 (hexane/EtOAc 10:1). - IR (film): v~ = 2975, 2933, 2875, 1717, 1455, 1376, 1361, 
1260, 1242, 1184, 1133, 1091, 1018, 992, 959, 927, 882, 790, 713 cm-1. - 1H NMR (400 
MHz): δ = 0.34 (m, 2H, CH2CH2CHCOH), 0.50 (m, 2H, CH2CH2CHCOH), 0.95 (m, 2H, 
CH2CH2CHC=O), 1.02-1.16 (m, 3H, CH2CHCOH, CH2CH2CHC=O), 1.12 (br. s, 9H, 
NCCH3), 1.19 (br. s, 3H, NCCH3), 1.22-1.62 (m, 6H, NCCH2CH2CH2CN), 2.03 (tt, J = 4.5, 
7.8 Hz, 1H, CH2CHC=O), 2.81 (A part of AB system, J = 16.3 Hz, 1H, COCH2COH), 3.03 
(B part of AB system, J = 16.3 Hz, 1H, COCH2COH), 3.76 (AB system, J = 8.3 Hz, 2H, 
CH2ON), 4.00 (br. s, 1H, OH). - 13C NMR (100 MHz): δ = −0.2 (t, CH2CHCOH), 0.2 (t, 
CH2CHCOH), 11.4 (t, CH2CHC=O), 11.9 (t, CH2CHC=O), 16.9 (t, NCCH2CH2CH2CN), 18.0 
(d, CH2CHCOH), 20.2 (q, NCCH3), 22.1 (d, CH2CHC=O), 32.8 (q, NCCH3), 32.9 (q, 
NCCH3), 39.7 (t, NCCH2CH2CH2CN), 49.1 (t, HOCCH2C=O), 59.9 (s, NCCH3), 70.8 (s, 
COH), 81.9 (t, CH2ON), 213.2 (s, CO). - MS (+ESI): m/z (%) = 669 (10) [2M+Na+], 583 (28), 
346 (100) [M+Na+], 271 (4). - Combustion analysis: C19H33NO3 (323.47): calc. C 70.55, H 
10.28, N 4.33; found C 70.60, H 10.33, N 4.48. 
 
1,4-Bis(cyclopropyl)butan-1,4-dione 3-12i and 1,4-Bis(cyclopropyl)-2-buten-1,4-dione 3-
12’i 
O O
O
3-12i
3-12'i
O
  
The dimers 3-12i and 3-12’i were isolated and analysed as an inseparable 1:1 mixture. Rf = 
0.34 (hexane/EtOAc 5:1). - IR (film): v~  = 3091, 3009, 2974, 2934, 1693, 1666, 1445, 1385, 
1264, 1243, 1183, 1144, 1074, 1023, 980, 902, 816 cm-1. - MS (+ESI): m/z (%) = 561 (39), 
510 (24), 479 (30), 428 (100), 426 (22), 189 (100) [M(3-12i)+Na+], 187 (8) [M(3-12’i)+Na+], 
167 (11) [M (3-12i)+H+]. - HRMS: 3-12i C10H14O2Na+: calc. 189.0891; found 189.0886. - 
HRMS: 3-12’i C10H12O2Na+: calc. 187.0735; found 187.0730. 
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3-12i: 1H NMR (400 MHz): δ = 0.88 (dt, J = 7.9, 3.3 Hz, 4H, CH2CH2CHCO), 1.06 (m, 4H, 
CH2CH2CHCO), 1.96 (tt, J = 7.8, 4.5 Hz, 2H, CHCOCH2), 2.86 (s, 4H, COCH2CH2CO). - 
13C NMR (100 MHz): δ = 10.6 (t, CH2CHCO), 20.5 (d, CH2CHCO), 36.4 (t, COCH2), 209.2 
(s, CO). 
3-12’i: 1H NMR (400 MHz): δ = 1.06 (m, 4H, CH2CH2CHCO), 1.18 (m, 4H, 
CH2CH2CHCO), 2.24 (tt, J = 7.8, 4.5 Hz, 2H, CHCOCH=), 7.05 (s, 2H, COCH=). - 13C 
NMR (100 MHz): δ = 12.2 (t, CH2CH2CHCO), 20.4 (d, CH2CHCO), 136.1 (d, COCH=), 
200.4 (s, CO). 
 
6-Methyl-1-(2,2,6,6-tetramethylpiperidin-1-yloxy)-5-hepten-2-one 3-11j 
O
O
N
 
Flash chromatography (hexane/ethyl acetate 80:1, gradient to 5:1) afforded ferrocene, 
followed by an inseparable mixture of 3-11j and 3-11’j, 3-12’ (containing small amounts of 
an unknown a dimer, which contains the tetramethylpiperidinyloxy unit), aldol/TEMPO 
trapping product 3-13j, 3-12j and 3-14j. For structure elucidation and analysis, a second and 
third purification was performed. Yield deprotonation 5 min: 3-11j and 3-11’j 90 mg (16%, 
1.9:1), 3-12’j 14 mg (6%, as a 30 mg mixture with a TEMPO-containing dimer (C26H45NO2)), 
3-13j 110 mg (26%), 3-12j 20 mg (8%). Yield with LiCl, deprotonation 5 min: 3-11j and 3-
11’j 244 mg (43%, 7.4:1), 3-13j 79 mg (19%) and 3-14j 24 mg (9%). The NMR data of 
compound 3-12j are identical with those reported earlier.25 Pale yellow oils. The following 
analyses were performed with the regioisomeric mixture of 3-11j and 3-11’j: IR (film): v~  = 
2972, 2929, 2873, 1718, 1467, 1447, 1376, 1359, 1262, 1244, 1209, 1185, 1133, 1071, 991, 
972, 957, 925, 792, 733, 706 cm-1. - MS (+ESI): m/z (%) = 585 (13) [2M+Na+], 304 (100) 
[M+Na+], 179 (11) [TEMPO+Na+]. - Combustion analysis: C17H31NO2 (281.43): calc. C 
72.55, H 11.10, N 4.98; found C 72.56, H 11.25, N 5.22.  
3-11j: Rf = 0.56 (hexane/EtOAc 10:1). - 1H NMR (400 MHz): δ = 1.13 (s, 6H, NCCH3), 1.16 
(s, 6H, NCCH3), 1.26-1.56 (m, 6H, NCCH2CH2CH2CN), 1.62 (s, 3H, =CCH3), 1.67 (d, J = 
1.1 Hz, 3H, =CCH3), 2.28 (q, J = 7.3 Hz, 2H, =CHCH2), 2.53 (t, J = 7.4 Hz, 2H, 
OCCH2CH2), 4.38 (s, 2H, CH2ON), 5.09 (tq, J = 7.2, 1.4 Hz, 1H, =CH). - 13C NMR (100 
MHz): δ = 16.9 (t, NCCH2CH2CH2CN), 17.6 (q, =CCH3), 20.1 (q, NCCH3), 21.9 (t, 
=CHCH2), 25.6 (q, =CCH3), 32.8 (q, NCCH3), 39.5 (t, NCCH2CH2CH2CN), 39.6 (t, CH2CO), 
60.0 (s, NCCH3), 83.1 (t, CH2ON), 122.7 (d, CH=C), 132.6 (s, CH=C), 208.4 (s, CO). 
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6-Methyl-3-(2,2,6,6-tetramethylpiperidin-1-yloxy)-5-hepten-2-one 3-11’j 
O
N
O
 
Rf = 0.56 (hexane/EtOAc 10:1). - Detectable resonances: 1H NMR (400 MHz): δ = 1.13 (s, 
6H, NCCH3), 1.16 (s, 6H, NCCH3), 1.43-1.50 (m, 6H, NCCH2CH2CH2CN), 1.59 (s, 3H, 
=CCH3), 1.67 (s, 3H, =CCH3), 2.17 (s, 3H, CH3CO), 4.14 (dd, J = 9.5, 4.4 Hz, 1H, CHON), 
5.02 (tq, J = 7.3, 1.4 Hz, 1H, =CH). - 13C NMR (100 MHz): δ = 17.0 (t, NCCH2CH2CH2CN), 
17.8 (q, =CCH3), 25.7 (q, =CCH3), 27.0 (q, OCCH3), 30.5 (t, =CHCH2), 40.2 (t, 
NCCH2CH2CH2CN), 60.0 (s, NCCH3), 91.0 (d, CHON), 117.8 (d, CH=C), 134.5 (s, CH=C), 
210.3 (s, CO). 
 
2,13-Dimethyl-2,7,12-tetradecatriene-6,9-dione 3-12’j 
O
O  
Product 3-12’j was isolated as an inseparable mixture with a dimer, which contained the 
tetramethylpiperidinyloxy unit (C26H45NO2). Rf = 0.50, 0.47 (hexane/EtOAc 10:1), Rf = 0.68 
(hexane/EtOAc 5:1). - Detectable resonances of 3-12’j: 1H NMR (400 MHz): δ = 1.62 (s, 6H, 
CH3C=), 1.68 (d, J = 1.0 Hz, 6H, CH3C=), 2.32 (q, J = 7.3 Hz, 4H, =CHCH2), 3.17 (t, J = 7.5 
Hz, 4H, CH2CO), 5.09 (m, 2H, CH=CCH3), 6.85 (s, 2H, COCH=CHCO). - 13C NMR (100 
MHz): δ = 17.6 (q, CH3C=), 22.3 (t, CH2CH=), 25.5 (q, CH3C=), 41.6 (d, CH2CO), 122.1 (d, 
CH=C), 133.1 (s, C=CH), 136.1 (d, COCH=CHCO), 200.2 (s, CO). 
 
6-Hydroxy-2,12-dimethyl-6-(2,2,6,6-tetramethylpiperidin-1-yloxymethyl)-2,11-
tridecadien-8-one 3-13j 
O
OH
O
N
 
Rf = 0.42 (hexane/EtOAc 10:1). - 1H NMR (400 MHz): δ = 1.09 (br. s, 6H, NCCH3), 1.14 (s, 
3H, NCCH3), 1.15 (s, 3H, NCCH3), 1.22-1.52 (m, 6H, NCCH2CH2CH2CN), 1.56 (m, 2H, 
CH2CH2COH), 1.61 (s, 6H, 2 =CCH3), 1.67 (s, 6H, 2 =CCH3), 2.07 (m, 2H, CH2CH2COH), 
2.26 (m, 2H, O=CCH2CH2CH=), 2.48 (m, 2H, CH2CH2C=O), 2.67 (AB system, J = 16.9 Hz, 
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2H, O=CCH2COH), 3.75 (AB system, J = 8.9 Hz, 2H, CH2ON), 5.07 (m, 2H, CH=). - 13C 
NMR (100 MHz): δ = 16.6 (t, NCCH2CH2CH2CN), 17.2 (q, =CCH3), 17.3 (q, =CCH3), 19.9 
(q, NCCH3), 21.5 (t, CH2CH2COH), 21.7 (t, CH2CH2C=O), 25.2 (q, =CCH3), 25.3 (q, 
=CCH3), 32.6 (q, NCCH3), 32.7 (q, NCCH3), 37.8 (t, CH2CH2COH), 39.4 (t, 
NCCH2CH2CH2CN), 44.1 (t, CH2CH2C=O), 47.0 (t, OCCH2COH), 59.6 (s, NCCH3), 72.9 (s, 
COH), 80.8 (t, CH2ON), 122.1 (d, CH=C), 123.9 (d, CH=C), 131.2 (s, CH=C), 132.4 (s, 
CH=C), 211.9 (s, CO). - IR (film): v~  = 3491, 2970, 2928, 1704, 1449, 1406, 1376, 1359, 
1262, 1243, 1184, 1132, 1077, 1051, 991, 957, 925, 835, 814, 705 cm-1. - MS (+ESI): m/z (%) 
= 707 (16), 585 (30), 563 (19), 430 (100) [M+Na+], 408 [M+H+], 304 (20) 
[(CH3)2C=CHCH2CH2COCH2OTMP+Na+], 301 (44). - HRMS: C25H46NO3+: calc. 408.3478; 
found 408.3472. - Combustion analysis: C25H45NO3 (407.63): calc. C 73.66, H 11.13, N 3.44; 
found C 73.71, H 11.46, N 3.49. 
 
6-Hydroxy-2,6,12-trimethyl-2,11-tridecadien-8-one 3-14j 
O
OH
 
Rf = 0.46 (hexane/EtOAc 5:1). - 1H NMR (400 MHz): δ = 1.21 (s, 3H, C(OH)CH3), 1.50 (m, 
2H, CH2CH2COH), 1.608 (s, 3H, =CCH3), 1.611 (s, 3H, =CCH3), 1.68 (s, 6H, 2 =CCH3), 
2.03 (m, 2H, CH2CH2COH), 2.25 (m, 2H, CH2CH2C=O), 2.44 (m, 2H, CH2CH2C=O), 2.58 
(AB system, J = 17.0 Hz, 2H, COCH2COH), 3.83 (s, 1H, OH), 5.06 (m, 2H, CH=C(CH3)2). - 
13C NMR (100 MHz): δ = 17.56 (q, =CCH3), 17.60 (q, =CCH3), 22.1 (t, CH2CH2C=O), 22.6 
(t, CH2CH2COH), 25.58 (q, =CCH3), 25.61 (q, =CCH3), 26.7 (q, C(OH)CH3), 41.9 (t, 
C(OH)CH2CH2), 44.6 (t, CH2CH2C=O), 51.5 (t, COCH2COH), 71.6 (s, COH), 122.3 (d, 
CH=C), 124.2 (d, CH=C), 131.6 (s, CH=C), 133.0 (s, CH=C), 213.0 (s, CO). 
 
1-(2,2,6,6-Tetramethylpiperidin-1-yloxy)-2-octanone 3-11k 
O
N
O
 
Flash chromatography (hexane/ethyl acetate 80:1, gradient to 5:1) gave ferrocene, followed 
by a mixture of 3-11k and 3-11’k, a mixture of 3-11k and 3-12’k, aldol/TEMPO trapping 
product 3-13k, and finally a mixture of 3-13k and 3-14k. The yield was determined from the 
NMR spectra. The products were further purified. Pale yellow oils. Yield with LiCl, 5 min 
deprotonation: 3-11k and 3-11’k 166 mg (29%, 12:1), 3-13k 124.3 mg (30%). Yield with 
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LiCl, 30 min deprotonation: 3-11k and 3-11’k 212 mg (37%, 8.8:1), small amounts of 3-12’k, 
3-13k 101mg (24%) and 3-14k 39 mg (14%). Pale yellow oils. Rf = 0.47 (hexane/EtOAc 
10:1). - IR (film): v~  = 2929, 2870, 1718, 1466, 1376, 1360, 1262, 1244, 1209, 1184, 1132, 
1074, 993, 972, 957, 926, 791, 722, 705 cm-1. - MS (+ESI): m/z (%) = 589 (10) [2M+Na+], 
306 (100) [M+Na+], 179 (3) [TEMPO+Na+]. - Combustion analysis: C17H33NO2 (283.45): 
calc. C 72.03, H 11.73, N 4.94; found C 71.92, H 11.74, N 5.07. - 1H NMR (400 MHz): δ = 
0.88 (t, J = 6.9 Hz, 3H, CH2CH3), 1.13 (s, 6H, NCCH3), 1.16 (s, 6H, NCCH3), 1.22-1.35 (m, 
7H, NCCH2CH2CH2CN, CH2CH2CH2CH3), 1.47 (m, 4H, NCCH2CH2CH2CN), 1.58 (m, 3H, 
CH2CH2CO, NCCH2CH2CH2CN), 2.51 (t, J = 7.4 Hz, 2H, CH2CO), 4.39 (s, 2H, CH2ON). - 
13C NMR (100 MHz): δ = 13.9 (q, CH2CH3), 16.9 (t, NCCH2CH2CH2CN), 20.0 (q, NCCH3), 
22.4 (t, CH2CH3), 23.1 (t, CH2CH2C=O), 28.8 (t, CH2CH2CH3 or CH2CH2CH2CH3), 31.5 (t, 
CH2CH2CH3 or CH2CH2CH2CH3), 32.7 (q, NCCH3), 39.5 (t, NCCH2CH2CH2CN), 39.6 (t, 
CH2CH2CO), 59.9 (s, NCCH3), 83.0 (t, CH2ON), 208.7 (s, CO).  
 
3-(2,2,6,6-Tetramethylpiperidin-1-yloxy)-2-octanone 3-11’k 
O
N
O
 
Rf = 0.47 (hexane/EtOAc 10:1). - Detectable resonances: 1H NMR (400 MHz): δ = 0.88 (m, 
3H, CH2CH3), 2.20 (s, 3H, CH3CO), 4.09 (dd, J = 4.0, 9.8 Hz, 1H, CHON). - 13C NMR (100 
MHz): δ = 13.8 (q, CH2CH3), 17.0 (t, NCCH2CH2CH2CN), 22.3 (t, CH2CH3), 23.9 (t, CH2), 
26.3 (q, CH3CO), 31.3 (t, CH2), 31.7 (t, CH2), 40.2 (t, NCCH2CH2CH2CN), 91.6 (d, CHON), 
210.5 (s, CO). 
 
7-Hydroxy-7-(2,2,6,6-tetramethylpiperidin-1-yloxymethyl)pentadecan-9-one 3-13k 
O
OH
O
N
 
Rf = 0.37 (hexane/EtOAc 10:1). - IR (film): v~  = 3498, 2928, 2871, 2858, 1702, 1467, 1407, 
1374, 1360, 1262, 1244, 1133, 1059, 1046, 993, 956, 925, 820, 725 cm-1. - 1H NMR (400 
MHz): δ = 0.87 (t, J = 6.7 Hz, 3H, CH2CH3), 0.88 (t, J = 6.8 Hz, 3H, CH2CH3), 1.09 (s, 6H, 
NCCH3), 1.12 (s, 3H, NCCH3), 1.14 (s, 3H, NCCH3), 1.28-1.70 (m, 24H, 
NCCH2CH2CH2CN, CH3CH2CH2CH2CH2CH2COH, CH3CH2CH2CH2CH2CH2CO), 2.47 (dt, 
J = 1.7, 7.4 Hz, 2H, CH2CH2C=O), 2.55 (A part of AB system, J = 16.9 Hz, 1H, 
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COCH2COH), 2.75 (B part of AB system, J = 16.8 Hz, 1H, COCH2COH), 3.74 (AB system, 
J = 8.8 Hz, 2H, CH2ON), 4.03 (s, 1H, OH). - 13C NMR (100 MHz): δ = 13.89 (q, CH2CH3), 
13.94 (q, CH2CH3), 16.9 (t, NCCH2CH2CH2CN), 20.2 (q, NCCH3), 22.4 (t, CH3CH2), 22.5 (t, 
CH3CH2), 23.1 (t, CH2), 23.2 (t, CH2), 28.7 (t, CH2), 29.7 (t, CH2), 31.5 (t, CH2), 31.7 (t, 
CH2), 33.0 (q, NCCH3), 38.4 (t, CH2), 39.7 (t, NCCH2CH2CH2CN), 44.5 (t, CH2CH2C=O), 
47.3 (t, OCCH2COH), 59.9 (s, NCCH3), 73.4 (s, COH), 81.2 (t, CH2ON), 212.7 (s, CO). - MS 
(+ESI): m/z (%) = 434 (100) [M+Na+], 412 (57) [M+H+], 301 (5), 277 (6), 241 (9) 
[M+−C6H13CO−C4H9]. - HRMS: C25H50NO3+: calc. 412.3791; found 412.3785. 
 
7-Hydroxy-7-methyl-6-(2,2,6,6-tetramethylpiperidin-1-yloxy)pentadecan-9-one 3-13’k 
O
OH
O
N
 
Rf = 0.35 (hexane/EtOAc 10:1). - Detectable resonances: 1H NMR (400 MHz): δ = 3.92 (d, 
1H, J = 10.2 Hz, OH), 4.19 (dd, J = 9.3, 4.1 Hz, 1H, CHON). 
 
7-Hydroxy-7-methyl-pentadecan-9-one 3-14k 
O
OH
 
Rf = 0.34 (hexane/EtOAc 5:1). - 1H NMR (400 MHz): δ = 0.88 (m, 6H, CH2CH3), 1.19 (s, 3H, 
C(OH)CH3), 1.20-1.40 (m, 14H, CH3(CH2)4CH2COH, CH3(CH2)3CH2CH2C=O), 1.46 (m, 2H, 
CH2CH2COH), 1.56 (m, 2H, CH2CH2C=O), 2.41 (t, J = 7.4 Hz, 2H, CH2CH2C=O), 2.57 (AB 
system, J = 16.9 Hz, 2H, COCH2COH), 3.89 (s, 1H, OH). - 13C NMR (100 MHz): δ = 13.8 
(q, CH2CH3), 13.9 (q, CH2CH3), 22.3 (t, CH3CH2), 22.4 (t, CH3CH2), 23.3 (t, CH2), 23.8 (t, 
CH2), 26.6 (q, CH3COH), 28.6 (t, CH2), 29.6 (t, CH2), 31.4 (t, CH2), 31.6 (t, CH2), 42.1 (t, 
C(OH)CH2CH2), 44.5 (t, CH2CH2C=O), 51.2 (t, COCH2COH), 71.6 (s, COH), 213.5 (s, CO). 
 
6.2. α-Hydroxy carbonyl compounds by reduction with zinc/acetic acid 
 
General procedure I: The pure substrates 3-2b,c, 3-5b,d and 3-11e,f,h (1 mmol) were heated 
with zinc dust (2.65 g, 40 mmol) and AcOH (6 mL, 105 mmol) in THF (2 mL) and H2O (2 
mL) at 50 °C until the reaction was complete (0.5-2 h). The reaction mixture was diluted with 
diethyl ether and filtered through a pad of silica gel. 
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General procedure II for α-oxygenation in one pot: To a solution of crude 3-1a, 3-4b and 
3-10c,f,g (2 mmol), containing ferrocene and residual LiCl, 0.25M in 1:1 THF/H2O or 
0.125M in 3:1 THF/H2O mixture (the crude product was completely dissolved in THF; thus 
the presence of ferrocene and residual LiCl required sometimes more THF; then the water 
was added) was added 12 mL (210 mmol) glacial acetic acid and 5.2 g (80 mmol) Zn dust at 
50-60 °C. The progress of the reaction was monitored by TLC (1-3.5 h). The reaction mixture 
was diluted with diethyl ether and filtered through a pad of silica gel.  
Isolation:  
Method A: For non-volatile products: The solvent was evaporated and the product was 
purified by flash chromatography. If the purified product still contained small amounts of 
acetic acid, it was dried in high vacuum, using a cooling trap. The product (preadsorbed on 
silica gel for general procedure II) was purified by flash chromatography with hexane/ethyl 
acetate. 
Method B: For volatile and non-volatile products: The filtrate was neutralised carefully with 
solid K2CO3 at 0 °C. The organic layer was decanted and the solid AcOK was washed well 
with diethyl ether. The combined organic layers were dried over Na2SO4. The solvent was 
evaporated carefully and the product was purified by flash chromatography with hexane/ethyl 
acetate. 
Method B’: The filtrate was neutralised carefully with K2CO3 at 0 °C and the solid AcOK 
was dissolved in water. The aqueous layer was extracted with diethyl ether. The combined 
organic layers were evaporated in vacuum. The product was purified by flash chromatography 
with hexane/ethyl acetate. 
Method C: For water-insoluble products: The filtrate was partitioned between water and 
diethyl ether. The aqueous layer was extracted with diethyl ether. The aqueous layer was 
extracted with diethyl ether. The combined ethereal layers were washed with water, saturated 
NaHCO3 solution and brine, dried over Na2SO4 and concentrated in vacuum.  
Method D: For water-soluble products: The reaction mixture was diluted with diethyl ether 
and filtered through a pad of silica gel with diethyl ether and ethyl acetate. The organic layer 
was extracted with water and NaHCO3 solution. The aqueous layer was carefully neutralised 
with saturated NaHCO3 solution, the water was evaporated and the product was extracted 
thoroughly with ethyl acetate from the colourless solid CH3COONa.  
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Ethyl 2-hydroxyvalerate 3-15a160 
OEt
O
OH  
Synthesis according to general procedure II/method A: Yield 223 mg (76%) as a colourless 
oil. Rf (hexane/ethyl acetate 10:1) = 0.21. - 1H NMR (200 MHz): δ = 0.90 (t, J = 7.2 Hz, 3H, 
CH2CH2CH3), 1.26 (t, J = 7.1 Hz, 3H, OCH2CH3), 1.32-1.82 (m, 4H, CH2CH2CH3), 2.93 (br. 
s, 1H, OH), 4.13 (m, 1H, CHOH), 4.20 (q, J = 7.1 Hz, 2H, CH3CH2O). - 13C NMR (50 MHz): 
δ = 13.6 (q, CH2CH2CH3), 14.1 (q, OCH2CH3), 18.0 (t, CH2CH2CH3), 36.4 (t, CHCH2CH2), 
61.5 (t, CH2O), 70.2 (d, CH), 175.5 (s, CO2). 
 
(2S,3R)- and (2S,3S)-Dimethyl 2,3-tartrates 3-15b 
MeOC
COMe
OH
HO
O
O  
Synthesis according to general procedure I/method B gave a 1:2 mixture of L- and meso-3-
15b and 2,2,6,6-tetramethylpiperidinium acetate (340 mg). The products could not be 
separated from the mixture. Pale yellow oils. Yield calculated from the NMR spectra: 133 mg 
(75%). 
Rf (EtOAc) = 0.51. - (2S,3R)-3-15b: 1H NMR (400 MHz): δ = 3.78 (s, 6H, COOCH3), 4.68 (s, 
2H, CHOH), 7.00-8.03 (br. s, 2H, OH). - 13C NMR (100 MHz): δ = 52.3 (q, CH3O), 73.1 (d, 
CHOH), 171.6 (s, CO). - (2S,3S)-3-15b: 1H NMR (400 MHz): δ = 3.83 (s, 6H, COOCH3), 
4.62 (s, 2H, CHOH), 7.00-8.03 (br. s, 2H, OH). - 13C NMR (100 MHz): δ = 52.6 (q, CH3O), 
72.3 (d, CHOH), 171.6 (s, CO). 
 
2-Hydroxybutyrolactone 3-15c161 
O
O
OH 
Synthesis according to general procedure I/isolation method D: Yield 55 mg (54%). Pale 
yellow oil, soluble in water. 
Rf(hexane/EtOAc 1:1) = 0.2. - 1H NMR (200 MHz): δ = 2.22 (m, 1H, CH2CHOH), 2.54 (m, 
1H, CH2CHOH), 3.45 (br. s, 1H, OH), 4.17 (m, 1H, CH2OCO), 4.37 (m, 1H, CH2OCO), 4.50 
(dd, J = 10.1, 8.3 Hz, 1H, CHOH). - 13C NMR (50 MHz): δ = 30.8 (t, CH2CHOH), 65.4 (t, 
CH2OC=O), 67.3 (d, CHOH), 178.7 (s, CO). 
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2-Hydroxyoctonitrile 3-16b162 
H11C5
CN
OH  
Synthesis according to general procedure I/ method C: Yield 133 mg (94%). General 
procedure II/method C: Yield 240 mg (85%). General procedure II/method C/15 mmol setup: 
Yield 1.14 g (54%) as a pale yellow oil. Rf (hexane/EtOAc 2:1) = 0.72. - IR (film): v
~
 = 3448, 
2955, 2928, 2859, 1459, 1417, 1379, 1337, 1125, 1069, 1039, 952, 899, 821, 725 cm-1. - 1H 
NMR (200 MHz): δ = 0.89 (t, J = 6.5 Hz, 3H, CH3CH2), 1.30-1.53 (m, 8H, CH3(CH2)4), 1.84 
(m, 2H, CH2CH), 3.32 (br. s, OH), 4.47 (t, J = 6.8 Hz, 1H, CHOH). - 13C NMR (50 MHz): δ = 
13.9 (q, CH3CH2), 22.4 (t, CH3CH2), 24.4 (t, CH3CH2CH2CH2), 28.5 (t, CH2), 31.5 (t, CH2), 
35.1 (t, CH2), 61.2 (d, CHOH), 120.1 (s, CN). 
 
N,N-Diethyl-2-hydroxy pentanoic amide 3-16d 
NEt2
O
OH
 
Synthesis according to general procedure I/method A: Yield 144 mg (83%). Pale yellow oil. 
Rf = 0.29 (hexane/EtOAc 2:1). - 1H NMR (200 MHz): δ = 0.91 (t, J = 6.9 Hz, 3H, 
CH2CH2CH3), 1.10 (t, J = 7.1 Hz, 3H, NCH2CH3), 1.18 (t, J = 7.2 Hz, 3H, NCH2CH3), 1.35-
1.58 (m, 4H, CHCH2CH2CH3), 3.14-3.38 (m, 3H, NCH2), 3.53 (sext, J = 6.7 Hz, 1H, NCH2), 
4.27 (dd, J = 6.9, 3.3 Hz, 1H, CHOH), 5.24 (br. s, 1H, OH). - 13C NMR (50 MHz): δ = 12.7 
(q, CH2CH2CH3), 13.8 (q, NCH2CH3), 14.0 (q, NCH2CH3), 18.2 (t, CH2CH2CH3), 37.5 (t, 
CHCH2), 40.2 (t, CH2N), 40.9 (t, CH2N), 67.7 (d, CHOH), 173.8 (s, CO). - IR (film): v~  = 
3418, 2962, 2936, 2874, 1636, 1464, 1399, 1382, 1363, 1309, 1281, 1220, 1122, 1101, 1071 
cm-1. - MS (EI): m/z (%) = 173 (1.2) [M+], 131 (32) [M+–C3H6], 130 (20) [M+–C3H7], 101 
(30) [M+–C3H7–C2H5], 100 (85) [Et2NC=O+], 86 (47) [M+–C3H7–C2H5–CH3], 72 (100) [NEt2 
and M+–NEt2–Et], 58 (27) [M+–C3H7–NEt2], 44 (24). - Combustion analysis: C9H19NO2 
(173.25): calc. C 62.39, H 11.05, N 8.08; found C 62.28, H 11.38, N 7.87. 
 
2,2-Dimethyl-4-hydroxypentan-3-one 3-17e163  
O
OH 
Synthesis according to general procedure I/method B: Yield 72 mg (55%). Isolation method 
B’: Yield 96 mg (71%). General procedure II/method B’: Yield 80 mg (31%). Pale yellow oil. 
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Rf (hexane/EtOAc 5:1) = 0.5. - 1H NMR (200 MHz): δ = 1.14 (s, 9H, (CH3)3C), 1.28 (d, J = 
6.8 Hz, 3H, CH3CH), 3.20 (br. s, 1H, OH), 4.57 (q, J = 6.7 Hz, 1H, CHOH). - 13C NMR (50 
MHz): δ = 21.4 (q, CHCH3), 26.6 (q, C(CH3)3), 42.6 (s, C(CH3)3), 68.4 (d, CHOH),  218.4 (s, 
CO). 
 
2-Hydroxycyclohexanone 3-17f164 
O
OH
 
Synthesis according to general procedure I/method B: Yield 103 mg (90%). General 
procedure II/ method B: Yield 106 mg (46%). Rf (hexane/EtOAc 2:1) = 0.43. - 1H NMR (200 
MHz): δ = 1.32-2.00 (m, 4H, CH2CH2CH2CO), 2.08 (m, 1H, CH2CHOH or CH2CO), 2.16-
2.59 (m, 3H, CH2C(O)CH(OH)CH2), 4.08 (dd, J = 16.7, 1.3 Hz, 1H, CHOH), 5.67 (br. s, 1H, 
OH). - 13C NMR (50 MHz): δ = 23.3 (t, CH2), 27.5 (t, CH2), 36.6 (t, CH2CHOH), 39.4 (t, 
CH2CO), 75.3 (d, CHOH), 207.3 (s, CO). 
 
2-Hydroxy cycloheptanone 3-17g165  
O
OH
 
Synthesis according to general procedure II/method B/the crude product was preadsorbed on 
silica gel: Yield 150 mg (59%). Colourless oil.  
Rf(hexane/EtOAc 2:1) = 0.5. - 1H NMR (200 MHz): δ = 1.29-2.13 (m, 8H, 
CH2CH2CH2CH2CHOH), 2.46 (ddd, J = 17.2, 10.4, 3.7 Hz, 1H, CH2CO), 2.71 (m, 1H, 
CH2CO), 3.85 (br. s, 1H, OH), 4.30 (dd, J = 9.4, 3.7 Hz, 1H, CHOH). - 13C NMR (50 MHz): 
δ = 23.4 (t, CH2), 26.5 (t, CH2), 29.4 (t, CH2), 33.7 (t, CH2CHOH), 40.0 (t, CH2C=O), 76.9 (d, 
CHOH), 213.7 (s, CO). 
 
2-exo- and 2-endo-(R)-Hydroxy-camphor 3-17h166  
O
OH
 
Synthesis according to general procedure I/isolation method A: Yield 120 mg (71%), 2-
endo:2-exo-3-17h 1:1.1. Isolation method C: Yield 146 mg (87%), 2-endo:2-exo-3-17h 8.5:1. 
Colourless solid. 
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2-endo-3-17h: Rf = 0.46 (hexane/EtOAc 2:1). - 1H NMR (400 MHz): δ = 0.84 (s, 3H, 
C(CH3)2), 0.89 (s, 3H, C(CH3)2), 0.97 (s, 3H, CH2CCH3), 1.37 (m, 1H, CH2CH2CCH3), 1.67 
(m, 2H, CH2CH2CH), 1.94 (m, 1H, CH2CH2CH), 2.22 (t, J = 4.6 Hz, 1H, CH2CHCHOH), 
3.39 (br. s, 1H, OH), 4.18 (d, J = 5.1 Hz, 1H, CHOH). - 13C NMR (100 MHz): δ = 8.9 (q, 
CH2CCH3), 17.5 (t, CH2CH2CH), 18.5 (q, CHCCH3), 19.6 (q, CHCCH3), 32.2 (t, CCH2CH2), 
42.7 (s, C(CH3)2), 48.3 (d, CHCHOH), 58.1 (s, CH3CC=O), 74.1 (d, CHOH), 220.5 (s, C=O). 
- 2-exo-3-17h: Rf = 0.46 (hexane/EtOAc 2:1). - 1H NMR (400 MHz): δ = 0.89 (s, 3H, 
CH2CCH3), 0.91 (s, 3H, C(CH3)2), 0.96 (s, 3H, C(CH3)2), 1.37 (m, 2H, CH2CH2CCH3), 1.67 
(m, 1H, CH2CH2CH), 1.94 (m, 1H, CH2CH2CH), 2.05 (d, J = 4.7 Hz, 1H, CH2CHCHOH), 
3.39 (br. s, 1H, OH), 3.72 (s, 1H, CHOH). - 13C NMR (100 MHz): δ = 8.6 (q, CH2CCH3), 
19.7 (q, CHCCH3), 20.6 (q, CHCCH3), 24.8 (t, CH2CH2CH), 28.2 (t, CCH2CH2), 46.4 (s, 
C(CH3)2), 49.0 (d, CHCHOH), 56.7 (s, CH3CC=O), 76.9 (d, CHOH), 220.2 (s, C=O). 
 
6.3. Reduction of α-(tetramethylpiperidinyloxy)carbonyl compounds with hydride reagents 
 
β-(2,2,6,6-Tetramethylpiperidin-1-yloxy) alcohols 
Method A: Excess NaBH4 (46 to 68 mg, 1.2 to 1.8 equiv.) was added to a solution of 1 mmol 
3-11a, 3-11b, 3-11f, 3-11g, or 3-11h in 5 mL dry methanol at 0 °C or r.t. in one portion. The 
reaction was monitored by TLC. After completion 10 mL of water was added and stirred for 5 
min. The mixture was diluted with 10 mL diethyl ether. The aqueous layer was extracted three 
times with diethyl ether. The combined ethereal layers were dried over Na2SO4. The solvent 
was removed in vacuum and the crude product was purified by flash chromatography. 
Method B: Excess LiAlH4 (46 to 68 mg, 1.2 to 1.8 equiv.) was added to a solution of 1 mmol 
3-11a, 3-11b, 3-11f, 3-11g, or 3-11h in 5 mL THF at –78 or at 0 °C. The solution was stirred 
until complete by TLC. The reaction was quenched with 5 drops of water, diluted with diethyl 
ether and warmed to room temperature. The mixture was filtered through a pad of silica with 
diethyl ether. The solvent was removed in vacuum and the crude product was purified by 
flash chromatography. 
 
1-Phenyl-2-(2,2,6,6)-tetramethylpiperidin-1-yloxy)-1-propanol 3-20a 
OH
Ph
O
N
 
Flash chromatography (hexane/ethyl acetate 40:1, gradient to 10:1) gave a mixture of syn-3-
20a and anti-3-20a. Colourless oil. Yield Method A (57 mg NaBH4, MeOH, r.t., 25 min): 259 
mg (89%) syn/anti 6.5:1. 
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Rf (hexane/EtOAc10:1) = 0.34. - IR (film): v~  = 3100-3300 (br. w), 3070 (w), 3017 (w), 2982 
(m), 2968 (m), 2931 (m), 2871 (w), 2848 (w), 1451 (m), 1380 (w), 1361 (m), 1336 (w), 1299 
(w), 1258 (w), 1241 (w), 1186 (w), 1135 (s), 1057 (w), 1029 (s), 958 (w), 936 (m), 915 (w), 
881 (w), 841 (w), 796 (m), 753 (s), 734 (s), 696 (s) cm-1. - MS (CI) m/z (%): 292 (100) 
[M+H+], 157 (5) [TEMPOH+], 142 (16) [TMPH2+], 69 (5), 61 (8). - MS (ESI) m/z (%): 605 
(25) [2M+Na+], 314 (100) [M+Na+], 180 (17) [TEMPOH+Na+], 163 (6) [TMP+Na+]. - 
HRMS (ESI): C18H29NO2Na+: calc. 314.2096; found 314.2107. - Combustion analysis: 
C18H29NO2 (291.43): calc. C 74.18, H 10.03, N 4.81; found: C 74.15, H 10.20, N 4.70. - syn-
isomer: 1H NMR (400 MHz): δ = 0.80 (d, J = 6.3 Hz, 3H, CH3CH), 1.16 (s, 3H, NC(CH3)2), 
1.19 (s, 3H, NC(CH3)2), 1.25 (br. s, 1H, OH), 1.32-1.65 (m, 6H, NCCH2CH2CH2CN), 1.40 (s, 
3H, NC(CH3)2), 1.44 (s, 3H, NC(CH3)2), 4.16 (dq, J = 8.6, 6.3 Hz, 1H, CHOTMP), 4.76 (d, J 
= 8.6 Hz, 1H, CHOH), 7.23-7.37 (m, 5H, CH arom.). - 13C NMR (100 MHz): δ = 16.3 (q, 
CH3CH), 17.2 (t, NCCH2CH2CH2CN), 20.4 (q, NCCH3), 20.5 (q, NCCH3), 32.2 (q, NCCH3), 
34.4 (q, NCCH3), 39.9 (t, NCCH2), 40.3 (t, NCCH2), 60.1 (s, NCCH3), 61.3 (s, NCCH3), 80.8 
(d, CHOTMP), 80.9 (d, CHOH), 127.4 (d, CH arom.), 127.6 (d, CH arom.), 128.1 (d, CH 
arom.), 141.8 (s, C arom.). - anti-isomer: 1.01 (d, J = 6.6 Hz, 3H, CH3CH), 1.13 (s, 3H, 
NC(CH3)2), 1.19 (s, 3H, NC(CH3)2), 1.40 (s, 3H, NC(CH3)2), 1.44 (s, 3H, NC(CH3)2), 1.32-
1.65 (m, 6H, NCCH2CH2CH2CN), 2.43 (d, J = 2.6 Hz, 1H, OH), 4.12 (dq, J = 13.1, 6.5, 3.2 
Hz, 1H, CHOTMP), 5.07 (t, J = 2.5 Hz, 1H, CHOH), 7.23-7.37 (m, 5H, CH arom.). - 13C 
NMR (100 MHz): δ = 12.6 (q, CH3CH), 17.2 (t, NCCH2CH2CH2CN), 20.4 (q, NCCH3), 20.5 
(q, NCCH3), 32.2 (q, NCCH3), 34.4 (q, NCCH3), 40.4 (NCCH2), 60.1 (s, NCCH3), 61.3 (s, 
NCCH3), 74.8 (d, CHOH), 82.8 (d, CHOTMP), 126.0 (d, CH arom.), 126.9 (d, CH arom.), 
128.0 (d, CH arom.), 141.1 (s, C arom.). 
 
1-Phenyl-2-(2,2,6,6)-tetramethylpiperidin-1-yloxy)-butanols 3-20b 
OH
Ph
O
N
 
Flash chromatography (hexane/ethyl acetate 40:1, gradient to 10:1) gave a mixture of syn-3-
20b and anti-3-20b. Colourless oil. Yield: Method A (1.75 equiv. NaBH4, MeOH, 0 °C-r.t., 4 
h):  302 mg (99%) syn/anti 9.2:1. Method A (46 mg NaBH4, MeOH):  290 mg (95%) syn/anti 
8:1. Method B (57 mg LiAlH4, 0 °C, 35 min): 260 mg (85%) syn/anti 11.2:1. 
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Rf (hexane/EtOAc10:1) = 0.41. - IR (ATR): v~  = 3173 (br. w), 3088 (w), 3064 (w), 2977 (m), 
2930 (m), 2875 (w), 1453 (m), 1381 (m), 1339 (w), 1257 (w), 1239 (w), 1181 (w), 1131 (m), 
1080 (m), 1048 (w), 1028 (w), 994 (w), 959 (s), 902 (w), 843 (w), 800 (w), 757 (s), 729 (m), 
699 (s), 640 (w) cm-1. - MS (CI) m/z (%): 306 (100) [M+H+], 157 (5) [TEMPOH+], 142 (20) 
[TMPH2+]. - MS (ESI) m/z (%): 633 (9) [2M+Na+], 328 (100) [M+Na+], 180 (9) 
[TEMPOH+Na+], 148 (7) [M-TEMPOH+]. - HRMS (ESI): C19H31NO2Na+: calc. 328.2252; 
found 328.2241. - Combustion analysis: C19H31NO2 (305.45): calc. C 74.71, H 10.23, N 4.59; 
found: C 74.79, H 10.41, N 4.63. - syn-isomer: 1H NMR (400 MHz): δ = 0.79 (t, J = 7.4 Hz, 
3H, CH3CH2), 1.02 (m, 1H, CH2CH3), 1.07-1.23 (m+br. s, 2H, CH2CH3, OH), 1.10 (s, 3H, 
NC(CH3)2), 1.15 (s, 3H, NC(CH3)2), 1.30-1.59 (m, 6H, NCCH2CH2CH2CN), 1.37 (s, 3H, 
NC(CH3)2), 1.39 (s, 3H, NC(CH3)2), 3.94 (dt, J = 8.5, 3.1 Hz, 1H, CHOTMP), 4.80 (d, J = 8.8 
Hz, 1H, CHOH), 7.15-7.31 (m, 5H, CH arom.). - 13C NMR (100 MHz): δ = 10.1 (q, 
CH2CH3), 17.1 (t, NCCH2CH2CH2CN), 20.53 (q, NCCH3), 20.55 (q, NCCH3), 24.1 (t, 
CH2CH3), 31.8 (q, NCCH3), 34.5 (q, NCCH3), 39.9 (t, NCCH2CH2CH2CN), 40.3 (t, 
NCCH2CH2CH2CN), 60.2 (s, NC(CH3)2), 61.7 (s, NC(CH3)2), 79.6 (d, CHOH), 84.9 (d, 
CHON), 127.4 (d, CH arom.), 127.5 (d, CH arom.), 128.0 (d, CH arom.), 141.8 (s, C arom.). -  
anti-isomer, detectable resonances: 1H NMR (400 MHz): δ = 0.73 (t, J = 7.5 Hz, 3H, 
CH3CH2), 2.44 (d, J = 4.4 Hz, 1H, OH), 3.94 (m, 1H, CHOTMP), 5.10 (br. s, 1H, CHOH), 
7.15-7.31 (m, 5H, CH arom.). - 13C NMR (100 MHz): δ = 11.3 (q, CH2CH3), 17.1 (t, 
NCCH2CH2CH2CN), 24.1 (t, CH2CH3), 40.7 (t, NCCH2CH2CH2CN), 60.2 (s, NC(CH3)2), 
61.7 (s, NC(CH3)2), 73.3 (d, CHOH), 87.5 (t, CHOTMP), 126.3 (d, CH arom.), 126.8 (d, CH 
arom.), 127.8 (d, CH arom.), 141.4 (s, C arom.).  
 
cis- and trans-2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)cyclohexanol 3-20f 
OH
O
N
 
Purification by flash chromatography (hexane/ethyl acetate 20:1, gradient to 2:1) gave small 
amounts of cis-3-20f followed by a mixture of cis- and trans-3-20f. Colourless solid in the 
fridge, otherwise colourless oil. Yield Method A (68 mg NaBH4, 0 °C, 30 min): 255 mg 
(100%) cis/trans 2.7:1. Method B (68 mg LiAlH4, –78 - –60 °C, 30 min): 230 mg (90%) 
trans/cis 1.1:1. All analyses were performed on cis/trans-3-20f mixtures. 
m.p. (cis/trans 1:1.5) 20 °C. - IR (ATR): v~  = 3445 (w), 3265 (w), 2970 (m), 2931 (s), 2869 
(m), 1451 (m), 1375 (m), 1360 (m), 1258 (w), 1240 (w), 1204 (w), 1182 (w), 1130 (s), 1068 
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(s), 1018 (s), 990 (m), 960 (m), 929 (w), 908 (w), 849 (w), 792 (w), 731 (w) cm-1. - MS 
(+ESI) m/z (%) = 533 (7) [2M+Na+], 278 (100) [M++Na+], 137 (7). - HRMS (ESI): 
C15H30NO2+: calc. 256.2277; found 256.2271. - Combustion analysis: C15H29NO2 (255.40): 
calc. C 70.54, H 11.45, N 5.48; found C 70.39, H 11.57, N 5.43. - cis-Isomer: Rf(hexane/ethyl 
acetate 10:1) = 0.33. - 1H NMR (400 MHz): δ = 1.15 (s+m, 13H, NC(CH3)2, 
CH2CH2CHOTMP), 1.28-1.42 (m, 3H, NCCH2CH2CH2CN, CH2CH2CHOH), 1.43-1.77 (m, 
8H, NCCH2CH2CH2CN, CH2CH2CH2CHOTMP), 1.91 (m, 2H, CH2CH2CH2CH2), 2.06 (s, 
1H, OH), 3.65 (ddd, J = 11.5, 4.4, 2.7 Hz, 1H, CHOTMP), 4.18 (br. d, J = 1.9 Hz, 1H, 
CHOH). - 13C-NMR (100 MHz): δ = 17.1 (t, NCCH2CH2CH2CN), 19.4 (t, 
CH2CH2CH2CHOH or CH2CH2CHOH), 20.3 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 24.6 (t, 
CH2CH2CH2CHOH or CH2CH2CHOH), 26.2 (t, CH2CHOTMP), 31.0 (t, CH2CHOH), 34.2 
(q, NC(CH3)2), 40.4 (t, NCCH2CH2CH2CN), 59.9 (s, NC(CH3)2), 68.1 (d, CHOH), 83.5 (d, 
CHOTMP). - trans-Isomer: Rf(hexane/ethyl acetate 10:1) = 0.26. - 1H NMR (400 MHz): δ = 
1.10 (s, 3H, NC(CH3)2), 1.16 (s, 3H, NC(CH3)2), 1.08-1.25 (m, 4H, CH2CH2CH2CHOH), 1.30 
(s, 3H, NC(CH3)2), 1.33 (s, 3H, NC(CH3)2), 1.35 (m, 1H, NCCH2CH2CH2CN), 1.43-1.77 (m, 
7H, NCCH2CH2CH2CN, CH2CH2CHOTMP), 1.83 (m, 1H, CH2CHOTMP), 1.91 (m, 1H, 
CH2CHOH), 3.76 (m, 2H, CH(OH)CHOTMP). - 13C-NMR (100 MHz): δ = 17.2 (t, 
NCCH2CH2CH2CN), 20.3 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 23.7 (t, CH2CH2CH2CHOH or 
CH2CH2CHOH), 24.5 (t, CH2CH2CH2CHOH or CH2CH2CHOH), 29.3 (t, CH2CHOTMP), 
32.4 (q, NC(CH3)2), 33.0 (t, CH2CHOH), 34.5 (q, NC(CH3)2), 39.9 (t, NCCH2CH2CH2CN), 
40.3 (t, NCCH2CH2CH2CN), 59.9 (s, NC(CH3)2),  61.3 (s, NC(CH3)2), 75.5 (d, CHOH), 83.8 
(d, CHOTMP). 
 
2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)cycloheptanol 3-20g 
HO
O N
 
Purification by flash chromatography (hexane/ethyl acetate 40:1, gradient to 2:1) gave cis-3-
20g followed by a mixture of cis- and trans-3-20g as colourless oils. Yield: Method A (68 mg 
NaBH4, 0 °C, 35 min, then r.t. 20 min): 202 mg (75%) cis/trans 4:1; Method B (68 mg 
LiAlH4, THF, −78 - −60 °C, 40 min) 248 mg (92%) cis/trans 2.9:1. All analyses were 
performed on cis/trans mixtures. 
IR (film): v~  = 3588 (w), 3491 (w), 2926 (s), 2866 (m), 1458 (m), 1376 (m), 1360 (m), 1257 
(m), 1206 (w), 1182 (w), 1132 (m), 1074 (m), 1046 (w), 1007 (m), 984 (m), 957 (m), 924 (m), 
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794 (w) cm-1. - MS (+CI) m/z (%): = 270 (100) [M+H+], 157 (7) [TEMPOH+], 142 (32) 
[TMPH2+], 140 (5) [TMP+]. - Combustion analysis: C16H31NO2 (269.42): calc. C 71.33, H 
11.60, N 5.20; found C 71.33, H 11.82, N 5.42. - cis-Isomer: Rf(hexane/EtOAc 10:1) = 0.35. - 
1H NMR (200 MHz): δ = 1.14 (s, 12H, NC(CH3)2), 1.20-1.84 (m, 15H, 
CH2CH2CH2CH2CH2CHOH, NCCH2CH2CH2CN), 2.00 (m, 1H, CH2CHOH), 2.50 (s, 1H, 
OH), 3.72 (ddd, J = 10.3, 3.2, 2.4 Hz, 1H, CHOTMP), 4.23 (m, 1H, CHOH). - 13C NMR (50 
MHz): δ = 16.5 (t, NCCH2CH2CH2CN), 19.9 (t+q, CH2, NC(CH3)2), 23.8 (t, CH2), 24.9 (t, 
CH2), 27.6 (t, CH2CHOTMP), 30.9 (t, CH2CHOH), 33.2 (q, NC(CH3)2), 39.8 (t, 
NCCH2CH2CH2CN), 59.3 (s, NC(CH3)2), 69.6 (d, CHOH), 86.0 (d, CHOTMP). - trans-
Isomer: Rf(hexane/EtOAc 10:1) = 0.29. - 1H NMR (200 MHz): δ = 1.11 (s, 3H, NCCH3), 1.16 
(s, 3H, NCCH3), 1.28 (s, 3H, NCCH3), 1.32 (s, 3H, NCCH3), 1.37-1.83 (m, 16H, 
CH2CH2CH2CH2CH2CHOH, NCCH2CH2CH2CN), 3.92 (m, 2H, CHOTMP, CHOH), 6.56 (s, 
1H, CHOH). - 13C NMR (50 MHz): δ = 16.5 (t, NCCH2CH2CH2CN), 19.8 (q, NC(CH3)2), 
21.9 (t, CH2), 22.0 (t, CH2), 26.9 (t, CH2), 28.5 (t, CH2CHOTMP), 31.8 (t, CH2CHOH), 31.9 
(q, NC(CH3)2), 33.8 (q, NC(CH3)2), 39.3 (t, NCCH2CH2CH2CN), 39.6 (t, 
NCCH2CH2CH2CN), 59.2 (s, NC(CH3)2), 60.6 (s, NC(CH3)2), 77.0 (d, CHOH), 86.2 (d, 
CHOTMP). 
 
(1R,2S,3R)-1,7,7-Trimethyl-3-(2,2,6,6-tetramethylpiperidin-1yloxy)bicyclo[2.2.1]heptan-
2-ol 3-20h 
H
O
H
N
OH
 
Flash chromatography (hexane/ethyl acetate 20:1, gradient to 10:1) gave 2-exo,3-exo-3-20h 
containing small amounts of 2-endo,3-endo-3-20h. Colourless solid. Yield Method B (46 mg 
LiAlH4, 0 °C, 30 min, then 23 mg LiAlH4, r.t., 30 min): 282 mg (91%) 2-exo,3-exo/2-endo,3-
endo 4.3:1. Method B (68 mg LiAlH4, 0 °C, 1 h): 232 mg (75%) 2-exo,3-exo/2-endo,3-endo 
20:1. The analyses were performed on a mixture 2-exo,3-exo/2-endo,3-endo-3-20h 4.3:1. 
Rf (hexane/EtOAc 20:1) = 0.31. - m.p. (2-exo,3-exo:2-endo,3-endo 4.3:1) 23 °C. - IR (film): 
v
~  = 3465 (w), 2969 (m), 2948 (s), 2931 (s), 2869 (m), 1475 (m), 1372 (m), 1361 (m), 1285 
(w), 1260 (w), 1242 (w), 1184 (w), 1130 (s), 1093 (m), 1042 (s), 991 (w), 956 (m), 929 (m), 
875 (w), 839 (w), 808 (m), 786 (w), 698 (w) cm-1. - 2-exo,3-exo-3-20h: 1H NMR (400 MHz): 
δ = 0.72 (s, 3H, C(CH3)2), 0.81 (m, 2H, CH2CH2CCH3), 0.87 (s, 3H, CH2CCH3), 1.00 (s, 3H, 
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C(CH3)2), 1.13 (m, 12H, NC(CH3)2), 1.32 (m, 1H, CH2CCH3), 1.41 (br. s, 6H, 
NCCH2CH2CH2CN), 1.56 (m, 1H, CH2CH2CH), 2.14 (d, J = 5.1 Hz, 1H, CHCH2), 3.12 (d, J 
= 3.9 Hz, 1H, OH), 3.58 (dd, J = 7.4, 3.7 Hz, 1H, CHOH), 3.92 (d, J = 7.4 Hz, 1H,  
CHOTMP). - 13C NMR (100 MHz): δ = 10.8 (q, CH3CCHOH), 17.0 (t, NCCH2CH2CH2CN), 
20.8 (q, CHC(CH3)2), 21.4 (q, CHC(CH3)2), 21.7 (q, NCCH3), 22.3 (q, NCCH3), 24.3 (t, 
CH2CH2CH), 32.6 (t, CCH2CH2), 35.0 (q, NCCH3), 35.4 (q, NCCH3), 40.4 (t, NCCH2), 46.3 
(s, C), 48.68 (s, C), 48.70 (d, CH2CHCH), 59.8 (s, NCCH3), 60.5 (s, NCCH3), 79.9 (d, 
CHOH), 90.8 (d, CHOTMP). - MS (ESI) m/z (%): 641 (7) [2M+Na+], 332 (100) [M+Na+], 
278 (14), 191 (18). - HRMS (ESI): C19H36NO2+: calc. 310.2746; found 310.2741. - 
Combustion analysis: C19H35NO2 (309.49): calc. C 73.74, H 11.40, N 4.53; found: C 73.94, H 
11.45, N 4.44. 
 
(1R,2R,3S)-1,7,7-Trimethyl-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)bicyclo[2.2.1]heptan-2-ol 2-endo,3-endo-3-20h and (1R,2S,3S)-1,7,7-Trimethyl-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)bicyclo[2.2.1]heptan-2-ol 2-exo,3-endo-3-20h 
OH
H
O
H
N H
H
O
OH
N
 
Flash chromatography (hexane/ethyl acetate 50:1, gradient to 5:1) gave 255 mg of 2-endo,3-
endo-3-20h, followed by 55 mg of 2-exo,3-endo-3-20h, as a colourless solid. Yield Method B 
(68 mg LiAlH4, 0 °C, 35 min, then r.t., 25 min): 310 mg (100%) cis/trans 4.6:1. 
2-endo,3-endo-3-20h (major): Rf (hexane/EtOAc10:1) = 0.68. - m.p. 121-123 °C. - 1H NMR 
(400 MHz): δ = 0.76 (s, 3H, C(CH3)2), 0.79 (s, 3H, CH2CCH3), 0.81 (s, 3H, C(CH3)2), 0.96-
1.59 (m, 20H, CHCH2CH2CCH3, NC(CH3)2, NCCH2CH2CH2CN), 1.64 (ddd, J = 12.5, 9.6, 
4.5 Hz, 1H, CH2C(CH3)CHOH or CH2CH2CH), 1.76 (m, 1H, CH2C(CH3)CHOH or 
CH2CH2CH), 1.97 (t, J = 4.5 Hz, 1H, CH2CHCHOTMP), 2.84 (d, J = 5.0 Hz, 1H, OH), 3.77 
(ddd, J = 9.3, 5.0, 1.8 Hz, 1H, CHOH), 4.20 (ddd, J = 9.4, 4.4, 2.0 Hz, CHOTMP). - 13C 
NMR (100 MHz): δ = 14.1 (q, CH3CCHOH), 17.0 (t, NCCH2CH2CH2CN), 18.3 (q, 
CHC(CH3)2), 18.4 (t, CH2CH2CH), 19.7 (q, CHC(CH3)2), 20.5 (q, NCCH3), 25.8 (t, 
CCH2CH2), 32.0 (q, NCCH3), 34.0 (q, NCCH3), 40.5 (t, NCCH2), 43.6 (s, C), 49.3 (d, 
CH2CHCH), 49.4 (s, C), 59.4 (s, NCCH3), 60.0 (s, NCCH3), 73.7 (d, CHOH), 82.9 (d, 
CHOTMP). - IR (ATR): v~  = 3483 (w), 2991 (w), 2948 (s), 2920 (s), 2871 (m), 1463 (m), 
1372 (m), 1357 (w), 1259 (w), 1185 (w), 1132 (m), 1098 (w), 1054 (s), 1024 (m), 990 (m), 
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951 (m), 925 (m), 876 (w), 832 (w), 807 (m), 783 (w), 719 (w) cm-1. - MS (ESI) m/z (%): 310 
(100) [M+H+], 288 (7). - HRMS (ESI): C19H36NO2+: calc. 310.2746; found 310.2741. - 2-
exo,3-endo-3-20h (minor): - 1H NMR (400 MHz): δ = 0.81 (s, 3H, C(CH3)2), 0.84 (s, 3H, 
C(CH3)2), 1.00 (q, CH3CCHOH), 1.14 (m, 10H, NC(CH3)2, CH2C(CH3)CHOH), 1.32 (br. s, 
5H, NCCH3, NCCH2CH2CH2CN), 1.43-1.52 (m, 5H, NCCH2CH2CH2CN, CH2CH2CH), 1.56 
(dt, J = 12.1, 4.4 Hz, 1H, CH2CCH3CHOH), 1.70 (s, 1H, OH), 1.80 (ddd, J = 12.5, 9.7, 4.4 
Hz, 1H, CH2CH2CH), 2.06 (t, J = 4.3 Hz, 1H, CH2CHCHON), 3.54 (d, J = 2.4 Hz, 1H, 
CHOH), 4.28 (dt, J = 4.5, 2.3 Hz, CHOTMP). - 13C NMR (100 MHz): δ = 11.3 (q, 
CH3CCHOH), 17.2 (t, NCCH2CH2CH2CN), 18.7 (t, CH2CH2CH), 19.9 (q, CHCCH3), 20.3 (q, 
NCCH3), 20.5 (q, CHCCH3+NCCH3), 33.8 (q, NCCH3), 34.0 (q, NCCH3), 34.5 (t, 
CCH2CH2), 40.1 (t, NCCH2), 46.5 (s, C), 49.5 (s, C), 49.7 (d, CH2CHCH), 59.3 (s, NCCH3), 
59.9 (s, NCCH3), 86.2 (d, CHOH), 94.8 (d, CHOTMP). - IR (ATR): v~  = 3479 (w), 2922 (s), 
2873 (m), 1473 (m), 1372 (m), 1358 (w), 1260 (w), 1186 (w), 1133 (m), 1099 (w), 1055 (s), 
1024 (m), 991 (m), 953 (m), 926 (m), 877 (w), 833 (w), 809 (w), 784 (w), 720 (w), 673 (w) 
cm-1. - MS (ESI) m/z (%): 310 (100) [M+H+], 288 (5). - HRMS (ESI): C19H36NO2+: calc. 
310.2746; found 310.2741. 
 
2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)-1-pentanol 3-23 
OH
O
N
 
LiAlH4 (25 mg, 0.66 mmol) was added at 0 °C in one portion to a solution of 3-2a (150 mg, 
0.63 mmol) in dry THF (5 mL). After the vigorous reaction had ceased, the reaction mixture 
was stirred for 75 min (complete by TLC). The mixture was hydrolysed with 5 drops of water, 
stirred for 15 min, diluted with 15 mL diethyl ether and filtered through a pad of silica gel to 
remove inorganic material. The solvent was evaporated in vacuo and the pale yellow oil was 
purified by flash chromatography (hexane/EtOAc 10:1) to give 3-23 as a colourless oil. 
Yield 116 mg (90%). Rf = 0.18 (hexane/EtOAc 10:1); Rf = 0.5 (hexane/EtOAc 5:1). - IR 
(film): v~ = 3430, 3305, 2956, 2932, 2872, 1455, 1380, 1363, 1254, 1243, 1212, 1182, 1131, 
1078, 1048, 1020, 992, 976, 958, 922, 724, 653 cm–1. - 1H NMR (400 MHz): δ = 0.86 (t, J = 
7.1 Hz, 3H, CH2CH3), 1.03 (s, 3H, CH3CN), 1.10 (s, 3H, CH3CN), 1.16 (m, 1H, 
NCCH2CH2CH2CN), 1.25 (s, 6H, NCCH3), 1.27-1.56 (m, 9H, NCCH2CH2CH2CN, 
CH(CH2)2CH3), 3.50 (br. d, J = 11.8 Hz, 1H, CHCH2OH), 3.89 (dd, J = 11.4, 9.7 Hz, 1H, 
CHCH2OH), 4.20 (dddd, J = 11.8, 9.4, 4.8, 2.0 Hz, 1H, CHON), 5.90 (s, 1H, OH). - 13C NMR 
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(100 MHz): δ = 14.2 (q, CH2CH3), 17.1 (t, NCCH2CH2CH2CN), 19.1 (t, CH2CH3), 20.3 (q, 
NCCH3), 20.4 (q, NCCH3), 32.3 (q, NCCH3), 33.3 (t, CH2CH2CH3), 34.6 (q, NCCH3), 39.8 (t, 
NCCH2CH2CH2CN), 40.3 (t, NCCH2CH2CH2CN), 59.7 (s, NCCH3), 61.4 (s, NCCH3), 68.6 
(t, CHCH2OH), 79.8 (d, CH2CHCH2OH). - MS (+ESI): m/z (%) = 244 (100) [M+]. - HRMS: 
C14H30NO2+: calc. 244.2277; found 244.2271. - Combustion analysis: C14H29NO2 (243.39): 
calc. C 69.09, H 12.01, N 5.75; found C 69.11, H 12.12, N 5.93. 
  
Reduction of the nitrile function in 3-5a,b to amino alkoxyamines 3-24 and 3-25: 
A solution of 3-5a,b (1 mmol) dissolved in dry diethyl ether (1 mL) was added to a 
suspension of LiAlH4 (76 mg, 2 mmol) in dry diethyl ether (2 mL) at room temperature. After 
1.5 h the reaction was quenched with water (0.3 mL), diluted with diethyl ether (10 mL) and 
stirred for further 10 min. The reaction mixture was decanted from the soft colourless solid 
thus formed. The solid residue was washed 3 times with diethyl ether. The combined ethereal 
layers were washed twice with saturated NaHCO3 solution and extracted three times with 2N 
HCl solution (10 mL). The combined aqueous layers were washed once with diethyl ether, 
made basic with 2N NaOH solution (40 mL) and extracted three times with diethyl ether (10 
mL). The combined ethereal layers were washed twice with water, twice with brine, dried 
over Na2SO4, evaporated and dried in vacuum to give the pure products 3-24 and 3-25. 
 
2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)-2-phenylethylamine 3-24 
NH2
O
N
 
Yield 204 mg (74%) as a pale yellow oil. Rf = base line (hexane/EtOAc 5:1). - IR (film): v~  = 
3380, 3001, 2970, 2929, 2870, 1600, 1452, 1376, 1360, 1258, 1241, 1132, 1015, 987, 956, 
922, 878, 847, 796, 759, 700 cm-1. - 1H NMR (200 MHz): δ = 0.71 (s, 3H, NCCH3), 1.06-1.47 
(m, 17H, NCCH3, NCCH2CH2CH2CN, NH2), 3.11 (d, J = 5.5 Hz, 2H, CH2NH2), 4.69 (t, J = 
5.4 Hz, 1H, CHON), 7.19-7.40 (m, 5H, Ph). - 13C NMR (50 MHz): δ = 17.1 (t, 
NCCH2CH2CH2CN), 20.4 (q, NCCH3), 33.9 (q, NCCH3), 40.4 (t, NCCH2CH2CH2CN), 46.6 
(t, CH2NH2), 59.8 (s, NCCH3), 87.9 (d, CHON), 127.2 (d, Ph), 127.4 (d, Ph), 128.0 (d, Ph), 
141.8 (s, Ph). - MS (+ESI): m/z (%) = 299 (18) [M+Na+], 277 (100) [M+H+]. - Combustion 
analysis: C17H36N2O (276.42): calc. C 73.87, H 10.21, N 10.13; found C 73.90, H 10.27, N 
10.36. 
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2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)-1-octylamine 3-25 
O
NH2
N
 
Yield 260 mg (91%) as a pale yellow oil. Rf = base line (hexane/EtOAc 5:1). - IR (film): v~  = 
3380, 2926, 2857, 1577, 1464, 1376, 1360, 1297, 1258, 1241, 1208, 1182, 1132, 958, 926, 
815, 786, 717 cm–1. - 1H NMR (200 MHz): δ = 0.89 (t, J = 6.5 Hz, 3H, CH2CH3), 1.13 (s, 6H, 
NCCH3), 1.13-1.46 (m, 17H, NCCH2CH2CH2CN, NH2, CH3(CH2)4, CH2CHON), 1.29 (s, 3H, 
NCCH3), 1.46 (s, 3H, NCCH3), 1.70 (m, 1H, CH2CHON), 2.82 (m, 2H, CH2NH2), 3.76 (m, 
1H, CHON). - 13C NMR (50 MHz): δ = 14.0 (q, CH2CH3), 17.2 (t, NCCH2CH2CH2CN), 20.4 
(q, NCCH3), 22.6 (t, CH3CH2), 26.0 (t, CH2), 29.6 (t, CH2), 31.1 (t, CH2), 31.8 (t, CH2), 34.3 
(q, NCCH3), 40.3 (t, NCCH2CH2CH2CN), 44.8 (t, CH2NH2), 59.8 (s, NCCH3), 83.2 (d, 
CHON). - MS (+ESI): m/z (%) = 285 (100) [M+H+]. - Combustion analysis: C17H36N2O 
(284.48): calc. C 71.77, H 12.76, N 9.85; found C 72.07, H 12.93, N 10.25. 
 
6.4. Reactivity of α ,β-unsaturated carbonyl compounds 3-28a,b towards LDA, 1-2 and 1-3 
 
Oxygenation of methyl trans-2-pentenoate 3-28a in the absence of additives 
BuLi (1.625 mL, 1.6M in hexane, 2.6 mmol) was added to a solution of dry iPr2NH (0.366 
mL, 2.6 mmol) in 20 mL dry THF (0.1M substrate concentration) at –78 °C. After stirring at –
78 °C for 30 min, 3-28a (228 mg, 2 mmol) dissolved in 1 mL THF was added at –78 °C. The 
mixture was stirred at –78 °C for 0.5 h, then TEMPO (343 mg, 2.2 mmol) was added and the 
mixture was stirred for 5 min until it dissolved. Ferrocenium hexafluorophosphate was added 
in portions at −78 °C, as it was consumed until the reaction mixture remained blue for 20 min 
(total 890 mg, 2.7 mmol). Consumption of the substrate and formation of products was 
monitored by TLC with hexane/EtOAc 10:1. The reaction was quenched with 10 drops of 
water, diluted with diethyl ether and warmed to r.t.. The mixture was filtered through a pad of 
silica gel, which was washed with diethyl ether. The solution was concentrated in vacuo and 
preadsorbed on silica gel. Flash chromatography (hexane/EtOAc 80:1 gradient to 5:1) 
afforded a mixture of ferrocene and anti-3-29a, followed by a mixture of anti-3-29a and syn-
3-29a, and finally a mixture of anti-3-29a, syn-3-29a, and 3-30a. All analyses were 
performed on a mixture of syn-3-29a and anti-3-29a. A second purification afforded pure 
anti-3-29a and its structure was assigned by X-ray crystallography. Product 3-30a was not 
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separable from the mixture. The yield was calculated from the NMR spectra: 3-29a 33%, 
anti-3-29a:syn-3-29a 5.1:1; 3-30a 10%. 
 
Oxygenation of methyl trans-2-pentenoate 3-28a in the presence of HMPA 
The reaction was performed as before, but 2.2 mL (13.8 mmol) of dry HMPA was added 
before oxidation. Flash chromatography with hexane/EtOAc 80:1 gradient to 5:1 afforded 80 
mg of a complex mixture, which was not assigned.  
  
Methyl 3-(N,N-diisopropylamino)-2-(2,2,6,6-tetramethylpiperidin-1-yloxy)pentanoate 3-
29a 
COOCH3
O
N
N
 
IR (ATR): v~  = 2976 (m), 2954 (m), 2934 (m), 2871 (m), 1744 (s), 1463 (w), 1393 (w), 1361 
(m), 1247 (w), 1205 (s), 1175 (s), 1132 (m), 1116 (w), 1047 (s), 995 (w), 965 (m), 907 (w), 
890 (w), 790 (w), 758 (w), 720 (w), 704 (m) cm-1. - MS (ESI): m/z (%): 763 (6) [2M+Na+], 
393 (100) [M+Na+], 142 (35) [TMPH2+]. - HRMS (ESI): C21H42N2O3Na+: calc. 393.3093; 
found 393.3096. - Combustion analysis: C21H42N2O3 (370.57): calc. C 68.06, H 11.42, N 
7.56; found C 68.04, H 11.69, N 7.58. - anti-3-29a: Rf(hexane/EtOAc 20:1) = 0.41. - m.p. 61-
63 °C. - 1H NMR (400 MHz): δ = 0.91 (d, J = 6.7 Hz, 6H, NCH(CH3)2), 1.05 (d, J = 6.6 Hz, 
6H, NCH(CH3)2), 1.02-1.14 (m, 6H, NC(CH3)2), 1.10 (t, J = 7.4 Hz, 3H, CH2CH3), 1.18 (br. 
s, 3H, NC(CH3)2), 1.26-1.56 (m, 6H, NCCH2CH2CH2CN), 1.41 (br. s, 3H, NC(CH3)2), 1.62 
(m, 1H, CH2CHNCH), 1.89 (sept, J = 7.2 Hz, 1H, CH2CHNCH), 3.07 (m, 3H, N(CH(CH3)2)2, 
CHCHOTMP), 3.62 (s, 3H, COOCH3), 4.42 (d, J = 10.0 Hz, 1H, CHOTMP). - 13C NMR (100 
MHz): δ = 13.2 (q, CH3CH2), 17.0 (t, NCCH2CH2CH2CN), 20.5 (q, NC(CH3)2), 20.8 (q, 
NC(CH3)2), 21.8 (q, NCH(CH3)2), 24.1 (q, NCH(CH3)2), 25.1 (t, CH3CH2), 33.0 (q, 
NC(CH3)2), 34.8 (q, NC(CH3)2), 40.6 (t, NCCH2CH2CH2CN), 40.9 (t, NCCH2CH2CH2CN), 
46.0 (d, NCH(CH3)2), 50.7 (q, OCH3), 59.2 (d, NCHCH2), 59.4 (s, NC(CH3)2), 61.0 (s, 
NC(CH3)2), 86.7 (d, CHOTMP), 173.4 (s, C=O). - syn-3-29a: Rf(hexane/EtOAc 20:1) = 0.41. 
- 1H NMR (400 MHz): δ = 0.97 (d, J = 6.5 Hz, 6H, NCH(CH3)2), 1.01 (d, J = 7.1 Hz, 6H, 
NCH(CH3)2), 1.02 (m, 3H, CH2CH3), 1.02-1.21 (m, 9H, NC(CH3)2), 1.26-1.56 (m, 9H, 
NCCH2CH2CH2CN, NC(CH3)2), 1.62 (m, 1H, CH2CHNCH), 1.98 (ddq, J = 3.7, 7.6, 14.5 Hz, 
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1H, CH2CHNCH), 3.07 (m, 2H, N(CH(CH3)2)2), 3.26 (ddd, J = 9.0, 5.1, 3.8 Hz, 1H, 
CHCHOTMP), 3.65 (s, 3H, COOCH3), 4.19 (d, J = 5.2, 1H, CHOTMP). - 13C NMR (100 
MHz): δ = 13.3 (q, CH3CH2), 17.1 (t, NCCH2CH2CH2CN), 20.3 (q, NC(CH3)2), 20.5 (q, 
NC(CH3)2), 22.4 (q, NCH(CH3)2), 23.8 (q, NCH(CH3)2), 31.5 (t, CH3CH2), 33.0 (q, 
NC(CH3)2), 34.8 (q, NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 40.6 (t, NCCH2CH2CH2CN), 
44.7 (d, NCH(CH3)2), 50.6 (q, OCH3), 58.2 (d, NCHCH2), 59.4 (s, NC(CH3)2), 61.0 (s, 
NC(CH3)2), 88.1 (d, CHOTMP), 173.7 (s, C=O). 
 
Methyl 4-(2,2,6,6-tetramethylpiperidin-1-yloxy)-2-pentenoate 3-30a 
O
OMe
O
N
 
Rf(hexane/EtOAc 10:1) = 0.44. - 1H NMR (400 MHz): δ = 1.07 (s, 3H, NC(CH3)2), 1.10 (s, 
6H, NC(CH3)2), 1.16 (s, 3H, NC(CH3)2), 1.28 (d, J = 6.6 Hz, 3H, CHCH3), 1.21-1.56 (m, 6H, 
NCCH2CH2CH2CN), 3.74 (s, 3H, COOCH3), 4.44 (quint, J = 6.6 Hz, CHOTMP), 5.91 (d, J = 
15.7 Hz, =CHCOOMe), 6.98 (dd, J = 15.8, 6.9 Hz, =CHCHOTMP). - 13C NMR (100 MHz): δ 
= 16.4 (t, NCCH2CH2CH2CN), 19.4 (q, CH3CH), 19.6 (q, NC(CH3)2), 33.4 (q, NC(CH3)2), 
33.7 (q, NC(CH3)2), 39.4 (t, NCCH2CH2CH2CN), 50.7 (q, OCH3), 59.0 (s, NC(CH3)2), 78.4 
(d, CHOTMP), 118.6 (d, =CHCOOMe), 150.6 (d, =CHCHOTMP), 166.2 (s, C=O).  
 
Oxygenation of N,N-dimethylcrotonamide 3-28b 
To a solution of 0.183 mL (1.3 mmol) dry iPr2NH in 10 mL dry THF (0.1M substrate 
solution) was added 0.812 mL (1.3 mmol) of a 1.6M solution of BuLi in hexane dropwise via 
syringe at –78 °C. This solution was stirred at –78 °C for 0.5 h. A solution of 113 mg (1 
mmol) of substrate dissolved in 1 mL THF was added at –78 °C. The mixture was stirred at –
78 °C for 0.5 h. TEMPO (172 mg, 1.1 mmol) was added and the mixture was stirred for 5 min 
until it dissolved. Ferrocenium hexafluorophosphate was added in portions at −78 °C as it was 
consumed until the reaction mixture remained blue for 20 min. Consumption of substrate and 
formation of products was monitored by TLC with hexane/EtOAc 10:1. The reaction was 
quenched with a few drops of water, diluted with diethyl ether and warmed to r.t. The mixture 
was filtered through a pad of silica gel, which was washed with diethyl ether. The solution 
was concentrated in vacuo and preadsorbed on silica gel. Flash chromatography with 
hexane/EtOAc 80:1, gradient to 1:1 afforded ferrocene, followed by anti-3-29b, a mixture of 
 171 
anti-3-29b and syn-3-29b, and finally impure 3-30b. Analyses were performed on the mixture 
of anti-3-29b and syn-3-29b. Yield 200 mg (54%) of anti-3-29b:syn-3-29b 36:1, as a waxy 
colourless solid; 15 mg (max 5%) of 3-30b as a pale yellow oil. 
 
3-(N,N-Diisopropylamino)-N’,N’-dimethyl-2-(2,2,6,6-tetramethylpiperidin-1-yloxy)- 
butanoic amide 3-29b 
O
N
O
N
N
 
IR (ATR): v~  = 2975 (m), 2961 (m), 2933 (s), 2872 (w), 1640 (s), 1465 (m), 1418 (w), 1393 
(m), 1361 (m), 1334 (w), 1259 (w), 1240 (w), 1210 (m), 1196 (m), 1159 (w), 1133 (s), 1034 
(s), 998 (w), 975 (m), 956 (m), 902 (w), 876 (w), 845 (w), 787 (w), 709 (m) cm-1. - MS (ESI): 
m/z (%): 392 (9) [M+Na+], 370 (100) [M+H+]. - HRMS: C21H44N3O2+: calc. 370.3434; found 
370.3428. - anti-3-29b: 1H NMR (400 MHz): δ = 0.92 (d, J = 6.8 Hz, 6H, NCH(CH3)2), 0.97 
(s, 3H, NC(CH3)2), 1.05 (d, J = 6.5 Hz, 6H, NCH(CH3)2), 1.07 (s, 3H, NC(CH3)2), 1.18 (s, 
3H, NC(CH3)2), 1.25-1.37 (m, 2H, NCCH2CH2CH2CN), 1.29 (d, J = 7.0 Hz, 3H, CH3CH), 
1.34 (s, 3H, NC(CH3)2), 1.41-1.51 (m, 4H, NCCH2CH2CH2CN), 2.87 (s, 3H, NCH3), 2.99 
(sept, J = 6.7 Hz, 2H, NCH(CH3)2), 3.23 (s, 3H, NCH3), 3.62 (dq, J = 9.9, 7.0 Hz, 1H, 
CH3CHCH), 4.57 (d, J = 9.9 Hz, 1H, CHOTMP). - 13C NMR (100 MHz): δ = 16.96 (t, 
NCCH2CH2CH2CN), 17.04  (q, CH3CHCH), 20.2 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 21.7 
(q, NCH(CH3)2), 23.9 (q, NCH(CH3)2), 32.8 (q, NC(CH3)2), 33.7 (q, NC(CH3)2), 35.7 (q, 
N(CH3)2), 37.9 (q, N(CH3)2), 41.0 (t, NCCH2CH2CH2CN), 41.1 (t, NCCH2CH2CH2CN), 45.6 
(d, NCH(CH3)2), 52.5 (d, NCHCH), 59.3 (s, NCCH3), 60.9 (s, NCCH3), 78.9 (d, CHOTMP), 
173.4 (s, C=O). - syn-3-29b Detectable resonances: 1H NMR (200 MHz): δ = 2.92 (s, 3H, 
NCH3), 3.23 (s, 3H, NCH3), 4.47 (d, J = 8.1 Hz, 1H, CHOTMP). 
 
N,N-Dimethyl-4-(2,2,6,6-tetramethylpiperidin-1-yloxy)-2-butenoic amide 3-30b 
O
N
O
N
 
Detectable resonances: 1H NMR (200 MHz): δ = 1.13 (s, 6H, NC(CH3)2), 1.14 (s, 6H, 
NC(CH3)2), 1.47 (m, 1H, NCCH2CH2CH2CN), 3.02 (s, 3H, NCH3), 3.10 (s, 3H, NCH3), 4.47 
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(dd, J = 4.1, 2.1 Hz, 2H, CH2OTMP), 6.54 (dt, J = 15.1, 2.0 Hz, 1H, CHCON), 6.84 (dt, J = 
15.3, 4.0 Hz, 1H, CHCH2OTMP). - 13C NMR (50 MHz): δ = 17.0 (t, NCCH2CH2CH2CN), 
20.1 (q, NC(CH3)2), 21.4 (q, NC(CH3)2), 32.7 (q, NC(CH3)2), 35.6 (q, N(CH3)2), 37.3 (q, 
N(CH3)2), 39.5 (t, NCCH2CH2CH2CN), 59.8 (s, NCCH3), 76.2 (t, CH2OTMP), 119.2 (d, 
CHCON), 140.8 (d, CHCH2OTMP). 
 
6.5. α-Oxygenations of carbonyl compounds with oxygen 
 
Oxygenation of the enolate of ethyl heptanoate with O2  
BuLi (1.62 mL, 2.6 mmol, 1.6M in hexane) was added to a solution of dry iPr2NH (0.366 mL, 
2.6 mmol) in 20 mL dry THF at –78 °C. After stirring for 30 min, ethyl heptanoate 3-1d (316 
mg, 2 mmol) dissolved in 2 mL THF was added via syringe and stirring was continued at the 
same temperature for 30 min. A stream of dry oxygen was bubbled through the solution at –
78 °C for 1 h. The reaction was monitored by TLC. The reaction was quenched with eight 
drops of water and warmed to room temperature. The reaction mixture was diluted with 
diethyl ether and filtered through a pad of silica gel. The solvent removed in vacuo. The 
substrate was recovered. 
 
Oxygenation of the enolate of ethyl heptanoate with O2 in the presence of LiCl 
To a solution of dry LiCl (169 mg, 4 mmol) and dry iPr2NH (0.183 mL, 1.3 mmol) in 8 mL 
dry THF BuLi (0.81 mL, 1.3 mmol, 1.6M in hexane) was added at –78 °C. The mixture was 
stirred at –78 °C for 30 min. Ethyl heptanoate 3-1d (158 mg, 1 mmol) dissolved in 1 mL THF 
was added via syringe and the reaction mixture was stirred at –78 °C for 30-90 min. A stream 
of oxygen dried over CaCl2 was bubbled through the solution at –78 °C for 30 min. The 
mixture was quenched with seven drops of water and warmed to room temperature. The 
reaction mixture was diluted with diethyl ether and saturated NH4Cl solution was added. The 
aqueous layer was extracted 3 times with diethyl ether. The combined organic layers were 
washed twice with water and dried over Na2SO4. The solvent was removed vacuo. Flash 
chromatography (hexane/ethyl acetate 50:1 gradient to 1:1) afforded mixtures of substrate 3-
1d, β-ketoester 3-35d,10a trimer 3-34d,10a and finally alcohol 3-15d.10a For yields see Table 
3.21. 
 
Oxygenation of the enolate of ethyl heptanoate with O2 in the presence of FeCp2PF6  
BuLi (1.62 mL, 2.6 mmol, 1.6M in hexane) was added to a solution of dry iPr2NH (0.366 mL, 
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2.6 mmol) in 20 mL dry THF at –78 °C. After 30 min, ethyl heptanoate 3-1d (316 mg, 2 
mmol) dissolved in 2 mL THF was added via syringe and stirring was continued at –78 °C for 
30 min. A stream of dry oxygen was bubbled through the solution at –78, –40 or –30 °C for 
30-60 min (See Table 3.22). Ferrocenium hexafluorophosphate was added in portions, while 
oxygen bubbling was continued, at –78 °C until a blue-green colour persisted in the reaction 
mixture for at least 10 min. The reaction was quenched with seven drops of water and warmed 
to room temperature. It was diluted with diethyl ether and filtered through a pad of silica gel. 
The solvent was removed in vacuo and the inhomogeneous residue was preadsorbed on silica 
gel. Flash chromatography with hexane/ethyl acetate 100:1, gradient to 1:1 afforded 
ferrocene, followed by a mixture of substrate 3-1d, meso-dimer 3-3d10a and β-ketoester 3-35d, 
a mixture of d,l-dimer 3-3d,10a α-ketoester 3-36d167 and trimer 3-34d, and finally alcohol 3-
15d. 
 
Oxygenation of the enolate of ethyl heptanoate with O2 in the presence of PhCHO and 
HMPA  
BuLi (0.81 mL, 1.3 mmol, 1.6M in hexane) was added to a solution of dry iPr2NH (0.183 mL, 
1.3 mmol) in 9 mL dry THF at –78 °C. After stirring for 30 min, ethyl heptanoate (158 mg, 1 
mmol) dissolved in 1 mL THF was added via syringe and the reaction mixture was stirred at –
78 °C for 15 min. HMPA (2 mL) was added and stirring was continued for 15 min. A stream 
of oxygen dried over CaCl2 was bubbled through the solution at –78 °C for 10 min. 
Benzaldehyde (0.101 mL, 1 mmol) was added and stirring was continued at the same 
temperature for 30 min. The mixture was quenched with seven drops of water and warmed to 
room temperature. The reaction mixture was diluted with diethyl ether and saturated NH4Cl. 
The aqueous layer was extracted three times with diethyl ether and the combined organic 
layers were washed with water. The combined organic layers were dried over MgSO4 and the 
solvent was removed in vacuo. Flash chromatography (hexane/ethyl acetate 80:1, gradient to 
1:1) afforded mixtures of substrate 3-1d, β-ketoester 3-35d and PhCHO, trimer 3-34d and 
alcohol 3-15d. For yields see Table 3.23. 
 
Aldol addition of ethyl heptanoate to benzaldehyde in the presence of HMPA 
BuLi (0.81 mL, 1.6M in hexane, 1.3 mmol) was added to a solution of dry iPr2NH (0.183 mL, 
1.3 mmol) in 9 mL dry THF at –78 °C. This mixture was stirred for 30 min. Ethyl heptanoate 
3-1d (158 mg, 1 mmol) dissolved in 1 mL THF was added via syringe and the reaction 
mixture was stirred at –78 °C for 15 min. HMPA (2 mL) was added and stirring was 
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continued for 15 min. Benzaldehyde (0.101 mL, 1 mmol) was added and the mixture was 
stirred for 30 min at –78 °C. The reaction was quenched with seven drops of water, warmed 
to room temperature and diluted with diethyl ether. The aqueous layer was extracted three 
times with diethyl ether. The combined organic layers were washed with water, dried over 
MgSO4 and the solvent was removed in vacuo. Flash chromatography (hexane/ethyl acetate 
80:1, gradient to 2:1 afforded 3-35d in 13% yield and 3-38d in 49% yield. 
 
Ethyl (2R*,3R*)- and (2R*,3S*)-2-(hydroxybenzyl)heptanoate 3-38d168 
O
OEt
H11C5
Ph OH  
IR (film): v~  = 3481 (w), 3064 (w), 3031 (w), 2956 (m), 2928 (m), 2859 (w), 1730 (s), 1710 
(s), 1453 (m), 1374 (m), 1346 (w), 1270 (w), 1249 (w), 1175 (s), 1156 (s), 1024 (s), 912 (w), 
849 (w), 765 (m), 699 (s) cm–1. - MS (EI): m/z (%): 264 (5) [M+], 193 (6) 
[Ph(OH)CHCHCOOEt]+, 158 (64), 129 (12), 115 (67), 107 (41) [PhCHOH+], 105 (58), 101 
(100), 91 (12), 87 (7), 79 (38), 77 (52) [C6H5•+], 73 (58) [COOEt]+, 55 (22), 51 (17), 41 (24). 
- Combustion analysis: C16H24O3 (264.36): calc. C 72.69, H 9.15; found: C 72.31, H 9.12. - 
(2R*,3R*)-3-38d: 1H NMR (200 MHz): δ = 0.76 (t, J = 6.4 Hz, 3H, (CH2)4CH3), 1.02 (t, J = 
7.1 Hz, 3H, OCH2CH3), 1.00-1.34 (m, 6H, CH3(CH2)3CH2), 1.60 (m, 2H, CH2CH), 2.61 (ddd, 
J = 10.0, 5.8, 4.4 Hz, 1H, CHCOOEt), 2.98 (br. s, 1H, OH), 3.95 (q, J = 7.1 Hz, 2H, 
OCH2CH3), 4.81 (d, J = 5.9 Hz, CHOH), 7.21 (m, 5H, arom. CH). - 13C NMR (50 MHz): δ = 
13.9 (q, CH3), 14.0 (q, CH3), 22.4 (t, CH2CH3), 27.1 (t, CH2CH2CH3), 31.6 (t, 
CH2CHCOOEt), 53.1 (d, CHCOOEt), 60.4 (t, OCH2CH3), 74.3 (d, CHOH), 126.2 (d, arom. 
CH), 127.6 (d, arom. CH), 128.2 (d, arom. CH), 141.7 (s, arom. C), 175.0 (s, COOEt). - 
(2R*,3S*)-3-38d: 1H NMR (200 MHz): δ = 0.74 (m, 3H, (CH2)4CH3), 1.09-1.26 (m, 7H, 
CH3(CH2)3CH2), 1.13 (t, J = 7.1 Hz, 3H, OCH2CH3), 1.49 (m, 1H, CH2CH), 2.65 (m, 1H, 
CHCOOEt), 2.78 (br. s, 1H, OH), 4.08 (q, J = 7.2 Hz, 2H, OCH2CH3), 4.70 (d, J = 7.7 Hz, 
CHOH), 7.23 (m, 5H, arom. CH). - 13C NMR (50 MHz): δ = 13.9 (q, CH3), 14.2 (q, CH3), 
22.3 (t, CH2CH3), 26.7 (t, CH2CH2CH), 29.5 (t, CH2CH2CH3), 31.4 (t, CH2CHCOOEt), 53.1 
(d, CHCOOEt), 60.5 (t, OCH2CH3), 75.3 (d, CHOH), 126.4 (d, arom. CH), 127.8 (d, arom. 
CH), 128.4 (d, arom. CH), 142.2 (s, arom. C), 175.4 (s, COOEt).  
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6.6. Coupling of organometallic compounds with the free radical 1,3,5-triphenylverdazyl 
 
2,4,6-Triphenyl-1,2,3,4-tetrahydro-1,2,4,5-tetrazin-1-yl (1,3,5-triphenylverdazyl) 3-39 
NN
N N
 
To a solution of formazane (3.5 g, 11.7 mmol), BaO (20.2 g, 0.13 mol) and Ba(OH)2·8H2O 
(1.2 g, 3.8 mmol) in 120 mL DMF (0.1M concentration of substrate) was added CH3I (35 mL, 
0.56 mol) of at 0 °C. The reaction was stirred open to the air at 25 °C for 64 h. During this 
time the colour of the solution changed to brownish green. The reaction mixture was diluted 
with CH2Cl2 (120 mL) and H2O (100 mL) and the layers were separated. The organic layer 
was washed thoroughly with water and finally NaHSO4 to neutral pH, dried over Na2SO4 and 
the solvent was removed in vacuum. The product dissolved in a minimal amount of CH2Cl2 
was crystallised by addition of CH3OH. Yield: 2.8 g (76%) as dark green crystals. - m.p. 136-
138 °C. - Combustion analysis: C20H17N4 (313.38) calc.: C 76.65, H 5.47, N 17.88; found C 
76.30, H 5.46, N 17.98. 
 
Ethyl 2-(2,4,6-triphenyl-1,2,3,4-tetrahydro-1,2,4,5-tetrazin-1-yl)heptanoate 3-44 
N
N
N
N
Ph
PhPh
OEt
O
 
BuLi (0.812 mL, 1.3 mmol, 1.6M in hexane) was added to a solution of dry iPr2NH (183 µL, 
1.3 mmol) in 10 mL dry THF at  –78 °C under nitrogen atmosphere and the mixture was 
stirred for 30 min. A solution of ethyl heptanoate 3-1d (158 mg, 1 mmol) dissolved in 1 mL 
dry THF was added and stirring was continued at –78 °C for 30 min. Verdazyl 3-39 (156 mg, 
0.5 mmol) was added and stirred for 5 min until it dissolved. Oxidation was conducted by 
adding 1-3 (447 mg, 1.35 mmol) in small portions at –78 °C until the colour of the reaction 
mixture changed to blue-green and persisted in the reaction mixture. The reaction was 
quenched with 7 drops of water, diluted with diethyl ether, warmed to room temperature and 
filtered through a pad of silica gel, which was washed with diethyl ether. Flash 
chromatography with hexane/EtOAc 80:1 gradient to 1:1 afforded ferrocene, a mixture of β-
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ketoester 3-35d and meso-dimer 3-3d, a mixture of d,l-dimer 3-3d and trimer 3-34d, and 
finally verdazyl adducts 3-44-I and 3-44-II (unknown). For yields see Table 3.25. 
 
Amination in the presence of LiCl 
LiCl (264 mg, 6 mmol) was flame dried 3 to 5 times in vacuo. The reaction was subsequently 
performed similarly according to standard procedure. Flash chromatography with 
hexane/EtOAc 80:1, gradient to 1:1 afforded ferrocene, followed by a mixture of substrate, 
meso-3-3d, d,l-3-3d, trimer 3-34d and ethyl heptenoate 3-46,169 a mixture of d,l-3-3d and 
malonate 3-45,170 and finally product 3-44-I and 3-44-II. For yields see Table 3.25. 
 
Amination using CuCl2 as the oxidant 
The reaction was performed according to the standard procedure until the oxidation step. 
CuCl2 (269 mg, 2 mmol, 2 equiv. based on the enolate) was added at once and the reaction 
mixture was stirred at –78 °C for 20 min. Flash chromatography with hexane/EtOAc 50:1, 
gradient to 1:1 afforded a mixture of meso-dimer and β-ketoester, followed by products 3-44-I 
and 3-44-II. For yields see Table 3.25. 
 
Ethyl 2-(2,4,6-triphenyl-1,2,3,4-tetrahydro-1,2,4,5-tetrazin-1-yl) heptanoate 3-44: 
IR (ATR): v~  = 3062 (w), 3026 (w), 2955 (w), 2928 (w), 2860 (w), 1733 (s), 1596 (s), 1491 
(s), 1445 (m), 1378 (w), 1279 (m), 1174 (s), 1113 (w), 1088 (w), 1074 (m), 1026 (m), 994 
(w), 967 (w), 941 (w), 918 (w), 877 (w), 770 (s), 745 (s), 689 (s) cm-1. - MS (m/z): 307 (7), 
292 (8), 263 (6), 201 (5), 156 (100) [H7C4CH=CHCOOEt]+⋅, 139 (7), 123 (20), 106 (88), 77 
(15), 69 (18), 55 (31). - Combustion analysis: C29H34N4O2 (470.61): calc. C 74.01, H 7.28, N 
11.91; found C 74.08, H 7.41, N 11.55. - 3-44-I: 1H NMR (400 MHz): δ = 0.72 (t, J = 6.8 Hz, 
3H, CH3CH2CH2), 0.93-1.31 (m, 6H, CH3CH2CH2CH2), 1.14 (t, J = 7.1 Hz, 3H, CH3CH2O), 
1.81 (m, 2H, CH2CH), 4.04 (m, 2H, OCH2), 4.15 (t, J = 7.1 Hz, 1H, CHCOOEt), 4.34 (d, J = 
11.4 Hz, 1H, NCH2N), 5.28 (d, J = 11.7 Hz, 1H, NCH2N), 6.75 (t, J = 7.2 Hz, 1H, arom. CH), 
6.93 (m, 1H, arom. CH), 7.04 (m, 2H, arom. CH), 7.17 (m, 6H, arom. CH), 7.40 (m, 3H, 
arom. CH), 7.70 (m, 2H, arom. CH). - 13C NMR (100 MHz) = 13.8 (q, CH3CH2CH2), 14.1 (q, 
CH3CH2O), 22.2 (t, CH3CH2CH2), 25.9 (t, CH2CH2CH), 27.7 (t, CH2CH), 31.5 (t, 
CH3CH2CH2), 60.7 (t, OCH2), 63.2 (t, NCH2N), 64.2 (d, CH2CHN), 113.8 (d, arom. CH), 
119.7 (d, arom. CH), 119.8 (d, arom. CH), 123.6 (d, arom. CH), 128.2 (d, arom. CH), 128.4 
(d, arom. CH), 128.8 (d, arom. CH), 128.9 (d, arom. CH), 129.2 (d, arom. CH), 135.0 (s, 
arom. C), 144.2 (s, arom. C), 146.1 (s, arom. C), 150.3 (s, N=CPh), 170.7 (s, COOEt). - 3-44-
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II (unknown compound, possible assignment): 1H NMR (400 MHz): δ = 0.72 (t, J = 6.8 Hz, 
3H, CH3CH2CH2), 0.87 (t, J = 7.1 Hz, 3H, CH3CH2O), 0.93-1.31 (m, 6H, CH3CH2CH2CH2), 
1.81 (m, 1H, CH2CH), 1.99 (m, 1H, CH2CH), 3.77 (dq, J = 10.7, 7.2 Hz, 1H, OCH2), 3.89 
(dq, J = 10.7, 7.2 Hz, 1H, OCH2), 4.33 (m, 1H, CHCOOEt), 4.37 (d, J = 11.4 Hz, 1H, 
NCH2N), 5.49 (d, J = 11.7 Hz, 1H, NCH2N), 6.75 (t, J = 7.2 Hz, 1H, arom. CH), 6.90 (m, 1H, 
arom. CH), 7.04 (m, 2H, arom. CH), 7.17 (m, 6H, arom. CH), 7.40 (m, 3H, arom. CH), 7.85 
(m, 2H, arom. CH). - 13C NMR (100 MHz) = 13.5 (q, CH3CH2O), 13.8 (q, CH3CH2CH2),  
22.2 (t, CH3CH2CH2), 25.8 (t, CH2CH2CH), 27.3 (t, CH2CH), 31.3 (t, CH3CH2CH2), 60.9 (t, 
OCH2), 64.4 (d, CH2CHN), 64.8 (t, NCH2N), 113.6 (d, arom. CH), 119.5 (d, arom. CH), 
119.8 (d, arom. CH), 123.3 (d, arom. CH), 128.2 (d, arom. CH), 128.6 (d, arom. CH), 128.7 
(d, arom. CH), 128.9 (d, arom. CH), 129.4 (d, arom. CH), 134.2 (s, arom. C), 143.3 (s, arom. 
C), 146.1 (s, arom. C), 149.4 (s, N=CPh), 170.7 (s, COOEt).  
 
Diethyl 2-methyl-2-(2,4,6-triphenyl-1,2,3,4-tetrahydro-1,2,4,5-tetrazin-1-yl)malonate 3-
48 
N
N
N
N
Ph
PhPh
OEt
O
EtO
O
 
BuLi (0.406 mL, 1.6M in hexane, 0.65 mmol) was added to a solution of dry iPr2NH (0.09 
mL, 0.65 mmol) in 4 mL dry THF at –78 °C. After stirring at –78 °C for 0.5 h, 3-47 (87 mg, 
0.5 mmol) dissolved in 2 mL of THF was added at –78 °C. The mixture was stirred at –78 °C 
for 0.5 h and 3-39 (148 mg, 0.47 mmol) dissolved in 1 mL of THF was added at 0 °C. The 
reaction was stirred for 15 min 1-3 (380 mg, 1.15 mmol) was added in small portions at 0 °C. 
Stirring was continued for 30 min, while the progress of the reaction was monitored by TLC 
(hexane/EtOAc 5:1). The reaction was quenched with 10 drops of water, diluted with 20 mL 
diethyl ether, warmed to r.t. and filtered through a pad of silica gel, which was washed with 
diethyl ether. The solvent was evaporated in vacuo. The inhomogeneous mixture was 
preadsorbed on silica gel. Flash chromatography with hexane/ethyl acetate 50:1, gradient to 
10:1 gave ferrocene, followed by 3-48 as a colourless solid. Yield: 200 mg (87%). 
Rf(hexane/EtOAc 5:1) = 0.30. - m.p. = 115-118 °C. - 1H NMR (400 MHz): δ = 1.09 (t, J = 7.1 
Hz, 3H, OCH2CH3), 1.15 (t, J = 7.1 Hz, 3H, OCH2CH3), 1.63 (s, 3H, CCH3), 3.84 (dq, J = 
10.8, 7.1 Hz, 1H, OCH2CH3), 3.98 (dq, J = 10.8, 7.1 Hz, 1H, OCH2CH3), 4.11 (dq, J = 10.8, 
7.1 Hz, 1H, OCH2CH3), 4.18 (dq, J = 10.8, 7.1 Hz, 1H, OCH2CH3), 4.83 (d, J = 12.1 Hz, 1H, 
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NCH2N), 5.61 (d, J = 12.1 Hz, 1H, NCH2N), 6.85 (tt, J = 7.2, 1.1 Hz, 1H, arom. CH), 6.93 (tt, 
J = 7.0, 1.3 Hz, 1H, arom. CH), 7.13 (m, 2H, arom. CH), 7.21-7.29 (m, 6H, arom. CH), 7.33 
(m, 3H, arom. CH), 7.60 (m, 2H, arom. CH). - 13C NMR (100 MHz, CDCl3): 13.6 (q, 
CH2CH3), 13.7 (q, CH2CH3), 22.9 (t, CCH3), 59.3 (t, NCH2N), 61.9 (t, CH2CH3), 62.0 (t, 
CH2CH3), 75.3 (s, CCH3), 113.2 (d, arom. CH), 117.4 (d, arom. CH), 119.8 (d, arom. CH), 
122.4 (d, arom. CH), 127.7 (d, arom. CH), 128.94 (d, arom. CH), 128.97 (d, arom. CH), 
129.02 (d, arom. CH), 129.7 (d, arom. CH), 135.9 (s, arom. C), 141.2 (s, arom. C), 145.8 (s, 
arom. C), 148.8 (s, N=C(Ph)N), 168.90 (s, CO), 168.96 (s, CO). - IR (Film): v~  = 3058 (w), 
2981 (w), 2901 (w), 1751 (w), 1729 (s), 1598 (m), 1546 (m), 1498 (m), 1468 (w), 1443 (w), 
1372 (m), 1268 (s), 1232 (m), 1203 (w), 1180 (m), 1166 (m), 1138 (s), 1079 (w), 1045 (w), 
1020 (w), 970 (w), 948 (w), 896 (w), 855 (w), 748 (s), 720 (m), 696 (s) cm-1. - MS (ESI): m/z 
(%) = 995 (100) [2M+Na+], 509 (100) [M+Na+], 487 (43) [M+H+], 404 (8), 313 (64) [1,3,5-
triphenylverdazyl+], 195 (9) [(EtOOC)2C=CH2+Na+]. - Combustion analysis: C28H30N4O4 
(486.56): calc. C 69.12, H 6.21, N 11.51; found C 68.43, H 6.21, N 11.87. 
 
Reaction of triphenylverdazyl with methyl acetoacetate 3-49 
BuLi (0.625 mL, 1.6M in hexane, 1 mmol) was added to a solution of dry iPr2NH (0.141 mL, 
1 mmol) in 5 mL dry THF at –78 °C. After stirring at –78 °C for 0.5 h, methyl acetoacetate 3-
49 (106 mg, 0.91 mmol) dissolved in 2 mL of THF was added at –78 °C. The mixture was 
stirred at this temperature for 0.5 h and 3-39 (272 mg, 0.87 mmol) dissolved in 1 mL of THF 
was added at –78 °C. The mixture was stirred for 15 min. 1-3 (440 mg, 1.33 mmol) was added 
in small portions at –78 °C. Stirring was continued for 30 min. The progress of the reaction 
was monitored by TLC (hexane/EtOAc 2:1). The reaction was quenched with 10 drops of 
water, diluted with 20 mL diethyl ether, warmed to r.t. and filtered through a pad of silica gel. 
The solvent was evaporated in vacuo. The inhomogeneous mixture was preadsorbed on silica 
gel. Flash chromatography (hexane/ethyl acetate) 50:1 gradient to 10:1 gave ferrocene, 
followed by 3-51. Colourless solid. Yield: 190 mg (75%). 
 
Methyl 1,3-diphenyl-1H-1,2,4-triazole-5-carboxylate 3-51 
N
N
N
Ph
Ph
COOMe
 
Rf(hexane/EtOAc 5:1) = 0.15. - m.p. = 146-148 °C. - 1H NMR (400 MHz): δ = 3.95 (s, 3H, 
CH3), 7.45 (m, 3H, arom. CH), 7.53 (s, 5H, arom. CH), 8.22 (m, 2H, arom. CH). - 13C-NMR 
(100 MHz, CDCl3): δ = 53.2 (q, CH3), 125.7 (d, arom. CH), 126.7 (d, arom. CH), 128.6 (d, 
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arom. CH), 129.0 (d, arom. CH), 129.6 (s, arom. C), 129.7 (d, arom. CH), 129.9 (d, arom. 
CH), 137.9 (s, arom. C), 145.0 (s, N=CPh), 157.8 (s, N=CCOOCH3), 162.0 (COOCH3). - IR 
(Film): v~  = 3064 (w), 3039 (w), 3004 (w), 2957 (w), 1728 (s), 1597 (w), 1521 (w), 1491 (s), 
1464 (m), 1445 (m), 1343 (w), 1303 (s), 1238 (s), 1147 (s), 1107 (s), 1072 (w), 1047 (w), 
1018 (m), 947 (w), 908 (w), 824 (m), 789 (w), 755 (s), 719 (s), 686 (s) cm-1. - MS (EI): m/z 
(%) = 279 (100) [M+], 221 (8) [M+ – COOCH2], 194 (34) [PhC=NNPh+], 118 (22), 91 (84) 
[PhN•+], 77 (11) [Ph•+], 65 (5), 64 (12), 51 (5).  
 
Reaction of octonitrile with verdazyl in the absence of ferrocenium hexafluorphosphate: 
BuLi (0.406 mL, 1.6M in hexane, 0.65 mmol) was added to a solution of dry iPr2NH (0.09 
mL, 0.65 mmol) in 5 mL dry THF at –78 °C. The mixture was stirred for 30 min and 
octonitrile 3-4b (0.077 mL, 0.5 mmol) dissolved in 2 mL THF was added at –78 °C. The 
reaction was stirred at this temperature for 0.5 h and 3-39 (156 mg, 0.5 mmol) dissolved in 2 
mL THF was added at 0 °C to the colourless solution. A sudden colour change indicated a fast 
reaction, the reaction mixture turned shortly to deep green and then immediately to dark red. 
The reaction was monitored by TLC (hexane/EtOAc 5:1), but no change was observed in the 
next 30 min. The reaction was quenched with 10 drops of water, diluted with 20 mL diethyl 
ether and 10 mL CH2Cl2 and warmed to r.t. The reaction mixture was filtered through a pad of 
silica gel with diethyl ether and the solvent was removed in vacuo. The inhomogeneous 
mixture was preadsorbed on silica. Flash chromatography with hexane/ethyl acetate 20:1 
gradient to 2:1 gave a mixture containing a major product that is probably 3-56a and a minor 
component which was assigned structure 3-57. Dark red oil. Yield: 150 mg 3-56a:3-57 4.7:1. 
 
Reaction of octonitrile with verdazyl in the presence of ferrocenium hexafluorphosphate: 
To the ketene iminate solution, prepared as above, was added 3-39 (156 mg, 0.5 mmol) 
dissolved in 2 mL of THF at 0 °C to the colourless solution. A sudden colour change 
indicated a fast reaction, the reaction mixture turned shortly to deep green and then 
immediately to dark red. After stirring for 5 min, 1-3 (590 g, 1.8 mmol) was added in portions 
and the reaction was stirred for further 35 min. The reaction was monitored by TLC 
(hexane/EtOAc 5:1), but the only new spot on TLC was that of ferrocene. The reaction was 
quenched with 10 drops of water, diluted with 20 mL diethyl ether and 10 mL CH2Cl2 and 
warmed to r.t. The reaction mixture was filtered through a pad of silica gel with diethyl ether 
and the solvent was removed in vacuum. The inhomogeneous mixture was preadsorbed on 
silica gel. Flash chromatography (hexane/ethyl acetate 20:1, gradient to 1:1) gave a mixture 
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containing a major unknown product that is probably 3-56a and a minor component which 
was assigned structure 3-57. Dark red oil. Yield: 60 mg, 3-56a:3-57 7:1. 
 
6-Heptyl-1,3-diphenyl-1,4-dihydro-1,2,4,5-tetrazine 3-56a 
N
N N
NH
Ph
C7H15
Ph
 
Rf(hexane/EtOAc 5:1) = 0.30. - Detectable resonances: 1H NMR (200 MHz): δ = 0.85 (t, J = 
6.8 Hz, 3H, CH3CH2), 1.21-1.41 (m, 8H, CH3(CH2)4), 1.78 (m, 2H, N=CCH2CH2), 2.82 (m, 
2H, N=CCH2), 7.34-7.57 (m, 8H, arom. CH), 8.15 (m, 2H, arom. CH). - 13C NMR (50 MHz, 
CDCl3): δ = 13.8 (q, CH3CH2), 22.3 (t, CH3CH2), 26.5 (t, CH2), 27.8 (t, CH2), 28.7 (t, CH2), 
31.2 (t, CH2), 125.1 (d, arom. CH), 126.3 (d, arom. CH), 128.4 (d, arom. CH), 128.8  (d, 
arom. CH), 129.0 (d, arom. CH), 129.3 (d, arom. CH), 130.8 (s, arom. C), 137.5 (s, arom. C), 
157.0 (s, N=C), 161.3 (s, N=C). 
 
2-((Phenylamino)methyl)octonitrile 3-57 
C6H13 CN
NHPh 
Rf(hexane/EtOAc 5:1) = 0.30. - Detectable resonances: 1H NMR (200 MHz): δ = 0.85 (m, 3H, 
CH3CH2), 1.21-1.67 (m, 11H, CH3(CH2)5CHCN), 3.38 (m, 2H, CHCH2NHPh), 4.02 (br. s, 
1H, NHPh), 6.60 (d, J = 7.6 Hz, 2H, arom. CH), 6.75 (t, J = 7.3 Hz, 1H, arom. CH), 7.20 (dd, 
J = 8.3, 7.5 Hz, 2H, arom. CH). - 13C NMR (50 MHz, CDCl3): δ = 13.8 (q, CH3CH2), 22.3 (t, 
CH3CH2), 29.6 (t, CH2), 31.3 (t, CH2), 32.2 (d, CHCN), 45.5 (t, CH2NHPh), 112.8 (d, arom. 
CH), 118.2 (s, CHCN). 
 
6.7. Reactions of 1,3,5-triphenylverdazyl with organometallic reagents 
 
Standard procedure: BuLi (0.156 mL, 1.6M in hexane, 0.25 mmol) was added to a solution 
of 3-39 (156 mg, 0.5 mmol) in 8 mL dry THF at –78 °C. The colour of the solution changed 
form deep green to brown. A stream of dry oxygen was bubbled through the solution for a 
few minutes, during which the dark green colour reappeared. The solution was purged with 
nitrogen, and titrated dropwise with BuLi. The addition was stopped when the colour changed 
from deep green to brown. A stream of dry stream of oxygen was bubbled through the 
solution until the brown colour changed back to green. The reaction mixture was again purged 
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with nitrogen. This was repeatedly performed until the brown colour of the mixture persisted 
for at least 20 min, and the amount of BuLi reached a total of 1.216 mL (1.9 mmol, 3.9 
equiv.). The progress of the reaction was monitored by TLC (hexane/EtOAc 5:1). The 
reaction was quenched with 10 drops of water, diluted with diethyl ether and warmed to r.t. 
This solution was filtered through a pad of silica gel, which was washed with diethyl ether. 
The solvent was removed in vacuo and the inhomogenous mixture was preadsorbed on silica. 
Flash chromatography (hexane/EtOAc 40:1 gradient to 1:1) afforded 3-58a (160 mg, 85%) as 
colourless solid. 
 
1-Butyl-2,4,6-triphenyl-1,2,3,4-tetrahydro-1,2,4,5-tetrazine 3-58a 
N
NN
N
Ph Ph
Ph
 
Rf(hexane/EtOAc 5:1) = 0.60. - m.p. 108-110 °C. - 1H NMR (200 MHz): δ = 0.76 (t, J = 7.3 
Hz, 3H, CH3CH2), 1.22 (sext, J = 7.3 Hz, 2H, CH3CH2), 1.65 (quint, J = 7.3 Hz, 2H, 
CH3CH2CH2), 2.60 (m, 1H, CH2CH2N), 3.22 (m, 1H, CH2CH2N), 4.24 (br. d, J = 12.1 Hz, 
1H, NCH2N), 5.54 (br. d, J = 11.8 Hz, 1H, NCH2N), 6.77 (m, 2H, arom. CH), 7.09 (m, 8H, 
arom. CH), 7.28 (m, 3H, arom. CH), 7.72 (m, 2H, arom. CH). - 13C NMR (50 MHz, CDCl3): 
δ = 13.9 (q, CH3CH2), 20.1 (t, CH3CH2), 29.6 (t, CH2CH2N), 55.1 (t, CH2CH2N), 57.7 (t, 
NCH2N), 113.4 (d, arom. CH), 117.0 (d, arom. CH), 119.9 (d, arom. CH), 121.9 (d, arom. 
CH), 127.2 (d, arom. CH), 128.4 (d, arom. CH), 129.0 (d, 3C, arom. CH), 135.2 (s, arom. C), 
144.6 (s, arom. C), 145.9 (s, arom. C), 149.0 (s, N=C(Ph)N). - IR (film): v~  = 3061 (w), 3027 
(w), 2963 (w), 2924 (w), 2858 (w), 1594 (s), 1554 (m), 1491 (s), 1467 (m), 1444 (m), 1379 
(m), 1334 (m), 1311 (m), 1285 (m), 1203 (m), 1181 (m), 1146 (m), 1115 (w), 1068 (m), 1027 
(m), 994 (m), 975 (w), 951 (w), 919 (w), 833 (w), 854 (m), 787 (w), 744 (s), 688 (s) cm-1. - 
MS (EI): m/z (%) = 370 (100) [M+], 313 (29) [1,3,5-triphenylverdazyl+], 263 (9), 235 (9), 194 
(10), 160 (19), 104 (100) [CH=NPh]+, 91 (22), 77 (36), 57 (5) [Bu]+. 
 
1-tert-Butyl-2,4,6-triphenyl-1,2,3,4-tetrahydro-1,2,4,5-tetrazine 3-58b 
N
NN
N
Ph Ph
Ph
 
According to the standard procedure 3-58b was synthesised by the addition of tBuLi (1.4M in 
pentane) to a solution of 3-39 (156 mg, 0.5 mmol) in THF at –78 °C. The deep green solution 
changed to brown after the addition of a total amount of 2.1 equiv. tBuLi (1.05 mL, 1.47 
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mmol). Titration with tBuLi, followed by reoxidation by an oxygen stream and finally 
purging nitrogen was performed until a total of 2.69 mmol tBuLi (1.925 mL) was added. 
Flash chromatography (hexane/EtOAc 40:1, gradient to 1:1) afforded 3-58b (90 mg, 48% 
yield) as a colourless solid. 
Rf(hexane/EtOAc 5:1) = 0.15. - m.p. 189-190 °C. - 1H NMR (200 MHz): δ = 1.25 (s, 9H, 
NC(CH3)3), 4.73 (d, J = 12.3 Hz, 1H, NCH2N), 5.78 (d, J = 12.3 Hz, 1H, NCH2N), 6.86 (m, 
2H, arom. CH), 7.11-7.26 (m, 8H, arom. CH), 7.33 (m, 3H, arom. CH), 7.63 (m, 2H, arom. 
CH). -  13C NMR (50 MHz): δ = 30.1 (q, NC(CH3)3), 60.3 (s, NC(CH3)3), 62.0 (t, NCH2N) 
112.8 (d, arom. CH), 117.1 (d, arom. CH), 119.6 (d, arom. CH), 121.6 (d, arom. CH), 127.8 
(d, arom. CH), 128.4 (d, arom. CH), 128.9 (d, arom. CH), 129.0 (d, 3C, arom. CH), 129.1 (d, 
arom. CH), 139.5 (s, arom. C), 142.9 (s, arom. C), 145.5 (s, arom. C), 150.0 (s, N=C(Ph)N). 
 
1-Ethyl-2,4,6-triphenyl-1,2,3,4-tetrahydro-1,2,4,5-tetrazine 3-58c 
N
NN
N
Ph Ph
Ph
 
 
Synthesis of 3-58c from 3-39 and EtMgBr 
According to the standard procedure, 3-58c was synthesised from 3-39 (313 mg, 1 mmol) and 
EtMgBr (1.83 mmol, 1.83 mL of a 1M solution in THF) at –78 °C. Flash chromatography 
(hexane/EtOAc 20:1, gradient to 2:1) afforded 160 mg (47%) 3-58c as a colourless solid. 
 
Synthesis of 3-58c from 3-39 and Et2Zn 
According to the standard procedure, 3-58c was synthesised from 3-39 (156.5 mg, 0.5 mmol) 
and Et2Zn (0.545 mmol, 0.545 mL of a 1M solution in diethyl ether) at 0 °C. Flash 
chromatography with hexane/EtOAc 40:1, gradient to 1:1 afforded 80 mg (47% yield) 3-58c 
as a colourless solid. 
Rf(hexane/EtOAc 5:1) = 0.55. - m.p. 132-134 °C. - 1H NMR (200 MHz): δ = 1.22 (t, J = 7.0 
Hz, 3H, CH3CH2N), 2.76 (br. s, 1H, NCH2CH3), 3.35 (br. s, 1H, NCH2CH3), 4.31 (d, J = 
11.9 Hz, 1H, NCH2N), 5.62 (d, J = 11.0 Hz, 1H, NCH2N), 6.82 (m, 2H, arom. CH), 7.14 (m, 
8H, arom. CH), 7.36 (m, 3H, arom. CH), 7.73 (m, 2H, arom. CH). - 13C NMR (50 MHz, 
CDCl3): δ = 12.9 (q, CH2CH3), 49.8 (t, NCH2CH3), 57.8 (t, NCH2N), 113.5 (d, arom. CH), 
117.0 (d, arom. CH), 120.0 (d, arom. CH), 122.0 (d, arom. CH), 127.2 (d, arom. CH), 128.5 
(d, arom. CH), 129.1 (d, arom. CH), 135.5 (s, arom. C), 144.5 (s, arom. C), 146.0 (s, arom. 
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C), 149.5 (s, N=C(Ph)N). - IR (ATR): v~  = 3057 (w), 3034 (w), 2980 (w), 2933 (w), 2887 
(w), 2855 (w), 1595 (s), 1547 (w), 1491 (s), 1463 (m), 1441 (w), 1386 (w), 1357 (w), 1331 
(m), 1304 (w), 1276 (m), 1188 (m), 1146 (m), 1058 (m), 1024 (m), 992 (w), 960 (m), 919 
(w), 874 (w), 831 (w), 762 (s), 741 (s), 685 (s), 666 (m) cm-1. - MS (EI): m/z (%) = 342 (100) 
[M+], 313 (11) [1,3,5-triphenylverdazyl•+], 132 (29), 104 (37) [(N=CPh)•+], 77 (19), 57 (8). 
 
6.8. Oxidative dimerisations of carbonyl compounds 
 
Dimerisation of ethyl valerate (General procedure): 
BuLi (1.22 mL, 1.95 mmol, 1.6M in hexane) was added to a solution of diisopropylamine 
(0.275 mL, 1.95 mmol) in 14 mL of dry THF at –78 °C. After stirring for 30 min, ethyl 
valerate 3-1a (195 mg, 1.5 mmol) dissolved in 1 mL of THF was added at –78 °C and stirring 
was continued for 30 min. Ferrocenium hexafluorophosphate 1-3 was added in portions at –78 
°C as the blue colour of the oxidant vanished in the reaction mixture. Addition was continued 
to a total amount of 880 mg (2.6 mmol) when a deep blue colour persisted in the solution for 
10 min. The reaction was quenched with a few drops of water, diluted with diethyl ether and 
warmed to r.t. The reaction mixture was filtered through a pad of silica gel. The solvent was 
concentrated in vacuo and the crude mixture was preadsorbed on silica gel. Flash 
chromatography (hexane/ethyl acetate 80:1, gradient to 10:1) afforded ferrocene, followed by 
meso-3-3a,25 a mixture of meso-3-3a and d,l-3-3a,25 and finally d,l-3-3a. Yield: 175 mg 
(89%) meso-3-3a:d,l-3-3a 2.5:1 (Rf(hexane/EtOAc 10:1) = 0.38, 0.34). 
 
Dimerisation of ethyl valerate 3-1a with addition of the oxidant in one portion 
The enolate of 3-1a (195 mg, 1.5 mmol) was generated according to the general procedure. 
Ferrocenium hexafluorophosphate 1-3 (993 mg, 3 mmol) was added in one portion at –78 °C 
and stirring was continued for 20 min. The reaction was quenched with a few drops of water, 
diluted with diethyl ether and warmed to r.t. Workup and purification were performed 
according to the general procedure. Yield: 117 mg (60%) meso-3-3a:d,l-3-3a 1.5:1; 2.9 mg of 
trimer 3-34a (1.7%) was detected in the NMR spectra. 
 
Dimerisation of 3-1a at –20 °C 
BuLi (1.5 mL, 1.6M in hexane, 2.4 mmol) was added to a solution of diisopropyl amine 
(0.338 mL, 2.4 mmol) in 17 mL dry THF at –78 °C. After stirring for 30 min, 3-1a (240 mg, 
1.8 mmol) dissolved in 1 mL of THF was added at –78 °C and stirring was continued for 30 
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min. Ferrocenium hexafluorophosphate 1-3 was added in portions at –20 °C as long as the 
blue colour of the oxidant disappeared in the reaction mixture. Addition was continued to a 
total amount of 880 mg (2.6 mmol) when a deep blue colour persisted in the solution for 10 
min. The reaction was quenched with a few drops of water, diluted with diethyl ether and 
warmed to r.t. The reaction mixture was filtered through silica gel. The solvent was 
concentrated in vacuo and the crude mixture was preadsorbed on silica gel. Flash 
chromatography (hexane/ethyl acetate 80:1, gradient to 10:1) afforded ferrocene, followed by 
meso-3-3a, a mixture of meso-3-3a and d,l-3-3a, and finally a mixture of d,l-3-3a and trimer 
3-34a. Yield: 123 mg (53%) meso-3-3a:d,l-3-3a 2.5:1; 51 mg (25%) of trimer 3-34a. 
 
Dimerisation of 3-1a in DME 
The reaction was performed according to the general procedure in 15 mL of dry DME. Flash 
chromatography (hexane/ethyl acetate 80:1 gradient to 10:1) afforded ferrocene, followed by 
meso-3-3a, a mixture of meso-3-3a and d,l-3-3a, and finally a mixture of d,l-3-3a and trimer 
3-34a. Yield: 106 mg (54%) meso-3-3a:d,l-3-3a 1:1.8; 2.2 mg (2%) trimer 3-34a. 
 
Dimerisation of 3-1a in 85% DME and 15% HMPA 
The reaction was performed according to the general procedure in 15 mL of dry DME/HMPA 
5.7:1. Flash chromatography (hexane/ethyl acetate 80:1 gradient to 10:1) afforded ferrocene, 
followed by a mixture of meso-3-3a and d,l-3-3a. Yield: 12 mg (16%). The ratio meso-3-
3a:d,l-3-3a could not be calculated from the NMR spectra. 
 
Dimerisation of 3-1a in DME in the presence of 0.4 equivalents of TEMPO 
The deprotonation of 3-1a (195 mg, 1.5 mmol) was performed in 15 mL of dry DME 
according to the general procedure. TEMPO 1-2 (93.6 mg, 0.6 mmol) was added at –78 °C 
and the reaction mixture was stirred for 5 min. Addition of 550 mg (1.7 mmol) of 1-3 and 
workup were performed according to the general procedure. Flash chromatography 
(hexane/ethyl acetate 80:1 gradient to 10:1) afforded ferrocene, followed by 3-2a, a mixture 
3-2a, meso-3-3a and β-ketoester 3-35a, d,l-3-3a, and finally a mixture of d,l-3-3a and trimer 
3-34a. Yield by NMR: 124 mg (29%) of 3-2a; 78 mg (40%) meso-3-3a:d,l-3-3a 1:1.5; β-
ketoester 3-35a 12 mg (6%); 46 mg (23%) trimer 3-34a. 
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4,6-Diethyl (4S*,5S*,6R*)-5-butyl-5-hydroxynonane-4,6-dioate (meso-3-34a):  
OH
Bu
EtOOC COOEt
OH
Bu
EtOOC COOEt
or
 
1H NMR (400 MHz): δ = 0.87 (m, 6H, 2xCH2CH2CH3), 1.24 (t, J = 7.1 Hz, 6H, 
2xOCH2CH3), 1.07-1.38 (m, 8H, 2xCHCH2CH2CH3, CH3(CH2)2CH2COH), 1.47  (m, 2H, 
CHCH2), 1.62 (m, 2H, CH2COH), 1.74 (m, 2H, CHCH2), 2.57 (dd, J = 11.7, 2.9 Hz, 2H, 
2xCHCOH), 4.06-4.18 (m, 4H, OCH2). - 13C NMR (100 MHz): δ = 13.9 (q, CH3CH2CH2), 
14.2 (q, OCH2CH3), 21.3 (t, CHCH2CH2CH3), 23.4 (t, CH3CH2(CH2)2), 25.8 (t, 
CH2CH2COH), 29.7 (t, CHCH2), 34.7 (t, CH2COH), 52.9 (d, CHCOH), 60.4 (t, OCH2CH3), 
75.5 (s, COH), 175.3 (s, CO). 
 
2,2’-Bi(2-oxocyclohexyl) 3-12f 
O O
meso-3-12f
O O
dl-3-12f  
 
Dimerisation of cyclohexanone according to the general procedure 
The reaction was performed with 3-10f (147 mg, 1.5 mmol) according to the general 
procedure. Flash chromatography (hexane/ethyl acetate 50:1 gradient to 2:1) afforded 
ferrocene, followed by d,l-3-12f, a mixture of d,l-3-12f and meso-3-12f, and finally meso-3-
12f. Yield: 125 mg (86%) meso-3-12f:d,l-3-12f 1:1.1. 
 
Dimerisation of cyclohexanone 3-10f in the presence of LiCl 
LiCl (399.5 mg, 9.4 mmol) was flame dried 3-4 times in vacuo. After cooling, it was 
dissolved in 19 mL of dry THF under a nitrogen atmosphere. Dry diisopropylamine (0.336 
mL, 2.6 mmol) and BuLi (1.625 mL, 1.6M in hexane, 2.6 mmol) were added, at –78 °C. After 
stirring for 30 min, 3-10f (196 mg, 2 mmol) dissolved in 1 mL of THF was added at –78 °C 
and stirring was continued for 30 min 1-3 was added in portions at –78 °C as the blue colour 
of the oxidant vanished in the reaction mixture. Addition was continued to a total amount of 
1.01 g (3.05 mmol) when a deep blue colour persisted in the solution for 10 min. The reaction 
was quenched with a few drops of water, diluted with diethyl ether and warmed to r.t. The 
reaction mixture was filtered through silica gel. The solvent was concentrated in vacuo and 
the crude mixture was preadsorbed on silica gel. Flash chromatography (hexane/ethyl acetate 
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50:1, gradient to 2:1) afforded ferrocene, followed by d,l-3-12f, and finally a mixture of d,l-3-
12f and meso-3-12f. Yield: 110 mg (56%) meso-3-12f:d,l-3-12f 1.2:1. 
 
Dimerisation of cyclohexanone in the presence of HMPA 
BuLi (1.625 mL, 1.6M in hexane, 2.6 mmol) was added to a solution of dry diisopropylamine 
(0.336 mL, 2.6 mmol) in 19 mL of dry THF at –78 °C. After stirring for 30 min, 3-10f (196 
mg, 2 mmol) dissolved in 1 mL of THF was added at –78 °C and stirring was continued for 
30 min. HMPA (2.1 mL, 12 mmol) was added via syringe and the solution was stirred for 5 
min. 1-3 was added in portions at –78 °C as the blue colour of the oxidant vanished in the 
reaction mixture. Addition was continued to a total amount of 980 g (3 mmol) when a deep 
blue colour persisted in the solution for 10 min. The reaction was quenched with a few drops 
of water, diluted with diethyl ether and warmed to r.t. The reaction mixture was filtered 
through a pad of silica gel. The solvent was concentrated in vacuo and the crude mixture was 
preadsorbed on silica gel. Flash chromatography (hexane/ethyl acetate 50:1, gradient to 2:1 
afforded ferrocene), followed by d,l-3-12f, and finally a mixture of d,l-3-12f and meso-3-12f. 
Yield: 130 mg (67%) meso-3-12f:d,l-3-12f 1:1. 
IR (ATR): v~  = 2932 (m), 2861 (w), 1700 (s), 1449 (w), 1312 (w), 1218 (w), 1129 (m), 1022 
(w), 833 (w) cm-1. - MS (EI) m/z (%): 194 (34) [M+], 176 (17) [M+−H2O], 169 (12), 148 (39), 
137 (25), 125 (20), 111 (36) [M+H+−2CH2CO·]+, 98 (100) [cyclohexanone + H]+, 81 (50), 69 
(59), 57 (76). Combustion analysis: C12H18O2 (194.27): calc. C 74.19, H 9.34; found: C 73.95, 
H 9.48. - d,l-3-12f: Rf(hexane/ethyl acetate 2:1) = 0.48. - 1H NMR (400 MHz): δ = 1.26 (dq, J 
= 3.6, 12.6 Hz, 2H, CHCH2), 1.48-1.60 (m, 2H, CH2CH2CO), 1.65 (tq, J = 3.5, 12.9 Hz, 2H, 
CH2CH2CH), 1.83 (m, 2H, CH2CH2CH), 1.95-2.07 (m, 4H, CHCH2CH2CH2), 2.33 (m, 4H, 
CH2CO), 2.83 (m, 2H, CHCO). - 13C NMR (100 MHz): δ = 25.4 (t, CH2), 28.0 (t, CH2), 30.1 
(t, CH2), 42.3 (t, CH2CO), 48.9 (d, CHCO), 211.8 (s, CO). - meso-3-12f: Rf(hexane/ethyl 
acetate 2:1) = 0.42. - 1H NMR (400 MHz): δ = 1.53-1.76 (m, 6H), 1.86-2.11 (m, 6H), 2.27 (m, 
2H, CH2CH), 2.39 (m, 2H, CH2CO), 2.63 (m, 2H, CHCO). - 13C NMR (100 MHz): δ = 24.8 
(t, CH2), 26.3 (t, CH2), 28.9 (t, CH2), 41.6 (t, CH2CO), 50.1 (d, CHCO), 210.5 (s, CO). 
 
Bi(1,7,7-trimethyl-2-oxobicyclo[2.2.1]hept-3-yl)s 3-12h  
BuLi (0.812 mL, 1.6M in n-hexane, 1.3 mmol) was added to a solution of dry iPr2NH (0.183 
mL, 1.3 mmol) in 9 mL dry THF at −78 °C under a nitrogen atmosphere. After stirring for 20 
min a solution of  1-(R)-camphor 3-10h (152 mg, 1 mmol) in 1 mL dry THF was added. After 
stirring for 30 min at −78 °C, 1-3 was added in portions as it was consumed. Addition was 
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performed until the blue colour of the mixture persisted for at least 10 min (total amount 440 
mg, 1.3 mmol). The reaction was monitored by TLC. The reaction mixture was quenched 
with a few drops of water, warmed to r.t., and diluted with diethyl ether. The mixture was 
filtered through a pad of silica gel, concentrated in vacuum and preadsorbed on a silica gel. 
Flash chromatography (hexane/ethyl acetate 5:1, gradient to 1:1) afforded ferrocene, followed 
by a mixture of 3,3’-exo,endo-3-12h and 3,3’-endo,endo-3-12h, which were not separable, 
and finally 3,3’-exo,exo-3-12h. Yield: 66% (100 mg), d.r. 3,3’-exo,endo-3-12h:3,3’-
endo,endo-3-12h:3,3’-exo,exo-3-12h 2.2:1.8:1. A second experiment with 2 mmol of 1-(R)-
camphor 3-10h under similar conditions afforded 200 mg of dimer (66% yield) with a d.r. 
3,3’-exo,endo-3-12h:3,3’-endo,endo-3-12h:3,3’-exo,exo-3-12h 1.7:1:1.8. Isomers 3,3’-
exo,endo-3-12h and 3,3’-endo,endo-3-12h were not separable and were analysed as a mixture. 
O O
HH
3,3'-exo,endo-3-12h 3,3'-endo,endo-3-12h
O
H
3,3'-exo,exo-3-12h
O
H
OO
H H
 
IR (ATR): v~  = 2958 (m), 2931 (m), 2872 (w), 1730 (s), 1482 (w), 1447 (w), 1392 (w), 1373 
(w), 1323 (w), 1266 (w), 1044 (m), 1026 (m), 749 (w), 655 (w), 568 (w) cm-1. - MS (EI) m/z 
(%): 302 (89) [M+], 274 (100) [M+−CH2=CH2], 259 (67) [M+−(CH3)2CH], 246 (10) 
[M+−2xCH2=CH2], 231 (27), 203 (18), 193 (27) [MH+−1,5,5-trimethyl-1,3-cyclopentadiene], 
191 (24), 163 (28), 151 (56) [(R)-Camphor+], 123 (22) [(R)-Camphor−CH2=CH2], 121 (26), 
108 (47) [1,5,5-trimethyl-1,3-cyclopentadiene], 83 (54) [COCH=CHCO· + H]+, 79 (31), 55 
(56) [CH3C=C=O+], 43 (15) [(CH3)2CH+]. - Combustion analysis: C20H30O2 (302.45): calc. C 
79.42, H 10.00; found: C 79.47, H 10.38. 
(1R,1R’,3R,3R’,4R,4R’)-Bi(1,7,7-trimethyl-2-oxobicyclo[2.2.1]hept-3-yl) (3,3’-endo,endo-
3-12h): Rf(hexane/ethyl acetate 5:1) = 0.59. - m.p. 20-22 °C. - 1H NMR (400 MHz): δ = 0.85 
(s, 12H, C(CH3)2), 0.97 (s, 6H, CH2CCH3), 1.60 (m, 4H, CH2CH2CH), 1.79 (m, 4H, 
CHCH2CH2), 1.96 (m, 2H, CH2CHCH), 2.43 (m, 2H, CHCO). - 13C NMR (100 MHz): δ = 9.7 
(q, CH2CCH3), 19.4 (q, C(CH3)2), 19.9 (q, C(CH3)2), 22.2 (t, CH2CCH3), 30.5 (t, 
CHCH2CH2), 45.7 (s, CCH3), 49.0 (d, CHCHCO), 49.1 (d, CHCO), 59.2 (s, CCH3), 218.7 (s, 
CO). 
(1R,1R’,3R,3S’,4R,4R’)-Bi(1,7,7-trimethyl-2-oxobicyclo[2.2.1]hept-3-yl) (3,3’-endo,exo-3-
12h): Rf(hexane/ethyl acetate 5:1) = 0.43. - m.p. 21-22 °C. - 1H NMR (400 MHz): δ = 0.77 (s, 
3H, C(CH3)2), 0.82  (s, 3H, C(CH3)2), 0.85 (s, 6H, C(CH3)2), 0.91 (s, 3H, CH2CCH3), 0.95 (s, 
3H, CH2CCH3), 1.21 (m, 1H, CH2CCO endo-part), 1.38 (m, 2H, CHCH2CH2 exo-part), 1.61 
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(m, 2H, CH2CCO endo-part+exo-part), 1.76 (m, 1H, CH2CH endo-part), 1.87 (m, 2H, 
CH2CHCHCO endo-part), 2.01 (m, 1H, CH2CH exo-part), 2.35 (t, J = 4.3 Hz, 1H, CHCO 
exo-part), 2.42 (m, 1H, CHCO endo-part), 2.67 (d, J = 4.0 Hz, 1H, CHCHCO exo-part). - 13C 
NMR (100 MHz): δ = 9.51 (q, CH2CCH3), 9.55 (q, CH2CCH3), 19.1 (q, C(CH3)2), 19.5 (q, 
C(CH3)2), 20.3 (q, C(CH3)2), 21.2 (t, CH2CH endo-part), 21.8 (q, C(CH3)2), 28.9 (t, 
CHCH2CH2 exo-part), 29.2  (t, CH2CCH3 exo-part), 30.6 (t, CH2CCH3 endo-part), 45.2 (s, 
CCH3), 46.3 (s, CCH3), 46.5 (d, CHCHCO exo-part), 46.6  (d, CHCO exo-part), 51.6 (d, 
CHCO endo-part), 51.7 (d, CHCHCO endo-part), 57.4 (s, CCH3), 58.4 (s, CCH3), 219.6 (s, 
CO), 220.6 (s, CO). 
(1R,1R’,3S,3S’,4R,4R’)-Bi(1,7,7-trimethyl-2-oxobicyclo[2.2.1]hept-3-yl) (3,3’-exo,exo-3-
12h): Rf(hexane/ethyl acetate 5:1) = 0.59. - m.p. 20-22 °C. - 1H NMR (400 MHz): δ = 0.72 (s, 
6H, C(CH3)2), 0.87 (s, 6H, CH2CCH3), 0.90 (s, 6H, C(CH3)2), 1.28 (ddd, J = 12.5, 9.0, 3.7 Hz, 
2H, CH2CH2CH), 1.48-1.64 (m, 4H, CH2CCO), 1.95 (ddd, J = 16.7, 10.9, 4.5 Hz, 2H, 
CHCH2CH2), 2.00 (s, 2H, CHCO), 2.08 (d, J = 4.1 Hz, 2H, CH2CHCH). - 13C NMR (100 
MHz): δ = 9.4 (q, CH2CCH3), 20.0 (q, C(CH3)2), 21.0 (q, C(CH3)2), 28.8 (t, CH2CCH3), 29.0 
(t, CHCH2CH2), 46.8 (d, CHCHCO), 54.2 (d, CHCO), 57.3 (s, CCH3), 219.3 (s, CO). 
 
d,l- and meso-2,3-Dimethyl-1,4-diphenyl-1,4-butandione 3-12a 
O
Ph
O
Ph
O
Ph
O
Ph
 
Combustion analysis: C18H18O2 (266.33): calc. C 81.17, H 6.81; found C 80.89, H 6.90. - d,l-
3-12a: Rf = 0.4 (hexane/EtOAc 5:1). - 1H NMR (200 MHz): δ = 1.19 (m, 6H, CHCH3), 3.89 
(m, 2H, CH), 7.16-7.48 (m, 6H, arom. CH), 7.93 (m, 4H, arom. CH). - 13C NMR (50 MHz): δ 
= 15.5 (q, CH3), 43.6 (d, CH), 128.4 (d, arom. CH), 128.6 (d, arom. CH), 132.9 (d, arom. 
CH), 136.1 (s, arom. C), 204.2 (s, CO). - meso-3-12a: Rf = 0.5 (hexane/EtOAc 5:1). - 1H 
NMR (200 MHz): δ = 1.08 (m, 6H, CHCH3), 3.98 (m, 2H, CH), 7.38-7.58 (m, 6H, arom. 
CH), 7.99 (m, 4H, arom. CH). - 13C NMR (50 MHz): δ = 17.4 (q, CH3), 43.3 (d, CH), 128.4 
(d, arom. CH), 128.8 (d, arom. CH), 133.3 (d, arom. CH), 136.8 (s, arom. C), 203.7 (s, CO). 
 
1-Phenyl-2-chloro-1-propanone 3-63a171 
O
Ph
Cl  
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1H NMR (400 MHz): δ = 1.74 (d, J = 6.7 Hz, 3H, CHCH3), 5.26 (d, J = 6.7 Hz, 1H, CH), 
7.44-7.65 (m, 3H, arom. CH), 8.04 (m, 2H, arom. CH). - 13C NMR (100 MHz): δ = 19.9 (q, 
CH3), 52.8 (d, CH), 128.7 (d, arom. CH), 129.0 (d, arom. CH), 133.7 (d, arom. CH), 134.1 (s, 
arom. C), 193.6 (s, CO). 
 
d,l- and meso-2,3-Diethyl-1,4-diphenyl-1,4-butandione 3-12b: 
O
Ph
O
Ph
O
Ph
O
Ph
 
d,l-3-12b: Rf = 0.5 (hexane/EtOAc 5:1). - 1H NMR (200 MHz): δ = 0.81 (t, J = 7.5 Hz, 6H, 
CH2CH3), 1.69-1.88 (m, 4H, CH2CH3), 4.07 (m, 2H, CHCH2), 7.36-7.54 (m, 6H, Ph), 7.97 
(m, 4H, Ph). - 13C NMR (50 MHz): δ = 10.1 (q, CH3), 21.9 (t, CH2CH3), 46.5 (d, CH), 128.2 
(d, Ph), 128.3 (d, Ph), 132.6 (d, Ph), 137.4 (s, Ph), 203.9 (s, CO). - MS (+ESI): m/z (%) = 611 
(3) [3M+Na+], 317 (100) [M+Na+], 295 (13) [M+H+]. - HRMS: C20H23O2+: calc. 295.1698; 
found: 295.1693; C20H22O2Na+: calc. 317.1517; found 317.1512. - Combustion analysis: 
C20H22O2 (294.39): calc. C 81.60, H 7.53; found C 81.42, H 7.50. - meso-3-12b detectable 
resonances: Rf = 0.57 (hexane/EtOAc 5:1). - 1H NMR (200 MHz): δ = 0.69 (t, J = 7.4 Hz, 6H, 
CH2CH3), 1.69-1.88 (m, 4H, CH2CH3), 3.94 (m, 2H, CHCH2), 7.36-7.54 (m, 6H, Ph), 8.07 
(m, 4H, Ph). - 13C NMR (50 MHz): δ = 11.5 (q, CH3), 25.2 (t, CH2CH3), 48.8 (d, CH), 128.6 
(d, Ph), 138.3 (s, Ph), 203.9 (s, CO). - MS (EI): m/z (%) = 294 (2) [M+], 276 (10), 261 (3), 
189 (3) [M+–PhCO], 161 (6), 148 (25), 105 (100) [PhCO+], 77 (45) [Ph+], 51 (7). - HRMS: 
C20H22O2+: calc. 294.1620; found 295.1616. 
 
meso- and d,l-N,N,N’,N’-Tetraethyl-2,3-dipropylsuccindiamide 3-60 
Pr Pr
NEt2
O
Et2N
O
Pr Pr
NEt2
O
Et2N
O
meso-3-60 d,l-3-60  
d,l-3-60: 1H NMR (400 MHz): δ = 0.86 (t, J = 7.3 Hz, 6H, CH2CH2CH3), 1.00 (t, J = 7.0 Hz, 
6H, NCH2CH3), 1.11 (t, J = 7.2 Hz, 6H, NCH2CH3), 1.09-1.26 (m, 4H, CH2CH2CH3), 1.56 
(m, 4H, CH2CH), 2.86 (m, 2H, CHCONEt2), 3.06-3.20 (m, 4H, NCH2), 3.31 (dq, J = 13.6, 6.8 
Hz, 2H, NCH2), 3.59 (dq, J = 14.7, 7.3 Hz, 2H, NCH2). - 13C NMR (100 MHz): δ = 13.0 (q, 
CH3CH2CH2), 14.4 (q, NCH2CH3), 14.6 (q, NCH2CH3), 20.6 (t, CH2CH2CH3), 33.5 (t, 
CHCH2CH2), 40.3 (t, NCH2CH3), 42.2 (t, NCH2CH3), 43.8 (d, CHCO), 174.2 (s, CO). - meso-
3-60: 1H NMR (400 MHz): δ = 0.79 (t, J = 7.1 Hz, 6H, CH2CH2CH3), 1.11 (t, J = 7.0 Hz, 6H, 
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NCH2CH3), 1.16 (t, J = 7.1 Hz, 6H, NCH2CH3), 1.05-1.33 (m, 6H, CH2CH2CH3), 1.54 (m, 
2H, CH2CH), 2.95 (m, 2H, CHCONEt2), 3.39 (2xdq, J = 14.4, 7.1 Hz, 8H, 4xNCH2). - 13C 
NMR (50 MHz): δ = 12.8 (q, CH3CH2CH2), 14.3 (q, NCH2CH3), 14.7 (q, NCH2CH3), 20.9 (t, 
CH2CH2CH3), 34.6 (t, CHCH2CH2), 40.4 (t, NCH2CH3), 42.0 (t, NCH2CH3), 44.9 (d, CHCO), 
174.3 (s, CO). 
 
N,N-Diethyl-2-pentenoic amide 3-61 
O
NEt2 
Detectable resonances: - 1H NMR (400 MHz): δ = 2.19 (m, 2H, CH2CH=), 6.14 (dt, J = 15.0, 
1.6 Hz, 1H, CH2CH=), 6.91 (dt, J = 15.0, 6.5 Hz, 1H, CH=CHCO). - 13C NMR (100 MHz): δ 
= 12.6 (q, CH3CH2CH), 25.5 (t, CHCH2CH3), 119.5 (d, CH=), 147.4 (d, CH=). 
 
2-(N’,N’-Diisopropylamino)-N,N-diethylvaleric amide 3-62 
O
NEt2
NiPr2  
1H NMR (400 MHz): δ = 0.87 (t, J = 7.3 Hz, 3H, CH2CH2CH3), 0.99 (d, J = 6.7 Hz, 6H, 
NCH(CH3)2), 1.00 (d, J = 6.6 Hz, 6H, NCH(CH3)2), 1.04 (t, J = 7.1 Hz, 3H, NCH2CH3), 1.15 
(t, J = 7.1 Hz, 3H, NCH2CH3), 1.25 (m, 2H, CH2CH2CH3), 1.49 (m, 1H, CH2CH), 1.60 (m, 
1H, CH2CH), 3.10 (dq, J = 13.6, 6.8 Hz, 1H, NCH2), 3.19 (dq, J = 14.6, 7.3 Hz, 1H, NCH2), 
3.36 (sept, J = 6.6 Hz, 2H, 2xNCH(CH3)2), 3.48 (m, 1H, NCH2), 3.51 (t, J = 6.9 Hz, 1H, 
NCHCH2), 3.62 (dq, J = 14.5, 7.2 Hz, 1H, NCH2). - 13C NMR (100 MHz): δ = 12.6 (q, 
CH3CH2CH2), 14.2 (q, NCH2CH3), 14.5 (q, NCH2CH3), 20.3 (t, CH2CH2CH3), 22.9 (q, 
NCHCH3), 23.3 (q, NCHCH3), 32.6 (t, CHCH2CH2), 39.9 (t, NCH2CH3), 41.2 (t, NCH2CH3), 
45.4 (d, NCH(CH3)2), 54.9 (d, CHCO), 174.6 (s, CO). 
 
Dimerisation of ethyl valerate 3-1a with substoichiometric amounts of TEMPO 1-2 
Method A: In five Schlenk flasks five experiments were performed in parallel. BuLi (1.21 
mL, 1.6M in hexane, 1.95 mmol) was added to a solution of dry iPr2NH (0.275 mL, 1.95 
mmol) in 14 mL dry THF at –78 °C. After stirring at –78 °C for 0.5 h, 3-1a (195 mg, 1.5 
mmol) dissolved in 1 mL of THF was added at –78 °C. The mixture was stirred at –78 °C for 
0.5 h, and TEMPO 1-2 (flask1: 23.4 mg, 0.15 mmol; flask 2: 46.8 mg, 0.3 mmol; flask 3: 70.2 
mg, 0.45 mmol; flask 4: 93.6 mg, 0.6 mmol; and flask 5: 117 mg, 0.75 mmol) was added as a 
solid at –78 °C and the mixtures were stirred for 5 min. Ferrocenium hexafluorophosphate 1-3 
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was added in small portions at –78 °C consecutively to each of the flasks until a deep blue 
colour persisted in the reaction mixtures for at least 10 min. The total amounts of 1-3 for 0.15 
mmol TEMPO to 0.75 mmol TEMPO were 853 mg, 963 mg, 923 mg, 923 mg and 883 mg, 
respectively. The progress of the reactions was monitored by TLC (hexane/EtOAc 10:1). The 
reactions were consecutively quenched with a few drops of water, diluted with diethyl ether, 
warmed to r.t. and filtered through a pad of silica gel, which was washed with diethyl ether. 
The solvent was evaporated in vacuo. The inhomogeneous mixtures were preadsorbed on 
silica gel. Flash chromatography (hexane/ethyl acetate 80:1, gradient to 10:1) afforded 
ferrocene, followed by a mixture of ferrocene, 3-2a and meso-3-3a, a mixture of 3-2a and 
meso-3-3a, and finally a mixture of meso-3-3a and d,l-3-3a. For yields and diastereomeric 
ratios see Table 3.34.  
 
Method B: In five Schlenk flasks five experiments were performed in parallel. Generation of 
the enolate of 3-1a (195 mg, 1.5 mmol) in each of the five flasks was performed as in method 
A.  
During deprotonation, 46.8 mg (0.3 mmol), 70.2 mg (0.45 mmol), 93.6 mg (0.6 mmol) or 117 
mg (0.75 mmol), respectively, of TEMPO 1-2 was homogeneously mixed with 1-3 (496 mg, 
1.5 mmol) in five vials. These mixtures were added in small portions at –78 °C consecutively 
to each of the reaction mixtures. Subsequently 331 mg of 1-3 was additionally added to each 
of the flasks and a deep blue colour persisted in the reaction mixtures. The progress of the 
reactions was monitored by TLC (hexane/EtOAc 10:1). Workup was performed as in method 
A. For yields and diastereomeric ratios see Table 3.35.  
 
Method C: In five Schlenk flasks five experiments were performed in parallel. Generation of 
the enolate of 3-1a (195 mg, 1.5 mmol) in each of the five flasks was performed as in method 
A.  
During deprotonation, 23.4 (0.15 mmol), 46.8 mg (0.3 mmol), 70.2 mg (0.45 mmol) and 93.6 
mg (0.6 mmol), respectively, TEMPO was homogeneously mixed with 496 mg (1.5 mmol) of 
1-3 in five vials. To each of the flasks 23.4 mg (0.15 mmol) TEMPO was added and these 
mixtures were stirred for 5 min. The mixtures of 1-2 and 1-3 were added in small portions 
consecutively to each of the flasks at –78 °C. Subsequently, 100 mg of 1-3 was added to each 
of the flasks and a deep blue colour persisted in the reaction mixtures. The progress of the 
reactions was monitored by TLC (hexane/EtOAc 10:1). The workup was performed as in 
method A. For yields and diastereomeric ratios see Table 3.36.  
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Dimerisation of the silyl ketene acetal E-3-75 (General procedure) 
To a solution of E-3-75 (E:Z 4:1, 0.362 mL, 1.5 mmol) in 5 mL dry CH2Cl2 1-3 was added in 
portions at r.t. The first two portions were consumed as it was observed by the disappearance 
of the deep blue colour. At further addition of 1-3 (total amount 510 mg, 1.54 mmol) the 
reaction mixture remained dark blue. The reaction mixture was stirred for 10.5 h. The reaction 
was quenched with a few drops of water, diluted with diethyl ether and filtered through a pad 
of silica gel. Flash chromatography with hexane/ethyl acetate 80:1, gradient to 5:1 afforded 
ferrocene (70 mg, 0.38 mmol) followed by 30 mg of meso-3-3a, 5 mg of a mixture of meso-3-
3a and d,l-3-3a, and finally 20 mg of d,l-3-3a. Yield: 28%, d.r. meso-3-3a:d,l-3-3a 1.3:1. 
 
Dimerisation of E-3-75 in the presence of diisopropylamine 
To a solution of E-3-75 (E:Z 4:1, 304 mg, 1.5 mmol) in 5 mL dry CH2Cl2 iPr2NH (0.423 mL, 
3 mmol) was added via syringe at r.t. 1-3 was added in portions. The first two portions were 
consumed in 5 min for each as it was observed by the disappearance of the deep blue colour. 
The third portion was consumed in 15 min (total 100 mg). Addition of 1-3 was continued 
until 580 mg (1.7 mmol) was consumed during 1.5 h. Further 3 mL of solvent and 110 mg of 
1-3 was added. After a total oxidation time of 2.5 h, the reaction was quenched with a few 
drops of water, diluted with diethyl ether and filtered through a pad of silica. Flash 
chromatography (hexane/ethyl acetate 50:1, gradient to 5:1) afforded ferrocene (110 mg, 0.59 
mmol) followed by meso-3-3a and d,l-3-3a. Yield: 10% (20 mg), the meso-3-3a:d,l-3-3a ratio 
could not be determined from the NMR spectrum. 
 
Dimerisation of the silyl ketene acetal E-3-75 after transmetallation with MeLi  
To a solution of E-3-75 (E:Z 4:1, 210 mg, 1.03 mmol) in 10 mL dry THF MeLi (1.6M in 
Et2O, 0.643 mL, 1.03 mmol) was added at –30 °C. The reaction was stirred at –30 °C for 5 
min and at r.t. for further 90 min. The solution was cooled to –78 °C and 1-3 was added in 
portions. After addition of 290 mg of oxidant (0.88 mmol), which was consumed in 5 min, the 
solution turned to dark blue. This colour persisted in the solution for the next 5-10 min, after 
which another portion of 60 mg of oxidant was added. Stirring was continued at –78 °C for 20 
min. The reaction was quenched with a few drops of water, diluted with diethyl ether and 
warmed to r.t. The reaction mixture was filtered through a pad of silica gel. The mixture was 
preadsorbed on silica gel and the solvent was removed in vacuum. Flash chromatography with 
hexane/ethyl acetate 50:1 gradient to 2:1 afforded a mixture of ferrocene and meso-3-3a, 
followed by a mixture of meso-3-3a and d,l-3-3a, and finally a mixture of d,l-3-3a and trimer 
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3-34a. The yields were determined from the NMR spectra: 3-3a 74 mg (56%) meso:d,l 1.8:1; 
3-34a 12 mg (10%). Similar experiments were performed under slightly different conditions. 
For conditions and yields see Table 3.39, entries 1-8.  
 
Dimerisation of silyl ketene acetal E-3-75 after transmetallation with MeLi and in the 
presence of diisopropylamine 
To a solution of E-3-75 (E:Z 4:1, 210 mg, 1.03 mmol) in 10 mL dry THF MeLi (1.6M in 
Et2O,  0.812 mL, 1.3 mmol) was added at –30 °C. The reaction was stirred at –30 °C for 5 
min and at r.t. for further 90 min. The solution was cooled to –78 °C and diisopropylamine 
(0.183 mL, 1.3 mmol) was added via syringe. 1-3 was added in portions (total amount 320 
mg, 0.97 mmol) at –78 °C over 15 min until a dark blue colour persised in the solution for at 
least 10 min. The reaction was quenched with a few drops of water, diluted with diethyl ether 
and warmed to r.t. The reaction mixture was filtered through a pad of silica gel. The mixture 
was preadsorbed on silica gel and the solvent was removed in vacuum. Flash chromatography 
with hexane/ethyl acetate 100:1, gradient to 2:1 afforded ferrocene (160 mg, 0.86 mmol), 
followed by meso-3-3a, a mixture of meso-3-3a and d,l-3-3a, and finally a mixture of d,l-3-3a 
and trimer 3-34a. The yields were determined from the NMR spectra: 3-3a 75 mg (58%) 
meso:d,l 3.2:1; 3-34a 34 mg (20%). This experiment was repeated. The yields were 
reproducible, while the diastereoselectivities were very different. For yields see Table 3.39, 
entries 9-11.  
 
Dimerisation of silyl ketene acetal E-3-75 after transmetallation with MeLi in the 
presence of TEMPO 
To a solution of E-3-75 (E:Z 4.5:1, 210 mg, 1.03 mmol) in 10 mL dry THF MeLi (1.6M in 
Et2O,  0.812 mL, 1.3 mmol) was added at –30 °C. The reaction was stirred at –30 °C for 5 
min and at r.t. for further 90 min. The solution was cooled to –78 °C and TEMPO (47 mg, 0.3 
mmol) was added and the solution was stirred for 5 min. Ferrocenium hexafluorophosphate 
was added in portions (total amount 350 mg, 1.06 mmol) at –78 °C over 15 min until a dark 
blue colour persised in the solution for at least 10 min. The reaction was quenched with a few 
drops of water, diluted with diethyl ether and warmed to r.t. The reaction mixture was filtered 
through a pad of silica gel. Flash chromatography (hexane/ethyl acetate 80:1 gradient to 2:1) 
afforded ferrocene, followed by a mixture of ferrocene, TEMPO trapping product 3-2a and 
meso-3-3a, a mixture of TEMPO trapping product 3-2a and meso-3-3a, and finally a mixture 
of d,l-3-3a and trimer 3-34a. Further purification was necessary. The yields were determined 
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from the NMR spectra: 77 mg (27%) 3-2a, 20 mg (15%) meso:d,l 4.6:1 3-3a; 36 mg (32%) 3-
34a. This experiment was repeated. The results were not well reproducible. For yields and 
conditions see Table 3.39, entries 12-14.  
 
6.9. Total syntheses of 15-F2t-isoprostane, 13,14-dihydro-15-oxo-15-E2-isoprostane and 
13,14-dihydro-15-oxo-15-prostaglandin-E2 
 
6.9.1 Substrate Synthesis 
 
 (2E,4E)-Ethyl 2,4-decadienoate (2E,4E)-4-14172a,b,d 
H11C5 OEt
O
 
A solution of 15 g (76.4 mmol) of (2E,4Z)-ethyl 2,4-decadienoate172c,d (2E,4Z)-4-13 and 0.83 
g (5 mol%) Ph2S2 in 225 mL benzene was irradiated with UV light of a 150 W quartz lamp 
under a nitrogen atmosphere for 3 h. The solvent was evaporated and the crude mixture was 
dried in high vacuum for 20 min. Distillation at 0.9 mbar gave 12.05 g pure ester, bp 83-93 
°C/0.9 mbar. The brown residue (5.3 g) was purified by flash chromatography (hexane/ethyl 
acetate 20:1 gradient 10:1) to give 1.2 g of the pure ester contaminated with 0.75 g of Ph2S2. 
Yield 88% yield (13.25 g), (2E,4E):(2E,4Z) 8.3:1. 
A second isomerisation with 15 g of (2E,4Z)-4-13 gave 11.8 g (79% yield) (2E,4E):(2E,4Z) 
8.3:1. The distillation gave 10.4 g of pure ester, but longer heating at higher temperatures (up 
to 140 °C) led to decomposition. Column chromatography of the distillation residue with 
hexane/ethyl acetate 20:1 gave 2.07 g containing 1.47 g ester and 0.59 g of Ph2S2. The 
presence of Ph2S2 did not disturb the reduction to (2E,4E)-4-15 and its purification. 
Rf (hexane/ethyl acetate 20:1) = 0.34. - bp 90-93 °C/0.9 mbar. - 1H NMR (300 MHz, CDCl3): 
δ = 0.89 (t, J = 6.8 Hz, 3H, CH2CH2CH3), 1.22-1.50 (m, 9H, CH2CH2CH2CH3, OCH2CH3), 
2.15 (m, 2H, CH2CH=), 4.19 (q, J = 7.1 Hz, 2H, OCH2CH3), 5.78 (d, J = 15.3 Hz, 1H, 
CH=CHCO2Et), 6.14 (m, 2H, CH2CH=CH), 7.25 (dd, J = 10.1, 15.4 Hz, 1H, CH=CHCO2Et). 
- 13C NMR (75 MHz, CDCl3): δ = 13.9 (q, OCH2CH3), 14.3 (q, CH2CH3), 22.4 (t, CH2CH3), 
28.4 (t, CH2CH2CH2CH3), 31.3 (t, CH2CH2CH2CH3), 32.9 (t, CH2CH=), 60.1 (t, OCH2CH3), 
119.1 (d, =CHCO2Et), 128.3 (d, =CHCH=CHCO2Et), 144.7 (d, CH2CH=), 145.1 (d, 
CH=CHCO2R), 167.3 (s, CO2Et). 
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(2E,4E)-Deca-2,4-dien-1-ol (2E,4E)-4-15 
OH  
To a solution of (2E,4E)-4-14 (11.87 g, 60.6 mmol) and residual of Ph2S2 (0.59 g, 2.7 mmol) 
in 250 mL CH2Cl2 DIBAL-H (160 mL = 63 mL 1M in CH2Cl2 + 97 mL 1M in hexane, 160 
mmol) was added dropwise with a dropping funnel over 55 min at −78 °C. The reaction was 
monitored by TLC from a hydrolysed sample. After 1 h of stirring at −78 °C, the reaction was 
complete. It was quenched very slowly with 40 mL of saturated NH4Cl solution at −78 °C and 
warmed to r.t. The white suspension was dissolved by careful addition of 100 mL 2M solution 
of H2SO4 with stirring. The aqueous layer was extracted with diethyl ether (4x30 mL). The 
combined organic layers were washed twice with water, twice with NaHCO3 and twice with 
brine. Drying over Na2SO4 and concentration gave the crude product (10.15 g), which was 
purified by flash chromatography with hexane/ethyl acetate 20:1 gradient to 2:1 (the product 
eluted at 5:1). Colourless oil, yield 8.73 g (94%), (2E,4E):(2E,4Z) 14:1. A repetition afforded 
the product in 79% yield and ratio of (2E,4E):(2E,4Z) 6:1. 
Rf (hexane/ethyl acetate 5:1) = 0.25 - 1H NMR (300 MHz, CDCl3): δ = 0.88 (t, J = 6.8 Hz, 
3H, CH2CH3), 1.23-1.47 (m, 6H, CH2CH2CH2CH3), 1.59 (br. s, 1H, OH), 2.07 (q, J = 6.9 Hz, 
2H, CH2CH2CH2CH2CH3), 4.17 (d, J = 6.0 Hz, 2H, CH2OH), 5.71 (m, 2H, CH=CHCH=CH), 
6.04 (dd, J = 15.2, 10.5 Hz, 1H, CHCH=CHCH2OH), 6.21 (dd, J = 15.1, 10.4 Hz, 1H, 
CH=CHCH2OH). - 13C NMR (75 MHz): δ = 14.0 (q, CH2CH3), 22.5 (t, CH2CH3), 28.9 (t, 
CH2CH2CH2CH3), 31.4 (t, CH2CH2CH2CH3), 32.6 (t, CH2CH=), 63.5 (t, CH2OH), 129.3 (d, 
=CHCH=CHCH2OH), 132.1 (d, =CHCH2OH), 135.8 (d, CH2CH2CH=). 
 
(2E,4Z)-Deca-2,4-dien-1-ol (2E,4Z)-4-15 
OH
H11C5  
To a solution of (2E,4Z)-4-13 (5.0 g, 26 mmol) in 120 mL dry THF was added LiAlH4 (1.03 
g, 27 mmol) at 0 °C under a N2 atmosphere, carefully in small portions. The reaction was 
monitored by TLC and was quenched after completion carefully dropwise with water at the 
same temperature. The white aluminium salts were dissolved by careful addition of a 10% 
H2SO4 solution. The aqueous layer was extracted three times with diethyl ether. The 
combined organic layers were washed three times with NaHCO3 solution and brine. They 
were dried over NaSO4 and the solvent was removed in vacuum. The crude product (4.8 g) 
was purified by flash chromatography with hexane/ethyl acetate 20:1, gradient to 5:1. Yield 
2.8 g  (71%) as a colourless oil.  
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Rf (hexane/ethyl acetate 5:1) = 0.23 - 1H NMR (200 MHz, CDCl3): δ = 0.89 (t, J = 6.6 Hz, 
3H, CH2CH3), 1.24-1.45 (m, 6H, CH2CH2CH2CH3), 1.73 (br. s, 1H, OH), 2.14 (q, J = 7.2 Hz, 
2H, =CHCH2CH2), 4.19 (d, J = 5.9 Hz, 2H, CH2OH), 5.46 (m, 1H, CH2CH2CH), 5.80 (dt, J = 
15.1, 5.9 Hz, 1H, CHCH2OH), 5.99 (t, J = 10.9 Hz, 1H, CHCH=CHCH2OH), 6.53 (ddt, J = 
15.3, 11.1, 1.3 Hz, 1H, CH=CHCH2OH). - 13C NMR (50 MHz): δ = 14.0 (q, CH2CH3), 22.5 
(t, CH2CH3), 27.7 (t, CH2CH2CH2CH3), 29.3 (t, CH2CH2CH2CH3), 31.4 (t, CH2CH=), 63.5 (t, 
CH2OH), 126.8 (d, CHCH=CHCH2OH), 127.5 (d, CHCH=CHCH2OH), 131.5 (d, 
=CHCH2OH), 133.2 (d, CH2CH2CH=). 
 
(2E,4Z)- and (2E,4E)-Bromodeca-2,4-diene 4-16 and (3E)-5-bromodeca-1,3-diene (3E)-4-
17 
Method A: A solution of PBr3 (0.99 mL, 10.5 mmol) dissolved in 5 mL diethyl ether was 
added with a dropping funnel to a solution of (2E,4E)-4-15 (4.77 g, 31 mmol) in 30 mL dry 
diethyl ether at −20 °C over 30 min. The reaction was stirred at −15 °C for 1.5 h. Since the 
TLC didn’t change anymore, PBr3 (0.3 mL, 3.2 mmol) was added via syringe to the reaction 
mixture and it was warmed to 0 °C for 30 min. The spot on TLC having the same Rf as the 
alcohol did not disappear, but was not UV active. The reaction was quenched very carefully 
with 70 mL saturated NaHCO3 solution. The aqueous phase was extracted three times with 
diethyl ether. The combined ethereal phases were washed with water and brine, dried over 
Na2SO4, concentrated and dried in high vacuum. The crude 3.8:1 mixture of (2E,4E)-4-16 and 
(3E)-4-17 (6.06 g) was employed without further purification in the subsequent alkylation. 
Method B: A solution of PBr3 (0.73 mL, 7.8 mmol) dissolved in 5 mL CH2Cl2 was added with 
a dropping funnel to a solution of (2E,4E)-4-15 (3.5 g, 23 mmol) in 13 mL dry CH2Cl2 at −20 
°C over 15 min. The reaction was stirred at −10 °C for 0.5 h, when it was complete by TLC 
(hexane/ethyl acetate 5:1). The reaction mixture was carefully quenched with 20 mL saturated 
NaHCO3 solution. The aqueous phase was extracted with diethyl ether. The combined organic 
layers were washed with brine, dried over Na2SO4, and concentrated in vacuum. The crude 
1.7:1 mixture (4.5 g) of (2E,4E)-4-16 and (3E)-4-17 was purified on a short column with 
hexane/ethyl acetate 30:1, gradient to 5:1. Yield 3.33 g (67%) of (2E,4E)-4-16:(3E)-4-17 as a 
8.7:1 mixture at 30:1-20:1 followed by 0.64 g (18%) of (3E)-4-18 at 10:1. 
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(2E,4E)-1-Bromodeca-2,4-diene (2E,4E)-4-16 
Br  
Rf(hexane/ethyl acetate 5:1) = 0.24. - 1H NMR (300 MHz, CDCl3): δ = 0.88 (t, J = 7.0 Hz, 
3H, CH2CH3), 1.29 (m, 4H, CH2CH2CH3), 1.38 (m, 2H, CH2CH2CH=), 2.09 (q, J = 7.0 Hz, 
2H, CH2CH=), 4.03 (d, J = 8.0 Hz, 2H, CH2Br), 5.76 (m, 2H, CH=CHCH=CHCH2Br), 6.03 
(dd, J = 15.1, 10.7 Hz, 1H, CH=CHCH2Br or =CHCH=CHCH2Br), 6.26 (dd, J = 15.1, 10.8 
Hz, 1H, CH=CHCH2Br or =CHCH=CHCH2Br). - 13C NMR (75 MHz): δ = 14.0 (q, CH2CH3), 
22.5 (t, CH2CH3), 28.7 (t, CH2CH2CH2CH3), 31.4 (t, CH2CH2CH3), 32.6 (t, 
CH2CH2CH2CH2CH3), 33.8 (t, CH2Br), 126.1 (d, =CHCH2Br or CH2CH2CH=), 128.7 (d, 
=CHCH=CHCH2Br or CH=CHCH2Br), 135.4 (d, =CHCH=CHCH2Br or CH=CHCH2Br), 
137.8 (d, =CHCH2Br or CH2CH2CH=). 
 
(3E)-5-Bromodeca-1,3-diene (3E)-4-17 
Br
 
Rf (hexane/ethyl acetate 5:1) = 0.24 - Detectable resonances: 1H NMR (400 MHz, CDCl3): 
δ = 0.89 (t, J = 6.9 Hz, 3H, CH2CH3), 1.25-1.42 (m, 6H, CH2CH2CH2CH3), 1.90 (m, 2H, 
CH2CHBr), 4.57 (dt, J = 9.5, 7.1 Hz, 2H, CHBr), 5.15 (dd, J = 11.1, 1.5 Hz, 1H, CH2=CH), 
5.26 (d, J = 16.3 Hz, 1H, CH2=CH), 5.85 (dd, J = 15.0, 9.1 Hz, 1H, =CHCHBr), 6.19 (m, 1H, 
=CHCH=CH2), 6.32 (m, 1H, CH=CH2). - 13C NMR (100 MHz): δ = 39.1 (t, CH2CHBr), 55.9 
(d, CHBr), 119.0 (t, CH2=CH), 132.2 (d, BrCHCH=CH), 134.7 (d, =CHCHBr), 135.6 (d, 
CH=CH2). 
 
(3E)-Deca-1,3-dien-5-ol (3E)-4-18 
OH
 
1H NMR (400 MHz, CDCl3): δ = 0.88 (m, 3H, CH2CH3), 1.29-1.47 (m, 6H, 
CH2CH2CH2CH3), 1.52 (m, 2H, CH2CHOH), 4.12 (m, 1H, CHOH), 5.06 (d, J = 9.8 Hz, 1H, 
CH2=CH), 5.18 (d, J = 16.6 Hz, 1H, CH2=CH), 5.71 (dd, J = 15.0, 6.6 Hz, 1H, 
CH=CHCHOH), 6.20 (m, 1H, CH2=CHCH), 6.32 (m, 1H, CH2=CH). - 13C NMR (100 MHz): 
δ = 13.8 (q, CH2CH3), 22.4 (t, CH2CH3), 24.9 (t, CH2CH2CH2CH3), 31.6 (t, CH2CH2CH3), 
37.1 (t, CH2CHOH), 72.1 (t, CHOH), 116.9 (t, CH2=CH), 130.5 (d, CH=CHCHOH), 136.3 
(d, CH2=CH), 136.8 (d, =CHCHOH). 
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(2E,4Z)-1-Bromodeca-2,4-diene (2E,4Z)-4-16 
Br  
Rf (hexane/ethyl acetate 5:1) = 0.24. - 1H NMR (200 MHz, CDCl3): δ = 0.89 (t, J = 6.6 Hz, 
3H, CH2CH3), 1.21-1.46 (m, 6H, CH2CH2CH2CH3), 2.15 (dq, J = 7.3, 1.1 Hz, 2H, CH2CH=), 
4.06 (dd, J = 7.8, 0.7 Hz, 2H, CH2Br), 5.52 (dt, J = 10.8, 7.7 Hz, 1H, CH=), 5.86 (m, 2H, 
CH=), 6.58 (m, 1H, CH=). - 13C NMR (50 MHz): δ = 14.0 (q, CH2CH3), 22.5 (t, CH2CH3), 
27.8 (t, CH2CH2CH2CH3), 29.2 (t, CH2CH2CH3), 31.4 (t, CH2CH2CH2CH2CH3), 33.6 (t, 
CH2Br), 126.9 (d, CH=), 128.1 (d, CH=), 130.2 (d, CH=), 135.1 (d, CH=). 
 
(3Z)-5-Bromodeca-1,3-diene (3Z)-4-17 
Br
 
Rf (hexane/ethyl acetate 5:1) = 0.24. - Detectable resonances 1H NMR (200 MHz, CDCl3): 
δ = 0.89 (m, 3H, CH2CH3), 1.21-1.46 (m, 6H, CH2CH2CH2CH3), 1.74-2.07 (m, 2H, 
CH2CHBr), 4.57 (dt, J = 9.5, 7.1 Hz, 1H, CHBr), 5.15 (m, 1H, CH2=CH), 5.26 (m, 1H, 
CH2=CH), 5.80 (m, 1H, CHCHBr), 6.25 (m, 2H, CHCH=CH2). - 13C NMR (50 MHz): δ = 
13.9 (q, CH2CH3), 22.4 (t, CH2CH3), 27.4 (t, CH2CH2CH2CH3), 31.1 (t, CH2CH2CH3), 39.1 
(t, CH2CHBr), 55.8 (d, CHBr), 119.0 (t, CH2=CH), 132.2 (d, BrCHCH=CH), 134.6 (d, 
=CHCHBr), 135.6 (d, CH2=CH). 
 
(6E,8E)- or (6E,8Z)-tert-Butyl or methyl 3-oxotetradeca-6,8-dienoates 4-20a,b 
Method A with crude 4-16/4-17: tert-Butyl acetoacetate 4-19b (7.34 mL, 45 mmol) diluted 
with 5 mL dry THF was added dropwise to a suspension of NaH (2.16 g, 54 mmol, 60% in 
mineral oil) in 100 mL dry THF at 0 °C. After stirring for 15 min the reaction was cooled to 
−50 °C and BuLi (31 mL, 49.5 mmol, 1.6M in hexane) was added. The reaction was stirred at 
this temperature for 30 min during which it became white inhomogeneous. The crude 3.8:1 
mixture of bromides (2E,4E)-4-16 and (3E)-4-17 (6.06 g, 29 mmol) diluted with dry THF was 
added at 0 °C. The reaction was stirred at this temperature until complete as indicated by TLC 
(1 h). It was quenched with a 10% HCl solution (20 mL). The aqueous layer was extracted 
three times with diethyl ether. The combined organic layers were washed with water, 
NaHCO3 solution and brine, dried over Na2SO4 and concentrated in vacuum. The crude 
mixture (12 g) was purified by flash chromatography (hexane/ethyl acetate 20:1 gradient to 
2:1). The products eluted in the following order: A complex mixture of 4-19b and byproduct 
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(3E)-4-21b, followed by (6E,8E)-4-20b containing traces of (3E)-4-21b. Yield 3.4 g (37%) 
based on the dienol (2E,4E)-4-15 as colourless oil. 
Method B with purified 4-16/4-17: A solution of methyl acetoacetate 4-19a (2.23 g, 19.2 
mmol) in 7 mL dry THF was added dropwise to a suspension of NaH (0.92 g, 23 mmol, 60% 
in mineral oil) in 25 mL dry THF at 0 °C. After stirring for 0.5 h, BuLi (13.2 mL, 21.1 mmol, 
1.6M solution in hexane) was added at −60 °C. The reaction mixture was stirred at −60 °C for 
15 min and at 0 °C for 15 min. The 8.7:1 mixture of (2E,4E)-4-16 and (3E)-4-17 (3.33 g, 15.3 
mmol) dissolved in 8 mL dry THF was added at 0 °C. The deep yellow colour changed to 
pale yellow and the reaction became inhomogeneous. The reaction was stirred at 0 °C for 1 h 
and at r.t. for 30 min. It was quenched with a 10% HCl solution. The aqueous layer was 
extracted with diethyl ether. The combined organic layers were washed with water, saturated 
NaHCO3 solution and brine, dried over Na2SO4 and concentrated in vacuum. The crude 
mixture (4.16 g) was purified by flash chromatography (hexane/ethyl acetate 30:1 gradient to 
10:1). The products eluted starting with 20:1 in the following order: 2.14 g of a 16:1 mixture 
of (6E,8E)-4-20a and (6E)-4-21a, followed by 0.32 g of a 8.8:1 mixture of (6E,8E)-4-20a and 
(6E)-4-21a. Yield 2.3 g (40%) based on the dienol (2E,4E)-4-15 as a colourless oil. 
Byproduct 4-21a was separated by a second column or by purification in the next step. 
 
(6E,8Z)-tert-Butyl 3-oxotetradeca-6,8-dienoate (6E,8Z)-4-20b 
O
OtBu
O
 
IR: v~  = 2957 (m), 2930 (m), 2861 (s), 1712 (s), 1642 (w), 1457 (w), 1367 (m), 1318 (m), 
1251 (m), 1146 (s), 967 (m), 840 (w), 730 (w). - MS (EI) m/z (%): 294 (3.8) [M+], 238 (18) 
[M+–H2CC(CH3)2], 221 (8) [M+–OC(CH3)3], 178 (12) [M+–CH3COOC(CH3)3], 136 (61) 
[M+– CH3COCH2COOC(CH3)3], 95 (22), 79 (57), 67 (35), 57 (100) [(CH2)3CH3+ or tBu+], 43 
(34) [(CH2)2CH3+]. - Combustion analysis: C18H30O3 (294.43): calc. C 73.43, H 10.27; found 
C 73.09, H 10.42. - Rf (hexane/ethyl acetate 5:1) = 0.60, Rf (hexane/ethyl acetate 10:1) = 0.34. 
- 1H NMR (400 MHz, CDCl3): δ = 0.85 (t, J = 6.9 Hz, 3H, CH2CH3), 1.23-1.41 (m, 6H, 
CH2CH2CH2CH3), 1.43 (s, 9H, C(CH3)3), 2.10 (m, 2H, =CHCH2), 2.35 (q, J = 7.3 Hz, 2H, 
CH2CH2CO), 2.60 (t, J = 7.4 Hz, 2H, CH2CH2CO), 3.30 (s, 2H, CH2COOtBu), 5.29 (dt, J = 
10.8, 7.6 Hz, 1H, =CH(CH2)3), 5.57 (dt, J = 15.1, 7.3 Hz, 1H, =CHCH2CH2CO), 5.87 (t, J = 
10.9 Hz, 1 H, CH=CH(CH2)3), 6.29 (ddd, J = 15.1, 10.9, 1.3 Hz, 1H, CH=CHCH2CH2CO). - 
13C NMR (100 MHz, CDCl3): δ = 14.0 (q, CH2CH3), 22.5 (t, CH2CH3), 26.6 (t, CH2CH2CO), 
27.6 (t, CH2CH2CH2CH2CH3), 27.9 (q, C(CH3)3), 29.3 (t, CH2CH2CH2CH3), 31.4 (t, 
CH2CH2CH3), 42.4 (t, CH2CH2CO), 50.6 (t, CH2COOtBu), 81.9 (s, C(CH3)3), 126.7 (d, 
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CH=CHCH2CH2CO), 128.1 (d, (CH2)3CH=CH) 131.1 (d, CH3(CH2)4CH), 131.6 (d, 
CH(CH2)2CO), 166.3 (s, CH2COOtBu), 202.3 (s, CH2COCH2). - Detectable resonances of the 
enol form: 1H NMR (400 MHz): δ = 1.45 (s, 9H, C(CH3)3), 4.86 (s, 1H, =CHCOOtBu). - 13C 
NMR (100 MHz): δ = 90.6 (d, =CHCOOtBu). 
 
(6E,8E)-tert-Butyl 3-oxotetradeca-6,8-dienoate (6E,8E)-4-20b 
O
O
O
 
Rf (hexane/ethylacetate 10:1) = 0.27. - 1H NMR (200 MHz, CDCl3): δ = 0.88 (t, J = 6.6 Hz, 
3H, CH2CH3), 1.20-1.45 (m, 6H, CH2CH2CH2CH3), 1.47 (s, 9H, C(CH3)3), 2.04 (q, J = 6.8 
Hz, 2H, CH2CH2CH2CH2CH3), 2.35 (q, J = 7.1 Hz, 2H, CH2CH2C=O), 2.62 (m, 2H, 
CH2CH2C=OCH2), 3.34 (s, 2H, CH2COOtBu), 5.57 (m, 2H, CH=CHCH=CHCH2), 5.97 (m, 
2H, CH=CHCH=CHCH2). - 13C NMR (50 MHz, CDCl3): δ = 13.9 (q, CH2CH3), 21.4 (t, 
CH2CH3), 26.3 (t, CH2CH2C=O), 27.9 (q, C(CH3)3), 28.9 (t, CH2CH2CH2CH3), 31.3 (t, 
CH2CH2CH3), 32.5 (t, CH2CH2CH2CH2CH3), 42.4 (t, CH2C=O), 50.6 (t, O=CCH2COOR), 
81.8 (s, C(CH3)3), 129.3 (d, CHCH2CH2CO), 129.8 (d, (CH2)3CH=CH) 131.5 (d, 
CH=CH(CH2)2CO), 133.5 (d, CH3(CH2)4CH), 166.3 (s, CH2COOtBu), 202.4 (s, CH2COCH2).  
- Detectable resonances of the enol form: 1H NMR (200 MHz): δ = 4.88 (s, 1H, 
=CHCOOMe). - 13C NMR (50 MHz): δ = 89.8 (d, =CHCOOMe). 
 
Methyl 3-oxotetradeca-6,8-dienoates (6E,8E)-4-20a and (6E,8Z)-4-20a 
IR (Film): v~  = 3019 (br. w), 2956 (w), 2926 (m), 2856 (w), 1747 (s), 1717 (s), 1653 (w), 
1629 (w), 1437 (m), 1407 (w), 1318 (m), 1237 (m), 1194 (w), 1153 (m), 986 (m), 949 (w), 
844 (w), 734 (w). - MS (EI) m/z (%): 252 (10) [M+], 234 (15) [M+–H2O], 220 (5) [M+–
CH3OH], 178 (11) [M+–CH3COOCH3], 150 (19) [M+–COCH2COOMe·-H·], 136 (56) [M+– 
CH3COCH2COOCH3], 101 (24) [COCH2COOMe+·], 93 (35) [M+–CH3COCH2COOCH3–
C3H7+·], 91 (24), 79 (100) [M+– CH3COCH2COOCH3-C4H9+·], 67 (53), 59 (21) [COOMe+·], 
55 (15). - Combustion analysis: C15H24O3 (252.35): calc. C 71.39, H 9.59; found C 70.98, H 
9.95. 
 
(6E,8E)-Methyl 3-oxotetradeca-6,8-dienoate (6E,8E)-4-20a 
O
OMe
O
 
Rf (hexane/ethyl acetate 5:1) = 0.47. - 1H NMR (400 MHz): δ = 0.88 (m, 3H, CH2CH3), 1.29 
(m, 4H, CH2CH2CH2CH3), 1.37 (m, 2H, CH2CH2CH2CH3), 2.04 (q, J = 7.2 Hz, 2H, 
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CH2(CH2)3CH3), 2.33 (m, 2H, CH2CH2CO), 2.64 (q, J = 7.4 Hz, 2H, CH2CH2CO), 3.446 (s, 
2H, CH2COOMe), 3.724 (s, 3H, COOCH3), 5.51 (dt, J = 14.0, 6.9 Hz, =CH(CH2)2CO), 5.60 
(m, 1H, (CH2)3CH=CH), 6.10 (m, 2H, (CH2)3CH=CHCH). - 13C NMR (100 MHz): δ = 13.8 
(q, CH2CH3), 22.4 (t, CH2CH3), 26.2 (t, CH2CH2CO), 28.8 (t, CH2CH2CH2CH3), 31.2 (t, 
CH2CH2CH3), 32.4 (t, CH2CH2CH2CH=), 42.4 (t, CH2CH2CO), 48.8 (t, CH2COOR), 52.1 (q, 
COOCH3), 129.0 (d, =CHCH2CH2CO), 129.7 (d, (CH2)3CH=CH), 131.5 (d, 
CH=CH(CH2)2CO), 133.4 (d, CH3(CH2)4CH=), 167.5 (s, CH2COOMe), 201.7 (s, 
CH2COCH2). - Detectable resonances of the enol: 1H NMR (400 MHz): δ = 4.99 (s, 1H, 
=CHCOOMe). - 13C NMR (100 MHz): δ = 93.8 (d, =CHCOOMe). 
 
(6E,8Z)-Methyl 3-oxotetradeca-6,8-dienoate (6E,8Z)-4-20a 
O
OMe
O
 
Rf (hexane/ethyl acetate 5:1) = 0.5. - 1H NMR (400 MHz): δ = 0.88 (m, 3H, CH2CH3), 1.29 
(m, 4H, CH2CH2CH2CH3), 1.37 (m, 2H, CH2CH2CH2CH3), 2.14 (q, J = 7.3 Hz, 2H, 
CH2(CH2)3CH3), 2.39 (q, J = 7.2 Hz, 2H, CH2CH2CO), 2.64 (q, J = 7.4 Hz, 2H, CH2CH2CO), 
3.45 (s, 2H, CH2COOMe), 3.722 (s, 3H, COOCH3), 5.33 (dt, J = 10.6, 7.6 Hz, 1H, 
(CH2)3CH=CH), 5.60 (dt, J = 14.1, 6.7 Hz, 1H, =CH(CH2)2CO), 5.91 (t, J = 10.9 Hz, 1H, 
(CH2)3CH=CH), 6.33 (dd, J = 15.0, 10.9 Hz, 1H, CH=CHCH2CH2CO). - 13C NMR (100 
MHz): δ = 13.8 (q, CH2CH3), 22.4 (t, CH2CH3), 26.5 (t, CH2CH2CO), 27.5 (t, 
CH2CH2CH2CH=) 29.2 (t, CH2CH2CH2CH3), 31.3 (t, CH2CH2CH3), 42.4 (t, CH2CH2CO), 
48.8 (t, CH2COOR), 52.1 (q, COOCH3), 126.7 (d, CH=CH(CH2)2CO), 127.9 (d, 
(CH2)3CH=CH), 131.0 (d, CH3(CH2)4CH=), 131.3 (d, =CHCH2CH2CO), 167.3 (s, 
CH2COOMe), 201.6 (s, CH2COCH2). - Detectable resonances of the enol: 1H NMR (400 
MHz): δ = 5.00 (s, 1H, =CHCOOMe). - 13C NMR (100 MHz): δ = 88.9 (d, =CHCOOMe). 
 
(6E,8E)- and (6E,8Z)-3-Hydroxytetradeca-6,8-dienoates 4-11a 
A solution of (6E,8E)-4-20a (2.23 g, 8.85 mmol) was added dropwise to a suspension of 
NaBH4 (403.6 mg, 10.62 mmol) in 30 mL dry MeOH at 0 °C, with strong stirring. The 
reaction was monitored by TLC (hexane/EtOAc 2:1). The reaction mixture was carefully 
quenched with 10 mL of NaHCO3 solution. The methanol was evaporated and the remaining 
aqueous layer was extracted three times with diethyl ether. The combined ethereal layers were 
dried over NaSO4 and concentrated in vacuum. Column chromatography (hexane/EtOAc 5:1 
gradient to 2:1) afforded 1.86 g (83%) (6E,8E)-4-11a as a colourless oil. 
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(6E,8E)-4-11a and (6E,8Z)-4-11a: IR (ATR): v~  = 3462 (w), 3018 (w), 2955 (m), 2925 (s), 
2856 (w), 1726 (s), 1438 (s), 1410 (w), 1356 (w), 1288 (w), 1252 (w), 1197 (m), 1160 (s), 
1084 (w), 1061 (w), 984 (s), 948 (m), 842 (w), 728 (w), 605 (w) cm-1. - MS (EI): m/z (%) = 
254 (3) [M+], 236 (18) [M+–H2O], 162 (18), 152 (15), 147 (28), 135 (9), 133 (17), 129 (13), 
119 (32), 105 (71), 97 (28) [C5H11CH=CH], 95 (39), 91 (54), 81 (60), 79 (59), 71 (41) 
[C5H11], 67 (100), 57 (68), 55 (73), 53 (19), 51 (13). - Combustion analysis: C15H26O3 
(254.36): calc. C 70.83, H 10.30; found C 70.46, H 10.47. 
 
(6E,8E)-Methyl 3-hydroxytetradeca-6,8-dienoate (6E,8E)-4-11a 
OH
OMe
O
 
Rf (hexane/ethyl acetate 5:1) = 0.25 - 1H NMR (400 MHz, CDCl3): δ = 0.88 (t, J = 6.8 Hz, 
3H, CH2CH3), 1.22-1.42 (m, 6H, CH2CH2CH2CH3), 1.51 (m, 1H, CH2CH2CHOH), 1.62 (m, 
1H, CH2CH2CHOH), 2.04 (q, J = 7.2 Hz, 2H, =CHCH2CH2CH2), 2.20 (m, 2H, 
CH2CH2CHOH), 2.46 (AB part of ABX system, J = 16.3, 8.6, 3.8 Hz, 2H, CH2COOMe), 3.11 
(s, OH), 3.70 (s, 3H, COOCH3), 4.01 (m, 1H, CHOH), 5.56 (m, 2H, CH=CHCH=CHCH2), 
6.01 (m, 2H, =CHCH=CHCH2) - 13C NMR (100 MHz, CDCl3): δ = 13.9 (q, CH2CH3), 22.4 
(t, CH2CH3), 28.4 (t, CH2CH2CHOH), 28.9 (t, CH2CH2CH2CH3), 31.3 (t, CH3CH2CH2), 32.4 
(t, CH2CH2CH2CH=), 36.0 (t, CH2CH2CHOH), 41.1 (t, CH2COOMe), 51.5 (d, COOCH3), 
67.2 (d, CHOH), 130.0 (d, CH=CH(CH2)3), 130.7 (d, CH=CH(CH2)2CHOH or 
=CH(CH2)2CHOH), 131.0 (d, CH=CH(CH2)2CHOH or =CH(CH2)2CHOH), 132.9 (d, 
=CH(CH2)3), 173.1 (s, COO). 
 
(6E,8Z)-Methyl 3-hydroxytetradeca-6,8-dienoate (6E,8Z)-4-11a 
OH
O
O
 
Rf (hexane/ethyl acetate 2:1) = 0.63 - 1H NMR (200 MHz, CDCl3): δ = 0.89 (t, J = 6.5 Hz, 
3H, CH2CH3), 1.22-1.37 (m, 6H, CH2CH2CH2CH3), 1.57 (m, 2H, CH2CH2CHOH), 2.18 (m, 
4H, =CHCH2CH2CH2CH2, CH2CH2CHOH), 2.48 (AB part of ABX system, J = 16.3, 8.0, 4.2 
Hz, 2H, CH2COOMe), 3.71 (s, 3H, COOCH3), 4.02 (m, 1H, CHOH), 5.32 (dt, J = 10.8, 7.6 
Hz, 1H, (CH2)4CH=), 5.64  (dt, J = 15.0, 7.0 Hz, 1H, =CHCH2CH2CHOH), 5.93 (t, J = 10.9 
Hz, 1H, (CH2)4CH=CH), 6.35 (ddd, J = 15.0, 10.9, 1.1 Hz, 1H, CH=CHCH2CH2CHOH). - 
13C NMR (50 MHz, CDCl3): δ = 14.0 (q, CH2CH3), 22.5 (t, CH2CH3), 27.6 (t, 
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CH2CH2CHOH), 28.7 (t, CH2CH2CH2CH3), 29.3 (t, CH3CH2CH2), 31.4 (t, 
CH2CH2CH2CH=), 36.0 (t, CH2CH2CHOH), 41.1 (t, CH2COOMe), 51.7 (d, COOCH3), 67.4 
(d, CHOH), 126.3 (d, CH=CHCH2CH2CHOH), 128.2 (d, CH=CH(CH2)4), 130.6 (d, 
=CH(CH2)4), 133.0 (d, =CHCH2CH2CHOH), 173.2 (s, COO). 
 
(6E,8E)-tert-Butyl 3-hydroxytetradeca-6,8-dienoate (6E,8E)-4-11b 
H11C5
OH
OtBu
O
 
Rf (hexane/ethyl acetate 5:1) = 0.38. - 1H NMR (400 MHz, CDCl3): δ = 0.88 (t, J = 6.9 Hz, 
3H, CH2CH3), 1.23-1.34 (m, 4H, CH2CH2CH3), 1.37 (quint, J = 7.1 Hz, CH2CH2CH2CH3), 
1.46 (s, 9H, C(CH3)3), 1.49 (m, 1H, CH2CHOH), 1.59 (m, 1H, CH2CHOH), 2.03 (q, J = 7.2 
Hz, 2H, =CHCH2CH2CH2CH2), 2.15 (m, 2H, CH2CH2CHOH), 2.36 (AB part of ABX system, 
J = 16.3, 8.7, 3.5 Hz, 2H, CH2COOtBu), 3.22 (d, J = 3.9 Hz, OH), 3.96 (m, 1H, CHOH), 
5.51-5.60 (m, 2H, CH=CHCH=CHCH2), 5.95-6.06 (m, 2H, CHCH=CHCH2). - 13C NMR 
(100 MHz, CDCl3): δ = 13.9 (q, CH2CH3), 22.4 (t, CH2CH3), 28.0 (q, C(CH3)3), 28.4 (t, 
CH2CH2CHOH), 29.0 (t, CH2CH2CH2CH3), 31.3 (t, CH3CH2CH2), 32.5 (t, CH3(CH2)3CH2), 
36.0 (t, CH2CHOH), 42.2 (t, CH2COOtBu), 67.4 (d, CHOH), 81.0 (s, C(CH3)3), 130.0 (d, 
CH=CH(CH2)3), 130.93 (d, CH=CH(CH2)2CHOH or CH=CH(CH2)2CHOH), 130.94 (d, 
CH=CH(CH2)2CHOH or CH=CH(CH2)2CHOH), 132.8 (d, =CH(CH2)3), 172.3 (s, COO). - IR 
(ATR): v~  = 3462 (w), 3011 (w), 2959 (w), 2926 (m), 2856 (w), 1714 (s), 1455 (w), 1393 (w), 
1367 (m), 1301 (w), 1253 (w), 1216 (w), 1150 (s), 1092 (w), 987 (s), 949 (w), 879 (w), 842 
(w), 761 (w) cm-1. - MS (EI): m/z (%) = 296 (3.8) [M+], 240 (18) [M+–CH2C(CH3)2], 223 (13) 
[M+–OC(CH3)3], 162 (20), 138 (63) [H11C5CH=CHCH=CHCH3], 105 (38), 79 (47), 67 (46), 
57 (100) [(CH2)3CH3+], 43 (18) [tBu+]. - Combustion analysis: C18H32O3 (296.44): calc. C 
72.93, H 10.88; found C 72.76, H 11.09. 
 
(6E,8Z)-tert-Butyl 3-hydroxytetradeca-6,8-dienoate (6E,8Z)-4-11b 
OH
OtBu
O
 
Rf (hexane/ethyl acetate 5:1) = 0.42. - 1H NMR (400 MHz): δ = 0.89 (t, J = 6.9 Hz, 3H, 
CH2CH3), 1.28 (m, 4H, CH2CH2CH3), 1.37 (m, 2H, CH2CH2CH2CH3), 1.47 (s, 9H, 
(CH3)3CO), 1.51 (m, 1H, CH2CH2CHOH), 1.62 (m, 1H, CH2CH2CHOH), 2.15 (q, J = 7.6 Hz, 
2H, =CHCH2CH2CH2), 2.24 (m, 2H, CH2CH2CHOH), 2.37 (AB part of ABX system, J = 
16.4, 8.9, 3.2 Hz, 1H, CH2COOtBu), 3.13 (s, 1H, OH), 3.97 (m, 1 H, CHOH), 5.32 (dt, J = 
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7.5, 10.7 Hz, 1H, =CHCH2CH2CH2), 5.65 (dt, J = 15.1, 7.0 Hz, 1H, =CHCH2CH2CHOH), 
5.93 (t, J = 11.0 Hz, 1H, CH=CH(CH2)3), 6.34 (ddd, J = 15.1, 11.0, 1.2 Hz, 1H, 
CH=CHCH2CH2CHOH). - 13C NMR (100 MHz): δ = 14.0 (q, CH2CH3), 22.5 (t, CH2CH3), 
27.7 (t, =CHCH2(CH2)3), 28.1 (q, (CH3)3CO), 28.8 (t, CH2CH2CHOH), 29.4 (t, 
CHCH2CH2CH2), 31.5 (t, CH2CH2CH3), 36.0 (t, CH2CH2CHOH), 42.2 (t, CH2COOtBu), 67.5 
(d, CHOH), 81.3 (s, (CH3)3CO), 126.3 (d, CH=CHCH2CH2CHOH), 128.3 (d, 
CH=CH(CH2)3), 130.7 (d, =CH(CH2)3), 133.3 (d, =CHCH2CH2CHOH), 172.5 (s, COO). - IR 
(ATR): v~  = 3448 (w), 3010 (w), 2958 (w), 2926 (m), 2856 (w), 1713 (s), 1456 (w), 1367 
(m), 1301 (w), 1253 (w), 1150 (s), 1082 (w), 986 (s), 948 (w), 842 (w), 761 (w) cm-1. - MS 
(EI): m/z (%) = 296 (2) [M+], 240 (28) [M+–CH2C(CH3)2], 222 (47) [M+–HOC(CH3)3], 162 
(27), 138 (86) [H11C5CH=CHCH=CHCH3], 105 (52), 93 (33), 79 (59), 67 (62), 57 (100) 
[tBu+], 41 (71). - Combustion analysis: C18H32O3 (296.44): calc. C 72.93, H 10.88; found C 
72.99, H 11.16. 
 
Table 6.1 Significant NMR data of (6E,8E)-4-20a,b and (6E,8Z)-4-11a,b. 
Product H3, C3 H6, C6 H9, C9 H8, C8 H7, C7 
(6E,8E)-4-20a - 
201.7 (s) 
5.51 (dt) 
129.0 (d) 
5.60 (m) 
133.4 (d) 
6.10 (m) 
129.7 (d) 
6.10 (m) 
131.5 (d) 
(6E,8Z)-4-20a 
 
- 
201.6 (s) 
5.60 (dt) 
131.3 (d) 
5.33 (dt)  
131.0 (d) 
5.91 (t) 
127.9 (d) 
6.33 (dd) 
126.7 (d) 
(6E,8E)-4-20b - 
202.4 (s) 
5.57 (m) 
129.3 (d) 
5.57 (m) 
133.5 (d) 
5.97 (m) 
129.8 (d) 
5.97 (m) 
131.5 (d) 
(6E,8Z)-4-20b - 
202.3 (s) 
5.57 (dt) 
131.6 (d) 
5.29 (dt) 
131.1 (d) 
5.87 (t) 
128.1 (d) 
6.29 (ddd) 
126.7 (d) 
(6E,8E)-4-11a 4.01 (quint) 
67.7 (d) 
5.51-5.62 (m) 
130.7 or 131.0 (d), 132.9 (d) 
5.95-6.06 (m) 
129.9 (d), 130.7 or 131.0 (d) 
(6E,8Z)-4-11a Not assigned 
67.2 (d) 
5.67 (m) 
133.0 (d) 
5.31 (m) 
130.5 (d) 
5.95 (m) 
126.2 (d) 
128.2 (d) 
6.34 (m) 
(6E,8E)-4-11b 3.96 (m) 
67.4 (d) 
5.51-5.60 (m) 
130.9 (d), 132.8 (d) 
5.95-6.06 (m) 
130.0 (d), 130.9 (d) 
(6E,8Z)-4-11b 3.97 (m) 
67.5 (d) 
5.65 (dt) 
133.3 (d) 
5.32 (dt) 
130.7 (d) 
5.93 (t) 
128.3 (d) 
6.34 (ddd) 
126.3 (d) 
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Table 6.2 Dienoate 4-20b by method A 
Entry Scale 
mmol 
Deprotonation of 4-22 
with LDA 
Deprotonation of 4-19b  Equiv. 
Additive 
Formation 
of 4-24 
4-20b 
(%) 
1 1  1.2 equiv./10 min 
1.1 equiv. 4-22 
2.2 equiv. LDA/30 min -a 1 h 27 
2 1  1.2 equiv./ 30 min 
1.1 equiv. 4-22 
2.2 equiv. LDA/30 min 4 HMPA 1.5 h 20 
3 2  1.4 equiv./40 min 
1.3 equiv. 4-22 
2.2 equiv. LDA/40 min 6 HMPA 3 h 25 
4 1  1.2 equiv./25 min  
1.1 equiv. 4-22 
1.2 equiv. NaH/30 min 
1.1 equiv. BuLi/30 min 
- 3 h 0 
5 27.2  1.2 equiv./50 min 
1.1 equiv. 4-22 
2.2 equiv. LDA/40 min -a 3.5 h 28 
6 1.1 1.2 equiv. LiHMDS/1 h 
1 equiv. 4-22 
2 equiv. LDA/25 min - 3.5 h 0 
a Decalin was used as an internal standard for GC monitoring of substrate consumption. 
 
(6E,8Z)-tert-Butyl 3-oxotetradeca-6,8-dienoate 4-20b via three component coupling 
(Representative procedure) 
Method A: To a solution of iPr2NH (0.169 mL, 1.2 mmol) in 5 mL dry THF BuLi (0.75 mL, 
1.6M in hexanes, 1.2 mmol) was added at –78 °C under a nitrogen atmosphere. After stirring 
for 20 min at this temperature phosphonium salt 4-22 (524 mg, 1.1 mmol) was added and the 
resulting brown suspension was warmed to –40 °C during 1 h, with stirring. In another flask 
BuLi (1.375 mL, 1.6M in hexanes, 2.2 mmol) was added to a solution of iPr2NH (0.311 mL, 
2.2 mmol) in 3 mL dry THF at –78 °C and the solution was stirred at this temperature for 30 
min. Acetoacetate 4-19b (174 mg, 1.1 mmol) dissolved in 2 mL dry THF was added via 
syringe. After stirring for 20 min the mixture was transferred via canula into the flask 
containing the suspension of butadienylphosphonium salt 4-23. The resulting mixture was 
stirred for 1h-3.5 h, while warmed to 0 °C. Hexanal 4-25 (100 mg, 1 mmol) dissolved in 2 mL 
dry THF was added and the reaction mixture was stirred for additional 30 min. The 
consumption was monitored by TLC (hexane/EtOAc 5:1). The reaction was quenched with 30 
mL ice cold 1% HCl and diluted with diethyl ether. The aqueous layer was extracted 3 times 
with diethyl ether. The combined ethereal layers were washed with brine and dried over 
Na2SO4. The solvent was evaporated. Purification of the crude mixture (260 mg) by flash 
chromatography with hexane/ethyl acetate 20:1 gradient to 2:1 afforded the products in 
following order: A mixture of triphenylphosphine, acetoacetate 4-19b and ketoester 4-20b, 
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followed by pure 4-20b and finally amine 4-26. Further purification gave 4-20b as yellowish 
oil. Yield: 27% (79 mg), (6E,8Z)-4-20b:(6E,8E)-4-20b 3.6:1. 
Optimisation experiments under different conditions for the alkylation reaction are presented 
in Table 6.2. 
Method B: The phosphonium salt and the acetoacetate were deprotonated in one pot. 
 
 (2E,4Z)- and (2E,4E)-Deca-2,4-dienyl-N,N-diisopropylamine (E,Z)-4-26 and (E,E)-4-26 
N C5H11
N
C5H11
(2E,4Z)-4-26 (2E,4E)-4-26  
IR: v~ = 3020 (w), 2960 (s), 2926 (s), 2859 (m), 2800 (w), 1722 (w), 1693 (w), 1648 (w), 1609 
(w), 1462 (m), 1379 (m), 1363 (m), 1203 (w), 1176 (m), 1138 (w), 1115 (w), 1034 (w), 983 
(m), 948 (m), 883 (w), 841 (w), 808 (w), 732 (w). - MS (EI, GC-MS) m/z (%): 237 (32) [M+], 
222 (89) [M+– CH3], 137 (42), 95 (71), 86 (70), 81 (7), 67 (100). - HRMS: C16H31N+: calc. 
237.2456; found 237.2448. 
(2E,4Z)-4-26: 1H NMR (400 MHz, CDCl3): δ = 0.81 (t, J = 7.0 Hz, 3H, CH2CH3), 0.93 (d, J = 
6.6 Hz, 12H, CH(CH3)2), 1.21-1.35 (m, 6H, CH2CH2CH2CH3), 2.09 (q, J = 7.0 Hz, 2H, 
CH2CH2CH2CH2CH3), 2.97 (sept, J = 6.6 Hz, 2H, CH(CH3)2), 3.09 (d, J = 6.2 Hz, 2H, 
CHNCH2), 5.26 (dt, J = 10.8, 7.6 Hz, 1H, =CH(CH2)3), 5.59 (dt, J = 15.1, 6.3 Hz, 1H, 
NCH2CH=), 5.91 (t, J = 11.0 Hz, 1H, CH=CH(CH2)3), 6.35 (dd, J = 15.1, 11.1 Hz, 1H, 
NCH2CH=CH). - 13C NMR (100 MHz, CDCl3): δ = 13.7 (q, CH2CH3), 20.4 (q, NCHCH3), 
22.2 (t, CH2CH3), 27.3 (t, =CHCH2CH2), 29.0 (t, CH2CH2CH2CH3), 31.1 (t, CH2CH2CH3), 
46.9 (t, NCH2CH=), 47.8 (d, NCH(CH3)2), 125.5 (d, NCH2CH=CH), 128.1 (d, 
(CH2)3CH=CH) 130.3 (d, =CH(CH2)3), 134.9 (d, NCH2CH=). - (2E,4E)-4-26: 1H NMR (400 
MHz, CDCl3): δ = 0.84 (t, J = 6.9 Hz, 3H, CH2CH3), 0.96 (d, J = 6.6 Hz, 12H, CH(CH3)2), 
1.22-1.37 (m, 6H, CH2CH2CH2CH3), 2.01 (q, J = 7.1 Hz, 2H, CH2CH2CH2CH2CH3), 3.00 
(sept, J = 6.6 Hz, 2H, CH(CH3)2), 3.07 (d, J = 6.4 Hz, 2H, CHNCH2), 5.56 (m, 2H, 
NCH2CH=CHCH=CH), 6.02 (m, 2H, NCH2CH=CHCH=). - 13C NMR (100 MHz, CDCl3): δ 
= 14.0 (q, CH2CH3), 20.6 (q, NCHCH3), 22.5 (t, CH2CH3), 29.0 (t, CH2CH2CH2CH3), 31.4 (t, 
CH2CH2CH3), 32.5 (t, =CHCH2CH2), 47.1 (t, NCH2CH=), 48.0 (d, NCH(CH3)2), 130.1 (d, 
NCH2CH=CH or (CH2)3CH=CH), 130.6 (d, NCH2CH=CH or (CH2)3CH=CH), 132.9 (d, 
=CH(CH2)3 or NCH2CH=), 133.0 (d, =CH(CH2)3 or NCH2CH=). 
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(6E,8E)-5-Hydroxy-3-oxo-6,8-tetradecadienoates 4-28a,b (General procedure): 
Acetoacetates 4-19a,b (24 mmol) dissolved in 3 mL dry THF were added dropwise via 
syringe to a suspension of NaH (1.06 g, 26.4 mmol, 60% in mineral oil) in 50 mL dry THF in 
a three necked flask at 0 °C under nitrogen. A strong gas evolution was observed, which 
ceased after 10 min. After 0.5 h of stirring, dry HMPA (5.0 mL, 28.8 mmol) was added to the 
resulting clear homogeneous reaction at 0 °C. After cooling the reaction mixture to –78 °C, n-
BuLi (15.8 mL, 25.2 mmol, 1.6M in hexanes) was added using a dropping funnel with good 
stirring over 10 min. The reaction mixture was warmed from –78 °C to –65 °C during 20 min 
whereupon it turned white inhomogeneous. It was cooled at –78 °C and stirred for another 0.5 
h. A solution of 4-27 (3.6 g, 23.6 mmol) dissolved in 7 mL THF was added via syringe over 5 
to 10 min with vigorous stirring. The reaction mixture became orange and remained 
inhomogeneous. The reaction was monitored by TLC with hexane/ethyl acetate 5:1. It was 
stirred for 0.5 h at –78 °C and then warmed to –45 °C over 1 h during which it became 
homogenous. The reaction was quenched at –40 °C with 50 mL of a 0.1M HCl solution, 
diluted with 40 mL of diethyl ether and warmed to r.t. The layers were separated, the aqueous 
was extracted three times with 20 mL diethyl ether. The combined organic layers were 
washed three times with 30 mL saturated NaHCO3 solution and twice with brine, dried over 
Na2SO4 and concentrated in vacuum to give the crude product. Purification by flash 
chromatography (hexane/ethyl acetate, gradient 20:1 to 2:1) gave the pure product 4-28a,b as 
a mixture of keto and enol tautomers in a ratio of 11:1. The labile product was kept frozen 
until the next day or used immediately for the next step. 
 
(6E,8E)-Methyl 5-hydroxy-3-oxo-6,8-tetradecadienoate 4-28a:  
O
HO
CO2Me
C5H11
 
Yield: 5.95 g (94%) as a pale yellow oil, Rf(hexane/ethyl acetate 5:1) = 0.20. - 1H NMR (400 
MHz): δ = 0.88 (t, J = 6.9 Hz, 3H, CH2CH3), 1.28 (m, 4H, CH2CH2CH3), 1.38 (tt, J = 7.7, 7.1 
Hz, 2H, CH2CH2CH=), 2.06 (q, J = 7.2 Hz, 2H, CH2CH=), 2.77 (m, 2H, CH(OH)CH2CO), 
2.91 (br. s, 1H, OH), 3.51 (s, 2H, CH2COOMe), 3.73 (s, 3H, OCH3), 4.61 (m, 1H, CHOH), 
5.55 (dd, J = 15.2, 6.3 Hz, 1H, =CHCHOH), 5.71 (dt, J = 15.2, 6.9 Hz, 1H, CH=CHCH2), 
5.99 (dd, J = 15.2, 10.4 Hz, 1H, CH=CHCH2), 6.22 (dd, J = 15.2, 10.5 Hz, 1H, 
CH=CHCHOH). - 13C NMR (100 MHz): δ = 13.9 (q, CH2CH3), 22.4 (t, CH2CH3), 28.7 (t, 
CH2CH2CH2CH3), 31.2 (t, CH2CH2CH3), 32.5 (t, CH2CH=), 49.60 (t, CH2COOMe or 
 208 
CH(OH)CH2), 49.61 (t, CH2COOMe or CH(OH)CH2), 52.3 (q, OCH3), 68.1 (d, CHOH), 
129.0 (d, CH=CHCH2), 130.7 (d, =CHCHOH), 131.2 (d, CH=CHCHOH), 136.2 (d, 
=CHCH2), 167.3 (s, COOCH3), 202.3 (s, CH2COCH2). 
Detectable resonances of the enol form: 1H NMR (400 MHz): δ = 2.42 (m, 2H, 
CH(OH)CH2C(OH)=CH), 4.50 (q, J = 6.5 Hz, 1H, =CHCHOH), 5.07 (s, 1H, =CHCOOMe). - 
13C NMR (100 MHz): δ = 42.9 (t, CH(OH)CH2COH), 51.1 (q, OCH3), 69.6 (d, CHOH), 90.8 
(d, =CHCOOMe). 
 
(6E,8E)-tert-Butyl 5-hydroxy-3-oxo-6,8-tetradecadienoate 4-28b:  
O
HO
CO2tBu
C5H11
 
Yield: 5.9 g (81%) as a pale yellow oil, Rf(hexane/ethyl acetate 5:1) = 0.25. - 1H NMR (400 
MHz): δ = 0.88 (t, J = 6,9 Hz, 3H, CH2CH3), 1.28 (m, 4H, CH3CH2CH2), 1.38 (m, 2H, 
CH2CH2CH=), 1.46 (s, 9H, OC(CH3)3), 2.06 (q, J = 7.2 Hz, 2H, CH2CH=CH), 2.75 (m, 2H, 
CH(OH)CH2CO), 3.22 (br. s, 1H, CHOH), 3.39 (s, 2H, CH2COOtBu), 4.62 (q, J = 6.1 Hz, 
1H, CHOH), 5.56 (dd, J = 15.2, 6.4 Hz, 1H, =CHCHOH), 5.69 (dt, J = 15.1, 7.0 Hz, 1H, 
CH2CH=CH), 6.00 (dd, J =15.2, 10.3 Hz, 1H, CH=CHCH2), 6.22 (dd, J = 15.1, 10.5 Hz, 1H, 
CH=CHCHOH). - 13C NMR (100 MHz): δ = 13.7 (q, CH3CH2), 22.2 (t, CH3CH2), 27.6 (q, 
(CH3)3CO), 28.6 (t, CH2CH2CH), 31.1 (t, CH3CH2CH2), 32.3 (t, CH2CH=CH), 49.5 (t, 
CH(OH)CH2CO), 51.0 (t, CH2COOtBu), 67.9 (d, CHOH), 81.7 (s, OC(CH3)3), 129.1 (d, 
CH2CH=CH), 130.8 (d, CH=CHCHOH), 131.1 (d, =CHCHOH), 135.5 (d, CH2CH=), 166.0 
(s, CH2COOtBu), 202.6 (s, CH2COCH2). 
Detectable resonances of the enol form: 1H NMR (400 MHz): δ = 2.38 (m, 2H, 
CH(OH)CH2C(OH)CH), 4.50 (m, 1H, =CHCHOH), 4.96 (s, 1H, C=CHCOOtBu). - 13C NMR 
(100 MHz): δ = 28.0 (q, (CH3)3CO), 42.9 (t, CH(OH)CH2COH), 69.2 (d, CHOH), 92.3 (d, 
=CHCOOMe). 
 
syn-(6E,8E)-3,5-Dihydroxy-6,8-tetradecadienoates 4-30a,b (General procedure): 
To a solution of 4-28a,b (11.4 mmol) dissolved in 100 mL dry THF/MeOH (4:1), 
diethyl(methoxy)borane (17.1 mL 1.0M solution in THF, 17.1 mmol) was added via syringe 
at –78 °C over 5 min. The solution was stirred for one hour at –78 to –65 °C. With good 
stirring, NaBH4 (650 mg, 17.1 mmol) was added in portions at –95 °C. A strong gas evolution 
was observed that lasted about 0.5 h. The reaction mixture was stirred at –78 °C for 3 h when 
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it was complete by TLC. The reaction was quenched at with 10 mL of AcOH –78 °C, diluted 
with 50 mL of diethyl ether, and allowed to warm to r.t. during 15 min. Saturated NaHCO3 
solution (100 mL) was added slowly and the mixture was stirred for 5 min. The aqueous layer 
was extracted three times with 30 mL of diethyl ether. The combined organic layers were 
washed five times with 30 mL of saturated NaHCO3 solution, twice with 50 mL of brine, 
dried over Na2SO4, concentrated and dried in vacuum to give a crude mixture of the cyclic 
boronate 4-29a,b (Rf(hexane/ethyl acetate 2:1) = 0.82) as main product and small amounts of 
the diols 4-30a,b. The crude mixture was dissolved in 40 mL of THF/H2O (3:1) and NaOAc 
(1.9 g, 23 mmol) was added. The resulting mixture was stirred for 5 min. It was immersed in 
an ice bath and 12 mL (1.05 mL/mmol) of a 30% solution of H2O2 was added slowly with 
stirring. The mixture was stirred at 0 °C for 0.5 h when it was complete by TLC. At 0 °C, 40 
mL of a saturated Na2SO3 solution was added slowly, followed by 40 mL of diethyl ether. 
Stirring was continued at r.t. for 10 min. The layers were separated, the aqueous layer was 
extracted three times with 25 mL of diethyl ether, the combined organic layers were washed 
once with water, once with brine, dried over Na2SO4 and concentrated to give crude products 
4-30a,b. The almost pure diols were purified by flash chromatography (hexane/ethyl acetate 
5:1 and 2:1).  
 
(3S*,5R*,6E,8E)-Methyl 3,5-dihydroxy-6,8-tetradecadienoate 4-30a:  
HO
HO
CO2Me
C5H11
 
Yield: 2.5 g (81%) as a colourless oil, Rf(hexane/ethyl acetate 2:1) = 0.23. - 1H NMR (400 
MHz): δ = 0.88 (t, J = 6.7 Hz, 3H, CH3CH2), 1.20-1.35 (m, 4H, CH3CH2CH2CH2), 1.39 (m, 
2H, CH2CH2CH=CH), 1.63 (ddd, J = 14.3, 4.0, 3.3 Hz, 1H, CH(OH)CH2CH(OH)), 1.73 (ddd, 
J = 14.3, 9.3, 9.2 Hz, 1H, CH(OH)CH2CH(OH)), 2.07 (m, 2H, CH2CH=CH), 2.50 (AB part of 
ABX system, J = 16.2, 7.4, 4.9 Hz, 2H, CH2COOMe), 3.25 (br. s, 1H, OH), 3.70 (s, 3H, 
OCH3), 3.84 (br. s, 1H, OH), 4.27 (m, 1H, CH2CH(OH)CH2), 4.41 (m, 1H, CHCH(OH)CH2), 
5.55 (dd, J = 15.2, 6.7 Hz, 1H, =CHCHOH), 5.70 (dt, J = 14.4, 6.9 Hz, 1H, CH2CH=), 6.00 
(m, 1H, CH2CH=CH), 6.20 (dd, J = 15.2, 10.3 Hz, 1H, CH=CHCHOH). - 13C NMR (50 
MHz): δ = 14.5 (q, CH3CH2), 23.0 (t, CH3CH2), 29.4 (t, CH2CH2CH), 31.9 (t, CH3CH2CH2), 
33.1 (t, CH2CH=), 42.2 (t, CH2COOMe), 43.2 (t, CH(OH)CH2CH(OH)), 52.3 (q, OCH3), 68.6 
(d, CH2CH(OH)CH2), 72.7 (d, =CHCHOH), 129.8 (d, CH2CH=CH), 131.4 (d, 
CH=CHCHOH), 133.0 (d, =CHCHOH), 136.3 (d, CH2CH=), 173.2 (s, COOMe). - IR (Film): 
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v
~  = 3462 (br. w), 3419 (br. w), 3032 (w), 3003 (w), 2956 (w), 2920 (m), 2853 (w), 1719 (s), 
1466 (w), 1435 (m), 1344 (w), 1324 (w), 1306 (w), 1257 (w), 1198 (m), 1172 (m), 1149 (m), 
1117 (m), 1064 (m), 1043 (w), 999 (s), 893 (w), 875 (w), 842 (m), 787 (w), 723 (w). - MS(EI) 
m/z (%): 270 (13) [M+], 252 (18) [M+–H2O], 234 (50) [M+–2H2O], 181 (37) [M+–C5H11–
H2O], 179 (20), 163 (10) [M+–C5H11–2H2O], 161 (13), 142 (22), 131 (18), 127 (37), 117 (45) 
[CH2CH(OH)CH2COOMe]+·, 105 (30) [(CH=CH)3CH=CH2]+·, 103 (62) 
[CH(OH)CH2COOMe]+·, 93 (51), 91 (68), 80 (50), 79 (100), 71 (40) [C5H11]+·, 67 (54), 61 
(15), 55 (34), 43 (44) [C3H7]+. - Combustion analysis: C15H26O4 (270.36): calc. C 66.64, H 
9.69; found C 66.80, H 9.90. 
 
(3S*,5R*,6E,8E)-tert-Butyl 3,5-dihydroxy-6,8-tetradecadienoate 4-30b:  
HO
HO
CO2tBu
C5H11
 
Yield: 2.9 g (81%) as a colourless oil, Rf(hexane/ethyl acetate 2:1) = 0.40. - 1H NMR (400 
MHz): δ = 0.88 (t, J = 6.9 Hz, 3H, CH3CH2), 1.23-1.33 (m, 4H, CH3CH2CH2CH2), 1.39 (m, 
2H, CH2CH2CH=CH), 1.46 (s, 9H, OC(CH3)3), 1.60 (ddd, J = 14.2, 3.5, 3.1 Hz, 1H, 
CH(OH)CH2CH(OH)), 1.70 (ddd, J = 14.2, 9.7, 9.3 Hz, 1H, CH(OH)CH2CH(OH)), 2.06 (q, J 
= 7.0 Hz, 2H, CH2CH=CH), 2.40 (m, 2H, CH2COOtBu), 4.21 (m, 1H, CH2CH(OH)CH2), 
4.42 (m, 1H, CHCH(OH)CH2), 5.56 (dd, J = 15.2, 6.7 Hz, 1H, =CHCHOH), 5.70 (dt, J = 
15.1, 7.3 Hz, 1H, CH2CH=), 6.00 (dd, J = 15.1, 10.4 Hz, 1H, CH2CH=CH), 6.21 (dd, J = 
15.2, 10.3 Hz, 1H, CH=CHCHOH). - 13C NMR (100 MHz): δ = 14.3 (q, CH3CH2), 22.8 (t, 
CH3CH2), 28.4 (q, C(CH3)3), 29.2 (t, CH2CH2CH ), 31.7 (t, CH3CH2CH2), 32.9 (t, CH2CH=), 
42.9 (t, CH2COOtBu), 43.1 (t, CH(OH)CH2CH(OH)), 68.7 (d, CH2CH(OH)CH2), 72.6 (d, 
=CHCHOH), 81.7 (s, OC(CH3)3), 129.6 (d, CH2CH=CH), 131.1 (d, CH=CHCHOH), 132.9 
(d, =CHCHOH), 136.0 (d, CH2CH=), 172.3 (s, COOtBu). - IR (Film): v~  = 3393 (br. w), 2957 
(m), 2928 (m), 2858 (w), 1726 (s), 1368 (m), 1301 (w), 1255 (w), 1149 (s), 1067 (m), 988 (s), 
844 (m). - MS(EI) m/z (%): 312 (0.5) [M+], 276 (8) [M+–2H2O], 256 (18) [M+–
H2C=C(CH3)2], 238 (10) [M+–H2O–H2C=C(CH3)2], 220 (21) [M+–2H2O–H2C=C(CH3)2], 179 
(12), 167 (18), 151 (14), 131 (14), 128 (17), 113 (26), 105 (18), 91 (36), 79 (55), 67 (25), 57 
(100) [tBu]+. - Despite many attempts, neither a satisfactory combustion analysis nor HRMS 
data could be obtained for this compound. 
 
(3S*,5R*,6E,8E)-5-(tert-Butyldimethylsilyloxy)-3-hydroxytetradeca-6,8-dienoates 4-
12a,b (General procedure): 2,6-Lutidine (2.9 mL, 24.9 mmol, 3 equiv.) was added to a 
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solution of 4-30a,b (8.3 mmol) in 78 mL dry CH2Cl2. The mixture was cooled to –78 °C and 
TBSOTf (2.0 mL, 8.7 mmol) was added dropwise via syringe. The reaction mixture was 
stirred at –78 °C for 3.5 h and monitored by TLC (hexane/ethyl acetate 2:1, Rf’s see below). 
Substrates 4-30a,b comigrate with 2,6-lutidine, but differentiation is easy by staining the TLC 
plate with KMnO4 solution: the diol is stained, but 2,6-lutidine not). The reaction was 
quenched with 60 mL of saturated KHSO4 solution, diluted with ethyl acetate (100 mL) and 
allowed to warm to r.t. with stirring. The layers were separated. The aqueous layer was 
extracted twice with diethyl ether and twice with ethyl acetate. The combined organic layers 
were washed subsequently with water, saturated NaHCO3 solution and twice with brine. The 
mixture was dried over Na2SO4, evaporated and dried in vacuum to give the crude product, 
which was purified by flash chromatography (hexane/ethyl acetate 10:1, gradient to 2:1). 
 
(3S*,5R*,6E,8E)-Methyl 5-(tert-butyldimethylsilyloxy)-3-hydroxy-6,8-tetradecadienoate 
4-12a: 
HO
TBSO
CO2Me
C5H11
TBSO
TBSO
CO2Me
C5H11
4-31a
+
 
The components of the mixture eluted in the following order: Trace amounts of disilyl diether 
4-31a, Rf(hexane/ethyl acetate 2:1) = 0.88; 2.53 g (79%) of 4-12a as a colourless oil, 
Rf(hexane/ethyl acetate 2:1) = 0.68; 0.42 g (19%) of substrate 4-30a, Rf(hexane/ethyl acetate 
2:1) = 0.23. - 1H NMR (400 MHz): δ = –0.04 (s, 3H, SiCH3), 0.00 (s, 3H, SiCH3), 0.80 (t+s, 
12H, CH3CH2, OSi(CH3)3), 1.16-1.26 (m, 4H, CH3CH2CH2CH2), 1.30 (quint, J = 7.1 Hz, 2H, 
CH3CH2CH2CH2), 1.53 (ddd, J = 14.0, 5.2, 3.0 Hz, 1H, CH2CHOTBS), 1.67 (ddd, J = 14.0, 
9.1, 8.0 Hz, 1H, CH2CHOTBS), 1.98 (dq, J = 0.9, 7.8 Hz, 2H, CH2CH=), 2.39 (AB part of 
ABX, J = 15.8, 7.5, 5.2 Hz, 2H, CH2COOMe), 3.47 (d, J = 2.3 Hz, 1H, CHOH), 3.60 (s, 3H, 
OCH3), 4.09 (m, 1H, CHOH), 4.31 (dt, J = 7.3, 5.4 Hz, 1H, CHOTBS), 5.40 (dd, J = 15.1, 7.4 
Hz, 1H, =CHCHOTBS), 5.59 (dt, J = 14.3, 6.9 Hz, 1H, CH2CH=), 5.89 (ddt, J = 10.4, 14.9, 
1.3 Hz, 1H, CH2CH=CH), 6.01 (dd, J = 10.3, 15.1 Hz, 1H, CH=CHCHOTBS). - 13C NMR 
(100 MHz): δ = –4.8 (q, SiCH3), –3.9 (q, SiCH3), 14.0 (q, CH3CH2), 18.0 (s, SiC(CH3)3), 22.5 
(t, CH3CH2), 25.8 (q, SiC(CH3)3), 28.8 (t, CH2CH2CH), 31.4 (t, CH3CH2CH2), 32.6 (t, 
CH2CH2CH), 41.7 (t, CH2COOMe), 44.3 (t, CH2CHOTBS), 51.6 (q, OCH3), 66.9 (d, CHOH), 
73.4 (d, CHOTBS), 129.2 (d, CH2CH=CH), 130.8 (d, CH=CHCHOTBS), 133.0 (d, 
=CHCHOTBS ), 135.7 (d, CH2CH=), 172.6 (s, COOMe). - IR (Film): v~  = 3520 (br. w), 3019 
(w), 2955 (s), 2929 (s), 2857 (m), 1739 (s), 1467 (w), 1439 (w), 1363 (w), 1254 (m), 1199 
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(w), 1169 (w), 1073 (m), 990 (s), 880 (w), 836 (s), 777 (s). - MS(EI) m/z (%): 384 (1) [M+], 
327 (5), 295 (5), 267 (9), 253 (8), 235 (12), 203 (7), 175 (10), 161 (12), 135 (19), 133 (9), 105 
(10), 91 (18), 79 (21), 75 (100). - HRMS: C21H40O4Si: calc. 384.2696; found 384.2687. - 
Combustion analysis: C21H40O4Si (384.63): calc. C 65.58, H 10.48; found C 65.56, H 10.84. 
 
(3S*,5R*,6E,8E)-tert-Butyl 5-(tert-butyldimethylsilyloxy)-3-hydroxy-6,8-
tetradecadienoate 4-12b:  
4-31b
HO
TBSO
CO2tBu
C5H11
TBSO
TBSO
CO2tBu
C5H11
+
 
In this case, 1.2 equiv. of TBSOTf was used. The components of the mixture eluted in the 
following order: 0.99 g (22%) of disilyl diether 4-31b as a colourless oil, Rf (hexane/ethyl 
acetate 5:1) = 0.8; 2.3 g (65%) of 4-12b as a colourless oil, Rf (hexane/ethyl acetate 5:1) = 
0.55. - 1H NMR (400 MHz): δ = –0.04 (s, 3H, SiCH3), 0.00 (s, 3H, SiCH3), 0.81 (t+s, 12H, 
CH3CH2, OSiC(CH3)3), 1.10-1.25 (m, 4H, CH3CH2CH2CH2), 1.35 (m, 2H, CH3CH2CH2CH2), 
1.37 (s, 9H, OC(CH3)3), 1.51 (ddd, J = 13.9, 5.8, 3.4 Hz, 1H, CH2CHOTBS), 1.67 (ddd, J = 
13.9, 9.0, 7.5 Hz, 1H, CH2CHOTBS), 1.99 (q, J = 7.0 Hz, 2H, CH2CH=), 2.30 (AB part of 
ABX, J = 16.0, 7.0, 5.5 Hz, 2H, CH2COOtBu), 3.40 (d, J = 2.7 Hz, 1H, CHOH), 4.01 (m, 1H, 
CHOH), 4.30 (q, J = 6.8 Hz, 1H, CHOTBS), 5.41 (dd, J = 15.1, 7.3 Hz, 1H, =CHCHOTBS), 
5.59 (dt, J = 14.4, 6.9 Hz, 1H, CH2CH=), 5.90 (dd, J = 14.9, 10.4 Hz, 1H, CH2CH=CH), 6.02 
(dd, J = 15.0, 10.4 Hz, 1H, CH=CHCHOTBS). - 13C NMR (100 MHz): δ = –4.8 (q, SiCH3), –
4.0 (q, SiCH3), 14.0 (q, CH3CH2), 18.0 (s, SiC(CH3)3), 22.5 (t, CH3CH2CH2), 25.8 (q, 
SiC(CH3)3), 28.1 (q, OC(CH3)3), 28.8 (t, CH2CH2CH), 31.4 (t, CH3CH2CH2), 32.6 (t, 
CH2CH=), 42.7 (t, CH2COOtBu), 44.5 (t, CH2CHOTBS), 66.6 (d, CHOH ), 72.8 (d, 
CHOTBS ), 80.8 (s, OC(CH3)3), 129.3 (d, CH2CH=CH), 130.7 (d, CH=CHCHOTBS), 133.2 
(d, =CHCHOTBS ), 135.6 (d, CH2CH=), 171.7 (s, COOtBu). - IR (Film): v~  = 3516 (br. w), 
2956 (w), 2929 (s), 2857 (w), 1728 (m), 1467 (w), 1367 (w), 1253 (m), 1151 (s), 1070 (m), 
988 (s), 834 (s), 775 (s), 669 (w). - MS(ESI) m/z (%): 876 (5) [2M+Na+–H+], 875 (8) 
[2M+Na+–2H], 450 (26) [M+Na+], 449 (100) [M+Na+–H]. - Combustion analysis: 
C24H46O4Si (426.71): calc. C 67.55, H 10.87; found C 67.77, H 11.12. 
 
(3S*,5R*,6E,8E)-tert-Butyl 3,5-(di-tert-butyldimethylsilyloxy)-6,8-tetradecadienoate 4-
31b:  
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1H NMR (400 MHz): δ = 0.00 (s, 3H, SiCH3), 0.036 (s, 3H, SiCH3), 0.043 (s, 3H, SiCH3), 
0.05 (s, 3H, SiCH3), 0.86 (t+s, 12H, CH3CH2, OSiC(CH3)3), 0.87 (s, 9H, OSiC(CH3)3), 1.23-
1.32 (m, 4H, CH3CH2CH2CH2), 1.36 (m, 2H, CH3CH2CH2CH2), 1.41 (s, 9H, OC(CH3)3), 1.61 
(m, 1H, CH2CH(OTBS)CH=), 1.77 (m, 1H, CH2CH(OTBS)CH=), 2.05 (q, J = 6.9 Hz, 2H, 
CH2CH=), 2.37 (AB part of ABX, J = 14.8, 6.5, 5.4 Hz, 2H, CH2COOtBu), 4.14 (dt, J = 11.9, 
6.2 Hz, 1H, CH(OTBS)CH2COOtBu), 4.19 (q, J = 6.6 Hz, 1H, =CHCHOTBS), 5.47 (dd, J = 
14.9, 6.9 Hz, 1H, =CHCHOTBS), 5.62 (dt, J = 14.7, 6.1 Hz, 1H, CH2CH=), 5.96 (dd, J = 
14.9, 10.4 Hz, 1H, CH2CH=CH), 6.02 (dd, J = 14.9, 10.6 Hz, 1H, CH=CHCHOTBS). - 13C 
NMR (100 MHz): δ = –4.8 (q, SiCH3), –4.5 (q, SiCH3), –4.1 (q, SiCH3), 14.0 (q, CH3CH2), 
17.9 (s, SiC(CH3)3), 18.1 (s, SiC(CH3)3), 22.5 (t, CH3CH2CH2), 25.86 (q, SiC(CH3)3), 25.91 
(q, SiC(CH3)3), 28.1 (q, OC(CH3)3), 28.9 (t, CH2CH2CH), 31.4 (t, CH3CH2CH2), 32.6 (t, 
CH2CH=), 43.8 (t, CH2COOtBu), 46.1 (t, CH2CH(OTBS)CH=), 66.7 (d, 
CH(OTBS)CH2COOtBu ), 72.6 (d, =CHCHOTBS ), 80.0 (s, OC(CH3)3), 129.6 (d, 
CH2CH=CH), 130.2 (d, CH=CHCHOTBS), 133.7 (d, =CHCHOTBS ), 134.7 (d, CH2CH=), 
170.6 (s, COOtBu). - IR (ATR): v~  = 2956 (w), 2929 (m), 2857 (w), 1733 (m), 1468 (w), 
1366 (w), 1253 (m), 1153 (m), 1084 (m), 987 (m), 955 (w), 894 (w), 833 (s), 809 (m), 774 (s). 
- MS(ESI) m/z (%): 563 (100) [M+Na+], 449 (100) [M–TBS+Na++H]. - Combustion analysis: 
C30H60O4Si2 (540.97): calc. C 66.61, H 11.18; found C 66.93, H 11.37. 
 
(E,E)-6-(2-Hydroxyundeca-3,5-dienyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 4-33 via 
vinylogous aldol addition under basic conditions (General procedure): 
O O
O
C5H11
HO  
To a solution of 0.42 mL (3 mmol) iPr2NH in 8 mL dry THF, 1.87 mL (3 mmol) n-BuLi 
(1.6M in n-hexane) was added at −78 °C under a nitrogen atmosphere. After stirring for 20 
min a solution of 0.40 mL (3 mmol) 2,2,6-trimethyl-4H-1,3-dioxin-4-one 4-32 in 1 mL dry 
THF was added. After stirring for 30 min at −78 °C, 0.35 mL (2 mmol) of (2E,4E)-deca-2,4-
dienal 4-27 dissolved in 1 mL dry THF was added at the given temperature (Table 4.4). The 
reaction was stirred until complete by TLC. The reaction mixture was quenched with a few 
drops of saturated NH4Cl solution, warmed to r.t., and diluted with diethyl ether. The layers 
were separated. The aqueous layer was extracted three times with diethyl ether. The combined 
etheral layers were washed with water, dried over Na2SO4 and concentrated in vacuum. The 
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product was purified by flash chromatography (hexane/ethyl acetate 5:1, gradient to 1:1). The 
Michael adduct 4-34 eluted first, followed by product 4-33. For yields see Table 4.4. 
 
(E,E)-6-(2-Hydroxyundeca-3,5-dienyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 4-33 via 
vinylogous Mukaiyama aldol addition: 
2,2-Dimethyl-6-methylene-4-(trimethylsilyloxy)-1,3-dioxine 4-35 (1.8 g, 8.5 mmol) in 20 mL 
dry CH2Cl2 was added dropwise to a solution of 1.05 mL (5.1 mmol) (2E,4E)-2,4-decadienal 
4-27 (85% purity) and 0.59 mL (5.4 mmol) TiCl4 in 40 mL dry CH2Cl2 at −78 °C. The 
homogenous red solution changed to a dark colour. The consumption was monitored by TLC 
(hexane/ethyl acetate 3.5:1 (Rf(4-27) = 0.59, Rf(4-32) = 0.22)). After 35 min another 0.17 mL 
(0.8 mmol) of 4-27 was added and stirring was continued at −78 °C for 1.5 h. The reaction 
mixture was quenched with 20 mL of a sat’d NaHCO3 solution and warmed to r.t. The 
aqueous layer was extracted three times with CH2Cl2. The combined organic layers were 
dried over Na2SO4 and concentrated in vacuum. The crude oily product was purified by flash 
chromatography (hexane/ethyl acetate 5:1, gradient to 2:1). Some 4-32 eluted first with 
hexane/ethyl acetate 5:1 followed by 1.64 g (94% based on 4-27) of 4-33 as a pale yellow oil 
that crystallises slowly. 
Rf(hexane/ethyl acetate 2:1) = 0.34. - m.p. 47-49 °C. - 1H NMR (400 MHz): δ = 0.85 (t, J = 
6.9 Hz, 3H, CH2CH3), 1.19-1.30 (m, 4H, CH2CH2CH3), 1.35 (quint, J = 7.2 Hz, 2H, 
CH2CH2CH), 1.64 (s, 3H, OCCH3), 1.65 (s, 3H, OCCH3), 2.04 (q, J = 7.1 Hz, 2H, CH2CH=), 
2.29 (br. s, 1H, OH), 2.42 (AB part of ABX system, J = 14.4, 7.6, 5.5 Hz, 2H, 
CH(OH)CH2CO), 4.39 (dt, J = 6.8, 6.4 Hz, 1H, CHOH), 5.28 (s, 1H, C(O)=CHCO2), 5.52 
(dd, J = 15.2, 6.8 Hz, 1H, =CHCHOH), 5.70 (dt, J = 15.1, 6.9 Hz, 1H, CH2CH=), 5.96 (dd, J 
= 15.1, 10.4 Hz, 1H, CH2CH=CH), 6.19 (dd, J = 15.2, 10.4 Hz, 1H, CH=CHCHOH). - 13C 
NMR (100 MHz): δ = 14.0 (q, CH2CH3), 22.4 (t, CH2CH3), 24.9 (q, OCCH3), 25.3 (q, 
OCCH3), 28.7 (t, CH2CH2CH2CH3), 31.3 (t, CH2CH2CH3), 32.5 (t, CH2CH=), 41.5 (t, 
CH(OH)CH2CO), 69.6 (d, CHOH), 95.2 (d, C(O)=CHCO2), 106.7 (s, C(CH3)2), 128.8 (d, 
CH2CH=CH), 130.9 (d, =CHCHOH), 132.3 (d, CH=CHCHOH), 137.0 (d, CH2CH=), 161.2 
(s, =CHCO2), 168.5 (s, CH2C(O)=CH). - IR (Film): v~  = 3443 (w), 3023 (w), 2997 (w), 2959 
(m), 2922 (m), 2853 (m), 1693 (s), 1629 (s), 1392 (s), 1379 (s), 1336 (w), 1279 (s), 1254 (m), 
1201 (s), 1097 (w), 1044 (m), 1016 (s), 990 (s), 906 (m), 876 (w), 840 (w), 811 (s), 618 (m) 
cm-1. - MS (EI): m/z (%) = 294 (2) [M+], 276 (<1) [M+–H2O], 236 (52) [M+–OC(CH3)2], 218 
(12) [M+–H2O–OC(CH3)2], 208 (9) [M+–C(CH3)2OC=O], 192 (20) [M+–OC(CH3)2OC=O], 
190 (14), 179 (9) [M+–OC(CH3)2OC(=O)CH], 165 (16), 153 (29) [M+–
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C5H11CH=CHCH=CHCHOH], 150 (12), 137 (17), 126 (39), 121 (11), 111 (16), 98 (25), 95 
(30), 84 (100), 79 (37), 69 (28), 67 (46), 59 (16) [HOC(CH3)2+], 55 (23), 44 (8). - HRMS: 
C17H26O4: calc. 294.1831; found 294.1822. - Combustion analysis: C17H26O4 (294.39): calc. C 
69.36, H 8.90; found C 69.68, H 9.10. 
 
(E and Z)-6-(2-(2-oxoethyl)-3-nonenyl)-2,2-dimethyl-4H-1,3-dioxin-4-one 4-34: 
O O
O
OHC
C5H11 
Rf(hexane/ethyl acetate 2:1) = 0.46. - IR (Film): v~  = 3100 (w), 2997 (w), 2957 (m), 2926 (s), 
2856 (m), 2722 (w), 1721 (s), 1632 (s), 1389 (s), 1375 (s), 1270 (s), 1251 (m), 1202 (s), 1012 
(s), 971 (w), 901 (m), 837 (w), 803 (m) cm-1. - MS (EI): m/z (%) = 294 (<1) [M+], 236 (30) 
[M+–OC(CH3)2], 218 (9) [M+–H2O–OC(CH3)2], 207 (35) [M+–OC(CH3)2–Et], 193 (25) 
[M+H+–OC(CH3)2OC=O], 175 (8) [M+–OC(CH3)2OC=O–OH], 161 (16), 152 (21) [M+–
2,2,6-Trimethyl-1,3-dioxin-4-one–H], 137 (49), 124 (61), 112 (30), 98 (59), 95 (34), 91 (27), 
84 (92), 79 (50), 69 (100), 67 (61), 55 (55), 44 (21), 43 (89). - MS (ESI): m/z (%) = 317 
[M+Na+]. - HRMS: C17H26O4Na+: calc. 317.1723; found 317.1722. 
(E)-Isomer: 1H NMR (400 MHz): δ = 0.80 (t, J = 7.0 Hz, 3H, CH2CH3), 1.13-1.28 (m, 6H, 
CH2CH2CH2CH3), 1.59 (s, 3H, OCCH3), 1.61 (s, 3H, OCCH3), 1.90 (m, 2H, CH2CH=), 2.17 
(A part of ABX system, J = 14.3, 8.8 Hz, 1H, CH2C(O)=CH), 2.29 (B part of ABX system, J 
= 14.2, 5.6 Hz, 1H, CH2C(O)=CH), 2.42 (dd, J = 6.9, 1.9 Hz, 2H, CH2CHO), 2.89 (m, 1H, 
CHCH2CHO), 5.15 (s, 1H, CHCOO), 5.18 (ddt, J = 15.3, 8.3, 1.4 Hz, 1H, CH2CH=CH), 5.45 
(ddt, J = 14.7, 6.8, 1.1 Hz, 1H, CH2CH=), 9.64 (t, J = 1.9 Hz, 1H, CHO). - 13C NMR (100 
MHz): δ = 13.9 (q, CH2CH3), 22.3 (t, CH2CH3), 24.9 (q, OCCH3), 25.3 (q, OCCH3), 28.8 (t, 
CH2CH2CH=), 31.2 (t, CH2CH2CH3), 32.2 (t, CH2CH=), 34.4 (d, CHCH2CHO), 39.0 (t, 
CH2C(O)=), 48.3 (t, CH2CHO), 94.7 (d, C(O)=CHCOO), 106.5 (s, C(CH3)2), 129.9 (d, 
CH=CHCH), 133.2 (d, CH=CHCH), 160.8 (s, COO), 169.2 (s, CH2C(O)=CH), 200.8 (d, 
CHO).  
Detectable resonances of (Z)-Isomer: 1H NMR (400 MHz): δ = 5.18 (m, 1H, =CH), 5.45 (m, 
1H, CH=). - 13C NMR (100 MHz): δ = 24.86 (q, OCCH3), 25.2 (q, OCCH3), 27.6 (t, 
CH2CH2CH=), 29.1 (t, CH2CH=), 31.5 (t, CH2CH2CH3), 39.2 (t, CH2C(O)=), 48.7 (t, 
CH2CHO), 94.7 (d, C(O)=CHCOO), 106.3 (s, C(CH3)2), 129.6 (d, CH=CHCH), 132.6 (d, 
CH=CHCH), 161.7 (s, COO), 200.6 (d, CHO). 
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(E,E)-6-[(2-tert-Butyldimethylsilyloxy)undeca-3,5-dienyl]-2,2-dimethyl-4H-1,3-dioxin-4-
one 4-36: 
O O
O
C5H11
TBSO  
To a yellow solution of 1.0 g (3.40 mmol) dioxinone 4-33, 580 mg (8.50 mmol, 2.5 equiv.) 
imidazole and 41 mg (0.34 mmol) DMAP in 10 mL dry CH2Cl2 was added 615 mg (4.10 
mmol, 1.2 equiv.) TBSCl at r.t. A precipitate formed immediately. The mixture was stirred at 
r.t. for 4.5 h when it was complete by TLC (hexane/ethyl acetate 20:1 and 5:1). The reaction 
mixture was quenched with 2 mL water, extracted with diethyl ether and the combined 
ethereal layers were washed with brine. The organic layer was dried over MgSO4 and 
evaporated to give 1.60 g of a pale yellow oil, which was purified by flash chromatography 
(hexane/ethyl acetate 20:1, gradient to 5:1). Yield 1.10 g (80%) as a colourless oil. 
 
Table 6.3 Optimisation of silylation conditions of crude aldol product 4-33 
Entry Scale (mmol) Reaction time (min) 4-36 (%) 4-37 (%) 
1 1.3 150 62 13 
2 1.1 90 72 10 
3 7.0 60 65 7 
 
Rf(hexane/ethyl acetate 10:1) = 0.68. - 1H NMR (400 MHz): δ = –0.07 (s, 3H, Si(CH3)2), –
0.05 (s, 3H, Si(CH3)2), 0.78 (s, 9H, SiC(CH3)3), 0.82 (m, 3H, CH2CH3), 1.16-1.25 (m, 4H, 
CH2CH2CH3), 1.29 (tt, J = 14.3, 7.2 Hz, 2H, CH2CH2CH), 1.56 (s, 3H, OCCH3), 1.58 (s, 3H, 
OCCH3), 1.97 (dt, J = 7.2, 7.3 Hz, 2H, CH2CH=), 2.30 (AB part of ABM system, J = 14.0, 
7.0, 5.4 Hz, 2H, TBSOCHCH2CO), 4.31 (dt, J = 6.6, 6.2 Hz, 1H, CHOTBS), 5.16 (s, 1H, 
C(O)=CHCO2), 5.39 (dd, J = 15.1, 6.9 Hz, 1H, =CHCHOTBS), 5.59 (dt, J = 14.6, 7.2 Hz, 1H, 
CH2CH=), 5.88 (dd, J = 15.0, 10.5 Hz, 1H, CH2CH=CH), 6.02 (dd, J = 15.0, 10.5 Hz, 1H, 
CH=CHCHOTBS). - 13C NMR (50 MHz): δ = –4.3 (q, Si(CH3)2), 14.0 (q, CH2CH3), 18.0 (s, 
SiC(CH3)3), 22.4 (t, CH2CH3), 24.6 (q, OCCH3), 25.6 (q, OCCH3), 25.7 (q, SiC(CH3)3), 28.8 
(t, CH2CH2CH2CH3), 31.4 (t, CH2CH2CH3), 32.6 (t, CH2CH=), 43.1 (t, TBSOCHCH2CO), 
70.5 (d, CHOTBS), 95.3 (d, C(O)=CHCO2), 106.3 (s, C(CH3)2), 128.9 (d, CH2CH=CH), 
131.1 (d, =CHCHOTBS), 131.9 (d, CH=CHCHOTBS), 136.0 (d, CH2CH=), 161.1 (s, 
=CHCO2), 168.5 (s, CH2C(O)=CH). - IR (Film): v~  = 3000 (w), 2957 (m), 2928 (w), 2856 
(w), 1732 (s), 1636 (m), 1465 (w), 1375 (m), 1272 (m), 1251 (m), 1203 (m), 1067 (m), 1011 
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(m), 989 (s), 899 (w), 832 (s), 807 (s), 774 (s) cm-1. - MS (EI): m/z (%) = 408 (<1) [M+], 350 
(4) [M+–OC(CH3)2], 293 (87) [M+–TBS], 267 (53) [M+–6-methylene-2,2-dimethyl-1,3-
dioxin-4-one], 251 (8), 225 (4), 195 (5), 169 (7), 147 (7), 143 (12), 141 (45) [6-methylene-
2,2-dimethyl-1,3-dioxin-4-one+], 115 (7) [TBS+], 99 (33), 79 (20), 73 (100), 69 (15), 59 (10), 
43 (37). - Combustion analysis: C23H40O4Si (408.65): calc. C 67.60, H 9.87; found C 67.69, H 
10.03. 
 
(6E,8E)-tert-Butyl 5-(tert-butyldimethylsilyloxy)-3-oxotetradeca-6,8-dienoate 4-38: 
O
TBSO
CO2tBu
C5H11
 
The TBS-protected dioxinone 4-36 (1.0 g, 2.45 mmol) was refluxed in 25 mL dry tert-butanol 
under an argon atmosphere at 150 °C bath temperature for 32 hours when finished by TLC 
(hexanes/ethyl acetate 10:1). The colourless solution was evaporated. The remaining oil was 
purified by flash chromatography (hexanes/ethyl acetate 10:1). Yield 1.0 g (96%) 4-33 and 50 
mg of recovered dioxinone 4-36. 
Rf(hexanes/EtOAc 10:1) = 0.52. - 1H NMR (400 MHz): δ = 0.00 (s, 3H, Si(CH3)2), 0.01 (s, 
3H, Si(CH3)2), 0.84 (s, 9H, SiC(CH3)3), 0.86 (t, J = 6.6 Hz, 3H, CH2CH3), 1.23-1.29 (m, 4H, 
CH2CH2CH3), 1.36 (quint, J = 7.1 Hz, 2H, CH2CH2CH=), 1.43 (s, 9H, OC(CH3)3), 2.03 (q, J 
= 7.1 Hz, 2H, CH2CH=), 2.55 (A part of ABX system, J = 15.1, 4.9 Hz, 1H, 
TBSOCHCH2CO), 2.75 (B part of ABX system, J = 15.1, 7.7 Hz, 1H, TBSOCHCH2CO), 
3.34 (s, 2H, CH2COOtBu), 4.60 (dt, J = 5.0, 6.9 Hz, 1H, CHOTBS), 5.48 (dd, J = 15.2, 6.7 
Hz, 1H, TBSOCHCH=), 5.65 (dt, J = 15.1, 6.9 Hz, 1H, CH2CH=), 5.94 (dd, J = 15.1, 10.4 
Hz, 1H, CH2CH=CH), 6.11 (dd, J = 15.2, 10.4 Hz, 1H, TBSOCHCH=CH). - 13C NMR (100 
MHz): δ = –5.0 (q, Si(CH3)2), –4.4 (q, Si(CH3)2), 14.0 (q, CH2CH3), 18.1 (s, SiC(CH3)3), 22.5 
(t, CH2CH3), 25.8 (q, SiC(CH3)3), 28.0 (q, OC(CH3)3), 28.8 (t, CH2CH2CH2CH3), 31.4 (t, 
CH2CH2CH3), 32.6 (t, CH2CH=), 51.2 (t, TBSOCHCH2CO), 52.1 (t, CH2COOtBu), 70.1 (d, 
CHOTBS), 81.7 (s, OC(CH3)3), 129.2 (d, CH2CH=CH), 130.5 (d, CH=CHCHOTBS), 132.4 
(d, =CHCHOTBS), 135.6 (d, CH2CH=), 166.2 (s, COO), 201.5 (s, CHCH2C=O). - IR 
(Film): v~  = 2956 (m), 2928 (s), 2857 (m), 1745 (w), 1717 (m), 1648 (w), 1476 (w), 1409 
(w), 1367 (w), 1318 (w), 1250 (m), 1144 (m), 1070 (m), 988 (m), 942 (w), 832 (s), 807 (m), 
776 (s) cm-1. - MS (EI): m/z (%) = 424 (<1) [M+], 368 (6) [M+–CH2=C(CH3)2], 311 (17), 293 
(12) [M+–OTBS], 267 (30) [M+–CH2COCH2CO2tBu], 215 (8), 187 (7) 
[HOCHCH2COCH2CO2tBu+], 177 (8) [M+–TBSO–CH3CO2tBu], 159 (100) 
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[CH3COCH2CO2tBu+H+], 153 (27) [C5H11(CH=CH)2CHOH+], 143 (12) [COCH2CO2tBu+], 
135 (8), 115 (13) [TBS+], 91 (9), 75 (82), 73 (30), 57 (25), 43 (7), 41 (22). - HRMS: 
C24H44O4Si: calc. 424.3009; found 424.2988. - Combustion analysis: C24H44O4Si (424.69): 
calc. C 67.87, H 10.44; found C 67.66, H 10.48. 
Detectable resonances of the enol form: 1H NMR (400 MHz): δ =  –0.02 (s, 3H, Si(CH3)2), –
0.01 (s, 3H, Si(CH3)2), 1.44 (s, 9H, OC(CH3)3), 2.25 (m, 2H, TBSOCHCH2COH), 4.46 (m, 
1H, CHOTBS), 4.88 (s, 1H, =CHCOOtBu), 5.48 (m, 1H, TBSOCHCH=), 5.65 (m, 1H, 
CH2CH=), 5.94 (m, 1H, CH2CH=CH), 6.11 (m, 1H, TBSOCHCH=CH). - 13C NMR (100 
MHz): δ = –5.3 (q, Si(CH3)2), –4.5 (q, Si(CH3)2), 18.2 (s, SiC(CH3)3), 25.8 (q, SiC(CH3)3), 
28.3 (q, OC(CH3)3), 44.7 (t, TBSOCHCH2COH), 70.3 (d, CHOTBS), 80.5 (s, OC(CH3)3), 
93.0 (d, CHCOOtBu), 129.4 (d, CH2CH=CH), 130.1 (d, CH=CHCHOTBS), 133.0 (d, 
=CHCHOTBS), 135.1 (d, CH2CH=), 172.5 (s, CO2tBu), 174.2 (s, CH2COH). 
 
(6E,8E)-tert-Butyl 5-hydroxy-3-oxo-6,8-tetradecadienoate 4-28b from 4-38: 
O
HO
CO2tBu
C5H11
 
To a solution of 600 mg (1.41 mmol) 4-38 in 10 mL dry THF was added consecutively 0.086 
mL (1.5 mmol) glacial AcOH and 3 mL (3.00 mmol) of a 1M TBAF solution in THF at 0 °C. 
The mixture was warmed to r.t. and stirred for 4 h when finished by TLC (hexanes/ethyl 
acetate 2:1). The reaction mixture was diluted with diethyl ether, 0.25 mL of water was added 
and the mixture was filtered through a pad of silica gel. The solvent was evaporated and the 
residue was purified by flash chromatography (hexanes/ethyl acetate 5:1, gradient to 2:1) to 
give 385 mg (88%) of 4-28b as colourless oil.  
 
6.9.2. Oxidative cyclisation of 3-hydroxy esters 4-11a,b and 4-12a,b 
 
Oxidative cyclisations of 3-hydroxyester dianions 4-11a,b (General procedures): 
Procedure A: Anhydrous LiCl (234 mg, 5.53 mmol or 402 mg, 9.5 mmol) was heated in 
vacuum with stirring 3-5 times for 3 min at 10 min intervals. It was dissolved in 18 mL dry 
THF under nitrogen (only in two experiments, Table 4.9, entries 4 and 6). All the other 
experiments began directly with the preparation of LDA. To 18 mL dry THF 0.230 mL (1.62 
mmol, 2.5 equiv.) iPr2NH and 1.01 mL (1.62 mmol, 2.5 equiv.) BuLi (1.6M in hexane) were 
added subsequently at –78 °C. The resulting mixture was stirred for 30 min. Esters 4-11a,b 
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(0.79 mmol) dissolved in 1 mL dry THF were added dropwise to the LDA solution at –78 °C. 
The vial was rinsed with 1 mL THF. The mixture was warmed from –78 to –30 °C during 1 h, 
and stirred at –30 °C for 20 min. After cooling to –78 °C, 0.868 mL (4.99 mmol) HMPA was 
added dropwise followed by addition of 148 mg (0.95 mmol) TEMPO 1-2 as a solid. 
Sometimes HMPA precipitated, therefore the acetone bath was taken away shortly (2 min) 
until the HMPA dissolved. The mixture was stirred at –78 °C for 5 min and FeCp2PF6 1-3 was 
added in small portions with vigorous stirring. Each portion was added after consumption of 
the previous as monitored by the disappearence of the blue colour (About 392 mg of 1-3 were 
added in 10 min, when the reaction mixture remained blue and inhomogeneous. Two 
additional spatula tips of 1-3 were added subsequently). After the addition was complete, the 
reaction mixture was stirred at –78 - –70 °C for 20 min.  
Procedure B: A 20% solution of tBuMgCl in THF (0.754 mL, 1.2 mmol) was added via 
syringe to a solution of esters 4-11a,b (1 mmol) in 5 mL dry THF at –78 °C. The mixture was 
stirred for 30 min at –78 - –50 °C. After cooling to –78 °C, 0.65 mL of a 2M LDA solution in 
THF/n-heptane (1.3 mmol) was added and the mixture was stirred at –78 to –40 °C for 1 h. 
Dry THF (15 mL) and HMPA (1.1 mL, 6.3 mmol) were added at –78 °C followed by TEMPO 
1-2 (187 mg, 1.2 mmol) as a solid and the reaction mixture was stirred for 10 min. FeCp2PF6 
1-3 was added in small portions with vigorous stirring at –78 °C. Each portion was added 
after consumption of the previous as monitored by the disappearence of the blue colour (340 
mg of 1-3 was added in 5-10 min until the reaction mixture remained blue and 
inhomogeneous. Two additional spatula tips of 1-3 were added subsequently, total 580 mg 
(1.7 mmol). After the addition was complete, the reaction mixture was stirred at –75 - –65 °C 
for 20 min. 
Workup and isolation: The reaction mixture was quenched with 6-7 drops of water, diluted 
with diethyl ether and warmed to r.t. It was filtered through a pad of silica, which was washed 
with diethyl ether (200 mL). Most of the solvent was evaporated and the remaining material 
was preadsorbed on silica gel and purified via flash chromatography (hexane/ethyl acetate, 
gradient 50:1, 20:1, 10:1, 5:1 and 2:1). Ferrocene eluted first at a polarity 50:1 hexane/ethyl 
acetate. The products eluted starting from polarity 10:1 in the following order: 4-11a,b + 4-
48a,b+4-47a,b+4-46a,b , then 4-45a,b and finally 4-7a,b, both as diastereomeric mixtures in 
15-position. The fractions containing diastereomeric 4-45a,b and 4-7a,b were further enriched 
by another flash chromatography. For yields and ratios, see Tables 4.9 and 4.10. 
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Methyl 2-hydroxy-5-[(E)-3-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-
yl]cyclopentanecarboxylates: IR (Film): v~  = 3434 (w), 2930 (s), 2969 (m), 1734 (s), 1461 
(m), 1437 (m), 1375 (m), 1359 (m), 1259 (w), 1242 (w), 1199 (m), 1176 (m), 1134 (m), 1044 
(w), 1019 (w), 973 (s), 957 (s), 712 (w). 
 
(1S*,2S*,5R*)-Methyl 2-hydroxy-5-[(1E, 3S*)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentanecarboxylate α-4-7a: 
COOMe
HO
C5H11
OTMP  
1H NMR (400 MHz): δ = 0.88 (m, 3H, CH2CH3), 1.02-1.19 (m, 12H, NC(CH3)2), 1.21-1.59 
(m, 13H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, CH2CHOTMP), 1.60-1.75 (m, 3H, 
CH2CHOTMP, CH2CH2CHOH), 2.02 (m, 1H, CH2CH2CHOH), 2.22 (m, 1H, CH2CHOH), 
2.81 (dd, J = 8.5, 6.7 Hz, 1H, CHCOOMe), 3.06 (m, 1H, CHCHCH=), 3.64 (s, 3H, 
COOCH3), 3.93 (dt, J = 4.6, 8.4 Hz, 1H, CHOTMP), 4.57 (m, 1H, CHOH), 5.28 (dd, J = 15.3, 
8.6 Hz, 1H, CH=CHCHOTMP), 5.38 (m, 1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = 
14.1 (q, CH2CH3), 17.3 (t, NCCH2CH2CH2CN), 20.2 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 
22.6 (t, CH2CH3), 25.0 (t, CH2CH2CH3CH3), 29.1 (t, CH2CH2CHOH), 32.0 (t, CH2CH2CH3), 
32.8 (t, CH2CHOH), 33.9 (q, NC(CH3)2), 34.5 (t, TMPOCHCH2), 35.4 (q, NC(CH3)2), 40.2 (t, 
NCCH2CH2CH2CN), 43.5 (d, CHCHCH=), 51.4 (q, COOCH3), 57.2 (d, CHCOOMe), 58.9 (s, 
NC(CH3)2), 59.2 (s, NC(CH3)2), 74.4 (d, CHOH), 84.8 (d, CHOTMP), 130.9 (d, 
CH=CHCHOTMP), 134.6 (d, =CHCHOTMP), 173.4 (s, C=O). 
 
(1S*,2S*,5R*)-Methyl 2-hydroxy-5-[(1E, 3R*)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentanecarboxylate β-4-7a: 
COOMe
HO
C5H11
OTMP  
1H NMR (400 MHz): δ = 0.89 (m, 3H, CH2CH3), 1.04-1.17 (m, 12H, NC(CH3)2), 1.19-1.34 
(m, 7H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.35-1.59 (m, 6H, NCCH2CH2CH2CN, 
CH2CHOTMP), 1.59-1.73 (m, 3H, CH2CHOTMP, CH2CH2CHOH), 1.97 (m, 1H, 
CH2CH2CHOH), 2.20 (m, 1H, CH2CHOH), 2.82 (dd, J = 8.4, 5.9 Hz, 1H, CHCOOMe), 3.07 
(m, 1H, CHCHCHOH), 3.67 (s, 3H, COOCH3), 3.99 (m, 1H, CHOTMP), 4.57 (m, 1H, 
CHOH), 5.35 (dd, J = 15.4, 7.0 Hz, 1H, CH=CHCHOTMP), 5.42 (dd, J = 15.5, 7.5 Hz, 
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=CHCHOTMP). - 13C NMR (100 MHz): δ = 14.0 (q, CH2CH3), 17.2 (t, NCCH2CH2CH2CN), 
20.2 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.6 (t, CH2CH3), 25.1 (t, CH2CH2CH3CH3), 29.2 (t, 
CH2CH2CHOH), 31.9 (t, CH2CH2CH3), 33.0 (t, CH2CHOH), 34.3 (t, TMPOCHCH2), 34.9 (q, 
NC(CH3)2), 35.2 (q, NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 43.2 (d, CH2CHCH=CH), 51.4 
(q, COOCH3), 57.0 (d, CHCOOMe), 58.9 (s, NC(CH3)2), 60.0 (s, NC(CH3)2), 74.7 (d, 
CHOH), 84.6 (d, CHOTMP), 130.5 (d, =CHCHOTMP), 134.0 (d, CH=CHCHOTMP), 173.5 
(s, C=O). 
 
(1R*,2S*,5R*)-Methyl 2-hydroxy-5-[(1E,3S*)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentanecarboxylate α-4-45a: 
COOMe
HO
C5H11
OTMP  
1H NMR (400 MHz): δ = 0.87 (t, J = 6.9 Hz, 3H, CH2CH3), 1.03 (br. s, 6H, NC(CH3)2), 1.10 
(br. s, 3H, NC(CH3)2), 1.15 (br. s, 3H, NC(CH3)2), 1.22-1.35 (m, 8H, NCCH2CH2CH2CN, 
CH2CH2CH2CH2CH3), 1.41-1.63 (m, 6H, NCCH2CH2CH2CN, CH2CHOTMP, 
CHβHCH2CHOH), 1.68 (m, 1H, CH2CHOTMP), 1.76 (m, 1H, CHαHCHOH), 1.98 (m, 1H, 
CHβHCHOH), 2.10 (m, 1H, CHαHCH2CHOH), 2.55 (dd, J = 10.6, 5.0 Hz, 1H, CHCOOMe), 
3.08 (m, 1H, CHCHCHOH), 3.71 (s, 3H, COOCH3), 3.99 (m, 1H, CHOTMP), 4.46 (dt, J = 
2.9, 5.1 Hz, 1H, CHOH), 5.42 (m, 2H, CH=CH). - 13C NMR (100 MHz): δ = 14.0 (q, 
CH2CH3), 17.3 (t, NCCH2CH2CH2CN), 20.2 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.6 (t, 
CH2CH3), 25.0 (t, CH2CH2CH2CH3), 29.9 (t, CH2CH2CHOH), 31.8 (t, CH2CH2CH3), 33.8 (q, 
NC(CH3)2), 33.9 (t, CH2CHOH), 34.4 (t, TMPOCHCH2), 35.2 (q, NC(CH3)2), 40.2 (t, 
NCCH2CH2CH2CN), 43.5 (d, CHCHCH=), 51.8 (q, COOCH3), 55.3 (d, CHCOOMe), 58.9 (s, 
NC(CH3)2), 60.0 (s, NC(CH3)2), 74.3 (d, CHOH), 85.0 (d, CHOTMP), 132.9 (d, CH=CH), 
133.2 (d, CH=CH), 174.6 (s, C=O). - Significant NOE enhancements: 
H4!
HO
H6
H2
H3
E
H5!
H4
H5
C5H11
OTMP
H8
H7
2.9
2.6
2.8
1.3
1.2
H9
0.7
1.0
4 (7+8)
2.4 (7+8)
6.5
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(1R*,2S*,5R*)-Methyl 2-hydroxy-5-[(1E,3R*)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentanecarboxylate β-4-45a: 
COOMe
HO
C5H11
OTMP  
1H NMR (400 MHz): δ = 0.88 (m, 3H, CH2CH3), 1.03 (br. s, 6H, NC(CH3)2), 1.10 (br. s, 3H, 
NC(CH3)2), 1.15 (br. s, 3H, NC(CH3)2), 1.23-1.40 (m, 7H, NCCH2CH2CH2CN, 
CH2CH2CH2CH2CH3), 1.41-1.61 (m, 7H, NCCH2CH2CH2CN, CH2CHOTMP, 
CHβHCH2CHOH), 1.67 (m, 1H, CH2CHOTMP), 1.77 (m, 1H, CHαHCHOH), 1.95 (m, 1H, 
CHβHCHOH), 2.13 (m, 1H, CHαHCH2CHOH), 2.48 (dd, J = 11.0, 4.6 Hz, 1H, CHCOOMe), 
3.07 (m, 1H, CHCHCHOH), 3.69 (s, 3H, COOCH3), 4.03 (m, 1H, CHOTMP), 4.45 (m, 1H, 
CHOH), 5.39 (m, 2H, CH=CH). - 13C NMR (100 MHz): δ = 14.0 (q, CH2CH3), 17.3 (t, 
NCCH2CH2CH2CN), 20.2 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.6 (t, CH2CH3), 25.0 (t, 
CH2CH2CH3CH3), 29.6 (t, CH2CH2CHOH), 31.9 (t, CH2CH2CH3), 33.9 (t, CH2CHOH), 34.0 
(q, NC(CH3)2),  34.3 (t, CH2CHOTMP), 35.3 (q, NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 
44.1 (d, CHCHCH=), 51.6 (q, COOCH3), 55.3 (d, CHCOOMe), 58.8 (s, NC(CH3)2), 60.1 (s, 
NC(CH3)2), 74.1 (d, CHOH), 85.0 (d, CHOTMP), 133.1 (d, CH=CH), 133.7 (d, CH=CH), 
174.8 (s, C=O).  
 
Methyl 2-hydroxy-3-[(1E,3S* and R*)-3-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-
1-yl]cyclopentanecarboxylate α- and β-4-46a: 
COOMe
HO
C5H11
OTMP  
4-46a-I5: 1H NMR (400 MHz): δ = 0.89 (m, 3H, CH2CH3), 1.03-1.52 (m, 25H, NC(CH3)2, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.68-1.94 (m, 6H, CH2CH2CHOH, 
CH2CHOTMP), 2.89 (dd, J = 8.7, 4.3 Hz, 1H, CHCOOMe), 2.95 (m, 1H, CHCHCHOH), 
3.74 (s, 3H, COOCH3), 4.01 (m, 1H, CHOTMP), 4.43 (m, 1H, CHOH), 5.40 (dd, J = 15.4, 
8.1, 1H, =CHCHOTMP), 5.53 (dd, J = 15.4, 8.2 Hz, 1H, CH=CHCHOTMP). - 13C NMR (100 
MHz): δ = 13.9 (q, CH2CH3), 17.2 (t, NCCH2CH2CH2CN), 20.3 (q, NC(CH3)2), 22.5 (t, 
CH2CH3), 25.1 (t, CH2CH2CH3CH3), 29.9 (t, CH2CH2CHOH), 31.9 (t, CH2CH2CH3), 33.3 (t, 
CH2CHOH), 33.4 (q, NC(CH3)2), 34.1 (q, NC(CH3)2), 34.3 (t, CH2CHOTMP), 40.2 (t, 
NCCH2CH2CH2CN), 43.4 (d, CHCHCH=), 51.4 (q, COOCH3), 52.8 (d, CHCOOMe), 73.8 (d, 
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CHOH), 84.2 (d, CHOTMP), 132.5 (d, CH=CHCHOTMP), 133.5 (d, =CHCHOTMP), 174.2 
(s, C=O).  
 
4-46a-I6: 1H NMR (400 MHz): δ = 0.89 (m, 3H, CH2CH3), 1.01-1.69 (m, 26H, NC(CH3)2, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.76 (m, 1H, CH2CHOH), 1.82-1.98 (m, 3H, 
CH2CHOH, CH2CH2CHOH), 2.82 (dd, J = 9.0, 4.1 Hz, 1H, CHCOOMe), 2.98 (m, 1H, 
CHCHCHOH), 3.66 (s, 3H, COOCH3), 3.85 (br. s, 1H, OH), 3.95 (dt, J = 8.4, 4.7 Hz, 1H, 
CHOTMP), 4.43 (m, 1H, CHOH), 5.31 (dd, J = 15.2, 8.6, 1H, =CHCHOTMP), 5.53 (m, 1H, 
CH=CHCHOTMP). - 13C NMR (100 MHz): δ = 14.0 (q, CH2CH3), 17.3 (t, 
NCCH2CH2CH2CN), 20.3 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.5 (t, CH2CH3), 25.0 (t, 
CH2CH2CH3CH3), 29.9 (t, CH2CH2CHOH), 32.1 (t, CH2CH2CH3), 33.5 (t, CH2CHOH), 33.9 
(q, NC(CH3)2),  34.6 (t, TMPOCHCH2), 35.3 (q, NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 
43.7 (d, CHCHCH=), 51.4 (q, COOCH3), 53.2 (d, CHCOOMe), 60.0 (s, NC(CH3)2), 60.3 (s, 
NC(CH3)2), 73.7 (d, CHOH), 84.6 (d, CHOTMP), 133.5 (d, CH=CH), 133.9 (d, CH=CH), 
174.3 (s, C=O). 
 
Assignable resonances of 4-46a-I7: 1H NMR (400 MHz): δ = 2.51 (m, 1H, CHCOOMe), 2.72 
(m, 1H, CHCHCH=), 3.68 (s, 3H, COOCH3), 4.40 (m, 1H, CHOH). - 13C NMR (100 MHz): δ 
= 45.1 (d, CHCHCH=), 51.5 (q, COOCH3), 76.5 (d, CHOH), 133.1 (d, CH=), 133.4 (d, =CH), 
174.8 (s, C=O). 
 
Assignable resonances of 4-46a-I8: 1H NMR (400 MHz): δ = 2.52 (m, 1H, CHCOOMe), 3.70 
(s, 3H, COOCH3), 3.99 (m, 1H, CHOTMP), 4.39 (m, 1H, CHOH). - 13C NMR (100 MHz): δ 
= 29.8 (t, CH2CH2CHOH), 31.8 (t, CH2CH2CH3), 33.6 (t, CH2CHOH), 34.4 (t, 
CH2CHOTMP), 40.2 (t, NCCH2CH2CH2CN), 44.6 (d, CHCHCH=), 51.8 (q, COOCH3), 59.1 
(d, CHCOOMe), 76.8 (d, CHOH), 84.9 (d, CHOTMP), 132.9 (d, CH=CH), 133.1 (d, 
CH=CH), 174.9 (s, C=O). 
 
(6E,8E)-Methyl 3-hydroxy-2-(2,2,6,6-tetramethylpiperidin-1-yloxy)tetradeca-6,8-
dienoate 4-48a: 
C5H11 OMe
OOH
OTMP  
1H NMR (400 MHz): δ = 0.89 (m, 3H, CH2CH3), 1.01-1.69 (m, 26H, NC(CH3)2, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, CH2CHOH), 2.04 (m, 2H, CH2CH2CH=), 2.15 
(m, 1H, CH2CH2CHOH), 2.29 (m, 1H, CH2CH2CHOH), 2.46 (m, 1H, OH), 3.74 (s, COOMe), 
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4.16 (dt, J = 8.7, 4.3 Hz, 1H, CHOH), 4.27 (d, J = 3.9 Hz, 1H, CHOTMP), 5.57 (m, 2H, 
CH=CHCH=CH), 6.00 (m, 2H, CH=CHCH=CH). - 13C NMR (100 MHz): δ = 14.1 (q, 
CH2CH3), 17.0 (t, NCCH2CH2CH2CN), 20.3 (q, NC(CH3)2), 20.7 (q, NC(CH3)2), 22.6 (t, 
CH2CH3), 28.8 (t, CH2CH2CHOH), 29.0 (t, CH2CH2CH2CH3), 31.4 (t, CH2CH2CH3), 32.5 (t, 
=CHCH2(CH2)3), 32.8 (t, CH2CHOH), 33.9 (q, NC(CH3)2), 34.5 (q, NC(CH3)2), 40.3 (t, 
NCCH2CH2CH2CN), 51.5 (q, COOCH3), 60.0 (s, NC(CH3)2), 60.3 (s, NC(CH3)2), 71.1 (d, 
CHOH), 87.1 (d, CHOTMP), 130.0 (d, =CH), 130.7 (d, CH=), 131.2 (d, =CH), 133.1 (d, 
=CH), 171.6 (s, C=O). 
 
(1S*,2S*,5R*)-tert-Butyl 2-hydroxy-5-[(1E,3S*)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentanecarboxylate α-4-7b: 
COOtBu
HO
C5H11
OTMP  
1H NMR (400 MHz): δ = 0.83 (m, 3H, CH2CH3), 1.02-1.08 (m, 12H, NC(CH3)2), 1.18-1.58 
(m, 13H, NCCH2CH2CH2CN, CH2CH2CH2CH3, CH2CHOTMP), 1.40 (s, 9H, C(CH3)3), 1.55 
(m, 1H, CH2CHOH), 1.64 (m, 2H, CH2CH2CHOH, CH2CHOTMP), 1.93 (m, 1H, 
CH2CH2CHOH), 2.16 (m, 1H, CH2CHOH), 2.65 (dd, J = 8.1, 6.2 Hz, 1H, CHCOOtBu), 2.97 
(m, 1H, CH2CHCH=), 3.96 (dt, J = 5.1, 7.6 Hz, 1H, CHOTMP), 4.46 (dd, J = 13.3, 6.2 Hz, 
1H, CHOH), 5.34 (dd, J = 15.3, 7.2 Hz, 1H, CH=CHCHOTMP), 5.40 (dd, J = 15.4, 7.2 Hz, 
1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = 13.9 (q, CH2CH3), 17.2 (t, 
NCCH2CH2CH2CN), 20.2 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.46 (t, CH2CH3), 25.0 (t, 
CH2CH2CH2CH3), 28.0 (q, C(CH3)3), 29.0 (t, CH2CH2CHOH), 32.0 (t, CH2CH2CH3), 32.5 (t, 
CH2CHOH), 33.9 (q, NC(CH3)2), 34.6 (t, CH2CHOTMP), 34.9 (q, NC(CH3)2), 40.1 (t, 
NCCH2CH2CH2CN), 43.3 (d, CH2CHCH=), 58.1 (d, CHCOOtBu), 58.9 (s, NC(CH3)2), 74.5 
(d, CHOH), 80.5 (s, C(CH3)3), 84.55 (d, CHOTMP), 131.1 (d, CH=CHCHOTMP), 134.0 (d, 
=CHCHOTMP), 172.3 (s, C=O). 
 
(1S*,2S*,5R*)-tert-Butyl 2-hydroxy-5-[(R*,E)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentanecarboxylate β-4-7b: 
COOtBu
HO
C5H11
OTMP  
1H NMR (400 MHz): δ = 0.83 (m, 3H, CH2CH3), 1.02-1.08 (m, 12H, NC(CH3)2), 1.18-1.58 
(m, 13H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, CH2CHOTMP), 1.43 (s, 9H, C(CH3)3), 
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1.55 (m, 1H, CH2CHOH), 1.64 (m, 2H, CH2CH2CHOH, CH2CHOTMP), 1.93 (m, 1H, 
CH2CH2CHOH), 2.16 (m, 1H, CH2CHOH), 2.66 (dd, J = 8.0, 5.7 Hz, 1H, CHCOOtBu), 2.99 
(m, 1H, CH2CHCH=), 3.96 (m, 1H, CHOTMP), 4.43 (dd, J = 12.9, 5.7 Hz, 1H, CHOH), 5.40 
(m, 2H, CH=CHCHOTMP). - 13C NMR (100 MHz): δ = 13.9 (q, CH2CH3), 17.2 (t, 
NCCH2CH2CH2CN), 20.2 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.48 (t, CH2CH3), 25.1 (t, 
CH2CH2CH2CH3), 28.1 (q, C(CH3)3), 29.1 (t, CH2CH2CHOH), 31.8 (t, CH2CH2CH3), 32.7 (t, 
CH2CHOH), 33.9 (q, NC(CH3)2), 34.1 (t, CH2CHOTMP), 34.9 (q, NC(CH3)2), 40.1 (t, 
NCCH2CH2CH2CN), 43.0 (d, CH2CHCH=), 57.8 (d, CHCOOtBu), 58.9 (s, NC(CH3)2), 74.8 
(d, CHOH), 80.6 (s, C(CH3)3), 84.48 (d, CHOTMP), 130.7 (d, CH=), 133.8 (d, =CH), 172.4 
(s, C=O). Significant NOE enhancements: 
H
4!
HO
H
6
E
H
3
H
2
H
5!
H
4"
H
5"
C5H11
OTMPH
8
H
7
H
9
3.8
2.9
2.5
2.2
1.3
4.6  
 
(1R*,2S*,5R*)-tert-Butyl 2-hydroxy-5-[(1E,3S*)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentanecarboxylate α-4-45b: 
COOtBu
HO
C5H11
OTMP  
1H NMR (400 MHz): δ = 0.83 (t, J = 6.8 Hz, 3H, CH2CH3), 1.10-1.12 (m, 12H, NC(CH3)2), 
1.15-1.30 (m, 7H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.30-1.60 (m, 7H, 
NCCH2CH2CH2CN, CH2CHOTMP, CH2CHOH), 1.43 (s, 9H, C(CH3)3), 1.71 (m, 2H, 
CH2CHOTMP, CH2CH2CHOH), 1.86 (m, 1H, CH2CH2CHOH), 2.06 (m, 1H, CH2CHOH), 
2.41 (dd, J = 10.3, 4.9 Hz, 1H, CHCOOtBu), 3.07 (m, 1H, CH2CHCH=), 3.98 (m, 1H, 
CHOTMP), 4.38 (m, 1H, CHOH), 5.40 (dd, J = 15.6, 7.3 Hz, 1H, CH=CHCHOTMP), 5.47 
(dd, J = 15.5, 6.0 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = 13.8 (q, CH2CH3), 
17.1 (t, NCCH2CH2CH2CN), 20.3 (q, NC(CH3)2), 22.4 (t, CH2CH3), 25.0 (t, 
CH2CH2CH2CH3), 28.00 (q, OC(CH3)3), 29.5 (t, CH2CHOH), 31.7 (t, CH2CH2CH3), 33.6 (t, 
CH2CH2CHOH), 33.9 (q, NC(CH3)2), 34.1 (t, CH2CHOTMP), 35.1 (q, NC(CH3)2), 40.0 (t, 
NCCH2CH2CH2CN), 42.9 (d, CH2CHCH=), 55.6 (d, CHCOOtBu), 58.9 (s, NC(CH3)2), 59.7 
(s, NC(CH3)2), 74.2 (d, CHOH), 81.1 (s, C(CH3)3), 84.6 (d, CHOTMP), 132.1 (d, 
CH=CHCHOTMP), 133.1 (d, =CHCHOTMP), 173.5 (s, C=O). 
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(1R*,2S*,5R*)-tert-Butyl 2-hydroxy-5-[(1E,3R*)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentanecarboxylate β-4-45b: 
COOtBu
HO
C5H11
OTMP  
1H NMR (400 MHz): δ = 0.83 (t, J = 6.8, 3H, CH2CH3), 1.10-1.12 (m, 12H, NC(CH3)2), 1.15-
1.30 (m, 7H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.30-1.60 (m, 7H, 
NCCH2CH2CH2CN, CH2CHOTMP, CH2CHOH), 1.43 (s, 9H, C(CH3)3), 1.71 (m, 2H, 
CH2CHOTMP, CH2CH2CHOH), 1.86 (m, 1H, CH2CH2CHOH), 2.06 (m, 1H, CH2CHOH), 
2.33 (dd, J = 10.6, 4.7 Hz, 1H, CHCOOtBu), 3.07 (m, 1H, CH2CHCH=), 3.98 (m, 1H, 
CHOTMP), 4.38 (m, 1H, CHOH), 5.37 (m, 2H, CH=CHCHOTMP). - 13C NMR (100 MHz): 
δ = 13.9 (q, CH2CH3), 17.1 (t, NCCH2CH2CH2CN), 20.3 (q, NC(CH3)2), 22.4 (t, CH2CH3), 
24.9 (t, CH2CH2CH2CH3), 27.97 (q, OC(CH3)3), 29.4 (t, CH2CHOH), 31.8 (t, CH2CH2CH3), 
33.7 (t, CH2CH2CHOH), 33.9 (q, NC(CH3)2), 34.4 (t, CH2CHOTMP), 35.1 (q, NC(CH3)2), 
40.1 (t, NCCH2CH2CH2CN), 43.7 (d, CH2CHCH=), 55.9 (d, CHCOOtBu), 58.9 (s, 
NC(CH3)2), 59.7 (s, NC(CH3)2), 74.1 (d, CHOH), 81.1 (s, C(CH3)3), 84.7 (d, CHOTMP), 
133.0 (d, CH=CHCHOTMP), 133.5 (d, =CHCHOTMP), 173.6 (s, C=O). 
 
tert-Butyl 2-hydroxy-5-[(1E,S* and R*)-3-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-
1-yl]cyclopentanecarboxylate α- and β-4-46b: 
COOtBu
HO
C5H11
OTMP  
Assignable resonances of 4-46b-I3-1: 1H NMR (400 MHz): δ = 1.27-1.58 (m, 6H, 
NCCH2CH2CH2CN, CH2CHOTMP), 1.64 (m, 3H, CH2CHOTMP, CH2CH2CHOH), 1.83 (m, 
1H, CH2CH2CHOH), 1.93 (m, 1H, CH2CHOH), 2.37 (dd, J = 9.5, 6.5 Hz, 1H, CHCOOtBu), 
2.71 (m, 1H, CH2CHCH=), 3.96 (m, 1H, CHOTMP), 4.30 (m, 1H, CHOH), 5.48 (dd, J = 
15.6, 6.6 Hz, 1H, CH=CHCHOTMP). - 13C NMR (100 MHz): δ = 29.4 (t, CH2CH2CHOH), 
31.8 (t, CH2CH2CH3), 33.4 (t, CH2CHOH), 34.3 (t, CH2CHOTMP), 43.7 (d, CH2CHCH=), 
59.8 (d, CHCOOtBu), 76.5 (d, CHOH), 84.8 (d, CHOTMP), 132.3 (d, =CHCHOTMP), 133.3 
(d, CH=CHCHOTMP), 170.2 (s, C=O). 
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Assignable resonances of 4-46b-I3-2: 1H NMR (400 MHz): δ = 1.67 (m, 3H, CH2CHOTMP, 
CH2CH2CHOH), 1.87 (m, 1H, CH2CH2CHOH), 1.99 (m, 1H, CH2CHOH), 2.36 (dd, J = 9.8, 
6.6 Hz, 1H, CHCOOtBu), 2.74 (m, 1H, CH2CHCH=), 3.99 (m, 1H, CHOTMP), 4.34 (m, 1H, 
CHOH), 5.52 (dd, J = 15.5, 6.6 Hz, 1H, CH=CHCHOTMP). - 13C NMR (100 MHz): δ = 14.0 
(q, CH2CH3), 17.2 (t, NCCH2CH2CH2CN), 22.5 (d, CH2CH3), 25.1 (t, CH2CH2CH2CH3), 28.1 
(q, C(CH3)3), 29.2 (t, CH2CH2CHOH), 31.9 (d, CH2CH2CH3), 33.4 (t, CH2CHOH), 34.4 (d, 
CH2CHOTMP), 40.2 (t, NCCH2CH2CH2CN), 44.7 (d, CH2CHCH=), 60.2 (d, CHCOOtBu), 
76.5 (d, CHOH), 80.5 (s, C(CH3)3), 84.9 (d, CHOTMP), 133.0 (d, =CHCHOTMP), 133.7 (d, 
CH=CHCHOTMP). 
 
4-46b-I4-1: 1H NMR (400 MHz): δ = 0.88 (m, 3H, CH2CH3), 1.03-1.17 (m, 12H, NC(CH3)2), 
1.26-1.58 (m, 13H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, CH2CHOTMP), 1.45 or 1.47 
(s, 9H, C(CH3)3), 1.60 (m, 1H, CH2CHOTMP), 1.82-1.89 (m, 4H, CH2CH2CHOH), 2.70 (dd, 
J = 8.4, 4.4 Hz, 1H, CHCOOtBu), 2.91 (m, 1H, CH2CHCH=), 4.02 (ddd, J = 8.5, 6.8, 5.5 Hz, 
1H, CHOTMP), 4.40 (m, 1H, CHOH), 5.37 (dd, J = 15.3, 8.7 Hz, 1H, =CHCHOTMP), 5.63 
(dd, J = 15.3, 9.0 Hz, 1H, CH=CHCHOTMP). - 13C NMR (100 MHz): δ = 13.9 (q, CH2CH3), 
17.2 (t, NCCH2CH2CH2CN), 20.5 (q, NC(CH3)2), 22.4 (t, CH2CH3), 24.9 (t, 
CH2CH2CH2CH3), 28.0 or 28.2 (q, OC(CH3)3), 29.8 (t, CH2CH2CHOH), 31.3 (t, 
CH2CH2CH3), 33.2 (t, CH2CHOH), 33.9 (q, NC(CH3)2), 34.7 (t, CH2CHOTMP), 34.8 (q, 
NC(CH3)2), 40.1 (t, NCCH2CH2CH2CN), 43.8 (d, CH2CHCH=), 53.6 (d, CHCOOtBu), 58.8 
(s, NC(CH3)2), 60.5 (s, NC(CH3)2), 73.7 (d, CHOH), 81.2 or 81.7 (s, C(CH3)3), 84.2 (d, 
CHOTMP), 133.1 (d, =CHCHOTMP), 133.4 (d, CH=CHCHOTMP), 173.1 or 174.3 (s, 
C=O). 
 
Assignable resonances of 4-46b-I4-2: 1H NMR (400 MHz): δ = 2.81 (dd, J = 8.6, 4.6 Hz, 1H, 
CHCOOtBu), 2.94 (m, 1H, CH2CHCH=), 4.03 (m, 1H, CHOTMP), 4.43 (m, 1H, CHOH). 
 
tert-Butyl 2-hydroxy-5-[(1S* and R*)-1-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-2-en-1-
yl]cyclopentanecarboxylate 4-47b: 
COOtBu
HO
OTMP
C5H11
 
4-47b-CPP1: 1H NMR (400 MHz): δ = 0.88 (m, 3H, CH2CH3), 1.03-1.17 (m, 12H, 
NC(CH3)2), 1.26-1.58 (m, 12H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.45 or 1.47 (s, 
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9H, C(CH3)3), 1.75 (m, 3H, CH2CH2CHOH), 1.97 (m, 1H, CH2CH2CHOH), 2.04 (m, 2H, 
CH2CHOTMP), 2.60 (m, 1H, CH2CHCH=), 2.88 (dd, J = 9.2, 4.9 Hz, 1H, CHCOOtBu), 4.26 
(m, 1H, CHOTMP), 4.40 (m, 1H, CHOH), 5.48 (m, 2H, CH =CHCHOTMP). - 13C NMR (100 
MHz): δ = 13.9 (q, CH2CH3), 17.2 (t, NCCH2CH2CH2CN), 20.5 (q, NC(CH3)2), 22.4 (t, 
CH2CH3), 24.2 (t, CH2CH2CHOH), 28.0 or 28.2 (q, OC(CH3)3), 28.6 (t, CH2CH2CH2CH3), 
32.0 (t, CH2CH2CH3), 32.1 (t, CH2CHOTMP), 33.9 (q, NC(CH3)2), 34.1 (t, CH2CHOH), 34.8 
(q, NC(CH3)2), 40.1 (t, NCCH2CH2CH2CN), 45.1 (d, CH2CHCH=), 51.5 (d, CHCOOtBu), 
58.8 (s, NC(CH3)2), 60.5 (s, NC(CH3)2), 74.6 (d, CHOH), 81.2 or 81.7 (s, C(CH3)3), 84.6 (d, 
CHOTMP), 130.8 (d, CH=), 133.9 (d, =CH), 173.1 or 174.3 (s, C=O). 
 
Assignable resonances of 4-47b-CPP2: 1H NMR (400 MHz): δ = 2.51 (dd, J = 9.6, 4.7 Hz, 
1H, CHCOOtBu), 2.78 (m, 1H, CH2CHCH=), 4.16 (dd, J = 9.1, 5.3 Hz, 1H, CHOTMP), 4.35 
(m, 1H, CHOH), 5.41 (m, 2H, CH =CHCHOTMP). - 13C NMR (100 MHz): δ = 24.4 (t, 
CH2CH2CHOH), 28.1 (q, OC(CH3)3), 28.8 (t, CH2CH2CH2CH3), 34.0 (t, CH2CHOH), 40.2 (t, 
NCCH2CH2CH2CN), 44.1 (d, CH2CHCH=), 52.1 (d, CHCOOtBu), 74.5 (d, CHOH), 86.6 (d, 
CHOTMP), 129.2 (d, CH=), 135.1 (d, =CH), 174.6 (s, C=O). 
 
(6E,8E)-tert-Butyl 3-hydroxy-2-(2,2,6,6-tetramethylpiperidin-1-yloxy)tetradeca-6,8-
dienoate 4-48b: 
C5H11 OtBu
OOH
OTMP  
1H NMR (400 MHz): δ = 0.88 (m, 3H, CH2CH3), 1.45 (m, 12H, NC(CH3)2), 1.26-1.49 (m, 
12H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.49 (s, 9H, OC(CH3)3), 1.54 (m, 2H, 
CH2CHOH), 2.04 (q, J = 7.2 Hz, 2H, CH2CH2CH2CH=), 2.14 (m, 1H, CH2CH2CHOH), 2.26 
(m, 1H, CH2CH2CHOH), 2.58 (m, 1H, OH), 4.14 (m, 1H, CHOTMP), 4.17 (m, 1H, CHOH), 
5.55 (m, 2H, CH=CHCH=CH), 6.01 (m, 2H, CH=CHCH=CH). - 13C NMR (100 MHz): δ = 
14.0 (q, CH2CH3), 17.1 (t, NCCH2CH2CH2CN), 20.1 (q, NC(CH3)2), 22.5 (t, CH2CH3), 28.1 
(q, C(CH3)3), 28.8 (t, CH2CH2CHOH), 29.0 (t, CH2CH2CH2CH3), 31.4 (t, CH2CH2CH3), 32.5 
(t, =CHCH2CH2CH2), 32.8 (q, NC(CH3)2), 33.0 (t, CH2CHOH), 33.3 (q, NC(CH3)2), 40.4 (t, 
NCCH2CH2CH2CN), 60.0 (s, NC(CH3)2), 71.5 (d, CHOH), 81.8 (s, C(CH3)3), 87.1 (d, 
CHOTMP), 130.1 (d, =CH), 130.8 (d, =CHCH2CH2CHOH), 131.1 (d, =CH), 132.9 (d, 
(CH2)4CH=), 170.2 (s, C=O). 
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Table 6.4 Significant NMR data of compounds 15α,β-4-7a,b and 15α,β-4-45a,b  
1H NMR H8 H9 H12 H13 H14 H15 
15α-4-7b 2.65 (dd) 4.46 (dd) 2.97 (m) 5.34 (m) 5.40 (m) 3.96 (dt) 
15β-4-7b 2.66 (dd) 4.43 (dd) 2.99 (m) 5.40 (m) 5.40 (m) 3.96 (m) 
15α-4-7a 2.82 (dd) 4.57 (m) 3.07 (m) 5.35 (dd) 5.42 (dd) 3.99 (m)  
15β-4-7a 2.81 (dd) 4.57 (m) 3.06 (m) 5.28 (dd) 5.38 (m) 3.93 (dt) 
15α-4-45b 2.41 (dd) 4.38 (dd) 3.07 (m) 5.47 (dd) 5.40 (dd) 3.98 (m) 
15β-4-45b 2.33 (dd) 4.38 (m) 3.07 (m) 5.37 (m) 5.37 (m) 3.98 (m) 
15α-4-45a 2.55 (dd) 4.46 (dt) 3.08 (m) 5.42 (m) 5.42 (m) 3.99 (m) 
15β-4-45a 2.48 (dd) 4.45 (m) 3.07 (m) 5.39 (m) 5.39 (m) 4.03 (m) 
13C NMR C8 C9 C12 C13 C14 C15 
15α-4-7b 58.1 (d) 74.5 (d) 43.3 (d) 131.1 (d) 134.0 (d) 84.5 (d) 
15β-4-7b 57.8 (d) 74.8 (d) 43.0 (d) 130.7 (d), 133.8 (d) 84.5 (d) 
15β-4-7a 57.0 (d) 74.7 (d) 43.2 (d) 130.5 (d), 134.0 (d) 84.6 (d) 
15α-4-7a 57.2 (d) 74.4 (d) 43.5 (d) 130.9 (d) 134.6 (d) 84.8 (d) 
15α-4-45b 55.6 (d) 74.2 (d) 42.9 (d) 132.1 (d) 133.1 (d) 84.6 (d) 
15β-4-45b 55.9 (d) 74.1 (d) 43.7 (d) 133.0 (d) 133.5 (d) 84.7 (d) 
15α-4-45a 55.3 (d) 74.3 (d) 43.5 (d) 132.9 (d), 133.2 (d)  85.0 (d) 
15β-4-45a 55.3 (d) 74.1 (d) 44.1 (d) 133.1 (d), 133.7 (d) 85.0 (d) 
 
Oxidative cyclisations of dianions of 3,5-dioxygenated esters 4-12 (General procedures): 
Procedure A: Anhydrous LiCl (193 mg, 4.5 mmol) was dried by heating in vacuum under 
stirring 3-5 times for 3 min at 10 min intervals. It was dissolved in 18 mL dry THF under 
nitrogen and iPr2NH (0.230 mL, 1.62 mmol) and BuLi (1.01 mL, 1.6M in hexane, 1.62 mmol) 
were added subsequently at –78 °C. The resulting mixture was stirred for 30 min. Esters 4-
12a,b (0.65 mmol) dissolved in 1 mL of dry THF were added dropwise to the LDA solution 
at –78 °C. The vial was rinsed with 1 mL THF. The mixture was warmed from –78 to –40 °C 
in 1 h, and stirred at –40 °C for 20 min. After cooling to –78 °C, 0.68 mL (3.9 mmol) HMPA 
was added dropwise followed by addition of 122 mg (0.78 mmol) TEMPO 1-2 as a solid. The 
mixture was stirred at –78 °C for 5 min and FeCp2PF6 1-3 was added in small portions with 
vigorous stirring. Each portion was added after consumption of the previous as monitored by 
the disappearence of the blue colour (About 300 mg of 1-3 were added in 10 min, when the 
reaction mixture remained blue and inhomogeneous. Two additional spatula tips of 1-3 were 
added subsequently, total 540 mg). After the addition was complete, the reaction mixture was 
stirred at –78 - –65 °C for 20 min.  
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Procedure B: iPr2NH (0.62 mL, 4.4 mmol) was added under nitrogen to a solution of LiCl 
(524 mg, 12.3 mmol, dried as described above) in 45 mL dry THF, and the mixture was 
cooled to –78 °C. BuLi (2.75 mL, 4.4 mmol, 1.6M in hexane) was added. After stirring for 0.5 
h, esters 4-12a,b (1.76 mmol) dissolved in 5 mL dry THF were added to the LDA solution at 
–78 °C. The mixture was warmed from –78 to –40 °C in 1 h, and stirred for additional 0.5 h at 
–40 °C. After cooling to –78 °C HMPA (1.8 mL, 10.6 mmol) was added dropwise followed 
by addition of solid TEMPO 1-2 (55 mg, 0.35 mmol). The reaction mixture was stirred at –78 
°C for 10 min. In the meantime, 1-2 (220 mg, 1.41 mmol) and 1-3 (583 mg, 1.76 mmol) were 
mixed to homogenity in a vial. This mixture of 1-3 and 1-2 was added in small portions with 
vigorous stirring. Each portion was added after consumption of the previous as monitored by 
the disappearence of the blue colour over a period of 13 min. After the addition was complete, 
the colour did not remain blue, therefore three additional portions of 1-3 (320 mg, 0.97 mmol) 
were added and the blue inhomogeneous reaction mixture was stirred at –78 - –60 °C for 30 
min. 
Procedure C: A 20% solution of tBuMgCl in THF (0.61 mL, 0.97 mmol) was added via 
syringe to a solution of esters 4-12a,b (0.65 mmol) in 5 mL dry THF at –78 °C. The mixture 
was stirred for 40 min at –78 - –50 °C. After cooling to –78 °C LDA (0.71 mL, 2M solution in 
THF/n-heptane, 1.43 mmol) was added and the mixture was stirred at –78 to –40 °C for 1 h. 
Dry THF (15 mL) and HMPA (0.68 mL, 3.9 mmol) were added at –78 °C followed by solid 
TEMPO 1-2 (122 mg, 0.78 mmol) and the reaction mixture was stirred for 10 min. FeCp2PF6 
1-3 was added in small portions with vigorous stirring at –78 °C. Each portion was added 
after consumption of the previous as monitored by the disappearence of the blue colour (380 
mg of 1-3 was added in 5-10 min until the reaction mixture remained blue and 
inhomogeneous. Two additional spatula tips of 1-3 were added subsequently, total 590 mg 
(1.8 mmol). After the addition was complete, the reaction mixture was stirred at –75 - –65 °C 
for 20 min. 
Workup and isolation: The reaction mixture was quenched with 7 drops of water, diluted 
with diethyl ether and allowed to warm to r.t. It was filtered through a pad of silica, which 
was washed with ether (200 mL). Most of the solvent was evaporated and the remaining 
material was preadsorbed on silica gel and purified via flash chromatography (hexane/ethyl 
acetate, gradient 50:1, 20:1, 10:1, 5:1 and 2:1). Ferrocene eluted first at a polarity 50:1 
hexane/ethyl acetate. The products eluted starting from polarity 20:1 in the following order: 4-
53a,b + 4-52a,b, 4-12a,b + 4-52a,b, traces of two unkown cyclic products (not always 
detected), 4-50a,b and finally 4-8a,b, both as diastereomeric mixtures in 15-position. The 
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desired products were isolated and their purity was determined by combustion analysis. The 
fractions containing diastereomeric 4-50a,b and 4-8a,b were further enriched by another flash 
chromatography. For yields and ratios, see Tables 4.11, 4.12 and 4.13. 
 
Methyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(E)-3-(2,2,6,6-tetramethylpiperidin-
1-yloxy)oct-1-en-1-yl]cyclopentanecarboxylates: IR (Film): v~  = 3441 (w), 2952 (m), 2929 
(s), 2857 (m), 1735 (m), 1465 (w), 1437 (w), 1375 (w), 1360 (w), 1254 (m), 1207 (w), 1170 
(w), 1130 (m), 1086 (m), 1006 (m), 974 (m), 862 (m), 836 (s), 776 (s), 714 (w). - MS(ESI) 
m/z (%): 1102 (22) [2M+Na++H], 562 (61) [M+Na+], 540 (100) [M+H+], 173 (10). - 
Combustion analysis: C30H57NO5Si (539.86): calc. C 66.74, H 10.64, N 2.59; found C 66.72, 
H 10.60, N 2.54. 
 
(1S*,2R*,3R*,5S*)-Methyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(1E,3S*)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopentanecarboxylate α-4-8a:  
HO
TBSO
CO2Me
OTMP
C5H11
 
1H NMR (400 MHz): δ = 0.01 (s, 3H, Si(CH3)2), 0.02 (s, 3H, Si(CH3)2), 0.816 (m, 3H, 
CH2CH3), 0.829 (s, 9H, SiC(CH3)3), 0.92-1.05 (m, 12H, NC(CH3)2), 1.10-1.27 (m, 7H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.28-1.52 (m, 6H, NCCH2CH2CH2CN, 
TMPOCHCH2), 1.57 (m, 1H, TMPOCHCH2), 1.66 (m, 1H, CHCH2CH), 2.28 (m, 1H, 
CHCH2CH), 2.55 (d, J = 6.9 Hz, 1H, OH), 2.96 (m, 1H, TBSOCHCH), 3.18 (dd, J = 8.2, 5.0 
Hz, 1H, CHCOOMe), 3.56 (s, 3H, OCH3), 3.87 (dt, J = 8.3, 4.6 Hz, 1H, CHOTMP), 4.08 (m, 
1H, CHOTBS), 4.52 (m, 1H, CHOH), 5.01 (dd, J = 15.3, 10.3 Hz, 1H, CH=CHCHOTMP), 
5.43 (dd, J = 15.4, 7.5 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = –4.9 (q, 
Si(CH3)2), –4.7 (q, Si(CH3)2), 14.1 (q, CH2CH3), 17.3 (t, NCCH2CH2CH2CN), 17.9 (s, 
SiC(CH3)3), 20.2 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.6 (t, CH2CH3), 24.9 (t, 
CH2CH2CH2CH3), 25.8 (q, SiC(CH3)3), 32.1 (t, CH2CH2CH3), 34.7 (t, TMPOCHCH2), 35.0 
(q, NC(CH3)2), 35.5 (q, NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 42.4 (t, CHCH2CH), 51.4 
(q, OCH3), 54.4 (d, CHCHCH=), 56.6 (d, CHCOOMe), 60.0 (s, NC(CH3)2), 60.1 (s, 
NC(CH3)2), 74.1 (d, CHOH), 78.4 (d, CHOTBS), 84.7 (d, CHOTMP), 127.5 (d, 
CH=CHCHOTMP), 136.9 (d, =CHCHOTMP), 173.4 (s, C=O). 
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(1S*,2R*,3R*,5S*)-Methyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(1E,3R*)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopentanecarboxylate β-4-8a: 
HO
TBSO
CO2Me
OTMP
C5H11
 
1H NMR (400 MHz): δ = –0.004 (s, 3H, Si(CH3)2), 0.000 (s, 3H, Si(CH3)2), 0.818 (m, 3H, 
CH2CH3), 0.822 (s, 9H, SiC(CH3)3), 0.92-1.05 (m, 12H, NC(CH3)2), 1.10-1.27 (m, 7H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.28-1.52 (m, 6H, NCCH2CH2CH2CN, 
TMPOCHCH2), 1.57 (m, 1H, TMPOCHCH2), 1.66 (m, 1H, CHCH2CH), 2.28 (m, 1H, 
CHCH2CH), 2.54 (d, J = 7.4 Hz, 1H, OH), 2.96 (m, 1H, TBSOCHCH), 3.15 (dd, J = 8.4, 4.8 
Hz, 1H, CHCOOMe), 3.61 (s, 3H, OCH3), 3.92 (dt, J = 8.1, 4.6 Hz, 1H, CHOTMP), 4.01 (dt, 
J = 5.1, 2.5 Hz, 1H, CHOTBS), 4.47 (m, 1H, CHOH), 5.10 (dd, J = 15.4, 9.1 Hz, 1H, 
CH=CHCHOTMP), 5.42 (dd, J = 15.4, 8.4 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): 
δ = –4.9 (q, Si(CH3)2), –4.8 (q, Si(CH3)2), 14.0 (q, CH2CH3), 17.3 (t, NCCH2CH2CH2CN), 
17.9 (s, SiC(CH3)3), 20.2 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.6 (t, CH2CH3), 25.1 (t, 
CH2CH2CH2CH3), 25.77 (q, SiC(CH3)3), 31.9 (t, CH2CH2CH3), 34.1 (q, NC(CH3)2), 34.4 (t, 
TMPOCHCH2), 40.2 (t, NCCH2CH2CH2CN), 42.5 (t, CHCH2CH), 51.6 (q, OCH3), 53.6 (d, 
CHCHCH=), 56.1 (d, CHCOOMe), 59.0 (s, NC(CH3)2), 59.1 (s, NC(CH3)2), 74.1 (d, CHOH), 
78.6 (d, CHOTBS), 84.4 (d, CHOTMP), 127.7 (d, CH=CHCHOTMP), 136.1 (d, 
=CHCHOTMP), 173.5 (s, C=O). 
 
(1R*,2R*,3R*,5S*)-Methyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(1E,3S*)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopentanecarboxylate α-4-50a: 
HO
TBSO
CO2Me
OTMP
C5H11
 
1H NMR (400 MHz): δ = 0.00 (s, 3H, Si(CH3)2), 0.03 (s, 3H, Si(CH3)2), 0.82 (m, 12H, 
CH2CH3, SiC(CH3)3), 0.86-1.09 (m, 12H, NC(CH3)2), 1.11-1.51 (m, 13H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, CH2CHOTMP), 1.61 (m, 1H, CH2CHOTMP), 
1.87 (m, 2H, CHCH2CH), 2.65 (dd, J = 8.3, 5.3 Hz, 1H, CHCOOMe), 3.18 (m, 1H, 
TBSOCHCH), 3.26 (br. s, 1H, OH), 3.65 (s, 3H, OCH3), 3.89 (m, 1H, CHOTMP), 4.01 (dt, J 
= 4.7, 2.5 Hz, 1H, CHOTBS), 4.39 (m, 1H, CHOH), 5.22 (dd, J = 15.4, 8.3 Hz, 1H, 
CH=CHCHOTMP), 5.38 (dd, J = 15.3, 8.7 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): 
δ = –5.0 (q, Si(CH3)2), –4.8 (q, Si(CH3)2), 13.9 (q, CH2CH3), 17.2 (t, NCCH2CH2CH2CN), 
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17.8 (s, SiC(CH3)3), 20.1 (q, NC(CH3)2), 20.3 (q, NC(CH3)2), 22.5 (t, CH2CH3), 25.0 (t, 
CH2CH2CH2CH3), 25.65 (q, SiC(CH3)3), 31.8 (t, CH2CH2CH3), 33.8 (q, NC(CH3)2), 34.4 (t, 
TMPOCHCH2), 35.3 (q, NC(CH3)2), 40.1 (t, NCCH2CH2CH2CN), 43.0 (t, CHCH2CH), 51.7 
(q, OCH3), 51.9 (d, CHCHCH=), 56.6 (d, CHCOOMe), 58.8 (s, NC(CH3)2), 60.1 (s, 
NC(CH3)2), 75.2 (d, CHOH), 79.5 (d, CHOTBS), 84.9 (d, CHOTMP), 131.2 (d, 
CH=CHCHOTMP), 134.3 (d, =CHCHOTMP), 172.1 (s, C=O). 
 
(1R*,2R*,3R*,5S*)-Methyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(1E,3R*)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopentanecarboxylate β-4-50a: 
HO
TBSO
CO2Me
OTMP
C5H11
 
1H NMR (400 MHz): δ = 0.00 (s, 3H, Si(CH3)2), 0.03 (s, 3H, Si(CH3)2), 0.79 (m, 3H, 
CH2CH3), 0.81 (s, 9H, SiC(CH3)3), 0.95-1.05 (m, 12H, NC(CH3)2), 1.11-1.51 (m, 13H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, CH2CHOTMP), 1.62 (m, 1H, CH2CHOTMP), 
1.82 (br. d, J = 14.3 Hz, 1H, CHCH2CH), 1.88 (dt, J = 14.0, 4.7 Hz, 1H, CHCH2CH), 2.59 
(dd, J = 8.1, 5.3 Hz, 1H, CHCOOMe), 3.17 (dt, J = <1, 7.9 Hz, 1H, TBSOCHCH), 3.31 (br. 
d, J = 9.1 Hz, 1H, OH), 3.63 (s, 3H, OCH3), 3.91 (dt, J = 4.7, 8.2 Hz, 1H, CHOTMP), 4.05 
(m, 1H, CHOTBS), 4.36 (m, 1H, CHOH), 5.24 (dd, J = 15.5, 7.9 Hz, 1H, CH=CHCHOTMP), 
5.45 (dd, J = 15.6, 8.0 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = –5.2 (q, 
SiC(CH3)2), –4.9 (q, SiC(CH3)2), 13.7 (q, CH2CH3), 17.0 (t, NCCH2CH2CH2CN), 17.6 (s, 
SiC(CH3)3), 19.9 (q, NC(CH3)2), 20.1 (q, NC(CH3)2), 22.3 (t, CH2CH3), 24.8 (t, 
CH2CH2CH2CH3), 25.4 (q, SiC(CH3)3), 31.5 (t, CH2CH2CH3), 33.7 (q, NC(CH3)2), 34.1 (t, 
TMPOCHCH2), 35.0 (q, NC(CH3)2), 39.8 (t, NCCH2CH2CH2CN), 42.7 (t, CHCH2CH), 51.4 
(d, CHCHCH=), 51.5 (q, OCH3), 56.3 (d, CHCOOMe), 58.7 (s, NC(CH3)2), 59.7 (s, 
NC(CH3)2), 74.8 (d, CHOH), 78.9 (d, CHOTBS), 84.6 (d, CHOTMP), 130.7 (d, 
CH=CHCHOTMP), 133.6 (d, =CHCHOTMP), 171.9 (s, C=O).  
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(1S*,2R*,3R*,5S*)-Methyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(1S* and R*,2E)-
1-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-2-en-1-yl]cyclopentanecarboxylate 4-52a-
CPP3 and 4-52a-CPP4: 
COOMe
HO
TBSO
C5H11
OTMP  
4-52a-CPP3: 1H NMR (400 MHz): δ = –0.01 (s, 6H, Si(CH3)2), 0.80 (s+m, 12H, SiC(CH3)3, 
CH2CH3), 0.91-1.02 (m, 12H, NC(CH3)2), 1.10-1.46 (m, 12H, NCCH2CH2CH2CN, 
CH2CH2CH2CH2CH3), 1.53 (m, 1H, CHCH2CH), 1.93 (m, 2H, CH2CH=CH), 2.26 (m, 1H, 
CHCH2CH), 2.57 (m, 1H, CHCHOTBS), 3.19 (dd, J = 8.2, 4.9 Hz, 1H, CHCOOMe), 3.591 
(s, 3H, COOCH3), 4.09 (m, 1H, CHOTMP), 4.16 (m, 1H, CHOTBS), 4.30 (m, 1H, CHOH), 
5.24 (dd, J = 15.3, 9.4 Hz, 1H, =CHCHOTMP), 5.35 (m, 1H, CH=CHCH2). - 13C NMR (100 
MHz): δ = –5.3 (q, Si(CH3)2), –5.0 (q, Si(CH3)2), 13.6 (q, CH2CH3), 16.81 (t, 
NCCH2CH2CH2CN), 17.27 (s, SiC(CH3)3), 19.9 (q, NC(CH3)2), 20.16 (q, NC(CH3)2), 22.0 (t, 
CH2CH3), 25.3 (q, SiC(CH3)3), 27.98 (t, =CHCH2CH2), 30.9 (t, CH2CH2CH3), 31.9 (t, 
=CHCH2CH2), 33.0 (q, NC(CH3)2), 34.3 (q, NC(CH3)2), 39.6 (t, NCCH2CH2CH2CN), 39.8 (t, 
NCCH2CH2CH2CN), 42.5 (t, CHCH2CH), 50.93 (q, COOCH3), 53.8 (d, CHCOOMe), 54.7 
(d, CHCHOTBS), 58.3 (s, NC(CH3)2), 59.9 (s, NC(CH3)2), 74.1 (d, CHOTBS), 74.7 (d, 
CHOH), 82.5 (d, CHOTMP), 130.1 (d, =CHCHOTMP), 134.8 (d, CH=CHCH2), 173.0 (s, 
C=O). 
4-52a-CPP4: 1H NMR (400 MHz): δ = –0.03 (s, 3H, Si(CH3)2), –0.02 (s, 3H, Si(CH3)2), 0.80 
(s+m, 12H, SiC(CH3)3, CH2CH3), 0.91-1.02 (m, 12H, NC(CH3)2), 1.10-1.46 (m, 12H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.53 (m, 1H, CHCH2CH), 1.93 (m, 2H, 
CH2CH=CH), 2.35 (m, 1H, CHCH2CH), 2.45 (m, 1H, CHCHOTBS), 3.08 (t, J = 8.0 Hz, 1H, 
CHCOOMe), 3.586 (s, 3H, COOCH3), 4.09 (m, 1H, CHOTMP), 4.42 (m, 1H, CHOTBS), 
4.49 (m, 1H, CHOH), 5.35 (m, 2H, CH=CHCH2). - 13C NMR (100 MHz): δ = –5.2 (q, 
Si(CH3)2), –5.0 (q, Si(CH3)2), 13.6 (q, CH2CH3), 16.77 (t, NCCH2CH2CH2CN), 17.34 (s, 
SiC(CH3)3), 20.24 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.0 (t, CH2CH3), 25.3 (q, SiC(CH3)3), 
28.05 (t, =CHCH2CH2), 30.9 (t, CH2CH2CH3), 31.8 (t, =CHCH2CH2), 33.5 (q, NC(CH3)2), 
34.0 (q, NC(CH3)2), 39.8 (t, NCCH2CH2CH2CN), 40.1 (t, NCCH2CH2CH2CN), 42.2 (t, 
CHCH2CH), 50.96 (q, COOCH3), 53.3 (d, CHCOOMe), 54.7 (d, CHCHOTBS), 58.3 (s, 
NC(CH3)2), 59.9 (s, NC(CH3)2), 72.6 (d, CHOTBS), 73.4 (d, CHOH), 82.0 (d, CHOTMP), 
129.4 (d, =CHCHOTMP), 135.1 (d, CH=CHCH2), 173.3 (s, C=O). 
 
 235 
(1R*,2R*,3R*,5S*)-Methyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(1S* and R*,2E)-
1-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-2-en-1-yl]cyclopentanecarboxylate 4-52a-
CPP1: 
COOMe
HO
TBSO
C5H11
OTMP  
4-52a-CPP1: 1H NMR (400 MHz): δ = 0.00 (s, 3H, Si(CH3)2), 0.03 (s, 3H, Si(CH3)2), 0.79 
(s+m, 12H, SiC(CH3)3, CH2CH3), 0.85-1.09 (m, 12H, NC(CH3)2), 1.12-45 (m, 12H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.65 (m, 1H, CHCH2CH), 1.84 (m, 1H, 
CHCH2CH), 1.95 (m, 1H, CH2CH2CH=), 2.78 (dd, J = 7.4, 4.9 Hz, 1H, CHCOOMe), 2.86 (t, 
J = 6.6 Hz, 1H, CHCHOTBS), 3.41 (d, J = 11.2 Hz, 1H, OH), 3.64 (s, 3H, COOCH3), 3.93 
(dd, J = 9.4, 6.0 Hz, 1H, CHOTMP), 4.25 (br. d, J = 4.0 Hz, 1H, CHOTBS), 4.35 (m, 1H, 
CHOH), 5.20 (dd, J = 15.2, 9.4 Hz, 1H, CH=CHCHOTMP), 5.38 (dt, J = 15.4, 6.5 Hz, 1H, 
=CHCH2CH2). - 13C NMR (100 MHz): δ = –5.5 (q, Si(CH3)2), –5.4 (q, Si(CH3)2), 13.3 (q, 
CH2CH3), 16.6 (t, NCCH2CH2CH2CN), 17.0 (s, SiC(CH3)3), 19.8 (q, NC(CH3)2), 19.9 (q, 
ONC(CH3)2), 21.8 (t, CH2CH3), 25.0 (q, SiC(CH3)3), 27.8 (t, CH2CH2CH2CH3), 30.7 (t, 
CH2CH2CH3), 31.9 (t, =CHCH2CH2), 33.6 (q, NC(CH3)2), 34.2 (q, NC(CH3)2), 39.7 (t, 
NCCH2CH2CH2CN), 42.7 (t, CHCH2CH), 50.9 (q, COOCH3), 53.25 (d, CHCHOTBS or 
CHCOOMe), 53.27 (d, CHCHOTBS or CHCOOMe), 58.2 (s, NC(CH3)2), 60.0 (s, 
NC(CH3)2), 75.9 (d, CHOH), 76.6 (d, CHOTBS), 84.6 (d, CHOTMP), 129.2 (d, 
CH=CHOTMP), 134.8 (d, CH=CHCH2), 171.6 (s, C=O). 
4-52a-CPP2: 1H NMR (400 MHz): δ = 0.00 (s, 3H, Si(CH3)2), 0.03 (s, 3H, Si(CH3)2), 0.78 
(s+m, 12H, SiC(CH3)3, CH2CH3), 0.89 (br. s, 3H, NC(CH3)2), 0.91 (br. s, 3H, NC(CH3)2), 
0.97-1.06 (m, 6H, NC(CH3)2), 1.12-1.52 (m, 12H, NCCH2CH2CH2CN, 
CH2CH2CH2CH2CH3), 1.67 (dt, J = 13.7, 4.5 Hz, 1H, CHCH2βCH), 1.82 (dt, J = 12.3, 1.5 Hz, 
1H, CHCH2αCH), 1.91 (hept, J = 7.3 Hz, 2H, CH2CH=CH), 2.70 (dd, J = 7.7, 5.3 Hz, 1H, 
CHCOOMe), 2.86 (dt, J = 6.3, 1.4 Hz, 1H, CHCHOTBS), 3.41 (d, J = 10.5 Hz, 1H, OH), 
3.62 (s, 3H, COOMe), 3.93 (dd, J = 9.4, 6.4 Hz, 1H, CHOTMP), 4.23 (m, 1H, CHOTBS), 
4.31 (dt, J = 9.8, 4.9 Hz, 1H, CHOH), 5.26 (dd, J = 15.2, 9.4 Hz, 1H, CH=CHCHOTMP), 
5.40 (dt, J = 15.3, 6.5 Hz, 1H, CH=CHCH2). - 13C NMR (100 MHz): δ = –4.8 (q, Si(CH3)2), –
4.7 (q, Si(CH3)2), 14.0 (q, CH2CH3), 17.3 (t, NCCH2CH2CH2CN), 17.8 (s, SiC(CH3)3), 20.6 
(q, NC(CH3)2), 22.5 (t, CH2CH3), 25.7 (q, SiC(CH3)3), 28.7 (t, =CHCH2CH2), 31.5 (t, 
CH2CH2CH3), 32.2 (t, =CHCH2CH2), 34.3 (q, NC(CH3)2), 35.2 (q, NC(CH3)2), 40.2 (t, 
NCCH2CH2CH2CN), 40.3 (t, NCCH2CH2CH2CN), 43.0 (t, CHCH2CH), 51.7 (q, COOCH3), 
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53.1 (d, CHCOOMe), 53.6 (d, CHCHOTBS), 58.8 (s, NC(CH3)2), 60.7 (s, NC(CH3)2), 75.7 
(d, CHOH), 76.0 (d, CHOTBS), 84.9 (d, CHOTMP), 129.7 (d, CH=CHCHOTMP), 135.3 (d, 
CH=CHCH2), 172.7 (s, C=O). - Significant H,H-NOESY interactions: 
H
10'
HO
H
12
H
8
H
9
E
TBSO
H
10
H
11
H
14
H
13
OTMP
R
H
15
 
 
 (2S or 2R,3S*,5R*,6E,8E)-Methyl 5-(tert-butyldimethylsilyloxy)-3-hydroxy-2-(2,2,6,6-
tetramethylpiperidin-1-yloxy)tetradeca-6,8-dienoate 4-53a: 
H11C5
TBSO
CO2Me
OH
O
N
 
1H NMR (400 MHz): δ = –0.06 (s, 3H, Si(CH3)2), –0.03 (s, 3H, Si(CH3)2), 0.78 (s, 9H, 
SiC(CH3)3), 0.79 (m, 3H, CH2CH3), 0.85-1.09 (m, 12H, NC(CH3)2), 1.12-1.45 (m, 12H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.60 (m, 1H, OCHCH2CHO), 1.71 (m, 1H, 
OCHCH2CHO), 1.95 (m, 2H, CH2CH2CH=), 3.63 (s, 3H, OCH3), 4.16 (m, 2H, 
HOCHCHOTMP), 4.30 (m, 1H, CHOTBS), 5.41 (m, 1H, =CHCHOTBS), 5.56 (dt, J = 14.3, 
7.0 Hz, 1H, =CHCH2), 5.89 (dd, J = 14.8, 10.4 Hz, 1H, CH2CH=CH), 6.00 (dd, J = 15.0, 10.4 
Hz, 1H, CH=CHCHOTBS). - 13C NMR (100 MHz): δ = –5.5 (q, Si(CH3)2), –4.7 (q, 
Si(CH3)2), 13.3 (q, CH2CH3), 16.3 (t, NCCH2CH2CH2CN), 17.3 (s, SiC(CH3)3), 19.5 (q, 
NC(CH3)2), 19.6 (q, NC(CH3)2), 21.8 (t, CH2CH3), 25.2 (q, SiC(CH3)3), 28.1 (t, 
CH2CH2CH2CH3), 30.7 (t, CH2CH2CH3), 31.5 (t, =CHCH2CH2), 32.3 (q, NC(CH3)2), 34.2 (q, 
ONC(CH3)2), 39.5 (t, NCCH2CH2CH2CN), 39.6 (t, NCCH2CH2CH2CN), 40.5 (t, CHCH2CH), 
50.7 (q, OCH3), 59.2 (s, NC(CH3)2), 59.7 (s, NC(CH3)2), 69.3 (d, CHOH), 72.5 (d, 
CHOTBS), 86.6 (d, CHOTMP), 128.6 (d, CH2CH=CH), 130.0 (d, CH=CHCHOTBS), 132.4 
(d, =CHCHOTBS), 134.7 (d, CH=CHCH2), 171.0 (s, C=O). 
 
tert-Butyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(E)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-enyl]cyclopentanecarboxylates: IR (Film): v~  = 3515 
(w), 2954 (m), 2930 (s), 2858 (w), 1734 (m), 1466 (w), 1366 (m), 1252 (m), 1153 (s), 1129 
(m), 1070 (m), 1003 (w), 975 (m), 901 (w), 836 (s), 776 (s), 714 (w), 668 (w). - MS(ESI) m/z 
 237 
(%): 1185 (19) [2M+Na+], 604 (82) [M+Na+], 464 (11), 448 (100) [M +Na+–TEMPO], 158 
(12) [TEMPOH2]+. - Combustion analysis: C33H63NO5Si (581.94): calc. C 68.11, H 10.91, N 
2.41; found C 67.93, H 11.01, N 2.36. 
 
(1S*,2R*,3R*,5S*)-tert-Butyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(1E,3S*)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-enyl]cyclopentanecarboxylate α-4-8b: 
HO
TBSO
CO2tBu
OTMP
C5H11
 
1H NMR (400 MHz): δ = 0.07 (s, 3H, Si(CH3)2), 0.08 (s, 3H, Si(CH3)2), 0.88 (m, 3H, 
CH2CH3), 0.89 (s, 9H, SiC(CH3)3), 0.99-1.15 (m, 12H, NC(CH3)2), 1.18-1.34 (m, 7H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.35-1.52 (m, 6H, NCCH2CH2CH2CN, 
CH2CHOTMP), 1.42 (s, 9H, OC(CH3)3), 1.62 (m, 1H, CH2CHOTMP), 1.68 (ddd, J = 14.3, 
3.2, 1.6 Hz, 1H, CHCH2CH), 2.36 (ddd, J = 14.3, 7.7, 5.0 Hz, 1H, CHCH2CH), 2.50 (d, J = 
7.2 Hz, 1H, OH), 2.97 (br. t, J = 8.4 Hz, 1H, CHCHOTBS), 3.10 (dd, J = 7.8, 5.2 Hz, 1H, 
CHCOOtBu), 3.99 (dt, J = 7.4, 6.7 Hz, 1H, CHOTMP), 4.15 (m, 1H, CHOTBS), 4.50 (m, 1H, 
CHOH), 5.18 (dd, J = 15.4, 9.0 Hz, 1H, CH=CHCHOTMP), 5.53 (ddd, J = 15.4, 8.6, 0.6 Hz, 
1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = –4.8 (q, Si(CH3)2), –4.6 (q, Si(CH3)2), 14.1 
(q, CH2CH3), 17.3 (t, NCCH2CH2CH2CN), 18.0 (s, SiC(CH3)3), 20.3 (q, NC(CH3)2), 22.6 (t, 
CH2CH3), 25.1 (t, CH2CH2CH2CH3), 25.8 (q, SiC(CH3)3), 28.2 (q, OC(CH3)3), 32.1 (t, 
CH2CH2CH3), 34.0 (q, NC(CH3)2), 34.9 (t, TMPOCHCH2), 35.3 (q, NC(CH3)2), 40.3 (t, 
NCCH2CH2CH2CN), 42.4 (t, CHCH2CH), 53.8 (d, CHCHOTBS), 57.1 (d, CHCOOtBu), 59.0 
(s, NC(CH3)2), 60.1 (s, NC(CH3)2), 74.1 (d, CHOH), 78.3 (d, CHOTBS), 80.6 (s, OC(CH3)3), 
84.4 (d, CHOTMP), 128.1 (d, CH=CHCHOTMP), 136.1 (d, =CHCHOTMP), 172.4 (s, C=O). 
- Significant NOE enhancements: 
H
4'
HO
H
6
E
H
3
H
2
TBSO
H
4
H
5
H
8
H
7
2.4
3.5 2.9
2.3
R
7.1
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(1S*,2R*,3R*,5S*)-tert-Butyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(1E,3R*)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-enyl]cyclopentanecarboxylate β-4-8b: 
HO
TBSO
CO2tBu
OTMP
C5H11
 
1H NMR (400 MHz): δ = 0.05 (s, 6H, Si(CH3)2), 0.87 (m, 3H, CH2CH3), 0.88 (s, 9H, 
SiC(CH3)3), 0.98-1.14 (m, 12H, NC(CH3)2), 1.19-1.32 (m, 7H, NCCH2CH2CH2CN, 
CH2CH2CH2CH2CH3), 1.37-1.51 (m, 6H, NCCH2CH2CH2CN, CH2CHOTMP), 1.46 (s, 9H, 
OC(CH3)3), 1.66 (m, 2H, CH2CHOTMP, CHCH2CH), 2.34 (m, 1H, CHCH2CH), 2.52 (m, 1H, 
OH), 2.96 (m, 1H, CHCHOTBS), 3.06 (dd, J = 8.4, 4.4 Hz, 1H, CHCOOtBu), 3.99 (m, 1H, 
CHOTMP), 4.10 (dt, J = 5.4, 2.7 Hz, 1H, CHOTBS), 4.44 (m, 1H, CHOH), 5.27 (dd, J = 
15.6, 8.3 Hz, 1H, CH=CHCHOTMP), 5.52 (dd, J = 15.5, 6.8 Hz, 1H, =CHCHOTMP). - 13C 
NMR (100 MHz): δ = –4.8 (q, Si(CH3)2), 14.0 (q, CH2CH3), 17.1 (t, NCCH2CH2CH2CN), 
17.9 (s, SiC(CH3)3), 20.2 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.6 (t, CH2CH3), 25.1 (t, 
CH2CH2CH2CH3), 25.8 (q, SiC(CH3)3), 28.2 (q, OC(CH3)3), 32.0 (t, CH2CH2CH3), 34.0 (q, 
NC(CH3)2), 34.3 (t, TMPOCHCH2), 35.3 (q, NC(CH3)2), 40.0 (t, NCCH2CH2CH2CN), 42.6 
(t, CHCH2CH), 53.1 (d, CHCHCH=), 56.9 (d, CHCOOtBu), 59.0 (s, NC(CH3)2), 60.1 (s, 
NC(CH3)2), 74.2 (d, CHOH), 78.5 (d, CHOTBS), 80.7 (s, OC(CH3)3), 84.3 (d, CHOTMP), 
127.9 (d, CH=CHCHOTMP), 135.9 (d, =CHCHOTMP), 172.5 (s, C=O). 
 
(1R*,2R*,3R*,5S*)-tert-Butyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(1E,3S*)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopentanecarboxylate α-4-50b: 
HO
TBSO
CO2tBu
OTMP
C5H11
 
1H NMR (400 MHz): δ = –0.02 (s, 3H, Si(CH3)2), 0.00 (s, 3H, Si(CH3)2), 0.79 (m, 3H, 
CH2CH3), 0.80 (s, 9H, SiC(CH3)3), 0.94-1.10 (m, 12H, NC(CH3)2), 1.12-1.20 (m, 7H, 
NCCH2CH2, CH2CH2CH2CH3), 1.31-1.53 (m, 6H, NCCH2CH2CH2CN, CH2CHOTMP), 1.38 
(s, 9H, OC(CH3)3), 1.59 (m, 1H, CH2CHOTMP), 1.78 (br. d, J = 13.8 Hz, 1H, CHCH2CH), 
1.85 (dt, J = 13.9, 4.7 Hz, 1H, CHCH2CH), 2.52 (dd, J = 8.4, 5.3 Hz, 1H, CHCOOtBu), 3.09 
(dt, J = 8.1, 5.5 Hz, 1H, CHCHOTBS), 3.17 (d, J = 9.7 Hz, 1H, OH), 3.88 (dt, J = 8.4, 4.6 Hz, 
1H, CHOTMP), 3.94 (m, 1H, CHOTBS), 4.32 (m, 1H, CHOH), 5.23 (dd, J = 15.4, 8.0 Hz, 
1H, CH=CHCHOTMP), 5.36 (dd, J = 15.6, 8.8 Hz, 1H, =CHCHOTMP). - 13C NMR (100 
MHz): δ = –4.9 (q, Si(CH3)2), –4.7 (q, Si(CH3)2), 14.0 (q, CH2CH3), 17.2 (t, NCCH2CH2), 
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17.8 (s, SiC(CH3)3), 20.2 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.6 (t, CH2CH3), 25.1 (t, 
CH2CH2CH2CH3), 25.7 (q, SiC(CH3)3), 28.1 (q, OC(CH3)3), 31.9 (t, CH2CH2CH3), 34.0 (q, 
NC(CH3)2), 34.5 (t, TMPOCHCH2), 35.6 (q, NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 43.1 
(t, CHCH2CH), 51.6 (d, CHCHOTBS), 57.2 (d, CHCOOtBu), 58.8 (s, NC(CH3)2), 60.0 (s, 
NC(CH3)2), 75.3 (d, CHOH), 79.6 (d, CHOTBS), 80.5 (s, OC(CH3)3), 85.0 (d, CHOTMP), 
131.6 (d, CH=CHCHOTMP), 133.8 (d, =CHCHOTMP), 170.9 (s, C=O). - Significant H,H-
NOESY interactions: 
H
4'
HO
H
6
H
2
H
3
E
TBSO
H
4
H
5
C5H11
OTMP
H
8
H
7
 
 
 (1R*,2R*3R*,5S*)-tert-Butyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(1E,3R*)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopentanecarboxylate β-4-50b: 
HO
TBSO
CO2tBu
OTMP
C5H11
 
1H NMR (400 MHz): δ = 0.00 (s, 3H, Si(CH3)2), 0.02 (s, 3H, Si(CH3)2), 0.80 (m, 3H, 
CH2CH3), 0.81 (s, 9H, SiC(CH3)3), 0.91-1.09 (m, 12H, NC(CH3)2), 1.11-1.25 (m, 7H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.30-1.54 (m, 6H, NCCH2CH2CH2CN, 
CH2CHOTMP), 1.38 (s, 9H, OC(CH3)3), 1.59 (m, 1H, CH2CHOTMP), 1.79 (br. d, J = 13.8 
Hz, 1H, CHCH2CH), 1.87 (dt, J = 13.8, 4.9 Hz, 1H, CHCH2CH), 2.47 (dd, J = 8.6, 5.3 Hz, 
1H, CHCOOtBu), 3.10 (m, 1H, CHCHOTBS), 3.18 (d, J = 9.6 Hz, 1H, OH), 3.93 (dt, J = 8.3, 
4.6 Hz, 1H, CHOTMP), 4.02 (m, 1H, CHOTBS), 4.33 (m, 1H, CHOH), 5.26 (dd, J = 15.5, 
7.8 Hz, 1H, CH=CHCHOTMP), 5.39 (dd, J = 15.4, 8.9 Hz, 1H, =CHCHOTMP). - 13C NMR 
(100 MHz): δ = –4.9 (q, Si(CH3)2), –4.6 (q, Si(CH3)2), 14.0 (q, CH2CH3), 17.3 (s, SiC(CH3)3), 
17.9 (t, NCCH2CH2CH2CN), 20.2 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.6 (t, CH2CH3), 25.1 
(t, CH2CH2CH3CH3), 25.7 (q, SiC(CH3)3), 28.1 (q, OC(CH3)3), 31.8 (t, CH2CH2CH3), 34.0 (q, 
NC(CH3)2), 34.4 (t, TMPOCHCH2), 35.3 (q, NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 43.1 
(t, CHCH2CH), 51.4 (d, CHCHCH=), 57.4 (d, CHCOOtBu), 59.0 (s, NC(CH3)2), 60.0 (s, 
NC(CH3)2), 75.1 (d, CHOH), 79.1 (d, CHOTBS), 80.6 (s, OC(CH3)3), 84.9 (d, CHOTMP), 
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131.4 (d, CH=CHCHOTMP), 133.6 (d, =CHCHOTMP), 170.9 (s, C=O). - Significant NOE 
enhancements: 
H
4'
HO
H
6
H
2
H
3
E
TBSO
H
4
H
5
C5H11
OTMP
8.5
H
8
H
7
3.0
3.2
2.0
2.9
1.0
3.9
 
 
(1R*,2R*,3R*,5S*)-tert-Butyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(1S* and 
R*,2E)-3-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-2-en-1-yl]cyclopentanecarboxylate 4-
52b: 
COOtBu
HO
TBSO
C5H11
OTMP  
4-52b-CPP1: 1H NMR (400 MHz): δ = 0.00 (s, 3H, Si(CH3)2), 0.03 (s, 3H, Si(CH3)2), 0.80 (s, 
9H, SiC(CH3)3), 0.81 (m, 3H, CH2CH3), 0.92 (br. s, 3H, NC(CH3)2), 0.94 (br. s, 3H, 
NC(CH3)2), 1.04 (br. s, 3H, NC(CH3)2), 1.07 (br. s, 3H, NC(CH3)2), 1.14-1.55 (m, 12H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.39 (s, 9H, OC(CH3)3), 1.62 (dt, J = 13.5, 4.3 
Hz, 1H, CHCH2CH), 1.83 (m, 1H, CHCH2CH), 1.95 (m, 2H, CH2CH2CH=), 2.73 (dd, J = 7.4, 
4.8 Hz, 1H, CHCOOtBu), 2.79 (m, 1H, CHCHOTBS), 3.32 (d, J = 11.3 Hz, 1H, OH), 3.91 
(dd, J = 9.4, 6.2 Hz, 1H, CHOTMP), 4.23 (br. d, J = 3.8 Hz, 1H, CHOTBS), 4.34 (m, 1H, 
CHOH), 5.23 (dd, J = 15.3, 9.5 Hz, 1H, CH=CHCHOTMP), 5.40 (dt, J = 15.2, 6.4 Hz, 1H, 
=CHCH2CH2). - 13C NMR (100 MHz): δ = –4.8 (q, Si(CH3)2), –4.7 (q, Si(CH3)2), 14.0 (q, 
CH2CH3), 17.3 (t, NCCH2CH2CH2CN), 17.7 (s, SiC(CH3)3), 20.6 (q, NC(CH3)2), 20.7 (q, 
NC(CH3)2), 22.5 (t, CH2CH3), 25.7 (q, SiC(CH3)3), 28.1 (q, OC(CH3)3), 28.5 (t, 
CH2CH2CH2CH3), 31.5 (t, CH2CH2CH3), 32.2 (t, =CHCH2CH2), 34.5 (q, NC(CH3)2), 34.9 (q, 
NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 40.4 (t, NCCH2CH2CH2CN), 43.3 (t, CHCH2CH), 
53.8 (d, CHCHOTBS or CHCOOtBu), 54.8 (d, CHCHOTBS or CHCOOtBu), 58.9 (s, 
NC(CH3)2), 60.6 (s, NC(CH3)2), 76.9 (d, CHOH), 77.4 (d, CHOTBS), 80.0 (s, OC(CH3)3), 
85.3 (d, CHOTMP), 130.3 (d, =CHCHOTMP), 135.2 (d, CH=CHCH2), 171.0 (s, C=O). 
The configuration of the ring was assigned by comparison with 4-8b and 4-50b. This isomer 
has very similar chemical shifts to PG isomer 4-50b but not to IsoP isomer 4-8b. 
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4-52b-CPP2: 1H NMR (400 MHz): δ = 0.01 (s, 3H, Si(CH3)2), 0.05 (s, 3H, Si(CH3)2), 0.80 (s, 
9H, SiC(CH3)3), 0.81 (m, 3H, CH2CH3), 0.92 (br. s, 3H, NC(CH3)2), 0.94 (br. s, 3H, 
NC(CH3)2), 1.04 (br. s, 3H, NC(CH3)2), 1.07 (br. s, 3H, NC(CH3)2), 1.14-1.55 (m, 12H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.38 (s, 9H, OC(CH3)3), 1.62 (dt, J = 13.5, 4.3 
Hz, 1H, CHCH2CH), 1.83 (m, 1H, CHCH2CH), 1.95 (m, 2H, CH2CH2CH=), 2.64 (dd, J = 7.5, 
5.3 Hz, 1H, CHCOOtBu), 2.79 (m, 1H, CHCHOTBS), 3.27 (d, J = 11.0 Hz, 1H, OH), 3.91 
(m, 1H, CHOTMP), 4.23 (m, 1H, CHOTBS), 4.34 (m, 1H, CHOH), 5.23 (m, 1H, 
CH=CHCHOTMP), 5.40 (m, 1H, =CHCH2CH2). - 13C NMR (100 MHz): δ = –4.7 (q, 
Si(CH3)2), –4.5 (q, Si(CH3)2), 14.0 (q, CH2CH3), 17.3 (t, NCCH2CH2CH2CN), 17.7 (s, 
SiC(CH3)3), 20.6 (q, NC(CH3)2), 20.7 (q, NC(CH3)2), 22.5 (t, CH2CH3), 25.8 (q, SiC(CH3)3), 
28.0 (q, OC(CH3)3), 28.5 (t, CH2CH2CH2CH3), 31.5 (t, CH2CH2CH3), 32.5 (t, =CHCH2CH2), 
34.5 (q, NC(CH3)2), 34.9 (q, NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 40.4 (t, 
NCCH2CH2CH2CN), 42.9 (t, CHCH2CH), 52.9 (d, CHCHOTBS or CHCOOtBu), 54.4 (d, 
CHCHOTBS or CHCOOtBu), 60.0 (s, NC(CH3)2), 60.6 (s, NC(CH3)2), 76.2 (d, CHOH), 76.3 
(d, CHOTBS), 80.0 (s, OC(CH3)3), 85.0 (d, CHOTMP), 129.9 (d, =CHCHOTMP), 134.9 (d, 
CH=CHCH2), 171.0 (s, C=O). 
The configuration of the ring was assigned by comparison with 4-8b and 4-50b. This isomer 
has very similar chemical shifts to PG isomer 4-50b but not to IsoP isomer 4-8b. 
 
(1S*,2R*,3R*,5S*)-Methyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(1S* or R*,1E)-1-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-2-en-1-yl]cyclopentanecarboxylate 4-52b-
CPP3: 
COOtBu
HO
TBSO
C5H11
OTMP  
4-52b-CPP3: Detectable resonances: 1H NMR (400 MHz): δ = –0.03 (s, 3H, Si(CH3)2), –0.02 
(s, 3H, Si(CH3)2), 0.80 (s+m, 12H, SiC(CH3)3, CH2CH3), 1.39 (s, 9H, OC(CH3)3), 1.96 (m, 
2H, CH2CH=CH), 2.34 (m, 1H, CHCH2CH), 3.01 (t, J = 7.9 Hz, 1H, CHCOOtBu), 4.41 (m, 
1H, CHOTBS), 4.49 (m, 1H, CHOH), 5.51 (dd, J = 15.3, 9.2 Hz, 1H, CH=CH). - 13C NMR 
(100 MHz): δ = –4.8 (q, Si(CH3)2), –4.5 (q, Si(CH3)2), 13.9 (q, CH2CH3), 17.8 (s, SiC(CH3)3), 
20.3 (q, NC(CH3)2), 22.5 (t, CH2CH3), 25.7 (q, SiC(CH3)3), 28.2 (q, OC(CH3)3), 28.5 (t, 
=CHCH2CH2), 31.3 (t, CH2CH2CH3), 32.2 (t, =CHCH2CH2), 32.5 (q, NC(CH3)2), 33.9 (q, 
NC(CH3)2), 40.1 (t, NCCH2CH2CH2CN), 43.2 (t, CHCH2CH), 55.0 (d, CHCOOtBu), 55.3 (d, 
CHCHOTBS), 58.7 (s, NC(CH3)2), 60.4 (s, NC(CH3)2), 72.3 (d, CHOTBS), 73.9 (d, CHOH), 
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80.1 (s, OC(CH3)3), 82.1 (d, CHOTMP), 130.5 (d, =CHCHOTMP), 134.2 (d, CH=CHCH2), 
172.8 (s, C=O). 
 
Detectable resonances of an unknown cyclic product: 1H NMR (400 MHz): δ = 2.92 (m, 1H), 
3.02 (m, 1H), 4.21 (m, 1H).  
 
Table 6.5: Significant NMR data of compounds 15α,β-4-8a,b and 15α,β-4-50a,b 
1H NMR H8 H9 H11 H12 H13 H14 H15 
15α-4-8a 3.18 (dd) 4.52 (m) 4.08 (m) 2.96 (m) 5.01 (dd) 5.43 (dd) 3.87 (dt) 
15β-4-8a 3.15 (dd) 4.47 (m) 4.01 (dt) 2.96 (m) 5.10 (dd) 5.42 (dd) 3.92 (dt) 
15α-4-8b 3.10 (dd) 4.50 (m) 4.15 (m) 2.97 (t) 5.18 (dd) 5.53 (dd) 3.99 (dt)  
15β-4-8b 3.06 (dd) 4.44 (m) 4.10 (dt) 2.96 (m) 5.27 (dd) 5.52 (dd) 3.99 (m) 
15α-4-50a 2.65 (dd) 4.39 (m) 4.01 (dt) 3.18 (m) 5.22 (dd) 5.38 (dd) 3.89 (m) 
15β-4-50a 2.59 (dd) 4.33 (m) 4.02 (m) 3.10 (m) 5.26 (dd) 5.39 (dd) 3.93 (dt) 
15α-4-50b 2.52 (dd) 4.32 (m) 3.94 (m) 3.09 (t) 5.23 (dd) 5.36 (ddd) 3.88 (dt) 
15β-4-50b 2.47 (dd) 4.33 (m) 4.02 (dt) 3.10 (m) 5.26 (dd) 5.39 (dd) 3.93 (m) 
13C NMR C8 C9 C11 C12 C13 C14 C15 
15α-4-8a 56.6 (d) 74.1 (d) 78.4 (d) 54.4 (d) 127.5 (d) 136.9 (d) 84.7 (d) 
15β-4-8a 56.1 (d) 74.1 (d) 78.6 (d) 53.6 (d) 127.7 (d) 136.1 (d) 84.5 (d) 
15α-4-8b 57.1 (d) 74.1 (d) 78.3 (d) 53.8 (d) 128.1 (d)  136.1 (d) 84.4 (d) 
15β-4-8b 56.9 (d) 74.2 (d) 78.5 (d) 53.1 (d) 127.9 (d) 135.9 (d) 84.3 (d) 
15α-4-50a 56.6 (d) 75.2 (d) 79.5 (d) 51.9 (d) 131.2 (d) 134.3 (d) 84.9 (d) 
15β-4-50a 56.3 (d) 74.8 (d) 78.9 (d) 51.4 (d) 130.7 (d) 133.6 (d) 84.6 (d) 
15α-4-50b 57.2 (d) 75.3 (d) 79.6 (d) 51.6 (d) 131.6 (d) 133.8 (d) 85.0 (d) 
15β-4-50b 57.4 (d) 75.1 (d) 79.1 (d) 51.4 (d) 131.4 (d) 133.6 (d) 84.9 (d) 
 
(2S* or 2R*,3S*,5R*,6E,8E)-tert-Butyl 5-(tert-butyldimethylsilyloxy)-3-hydroxy-2-
(2,2,6,6-tetramethylpiperidin-1-yloxy)-6,8-tetradecadienoate 4-53b: 
H11C5
TBSO
CO2tBu
OH
O
N
 
1H NMR (400 MHz): δ = –0.03 (s, 3H, Si(CH3)2), 0.00 (s, 3H, Si(CH3)2), 0.82 (s, 9H, 
SiC(CH3)3), 0.83 (m, 3H, CH2CH3), 0.94-1.14 (m, 12H, NC(CH3)2), 1.16-1.53 (m, 12H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.42 (s, 9H, OC(CH3)3), 1.53-1.67 (m, 2H, 
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OCHCH2CHO), 1.99 (m, 2H, CH2CH=), 4.06 (m, 1H, CHOTMP), 4.14 (m, 1H, CHOH), 4.31 
(m, 1H, CHOTBS), 5.43 (m, 1H, =CHCHOTBS), 5.58 (dt, J = 14.4, 7.0 Hz, 1H, =CHCH2), 
5.92 (dd, J = 14.9, 10.4 Hz, 1H, CH2CH=CH), 6.04 (dd, J = 15.0, 10.4 Hz, 1H, 
CH=CHCHOTBS). - 13C NMR (100 MHz): δ = –4.8 (q, Si(CH3)2), –4.1 (q, Si(CH3)2), 14.0 
(q, CH2CH3), 17.1 (t, NCCH2CH2CH2CN), 18.1 (s, SiC(CH3)3), 20.1 (q, NC(CH3)2), 20.6 (q, 
NC(CH3)2), 22.5 (t, CH2CH3), 25.9 (q, SiC(CH3)3), 28.1 (q, OC(CH3)3), 28.9 (t, 
CH2CH2CH2CH3), 31.4 (t, CH2CH2CH3), 32.6 (t, =CHCH2), 34.5 (q, NC(CH3)2), 39.6 (t, 
NCCH2CH2CH2CN), 40.4 (t, CHCH2CH), 60.3 (s, NC(CH3)2), 69.8 (d, CHOH), 72.3 (d, 
CHOTBS), 81.5 (s, OC(CH3)3), 87.7 (d, CHOTMP), 129.4 (d, CH2CH=CH), 130.8 (d, 
CH=CHCHOTBS), 133.2 (d, =CHCHOTBS), 135.1 (d, CH=CHCH2), 170.2 (s, C=O). 
 
6.9.3. Reduction of cyclopentanecarboxylic esters 15α ,β-4-7b and 15α ,β-4-8a,b 
 
Reduction of cyclopentanecarboxylic esters 15α-4-7b and 15β-4-7b: 
To a suspension of fresh LiAlH4 (68 mg, 1.8 mmol) in 3 mL THF was added 4-7b (80 mg, 
0.18 mmol) dissolved in 3 mL THF slowly at –40 °C with good stirring. The solution was 
warmed to 0 °C during 2.5 h and stirred at r.t. for 0.5 h. The reaction was quenched with 15 
drops of water at 0 °C, and stirred for further 15 min. The reaction mixture was diluted with 
diethyl ether and filtered through a pad of silica gel, which was washed thoroughly with 
diethyl ether. After evaporation of the solvent, the product was purified by flash 
chromatography (hexane/ethyl acetate 2:1) to give 70 mg (100%) of the pure diol 4-54 as a 
mixture of inseparable 15α- and 15β-diastereomers as a colourless oil, Rf(hexane/ethyl 
acetate 2:1) = 0.14. Similar reductions were performed on PG isomers 15α-4-45b and 15β-4-
45b. The configuration of the diols was assigned by analogy to the substrates used. 
 
2-Hydroxymethyl-3-[(E)-3-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-
yl]cyclopentan-1-ols: MS(ESI) m/z (%): 404 (100) [M+Na+], 248 (39) [M–TEMPO+Na+], 
158 (8) [TEMPOH2]+. - HRMS: C23H43NO3Na+: calc. 404.3141; found 404.3150. 
 
(1S*,2R*,3R*)-2-Hydroxymethyl-3-[(E,S*)-3-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-
1-en-1-yl]cyclopentan-1-ol 15α-4-54: 
HO
C5H11
OTMP
OH
 
1H NMR (400 MHz): δ = 0.88 (t, J = 6.8 Hz, 3H, CH2CH3), 1.05 (br. s, 6H, NC(CH3)2), 1.12 
(br. s, 3H, NC(CH3)2), 1.16 (br. s, 3H, NC(CH3)2), 1.19-1.42 (m, 12H, NCCH2CH2CH2CN, 
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CH2CH2CH2CH2CH3, CH2CHOTMP), 1.50-1.70 (m, 4H, NCCH2CH2CH2CN, 
CH2CHOTMP, CH2CH2CHOH), 1.91 (m, 1H, CH2CH2CHOH), 2.15 (m, 2H, CH2CHOH, 
CHCH2OH), 2.79 (br. s, 1H, OH), 2.87 (m, 1H, CHCH=CHCHOTMP), 3.01 (br. s, 1H, OH), 
3.59 (A part of ABX system, J = 16.8, 6.7 Hz, 1H, CH2OH), 3.68 (B part of ABX system, J = 
16.8, 6.3 Hz, 1H, CH2OH), 4.09 (m, 1H, CHOTMP), 4.16 (m, 1H, CHOH), 5.38 (ddd, J = 
15.5, 9.0, 1.3 Hz, 1H, =CHCHOTMP), 5.60 (dd, J = 15.5, 7.0 Hz, CH=CHCHOTMP). - 13C 
NMR (100 MHz): δ = 14.0 (q, CH2CH3), 17.2 (t, NCCH2CH2CH2CN), 20.5 (q, NC(CH3)2), 
22.6 (t, CH2CH3), 25.2 (t, CH2CH2CH3CH3), 27.5 (t, CH2CH2CHOH), 31.9 (t, CH2CH2CH3), 
33.5 (t, CH2CHOH), 34.0 (q, NC(CH3)2), 34.5 (t, CH2CHOTMP), 34.8 (q, NC(CH3)2), 39.6 (t, 
NCCH2CH2CH2CN), 39.8 (t, NCCH2CH2CH2CN), 41.8 (d, CHCHCH=), 53.2 (d, 
CHCH2OH), 59.1 (s, NC(CH3)2), 60.5 (s, NC(CH3)2), 62.7 (t, CH2OH), 76.4 (d, CHOH), 84.6 
(d, CHOTMP), 132.4 (d, =CHCHOTMP), 133.5 (d, CH=CHCHOTMP). 
 
(1S*,2R*,3R*)-2-Hydroxymethyl-3-[(E,R*)-3-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-
1-en-1-yl]cyclopentan-1-ol 15β-4-54: 
HO
C5H11
OTMP
OH
 
Detectable resonances: 1H NMR (400 MHz): δ = 2.15 (m, 2H, CH2CHOH, CHCH2OH), 2.82 
(br. s, 2H, OH), 2.87 (m, 1H, CHCH=CHCHOTMP), 3.76 (m, 2H, CH2OH), 4.16 (m, 2H, 
CHOH, CHOTMP), 5.43 (m, 1H, =CHCHOTMP), 5.49 (dd, J = 14.9, 8.8 Hz, 1H, 
CH=CHCHOTMP). - 13C NMR (100 MHz): δ = 14.0 (q, CH2CH3), 17.2 (t, 
NCCH2CH2CH2CN), 20.5 (q, NC(CH3)2), 22.6 (t, CH2CH3), 25.2 (t, CH2CH2CH3CH3), 29.0 
(t, CH2CH2CHOH), 31.9 (t, CH2CH2CH3), 33.3 (t, CH2CHOH), 34.0 (q, NC(CH3)2), 34.5 (t, 
CH2CHOTMP), 34.8 (q, NC(CH3)2), 39.6 (t, NCCH2CH2CH2CN), 42.7 (d, CHCHCH=), 54.0 
(d, CHCH2OH), 61.5 (t, CH2OH), 74.7 (d, CHOH), 84.1 (d, CHOTMP), 133.0 (d, 
=CHCHOTMP), 135.6 (d, CH=CHCHOTMP). 
 
(1S*,2S*,3R*)-2-Hydroxymethyl-3-[(E,S*)-3-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-
en-1-yl]cyclopentan-1-ol 15α-4-55: 
HO
C5H11
OTMP
OH
 
1H NMR (200 MHz): δ = 0.88 (t, J = 6.5 Hz, 3H, CH2CH3), 1.05-1.47 (m, 27H, NC(CH3)2, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, OH), 1.70 (m, 3H, CH2CH2CHOH), 2.03 (m, 2H, 
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CH2CHOH, CHCH2OH), 2.17 (br. s, 1H, OH), 2.61 (m, 1H, CHCH=CHCHOTMP), 3.86 (AB 
part of ABX system, J = 11.0, 11.2, 5.3 Hz, 2H, CH2OH), 4.07 (m, 1H, CHOTMP), 4.42 (dt, 
J = 2.7, 5.5 Hz, 1H, CHOH), 5.34 (dd, J = 15.3, 8.1 Hz, 1H, =CHCHOTMP), 5.48 (dd, J = 
15.3, 8.2 Hz, CH=CHCHOTMP). - 13C NMR (50 MHz): δ = 14.0 (q, CH2CH3), 17.3 (t, 
NCCH2CH2CH2CN), 20.4 (q, NC(CH3)2), 22.6 (t, CH2CH3), 25.2 (t, CH2CH2CH3CH3), 30.4 
(t, CH2CH2CHOH), 31.8 (t, CH2CH2CH3), 34.4 (q, NC(CH3)2), 34.6 (t, CH2CHOH), 35.0 (q, 
NC(CH3)2), 34.7 (t, CH2CHOTMP), 39.9 (t, NCCH2CH2CH2CN), 43.4 (d, 
CHCH=CHCHOTMP), 52.8 (d, CHCH2OH), 60.0 (q, NC(CH3)2), 62.2 (t, CH2OH), 75.4 (d, 
CHOH), 84.6 (d, CHOTMP), 133.1 (d, =CH), 135.5 (d, CH=). 
 
(1S*,2S*,3R*)-2-Hydroxymethyl-3-[(1E,3R*)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentan-1-ol 15β-4-55: 
HO
C5H11
OTMP
OH
 
Detectable resonances: 1H NMR (200 MHz): δ = 2.03 (m, 2H, CH2CHOH, CHCH2OH), 2.61 
(m, 1H, CHCH=CHCHOTMP), 3.86 (m, 2H, CH2OH), 4.07 (m, 1H, CHOTMP), 4.42 (m, 
1H, CHOH), 5.34 (m, 2H, CH=CH). - 13C NMR (50 MHz): δ = 14.0 (q, CH2CH3), 17.3 (t, 
NCCH2CH2CH2CN), 20.4 (q, NC(CH3)2), 22.6 (t, CH2CH3), 25.3 (t, CH2CH2CH3CH3), 30.0 
(t, CH2CH2CHOH), 31.8 (t, CH2CH2CH3), 34.4 (t, CH2CHOH), 34.7 (t, CH2CHOTMP), 39.9 
(t, NCCH2CH2CH2CN), 42.0 (d, CHCHCH=), 51.6 (d, CHCH2OH), 61.5 (t, CH2OH), 75.3 (d, 
CHOH), 85.1 (d, CHOTMP), 133.3 (d, =CH), 134.5 (d, CH=). 
 
2-Hydroxymethyl-3-[(E)-3-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-
yl]cyclopentan-1-ol 4-56: 
HO
C5H11
OTMP
OH
 
4-56-I3-2 (detectable resonances): 1H NMR (400 MHz): δ = 2.87 (m, 1H, 
CHCH=CHCHOTMP), 3.31 (br. s, 1H, OH), 3.53 (dd, J = 10.4, 8.7 Hz, 1H, CH2OH), 3.62 
(dd, J = 10.5, 4.4 Hz, 1H, CH2OH or CHOH), 3.98 (dt, J = 4.8, 8.4 Hz, 1H, CHOTMP), 5.31 
(dd, J = 15.4, 8.3 Hz, =CHCHOTMP), 5.38 (m, 1H, CH=CHCHOTMP). - 13C NMR (100 
MHz): δ = 29.3 (t, CH2CH2CHOH), 33.0 (t, CH2CHOH), 34.4 (t, CH2CHOTMP), 40.2 (t, 
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NCCH2CH2CH2CN), 43.5 (d, CHCHCH=), 55.1 (d, CHCH2OH), 64.7 (t, CH2OH), 77.5 (d, 
CHOH), 84.9 (d, CHOTMP), 133.1 (d, =CHCHOTMP), 134.6 (d, CH=CHCHOTMP). 
 
Reduction of cyclopentanecarboxylic esters 4-8a,b: 
4-57 from 4-8a (Method A): To a suspension of fresh LiAlH4 (40 mg, 1.05 mmol) in 3 mL 
THF was added 4-8a (60 mg, 0.11 mmol) dissolved in 2 mL THF slowly at –45 °C with good 
stirring. The solution was warmed to r.t. during 1 h and stirred for another hour. The reaction 
was quenched with 10 drops of water at 0 °C, diluted with diethyl ether and stirred for 20 min 
at room temperature. The reaction mixture was filtered through a pad of silica gel, which was 
washed thoroughly with diethyl ether. After evaporation of the solvent, the product was 
purified by flash chromatography (hexane/ethyl acetate 2:1) to give 50 mg (89%) of the pure 
diol 4-57 as a mixture of inseparable 15α- and 15β-diastereomers as a colourless oil, 
Rf(hexane/ethyl acetate 2:1) = 0.38. Reductions were similarly performed with mixtures of α-
4-8a, β-4-8a and α-4-50a. The inseparable diastereomers of α- and β-4-57 and the diol with 
PG configuration 4-58 were further enriched by another flash chromatography. 
4-57 from 4-8b (Method B): To a suspension of LiAlH4 (55 mg, 1.44 mmol) in 5 mL THF 
was added 4-8b (280 mg, 0.48 mmol) dissolved in 2 mL THF slowly at –70 °C with good 
stirring. The solution was warmed to 0 °C during 1.5 h, and stirred at 0 °C for 30 min. The 
reaction mixture was quenched carefully with 10 drops of water at 0 °C, diluted with diethyl 
ether and stirred at r.t. for 20 min. The reaction mixture was filtered through a pad of silicagel, 
which was washed thoroughly with diethyl ether. After evaporation of the solvent, flash 
chromatography (hexane/ethyl acetate 10:1, gradient to 2:1) gave 40 mg (16%) of the 
aldehyde 4-59 as a colourless oil, Rf(hexane/ethyl acetate 2:1) = 0.9; 130 mg (53%) of pure 
diol 4-57 as colourless oil and at last 20 mg (8%) of the TBS-deprotected cyclopentane ester 
4-60, Rf(hexane/ethyl acetate 2:1) = baseline. 
Variations of workup: 
Method C: The reaction was quenched with 1 mL ethyl acetate at –70 °C. After 5 min 0.3 mL 
of water was added, and after another 5 min the mixture was diluted with diethyl ether and 
allowed to warm to r.t. Then 3 g of silica gel was added and it was stirred for 30 min. This 
mixture was then filtered using a frit. 
Method D: The reaction was quenched with 20 mL of solution of sodium potassium tartrate at 
0 °C, diluted with diethyl ether and warmed to r.t., followed by a standard aqueous workup. 
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4-(tert-Butyldimethylsilyloxy)-2-hydroxymethyl-3-[(E)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentan-1-ols: IR (Film): v~  = 3381 (w), 2928 (s), 2857 (m), 1465 
(m), 1376 (w), 1360 (w), 1254 (m), 1182 (w), 1130 (m), 1098 (m), 1061 (m), 1025 (m), 976 
(m), 836 (s), 775 (s), 715 (w). - MS(ESI) m/z (%): 512 (100) [M+H+], 158 (13) [TEMPOH2]+. 
- HRMS: C29H58NO4Si: calc. 512.4135; found 512.4130. 
 
(1S*,2R*,3R*,4R*)-4-(tert-Butyldimethylsilyloxy)-2-hydroxymethyl-3-[(1E,3S*)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopentan-1-ol 15α-4-57: 
HO
TBSO OTMP
C5H11
OH
 
1H NMR (400 MHz): δ = 0.00 (s, 6H, Si(CH3)2), 0.82 (m+s, 12H, CH2CH3 + SiC(CH3)3), 
0.99 (br. s, 3H, NC(CH3)2), 1.00 (br. s, 3H, NC(CH3)2), 1.05 (br. s, 3H, NC(CH3)2), 1.08 (br. 
s, 3H, NC(CH3)2), 1.13-1.28 (m, 8H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.30-1.53 
(m, 5H, NCCH2CH2CH2CN, TMPOCHCH2), 1.59 (m, 1H, TMPOCHCH2), 1.64 (dt, J = 13.8, 
4.3 Hz, 1H, CHCH2CH), 2.20 (br. s, 2H, OH), 2.25 (ddd, J = 13.7, 7.1, 5.3 Hz, 1H, 
CHCH2CH), 2.36 (m, 1H, CHCH2OH), 2.75 (dt, J = 8.4, 3.4 Hz, 1H, TBSOCHCH), 3.61 (AB 
part of ABX system, J = 11.4, 6.5, 6.0 Hz, 2H, CH2OH), 4.00 (dt, J = 5.3, 8.2 Hz, 1H, 
CHOTMP), 4.08 (m, 2H, CHOH, CHOTBS), 5.27 (dd, J = 15.5, 8.4 Hz, 1H, 
CH=CHCHOTMP), 5.44 (ddd, J = 15.5, 8.8, 0.9 Hz, 1H, =CHCHOTMP). - 13C NMR (100 
MHz): δ = –4.7 (q, Si(CH3)2), –4.6 (q, Si(CH3)2), 14.0 (q, CH2CH3), 17.3 (t, 
NCCH2CH2CH2CN), 17.9 (s, SiC(CH3)3), 20.5 (q, NC(CH3)2), 22.6 (t, CH2CH3), 25.2 (t, 
CH2CH2CH2CH3), 25.8 (q, SiC(CH3)3), 31.9 (t, CH2CH2CH3), 34.1 (q, NC(CH3)2), 34.6 (t, 
TMPOCHCH2), 35.0 (q, NC(CH3)2), 40.1 (t, NCCH2CH2CH2CN), 43.3 (t, CHCH2CH), 52.2 
(d, CHCHCH=), 52.6 (d, CHCH2OH), 59.2 (s, NC(CH3)2), 62.9 (t, CH2OH), 75.5 (d, CHOH), 
76.7 (d, CHOTBS), 84.8 (d, CHOTMP), 129.8 (d, CH=CHCHOTMP), 134.7 (d, 
=CHCHOTMP). - H,H-NOESY of 15α-4-57: 
H
OTBS
H
H C5H11
OTMP
H
OH
H
HO
H
H
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(1S*,2R*,3R*,4R*)-4-(tert-Butyldimethylsilyloxy)-2-hydroxymethyl-3-[(1E,3R*)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopentan-1-ol 15β-4-57:  
HO
TBSO OTMP
C5H11
OH
 
1H NMR (400 MHz): δ = 0.00 (s, 6H, Si(CH3)2), 0.83 (m+s, 12H, SiC(CH3)3 + CH2CH3), 
1.01 (s, 3H, NC(CH3)2), 1.04 (s, 3H, NC(CH3)2), 1.09 (s, 3H, NC(CH3)2), 1.10 (s, 3H, 
NC(CH3)2), 1.14-1.63 (m, 14H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.68 (dt, J = 
13.8, 3.5 Hz, 1H, CHCH2CH), 2.16 (ddd, J = 13.7, 6.9, 5.0 Hz, 1H, CHCH2CH), 2.44 (m, 2H, 
CHCH2OH), 2.76 (m, 1H, TBSOCHCH), 3.08 (br. s, 1H, OH), 3.69 (A part of ABX system, J 
= 11.9, 7.9 Hz, 1H, CH2OH), 3.76 (B part of ABX system, J = 11.8, 4.6 Hz, 1H, CH2OH), 
3.89 (m, 1H, CHOTBS), 4.00 (m, 1H, CHOH), 4.11 (m, 1H, CHOTMP), 5.28 (dd, J = 15.4, 
10.7 Hz, 1H, CH=CHCHOTMP), 5.51 (dd, J = 15.1, 9.4 Hz, 1H, =CHCHOTMP). - 13C NMR 
(100 MHz): δ = –4.9 (q, Si(CH3)2), –4.8 (q, Si(CH3)2), 14.0 (q, CH2CH3), 17.2 (t, 
NCCH2CH2CH2CN), 18.0 (s, SiC(CH3)3), 20.6 (q, NC(CH3)2), 20.7 (q, NC(CH3)2), 22.6 (t, 
CH2CH3), 25.2 (t, CH2CH2CH2CH3), 25.8 (q, SiC(CH3)3), 31.9 (t, CH2CH2CH3), 34.2 (q, 
NC(CH3)2), 34.5 (t, TMPOCHCH2), 39.1 (t, NCCH2CH2CH2CN), 39.6 (t, 
NCCH2CH2CH2CN), 43.0 (t, CHCH2CH), 53.4 (d, CHCHCH=), 53.6 (d, CHCH2OH), 59.4 
(s, NC(CH3)2), 60.9 (s, NC(CH3)2), 61.4 (t, CH2OH), 74.3 (d, CHOH), 78.3 (d, CHOTBS), 
84.0 (d, CHOTMP), 132.5 (d, CH=CHCHOTMP), 135.3 (d, =CHCHOTMP). - H,H-NOESY 
of 15β-17: 
H
OTBS
H
H C5H11
OTMP
H
OH
H
HO
H
H
 
 
(1S*,2S*,3R*,4R*)-4-(tert-Butyldimethylsilyloxy)-2-hydroxymethyl-3-[(1E,3S*)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopentan-1-ol 4-58: 
HO
TBSO OTMP
C5H11
OH
 
1H NMR (400 MHz): δ = –0.01 (s, 6H, Si(CH3)2), 0.82 (s+m, 12H, SiC(CH3)3 + CH2CH3), 
0.99 (br. s, 3H, NC(CH3)2), 1.01 (br. s, 3H, NC(CH3)2), 1.05 (br. s, 3H, NC(CH3)2), 1.08 (br. 
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s, 3H, NC(CH3)2), 1.14-1.24 (m, 7H, CH2CH2CH2CH2CH3, NCCH2CH2CH2CN), 1.30-1.52 
(m, 6H, NCCH2CH2CH2CCN, TMPOCHCH2), 1.60 (m, 1H, TMPOCHCH2), 1.73 (br. d, J = 
14.2 Hz, 1H, CHCH2CH), 1.82 (m, 1H, CHCH2OH), 1.99 (dt, J = 14.0, 5.4 Hz, 1H, 
CHCH2CH), 2.45 (dt, J =3.5, 8.8 Hz, 1H, TBSOCHCH), 2.82 (br. s, 1H, OH), 3.00 (br. d, J = 
8.2 Hz, 1H, OH), 3.80 (m, 2H, CH2OH), 3.95 (m, 1H, CHOTBS), 3.99 (m, 1H, CHOTMP), 
4.28 (m, 1H, CHOH), 5.23 (dd, J = 15.3, 8.9 Hz, 1H, CH=CHCHOTMP), 5.41 (dd, J = 15.4, 
9.1 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = –4.9 (q, Si(CH3)2), –4.7 (q, 
Si(CH3)2), 14.0 (q, CH2CH3), 17.2 (t, NCCH2CH2CH2CN), 17.8 (s, SiC(CH3)3), 20.4 (q, 
NC(CH3)2), 22.6 (t, CH2CH3), 25.1 (t, CH2CH2CH2CH3), 25.7 (q, SiC(CH3)3), 31.9 (t, 
CH2CH2CH3), 34.0 (q, NC(CH3)2), 34.6 (t, TMPOCHCH2), 35.2 (q, NC(CH3)2), 39.7 (t, 
NCCH2CH2CH2CN), 40.0 (t, NCCH2CH2CH2CN), 43.4 (t, CHCH2CH), 52.0 (d, CHCH2OH), 
52.9 (d, CHCHCH=), 59.0 (s, NC(CH3)2), 59.1 (s, NC(CH3)2), 62.4 (t, CH2OH), 75.0 (d, 
CHOH), 79.3 (d, CHOTBS), 84.7 (d, CHOTMP), 132.8 (d, CH=CHCHOTMP), 134.2 (d, 
=CHCHOTMP). - MS(ESI) m/z (%): 1045 (18) [2M+Na+], 534 (84) [M+Na+], 378 (100) 
[M+Na+–TEMPO], 158 (8) [TEMPOH2]+. - HRMS: C29H58NO4Si: calc. 512.4135; found 
M+H+ 512.4133. 
 
(1R*,2R*,3R*,5S*)-3-(tert-Butyldimethylsilyloxy)-5-hydroxy-2-[(R* and S*,E)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopentanecarbaldehyde 4-59: 
HO
TBSO
CHO
OTMP
C5H1115
 
15α-4-59: Rf(hexane/ethyl acetate 2:1) = 0.9. - 1H NMR (400 MHz): δ = 0.00 (s, 6H, 
Si(CH3)2), 0.812 (s, 9H, SiC(CH3)3), 0.83 (m, 3H, CH2CH3), 1.00-1.09 (m, 12H, NC(CH3)2), 
1.14-1.57 (m, 13H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, CH2CHOTMP), 1.69 (m, 1H, 
CH2CHOTMP), 1.90 (m, 2H, CHCH2CH), 2.48 (m, 1H, CHCHO), 2.66 (m, 1H, 
CHCHOTBS), 4.02 (m, 1H, CHOTMP), 4.58 (m, 1H, CHOTBS), 4.63 (m, 1H, CHOH), 5.48 
(m, 2H, CH=CHCHOTMP), 9.65 (d, J = 1.2 Hz, 1H, CHO). - 13C NMR (100 MHz): δ = –4.5 
(q, Si(CH3)2), –4.4 (q, Si(CH3)2), 14.3 (q, CH2CH3), 17.5 (t, NCCH2CH2CH2CN), 18.2 (s, 
SiC(CH3)3), 20.5 (q, NC(CH3)2), 20.6 (q, NC(CH3)2), 22.8 (t, CH2CH3), 25.5 (t, 
CH2CH2CH2CH3), 25.99 (q, SiC(CH3)3), 32.1 (t, CH2CH2CH3), 34.2 (q, NC(CH3)2), 34.7 (t, 
TMPOCHCH2), 35.4 (q, NC(CH3)2), 40.4 (t, NCCH2CH2CH2CN), 43.7 (t, CHCH2CH), 51.9 
(d, CHCHCH=), 59.4 (s, NC(CH3)2), 60.3 (s, NC(CH3)2), 64.2 (d, CHCHO), 71.1 (d, CHOH), 
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77.0 (d, CHOTBS), 84.8 (d, CHOTMP), 130.8 (d, CH=CHCHOTMP), 135.1 (d, 
=CHCHOTMP), 202.3 (d, CHO). 
15β-4-59: 1H NMR (400 MHz): δ = –0.02 (s, 6H, Si(CH3)2), 0.808 (s, 9H, SiC(CH3)3), 0.83 
(m, 3H, CH2CH3), 1.00-1.09 (m, 12H, NC(CH3)2), 1.14-1.57 (m, 13H, NCCH2CH2CH2CN, 
CH2CH2CH2CH2CH3, CH2CHOTMP), 1.69 (m, 1H, CH2CHOTMP), 1.90 (m, 2H, 
CHCH2CH), 2.48 (m, 1H, CHCHO), 2.66 (m, 1H, CHCHOTBS), 4.02 (m, 1H, CHOTMP), 
4.58 (m, 1H, CHOTBS), 4.61 (m, 1H, CHOH), 5.44 (m, 2H, CH=CHCHOTMP), 9.69 (d, J = 
0.9 Hz, 1H, CHO). - 13C NMR (100 MHz): δ = –4.5 (q, Si(CH3)2), –4.4 (q, Si(CH3)2), 14.3 (q, 
CH2CH3), 17.4 (t, NCCH2CH2CH2CN), 18.3 (s, SiC(CH3)3), 20.5 (q, NC(CH3)2), 20.6 (q, 
NC(CH3)2), 22.8 (t, CH2CH3), 25.3 (t, CH2CH2CH2CH3), 25.96 (q, SiC(CH3)3), 32.2 (t, 
CH2CH2CH3), 34.0 (t, TMPOCHCH2), 34.2 (q, NC(CH3)2), 35.4 (q, NC(CH3)2), 40.3 (t, 
NCCH2CH2CH2CN), 43.1 (t, CHCH2CH), 52.1 (d, CHCHCH=), 59.4 (s, NC(CH3)2), 60.3 (s, 
NC(CH3)2), 64.1 (d, CHCHO), 70.7 (d, CHOH), 76.9 (d, CHOTBS), 84.9 (d, CHOTMP), 
131.1 (d, CH=CHCHOTMP), 135.7 (d, =CHCHOTMP), 202.3 (d, CHO). 
 
(1S*,2R*,3R*,5S*)-tert-Butyl 3,5-dihydroxy-2-[(R* and S*,E)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-enyl]cyclopentanecarboxylate 4-60: 
HO
HO
CO2tBu
OTMP
C5H11
 
Rf(hexane/ethyl acetate 2:1) = baseline. - IR (Film): v~  = 3407 (br. w), 2931 (s), 2859 (w), 
1723 (m), 1367 (m), 1256 (w), 1153 (m), 1077 (w), 974 (w) cm-1. - MS(ESI) m/z (%): 490 
(10) [M+Na+], 468 (100) [M+H+], 334 (12) [M+Na+–TEMPO], 158 (26) [TEMPOH2+]. - 
HRMS: C27H50NO5+: calc. 468.3689; found 468.3683. 
15α-4-60: 1H NMR (400 MHz): δ = 0.84 (m, 3H, CH2CH3), 1.01-1.07 (m, 12H, NC(CH3)2), 
1.15-1.55 (m, 14H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, CH2CHOTMP, OH), 1.39 (s, 
9H, OC(CH3)3), 1.49 (br. s, 1H, OH), 1.61 (m, 2H, CH2CHOTMP, CHCH2CH), 2.49 (ddd, J 
= 17.7, 13.8, 7.1 Hz, 1H, CHCH2CH), 2.86 (m, 1H, OHCHCHCH=), 2.95 (dd, J = 8.6, 4.6 
Hz, 1H, CHCOOtBu), 4.00 (m, 1H, CHOTMP), 4.08 (m, 1H, HOCHCHCH=), 4.49 (m, 1H, 
CH(OH)CHCOOtBu), 5.24 (dd, J = 15.3, 9.0 Hz, 1H, CH=CHCHOTMP), 5.53 (dd, J = 15.3, 
9.0 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = 14.1 (q, CH2CH3), 17.2 (t, 
NCCH2CH2CH2CN), 20.4 (q, NC(CH3)2), 22.57 (t, CH2CH3), 25.18 (t, CH2CH2CH2CH3), 
28.19 (q, OC(CH3)3), 32.0 (t, CH2CH2CH3), 33.9 (q, NC(CH3)2), 34.7 (t, TMPOCHCH2), 34.9 
(q, NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 41.7 (t, CHCH2CH), 53.3 (d, CHCHCH=), 56.5 
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(d, CHCOOtBu), 59.2 (s, NC(CH3)2), 60.4 (s, NC(CH3)2), 73.0 (d, CH(OH)CHCOOtBu), 
75.9 (d, HOCHCHCH=), 80.9 (s, OC(CH3)3), 84.54 (d, CHOTMP), 128.9 (d, 
CH=CHCHOTMP), 136.4 (d, =CHCHOTMP), 172.3 (s, COOtBu). 
15β-4-60: 1H NMR (400 MHz): δ = 0.84 (m, 3H, CH2CH3), 1.01-1.07 (m, 12H, NC(CH3)2), 
1.15-1.55 (m, 14H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, CH2CHOTMP, OH), 1.38 (s, 
9H, OC(CH3)3), 1.61 (m, 2H, CH2CHOTMP, CHCH2CH), 2.49 (m, 1H, CHCH2CH), 2.86 (m, 
1H, OHCHCHCH=), 3.00 (dd, J = 8.2, 4.5 Hz, 1H, CHCOOtBu), 4.00 (m, 1H, CHOTMP), 
4.08 (m, 1H, HOCHCHCH=), 4.49 (m, 1H, CH(OH)CHCOOtBu), 5.28 (m, 1H, 
CH=CHCHOTMP), 5.53 (dd, J = 15.4, 6.6 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): 
δ = 14.0 (q, CH2CH3), 17.3 (t, NCCH2CH2CH2CN), 20.4 (q, NC(CH3)2), 22.61 (t, CH2CH3), 
25.23 (t, CH2CH2CH2CH3), 28.24 (q, OC(CH3)3), 31.9 (t, CH2CH2CH3), 33.9 (q, NC(CH3)2), 
34.2 (t, TMPOCHCH2), 34.9 (q, NC(CH3)2), 40.1 (t, NCCH2CH2CH2CN), 42.0 (t, 
CHCH2CH), 52.7 (d, CHCHCH=), 56.8 (d, CHCOOtBu), 59.2 (s, NC(CH3)2), 60.4 (s, 
NC(CH3)2), 73.2 (d, CH(OH)CHCOOtBu), 76.9 (d, HOCHCHCH=), 81.0 (s, OC(CH3)3), 
84.48 (d, CHOTMP), 127.7 (d, CH=CHCHOTMP), 136.5 (d, =CHCHOTMP), 172.3 (s, 
COOtBu). 
 
6.9.4. Introduction of a leaving group 
 
Bromination of diol 4-55:  
To a solution of a 2.2:1 mixture of diols 15α /β-4-55 (50 mg, 0.13 mmol) in 5 mL dry CH2Cl2 
Ph3P (68 mg, 0.26 mmol) was added at 0 °C. After stirring shortly CBr4 (42 mg, 0.13 mmol) 
was added. The reaction mixture was warmed to r.t. and stirred for 15 h. The progress of the 
reaction was monitored by TLC (hexane/ethyl acetate 2:1 and 5:1). Dry methanol (7 mL) was 
added and the reaction mixture was stirred for 30 min. The reaction mixture was diluted with 
diethyl ether and filtered through a pad of silica gel. The solvent was evaporated and the 
residue (120 mg) was purified immediately on a short column (hexane/ethyl acetate 40:1, 
gradient to 2:1). First, 4-66 eluted at a polarity of 40:1, followed by a 2.7:1 mixture of 15α,β-
4-65 at a polarity of 10:1. Yields: 30 mg (51%) 4-65 as a pale yellow oil and 20 mg (30%) 4-
66 as a pale yellow oil. Two bromination experiments using IsoP 4-54, performed similarly, 
gave complex mixtures. NMR spectra showed that decomposition occurred. The labile 
bromide 4-65 was immediately subjected to an alkylation reaction. 
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 (1S*,2R*,3R*)-2-(Bromomethyl)-3-[(1E,3S*)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentan-1-ol 15α-4-65: 
HO
OTMP
C5H11
Br
 
1H NMR (200 MHz): δ = 0.87 (t, J = 6.3 Hz, 3H, CH2CH3), 1.10-1.71 (m, 28H, NC(CH3)2), 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, CH2CH2CHOH), 1.85-2.17 (m, 3H, CH2CHOH, 
CHCHCHOH), 2.36 (m, 1H, CHCH2Br), 3.45 (m, 1H, CH2Br), 3.66 (dd, J = 9.8, 4.1 Hz, 1H, 
CH2Br), 4.05 (m, 1H, CHOTMP), 4.44 (m, 1H, CHOH), 5.20 (dd, J = 15.3, 8.2 Hz, 1H, 
CH=CH), 5.42 (dd, J = 15.3, 8.2 Hz, 1H, CH=CH). - 13C NMR (50 MHz):  
δ = 14.0 (q, CH2CH3), 17.3 (t, NCCH2CH2CH2CN), 20.1 (q, NC(CH3)2), 22.6 (t, CH2CH3), 
25.1 (t, CH2CH2CH2CH3), 31.1 (t, CH2CH2CHOH), 31.8 (t, CH2CH2CH3), 32.2 (t, CH2Br), 
33.1 (t, CH2CHOH), 34.0 (q, NC(CH3)2), 34.6 (t, TMPOCHCH2), 35.1 (q, NC(CH3)2), 40.2 (t, 
NCCH2CH2CH2CN), 45.4 (d, CH2CHCH=), 54.2 (d, CHCH2Br), 58.9 (s, NC(CH3)2), 60.1 (s, 
NC(CH3)2), 73.4 (d, CHOH), 84.8 (d, CHOTMP), 133.7 (d, CH=CH), 134.2 (d, CH=CH). 
 
(1S*,2R*,3R*)-2-(Bromomethyl)-3-[(1E,3R*)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentan-1-ol 15β-4-65: 
HO
OTMP
C5H11
Br
 
15β-4-65, detectable resonances: 1H NMR (200 MHz): δ = 2.36 (m, 1H, CHCH2Br), 3.45 (m, 
2H, CH2Br), 4.03 (m, 1H, CHOTMP), 4.44 (m, 1H, CHOH), 5.20 (m, 2H, CH=CH). - 13C 
NMR (50 MHz): δ = 133.5 (d, CH=CH), 134.2 (d, CH=CH). 
 
(1S*,2S*,3R*)-2-(Bromomethyl)-3-[(1E,3S* and R*)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentyl bromide 15α- and 15β-4-66: 
Br
OTMP
C5H11
Br
 
MS(EI) m/z (%): 348/350/352 (4) [M–TEMPOH+], 260/271 (8) [M+–TEMPO–Br], 213/215 
(4), 189 (6), 157 (56) [TEMPOH]+, 142 (100) [TMPH2+], 123 (12), 97 (12) [C7H15+], 81 (12) 
[C6H9+], 69 (26), 55 (20), 44 (14) [C3H8+]. - 15α-4-66: 1H NMR (200 MHz): δ = 0.81 (t, J = 
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7.0 Hz, 3H, CH2CH3), 0.98-1.90 (m, 28H, NC(CH3)2), NCCH2CH2CH2CN, 
CH2CH2CH2CH2CH3, CH2CH2CHBr), 2.06 (m, 2H, CH2CHBr, CHCHCHBr), 2.32 (m, 2H, 
CH2CHBr, CHCH2Br), 3.59 (A part of ABX, J = 10.6, 3.3 Hz, 1H, CH2Br), 3.72 (B part of 
ABX, J = 10.4, 3.0 Hz, CH2Br), 4.05 (m, 2H, CHOTMP, CHBr), 5.20 (dd, J = 15.3, 8.4 Hz, 
1H, CH=CH), 5.45 (dd, J = 15.3, 8.6 Hz, 1H, CH=CH). - 13C NMR (50 MHz):  
δ = 14.0 (q, CH2CH3), 17.3 (t, NCCH2CH2CH2CN), 20.0 (q, NC(CH3)2), 20.1 (q, NC(CH3)2), 
22.6 (t, CH2CH3), 25.1 (t, CH2CH2CH2CH3), 31.5 (t, CH2CH2CHBr), 31.8 (t, CH2CH2CH3), 
34.0 (t, CH2Br), 34.2 (q, NC(CH3)2), 34.6 (t, CH2CHBr), 35.4 (t, TMPOCHCH2), 40.2 (t, 
NCCH2CH2CH2CN), 44.3 (d, CH2CHCH=), 51.2 (d, CHCH2Br), 56.3 (d, CHBr), 59.0 (s, 
NC(CH3)2), 60.0 (s, NC(CH3)2), 84.7 (d, CHOTMP), 132.6 (d, CH=CH), 135.1 (d, CH=CH). - 
15β-4-66, assignable resonances: 1H NMR (200 MHz): δ = 3.66 (m, 2H, CH2Br), 4.05 (m, 
2H, CHOTMP, CHBr), 5.34 (m, 2H, CH=CH). 
 
Mesylation of 4-57:  
 
HO
TBSO OTMP
C5H11
4-67a
OSO2CH3
H3CO2SO
TBSO OTMP
C5H11
4-68a
OSO2CH3
H3CO2SO
TBSO OTMP
C5H11
4-69a
OH
 
Method A: To a solution of 15α-4-57 (100 mg, 0.196 mmol) in 5 mL dry CH2Cl2, dry Et3N 
(0.056 mL, 0.392 mmol) and MsCl (0.185 mL, 1M solution of in dry CH2Cl2, 0.185 mmol) 
were added subsequently slowly with good stirring at –50 °C. The reaction mixture was 
stirred at –50 °C for ca. 1.5 h. The progress of the reaction was monitored by TLC 
(hexane/ethyl acetate 2:1 and 5:1). Water (2 mL) was added and the layers were separated. 
The aqueous layer was extracted three times with CH2Cl2. The combined organic layers were 
washed with water, twice with saturated NaHCO3 solution, and brine and dried over Na2SO4. 
The solvent was evaporated and the residue was purified immediately on a short column 
(hexane/ethyl acetate 10:1, gradient to pure ethyl acetate). First, 4-68a and 4-69a eluted as a 
mixture, followed by 4-67a and unreacted 4-57 as a partly separable mixture. For yields see 
Table 6.6, entry 1. 
Method B: The reaction was performed as above using 15α /β-4-57 (15α:15β = 3.1:1, 30 mg, 
0.058 mmol), NEt3 (0.016 mL, 0.116 mmol), and a 1M solution of MsCl in dry CH2Cl2 (0.063 
mL, 0.063 mmol) at –20 °C for 2 h. The residue was purified immediately on a short column 
(hexane/ethyl acetate 10:1, gradient to 2:1). For yields see Table 6.6, entry 2.  
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Table 6.6 Yields of mesylation experiments with 4-57 
Entry Method (Config. 
in 15-Pos.) 
4-67a (%) 4-68a (%) 4-69a (%) 4-57 (%) 
1 A (α) 39.5 mg (34) 12 mg (9) 13 mg (17) 34.2 mg (34) 
2 B (α:β = 3.1:1) 16.3 mg (48, 
α:β 3.8:1) 
13.5 mg (35, 
α:β 5.3:1) 
2.5 mg (7, 
α:β 1:1) 
2.1 mg (7, 
α:β 1:2) 
 
[(1S*,2R*,3R*,4R*)-4-(tert-Butyldimethylsilyloxy)-1-hydroxy-3-[(R* and S*,E)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopent-2-yl]methyl mesylate 15α- 
and 15β-4-67a: 
HO
TBSO OTMP
C5H11
OSO2CH3
 
15α-4-67a: Rf (hexane/ethyl acetate 2:1) = 0.44. - 1H NMR (400 MHz): δ = 0.00 (s, 6H, 
Si(CH3)2), 0.82 (s+m, 12H, SiC(CH3)3, CH2CH3), 0.98-1.06 (m, 12H, NC(CH3)2), 1.18-1.47 
(m, 13H, NCCH2CH2CH2CN, CH2CH2CH2CH3, TMPOCHCH2), 1.64 (m, 2H, 
TMPOCHCH2, CHCH2CH), 2.24 (ddd, J = 14.5, 7.5, 4.7 Hz, 1H, CHCH2CH), 2.59 (m, 1H, 
CHCH2OSO2), 2.80 (m, 1H, CHCHCH=), 2.94 (s, 3H, OSO2CH3), 3.89-4.03 (m, 3H, CHOH, 
CHOTBS, CHOTMP), 4.08 (A part of ABX system, J = 9.9, 8.5 Hz, 1H, CHCH2OSO2), 4.16 
(B part of ABX system, J = 10.0, 6.4 Hz, 1H, CHCH2OSO2), 4.99 (dd, J = 15.3, 10.0 Hz, 1H, 
CH=CHCHOTMP), 5.46 (dd, J = 15.3, 8.4 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): 
δ = –4.9 (q, Si(CH3)2), –4.7 (q, Si(CH3)2), 14.04 (q, CH2CH3), 17.2 (t, NCCH2CH2CH2CN), 
17.9 (s, SiC(CH3)3), 20.4 (q, NC(CH3)2), 22.5 (t, CH2CH3), 25.1 (t, CH2CH2CH2CH3), 25.8 
(q, SiC(CH3)3), 31.94 (t, CH2CH2CH3), 34.0 (q, NC(CH3)2), 34.5 (t, CH2CHOTMP), 35.4 (q, 
NC(CH3)2), 37.5 (q, OSO2CH3), 40.2 (t, NCCH2CH2CH2CN), 42.8 (t, CHCH2CH), 50.0 (d, 
CHCH2OSO2), 53.4 (d, CHCHCH=), 59.0 (s, NC(CH3)2), 60.1 (s, NC(CH3)2), 69.8 (t, 
CH2OSO2), 75.1 (d, CHOH), 77.8 (d, CHOTBS), 84.7 (d, CHOTMP), 126.8 (d, 
CH=CHCHOTMP), 137.5 (d, =CHCHOTMP).  
15β-4-67a detectable resonances: 1H NMR (400 MHz): δ = –0.02 (s, 6H, Si(CH3)2), 2.19 (m, 
1H, CHCH2CH), 2.59 (m, 1H, CHCH2OSO2), 2.74 (m, 1H, CHCHCH=), 2.97 (s, 3H, 
OSO2CH3), 3.89-4.18 (m, 4H, CHOH, CHOTBS, CHOTMP, CHCH2OSO2), 4.30 (B part of 
ABX system, J = 10.1, 5.7 Hz, 1H, CHCH2OSO2), 5.06 (dd, J = 15.3, 9.9 Hz, 1H, 
CH=CHCHOTMP), 5.46 (m, 1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = –4.9 (q, 
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Si(CH3)2), –4.8 (q, Si(CH3)2), 14.00 (q, CH2CH3), 31.89 (t, CH2CH2CH3), 34.4 (t, 
CH2CHOTMP), 37.6 (q, OSO2CH3), 42.9 (t, CHCH2CH), 49.8 (d, CHCH2OSO2), 53.2 (d, 
CHCHCH=), 70.0 (t, CH2OSO2), 74.9 (d, CHOH), 78.0 (d, CHOTBS), 84.4 (d, CHOTMP), 
127.6 (d, CH=CHCHOTMP), 137.1 (d, =CHCHOTMP). 
 
[(1S*,2R*,3R*,4R*)-4-(tert-Butyldimethylsilyloxy)-1-(mesyloxy)-3-[(R*,E and S*,E)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopent-2-yl]methyl mesylate 15α- 
and 15β-4-68a: 
H3CO2SO
TBSO OTMP
C5H11
OSO2CH3
 
15α-4-68a: Rf (hexane/ethyl acetate 2:1) = 0.65. - 1H NMR (400 MHz): δ = 0.00 (s, 6H, 
Si(CH3)2), 0.82 (s+m, 12H, SiC(CH3)3, CH2CH3), 0.98-1.09 (m, 12H, NC(CH3)2), 1.21-1.62 
(m, 14H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.89 (m, 1H, CHCH2CH), 2.53 (m, 1H, 
CHCH2CH), 2.77 (m, 1H, CHCHCH=), 2.88 (quint, J = 7.0 Hz, 1H, CHCH2OSO2), 2.95 (s, 
3H, OSO2CH3), 2.98 (s, 3H, OSO2CH3), 3.94 (dt, J = 8.1, 5.0 Hz, 1H, CHOTMP), 4.01 (dt, J 
= 5.6, 2.8 Hz, 1H, CHOTBS), 4.18 (AB part of ABX system, J = 10.1, 7.3, 6.5 Hz, 2H, 
CHCH2OSO2), 4.90 (m, 1H, CHOSO2), 5.02 (dd, J = 15.3, 9.7 Hz, 1H, CH=CHCHOTMP), 
5.53 (dd, J = 15.4, 8.6 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = –4.8 (q, 
Si(CH3)2), –4.7 (q, Si(CH3)2), 14.0 (q, CH2CH3), 17.2 (t, NCCH2CH2CH2CN), 17.9 (s, 
SiC(CH3)3), 20.3 (q, NC(CH3)2), 20.4 (q, NC(CH3)2), 22.5 (t, CH2CH3), 25.2 (t, 
CH2CH2CH2CH3), 25.73 (q, SiC(CH3)3), 31.9 (t, CH2CH2CH3), 34.3 (q, NC(CH3)2), 34.4 (t, 
CH2CHOTMP), 35.3 (q, NC(CH3)2), 37.3 (q, OSO2CH3), 38.4 (q, OSO2CH3), 40.2 (t, 
NCCH2CH2CH2CN), 41.4 (t, CHCH2CH), 46.5 (d, CHCH2OSO2), 52.7 (d, CHCHCH=), 59.1 
(s, NC(CH3)2), 60.2 (s, NC(CH3)2), 68.4 (t, CH2OSO2), 75.7 (d, CHOTBS), 81.5 (d, 
CHOSO2), 84.5 (d, CHOTMP), 125.7 (d, CH=CHCHOTMP), 138.5 (d, =CHCHOTMP). 
15β-4-68a, detectable resonances: 1H NMR (400 MHz): δ = 4.29 (AB part of ABX system, J 
= 10.1, 6.7, 5.1 Hz, 2H, CHCH2OSO2), 5.10 (dd, J = 15.3, 9.1 Hz, 1H, CH=CHCHOTMP). - 
13C NMR (100 MHz): δ = 25.69 (q, SiC(CH3)3), 52.4 (d, CHCHCH=), 68.5 (t, CH2OSO2), 
75.8 (d, CHOTBS), 81.3 (d, CHOSO2), 126.7 (d, CH=CHCHOTMP), 138.3 (d, 
=CHCHOTMP). 
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(1S*,2R*,3R*,4R*)-4-(tert-Butyldimethylsilyloxy)-2-(hydroxymethyl)-3-[(S*,E)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopent-1-yl mesylate 15α-4-69a: 
H3CO2SO
TBSO OTMP
C5H11
OH
 
1H NMR (400 MHz): δ = –0.001 (s, 3H, Si(CH3)2), 0.004 (s, 3H, Si(CH3)2), 0.81 (s+m, 12H, 
SiC(CH3)3, CH2CH3), 1.00-1.13 (m, 12H, NC(CH3)2), 1.15-1.62 (m, 14H, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.88 (m, 1H, CHCH2CH), 2.51 (m, 2H, 
CHCH2CH, CHCH2OH), 2.75 (m, 1H, CHCHCH=), 2.97 (s, 3H, OSO2CH3), 3.65 (m, 2H, 
CH2OH), 4.09 (m, 2H, CHOTMP, CHOTBS), 4.95 (m, 1H, CHOSO2), 5.36 (dd, J = 15.6, 7.2 
Hz, 1H, CH=CHCHOTMP), 5.53 (dd, J = 15.4, 8.7 Hz, 1H, =CHCHOTMP). - 13C NMR 
(100 MHz): δ = –4.8 (q, Si(CH3)2), –4.4 (q, Si(CH3)2), 14.0 (q, CH2CH3), 17.3 (t, 
NCCH2CH2CH2CN), 17.8 (s, SiC(CH3)3), 20.5 (q, NC(CH3)2), 20.7 (q, NC(CH3)2), 22.6 (t, 
CH2CH3), 25.3 (t, CH2CH2CH2CH3), 25.7 (q, SiC(CH3)3), 31.9 (t, CH2CH2CH3), 34.1 (q, 
NC(CH3)2), 34.3 (q, NC(CH3)2), 34.6 (t, CH2CHOTMP), 38.2 (q, OSO2CH3), 40.2 (t, 
NCCH2CH2CH2CN), 41.5 (t, CHCH2CH), 49.2 (d, CHCH2OH), 50.8 (d, CHCHCH=), 59.1 
(s, NC(CH3)2), 59.3 (s, NC(CH3)2), 61.0 (t, CH2OH), 74.0 (d, CHOTBS), 82.1 (d, CHOSO2), 
84.5 (d, CHOTMP), 129.2 (d, CH=CHCHOTMP), 135.0 (d, =CHCHOTMP). 
 
Tosylation of 15α-4-57: 
HO
TBSO OTMP
C5H11
OTs
4-67b
TsO
TBSO OTMP
C5H11
OTs
4-68b
TsO
TBSO OTMP
C5H11
OH
4-69b
H
TBSO
CHO
OTMP
C5H11
Enal  
Method A: To a solution of 15α-4-57 (30 mg, 0.059 mmol) in 4 mL dry CH2Cl2, dry Et3N 
(0.035 mL, 0.25 mmol) and 1 mL of a freshly prepared 0.063M solution of TsCl in dry 
CH2Cl2 (12 mg, 0.063 mmol) were added subsequently very slowly with good stirring via 
syringe at  –80 °C. A spatula tip of DMAP was added, the reaction mixture was stirred at –78 
°C for ca. 30 min, warmed to –20 °C during 3 h and subsequently to 0 °C during 2.5 h. The 
reaction, which was not complete by TLC, was hydrolysed with 5 mL water and diluted with 
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diethyl ether. The aqueous layer was extracted three times with diethyl ether. The combined 
organic layers were washed with brine and dried over Na2SO4. The solvent was evaporated in 
vacuum to give 40 mg of a crude product, which was purified immediately on a short column 
(hexane/ethyl acetate 10:1, gradient to 2:1). For yields, see Table 6.7, entry 1. 
Method B: The reaction was performed under similar conditions with 50 mg (0.098 mmol) of 
15α-4-57, 20 mg (0.104 mmol) TsCl, and 0.027 mL (0.194 mmol) of Et3N. The mixtures was 
stirred at 0 °C for 2.5 h. The crude product was purified immediately on a short column 
(hexane/ethyl acetate 10:1, gradient to 2:1). For yields, see Table 6.7, entry 2.  
Method C: The reaction was performed under similar conditions with 40 mg (0.078 mmol) of 
15α-4-57, 0.02 mL (0.14 mmol) of Et3N, and 20 mg (0.105 mmol) of TsCl at 0 °C for 0.5 h 
and stirred at room temperature for 28 h, after which it was not complete by TLC. Another 
0.02 mL (0.14 mmol) of Et3N and 12 mg (0.06 mmol) of TsCl were added and stirring was 
continued for additional 24 h. Workup was performed similarly as above and the crude 
product was purified immediately on a short column (hexane/ethyl acetate 10:1, gradient to 
2:1). For yields, see Table 6.7, entry 3.  
 
Table 6.7 Tosylation of Diol 15α-4-57. 
Entry Method 4-67b (%) 4-68b (%) 4-69b (%) 15α-4-57 (%) Enal 
1 A 10 mg (25) - (0) 2 mg (5) 20 mg (67) - (0) 
2 B 10 mg (15) 8 mg (10) 2 mg (3) 14 mg (28) traces 
3 C 10 mg (19) 30 mg (47) - (0) 5 mg (12) 8 mg (22) 
 
[(1S*,2R*,3R*,4R*)-4-(tert-Butyldimethylsilyloxy)-1-hydroxy-3-[(S*,E)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopent-2-yl]methyl tosylate 15α-67b: 
HO
TBSO OTMP
C5H11
OTs
 
Rf (hexane/ethyl acetate 2:1) = 0.59. - 1H NMR (400 MHz): δ = 0.00 (s, 6H, Si(CH3)2), 0.82 
(s, 9H, SiC(CH3)3), 0.83 (m, 3H, CH2CH3), 0.98-1.12 (m, 12H, NC(CH3)2), 1.14-1.29 (m, 7H, 
NCCH2CH2CH2CN, CH2CH2CH2CH3), 1.31-1.42 (m, 5H, TMPOCHCH2, 
NCCH2CH2CH2CN), 1.55 (m, 2H, NCCH2CH2CH2CN, TMPOCHCH2), 1.63 (m, 1H, 
CHCH2CH), 2.22 (m, 1H, CHCH2CH), 2.40 (s, 3H, C6H4CH3), 2.49 (m, 1H, CHCH2OSO2), 
2.76 (m, 1H, CHCHCH=), 3.88-4.06 (m, 5H, CHCH2OSO2, CHOH, CHOTBS, CHOTMP), 
4.96 (dd, J = 15.3, 9.3 Hz, 1H, CH=CHCHOTMP), 5.43 (dd, J = 15.3, 8.4 Hz, 1H, 
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=CHCHOTMP), 7.28 (d, J = 8.1 Hz, 2H, arom. H), 7.73 (d, J = 8.3 Hz, 2H, arom. H). - 13C 
NMR (100 MHz): δ = –4.9 (q, Si(CH3)2), –4.7 (q, Si(CH3)2), 14.1 (q, CH2CH3), 17.3 (t, 
NCCH2CH2CH2CN), 17.9 (s, SiC(CH3)3), 20.3 (q, NC(CH3)2), 21.6 (q, OSO2C6H4CH3), 22.5 
(t, CH2CH3), 25.1 (t, CH2CH2CH2CH3), 25.8 (q, SiC(CH3)3), 32.0 (t, CH2CH2CH3), 34.0 (q, 
NC(CH3)2), 34.6 (t, CH2CHOTMP), 35.3 (q, NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 42.9 
(t, CHCH2CH), 49.9 (d, CHCH2OSO2), 53.3 (d, CHCHCH=), 60.2 (s, NC(CH3)2), 70.4 (t, 
CH2OSO2), 75.1 (d, CHOH), 77.7 (d, CHOTBS), 84.7 (d, CHOTMP), 126.9 (d, 
CH=CHCHOTMP), 127.8 (d, CH arom.), 129.8 (d, CH arom.), 133.2 (s, CSO2), 137.3 (d, 
=CHCHOTMP), 144.7 (s, CCH3). - IR (Film): v~  = 3443 (w), 2929 (s), 2858 (m), 1467 (w), 
1364 (m), 1257 (w), 1179 (m), 1100 (w), 959 (m), 839 (m), 816 (w), 779 (m), 667 (w) cm-1. - 
MS(ESI) m/z (%): 666 (100) [M+H+], 158 (9) [TEMPOH2+]. - HRMS: C36H64NO6SSi+: calc. 
666.4224; found 666.4230. 
 
[(1S*,2R*,3R*,4R*)-4-(tert-Butyldimethylsilyloxy)-3-[(S*,E)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]-1-(tosyloxy)cyclopent-2-yl]methyl tosylate 
15α-4-68b: 
TsO
TBSO OTMP
C5H11
OTs
 
Rf (hexane/ethyl acetate 2:1) = 0.75. - 1H NMR (200 MHz): δ = 0.00 (s, 3H, Si(CH3)2), 0.01 
(s, 3H, Si(CH3)2), 0.85 (s, 9H, SiC(CH3)3), 0.90 (m, 3H, CH2CH3), 1.04-1.78 (m, 27H, 
NC(CH3)2, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, CHCH2CH), 2.36 (m, 1H, 
CHCH2CH), 2.48 (s, 6H, C6H4CH3), 2.67 (m, 2H, CHCHCH=, CHCH2OSO2), 4.02 (m, 4H, 
CHOTMP, CHOTBS, CHCH2OSO2), 4.63 (m, 1H, CHOSO2), 4.95 (dd, J = 15.6, 8.6 Hz, 1H, 
CH=CHCHOTMP), 5.52 (dd, J = 15.4, 8.7 Hz, 1H, =CHCHOTMP), 7.36 (dd, J = 8.0, 0.5 
Hz, 4H, arom. H), 7.77 (m, 4H, arom. H). - 13C NMR (50 MHz): δ = –4.6 (q, Si(CH3)2), –4.5 
(q, Si(CH3)2), 14.3 (q, CH2CH3), 17.5 (t, NCCH2CH2CH2CN), 18.1 (s, SiC(CH3)3), 20.5 (q, 
NC(CH3)2), 20.6 (q, NC(CH3)2), 21.85 (q, OSO2C6H4CH3), 21.86 (q, OSO2C6H4CH3), 22.8 (t, 
CH2CH3), 25.4 (t, CH2CH2CH2CH3), 26.0 (q, SiC(CH3)3), 32.1 (t, CH2CH2CH3), 34.3 (q, 
NC(CH3)2), 34.8 (t, CH2CHOTMP), 35.5 (q, NC(CH3)2), 40.4 (t, NCCH2CH2CH2CN), 41.1 
(t, CHCH2CH), 47.1 (d, CHCH2OSO2), 52.1 (d, CHCHCH=), 59.3 (s, NC(CH3)2), 60.3 (s, 
NC(CH3)2), 68.5 (t, CH2OSO2), 75.8 (d, CHOTBS), 82.1 (d, CHOSO2), 84.7 (d, CHOTMP), 
126.1 (d, CH=CHCHOTMP), 128.06 (d, CH arom.), 128.1 (d, CH arom.), 130.07 (d, CH 
arom.), 130.09 (d, CH arom.), 133.2 (s, CSO2), 134.0 (s, CSO2), 138.5 (d, =CHCHOTMP), 
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145.0 (s, CCH3). - IR (Film): v~  = 2928 (m), 2857 (w), 1361 (m), 1189 (m), 1176 (s), 1097 
(m), 957 (w), 835 (s), 813 (m), 777 (m), 665 (w) cm-1. - MS(ESI) m/z (%): 820 (100) [M+H+], 
686 (32) [M+Na+–TEMPO], 582 (10), 492 (8) [M–TEMPO–TsO]. - HRMS: C43H70NO8S2Si+: 
calc. 820.4312; found 820.4306. 
 
(1S*,2R*,3R*,4R*)-4-(tert-Butyldimethylsilyloxy)-2-(hydroxymethyl)-3-[(S*,E)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopent-1-yl tosylate 15α-4-69b: 
TsO
TBSO OTMP
C5H11
OH
 
Rf (hexane/ethyl acetate 2:1) = 0.68. - 1H NMR (200 MHz): δ = –0.02 (s, 3H, Si(CH3)2), 0.00 
(s, 3H, Si(CH3)2), 0.83 (s, 9H, SiC(CH3)3), 0.88 (m, 3H, CH2CH3), 1.04-1.10 (m, 12H, 
NC(CH3)2), 1.26-1.79 (m, 15H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3, CHCH2CH), 2.31 
(m, 1H, CHCH2CH), 2.45 (s, 3H, C6H4CH3), 2.57 (m, 1H, CHCH2OH), 2.73 (m, 1H, 
CHCHCH=), 3.53 (m, 2H, CHCH2OH), 4.04 (m, 2H, CHOTMP, CHOTBS), 4.81 (m, 1H, 
CHOSO2), 5.48 (m, 2H, CH=CHCHOTMP), 7.34 (m, 2H, arom. H), 7.79 (m, 2H, arom. H). 
 
(4R*,5R*)-4-(tert-Butyldimethylsilyloxy)-5-[(S*,E)-3-(2,2,6,6-tetramethylpiperidin-1-
yloxy)oct-1-en-1-yl]cyclopentenecarbaldehyde: 
H
TBSO
CHO
OTMP
C5H11
Enal  
Rf (hexane/ethyl acetate 2:1) = 0.85. - 1H NMR (200 MHz): δ = –0.07 (s, 3H, Si(CH3)2), 0.00 
(s, 3H, Si(CH3)2), 0.80 (s+m, 12H, SiC(CH3)3+CH2CH3), 0.96-1.51 (m, 26H, NC(CH3)2, 
NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 2.39 (m, 1H, CHCH2CH), 2.82 (m, 1H, 
CHCH2CH), 3.41 (m, 1H, CHCHCH=), 3.90 (dt, J = 8.3, 4.4 Hz, 1H, CHOTMP), 4.21 (m, 
1H, CHOTBS), 5.21 (dd, J = 15.6, 7.3 Hz, 1H, CH=CHCHOTMP), 5.37 (dd, J = 15.4, 7.9 
Hz, 1H, =CHCHOTMP), 6.75 (br. s, 1H, CH=CCHO), 9.68 (s, 1H, CHO). 
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[(1S*,2R*,3R*,4R*)-4-(tert-Butyldimethylsilyloxy)-1-hydroxy-3-[(S*,E)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopent-2-yl]methyl triflate 
 15α-4-67c: 
HO
TBSO OTMP
C5H11
OSO2CF3
 
To a solution of 15α-4-57 (70 mg, 0.137 mmol) in 3 mL dry CH2Cl2, dry 2,6-lutidine (0.052 
mL, 0.44 mmol) and fresh triflic anhydride (0.022 mL, 0.137 mmol) were added subsequently 
slowly via syringe with good stirring at –78 °C. The reaction mixture was stirred at –78 °C for 
ca. 2.5 h and monitored by TLC (Rf(15α-4-67c hexane/ethyl acetate 5:1) = 0.50). A spatula 
tip of DMAP was added at –78 °C, the reaction was stirred for another 30 min and allowed to 
warm to  –20 °C during 2.5 h. Although not complete by TLC, the reaction was quenched 
with 10 mL of water at –80 °C and diluted with 5 mL of diethyl ether. The aqueous layer was 
extracted three times with diethyl ether. The combined organic layers were washed twice with 
NaHCO3 solution, twice with brine and dried over Na2SO4. The solvent was evaporated in 
vacuum to give 90 mg of crude product, which was purified immediately on a short column 
(hexane/ethyl acetate 20:1, gradient to 2:1) to give 15α-4-67c (35 mg, 40%) and diol 4-57 (20 
mg, 28%). Colourless unstable oil, which was used immediately for the next step. 
Rf (hexane/ethyl acetate 5:1) = 0.50. - 1H NMR (200 MHz, CDCl3): δ = 0.00 (s, 6H, 
Si(CH3)2), 0.81 (m+s, 12H, CH2CH3, SiC(CH3)3), 0.90-1.02 (m, 12H, NC(CH3)2), 1.19-1.41 
(m, 13H, NCCH2CH2CH2CN, CH2CH2CH2CH3, CH2CHOTMP), 1.63 (m, 2H, CHCH2CH, 
CH2CHOTMP), 2.23 (d, J = 8.8 Hz, 1H, OH), 2.26 (m, 1H, CHCH2CH), 2.67 (dq, J = 5.1, 7.5 
Hz, 1H, CHCH2OSO2CF3), 2.80 (m, 1H, CHCHOTBS), 3.95 (m, 3H, CHOTBS, CHOH, 
CHOTMP), 4.44 (d, J = 7.2 Hz, 2H, CH2OSO2CF3), 4.94 (dd, J = 15.2, 10.0 Hz, 1H, 
CH=CHCHOTMP), 5.49 (dd, J = 15.1, 8.7 Hz, 1H, =CHCHOTMP). - 13C NMR (50 MHz, 
CDCl3): δ = –4.9 (q, Si(CH3)2), –4.7 (q, Si(CH3)2), 14.0 (q, CH2CH3), 17.3 (t, 
NCCH2CH2CH2CN), 17.9 (s, SiC(CH3)3), 20.3 (q, NC(CH3)2), 22.5 (t, CH2CH3), 25.1 (t, 
CH2CH2CH2CH3), 25.8 (q, SiC(CH3)3), 31.9 (t, CH2CH2CH3), 33.9 (q, NC(CH3)2), 34.5 (t, 
CH2CHOTMP), 35.6 (q, NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 43.0 (t, CHCH2CH), 50.3 
(d, CHCH2OSO2CF3), 53.4 (d, CHCHOTBS), 60.2 (s, NC(CH3)2), 74.6 (d, CHOH), 77.0 (t, 
CH2OTf), 77.6 (d, CHOTBS), 84.7 (d, CHOTMP), 126.0 (d, CH=CHCHOTMP), 138.4 (d, 
=CHCHOTMP). 
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[(1S*,2S*,3R*,4R*)-4-(tert-Butyldimethylsilyloxy)-1-hydroxy-3-[(S*,E)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopent-2-yl]methyl iodide 15α-4-70: 
HO
TBSO OTMP
C5H11
I
 
A mixture of flame-dried NaI (120 mg, 0.8 mmol), a spatula tip of activated powdered 
molecular sieves 4Å, a spatula tip of K2CO3, 15α-4-67a (39.5 mg, 0.067 mmol), 15α-4-69a 
(6.3 mg, 0.0106 mmol) and diol 15α-4-57 (34.2 mg (0.067 mmol) in 2.5 mL ethyl methyl 
ketone was heated with stirring at 80 °C for 1 h and at 60 °C for 1.5 h. Column 
chromatography of the crude mixture (hexane/ethyl acetate 10:1, gradient to 5:1) gave 30 mg 
(72%) of 15α-4-70 and 30 mg of unchanged diol 15α-4-57. Colourless oil, which was used 
without further characterisation in the next step. 
Rf(hexane/ethyl acetate 2:1) = 0.80. - 1H NMR (400 MHz): δ = 0.00 (s, 3H, Si(CH3)2), 0.01 
(s, 3H, Si(CH3)2), 0.81 (s+m, 12H, SiC(CH3)3, CH2CH3), 0.99-1.13 (m, 12H, NC(CH3)2), 
1.15-1.59 (m, 13H, NCCH2CH2CH2CN, CH2CH2CH2CH3, TMPOCHCH2), 1.62-1.72 (m, 2H, 
TMPOCHCH2, CHCH2CH), 2.03 (d, J =  8.2 Hz, 1H, OH), 2.36 (ddd, J = 14.4, 8.1, 4.9 Hz, 
1H, CHCH2CH), 2.63 (m, 1H, CHCH2I), 2.78 (m, 1H, CHCHCH=), 2.91 (t, J = 9.4 Hz, 1H, 
CH2I), 3.23 (dd, J = 9.5, 7.2 Hz, 1H, CH2I), 3.88 (m, 1H, CHOTBS), 3.91 (dt, J = 4.6, 8.7 Hz, 
1H, CHOTMP), 4.02 (m, 1H, CHOH), 4.91 (dd, J = 15.2, 10.1 Hz, 1H, CH=CHCHOTMP), 
5.53 (dd, J = 15.2, 8.8 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = –4.9 (q, 
Si(CH3)2), –4.7 (q, Si(CH3)2), 6.2 (t, CH2I), 14.1 (q, CH2CH3), 17.3 (t, NCCH2CH2CH2CN), 
18.0 (s, SiC(CH3)3), 20.4 (q, NC(CH3)2), 22.7 (t, CH2CH3), 25.2 (t, CH2CH2CH2CH3), 25.8 
(q, SiC(CH3)3), 31.9 (t, CH2CH2CH3), 33.9 (q, NC(CH3)2), 34.6 (t, CH2CHOTMP), 35.6 (q, 
NC(CH3)2), 40.2 (t, NCCH2CH2CH2CN), 43.9 (t, CHCH2CH), 53.7 (d, CHCH2I), 55.6 (d, 
CHCHCH=), 58.9 (s, NC(CH3)2), 60.2 (s, NC(CH3)2), 77.1 (d, CHOH), 77.6 (d, CHOTBS), 
85.2 (d, CHOTMP), 126.3 (d, CH=CHCHOTMP), 140.0 (d, =CHCHOTMP).  
Minor 15-Isomer: 1H NMR (400 MHz): δ = 3.14 (t, J = 9.4 Hz, 1H, CH2I), 3.24 (dd, J = 9.7, 
7.0 Hz, 1H, CH2I), 4.02 (m, 1H, CHOH), 5.06 (dd, J = 15.2, 9.8 Hz, 1H, CH=CHCHOTMP), 
5.49 (dd, J = 15.2, 8.8 Hz, 1H, =CHCHOTMP). 
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[(1R*,2R*,5S*)-2-[(1E,3R* and S*)-2-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-
yl]-5-(triethylsilyloxy)cyclopent-1-yl]methyl trifluoromethanesulfonate 15α- and 15β-4-
71: 
TESO
C5H11
OTMP
OTf
TESO
C5H11
OTMP
OTES
15!/"-4-71 4-71TES2
TESO
C5H11
OTMP
OTf
4-72-I3-2  
To a solution of diol 4-54 (160 mg, 0.42 mmol, Rf(hexane/ethyl acetate 2:1) = 0.15) in 5 mL 
of dry CH2Cl2 dry 2,6-lutidine (0.147 mL, 1.26 mmol, 3 equiv.) was added via syringe at –78 
°C. After stirring the solution shortly, fresh triflic anhydride (73 µl, 0.44 mmol, 1.05 equiv.) 
was added very slowly under good stirring and the reaction mixture was stirred at –78 °C for 
ca. 30 min until complete by TLC (Rf of the sulfonylated alcohol (hexane/ethyl acetate 2:1) = 
0.51 and (hexane/ethyl acetate 5:1) = 0.32). Two smaller spots were also observed on TLC 
with (hexane/ethyl acetate 2:1) = 0.62, 0.75. The reaction was quenched at –78 °C with 10 mL 
water, diluted with diethyl ether and warmed to r.t. in 10 min. The aqueous layer was 
extracted three times with diethyl ether. The combined organic layers were washed with 
NaHCO3 solution, brine and dried over Na2SO4. The solvent was evaporated in vacuum to 
give 200 mg of crude product. This was dissolved in diethyl ether and transferred to a 
different flask, weight 185 mg. The crude product was dissolved in 5 mL dry CH2Cl2 and dry 
2,6-lutidine (0.126 mL, 1.08 mmol, 3 equiv.) was added via syringe at –78 °C. Subsequently 
triethylsilyl triflate (0.122 mL, 0.54 mmol, 1.5 equiv.) was added at –78 °C and the reaction 
was stirred at this temperature for 30 min. The consumption was monitored by TLC 
(hexane/ethyl acetate 10:1 and 20:1). The reaction was quenched at –80 °C with 10 mL water, 
diluted with 20 mL diethyl ether and warmed to r.t. in 10 min. The aqueous layer was 
extracted three times with diethyl ether. The combined organic layers were washed twice with 
NaHCO3 solution, twice with brine and dried over Na2SO4. The solvent was evaporated in 
vacuum to give 200 mg of crude product. It was purified immediately on a short column 
(hexane/ethyl acetate 20:1, gradient to 10:1) to give 140 mg of an inseparable mixture of 
15α−4-71/15β−4-71/4-72-Ι3−2/4-71TES2 (5:1:trace:2) as a colourless oil, Rf (hexane/ethyl 
acetate 10:1) = 0.41. Yield: 4-71 106 mg (47%); 4-71TES2 34 mg (15%). 
15α-/15β-4-71: IR (Film): v~  = 2953 (m), 2932 (s), 2875 (m), 1462 (w), 1416 (m), 1376 (w), 
1360 (w), 1243 (m), 1209 (m), 1147 (m), 1131 (w), 1086 (m), 1006 (m), 974 (m), 936 (s), 809 
(w), 740 (s), 727 (s). - MS(ESI) m/z (%): 996 (10), 974 (25), 842 (24), 629 (37) [M+H+], 628 
(91) [M+], 610 (84) [4-71TES2+], 496 (78) [M–TEMPO+H+Na+ or M+–OTES], 478 (100) 
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[M+–CF3SO2OH], 364 (13) [M–OTES–TEMPO+H+Na]+, 158 (63) [TEMPOH2]+, 144 (13). - 
HRMS: C30H57F3NO5SSi+: calc. 628.3679; found 728.3681. 
15α-IsoP-4-71: 1H NMR (400 MHz, C6D6): δ = 0.56 (m, 6H, Si(CH2CH3)3), 0.93 (m, 3H, 
CH2CH2CH3), 0.97-1.10 (m, 9H, Si(CH2CH3)3), 1.17-1.59 (m, 26H, NCCH2CH2CH2CN, 
NC(CH3)2, CH2CH2CH2CH2CH3, CH2CH2CHOTES), 1.60 (m, 1H, CH2CHOTMP), 1.70-1.95 
(m, 3H, CH2CH2CHOTES, CH2CHOTMP), 2.22 (m, 1H, CHCH2OSO2CF3), 2.76 (dt, J = 
15.7, 7.9 Hz, 1H, CH2CHCH=), 3.98 (dd, J = 11.6, 5.5 Hz, 1H, CHOTES), 4.19 (m, 1H, 
CHOTMP), 4.27 (m, 1H, CH2OSO2CF3), 4.49 (dt, J = 9.7, 6.8 Hz, 1H, CH2OSO2CF3), 5.24 
(dd, J = 15.3, 8.3 Hz, 1H, CH=CHCHOTMP), 5.43 (dd, J = 15.3, 8.6 Hz, 1H, 
=CHCHOTMP). - 13C NMR (100 MHz): δ = 5.1 (t, SiCH2), 7.1 (q, SiCH2CH3), 14.30 (q, 
CH2CH2CH3), 17.8 (t, NCCH2CH2CH2CN), 20.6 (q, NC(CH3)2), 20.8 (q, NC(CH3)2), 23.0 (t, 
CH2CH2CH3), 25.7 (t, CH2CH2CH2CH3), 28.4 (t, CH2CH2CHOTES), 32.45 (t, CH2CH2CH3), 
34.0 (t, CH2CHOTES), 34.5 (q, NC(CH3)2), 35.0 (t, CH2CHOTMP), 35.8 (q, NC(CH3)2), 40.7 
(t, NCCH2CH2CH2CN), 41.9 (d, CH2CHCH=), 52.0 (d, CHCH2OSO2CF3), 59.3 (s, 
NC(CH3)2), 60.5 (s, NC(CH3)2), 74.7 (d, CHOTES), 77.3 (t, CH2OTf), 85.3 (d, CHOTMP), 
117.8 (q, CF3), 130.6 (d, CH=CHCHOTMP), 135.9 (d, =CHCHOTMP). 
15β-IsoP-4-71, detectable resonances: 1H NMR (400 MHz, C6D6): δ = 1.60 (m, 1H, 
CH2CHOTMP), 1.70-1.95 (m, 3H, CH2CH2CHOTES, CH2CHOTMP), 2.29 (m, 1H, 
CHCH2OSO2CF3), 2.82 (m, CH2CHCH=), 4.08 (m, 1H, CHOTES), 4.19 (m, 1H, CHOTMP), 
4.27 (m, 1H, CH2OSO2CF3), 4.57 (m, 1H, CH2OSO2CF3), 5.24 (m, 1H, CH=CHCHOTMP), 
5.43 (m, 1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = 4.9 (t, SiCH2), 7.18 (q, SiCH2CH3), 
14.34 (q, CH2CH2CH3), 17.7 (t, NCCH2CH2CH2CN), 20.6 (q, NC(CH3)2), 20.7 (q, 
NC(CH3)2), 23.1 (t, CH2CH2CH3), 25.9 (t, CH2CH2CH2CH3), 32.38 (t, CH2CH2CH3), 35.1 (t, 
CH2CHOTMP), 36.2 (q, NC(CH3)2), 40.7 (t, NCCH2CH2CH2CN), 41.9 (d, CH2CHCH=), 
55.9 (d, CHCH2OSO2CF3), 75.0 (d, CHOTES), 77.5 (t, CH2OTf), 85.6 (d, CHOTMP), 133.7 
(d, CH=CHCHOTMP). 
4-72-I3-2 (detectable resonances): 1H NMR (400 MHz, C6D6): δ = 4.34 (m, 1H, 
CH2OSO2CF3), 4.46 (m, 1H, CH2OSO2CF3). 
4-71TES2 (detectable resonances): 1H NMR (400 MHz, C6D6): δ = 0.61-0.71 (m, 6H, 
Si(CH2CH3)3), 3.12 (m, CH2CHCH=), 3.53 (m, 1H, CH2OTES), 3.80 (m, 1H, CH2OTES), 
4.19 (m, 1H, CHOTMP), 4.41 (m, 1H, CHOTES), 5.47-5.65 (m, 2H, CH=CHCHOTMP). - 
13C NMR (100 MHz): δ = 5.4 (t, SiCH2), 7.2 (q, SiCH2CH3), 42.8 (d, CH2CHCH=), 62.0 (t, 
CH2OTES), 75.9 (d, CHOTES), 85.8 (d, CHOTMP), 133.0 (d, CH=CHCHOTMP), 134.0 (d, 
=CHCHOTMP). 
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[(1R*,2R*,3R*,5S*)-3-(tert-Butyldimethylsilyloxy)-2-[(1E,3R* and S*)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]-5-(triethylsilyloxy)cyclopent-1-yl]methyl 
trifluoromethanesulfonate 15α- and 15β-4-73: 
TESO
TBSO OTMP
C5H1115
OTf
 
To a solution of diol 4-54 (15α/β 1:1.4, 270 mg, 0.528 mmol, Rf(hexane/ethyl acetate 2:1) = 
0.4) in 7 mL of dry CH2Cl2 dry 2,6-lutidine (0.18 mL, 1.58 mmol, 3 equiv.) was added via 
syringe at –78 °C. After stirring the solution shortly, fresh triflic anhydride (0.091 mL, 0.55 
mmol, 1.05 equiv.) was added very slowly under good stirring and the reaction mixture was 
stirred at –78 °C for ca. 30 min until complete by TLC (Rf of the sulfonylated alcohol 
(hexane/ethyl acetate 5:1) = 0.5). Subsequently triethylsilyl triflate (0.18 mL, 0.79 mmol, 1.5 
equiv.) was added at –78 °C and the reaction was stirred at this temperature for another 30 
min. The consumption was monitored by TLC (hexane/ethyl acetate 5:1 and 10:1). The 
reaction was quenched at –80 °C with 5 mL water, diluted with 20 mL diethyl ether and 
warmed to r.t. in 10 min. The aqueous layer was extracted three times with diethyl ether. The 
combined organic layers were washed twice with NaHCO3 solution, twice with brine and 
dried over Na2SO4. The solvent was evaporated in vacuum to give 400 mg of crude product. It 
was purified immediately on a short column (hexane/ethyl acetate 40:1, gradient to 20:1) to 
give 320 mg (81%) of 4-73 as an inseparable mixture of 15α/15β-isomers in a 1:1.2 ratio as a 
colourless oil, Rf (hexane/ethyl acetate 10:1) = 0.57, which was unstable and used 
immediately for the next step. 
15α-/15β-4-73: IR (Film): v~  = 2955 (m), 2932 (m), 2878 (w), 1464 (w), 1416 (m), 1377 (w), 
1245 (m), 1207 (s), 1146 (m), 1068 (m), 1006 (m), 975 (w), 935 (s), 834 (s), 776 (s), 728 (s) 
cm-1. - MS(ESI) m/z (%): 776 (16), 759 (48) [M+H+], 758 (100) [M+], 690 (8), 668 (13), 625 
(28) [M+Na+–TEMPO], 624 (57) [M+Na+–TEMPOH], 608 (49) [M+–TfOH], 557 (8), 536 
(19), 535 (45), 494 (15) [M+–OTf–TES], 476 (7) [M+Na+–TEMPO–OTf], 379 (24) [M+–
TES–TBS–OTf] or [M+–OTf–CH2CH(OTMP)C5H11], 322 (8), 158 (16) [TEMPOH2+]. - 
HRMS: C36H70F3NO6SSi2+: calc. 758.4493; found 758.4495. 
15β-4-73: 1H NMR (400 MHz, C6D6): δ = –0.003 (s, 3H, Si(CH3)2), 0.000 (s, 3H, Si(CH3)2), 
0.51 (q, J = 7.9 Hz, 6H, Si(CH2CH3)3), 0.91 (t, J = 7.0 Hz, 3H, CH2CH2CH3), 0.94 (s, 9H, 
SiC(CH3)3), 0.95 (t, J = 7.9 Hz, 9H, Si(CH2CH3)3), 1.09-1.21 (m, 13H, NCCH2CH2CH2CN, 
NC(CH3)2), 1.24-1.40 (m, 8H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.40-1.61 (m, 4H, 
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TMPOCHCH2, NCCH2CH2CH2CN), 1.73 (m, 2H, CHCH2CH, TMPOCHCH2), 2.28 (dt, J = 
13.9, 7.0 Hz, 1H, CHCH2CH), 2.62 (dq, J = 8.1, 6.4 Hz, 1H, CHCH2OSO2CF3), 2.82 (m, 1H, 
CHCHOTBS), 3.89 (dt, J = 6.5, 5.2 Hz, 1H, CHOTBS), 4.01 (dt, J = 7.3, 6.2 Hz, 1H, 
CHOTES), 4.17 (m, 1H, CHOTMP), 4.51 (A part of ABX system, J = 10.1, 6.1 Hz, 1H, 
CH2OSO2CF3), 4.60 (B part of ABX system, J = 9.9, 6.4 Hz, 1H, CH2OSO2CF3), 5.17 (dd, J 
= 15.3, 9.5 Hz, 1H, CH=CHCHOTMP), 5.54 (dd, J = 15.3, 8.6 Hz, 1H, =CHCHOTMP). - 
13C NMR (100 MHz, C6D6): δ = –4.5 (q, Si(CH3)2), –4.4 (q, Si(CH3)2), 6.8 (t, SiCH2), 7.1 (q, 
SiCH2CH3), 14.3 (q, CH2CH2CH3), 17.7 (t, NCCH2CH2CH2CN), 18.2 (s, SiC(CH3)3), 20.7 (q, 
NC(CH3)2), 23.1 (t, CH2CH2CH3), 25.7 (t, CH2CH2CH2CH3), 26.0 (q, SiC(CH3)3), 32.5 (t, 
CH2CH2CH3), 34.6 (q, NC(CH3)2), 35.02 (t, TMPOCHCH2), 35.05 (q, NC(CH3)2), 40.6 (t, 
NCCH2CH2CH2CN), 44.8 (t, CHCH2CH), 50.4 (d, CHCH2OSO2CF3), 52.1 (d, CHCHOTBS), 
59.4 (s, NC(CH3)2), 72.9 (d, CHOTES), 76.4 (d, CHOTBS), 77.3 (t, CH2OTf), 84.9 (d, 
CHOTMP), 119.4 (q, JC-F = 320 Hz, CF3), 128.5 (d, CH=CHCHOTMP), 138.0 (d, 
=CHCHOTMP). 
15α-4-73: 1H NMR (400 MHz, C6D6): δ = 0.02 (s, 3H, Si(CH3)2), 0.04 (s, 3H, Si(CH3)2), 0.52 
(q, J = 7.9 Hz, 6H, Si(CH2CH3)3), 0.90 (t, J = 8.1 Hz, 9H, Si(CH2CH3)3), 0.91 (t, J = 7.0 Hz, 
3H, CH2CH2CH3), 0.93 (s, 9H, SiC(CH3)3), 1.09-1.21 (m, 13H, NCCH2CH2CH2CN, 
NC(CH3)2), 1.24-1.40 (m, 8H, NCCH2CH2CH2CN, CH2CH2CH2CH2CH3), 1.40-1.61 (m, 4H, 
TMPOCHCH2, NCCH2CH2CH2CN), 1.73 (m, 2H, CHCH2CH, TMPOCHCH2), 2.17 (ddd, J 
= 6.4, 7.8, 14.1 Hz, 1H, CHCH2CH), 2.70 (quint, J = 7.1 Hz, 1H, CHCH2OSO2CF3), 2.82 (m, 
1H, CHCHOTBS), 3.91 (m, 1H, CHOTES), 3.96 (ddd, J = 13.7, 7.1, 3.3 Hz, 1H, CHOTBS), 
4.17 (m, 1H, CHOTMP), 4.44 (m, 2H, CH2OSO2CF3), 5.08 (dd, J = 15.3, 9.4 Hz, 1H, 
CH=CHCHOTMP), 5.53 (dd, J = 15.1, 8.7 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz, 
C6D6): δ = –4.45 (q, Si(CH3)2), –4.41 (q, Si(CH3)2), 5.1 (t, SiCH2), 7.0 (q, SiCH2CH3), 14.3 
(q, CH2CH2CH3), 17.7 (t, NCCH2CH2CH2CN), 18.2 (s, SiC(CH3)3), 20.7 (q, NC(CH3)2), 23.0 
(t, CH2CH2CH3), 25.7 (t, CH2CH2CH2CH3), 26.0 (q, SiC(CH3)3), 32.5 (t, CH2CH2CH3), 34.6 
(q, NC(CH3)2), 35.0 (t, TMPOCHCH2), 35.3 (q, NC(CH3)2), 40.6 (t, NCCH2CH2CH2CN), 
44.6 (t, CHCH2CH), 50.1 (d, CHCH2OSO2CF3), 52.5 (d, CHCHOTBS), 60.5 (s, NC(CH3)2), 
73.1 (d, CHOTES), 76.2 (d, CHOTBS), 77.1 (t, CH2OTf), 85.2 (d, CHOTMP), 119.4 (q, JC-F 
= 320 Hz, CF3), 127.5 (d, CH=CHCHOTMP), 138.1 (d, =CHCHOTMP). 
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6.9.5. Completion of the 20 carbon atom skeleton 
 
(1R*,2R*,3S*,4S*)-1-(tert-Butyldimethylsilyloxy)-3-[7-(triethylsilyloxy)hept-2-yn-1-yl]-2-
[(R*,E and S*,E)-3-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]-4-
(triethylsilyloxy)cyclopentane 15α- and 15β-4-6a: 
TESO
TBSO OTMP
C5H11
4-6a  72%
OTES
OTESTES
4-74
+
 
BuLi (0.21 mL, 0.336 mmol, 1.19 equiv. based on 4-9, 1.6 M in hexane) was added to a 
solution of alkyne 4-9 (60 mg, 0.283 mmol, 1.95 equiv. based on 4-73) in 4 mL THF/HMPA 
5:1 and stirred at –60 - –40 °C for 25 min. Triflate 4-73 (110 mg, 0.145 mmol, 15β/α = 2.1:1) 
dissolved in 1 mL THF was added to the lithium acetylide at –78 °C. The vial and the syringe 
were rinsed with 1 mL THF and another 0.4 mL HMPA was added to the reaction mixture. 
The reaction mixture was stirred for 3 h from –78 to 0 °C, when finished by TLC 
(hexane/ethyl acetate 20:1). The reaction mixture was quenched with 10 mL water and diluted 
with diethyl ether at 0 °C. The aqueous layer was extracted three times with diethyl ether. The 
combined organic layers were washed with brine and dried over Na2SO4. The solvent was 
evaporated in vacuum and the crude product was purified by flash column chromatography 
using a short column (hexane/ethyl acetate 5:1). Compounds 4-6a (15β/α = 1.6:1), 4-9 and 4-
74 were isolated as an inseparable mixture of 140 mg weight (Rf(hexane/ethyl acetate 20:1 = 
0.4). The yield of 15α/β-4-6a was calculated to 72% from the 1H NMR spectrum; that of 4-74 
to 25%. The mixture was used without further separation in the next step. 
IR (Film): v~  = 2953 (m), 2932 (m), 2876 (w), 1461 (w), 1377 (w), 1360 (w), 1251 (w), 1104 
(m), 1006 (m), 974 (w), 835 (m), 775 (w), 725 (s), 670 (w) cm-1. - MS(ESI) m/z (%): 820 
(100) [M+H+], 706 (22) [M+H+–TBS], 688 (8) [M+–TESOH], 608 (9), 494 (7), 158 
[TEMPOH2+]. - HRMS: C47H94NO4Si3+: calc. 820.6491; found 820.6504. 
15β-4-6a: 1H NMR (400 MHz, C6D6): δ = –0.01 (s, 3H, Si(CH3)2), 0.00 (s, 3H, Si(CH3)2), 
0.39-0.60 (m, 12H, Si(CH2CH3)3), 0.79-1.00 (m, 30H, SiC(CH3)3, Si(CH2CH3)3, CH2CH3), 
1.02-1.30 (m, 19H, NCCH2CH2CH2CN, NC(CH3)2, CH2(CH2)2CH3, (CH2)2CH2OTES), 1.31-
1.57 (m, 10H, NCCH2CH2CH2CN, CH2(CH2)2CH3, CH2CHOTMP, (CH2)2CH2OTES), 1.74 
(m, 2H, CH2CHOTMP, CHCH2CH), 2.02 (m, 4H, CHCH2C≡, CH2CH2C≡), 2.20-2.48 (m, 
2H, CHCH2CH, CHCH2C≡), 2.97 (m, 1H, CHCHOTBS), 3.45 (t, J = 5.7 Hz, 2H, CH2OTES), 
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4.07 (m, 1H, CHOTBS), 4.17 (m, 2H, CHOTMP, CHOTES), 5.49 (m, 2H, CH=CH). - 13C 
NMR (100 MHz, C6D6): δ = –4.3 (q, Si(CH3)2), –4.2 (q, Si(CH3)2), 5.1 (t, SiCH2CH3), 7.8 (q, 
SiCH2CH3), 14.4 (q, CH2CH2CH3), 17.8 (t, NCCH2CH2CH2CN), 18.3 (s, SiC(CH3)3), 18.9 (t, 
CH2CH2C≡), 19.1 (t, CHCH2C≡), 20.7 (q, NC(CH3)2), 20.8 (q, NC(CH3)2), 23.1 (t, 
CH2CH2CH3), 25.6 (t, CH2CH2CH2C≡), 26.08 (t, CH2CH2CH2CH3), 26.15 (q, SiC(CH3)3), 
32.2 (t, CH2CH2OTES), 32.6 (t, CH2CH2CH3), 34.6 (q, NC(CH3)2), 35.20 (t, CH2CHOTMP), 
35.3 (q, NC(CH3)2), 40.7 (t, NCCH2CH2CH2CN), 45.2 (t, CHCH2CH), 50.8 (d, CHCH2C≡), 
52.9 (d, CHCHCH=), 59.4 (s, NC(CH3)2), 60.4 (s, NC(CH3)2), 62.5 (t, CH2OTES), 75.5 (d, 
CHOTES), 76.5 (d, CHOTBS), 80.1 (s, C≡C), 81.1 (s, C≡C), 85.4 (d, CHOTMP), 131.6 (d, 
CH=CHCHOTMP), 136.0 (d, =CHCHOTMP). 
15α-4-6a: 1H NMR (400 MHz, C6D6): δ = 0.01 (s, 3H, Si(CH3)2), 0.04 (s, 3H, Si(CH3)2), 
0.39-0.60 (m, 12H, Si(CH2CH3)3), 0.79-1.00 (m, 30H, SiC(CH3)3, Si(CH2CH3)3, CH2CH3), 
1.02-1.30 (m, 19H, NCCH2CH2CH2CN, NC(CH3)2, CH2(CH2)2CH3, (CH2)2CH2OTES), 1.31-
1.57 (m, 10H, NCCH2CH2CH2CN, CH2(CH2)2CH3, CH2CHOTMP, (CH2)2CH2OTES), 1.74 
(m, 2H, CH2CHOTMP, CHCH2CH), 2.02 (m, 2H, CH2CH2C≡), 2.20-2.48 (m, 4H, 
CHCH2CH, CHCH2C≡, CHCH2C≡), 2.97 (m, 1H, CHCHOTBS), 3.43 (t, J = 6.4 Hz, 2H, 
CH2OTES), 3.96 (m, 1H, CHOTES), 4.07 (m, 1H, CHOTBS), 4.17 (m, 1H, CHOTMP), 5.30 
(dd, J = 15.3, 9.2 Hz, 1H, CH=CHCHOTMP), 5.58 (m, 1H, =CHCHOTMP). - 13C NMR (100 
MHz, C6D6): δ = –4.3 (q, Si(CH3)2), –4.2 (q, Si(CH3)2), 5.3 (t, SiCH2CH3), 7.1 (q, 
SiCH2CH3), 14.4 (q, CH2CH2CH3), 17.8 (t, NCCH2CH2CH2CN), 18.3 (s, SiC(CH3)3), 18.9 (t, 
CH2CH2C≡), 19.0 (t, CHCH2C≡), 20.6 (q, NC(CH3)2), 20.7 (q, NC(CH3)2), 23.2 (t, 
CH2CH2CH3), 25.79 (t, CH2CH2CH2C≡), 25.84 (t, CH2CH2CH2CH3), 26.2 (q, SiC(CH3)3), 
32.3 (t, CH2CH2OTES), 32.5 (t, CH2CH2CH3), 34.5 (q, NC(CH3)2), 35.16 (t, CH2CHOTMP), 
35.4 (q, NC(CH3)2), 40.8 (t, NCCH2CH2CH2CN), 45.1 (t, CHCH2CH), 50.6 (d, CHCH2C≡), 
53.4 (d, CHCHCH=), 59.4 (s, NC(CH3)2), 60.5 (s, NC(CH3)2), 62.5 (t, CH2OTES), 75.9 (d, 
CHOTES), 76.1 (d, CHOTBS), 79.7 (s, C≡C), 80.8 (s, C≡C), 85.8 (d, CHOTMP), 129.8 (d, 
CH=CHCHOTMP), 136.3 (d, =CHCHOTMP). 
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(1S*,2S*,3R*)-2-[7-(triethylsilyloxy)hept-2-yn-1-yl]-3-[(R*,E and S*,E)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]-1-(triethylsilyloxy)cyclopentane 15α- and 
15β-4-5: 
TESO
OTMP
C5H11
4-5
OTES
OTESTES
4-74
+
 
The alkylation of a mixture of 15α−4−71/15β−4−71/4-71TES2 (5:1:2, 120 mg), containing 
91 mg (0.14 mmol) of triflates 4-71 and 29 mg (0.047 mmol) of 4-71TES2, with alkyne 4-9 
(111 mg, 0.52 mmol) was performed similar to the alkylation of compound 4-73, with the 
exception that the reaction time was much longer (5.5 h at –78 - –10 °C, then 17 h at –10 °C - 
r.t.). The prolonged reaction time was probably the reason for low yields. Purification of the 
crude product by flash column chromatography with hexane/ethyl acetate 20:1 gradient to 
10:1 afforded compounds 15β/α-4-5, 4-9, 4-74 and 4-71TES2 as an inseparable mixture of 
110 mg weight (Rf(hexane/ethyl acetate 20:1 = 0.37-0.49). After a second purification, two 
fractions of 40 mg and 20 mg, both containing the same mixture in different ratios were 
isolated. The yield of 15α/β-4-5 was calculated to 29% (27.9 mg) from the 1H NMR 
spectrum; that of 4-74 to 6% (11.8 mg).  
15α-4-5: 1H NMR (400 MHz, C6D6): δ = 0.62 (m, 12H, Si(CH2CH3)3), 0.88-1.13 (m, 21H, 
Si(CH2CH3)3, CH2CH3), 1.14-1.42 (m, 18H, NCCH2CH2CH2CN, NC(CH3)2, CH2(CH2)2CH3), 
1.43-1.71 (m, 14H, NCCH2CH2CH2CN, CH2CH2(CH2)2CH3, (CH2)2CH2OTES, 
(CH2)2CHOTES), 1.79-1.96 (m, 2H, CH2CHOTMP, CH2CHOTES), 2.14-2.41 (m, 5H, 
CHCH2C≡, CH2CH2C≡), 3.13 (m, 1H, CHCH=CHCHOTMP), 3.57 (t, J = 6.0 Hz, 2H, 
CH2OTES), 4.26 (m, 2H, CHOTMP, CHOTES), 5.55 (m, 2H, CH=CH). - 13C NMR (100 
MHz, C6D6): δ = 5.1 (t, SiCH2CH3), 7.8 (q, SiCH2CH3), 14.3 (q, CH2CH2CH3), 17.8 (t, 
NCCH2CH2CH2CN), 18.5 (t, CH2CH2C≡), 19.1 (t, CHCH2C≡), 20.6 (q, NC(CH3)2), 20.8 (q, 
NC(CH3)2), 23.1 (t, CH2CH2CH3), 25.8 (t, CH2CH2CH2CH3), 26.1 (t, CH2CH2CH2C≡), 27.9 
(t, CH2CH2CHOTES), 32.4 (t, CH2CH2OTES), 32.5 (t, CH2CH2CH3), 34.5 (q+t, NC(CH3)2, 
CH2CHOTES), 35.1 (t, CH2CHOTMP), 35.9 (q, NC(CH3)2), 40.7 (t, NCCH2CH2CH2CN), 
43.2 (d, CHCH=CHCHOTMP), 52.9 (d, CHCH2C≡), 59.2 (s, NC(CH3)2), 60.5 (s, NC(CH3)2), 
62.5 (t, CH2OTES), 77.5 (d, CHOTES), 79.8 (s, C≡C), 80.8 (s, C≡C), 85.9 (d, CHOTMP), 
132.9 (d, CH=CHCHOTMP), 134.4 (d, =CHCHOTMP). 
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15β-4-5 (detectable resonances): 1H NMR (400 MHz, C6D6): δ = 0.62 (m, 12H, 
Si(CH2CH3)3), 0.88-1.13 (m, 21H, Si(CH2CH3)3, CH2CH3), 1.14-1.42 (m, 18H, 
NCCH2CH2CH2CN, NC(CH3)2, CH2(CH2)2CH3), 1.43-1.71 (m, 14H, NCCH2CH2CH2CN, 
CH2CH2(CH2)2CH3, (CH2)2CH2OTES, (CH2)2CHOTES), 1.79-1.96 (m, 2H, CH2CHOTMP, 
CH2CHOTES), 2.14-2.41 (m, 5H, CHCH2C≡, CH2CH2C≡), 3.13 (m, 1H, 
CHCH=CHCHOTMP), 3.57 (t, J = 6.0 Hz, 2H, CH2OTES), 4.26 (m, 2H, CHOTMP, 
CHOTES), 5.51 (m, 1H, CH=CHCHOTMP), 5.63 (dd, J = 15.5, 7.6 Hz, 1H, CHCHOTMP). - 
13C NMR (100 MHz, C6D6): δ = 52.8 (d, CHCH2C≡), 62.5 (t, CH2OTES), 76.1 (d, CHOTES), 
85.6 (d, CHOTMP), 133.7 (d, CH=CHCHOTMP), 135.1 (d, =CHCHOTMP). 
 
(1R*,2R*,3S*,4S*)-1-(tert-Butyldimethylsilyloxy)-3-[6-(4-methyl-2,6,7-
trioxabicyclo[2.2.2]octan-1-yl)hex-2-yn-1-yl]-2-[(R*,E and S*,E)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]-4-(triethylsilyloxy)cyclopentane 15α- and 
15β-4-6b and corresponding deprotected alcohols 15α- and 15β-4-75b: 
O
O
O
OTES
OTBS OTMP
C5H11
4-6b
15 O
O
O
OH
OTBS OTMP
C5H11
4-75
15 O
O
O
4-10
O
O
O
4-76
TES
 
4-Methyl-1-(4-pentynyl)-2,6,7-trioxabicyclo[2.2.2]octane 4-10 (59 mg, 0.3 mmol, 3 equiv. 
based on triflate 4-73) dissolved in 3 mL dry THF and 1 mL dry HMPA was treated with 
BuLi (0.225 mL, 0.36 mmol, 1.6M in hexane, 1.2 equiv. based on 4-10) at –78 - –45 °C for 35 
min. Triflate 4-73 (15α/β 1:1.2, 80 mg, 0.1 mmol) dissolved in 1 mL dry THF was added to 
the lithium acetylide solution at –78 °C. The vial and the syringe were rinsed twice with 0.5 
mL THF. The reaction mixture was stirred from –78 to –15 °C for 2 h and 10 min, and 
another 30 min at –15 °C until complete by TLC (hexane/ethyl acetate 5:1 and 10:1). The 
reaction mixture was quenched with 10 mL water and diluted with diethyl ether. The aqueous 
layer was extracted three times with diethyl ether. The organic layer was washed with brine 
and dried over Na2SO4. The solvent was evaporated in vacuum and the crude product (440 
mg) was purified on a short column (hexane/ethyl acetate/triethylamine 40:1:1 gradient 30:1:1 
and 10:5:1). The products eluted in the following order: 40 mg (50 %) 4-6b as an inseparable 
mixture of 15α/15β-isomers in a 1:1.6 ratio, Rf(hexane/ethyl acetate 5:1) = 0.6; 27 mg (29%)
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of 4-methyl-1-(5-triethylsilyl-4-pentynyl)-2,6,7-trioxabicyclo[2.2.2]octane 4-76, 
Rf(hexane/ethyl acetate 5:1) = 0.5; 16 mg (10%) of alkyne 4-10, Rf(hexane/ethyl acetate 5:1) 
= 0.38; 24 mg of 4-75 as an inseparable mixture of 15α/15β-isomers in a 1:1.2 ratio, 
Rf(hexane/ethyl acetate 2:1) = 0.62. Because of co-migration with NEt3, product 4-75 cannot 
be detected on TLC. It was isolated by collecting all fractions eluting with hexane/ethyl 
acetate/NEt3 10:5:1. Further purification of these 24 mg gave 18 mg (26%) of 4-75. 
 
15α-/15β-4-6b: IR (Film): v~  = 2954 cm-1 (s), 2931 (s), 2875 (m), 1462 (w), 1397 (w), 1377 
(w), 1358 (w), 1253 (w), 1186 (w), 1062 (s), 1005 (m), 959 (m), 891 (w), 836 (s), 776 (m), 
744 (m), 727 (m), 669 (w). - MS(ESI) m/z (%): 804 (100) [M+H+]. - HRMS: C46H86NO6Si2+: 
calc. 804.5994; found 804.6012. 
15β-4-6b: 1H NMR (400 MHz, C6D6): δ = –0.10 (s, 3H, (OCH2)3CCH3), 0.00 (s, 3H, SiCH3), 
0.02 (s, 3H, SiCH3), 0.46-0.62 (m, 6H, Si(CH2CH3)3), 0.80 (m, 3H, CH2CH2CH3), 0.84-1.03 
(m, 18H, SiC(CH3)3, Si(CH2CH3)3), 1.07-1.42 (m, 24H, NCCH2CH2CH2CN, NC(CH3)2, 
CH2(CH2)3CH3), 1.51 (m, 1H, CH2CHOTMP), 1.70 (m, 2H, CH2CHOTMP, CHCH2CH), 
1.84 (m, 2H, CH2CH2C(OCH2)3), 1.97 (m, 2H, CH2C(OCH2)3), 2.05 (m, 2H, ≡CCH2CH2), 
2.18 (m, 2H, CHCH2C≡), 2.29 (m, 1H, CHCH2CH), 2.42 (m, 1H, CHCH2C≡), 2.99 (m, 1H, 
CHCHOTBS), 3.42 (s, 6H, CH2C(OCH2)3), 4.05 (m, 1H, CHOTBS), 4.18 (m, 2H, CHOTES, 
CHOTMP), 5.50 (m, 2H, CH=CH). - 13C NMR (100 MHz): δ = –4.3 (q, SiCH3), –4.2 (q, 
SiCH3), 5.4 (t, SiCH2CH3), 7.2 (q, SiCH2CH3), 14.0 (q, (OCH2)3CCH3), 14.4 (q, 
CH2CH2CH3), 17.8 (t, NCCH2CH2), 18.3 (s, SiC(CH3)3), 19.1 (t, CHCH2C≡), 19.2 (t, 
CH2CH2C≡), 20.8 (q, NC(CH3)2), 23.1 (t, CH2CH2CH3), 23.7 (t, CH2CH2C≡), 25.8 (t, 
CH2CH2CH2CH3), 26.2 (q, SiC(CH3)3), 29.9 (s, (OCH2)3CCH3), 32.6 (t, CH2CH2CH3), 34.6 
(q, NC(CH3)2), 35.2 (t, CH2CHOTMP), 35.9 (q, NC(CH3)2), 36.6 (t, CH2C(OCH2)3), 40.7 (t, 
NCCH2CH2), 45.2 (t, CHCH2CH), 50.9 (d, CHCH2C≡), 53.0 (d, CHCHCH=), 60.5 (s, 
NC(CH3)2), 72.5 (t, CH2C(OCH2)3), 75.5 (d, CHOTES), 76.6 (d, CHOTBS), 80.1 (s, C≡C), 
81.4 (s, C≡C), 85.3 (d, CHOTMP), 109.5 (s, CH2C(OCH2)3), 131.9 (d, CH=CHCHOTMP), 
136.0 (d, =CHCHOTMP). 
15α-4-6b: 1H NMR (400 MHz, C6D6): δ = –0.09 (s, 3H, (OCH2)3CCH3), 0.03 (s, 3H, SiCH3), 
0.07 (s, 3H, SiCH3), 0.46-0.62 (m, 6H, Si(CH2CH3)3), 0.80 (m, 3H, CH2CH2CH3), 0.84-1.03 
(m, 18H, SiC(CH3)3, Si(CH2CH3)3), 1.07-1.42 (m, 24H, NCCH2CH2CH2CN, NC(CH3)2, 
CH2(CH2)3CH3), 1.51 (m, 1H, CH2CHOTMP), 1.70 (m, 2H, CH2CHOTMP, CHCH2CH), 
1.84 (m, 2H, CH2CH2C(OCH2)3), 1.97 (m, 2H, CH2C(OCH2)3), 2.05 (m, 2H, ≡CCH2CH2), 
2.18 (m, 2H, CHCH2C≡), 2.29 (m, 1H, CHCH2CH), 2.42 (m, 1H, CHCH2C≡), 2.99 (m, 1H, 
 271 
CHCHOTBS), 3.44 (s, 6H, CH2C(OCH2)3), 3.99 (m, 1H, CHOTES), 4.05 (m, 1H, CHOTBS), 
4.18 (m, 1H, CHOTMP), 5.33 (dd, J = 15.4, 9.2 Hz, 1H, CH=CHCHOTMP), 5.64 (dd, J = 
15.4, 8.6 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = –4.3 (q, SiCH3), –4.17 (q, 
SiCH3), 5.3 (t, SiCH2CH3), 7.1 (q, SiCH2CH3), 14.0 (q, (OCH2)3CCH3), 14.4 (q, 
CH2CH2CH3), 17.8 (t, NCCH2CH2), 18.3 (s, SiC(CH3)3), 19.0 (t, CHCH2C≡), 19.2 (t, 
CH2CH2C≡), 20.6 (q, NC(CH3)2), 23.2 (t, CH2CH2CH3), 23.7 (t, CH2CH2C≡), 25.8 (t, 
CH2CH2CH2CH3), 26.24 (q, SiC(CH3)3), 29.9 (s, (OCH2)3CCH3), 32.5 (t, CH2CH2CH3), 34.5 
(q, NC(CH3)2), 35.0 (t, CH2CHOTMP), 35.9 (q, NC(CH3)2), 36.5 (t, CH2C(OCH2)3), 40.5 (t, 
NCCH2CH2), 40.8 (t, NCCH2CH2), 45.1 (t, CHCH2CH), 50.6 (d, CHCH2C≡), 53.5 (d, 
CHCHCH=), 59.4 (s, NC(CH3)2), 72.5 (t, CH2C(OCH2)3), 75.8 (d, CHOTES), 76.3 (d, 
CHOTBS), 79.7 (s, C≡C), 81.0 (s, C≡C), 85.9 (d, CHOTMP), 109.5 (s, CH2C(OCH2)3), 129.9 
(d, CH=CHCHOTMP), 136.3 (d, =CHCHOTMP).  
 
(1S*,2S*,3R*,4R*)-4-(tert-Butyldimethylsilyloxy)-2-[6-(4-methyl-2,6,7-
trioxabicyclo[2.2.2]octan-1-yl)hex-2-yn-1-yl]-3-[(R*,E and S*,E)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-en-1-yl]cyclopentanol 4-75: 
15α-/15β-4-75: IR (Film): v~  = 3436 cm-1 (br. w), 2929 (s), 2874 (m), 1464 (w), 1398 (w), 
1378 (w), 1356 (w), 1261 (m), 1188 (w), 1132 (w), 1058 (s), 993 (s), 959 (s), 889 (w), 837 
(m), 777 (m). - MS(ESI) m/z (%): 713 (22) [M+Na+ with 13C], 712 (46) [M+Na+], 691 (48) 
[M+H+ with 13C], 690 (100) [M+H+], 305 (26), 158 (17) [TEMPOH2+]. - HRMS: 
C40H72NO6Si+: calc. 690.5129; found 690.5133. 
15β-4-75: 1H NMR (600 MHz, C6D6): δ = –0.14 (s, 3H, (OCH2)3CCH3), 0.00 (s, 3H, SiCH3), 
0.03 (s, 3H, SiCH3), 0.84 (m, 3H, CH2CH3), 0.87 (s, 9H, SiC(CH3)3), 1.05-1.46 (m, 24H, 
NC(CH3)2, NCCH2CH2CH2CN, CH2(CH2)3CH3), 1.50 (m, 1H, CH2CHOTMP), 1.63 (m, 1H, 
CHCH2CH), 1.77 (m, 1H, CH2CHOTMP), 1.82 (m, 2H, CH2CH2C(OCH2)3), 2.01 (m, 4H, 
≡CCH2CH2CH2C(OCH2)3), 2.05 (m, 2H, CHCH2C≡), 2.12 (m, 1H, CHCH2CH), 2.41 (m, 1H, 
CHCH2C≡), 2.79 (m, 1H, TBSOCHCH), 3.41 (s, 6H, CH2C(OCH2)3), 3.88 (m, 1H, 
CHOTBS), 3.95 (m, 1H, CHOH), 4.09 (m, 1H, CHOTMP), 5.05 (dd, J = 15.2, 9.8 Hz, 1H, 
CH=CHCHOTMP), 5.47 (dd, J = 15.3, 8.8 Hz, 1H, =CHCHOTMP). - 13C NMR (150 MHz): 
δ = –4.45 (q, SiCH3), –4.35 (q, SiCH3), 13.91 (q, (OCH2)3CCH3), 14.4 (q, CH2CH3), 17.7 (t, 
NCCH2CH2), 18.3 (s, SiC(CH3)3), 18.8 (t, CH2CH2C≡), 19.6 (t, CHCH2C≡), 20.5 (q, 
NC(CH3)2), 20.8 (q, NC(CH3)2), 23.2 (t, CH2CH3), 23.6 (t, CH2CH2C≡), 25.8 (t, 
CH2CH2CH2CH3), 26.2 (q, SiC(CH3)3), 29.84 (s, (OCH2)3CCH3), 32.43 (t, CH2CH2CH3), 
34.4 (q, NC(CH3)2), 35.0 (t, CH2CHOTMP), 35.9 (q, NC(CH3)2), 36.2 (t, CH2C(OCH2)3), 
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40.56 (t, NCCH2CH2), 40.59 (t, NCCH2CH2), 43.9 (t, CHCH2CH), 50.32 (d, CHCH2C≡), 54.8 
(d, CHCHCH=), 59.3 (s, NC(CH3)2), 60.4 (s, NC(CH3)2), 72.40 (t, CH2C(OCH2)3), 76.5 (d, 
CHOTBS), 77.0 (d, CHOH), 79.9 (s, C≡C), 81.3 (s, C≡C), 85.8 (d, CHOTMP), 109.5 (s, 
CH2C(OCH2)3), 129.6 (d, CH=CHCHOTMP), 136.5 (d, =CHCHOTMP). 
15α-4-75: 1H NMR (600 MHz, C6D6): δ = –0.12 (d, J = 1.1 Hz, 3H, (OCH2)3CCH3), –0.03 (s, 
3H, SiCH3), –0.02 (s, 3H, SiCH3), 0.84 (m, 3H, CH2CH3), 0.87 (s, 9H, SiC(CH3)3), 1.05-1.46 
(m, 24H, NC(CH3)2, NCCH2CH2CH2CN, CH2(CH2)3CH3), 1.50 (m, 1H, CH2CHOTMP), 1.71 
(m, 1H, CHCH2CH), 1.77 (m, 1H, CH2CHOTMP), 1.87 (m, 2H, CH2CH2C(OCH2)3), 2.01 
(m, 4H, ≡CCH2CH2CH2C(OCH2)3), 2.05 (m, 2H, CHCH2C≡), 2.25 (m, 1H, CHCH2CH), 2.35 
(m, 1H, CHCH2C≡), 2.79 (m, 1H, TBSOCHCH), 3.41 (d, J = 1.8 Hz, 6H, CH2C(OCH2)3), 
3.88 (m, 1H, CHOH), 4.03 (m, 1H, CHOTBS), 4.14 (m, 1H, CHOTMP), 5.22 (dd, J = 15.3, 
9.6 Hz, 1H, CH=CHCHOTMP), 5.43 (dd, J = 15.3, 8.9 Hz, 1H, =CHCHOTMP). - 13C NMR 
(150 MHz): δ = –4.43 (q, SiCH3), –4.41 (q, SiCH3), 13.93 (q, (OCH2)3CCH3), 14.4 (q, 
CH2CH3), 17.7 (t, NCCH2CH2), 18.3 (s, SiC(CH3)3), 18.9 (t, CH2CH2C≡), 19.7 (t, 
CHCH2C≡), 20.5 (q, NC(CH3)2), 20.7 (q, NC(CH3)2), 23.1 (t, CH2CH3), 23.4 (t, CH2CH2C≡), 
25.8 (t, CH2CH2CH2CH3), 26.1 (q, SiC(CH3)3), 29.86 (s, (OCH2)3CCH3), 32.47 (t, 
CH2CH2CH3), 34.6 (q, NC(CH3)2), 35.1 (t, CH2CHOTMP), 35.2 (q, NC(CH3)2), 36.3 (t, 
CH2C(OCH2)3), 40.47 (t, NCCH2CH2), 40.7 (t, NCCH2CH2), 44.0 (t, CHCH2CH), 50.26 (d, 
CHCH2C≡), 54.2 (d, CHCHCH=), 59.3 (s, NC(CH3)2), 60.5 (s, NC(CH3)2), 72.41 (t, 
CH2C(OCH2)3), 76.2 (d, CHOTBS), 77.1 (d, CHOH), 80.2 (s, C≡C), 81.6 (s, C≡C), 85.2 (d, 
CHOTMP), 109.5 (s, CH2C(OCH2)3), 131.4 (d, CH=CHCHOTMP), 135.9 (d, 
=CHCHOTMP).  
 
(1S*,2S*,5R*)-5-[(1E,3S*)-3-(2,2,6,6-Tetramethylpiperidin-1-yloxy)oct-1-en-yl]-2-
oxabicyclo[3.2.0]heptane 15α-4-81: 
O
C5H11
OTMP  
6-Hexynoic acid 4-77 (23 mg, 0.2 mmol, 3 equiv. based on bromide 4-65) dissolved in 3 mL 
dry THF and 1 mL dry HMPA was treated with BuLi (0.26 mL, 1.6M in hexan, 0.41 mmol, 
2.1 equiv. based on 4-77) at –78 - –45 °C for 35 min. Bromide 15α/β-4-65 2.7:1 (30 mg, 
0.067 mmol) dissolved in 1 mL dry THF was added to the lithium acetylide solution at –78 
°C. The reaction mixture was stirred from –78 to –15 °C for 2 h when it was complete as 
indicated by TLC (hexane/ethyl acetate 5:1). The reaction was quenched with 10 mL of a 
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0.1M H2SO4 solution and diluted with diethyl ether. The aqueous layer was extracted three 
times with diethyl ether. The organic layer was washed with water and brine and dried over 
Na2SO4. The solvent was evaporated in vacuum and the crude product was purified by flash 
chromatography with hexane/ethyl acetate 20:1, gradient to 2:1 to give the product 4-81 as a 
predominant 15α-isomer, Rf(hexane/ethyl acetate 5:1) = 0.54. 15β-4-81 was detected in trace 
amounts. Yield: 20 mg as a colourless oil (82%). 
 
15α-4-81: 1H NMR (200 MHz, CDCl3): δ = 0.87 (t, J = 6.5 Hz, 3H, CH2CH2CH3), 1.03-1.90 
(m, 30H, OCHCH2CH2, NC(CH3)2, NCCH2CH2CH2CN, (CH2)4CH3), 2.48 (m, 1H, 
CHCH2OCH), 2.66 (m, 1H, CH2CHCH=), 3.12 (m, 1H, CHOCH2), 3.94 (m, 1H, CHOTMP), 
4.13 (A part of ABX, J = 6.2, 4.6 Hz, 1H, CH2OCH), 4.78 (B part of ABX, J = 7.7, 6.3 Hz, 
1H, CH2OCH), 5.29 (m, 2H, CH=CH). - 13C NMR (50 MHz): δ = 14.0 (q, CH2CH3), 17.3 (t, 
NCCH2CH2CH2CN), 20.0 (q, NC(CH3)2), 20.1 (q, NC(CH3)2), 22.6 (t, CH2CH3), 25.1 (t, 
CH2CH2CH2CH3), 29.6 (t, CH2CH2CHOCH2), 31.8 (t, CH2CH2CH3), 32.8 (t, CH2CHOCH2), 
33.0 (q, NC(CH3)2), 34.5 (t, CH2CHOTMP), 35.1 (q, NC(CH3)2), 40.2 (t, 
NCCH2CH2CH2CN), 43.4 (d, CH2CHCH=), 45.0 (d, CHCH2O), 74.4 (t, CH2OCH), 85.2 (d, 
CHOTMP), 88.4 (d, CHOCH2), 131.9 (d, CH=), 133.6 (d, =CHCHOTMP). 
15β-4-81 (detectable resonances): 1H NMR (200 MHz, CDCl3): δ = 5.20 (m, 1H, CH=). 
 
6.9.6. Completion of the total synthesis of 15-F2t-IsoP 
 
Methyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(E)-3-oxo-oct-1-en-1-
yl]cyclopentanecarboxylates: 
HO
TBSO
COOMe
C5H11
O
HO
TBSO
COOMe
C5H11
O
HO
TBSO
COOMe
C5H11
O
4-83 4-84 4-85 = 12-epi-4-83  
mCPBA (70%, 48 mg, 0.195 mmol, 1.5 equiv.) was added to a solution of 70 mg (0.13 mmol) 
of methyl esters 15α,β-4-8a and 15α,β-4-50a (IsoP:PG:3rd isomer 13:8:1) in 4 mL dry 
CH2Cl2 at 0 °C. The reaction was monitored by TLC (hexane/ethyl acetate 2:1: Rf(4-83a) = 
0.39, Rf(4-84a) = 0.48, Rf(substrate) = 0.62 and Rf(mCPBA) = 0.69). After 30 min, the 
reaction mixture was quenched with 5 mL concentrated Na2S2O3 solution, diluted with ethyl 
acetate and stirred at r.t. for 10 min. The aqueous layer was extracted three times with diethyl 
ether. The combined organic layers were washed with brine, dried over Na2SO4 and 
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concentrated in vacuum. The crude product was purified on a short column with hexane/ethyl 
acetate 20:1, gradient to 2:1. The products were isolated as an inseparable mixture of 4-83a, 
4-84a and 4-85a in a ratio 4.3:4.5:1. Yield: 38 mg (73%). Identical experiments were 
performed with tBu-esters 4-8b and 4-50b. Flash chromatography afforded 4-84b, followed 
by a mixture of 4-83b, 4-85b and 4-86b. For yields and ratios see Table 4.24. 
 
4-84a: 1H NMR (400 MHz): δ = –0.007 or 0.000 (s, 3H, Si(CH3)2), 0.000 or 0.006 (s, 3H, 
Si(CH3)2), 0.80 (m, 3H, CH2CH3), 0.824 (s, 9H, SiC(CH3)3), 1.24 (m, 4H, CH2CH2CH2CH3), 
1.54 (m, 2H, CH2CH2CH2CH3), 1.85 (dt, J = 14.1, 2.4 Hz, 1H, CH2CHOH), 2.08 (ddd, J = 
14.1, 6.1, 5.3 Hz, 1H, CH2CHOH), 2.43 or 2.45 (t, J = 7.6 Hz, 2H, CH2CO), 2.67 (dd, J = 9.5, 
5.3 Hz, 1H, CHCOOMe), 3.27 (dt, J = 4.3, 9.0 Hz, 1H, CHCH=CH), 3.59 or 3.68 (s, 3H, 
COOCH3), 4.04 (m, 1H, CHOTBS), 4.44 (m, 1H, CHOH), 6.13 (dd, J = 15.7, 0.9 Hz, 1H, 
=CHCO), 6.59 (dd, J = 15.7, 8.7 Hz, 1H, CH=CHCO). - 13C NMR (100 MHz): δ = –4.92 or –
4.89 (q, Si(CH3)2), –4.86 or –4.82 (q, Si(CH3)2), 13.8 (q, CH2CH3), 17.8 (s, SiC(CH3)3), 22.3 
(t, CH2CH3), 23.7 or 23.8 (t, CH2CH2CH2CH3), 25.60 or 25.63 (q, SiC(CH3)3), 31.32 or 31.34 
(t, CH2CH2CH3), 40.2 or 40.9 (t, CH2CH2CO), 43.2 (t, CHCH2CH), 51.6 (d, CHCHCH=), 
51.7 or 52.0 (q, OCH3), 55.2 (d, CHCOOMe), 73.8 (d, CHOH), 77.9 (d, CHOTBS), 130.3 (d, 
=CHCO), 145.0 (d, CH=CHCO), 171.6 or 172.8 (s, COOMe), 200.10 or 200.14 (s, C=O). 
4-83a: 1H NMR (400 MHz): δ = –0.007 or 0.000 (s, 3H, Si(CH3)2), 0.000 or 0.006 (s, 3H, 
Si(CH3)2), 0.80 (m, 3H, CH2CH3), 0.821 (s, 9H, SiC(CH3)3), 1.24 (m, 4H, CH2CH2CH2CH3), 
1.54 (m, 2H, CH2CH2CH2CH3), 1.72 (dt, J = 14.0, 4.0 Hz, 1H, CH2CHOH), 2.37 (ddd, J = 
14.1, 7.1, 5.8 Hz, 1H, CH2CHOH), 2.43 or 2.45 (t, J = 7.6 Hz, 2H, CH2CO), 3.06 (m, 1H, 
CHCH=CH), 3.20 (dd, J = 8.6, 4.6 Hz, 1H, CHCOOMe), 3.59 or 3.68 (s, 3H, COOCH3), 4.11 
(m, 1H, CHOTBS), 4.50 (m, 1H, CHOH), 6.05 (dd, J = 15.7, 0.4 Hz, 1H, =CHCO), 6.43 (dd, 
J = 15.8, 9.7 Hz, 1H, CH=CHCO). - 13C NMR (100 MHz): δ = –4.92 or –4.89 (q, Si(CH3)2), –
4.86 or –4.82 (q, Si(CH3)2), 13.8 (q, CH2CH3), 17.70 or 17.83 (s, SiC(CH3)3), 22.3 (t, 
CH2CH3), 23.7 or 23.8 (t, CH2CH2CH2CH3), 25.60 or 25.63 (q, SiC(CH3)3), 31.32 or 31.34 (t, 
CH2CH2CH3), 40.2 or 40.9 (t, CH2CH2CO), 42.8 (t, CHCH2CH), 51.7 or 52.0 (q, OCH3), 53.1 
(d, CHCHCH=), 56.2 (d, CHCOOMe), 73.5 (d, CHOH), 76.9 (d, CHOTBS), 132.0 (d, 
=CHCO), 142.5 (d, CH=CHCO), 171.6 or 172.8 (s, COOMe), 200.10 or 200.14 (s, C=O). 
4-85a (detectable resonances): 1H NMR (400 MHz): δ = 2.08 (m, 1H, CH2CHOH), 2.19 (m, 
1H, CH2CHOH), 2.80 (m, 1H, CHCH=CH), 2.98 (dd, J = 9.8, 3.4 Hz, 1H, CHCOOMe), 3.65 
(s, 3H, COOCH3), 4.29 (br. t, J = 3.6 Hz, 1H, CHOTBS), 4.36 (m, 1H, CHOH), 6.07 (dd, J = 
16.0, 0.7 Hz, 1H, =CHCO), 6.82 (dd, J = 16.0, 8.5 Hz, 1H, CH=CHCO). 
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tert-Butyl 3-(tert-butyldimethylsilyloxy)-5-hydroxy-2-[(E)-3-oxo-oct-1-en-1-
yl]cyclopentanecarboxylates: 
HO
TBSO
COOtBu
C5H11
O
HO
TBSO
COOtBu
C5H11
O
HO
TBSO
COOtBu
C5H11
O
4-83b 4-84b 4-85b  
4-84b: Rf(hexane/EtOAc 2:1) = 0.47. - 1H NMR (400 MHz): δ = 0.00 (s, 6H, Si(CH3)2), 0.83 
(s, 9H, SiC(CH3)3), 0.85 (t, J = 7.4 Hz, 3H, CH2CH3), 1.23-1.31 (m, 4H, CH2CH2CH2CH3), 
1.41 (s, 9H, OC(CH3)3), 1.58 (m, 2H, CH2CH2CH2CH3), 1.80 (ddd, J = 14.1, 4.2, 2.3 Hz, 1H, 
CH2CHOH), 2.14 (ddd, J = 14.1, 6.9, 5.5 Hz, 1H, CH2CHOH), 2.47 (t, J = 7.4 Hz, 2H, 
CH2CO), 2.55 (dd, J = 10.4, 5.2 Hz, 1H, CHCOOtBu), 3.18 (dt, J = 5.5, 9.5 Hz, 1H, 
CHCH=CH), 3.22 (d, J = 6.8 Hz, 1H, OH), 4.00 (m, 1H, CHOTBS), 4.40 (m, 1H, CHOH), 
6.15 (dd, J = 15.7, 0.8 Hz, 1H, =CHCO), 6.64 (dd, J = 15.7, 8.8 Hz, 1H, CH=CHCO). - 13C 
NMR (100 MHz): δ = –4.81 (q, Si(CH3)2), –4.76 (q, Si(CH3)2), 13.8 (q, CH2CH3), 17.9 (s, 
SiC(CH3)3), 22.4 (t, CH2CH3), 23.8 (t, CH2CH2CH2CH3), 25.7 (q, SiC(CH3)3), 28.1 (q, 
OC(CH3)3), 31.4 (t, CH2CH2CH3), 40.8 (t, CH2CH2CO), 43.3 (t, CHCH2CH), 51.7 (d, 
CHCHCH=), 55.0 (d, CHCOOtBu), 73.1 (d, CHOH), 77.4 (d, CHOTBS), 81.6 (s, OC(CH3)3), 
130.5 (d, =CHCO), 145.8 (d, CH=CHCO), 170.8 (s, COOtBu), 200.2 (s, C=O). 
4-83b: Rf(hexane/EtOAc 2:1) = 0.35. - 1H NMR (400 MHz): δ = –0.005 (s, 3H, Si(CH3)2), 
0.000 (s, 3H, Si(CH3)2), 0.82 (s, 10H, SiC(CH3)3, OH), 0.83 (m, 3H, CH2CH3), 1.24 (m, 4H, 
CH2CH2CH2CH3), 1.35 (s, 9H, OC(CH3)3), 1.55 (m, 2H, CH2CH2CH2CH3), 1.71 (dt, J = 13.9, 
4.1 Hz, 1H, CH2CHOH), 2.36 (m, J = 6.6 Hz, 1H, CH2CHOH), 2.43 (t, J = 7.4 Hz, 2H, 
CH2CO), 3.01 (dt, J = 3.4, 9.1 Hz, 1H, CHCH=CH), 3.07 (dd, J = 8.8, 4.3 Hz, 1H, 
CHCOOtBu), 4.09 (m, 1H, CHOTBS), 4.46 (m, 1H, CHOH), 6.08 (d, J = 15.8 Hz, 1H, 
=CHCO), 6.50 (dd, J = 15.8, 9.5 Hz, 1H, CH=CHCO). - 13C NMR (100 MHz): δ = –4.98 (q, 
Si(CH3)2), –4.95 (q, Si(CH3)2), 13.7 (q, CH2CH3), 17.7 (s, SiC(CH3)3), 22.2 (t, CH2CH3), 23.6 
(t, CH2CH2CH2CH3), 25.5 (q, SiC(CH3)3), 27.9 (q, OC(CH3)3), 31.2 (t, CH2CH2CH3), 40.1 (t, 
CH2CH2CO), 42.7 (t, CHCH2CH), 53.0 (d, CHCHCH=), 56.9 (d, CHCOOtBu), 73.4 (d, 
CHOH), 76.9 (d, CHOTBS), 81.2 (s, OC(CH3)3), 131.7 (d, =CHCO), 143.0 (d, CH=CHCO), 
171.5 (s, COOtBu), 199.9 (s, C=O). 
4-85b (detectable resonances): Rf(hexane/EtOAc=2:1) = 0.35. - 1H NMR (400 MHz): δ = 
1.37 (s, 9H, OC(CH3)3), 1.84 (m, 1H, CH2CHOH), 2.04 (ddd, J = 14.2, 6.8, 3.7 Hz, 1H, 
CH2CHOH), 2.72 (dt, J = 3.7, 9.1 Hz, 1H, CHCH=CH), 2.87 (dd, J = 9.6, 3.3 Hz, 1H, 
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CHCOOtBu), 4.29 (br. t, J = 3.6 Hz, 1H, CHOTBS), 4.34 (m, 1H, CHOH), 6.07 (dd, J = 16.1, 
0.7 Hz, 1H, =CHCO), 6.84 (dd, J = 16.0, 8.5 Hz, 1H, CH=CHCO). - 13C NMR (100 MHz): δ 
= 43.9 (t, CHCH2CH), 52.2 (d, CHCHCH=), 58.6 (d, CHCOOtBu), 76.7 (d, CHOH), 77.2 (d, 
CHOTBS), 81.0 (s, OC(CH3)3), 131.5 (d, =CHCO), 144.8 (d, CH=CHCO), 170.4 (s, 
COOtBu), 200.1 (s, C=O). 
 
tert-Butyl (5S*)-5-hydroxy-2-[(E)-3-oxooct-1-en-1-yl]cyclopent-2-ene-1-carboxylates: 
HO
H
COOtBu
C5H11
O  
4-86 (detectable resonances): Rf(hexane/EtOAc2:1) = 0.35. - 1H NMR (400 MHz): δ = 1.38 
(s, 9H, OC(CH3)3), 3.47 (br. s, CHCOOtBu), 4.63 (br. d, J = 5.5 Hz, 1H, CHOH), 6.18 (d, J = 
16.1 Hz, 1H, CHCO), 6.28 (br. s, 1H, CH2CH=), 7.26 (d, J = 16.0 Hz, 1H, CH=CHCO). - 13C 
NMR (100 MHz): δ = 43.0 (t, CHCH2CH), 60.1 (d, CHCOOtBu), 75.4 (d, CHOH), 127.5 (d, 
=CHCO), 136.7 (d, CH=CHCO), 140.5 (d, =CHCH2CHOH), 200.6 (s, C=O). 
 
(1R*,2R*,3S*,4S*)-1-(tert-Butyldimethylsilyloxy)-3-[7-(triethylsilyloxy)hept-2-yn-1-yl]-2-
[(E)-3-(oxo)oct-1-en-1-yl]-4-(triethylsilyloxy)cyclopentane 4-87: 
TESO
TBSO O
OTES
 
mCPBA (70%, 11 mg, 0.043 mmol, 1.95 equiv.) was added to a solution of a mixture of 30 
mg 4-6a (17.2 mg, 0.021 mmol), and alkynes 4-9 and 4-74 (12.8 mg) in 3 mL dry CH2Cl2 at 0 
°C. The reaction was monitored by TLC (hexane/ethyl acetate 20:1). After 20 min, the 
reaction was quenched with 5 mL concentrated Na2S2O3 solution, diluted with ethyl acetate 
and stirred at r.t. for 10 min. The aqueous layer was extracted three times with ethyl acetate 
and three times with diethyl ether. The combined organic layers were washed with brine, 
dried over Na2SO4 and concentrated in vacuum. The crude product was purified on a short 
column with hexane/ethyl acetate 50:1, gradient to 5:1. The product 4-87 (10 mg) eluted with 
hexane/ethyl acetate 50:1 and 20:1 (Rf = 0.32). Yield 70%.  
IR (ATR): v~  = 2955 (s), 2933 (s), 2877 (m), 2860 (m), 1698 (w), 1676 (w), 1629 (w), 1462 
(w), 1414 (w), 1379 (w), 1253 (w), 1105 (m), 1075 (m), 1008 (m), 979 (w), 837 (m), 777 (m), 
743 (m). - MS(ESI) m/z (%): 701 (100) [M+H+], 679 (20) [M+], 547 (6), 489 (11). - HRMS: 
C38H75O4Si3+: calc. 679.4973; found 679.4975; C38H75O4Si3Na+: calc. 701.4793; found 
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701.4774. - 1H NMR (400 MHz): δ = –0.009 (s, 3H, Si(CH3)2), 0.000 (s, 3H, Si(CH3)2), 0.56 
(m, 12H, SiCH2CH3), 0.79 (t, J = 7.0 Hz, 3H, CH2CH3), 0.89 (s, 9H, SiC(CH3)3), 0.96 (2xt, J 
= 7.9 Hz, 18H, SiCH2CH3), 1.18 (m, 4H, CH2CH2CH3), 1.55-1.62 (m, 6H, 
CH2CH2CH2OTES, CH2CH2CH2CH3), 1.77 (m, 1H, CHCHHαCHOTES), 2.03 (m, 1H, 
CHCH2C≡), 2.10 (m, 2H, CH2CH2C≡), 2.17 (m, 1H, CHCH2C≡), 2.28 (t, J = 7.6 Hz, 2H, 
CH2COCH=), 2.32 (m, 1H, CHCHHβCHOTES), 2.37 (m, 1H, CHCH2C≡), 3.01 (dt, J = 7.1, 
8.5 Hz, 1H, CHCH=CH), 3.52 (t, J = 5.8 Hz, CH2OTES), 4.03 (q, J = 6.6 Hz, 1H, CHOTBS), 
4.14 (m, 1H, CHOTES), 6.17 (d, J = 15.6 Hz, 1H, CHCO), 6.90 (dd, J = 15.6, 9.7 Hz, 1H, 
CH=CHCO). - 13C NMR (100 MHz): δ = –4.41 (q, Si(CH3)2), –4.37 (q, Si(CH3)2), 4.8 (t, 
SiCH2CH3), 5.2 (t, SiCH2CH3), 7.1 (q, SiCH2CH3), 14.2 (q, CH2CH3), 18.2 (s, SiC(CH3)3), 
18.9 (t, CHCH2C≡), 19.0 (t, CH2CH2C≡), 22.9 (t, CH2CH3), 24.2 (t, CH2CH2CH2C≡), 26.0 (q, 
SiC(CH3)3), 31.8 (t, CH2CH2CH3), 32.5 (t, CH2CH2CH2CH3), 41.2 (t, CH2COCH=), 45.0 (t, 
CHCH2CH), 50.8 (d, CHCH2C≡), 53.2 (d, CHCHCH=), 62.4 (t, CH2OTES), 75.2 (d, 
CHOTES), 78.8 (d, CHOTBS), 79.2 (s, C≡C), 81.9 (s, C≡C), 132.3 (d, CH=CHCO), 144.1 (d, 
CH=CHCO), 198.2 (s, C=O). - Significant NOESY interactions: 
H
10'
OTES
H
12
R
H
9
H
8
TBSO
H
10
H
11
H
14
H
13
R'
 
 
Synthesis of 4-89 from 4-6b in overall yield of 61% (see Scheme 4.34) 
(1R*,2R*,3S*,4S*)-1-(tert-Butyldimethylsilyloxy)-3-[6-(4-methyl-2,6,7-
trioxabicyclo[2.2.2]octan-1-yl)hex-2-yn-1-yl]-2-[(E)-3-(oxo)oct-1-en-1-yl]-4-
(triethylsilyloxy)cyclopentane 4-90: 
C5H11
O
OBO
4-90
TESO
TBSO
C5H11
O
OBO
TESO
TBSO
12-epi-4-90  
mCPBA (12 mg, 70% purity, 0.049 mmol, 2 equiv.) was added to a solution of 4-6b 
(15α/β 1:1.6, 20 mg, 0.025 mmol) in 2.5 mL of dry CH2Cl2 at 0 °C. The reaction mixture was 
stirred until it was complete as indicated by TLC after 5 min (hexane/ethyl acetate 10:1 
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(Rf(substrates) = 0.45; Rf(product) = 0.28). After a total time of 15 min at 0 °C, the reaction 
miture was quenched with 3.5 mL saturated Na2S2O3 solution and diluted with diethyl ether. 
The aqueous layer was extracted three times with diethyl ether. The combined organic layers 
were washed with NaHCO3 solution, brine and dried over Na2SO4. The solvent was 
evaporated in vacuum to give 10 mg of crude product. The product was purified immediately 
by flash chromatography (hexane/ethyl acetate/Et3N 20:1:1, and finally 10:1:1) to give 10.1 
mg (61%) of an inseparable mixture of 4-90 and 12-epi-4-90 in a ratio of 4:1, Rf (hexane/ethyl 
acetate 5:1) = 0.51. 
 
4-90: 1H NMR (600 MHz, C6D6): δ = 0.00 (s, 3H, (OCH2)3CCH3), 0.07 (s, 3H, SiCH3), 0.09 
(s, 3H, SiCH3), 0.65 (q, J = 7.9 Hz, 6H, Si(CH2CH3)3), 0.87 (t, J = 6.8 Hz, 3H, CH2CH2CH3), 
0.97 (s, 9H, SiC(CH3)3), 1.04 (t, J = 7.9 Hz, 9H, Si(CH2CH3)3), 1.25 (m, 4H, CH2(CH2)2CH3), 
1.69 (quint, J = 7.3 Hz, 2H, =CHCOCH2CH2), 1.82 (dt, J = 13.3, 6.0 Hz, 1H, CHCH2CH), 
2.00 (m, 3H, CHCH2C≡, CH2CH2C(OCH2)3), 2.17 (m, 5H, CHCH2C≡CCH2, CH2C(OCH2)3), 
2.34-2.42 (m, 4H, CHCH2C≡, =CHCOCH2, CHCH2CH), 3.07 (dt, J = 8.8, 6.9 Hz, 1H, 
CHCHOTBS), 3.56 (s, 6H, CH2C(OCH2)3), 4.09 (q, J = 6.7 Hz, 1H, CHOTBS), 4.22 (dt, J = 
6.6, 5.2 Hz, 1H, CHOTES), 6.26 (dd, J = 15.7, 0.7 Hz, 1H, =CHCO), 6.93 (dd, J = 15.7, 9.7 
Hz, CH=CHCO). - 13C NMR (300 MHz): δ = –4.42 (q, SiCH3), –4.37 (q, SiCH3), 5.2 (t, 
SiCH2CH3), 7.17 (q, SiCH2CH3), 13.9 (q, (OCH2)3CCH3), 14.2 (q, CH2CH2CH3), 18.2 (s, 
SiC(CH3)3), 18.8 (t, CHCH2C≡), 19.0 (t, CH2CH2C≡), 23.0 (t, CH2CH2CH3), 23.6 (t, 
CH2CH2C≡), 24.25 (t, CH2CH2CH2CH3), 26.0 (q, SiC(CH3)3), 29.88 (s, (OCH2)3CCH3), 31.8 
(t, CH2CH2CH3), 36.52 (t, CH2C(OCH2)3), 40.9 (t, =CHCOCH2), 45.0 (t, CHCH2CH), 50.7 
(d, CHCH2C≡), 53.1 (d, CHCHCH=), 72.4 (t, CH2C(OCH2)3), 75.1 (d, CHOTES), 75.8 (d, 
CHOTBS), 79.3 (s, C≡C), 81.9 (s, C≡C), 109.4 (s, CH2C(OCH2)3), 132.6 (d, =CHCO), 144.2 
(d, CH=CHCO), 198.5 (s, CO). 
12-epi-4-90: 1H NMR (600 MHz, C6D6): δ = 0.00 (s, 3H, (OCH2)3CCH3), 0.04 (s, 3H, 
SiCH3), 0.05 (s, 3H, SiCH3), 0.69 (q, J = 8.0 Hz, 6H, Si(CH2CH3)3), 0.87 (m, 3H, 
CH2CH2CH3), 0.98 (s, 9H, SiC(CH3)3), 1.08 (t, J = 7.9 Hz, 9H, Si(CH2CH3)3), 1.25 (m, 4H, 
CH2(CH2)2CH3), 1.69 (m, 2H, =CHCOCH2CH2), 1.78 (ddd, J = 13.8, 6.0, 2.5 Hz, 1H, 
CHCH2CH), 2.00 (m, 2H, CH2CH2C(OCH2)3), 2.17 (m, 4H, ≡CCH2CH2CH2C(OCH2)3), 
2.21-2.31 (m, 3H, CHCH2C≡, CHCH2CH), 2.40 (m, 1H, =CHCOCH2), 2.46 (m, 1H, 
=CHCOCH2), 2.54 (m, 1H, CHCH2C≡), 2.60 (ddd, J = 11.6, 9.4, 5.2 Hz, 1H, CHCHOTBS), 
3.58 (s, 6H, CH2C(OCH2)3), 3.99 (dt, J = 2.5, 5.5 Hz, 1H, CHOTBS), 4.26 (dt, J = 6.0, 8.2 
Hz, 1H, CHOTES), 6.39 (d, J = 16.1 Hz, 1H, =CHCO), 7.03 (dd, J = 16.1, 9.3 Hz, 
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CH=CHCO). - 13C NMR (300 MHz): δ = –4.8 (q, SiCH3), –4.5 (q, SiCH3), 5.3 (t, SiCH2CH3), 
7.19 (q, SiCH2CH3), 13.9 (q, (OCH2)3CCH3), 14.2 (q, CH2CH2CH3), 18.2 (s, SiC(CH3)3), 
18.3 (t, CHCH2C≡), 18.9 (t, CH2CH2C≡), 22.9 (t, CH2CH2CH3), 23.8 (t, CH2CH2C≡), 24.21 
(t, CH2CH2CH2CH3), 26.0 (q, SiC(CH3)3), 29.89 (s, (OCH2)3CCH3), 31.9 (t, CH2CH2CH3), 
36.46 (t, CH2C(OCH2)3), 39.9 (t, =CHCOCH2), 45.5 (t, CHCH2CH), 49.0 (d, CHCH2C≡), 
50.1 (d, CHCHCH=), 72.5 (t, CH2C(OCH2)3), 74.2 (d, CHOTBS), 74.5 (d, CHOTES), 77.3 
(s, C≡C), 82.7 (s, C≡C), 109.4 (s, CH2C(OCH2)3), 132.4 (d, =CHCO), 145.5 (d, CH=CHCO), 
198.8 (s, CO). 
 
Table 6.8 NMR chemical shifts and multiplicities of compounds 4-90, 12-epi-4-90, 4-89, 12-
epi-4-89 and 4-91 
Compound/1H NMR H9 H11 H12 H13 H14 H15 
4-90 4.22 (dt) 4.09 (q) 3.07 (dd) 6.93 (dd) 6.26 (dd) - 
12-epi-4-90 4.26 (dt) 3.99 (dt) 2.60 (ddd) 7.03 (dd) 5.39 (d) - 
4-89 3.95 (m) 3.79 (dd) 2.80 (m) 6.63 (dd) 6.12 (d) - 
12-epi-4-89 4.08 (m) 3.91 (br. s) 2.05-2.21 (m) 7.05 (dd) 6.15 (d) - 
4-91 4.37 (br. d) 5.73 (br. s) - 6.04 (d) 7.29 (d) - 
Compound/13C NMR C9 C11 C12 C13 C14 C15 
4-90 75.1 (d) 75.8 (d) 53.1 (d) 144.2 (d) 132.6 (d) 198.5 (d) 
12-epi-4-90 74.5 (d) 74.2 (d) 50.1 (d) 145.5 (d) 132.4 (d) 198.8 (s) 
4-89 75.9 (d) 75.5 (d) 53.36 (d) 143.7 (d) 132.2 (d) 198.6 (s) 
12-epi-4-89 77.5 (d) 76.3 (d) 53.43 (d) 145.2 (d) 132.2 (d) 199.2 (s) 
4-91 76.7 (d) 138.8 (d) 141.9 (s) 126.8 (d) 136.8 (d) 199.0 (s) 
 
3-[6-(4-methyl-2,6,7-trioxabicyclo[2.2.2]octan-1-yl)hex-2-yn-1-yl]-2-2-[(E)-3-(oxo)oct-1-
en-1-yl]-1,4-cyclopentanediol 4-89: 
C5H11
O
OBO
4-89
HO
HO
C5H11
O
OBO
HO
HO
12-epi-4-89
C5H11
O
OBO
HO
4-91
H
 
A 4:1 mixture of orthoesters 4-90 and 12-epi-4-90 (10 mg, 0.015 mmol) in 3 mL dry THF 
was treated at 0 °C with 0.075 mL (0.075 mmol) of a 1M TBAF solution in THF. The colour 
of the reaction mixture became dark orange after 3 min. The reaction was finished as 
indicated by TLC after 5 min (hexane/ethyl acetate 5:1). The reaction mixture was stirred at 0 
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°C for totally 30 min. It was diluted with 10 mL of a mixture diethyl ether/acetone/Et3N 
10:10:1 and filtered through a pad of silica gel. The solvent was concentrated in vacuum to 
give 11 mg of crude product. A TLC with CH2Cl2/acetone 2:1 showed three spots: Rf = 0.37, 
0.48, 0.74. Flash chromatography (hexane/ethyl acetate/triethylamine 20:10:1, then 10:2:1 
and finally 8:4:1) eluted 6.6 mg (100%) of ketones 4-89, 12-epi-4-89 and 4-91 in a ratio of 
5:4:1. The products were well retained on silica and eluted in low concentration. Elution 
could not be detected by TLC, therefore the products were isolated as a mixture. Colourless 
oil, which displayed four spots on TLC: Rf(CH2Cl2/acetone 2:1) = 0.18, 0.39, 0.54, 0.79. A 
fourth minor component in this mixture was also detected in the NMR spectra.  
 
4-89: 1H NMR (600 MHz, C6D6): δ = –0.02 (s, 3H, (OCH2)3CCH3), 0.88 (m, 3H, 
CH2CH2CH3), 1.17-1.50 (m, 4H, CH2(CH2)2CH3), 1.62 (m, 3H, =CHCOCH2CH2, 
CHCH2CH), 1.85 (m, 1H, CHCH2C≡), 1.88-2.00 (m, 3H, CHCH2C≡, CH2CH2C(OCH2)3), 
2.05-2.21 (m, 5H, CHCH2CH, ≡CCH2CH2CH2C(OCH2)3), 2.24-2.42 (m, 3H, CHCH2C≡, 
=CHCOCH2), 2.80 (m, 1H, CHCH=CHCO), 3.54 (s, 6H, CH2C(OCH2)3), 3.79 (dt, J = 5.4, 
6.1 Hz, 1H, CHCHCH=), 3.95 (m, 1H, CHCHCH2C≡), 6.12 (d, J = 15.7 Hz, 1H, =CHCO), 
6.63 (dd, J = 15.7, 9.5 Hz, CH=CHCO). - 13C NMR (150 MHz): δ = 13.9 (q, (OCH2)3CCH3), 
14.2 (q, CH2CH2CH3), 18.7 (t, CH2CH2C≡), 19.3 (t, CHCH2C≡), 22.94 (t, CH2CH2CH3), 23.6 
(t, CH2CH2C≡), 24.1 (t, CH2CH2CH2CH3), 29.8 (s, (OCH2)3CCH3), 31.81 (t, CH2CH2CH3), 
36.20 (t, CH2C(OCH2)3), 39.9 or 40.8 (t, =CHCOCH2), 42.9 (t, CHCH2CH), 50.8 (d, 
CHCH2C≡), 53.36 (d, CHCHCH=), 72.4 (t, CH2C(OCH2)3), 75.5 (d, HOCHCHCH=), 75.9 (d, 
CHCHCH2C≡), 78.4 (s, C≡C), 79.5 (s, C≡C), 109.46 (s, CH2C(OCH2)3), 132.20 (d, =CHCO), 
143.7 (d, CH=CHCO), 198.6 (s, CO). 
12-epi-4-89: 1H NMR (600 MHz, C6D6): δ = –0.04 (s, 3H, (OCH2)3CCH3), 0.88 (m, 3H, 
CH2CH2CH3), 1.17-1.50 (m, 4H, CH2(CH2)2CH3), 1.62 (m, 2H, =CHCOCH2CH2), 1.76-1.86 
(m, 2H, CHCH2CH), 1.88-2.00 (m, 3H, CHCH2C≡, CH2CH2C(OCH2)3), 2.05-2.21 (m, 6H, 
CHCH=CHCO, CHCH2C≡CCH2CH2CH2C(OCH2)3), 2.24-2.43 (m, 3H, =CHCOCH2, 
CHCH2C≡), 3.54 (s, 6H, CH2C(OCH2)3), 3.91 (br. s, HOCHCHCH=), 4.08 (m, 1H, 
CHCHCH2C≡), 6.15 (d, J = 16.1 Hz, 1H, =CHCO), 7.05 (dd, J = 16.1, 8.2 Hz, CH=CHCO). - 
13C NMR (300 MHz): δ = 13.9 (q, (OCH2)3CCH3), 14.2 (q, CH2CH2CH3), 18.8 (t, 
CH2CH2C≡), 20.9 (t, CHCH2C≡), 22.95 (t, CH2CH2CH3), 23.5 (t, CH2CH2C≡), 24.1 (t, 
CH2CH2CH2CH3), 29.8 (s, (OCH2)3CCH3), 31.83 (t, CH2CH2CH3), 36.18 (t, CH2C(OCH2)3), 
39.9 or 40.8 (t, =CHCOCH2), 43.5 (t, CHCH2CH), 51.2 (d, CHCH2C≡), 53.44 (d, 
CHCHCH=), 72.4 (t, CH2C(OCH2)3), 76.3 (d, HOCHCHCH=), 77.5 (d, CHCHCH2C≡), 81.8 
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(s, C≡C), 82.0 (s, C≡C), 109.43 (s, CH2C(OCH2)3), 132.24 (d, =CHCO), 145.2 (d, 
CH=CHCO), 199.2 (s, CO). 
4-91, detectable resonances: 1H NMR (600 MHz, C6D6): δ = 2.19 (m, 1H, CHCH2CH), 2.53 
(m, 1H, CHCH2CH), 4.37 (br. d, J = 5.9 Hz, 1H, CHCHCH2C≡), 5.73 (br. s, CH=CCH=), 
6.04 (d, J = 16.2 Hz, CH=CHCO), 7.29 (d, J = 16.1 Hz, 1H, =CHCO). - 13C NMR (150 
MHz): δ = 41.9 (t, CHCH2CH), 76.7 (d, CHCHCH2C≡), 78.8 (s, C≡C), 82.0 (s, C≡C), 109.5 
(s, CH2C(OCH2)3), 126.8 (d, CH=CHCO), 136.8 (d, =CHCO), 138.8 (d, CH=CCH=CHCO), 
141.9 (s, =CCH=CHCO), 199.0 (s, CO). 
 
Synthesis of 4-92 from 4-6b (path I, II and III, see Scheme 4.35) 
 
Table 6.9 Optimisation of the conversion of OBO esters to methyl esters 
Entry (Path) Yield  Conditions 
1 (I) 4-92 from 4-88 
98% 
1) TBAF; 2) 0.078 mmol; 0.3 mL 0.28M NaHSO4 (0.2 
equiv.), 3.7 mL DME, no workup; LiOH⋅H2O 24 equiv., 2 mL 
H2O, workup; esterification. 
2 (II) 4-92 from 4-88 
45% 
0.035 mmol; 10 mL 0.15M NaHSO4 (4.3 equiv.), 3 mL DME, 
workup; LiOH⋅H2O 50 equiv., THF 5 mL, 1.5 mL H2O, 
workup; esterification 
3 (III) 4-78 from 4-6b 
62% 
(+6% of 4-92) 
0.232 mmol; 0.3 mL 0.14M NaHSO4 (0.18 equiv.), 4 mL 
DME, 1.8 equiv. LiOH⋅H2O, 1 mL H2O, workup: no 
saponification occurred; 6 equiv. LiOH⋅H2O, 5 mL DME, 2 
mL H2O, workup; esterification; acidic workup. 
 
Path I: Synthesis of 4-92 from 4-6b in 98% yield (see Scheme 4.35) 
Deprotection of 4-6b to the corresponding diol 4-88 (The same procedure was also used to 
deprotect 4-75 and mixtures of 4-6a/4-75): 
OH
OH OTMP
C5H11
15 O
O
O
 
A mixture of orthoester 4-6b (15α/β 1.2:1, 45 mg, 0.056 mmol) and 1-(5-triethylsilyl-4-
pentynyl)-4-methyl-2,6,7-trioxabicyclo[2.2.2]octane 4-76 (35 mg, 0.113 mmol) in 4.5 mL dry 
THF was treated at 0 °C with 1.7 mL (1.7 mmol) of a 1M TBAF solution in THF. The 
reaction mixture was stirred for 4.5 h at 0 °C, when it was complete as indicated by TLC. The 
reaction miture was quenched with 5 mL of saturated NH4Cl solution, 2 mL of water and 
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diluted with diethyl ether. The aqueous layer was extracted three times with diethyl ether and 
once with ethyl acetate. The combined organic layers were washed with brine, dried over 
Na2SO4 and the solvent was evaporated to give 130 mg of crude product. Flash 
chromatography (hexane/ethyl acetate/triethylamine 100:20:3) eluted 20 mg (90%) of 
hexynoic acid orthoester 4-10, on changing to CH2Cl2/acetone/triethylamine 25:5:1 and 
10:5:1, 32 mg (100% yield) of pure 4-88 as an inseparable mixture of 15α/15β-isomers in a 
1:1 ratio was isolated as a colourless oil, Rf(CH2Cl2/acetone 2:1) = 0.65, 0.56; Rf(ethyl 
acetate) = 0.55, 0.45. The stereochemistry of the 15-position could not be assigned. 
 
15α-/15β-4-88: IR (Film): v~  = 3400 cm-1 (br. w), 2929 (s), 2874 (m), 1461 (w), 1398 (w), 
1377 (w), 1356 (w), 1265 (w), 1186 (w), 1133 (w), 1058 (s), 991 (m), 958 (s). - MS(ESI) m/z 
(%): 598 (38) [M+Na+], 576 (100) [M+H+]. - HRMS: C34H58NO6+: calc. 576.4264; found 
576.4257. 
4-88-Isomer 1: 1H NMR (600 MHz, C6D6): δ = 0.01 (s, 3H, (OCH2)3CCH3), 0.93 (t, J = 7.0 
Hz, 3H, CH2CH3), 1.12-1.42 (m, 21H, NCCH2CH2CH2CN, NC(CH3)2, CH2(CH2)3CH3),  
1.43-1.63 (m, 4H, NCCH2CH2CH2CN, CH2CHOTMP), 1.83 (m, 2H, CH2CHOTMP, 
CHCH2CH), 1.93 (m, 2H, CH2CH2C≡), 2.09-2.25 (m, 6H, CH2C≡CCH2CH2CH2), 2.33 (m, 
1H, CHCH2CH), 2.42 (m, 1H, CHCH2C≡), 2.80 (br. s, 2H, OH), 2.89 (m, 1H, 
HOCHCHCH=), 3.55 (s, 6H, CH2C(OCH2)3), 4.00 (m, 1H, HOCHCHCH=), 4.08 (dt, J = 7.3, 
5.1 Hz, 1H, HOCHCHCH2), 4.22 (m, 1H, CHOTMP), 5.31 (dd, J = 15.4, 9.0 Hz, 1H, 
CH=CHCHOTMP), 5.57 (dd, J = 15.4, 8.9 Hz, 1H, =CHCHOTMP). - 13C NMR (150 MHz): 
δ = 13.9 (q, (OCH2)3CCH3), 14.3 (q, CH2CH3), 17.7 (t, NCCH2CH2), 18.9 (t, CHCH2C≡), 
19.59 (t, CH2CH2C≡), 20.6 (q, NC(CH3)2), 20.7 (q, NC(CH3)2), 23.1 (t, CH2CH3), 23.6 (t, 
CH2CH2C≡), 25.78 (t, CH2CH2CH2CH3), 29.86 (s, (OCH2)3CCH3), 32.4 (t, CH2CH2CH3), 
34.6 (q, NC(CH3)2), 35.02 (t, CH2CHOTMP), 35.6 (q, NC(CH3)2), 36.2 (t, CH2C(OCH2)3), 
40.4 (t, NCCH2CH2), 40.7 (t, NCCH2CH2), 42.8 (t, CHCH2CH), 50.4 (d, CHCH2C≡), 54.5 (d, 
CHCHCH=), 59.3 (s, NC(CH3)2), 60.5 (s, NC(CH3)2), 72.42 (t, CH2C(OCH2)3), 76.0 (d, 
HOCHCHCH=), 76.28 (d, HOCHCHCH2), 80.1 (s, C≡C), 81.2 (s, C≡C), 85.8 (d, CHOTMP), 
109.5 (s, CH2C(OCH2)3), 130.4 (d, CH=CHCHOTMP), 136.3 (d, =CHCHOTMP). 
4-88-Isomer 2: 1H NMR (600 MHz, C6D6): δ = 0.00 (s, 3H, (OCH2)3CCH3), 0.90 (t, J = 6.9 
Hz, 3H, CH2CH3), 1.12-1.42 (m, 21H, NCCH2CH2CH2CN, NC(CH3)2, CH2(CH2)3CH3), 1.43-
1.63 (m, 4H, NCCH2CH2CH2CN, CH2CHOTMP), 1.83 (m, 2H, CH2CHOTMP, CHCH2CH), 
1.93 (m, 2H, CH2CH2C≡), 2.09-2.25 (m, 6H, CH2C≡CCH2CH2CH2), 2.33 (m, 1H, 
CHCH2CH), 2.50 (m, 1H, CHCH2C≡), 2.80 (br. s, 2H, OH), 2.89 (m, 1H, HOCHCHCH=), 
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3.54 (s, 6H, CH2C(OCH2)3), 3.96 (ddd, J = 10.8, 7.2, 4.6 Hz, 1H, HOCHCHCH=), 4.18 (dt, J 
= 7.2, 4.5 Hz, 1H, HOCHCHCH2), 4.22 (m, 1H, CHOTMP), 5.28 (dd, J = 15.4, 9.7 Hz, 1H, 
CH=CHCHOTMP), 5.60 (dd, J = 15.3, 9.0 Hz, 1H, =CHCHOTMP). - 13C NMR (150 MHz): 
δ = 13.9 (q, (OCH2)3CCH3), 14.4 (q, CH2CH3), 17.7 (t, NCCH2CH2), 18.8 (t, CHCH2C≡), 
19.64 (t, CH2CH2C≡), 20.8 (q, NC(CH3)2), 23.1 (t, CH2CH3), 23.6 (t, CH2CH2C≡), 25.81 (t, 
CH2CH2CH2CH3), 29.87 (s, (OCH2)3CCH3), 32.4 (t, CH2CH2CH3), 34.3 (q, NC(CH3)2), 35.1 
(t, CH2CHOTMP), 35.3 (q, NC(CH3)2), 36.2 (t, CH2C(OCH2)3), 40.46 (t, NCCH2CH2), 40.50 
(t, NCCH2CH2), 43.0 (t, CHCH2CH), 50.8 (d, CHCH2C≡), 53.9 (d, CHCHCH=), 59.4 (s, 
NC(CH3)2), 60.6 (s, NC(CH3)2), 72.41 (t, CH2C(OCH2)3), 76.34 (d, HOCHCHCH2), 76.41 (d, 
HOCHCHCH=), 80.3 (s, C≡C), 81.3 (s, C≡C), 85.3 (d, CHOTMP), 109.5 (s, CH2C(OCH2)3), 
130.9 (d, CH=CHCHOTMP), 135.9 (d, =CHCHOTMP). 
 
Methyl 7-[(1S*,2R*,3R*,5S*)-3,5-dihydroxy-2-[(R*,E and S*,E)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-enyl]cyclopentyl]hept-5-ynoate 4-92: 
HO
HO OTMP
C5H11
15
CO2Me
 
NaHSO4 (10 mg, 0.083 mmol, 1.5 equiv.) was added at 0 °C to a solution of diol 4-88 (32 mg, 
0.056 mmol) resulting from deprotection of 4-6b/4-75 in 3.7 mL DME and 0.3 mL water. The 
solution was stirred at 0 °C for 45 min and at r.t. for 20 min. Then LiOH (78 mg, 1.85 mmol, 
33 equiv.) was added and the reaction mixture was stirred at 0 °C for 2 h and finally at r.t. for 
0.5 h. It was diluted with ethyl acetate and acidified with 4.5M HCl solution to pH 1. The 
layers were separated. The aqueous layer was extracted three times with ethyl acetate and 
three times with diethyl ether. The combined organic layers were dried over Na2SO4. The 
solvent was evaporated to give 45 mg of the acid as a very thick oil, which was difficult to 
dissolve in any solvent later on. Therefore, the esterification was performed immediately in 
the same flask. The crude acid was dissolved in 3 mL of dry THF and 0.8 mL of dry MeOH 
under a nitrogen atmosphere. To this solution 0.59 mL (1.2 mmol) of a 2M solution of 
TMSCHN2 in diethyl ether was added and the reaction was stirred at r.t. for 2 h 15 min. The 
reaction was quenched carefully with 3.5 mL of a 2M HCl solution and stirred for 5 min. The 
aqueous layer was extracted three times with ethyl acetate and three times with diethyl ether. 
The combined organic layers were washed with brine, dried over Na2SO4, and the solvent was 
evaporated to give the crude product (60 mg). Purification by flash chromatography (ethyl 
acetate/acetone 50:1, gradient to 20:1 and 10:1; the product eluted with 20:1) gave 28 mg 
 284 
(98% yield based on 4-6b+4-75) of pure 4-92 as an inseparable mixture of 15α/15β-isomers. 
The diastereomeric ratio was 1:1. The configuration in 15-position could not be established. 
Rf(ethyl acetate) = 0.66 and 0.60, Rf(CH2Cl2/acetone (1:1) = 0.78 and 0.72. Both isomers are 
well retained on silica and elute only in the presence of acetone. 
 
15α-/15β-4-92: IR (Film): v~  = 3402 cm-1 (br. w), 2929 (s), 2870 (m), 1740 (s), 1456 (m), 
1437 (m), 1375 (m), 1360 (m), 1242 (m), 1160 (m), 1134 (m), 1082 (m), 974 (m). - MS(ESI) 
m/z (%): 1033 (38) [2M+Na+], 528 (100) [M+Na+], 506 (67) [M+H+], 372 (43) [M–
TEMPO+Na+], 158 (18) [TEMPOH2]+. - HRMS: C30H51NO5Na+: calc. 528.3665; found 
528.3665. 
4-92-Major isomer: 1H NMR (600 MHz, C6D6): δ = 0.67 (br. s, 2H, OH), 0.91 (t, J = 7.0 Hz, 
3H, CH2CH3), 1.15-1.30 (m, 13H, NCCH2CH2CH2CN, NC(CH3)2), 1.27-1.41 (m, 8H, 
CH2CH2CH2CH2CH3, NCCH2CH2CH2CN), 1.45-1.59 (m, 4H, NCCH2CH2CH2CN, 
TMPOCHCH2), 1.68 (m, 3H, CHCH2CH, CH2CH2COOMe), 1.84 (m, 1H, TMPOCHCH2), 
2.01 (m, 2H, ≡CCH2CH2), 2.15 (ddt, J = 15.1, 6.6, 2.3 Hz, 1H, CHCH2C≡), 2.24 (t, J = 7.3 
Hz, 2H, CH2COOMe), 2.24 (m, 1H, CHCH2CH), 2.40 (m, 2H, CHCH2C≡), 2.78 (m, 1H, 
HOCHCHCH=), 3.31 (s, 3H, OCH3), 3.85 (dt, J = 6.3, 4.4 Hz, 1H, HOCHCHCH=), 4.07 (dt, 
J = 7.2, 4.7 Hz, 1H, HOCHCHCH2), 4.22 (m, 1H, CHOTMP), 5.25 (dd, J = 15.3, 9.3 Hz, 1H, 
CH=CHCHOTMP), 5.53 (dd, J = 15.5, 8.8 Hz, 1H, =CHCHOTMP). - 13C NMR (150 MHz): 
δ = 14.3 (q, CH2CH3), 17.74 (t, NCCH2CH2CH2CN), 18.38 (t, CH2CH2C≡), 19.58 (t, 
CHCH2C≡), 20.64 (q, NC(CH3)2), 20.7 (q, NC(CH3)2), 23.10 (t, CH2CH3), 24.5 (t, 
CH2CH2COOMe), 25.82 (t, CH2CH2CH2CH3), 32.3 (t, CH2CH2CH3), 32.8 (t, CH2COOMe), 
34.5 (q, NC(CH3)2), 35.02 (t, TMPOCHCH2), 35.2 (q, NC(CH3)2), 40.48 (t, 
NCCH2CH2CH2CN), 40.66 (t, NCCH2CH2CH2CN), 42.9 (t, CHCH2CH), 50.4 (d, 
CHCH2C≡), 51.1 (q, OCH3), 53.9 (d, CHCHCH=), 59.3 (s, NC(CH3)2), 60.5 (s, NC(CH3)2), 
76.3 (d, HOCHCHCH=), 76.4 (d, HOCHCHCH2), 80.3 (s, C≡C), 80.8 (s, C≡C), 85.3 (d, 
CHOTMP), 130.6 (d, CH=CHCHOTMP), 136.1 (d, =CHCHOTMP), 173.11 (s, COOMe). 
4-92-Minor isomer: 1H NMR (600 MHz, C6D6): δ = 0.67 (br. s, 2H, OH), 0.92 (t, J = 7.0 Hz, 
3H, CH2CH3), 1.15-1.30 (m, 13H, NCCH2CH2CH2CN, NC(CH3)2), 1.27-1.41 (m, 8H, 
CH2CH2CH2CH2CH3, NCCH2CH2CH2CN), 1.45-1.59 (m, 4H, NCCH2CH2CH2CN, 
TMPOCHCH2), 1.68 (m, 3H, CHCH2CH, CH2CH2COOMe), 1.84 (m, 1H, TMPOCHCH2), 
2.01 (m, 2H, ≡CCH2CH2), 2.06 (ddt, J = 16.5, 8.7, 2.3 Hz, 1H, CHCH2C≡), 2.24 (t, J = 7.3 
Hz, 2H, CH2COOMe), 2.24 (m, 1H, CHCH2CH), 2.34 (m, 1H, CHCH2C≡), 2.40 (m, 1H, 
CHCH2C≡), 2.78 (m, 1H, HOCHCHCH=), 3.32 (s, 3H, OCH3), 3.91 (m, 1H, 
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HOCHCHCH=), 3.97 (dt, J = 7.2, 5.2 Hz, 1H, HOCHCHCH2), 4.22 (m, 1H, CHOTMP), 5.24 
(dd, J = 15.2, 9.3 Hz, 1H, CH=CHCHOTMP), 5.56 (dd, J = 15.9, 9.9 Hz, 1H, 
=CHCHOTMP). - 13C NMR (150 MHz): δ = 14.3 (q, CH2CH3), 17.65 (t, 
NCCH2CH2CH2CN), 18.34 (t, CH2CH2C≡), 19.62 (t, CHCH2C≡), 20.61 (q, NC(CH3)2), 20.7 
(q, NC(CH3)2), 23.13 (t, CH2CH3), 24.5 (t, CH2CH2COOMe), 25.77 (t, CH2CH2CH2CH3), 
32.34 (t, CH2CH2CH3), 32.8 (t, CH2COOMe), 34.3 (q, NC(CH3)2), 35.04 (t, TMPOCHCH2), 
35.6 (q, NC(CH3)2), 40.40 (t, NCCH2CH2CH2CN), 40.47 (t, NCCH2CH2CH2CN), 42.8 (t, 
CHCH2CH), 50.1 (d, CHCH2C≡), 51.1 (q, OCH3), 54.4 (d, CHCHCH=), 59.4 (s, NC(CH3)2), 
60.6 (s, NC(CH3)2), 75.9 (d, HOCHCHCH=), 76.3 (d, HOCHCHCH2), 80.2 (s, C≡C), 80.5 (s, 
C≡C), 85.6 (d, CHOTMP), 130.1 (d, CH=CHCHOTMP), 136.5 (d, =CHCHOTMP), 173.08 
(s, COOMe).  
 
Path III: Synthesis of 4-92 from 4-6b in overall yield of 43% (see Scheme 4.35) 
1) Conversion of 4-6b to the corresponding methyl ester 4-78 (62%); 2) Methyl ester 4-78 
was deprotected with TBAF to diol 4-92 (70%). 
Methyl 7-[(1S*,2R*,3R*,5S*)-3-(tert-Butyldimethylsilyloxy)-5-hydroxy-2-[(R*,E and 
S*,E)-3-(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-enyl]cyclopentyl]hept-5-ynoate 4-78 
C5H11
OTMP
COOCH3
HO
TBSO  
To a mixture of 4-6b (15α/β 1.2:1, 62.8 mg, 0.078 mmol) and TES-alkyne 4-76 (47.2 mg, 
0.152 mmol) in 4 mL DME 0.3 mL of a 0.14 M aqueous solution of NaHSO4 (5 mg, 0.042 
mmol, 0.18 equiv. based on substrates) was added and the solution was stirred at 0 °C for 30 
min. The consumption of the substrate was monitored by TLC with hexane/ethyl acetate 10:1. 
Then 1 mL of a 0.42 M aqueous solution of LiOH (17.5 mg, 0.42 mmol) was added and the 
reaction mixture was stirred at 0 °C for 2 h 40 min and at r.t. for 50 min. TLC with 
CH2Cl2/acetone 5:1 showed two spots at Rf = 0.48 and 0.93. The reaction mixture was diluted 
with 3 mL of ethyl acetate.  The organic layer was extracted twice with 3 mL of water and 
once with 3 mL of 0.3 M LiOH solution. The organic layer, which contained a solid residue 
was filtered through cotton and concentrated in vacuum to give 120 mg of a mixture of K and 
H (Rf with hexane/ethyl acetate 5:1 = 0.58). Surprisingly the 13C NMR spectrum of the crude 
product displayed four triplets at 65.9, 66.8, 67.0 and 68.1, which could correspond to the 
methylene positions in the ester unit COOCH2C(CH2OH)CH3. Probably ester G was not 
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completely saponified, and still present in the mixture. The combined aqueous layers were 
acidified with NaHSO4 solution to pH 3, and then it was extracted with ethyl acetate and 
diethyl ether. The combined organic layers were washed with brine, dried over Na2SO4 and 
concentrated in vacuum to give 30 mg of a mixture of acids I and J.  
C5H11
OTMP
COOR
G     R =  CH2C(CH2OH)CH3
TESO
TBSO TES
COO OH
HO
H
COOH
I
TES
COOH
J
K     R = H
 
 
The saponification of the crude mixture of K, G and H was repeated. To a solution of 120 mg 
of this mixture in 5 mL DME and 2 mL of water 60 mg (1.43 mmol) of LiOH was added at 
r.t. (pH 10) and the reaction was stirred at this temperature for 6.5 h. The reaction mixture was 
diluted with ethyl acetate and the layers were separated. The organic layer (Organic layer 1 
OL1) was extracted 3 times with water and preserved. 
1) The combined aqueous phases were acidified with 430 mg NaHSO4 to pH 2 and extracted 
three times with ethyl acetate and once with diethyl ether. The organic layers (OL 2) were 
dried over Na2SO4 and concentrated in vacuum to give 12 mg of the acid J.  
2) Organic layer 1 OL1 was diluted with diethyl ether and stirred for 15 min with 2 mL of a 
2.5 M NaHSO4 solution. The aqueous phase was extracted three times with diethyl ether. The 
combined organic layers were dried over Na2SO4 and the solvent was removed in vacuum to 
give 55 mg of the crude acid K (TLC with hexane/ethyl acetate 2:1 gives two spots with Rf = 
0.69 and respectively Rf = 0.50; TLC with hexane/ethyl acetate 5:1 gives two spots with Rf = 
0.55 and respectively Rf = 0.13).  
The crude acid K (55 mg) was dissolved in 5 mL dry THF and 0.5 mL dry MeOH under a 
nitrogen atmosphere. To this solution 0.39 mL (0.78 mmol) of a 2M solution of TMSCHN2 in 
diethyl ether was added and the reaction was stirred at r.t. for 3.5 h. The reaction was 
quenched carefully with 5 mL of a 1.2M HCl solution, diluted with diethyl ether and stirred 
for 5 min. The aqueous layer was extracted three times with ethyl acetate and once with 
diethyl ether. The combined organic layers were washed with brine, dried over Na2SO4, and 
the solvent was evaporated to give the crude product (90 mg). Purification by flash 
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chromatography (hexane/ethyl acetate 20:1, gradient to 5:1, 2.5:1 and pure EtOAc; the 
product eluted with 2.5:1 and pure EtOAc) gave 30 mg (62% yield based on 4-6b) of pure 4-
78 as an inseparable mixture of 15α/15β-isomers in a 1:1 ratio, Rf(hexane/ethyl acetate 5:1) = 
0.40. Flashing the column with acetone gave a fraction of 10 mg containing aproxim. 3 mg of 
impure deprotected diol 4-92 (6% yield).  
 
4-78-Isomer I: 1H NMR (400 MHz, C6D6): δ = –0.01 (s, 3H, SiCH3), 0.00 (s, 3H, SiCH3), 
0.84 (m, 3H, CH2CH3), 0.88 (s, 9H, SiC(CH3)3), 1.11-1.37 (m, 23H, NCCH2CH2CH2CN, 
NC(CH3)2, CH2CH2CH2CH2CH3), 1.42-1.55 (m, 2H, NCCH2CH2CH2CN, CH2CHOTMP), 
1.58 or 1.59 (quint, J = 7.1 Hz, 2H, CH2CH2COOMe), 1.62-1.84 (m, 2H, CH2CHOTMP, 
CHCH2CH), 1.92 (m, 2H, ≡CCH2CH2), 2.16 (t, J = 7.3 Hz, 2H, CH2COOMe), 2.22 (m, 2H, 
CHCH2CH, CHCH2C≡), 2.34 (m, 1H, CHCH2C≡), 2.39 (m, 1H, CHCH2C≡), 2.89 (m, 1H, 
=CHCHCHOTBS), 3.237 (s, 3H, COOCH3), 3.92  (dt, J = 6.1, 4.3 Hz, 1H, CHOTBS), 4.00 
(m, 1H, CHOH), 4.17 (m, 1H, CHOTMP), 5.22 (dd, J = 15.3, 9.6 Hz, 1H, 
CH=CHCHOTMP), 5.48 (dd, J = 14.9, 8.9 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): 
δ = 14.3 (q, CH2CH3), 17.7 (t, NCCH2CH2CH2CN), 18.4 (s, SiC(CH3)3), 18.42 (t, 
CH2CH2C≡), 19.7 (t, CHCH2C≡), 20.7 (q, NC(CH3)2), 23.1 (t, CH2CH3), 24.59 (t, 
CH2CH2COOMe), 25.8 (t, CH2CH2CH2CH3), 26.10 (q, C(CH3)3), 32.4 (t, CH2CH2CH3), 
32.84 (t, CH2COOMe), 34.4 (q, NC(CH3)2), 35.11 (t, CH2CHOTMP), 35.9 (q, NC(CH3)2), 
40.5 (t, NCCH2CH2CH2CN), 40.6 (t, NCCH2CH2CH2CN), 44.0 (t, CHCH2CH), 50.2 (d, 
CHCH2C≡), 51.0 (q, OCH3), 54.4 (d, =CHCHCHOTBS), 60.5 (s, NC(CH3)2), 76.5 (d, 
CHOH), 77.3 (d, CHOTBS), 80.48 (s, C≡C), 80.8 (s, C≡C), 85.2 (d, CHOTMP), 129.4 (d, 
CH=CHCHOTMP), 136.1 (d, =CHCHOTMP), 172.9 (s, COOMe). 
4-78-Isomer II: 1H NMR (400 MHz, C6D6): δ = 0.01 (s, 3H, SiCH3), 0.05 (s, 3H, SiCH3), 
0.84 (m, 3H, CH2CH3), 0.89 (s, 9H, SiC(CH3)3), 1.11-1.37 (m, 23H, NCCH2CH2CH2CN, 
NC(CH3)2, CH2CH2CH2CH2CH3), 1.42-1.55 (m, 2H, NCCH2CH2CH2CN, CH2CHOTMP), 
1.58 or 1.59 (quint, J = 7.1 Hz, 2H, CH2CH2COOMe), 1.62-1.84 (m, 2H, CH2CHOTMP, 
CHCH2CH), 1.92 (m, 2H, ≡CCH2CH2), 2.10 (m, 2H, CHCH2CH, CHCH2C≡), 2.16 (t, J = 
1.0, 7.3 Hz, 2H, CH2COOMe), 2.37-2.47 (m, 2H, CHCH2C≡), 2.89 (m, 1H, 
=CHCHCHOTBS), 3.243 (s, 3H, COOCH3), 3.85 (m, 1H, CHOH), 4.00 (m, 1H, CHOTBS), 
4.12 (dt, J = 4.7, 8.6 Hz, 1H, CHOTMP), 5.06 (dd, J = 15.3, 9.9 Hz, 1H, CH=CHCHOTMP), 
5.49 (dd, J = 15.1, 8.7 Hz, 1H, =CHCHOTMP). - 13C NMR (100 MHz): δ = 14.3 (q, 
CH2CH3), 17.8 (t, NCCH2CH2CH2CN), 18.3 (s, SiC(CH3)3), 18.37 (t, CH2CH2C≡), 19.6 (t, 
CHCH2C≡), 20.5 (q, NC(CH3)2), 23.2 (t, CH2CH3), 24.57 (t, CH2CH2COOMe), 25.8 (t, 
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CH2CH2CH2CH3), 26.13 (q, C(CH3)3), 32.4 (t, CH2CH2CH3), 32.86 (t, CH2COOMe), 34.4 (q, 
NC(CH3)2), 35.14 (t, CH2CHOTMP), 35.9 (q, NC(CH3)2), 40.6 (t, NCCH2CH2CH2CN), 40.7 
(t, NCCH2CH2CH2CN), 43.9 (t, CHCH2CH), 50.3 (d, CHCH2C≡), 51.0 (q, OCH3), 55.0 (d, 
=CHCHCHOTBS), 59.3 (s, NC(CH3)2), 76.7 (d, CHOH), 77.2 (d, CHOTBS), 80.2 (s, C≡C), 
80.53 (s, C≡C), 85.7 (d, CHOTMP), 128.7 (d, CH=CHCHOTMP), 136.6 (d, =CHCHOTMP), 
172.9 (s, COOMe). 
 
Path V: Synthesis of 4-92 from 4-6b (see Scheme 4.36) 
1,3-Dihydroxy-2-methylprop-2-yl 7-[(1S*,2R*,3R*,5S*)-3-[(tert-butyldimethylsilyl)oxy]-
5-hydroxy-2-[(1E)-3-[(2,2,6,6-tetramethylpiperidin-1-yl)oxy]oct-1-en-1-
yl]cyclopentyl]hept-5-ynoate 4-93 and 1,3-dihydroxy-2-methylpropan-2-yl 7-
[(1S*,2R*,3R*,5S*)-3,5-dihydroxy-2-[(1E)-3-[(2,2,6,6-tetramethylpiperidin-1-yl)oxy]oct-
1-en-1-yl]cyclopentyl]hept-5-ynoate 4-94: 
C5H11
OTMP
COO
HO
TBSO
4-93
OH
HO
C5H11
OTMP
COO
HO
HO
4-94
OH
HO
 
p-TsOH·H2O (3.2 mg, 0.017 mmol, 0.6 equiv.) was added at r.t. to a solution of 4-6b (15α/β 
aprox. 1:1.3, 22 mg, 0.027 mmol) in 4 mL MeOH and 0.2 mL water. The consumption was 
monitored by TLC with hexane/ethyl acetate 5:1 (Rf substrate = 0.63). After 24 h of stirring at 
r.t., a spatula tip of Na2CO3 was added and the reaction mixture was stirred for 10 min. The 
solvent was concentrated and the reaction mixture was partitioned between diethyl ether and 
water. The aqueous phase was extracted with diethyl ether. The combined ethereal phases 
were washed with brine and dried over Na2SO4. The solvent was evaporated to give 24 mg of 
crude 4-93 Rf(CH2Cl2/acetone 2:1) = 0.61. Crude 4-93 dissolved in 4 mL dry THF was treated 
at 0 °C with 0.135 mL (0.135 mmol) of a 1M TBAF solution in THF. The reaction mixture 
was stirred at 0 °C for 3 h and at r.t. for 30 min. The consumption was monitored by TLC 
with CH2Cl2/acetone 2:1. Then 0.07 mL of 1M TBAF solution in THF was added and stirred 
at r.t. for 10 min. It was quenched with 5 mL of saturated NH4Cl solution and diluted with 
diethyl ether. The aqueous layer was extracted three times with diethyl ether and once with 
ethyl acetate. The combined organic layers were washed with brine, dried over Na2SO4 and 
the solvent was evaporated to give 20 mg of crude 4-94.  
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7-[(1S*,2R*,3R*,5S*)-3,5-Dihydroxy-2-[(1E)-3-[(2,2,6,6-tetramethylpiperidin-1-
yl)oxy]oct-1-en-1-yl]cyclopentyl]hept-5-ynoic acid 4-95: 
C5H11
OTMP
COOH
HO
HO
4-95  
Crude 4-94 was dissolved in 3 mL THF and 0.5 mL water. LiOH⋅H2O (43 mg, 1.02 mmol) 
was added at r.t. and the reaction mixture was stirred for 6.5 h. The reaction mixture was 
diluted with 10 mL diethyl ether and 3 mL of water. The aqueous layer was acidified with 20 
mL of a 2M NaHSO4 solution and extracted four times with diethyl ether. The ethereal layer 
was dried over Na2SO4 and concentrated in vacuo to give 9 mg of crude acids 15α/β-4-95 
(Rf(CH2Cl2/acetone 2:1) = 0.31, 0.37). The crude acids 15α/β-4-95 were dissolved in 2 mL of 
dry THF and 0.2 mL of dry MeOH under a nitrogen atmosphere. To this solution 0.09 mL 
(0.18 mmol) of a 2M solution of TMSCHN2 in diethyl ether was added and the reaction 
mixture was stirred at r.t. for 1 h and 20 min. The reaction mixture was evaporated to give the 
crude product. Purification by flash chromatography (CH2Cl2/acetone 10:1, gradient to 5:1, 
2:1 and 1:1; the product eluted with 5:1) gave 6.5 mg (47% yield based on 4-6b) of pure 4-92 
as an inseparable mixture of 15α/15β-isomers. The diastereomeric ratio was 1.3:1, the relative 
configuration could however not be determined. Rf(ethyl acetate) = 0.53 and 0.60, 
Rf(CH2Cl2/acetone 2:1) = 0.53 and 0.62. Both isomers are well retained on silica and elute 
only in the presence of acetone. 
 
5,6-Dehydro-15-oxo-F2t-isoprostane 4-96:  
HO
HO O
C5H11
15
CO2Me
 
mCPBA (11.4 mg, 0.066 mmol, 1.4 equiv.) was added to a solution of 4-92 (17 mg, 0.033 
mmol) in 3.5 mL of dry CH2Cl2 at 0 °C. The consumption was monitored by TLC with ethyl 
acetate (Rf(substrates) = 0.59, 0.67; Rf(product) = 0.39). The solution was stirred for 10 min at 
0 °C, quenched with 5mL saturated Na2S2O3 solution and diluted with ethyl acetate. The 
aqueous layer was extracted twice with diethyl ether and three times with ethyl acetate. The 
combined organic layers were washed with brine and dried over Na2SO4. The solvent was 
evaporated in vacuum to give 50 mg of crude product. To avoid epimerisation, the product 
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was purified immediately. Flash chromatography (hexane/ethyl acetate 1:1 followed by ethyl 
acetate) gave 11.2 mg (93%) of pure 4-96, Rf (ethyl acetate) = 0.39. The ketone 4-96 was 
reduced immediately or it was dried and stored in the freezer. Storage in solution for longer 
time leads to the formation of 12-epi-5,6-dehydro-15-oxo-F2t-IsoP (4-96/12-epi-4-96>10:1). 
1H NMR (600 MHz, C6D6): δ = 0.86 (t, J = 7.1 Hz, 3H, CH2CH3), 1.23 (m, 4H, 
CH2CH2CH2CH3), 1.30 (br. s, 2H, OH), 1.59 (m, 1H, CHCH2CH), 1.66 (m, 4H, 
CH3(CH2)2CH2, CH2CH2COOMe), 1.89 (ddt, J = 16.7, 8.3, 2.5 Hz, 1H, CHCH2C≡), 2.00 (m, 
3H, ≡CCH2CH2, CHCH2C≡), 2.13 (quint, J = 7.0 Hz, 1H, CHCH2CH), 2.23 (t, J = 7.3 Hz, 
2H, CH2COOMe), 2.27 (t, J = 7.3 Hz, 2H, COCH2CH2), 2.31 (m, 1H, CHCH2C≡), 2.80 (m, 
1H, HOCHCHCH=), 3.32 (s, 3H, OCH3), 3.77 (dd, J = 11.3, 5.0 Hz, 1H, HOCHCHCH=), 
3.89 (dt, J = 6.8, 4.8 Hz, 1H, HOCHCHCH2), 6.10 (dd, J = 15.6, 0.7 Hz, 1H, =CHCO), 6.64 
(dd, J = 15.6, 9.5 Hz, 1H, CH=CHCO). - 13C NMR (150 MHz): δ = 14.2 (q, CH2CH3), 18.3 (t, 
CH2CH2C≡), 19.2 (t, CHCH2C≡), 22.9 (t, CH2CH3), 24.0 (t, CH2CH2CH2CH3), 24.5 (t, 
CH2CH2C≡), 31.8 (t, CH2CH2CH3), 32.8 (t, CH2COOMe), 41.1 (CHCOCH2), 43.0 (t, 
CHCH2CH), 50.6 (d, CHCH2C≡), 51.1 (q, OCH3), 53.4 (d, CHCHCH=), 75.5 (d, 
HOCHCHCH=), 75.9 (d, HOCHCHCH2), 79.9 (s, C≡C), 80.7 (s, C≡C), 132.0 (d, =CHCO), 
143.4 (d, CH=CHCO), 173.2 (s, COOMe), 198.6 (s, CO). - IR (Film): v~  = 3433 (br. w), 2923 
(s), 2853 (s), 1737 (s), 1668 (m), 1625 (w), 1461 (w), 1438 (w), 1260 (w), 1080 (w), 1028 
(w), 800 (w). - MS(ESI) m/z (%): 751 (17) [2M+Na+], 387 (100) [M+Na+]. - HRMS: 
C21H32O5Na+: calc. 387.2147; found 387.2136. 
NOESY experiment of 4-96: 
HO
HO
H
9
H
11
H
8
H
12H
10!
H
10"
H
14
H
13
R
1
H H
R
2
weak
weak
 
 
12-epi-5,6-Dehydro-15-oxo-F2t-isoprostane: This product was detected in the solution of 
5,6-dehydro-15-oxo-F2t-IsoP in small amounts. NOE Experiments for proving its 
stereochemistry were not possible. Based on the evidence, we assign it the 12-epi structure. 
Detectable resonances of this isomer are: 1H NMR (600 MHz, C6D6): δ = 3.31 (s, 3H, OCH3), 
3.89 (m, 1H, HOCHCHCH2), 4.01 (m, 1H, HOCHCHCH=), 6.12 (m, 1H, =CHCO), 6.64 (m, 
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1H, CH=CHCO). - 13C NMR (150 MHz): δ = 40.09 (CHCOCH2), 43.51 (t, CHCH2CH), 
53.32 (d, CHCH2C≡), 76.12 (d, HOCHCHCH2), 77.46 (d, HOCHCHCH=), 78.89 (s, C≡C), 
80.87 (s, C≡C), 132.2 (d, =CHCO), 145.0 (d, CH=CHCO), 173.1 (s, COOMe), 199.2 (s, CO). 
 
5,6-Dehydro-15-F2t-isoprostane methyl ester and 15-epi-5,6-dehydro-15-F2t-isoprostane 
methyl ester 4-98: 
HO
HO OH
C5H11
15
CO2Me
 
HO
HO OH
C5H11
15
CO2Me
 
A 1.7M solution of DIBAL-H (0.22 mL, 0.38 mmol, 12 equiv. based on 4-96) in toluene was 
added to a solution of 111 mg (0.503 mmol, 1.32 equiv. based on DIBAL-H) of 2,6-di-tert-
butyl-4-methylphenol in 1.3 mL of dry toluene at 0 °C and the solution was stirred for 1 h 15 
min. After cooling to –95 °C, 11.2 mg (0.0307 mmol) 4-96 dissolved in 0.6 mL toluene was 
added to the colourless solution (reaching a reagent concentration of 0.2 M). A yellow to 
orange coloration was observed on addition of the substrate. The reaction mixture was 
warmed to –78 °C and stirred at this temperature for 2 h, then at –50 °C for 3 h, and finally it 
was allowed to warm up to –10 °C for 1 h 15 min, when it was complete by TLC (4-96 
Rf(ethyl acetate) = 0.39; 5,6-dehydro-15-F2t-IsoP, Rf (ethyl acetate) = 0.15 (15-α) and 0.23 
(15-β)). The reaction was quenched with 5 mL 1M HCl solution and diluted with ethyl 
acetate. The mixture was stirred for 5 min while allowed to warm up to room temperature. 
The aqueous layer was extracted four times with ethyl acetate and twice with diethyl ether. 
The combined etheral layers were washed with brine and dried over Na2SO4. Flash 
chromatography of the crude product (190 mg) was performed with hexane/ethyl acetate 1:1, 
followed by ethyl acetate and CH2Cl2/acetone 1:1. The products eluted with CH2Cl2/acetone 
1:1 and a mixture of 5,6-dehydro-15-F2t-IsoP and 15-epi-5,6-dehydro-15-F2t-IsoP was isolated 
in 92% yield (10.4 mg) in a ratio of 1.7:1 (15-epi-5,6-dehydro-15-F2t-IsoP Rf(CH2Cl2/acetone 
2:1) = 0.23; 5,6-dehydro-15-F2t-IsoP Rf(CH2Cl2/acetone 2:1) = 0.17). Although the Rf values 
of the products with ethyl acetate are 0.15 and 0.23, they elute only in the presence of acetone. 
At this stage, MS- and HRMS data were recorded. The products were separated by a second 
column using ethyl acetate/acetone 8:1 followed by 1:1 as the eluent. Three fractions were 
obtained: 2 mg of pure 15-epi-5,6-dehydro-15-F2t-IsoP, 3.7 mg of a 1:1 mixture of 15-epi-5,6-
dehydro-15-F2t-IsoP and 5,6-dehydro-15-F2t-IsoP, and finally 4.7 mg of pure 5,6-dehydro-15-
F2t-IsoP. 
 
 292 
15α-/15β-5,6-Dehydro-15-F2t-IsoP: IR (Film): v~  = 3320 cm-1 (m), 2954 (m), 2928 (s), 2857 
(m), 1739 (m), 1437 (m), 1249 (w), 1162 (w), 1162 (w), 1086 (w), 1060 (m), 971 (w). - 
MS(ESI) m/z (%): 389 (100) [M+Na+]. - HRMS: C21H34O5Na+: calc. 389.2304; found 
389.2305. 
5,6-Dehydro-15-F2t-IsoP: Rf(CH2Cl2/acetone 2:1) = 0.17. - 1H NMR (600 MHz, CDCl3): δ = 
0.89 (t, J = 6.7 Hz, 3H, CH2CH3), 1.20-1.35 (m, 5H, CH2CH2CH2CH3), 1.39 (m, 1H, 
CH2CH2CH2CH3), 1.47 (m, 1H, HOCHCH2CH2), 1.56 (m, 1H, HOCHCH2CH2), 1.65 (br. s, 
2H, OH), 1.70 (dt, J = 14.2, 4.9 Hz, 1H, CHCH2CH), 1.80 (quint, J = 7.1 Hz, 2H, 
CH2CH2COOMe), 2.05 (m, 1H, CHCH2C≡), 2.19 (m, 1H, CHCH2C≡), 2.22 (t, J = 7.0 Hz, 
2H, ≡CCH2CH2), 2.32 (m, 2H, CHCH2C≡, OH), 2.44 (t, J = 7.4 Hz, 2H, CH2COOMe), 2.47 
(m, 1H, CHCH2CH), 2.78 (dt, J = 4.8, 8.9 Hz, 1H, HOCHCHCH=), 3.68 (s, 3H, OCH3), 4.03 
(q, J = 4.9 Hz, 1H, HOCHCHCH=), 4.06 (q, J = 6.3 Hz, 1H, =CHCHOH), 4.14 (dt, J = 7.0, 
5.1 Hz, 1H, HOCHCHCH2), 5.42 (dd, J = 15.3, 9.7 Hz, 1H, CH=CHCHOH), 5.59 (dd, J = 
15.3, 6.9 Hz, 1H, =CHCHOH). - 13C NMR (150 MHz): δ = 14.0 (q, CH2CH3), 18.1 (t, 
≡CCH2CH2), 19.07 (t, CHCH2C≡), 22.6 (t, CH2CH3), 24.1 (t, CH2CH2COOMe), 25.1 (t, 
CH2CH2CH2CH3), 31.7 (t, CH2CH2CH3), 32.9 (t, CH2COOMe), 37.29 (t, HOCHCH2CH2), 
42.26 (t, CHCH2CH), 49.69 (d, CHCH2C≡), 51.7 (q, OCH3), 53.4 (d, CHCHCH=), 72.61 (d, 
HOCHCH2CH2), 76.08 (d, HOCHCHCH=), 76.23 (d, HOCHCHCH2), 79.87 (s, C≡C), 80.24 
(s, C≡C), 128.3 (d, CH=CHCHOH), 136.62 (d, =CHCHOH), 173.81 (s, COOMe). 
15-epi-5,6-dehydro-15-F2t-IsoP: Rf(CH2Cl2/acetone 2:1) = 0.23. - 1H NMR (600 MHz, 
CDCl3): δ = 0.89 (m, 3H, CH2CH3), 1.20-1.35 (m, 5H, CH2CH2CH2CH3), 1.39 (m, 1H, 
CH2CH2CH2CH3), 1.48 (m, 1H, HOCHCH2CH2), 1.55 (m, 1H, HOCHCH2CH2), 1.61 (br. s, 
3H, OH), 1.70 (dt, J = 14.3, 4.7 Hz, 1H, CHCH2CH), 1.80 (quint, J = 7.0 Hz, 2H, 
CH2CH2COOMe), 2.07 (m, 1H, CHCH2C≡), 2.22 (t, J = 6.7 Hz, 2H, ≡CCH2CH2), 2.23 (m, 
1H, CHCH2C≡), 2.34 (m, 1H, CHCH2C≡), 2.44 (t, J = 7.3 Hz, 2H, CH2COOMe), 2.47 (m, 
1H, CHCH2CH), 2.80 (dt, J = 4.5, 8.8 Hz, 1H, HOCHCHCH=), 3.68 (s, 3H, OCH3), 4.03 (dd, 
J = 10.5, 4.6 Hz, 1H, HOCHCHCH=), 4.08 (q, J = 6.5 Hz, 1H, =CHCHOH), 4.15 (dt, J = 7.2, 
4.9 Hz, 1H, HOCHCHCH2), 5.44 (dd, J = 15.3, 9.5 Hz, 1H, CH=CHCHOH), 5.62 (dd, J = 
15.4, 6.4 Hz, 1H, =CHCHOH). - 13C NMR (150 MHz): δ = 14.0 (q, CH2CH3), 18.1 (t, 
≡CCH2CH2), 19.11 (t, CHCH2C≡), 22.6 (t, CH2CH3), 24.1 (t, CH2CH2COOMe), 25.1 (t, 
CH2CH2CH2CH3), 31.7 (t, CH2CH2CH3), 32.9 (t, CH2COOMe), 37.27 (t, HOCHCH2CH2), 
42.23 (t, CHCH2CH), 49.71 (d, CHCH2C≡), 51.7 (q, OCH3), 53.6 (d, CHCHCH=), 72.9 (d, 
HOCHCH2CH2), 76.06 (d, HOCHCHCH=), 76.21 (d, HOCHCHCH2), 79.78 (s, C≡C), 80.24 
(s, C≡C), 127.7 (d, CH=CHCHOH), 136.7 (d, =CHCHOH), 173.77 (s, COOMe).  
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15-F2t-IsoP 15α-4-1 and 15-epi-15-F2t-IsoP 15β-4-1: In a Schlenk flask, 5 mg of the Lindlar 
catalyst (~5% Pd on calcium carbonate, poisoned with lead, FLUKA, filling code 1308421 
11607082) was evacuated and flushed with nitrogen three times. In a separate Schlenk flask, a 
mixture of HPLC grade ethyl acetate/HPLC grade ethanol/distilled pyridine 11:6:1 was 
deoxygenated by five freeze-pump-thaw cycles and 3 mL of this solvent mixture was added to 
the catalyst. The suspension was subsequently evacuated and flushed three times with 
hydrogen and was then stirred under a positive pressure of H2 at r.t. for 45 min. 
Hydrogenation was started by addition of a carefully deoxygenated solution of 5 mg (0.013 
mmol) 5,6-dehydro-15-F2t-IsoP or 15-epi-5,6-dehydro-15-F2t-IsoP, respectively, in 1.5 mL of 
the same solvent mixture. The reaction mixture was stirred at r.t. for 24 hours under a slightly 
positive pressure of hydrogen (2 balloons). The reaction mixture was diluted with ethyl 
acetate and filtered through a pad of Celite, which was washed with ethyl acetate and diethyl 
ether. The crude products were purified by flash chromatography on silica using first ethyl 
acetate to flush down unpolar impurities, followed by a gradient of ethyl acetate/acetone 10:1, 
and final product elution with ethyl acetate/acetone 3:1. 
 
15-F2t-IsoP methyl ester 15α-4-1: Yield 4.8 mg (96%) of pure F2t-IsoP as a colourless oil, 
Rf(ethyl acetate) = 0.16. Only trace amounts, if at all of fully hydrogenated product were 
observed in the NMR spectra. The product matches the analytical data of the natural product. 
HO
HO
COOMe
OH  
1H NMR (600 MHz, CDCl3): δ = 0.88 (t, J = 6.8 Hz, 3H, CH2CH3), 1.24-1.42 (m, 6H, 
CH2CH2CH2CH3), 1.48 (m, 1H, HOCHCH2CH2), 1.56 (m, 1H, HOCHCH2CH2), 1.67 (m, 3H, 
HOCHCH2CHOH, CH2CH2COOMe), 2.01 (m, 5H, CHCH2CH=, OH), 2.07 (q, J = 6.9 Hz, 
2H, =CHCH2CH2), 2.18 (m, 1H, CHCH2C=), 2.32 (t, J = 7.2 Hz, 2H, CH2COOMe), 2.44 (dt, 
J = 14.6, 6.8 Hz, 1H, HOCHCH2CHOH), 2.78 (dt, J = 8.6, 4.4 Hz, 1H, HOCHCHCH=), 3.68 
(s, 3H, OCH3), 3.98 (dt, J = 7.1, 4.5 Hz, 1H, HOCHCHCH2), 4.05 (dt, J = 6.3, 4.2 Hz, 1H, 
HOCHCHCH=), 4.08 (q, J = 6.4 Hz, 1H, =CHCHOH), 5.43 (m, 3H, CH=CHCHOH, 
CH2CH=CHCH2), 5.59 (dd, J = 15.3, 6.7 Hz, 1H, =CHCHOH). - 13C NMR (150 MHz): δ = 
14.05 (q, CH2CH3), 22.62 (t, CH2CH3), 24.67 (t, CH2CH2COOMe), 25.16 (t, 
CH2CH2CH2CH3), 26.67 (t, CH2CH2CH2COOMe), 26.98 (t, CHCH2CH=), 31.72 (t, 
CH2CH2CH3), 33.31 (t, CH2COOMe), 37.24 (t, HOCHCH2CH2), 42.31 (t, 
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HOCHCH2CHOH), 50.80 (d, CHCH2CH=), 51.64 (q, OCH3), 53.66 (d, CHCHCH=), 72.78 
(d, HOCHCH2CH2), 76.46 (d, HOCHCHCH= or HOCHCHCH2), 76.47 (d, HOCHCHCH= or 
HOCHCHCH2), 128.81 (d, CHCH=CHCHOH), 129.17 (d, CHCH2CH=CHCH2 or 
CHCH2CH=CHCH2), 129.89 (d, CHCH2CH=CHCH2 or CHCH2CH=CHCH2), 136.20 (d, 
=CHCHOH), 174.25 (s, COOMe). - IR (Film): v~  = 3348 (br. m), 3006 (w), 2930 (s), 2859 
(m), 1739 (s), 1438 (m), 1245 (w), 1169 (w), 1071 (m), 973 (m). - MS(ESI) m/z (%): 759 (5) 
[2M+Na+], 391 (100) [M+Na+]. - HRMS: C23H44O5Na+: calc. 391.2460; found 391.2466. - 
NOESY-correlations in 15α-4-1: 
HO
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15-epi-15-F2t-IsoP methyl ester 15β-4-1: Yield 4.9 mg (99%) as a colourless oil, Rf(ethyl 
acetate) = 0.22. Only trace amounts, if at all of fully hydrogenated product were observed in 
the NMR spectra. The analytical data of the synthesised product match those of the natural 
product. 
HO
HO
COOMe
OH  
1H NMR (600 MHz, CDCl3): δ = 0.89 (t, J = 6.8 Hz, 3H, CH2CH3), 1.25-1.42 (m, 6H, 
CH2CH2CH2CH3), 1.48 (m, 1H, HOCHCH2CH2), 1.55 (m, 1H, HOCHCH2CH2), 1.67 (m, 3H, 
HOCHCH2CHOH, CH2CH2COOMe), 1.91 (br. s, 2H, OH), 1.96 (br. s, 1H, OH), 2.05 (q, J = 
7.3 Hz, 2H, CHCH2CH=), 2.07 (q, J = 7.4 Hz, 2H, =CHCH2CH2), 2.20 (m, 1H, CHCH2CH=), 
2.33 (t, J = 7.2 Hz, 2H, CH2COOMe), 2.44 (ddd, J = 14.1, 7.4, 6.7 Hz, 1H, 
HOCHCH2CHOH), 2.79 (ddd, J = 8.9, 8.2, 4.0 Hz, 1H, HOCHCHCH=), 3.68 (s, 3H, OCH3), 
4.00 (m, 1H, HOCHCHCH2), 4.04 (ddd, J = 7.0, 4.0, 3.0 Hz, 1H, HOCHCHCH=), 4.09 (q, J 
= 6.3 Hz, 1H, =CHCHOH), 5.45 (m, 3H, CH=CHCHOH, CH2CH=CHCH2), 5.60 (dd, J = 
15.3, 6.5 Hz, 1H, =CHCHOH). - 13C NMR (150 MHz): δ = 14.06 (q, CH2CH3), 22.62 (t, 
CH2CH3), 24.62 (t, CH2CH2COOMe), 25.16 (t, CH2CH2CH2CH3), 26.65 (t, 
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CH2CH2CH2COOMe), 26.96 (t, CHCH2CH=), 31.72 (t, CH2CH2CH3), 33.23 (t, 
CH2COOMe), 37.24 (t, HOCHCH2CH2), 42.34 (t, HOCHCH2CHOH), 50.72 (d, 
CHCH2CH=), 51.68 (q, OCH3), 53.71 (d, CHCHCH=), 72.70 (d, HOCHCH2CH2), 76.54 (d, 
HOCHCHCH= or HOCHCHCH2), 76.62 (d, HOCHCHCH= or HOCHCHCH2), 128.43 (d, 
CHCH=CHCHOH), 129.26 (d, CHCH2CH=CHCH2 or CHCH2CH=CHCH2), 129.91 (d, 
CHCH2CH=CHCH2 or CHCH2CH=CHCH2), 136.29 (d, =CHCHOH), 174.34 (s, COOMe). 
 
6.9.7. Completion of the total syntheses of 13,14-dihydro-15-oxo-15-E2-isoprostane 4-3 and 
13,14-dihydro-15-oxoprostaglandin E2 4-4 
 
Methyl 7-[(1S*,2R*,3R*)-3-(tert-butyldimethylsilyloxy)-5-oxo-2-[(R*,E and S*,E)-3-
(2,2,6,6-tetramethylpiperidin-1-yloxy)oct-1-enyl]cyclopent-1-yl]hept-5-ynoate 4-99: 
O
TBSO OTMP
C5H11
CO2Me
 
1. Tandem TES deprotection/Swern-type oxidation: A 2.0 M solution of oxalyl chloride in 
CH2Cl2 (0.43 mL, 0.86 mmol, 7 equiv.) was added at −70 °C to a solution of DMSO (0.122 
mL, 1.72 mmol, 14 equiv.) in 2 mL dry CH2Cl2 and stirred for 40 min at this temperature. The 
mixture of 4-6a (15α/β 1:1.6, 0.042 mmol), 4-9 (0.047 mmol) and 4-74 (0.034 mmol) (60 mg, 
1.25:1.4:1) dissolved in 3 mL of dry CH2Cl2 was added at −70 °C. The reaction mixture was 
stirred at −70 - −40 °C for one hour and 40 min. It was cooled to −75 °C and Et3N (0.48 mL, 
3.44 mmol, 28 equiv.) was added. The consumption was followed by TLC (hexane/ethyl 
acetate 20:1 and 10:1; Rf(4-6a, hexane/ethyl acetate 20:1) = 0.4, Rf(aldehydes, hexane/ethyl 
acetate 10:1) = 0.30-0.45). The reaction was stirred at −40 - 0 °C for 2.5 h and quenched with 
5 mL water. The aqueous layer was extracted three times with CH2Cl2. The combined organic 
layers were dried over Na2SO4 and concentrated in vacuum. The crude product was 
suspended in diethyl ether and separated from a colourless solid to give 100 mg of a pale 
yellow oil. The reaction was similarly repeated with further 30 mg of the same mixture of 
15α,β-4-6a, 4-9 and 4-74. The combined crude products from both experiments (total 130 
mg) were used immediately for the next step. 
2. Aldehyde to acid oxidation and esterification to 4-99: The crude mixture of aldehydes 
(130 mg) was dissolved in 4.2 mL of a 2:1 tBuOH/H2O mixture. NaH2PO4 (104.4 mg, 0.87 
mmol, 4.7 equiv.) dissolved in a small amount of water and 2-methyl-2-butene (0.184 mL, 
1.74 mmol, 9.4 equiv.) were added to this solution. NaClO2 (79 mg, 0.87 mmol, 4.7 equiv.) 
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was added in one portion at 0 °C and the reaction was stirred at r.t. for 2 h. The consumption 
of the aldehydes was followed by TLC (hexane/ethyl acetate 10:1). The reaction mixture was 
quenched with 4 mL of a 5% HCl solution. The aqueous layer was extracted with diethyl 
ether, the combined organic layers were washed with brine, dried over Na2SO4 and 
concentrated in vacuum. The mixture of crude acids (100 mg) was dissolved in 5.6 mL of a 
dry 8.5:1 THF/MeOH mixture. Trimethylsilyldiazomethane (0.725 mL, 1.45 mmol, 2.0 M in 
Et2O, 7.9 equiv.) was added and the reaction mixture was stirred at r.t. for 3 h. The formation 
of the methyl esters was followed by TLC (hexane/ethyl acetate 5:1: Rf(products 5:1) = 0.54). 
The solvent was evaporated to give 100 mg of crude esters. Flash chromatography 
(hexane/ethyl acetate 40:1, gradient to 2:1) gave first 20 mg of TES-alkyne methyl ester C 
(hexane/ethyl acetate 40-20:1), 5 mg of a 15β-4-99/PG isomer D mixture (5.25:1) (with 
hexane/ethyl acetate 10:1) and 23 mg of 4-99 (15β/α = 1.4:1) (with hexane/ethyl acetate 5:1). 
Yield 28 mg (72%) from 15α/β-4-6a in an overall 15β/α-ratio of 1.8:1 and a 4-99:D ratio of 
34:1. Epimerisation to isomer D with PG configuration occurred thus only to a very small 
extent at this stage. 
CO2Me
TES
4-74
O
TBSO OTMP
C5H11
CO2Me
D  
IR (Film): v~  = 2953 (s), 2931 (s), 2858 (m), 1745 (s), 1466 (w), 1437 (w), 1375 (w), 1361 
(w), 1255 (w), 1133 (w), 1077 (w), 1006 (w), 975 (w), 909 (w), 836 (m), 778 (m) cm-1. - 
MS(ESI) m/z (%): 640 (100) [M+Na+], 618 (16) [M+H+], 484 (52) [M+H+–TEMPO], 158 
(26) [TEMPOH2+]. - HRMS: C36H63NO5SiNa+: calc. 640.4373; found 640.4371. 
15β-4-99: 1H NMR (600 MHz, C6D6): δ = 0.02 (s, 3H, Si(CH3)2), 0.07 (s, 3H, Si(CH3)2), 0.92 
(m, 12H, CH2CH3, SiC(CH3)3), 1.14-1.52 (m, 12H, CH2CH2CH2CH2CH3, 
NCCH2CH2CH2CN), 1.21 (s, 3H, NC(CH3)2), 1.23 (s, 3H, NC(CH3)2), 1.26 (s, 3H, 
NC(CH3)2), 1.27 (s, 3H, NC(CH3)2), 1.57 (m, 1H, CH2CHOTMP), 1.68 (m, 2H, 
CH2CH2COOMe), 1.84 (m, 1H, CH2CHOTMP), 2.02 (m, 2H, ≡CCH2CH2), 2.20 (m, 1H, 
COCH2CHO), 2.25 (t, J = 7.4 Hz, 2H, CH2COOMe), 2.35 (dd, J = 18.7, 5.7 Hz, 1H, 
COCH2CHO), 2.41 (ddt, J = 16.7, 9.5, 2.4 Hz, 1H, CHCH2C≡), 2.88 (ddt, J = 16.6, 3.8, 2.3 
Hz, 1H, CHCH2C≡), 2.95 (dt, J = 3.6, 8.9 Hz, 1H, CHCH2C≡), 3.16 (br. t, J = 8.6 Hz, 1H, 
CHCHCH=), 3.33 (s, 3H, COOCH3), 4.25 (m, 1H, CHOTMP), 4.33 (dt, J = 2.7, 5.5 Hz, 1H, 
CHOTBS), 5.30 (dd, J = 15.4, 9.3 Hz, 1H, CH=CHCHOTMP), 5.72 (dd, J = 15.4, 8.8 Hz, 
1H, =CHCHOTMP). - 13C NMR (150 MHz, C6D6): δ = –4.75 (q, Si(CH3)2), –4.71 (q, 
Si(CH3)2), 14.27 (q, CH2CH3), 16.0 (t, CHCH2C≡), 17.69 (t, NCCH2CH2CH2CN), 18.23 (s, 
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SiC(CH3)3), 18.4 (t, CH2CH2C≡), 20.6 (q, NC(CH3)2), 20.73 (q, NC(CH3)2), 23.07 (t, 
CH2CH3), 24.50 (t, CH2CH2COOMe), 25.7 (t, CH2CH2CH2CH3), 25.96 (q, SiC(CH3)3), 32.3 
(t, CH2CH2CH3), 32.82 (t, CH2COOMe), 34.5 (q, NC(CH3)2), 34.9 (t, CH2CHOTMP), 35.3 
(q, NC(CH3)2), 40.4 (t, NCCH2CH2CH2CN), 40.6 (t, NCCH2CH2CH2CN), 46.1 (t, 
COCH2CHO), 50.8 (d, CHCH2C≡), 50.99 (q, COOCH3), 52.1 (d, CHCHCH=), 59.4 (s, 
NC(CH3)2), 60.5 (s, NC(CH3)2), 73.1 (d, CHOTBS), 79.6 (s, C≡C), 80.3 (s, C≡C), 85.2 (d, 
CHOTMP), 128.6 (d, CH=CHCHOTMP), 137.5 (d, =CHCHOTMP), 172.9 (s, COOMe), 
213.6 (s, C=O). - Significant NOESY interactions: 
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15α-4-99: 1H NMR (600 MHz, C6D6): δ = 0.02 (s, 3H, Si(CH3)2), 0.08 (s, 3H, Si(CH3)2), 0.89 
(m, 12H, CH2CH3, SiC(CH3)3), 1.11-1.51 (m, 12H, CH2CH2CH2CH2CH3, 
NCCH2CH2CH2CN), 1.18 (s, 3H, NC(CH3)2), 1.22 (s, 3H, NC(CH3)2), 1.26 (s, 3H, 
NC(CH3)2), 1.28 (s, 3H, NC(CH3)2), 1.56 (m, 1H, CH2CHOTMP), 1.66 (m, 2H, 
CH2CH2COOMe), 1.88 (m, 1H, CH2CHOTMP), 2.01 (m, 2H, ≡CCH2CH2), 2.08 (m, 3H, 
COCH2CHO, CHCH2C≡), 2.23 (t, J = 7.7 Hz, 2H, CH2COOMe), 2.82 (m, 1H, CHCH2C≡), 
2.98 (ddd, J = 3.9, 7.6, 11.3 Hz, 1H, CHCH2C≡), 3.22 (m, 1H, CHCHCH=), 3.33 (s, 3H, 
COOCH3), 4.13 (dt, J = 4.6, 8.9 Hz, 1H, CHOTMP), 4.25 (m, 1H, CHOTBS), 4.96 (dd, J = 
15.1, 10.4 Hz, 1H, CH=CHCHOTMP), 5.75 (dd, J = 15.2, 9.0 Hz, 1H, =CHCHOTMP). - 13C 
NMR (150 MHz, C6D6): δ = –4.81 (q, Si(CH3)2), –4.68 (q, Si(CH3)2), 14.34 (q, CH2CH3), 
15.9 (t, CHCH2C≡), 17.68 (t, NCCH2CH2CH2CN), 18.23 (s, SiC(CH3)3), 18.3 (t, 
CH2CH2C≡), 20.4 (q, NC(CH3)2), 20.73 (q, NC(CH3)2), 23.14 (t, CH2CH3), 24.54 (t, 
CH2CH2COOMe), 25.6 (t, CH2CH2CH2CH3), 25.98 (q, SiC(CH3)3), 32.4 (t, CH2CH2CH3), 
32.78 (t, CH2COOMe), 34.2 (q, NC(CH3)2), 35.0 (t, CH2CHOTMP), 36.2 (q, NC(CH3)2), 40.5 
(t, NCCH2CH2CH2CN), 40.7 (t, NCCH2CH2CH2CN), 45.6 (t, COCH2CHO), 49.9 (d, 
CHCH2C≡), 51.01 (q, COOCH3), 52.9 (d, CHCHCH=), 59.2 (s, NC(CH3)2), 60.6 (s, 
NC(CH3)2), 72.6 (d, CHOTBS), 79.1 (s, C≡C), 80.0 (s, C≡C), 85.8 (d, CHOTMP), 127.2 (d, 
CH=CHCHOTMP), 138.6 (d, =CHCHOTMP), 172.8 (s, COOMe), 213.9 (s, C=O). - 
Significant NOESY interactions: 
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PG-Isomer D, detectable resonances: 1H NMR (600 MHz, C6D6): δ = 2.20 (m, 1H, 
COCH2CHO), 2.56 (m, 1H, COCH2CHO), 3.77 (br. d, J = 6.8 Hz, 1H, CHCHCH=), 4.25 (m, 
2H, CHOTBS, CHOTMP), 5.61 (dd, J = 15.5, 6.8 Hz, 1H, CH=CHCHOTMP), 5.66 (dd, J = 
15.4, 8.3 Hz, 1H, =CHCHOTMP). - 13C NMR (150 MHz, C6D6): δ = 47.3 (t, COCH2CHO), 
57.8 (d, CHCHCH=), 78.5 (d, CHOTBS), 85.8 (d, CHOTMP), 130.0 (d, CH=CHCHOTMP). 
 
Methyl 7-[(1S*,2R*,3R*)-3-hydroxy-5-oxo-2-[(R*,E and S*,E)-3-(2,2,6,6-
tetramethylpiperidin-1-yloxy)oct-1-enyl]cyclopentyl]hept-5-ynoate 4-100a: 
O
HO OTMP
C5H1115
CO2Me
8
 
40% HF (0.11 mL, 2.5 mmol, 9.2 equiv. based on pyridine) was added to a solution of 
pyridine (0.022 mL, 0.272 mmol, 8.5 equiv. based on 15α/β-4-99) in 1.5 mL CH3CN at 0 °C. 
A solution of pure 4-99 (15β/α 1.4:1, 20 mg, 0.032 mmol)) dissolved in 1 mL acetonitrile was 
added at 0 °C to this solution and the flask was rinsed with 1 mL acetonitrile. The reaction 
mixture was allowed to warm to room temperature and stirred until complete by TLC (Rf(4-
99, hexane/ethyl acetate 5:1) = 0.56; Rf(4-100a-Isomer I, hexane/ethyl acetate 2:1) = 0.48; 
Rf(4-100a-Isomer II, hexane/ethyl acetate 2:1) = 0.57). After 19 h, the reaction was quenched 
with sat’d NaHCO3 solution and diluted with CH2Cl2. The aqueous layer was extracted three 
times with CH2Cl2. The combined organic layers were washed with brine, dried over Na2SO4 
and concentrated in vacuum. The crude product (18.7 mg) was purified by flash 
chromatography (hexane/ethyl acetate 4:1, gradient to 2:1, and finally to ethyl acetate). 
Product 15α/β-4-100a eluted with hexane/ethyl acetate 2:1. Yield 10.2 mg (63%) with a 4-
100a:4-100b ratio of >9:1. Compound 4-100a was isolated as a 1:1 mixture of the 15α/β-
diastereomers. The sterochemistry at the 15-position could however not be assigned. 
IR (Film): v~  = 3475 (br. w), 2931 (s), 2871 (w), 1742 (s), 1459 (w), 1437 (w), 1376 (w), 
1240 (w), 1162 (w), 1134 (w), 975 (w) cm-1. - MS(ESI) m/z (%): 1029 (20) [2M+Na+], 526 
(100) [M+Na+], 370 (39) [M+Na+–TEMPO]. - HRMS: C30H49NO5Na+: calc. 526.3508; found 
526.3506. 
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4-100a-Isomer I: 1H NMR (600 MHz, C6D6): δ = 0.73 (br. s, 1H, OH), 0.91 (m, 3H, 
CH2CH3), 1.11-1.44 (m, 21H, CH2CH2CH2CH2CH3, NCCH2CH2CH2CN, NC(CH3)2), 1.48-
1.62 (m, 4H, NCCH2CH2CH2CN, CH2CHOTMP), 1.66 (m, 2H, CH2CH2COOMe), 1.83 (m, 
1H, CH2CHOTMP), 1.95-2.09 (m, 3H, ≡CCH2CH2, COCH2CHO), 2.12-2.28 (m, 3H, 
COCH2CHO, CH2COOMe), 2.37 (m, 1H, CHCH2C≡), 2.79 (m, 1H, CHCH2C≡), 2.87 (m, 
1H, CHCH2C≡), 2.93 (m, 1H, CHCHCH=), 3.31 (s, 3H, COOCH3), 4.03 (m, 1H, CHOH), 
4.19 (m, 1H, CHOTMP), 5.17 (dd, J = 15.4, 9.2 Hz, 1H, CH=CHCHOTMP), 5.65 (dd, J = 
15.4, 8.8 Hz, 1H, =CHCHOTMP). - 13C NMR (150 MHz, C6D6): δ = 14.31 (q, CH2CH3), 15.9 
(t, CHCH2C≡), 17.7 (t, NCCH2CH2CH2CN), 18.5 (t, CH2CH2C≡), 20.6 (q, NC(CH3)2), 20.7 
(q, NC(CH3)2), 23.09 (t, CH2CH3), 24.48 (t, CH2CH2COOMe), 25.7 (t, CH2CH2CH2CH3), 
32.3 (t, CH2CH2CH3), 32.85 (t, CH2COOMe), 34.5 (q, NC(CH3)2), 35.0 (t, CH2CHOTMP), 
35.2 (q, NC(CH3)2), 40.5 (t, NCCH2CH2CH2CN), 40.6 (t, NCCH2CH2CH2CN), 45.1 (t, 
COCH2CHO), 50.7 (d, CHCH2C≡), 51.06 (q, COOCH3), 51.4 (d, CHCHCH=), 59.4 (s, 
NC(CH3)2), 60.6 (s, NC(CH3)2), 71.9 (d, CHOH), 79.7 (s, C≡C), 80.22 (s, C≡C), 85.2 (d, 
CHOTMP), 128.3 (d, CH=CHCHOTMP), 137.5 (d, =CHCHOTMP), 173.1 (s, COOMe), 
213.6 (s, C=O). - Significant NOESY interactions: 
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4-100a-Isomer II: 1H NMR (600 MHz, C6D6): δ = 0.73 (br. s, 1H, OH), 0.91 (m, 3H, 
CH2CH3), 1.11-1.44 (m, 21H, CH2CH2CH2CH2CH3, NCCH2CH2CH2CN, NC(CH3)2), 1.48-
1.62 (m, 4H, NCCH2CH2CH2CN, CH2CHOTMP), 1.66 (m, 2H, CH2CH2COOMe), 1.83 (m, 
1H, CH2CHOTMP), 1.95-2.09 (m, 3H, ≡CCH2CH2, COCH2CHO), 2.12-2.28 (m, 4H, 
COCH2CHO, CH2COOMe, CHCH2C≡), 2.70 (m, 1H, CHCH2C≡), 2.79 (m, 1H, CHCH2C≡), 
2.93 (m, 1H, CHCHCH=), 3.33 (s, 3H, COOCH3), 4.09 (m, 1H, CHOH), 4.19 (m, 1H, 
CHOTMP), 5.13 (dd, J = 15.2, 10.0 Hz, 1H, CH=CHCHOTMP), 5.69 (dd, J = 15.2, 8.9 Hz, 
1H, =CHCHOTMP). - 13C NMR (150 MHz, C6D6): δ = 14.35 (q, CH2CH3), 16.1 (t, 
CHCH2C≡), 17.6 (t, NCCH2CH2CH2CN), 18.3 (t, CH2CH2C≡), 20.5 (q, NC(CH3)2), 20.7 (q, 
NC(CH3)2), 23.13 (t, CH2CH3), 24.49 (t, CH2CH2COOMe), 25.6 (t, CH2CH2CH2CH3), 32.4 
(t, CH2CH2CH3), 32.81 (t, CH2COOMe), 34.2 (q, NC(CH3)2), 35.1 (t, CH2CHOTMP), 35.7 
(q, NC(CH3)2), 40.4 (t, NCCH2CH2CH2CN), 40.5 (t, NCCH2CH2CH2CN), 45.0 (t, 
COCH2CHO), 49.9 (d, CHCH2C≡), 51.07 (q, COOCH3), 52.1 (d, CHCHCH=), 59.3 (s, 
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NC(CH3)2), 60.4 (s, NC(CH3)2), 71.6 (d, CHOH), 79.1 (s, C≡C), 80.21 (s, C≡C), 85.6 (d, 
CHOTMP), 127.8 (d, CH=CHCHOTMP), 137.9 (d, =CHCHOTMP), 173.0 (s, COOMe), 
213.9 (s, C=O). - Significant NOESY interactions: 
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4-100b - detectable resonances: 1H NMR (600 MHz, C6D6): δ = 1.63 (m, 1H, CHCH2C≡), 
2.13 (m, 1H, COCH2CHO), 2.45 (m, 1H, COCH2CHO), 2.85 (m, 1H, CHCHCH=), 3.28 (s, 
3H, COOCH3), 3.59 (m, 1H, CHOH), 4.25 (m, 1H, CHOTMP), 5.24 (dd, J = 15.4, 8.3 Hz, 
1H, CH=CHCHOTMP), 5.73 (dd, J = 15.4, 9.0 Hz, 1H, =CHCHOTMP). - 13C NMR (150 
MHz, C6D6): δ = 47.0 (t, COCH2CHO), 51.10 (q, COOCH3), 52.5 (d, CHCHCH=), 53.6 (d, 
CHCH2C≡), 72.1 (d, CHOH), 78.1 (s, C≡C), 81.4 (s, C≡C), 85.5 (d, CHOTMP), 131.0 (d, 
CH=CHCHOTMP), 137.2 (d, =CHCHOTMP), 173.2 (s, COOMe), 211.3 (s, C=O). - 
Significant NOESY interactions: 
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Methyl 7-[(1S*,2R*,3R*)-3-hydroxy-5-oxo-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-
ynoate 4-101a, methyl 7-[(1R*,2R*,3R*)-3-hydroxy-5-oxo-2-[(E)-3-oxooct-1-
enyl]cyclopentyl]hept-5-ynoate 4-101b and methyl 7-[(1S*,2S*,3R*)-3-hydroxy-5-oxo-2-
[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-ynoate 4-101c: 
O
HO O
C5H11
4-101a
12
CO2Me
8
O
HO O
C5H11
4-101b
12
CO2Me
8
O
HO O
C5H11
4-101c
12
CO2Me
8
 
mCPBA (70%, 10 mg, 0.04 mmol, 2 equiv.) was added to a solution of 10 mg of ketone 
15α,β-4-100a and 4-100b (0.02 mmol, 9:1) in 3 mL dry CH2Cl2 at 0 °C. The reaction was 
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monitored by TLC (hexane/ethyl acetate 2:1: Rf(4-100a-major) = 0.48, Rf(4-100a-minor) = 
0.57, Rf(4-101a/4-101b/4-101c) = 0.19 and Rf(mCPBA) = 0.69). After 13 min, the reaction 
was quenched with 5 mL concentrated Na2S2O3 solution, diluted with ethyl acetate and stirred 
at r.t. for 10 min. The aqueous layer was extracted three times with ethyl acetate and three 
times with diethyl ether. The combined organic layers were washed with brine, dried over 
Na2SO4 and concentrated in vacuum. The crude product was purified on a short column with 
hexane/ethyl acetate 5:1, gradient to ethyl acetate. The product 4-101a contaminated with m-
chlorobenzoic acid (total 10 mg) eluted with hexane/ethyl acetate 1:1 (Rf = 0.39) and ethyl 
acetate. A second purification with hexane/ethyl acetate 2:1 and 1:1 gave 5.4 mg (75% yield) 
of an inseparable mixture of 4-101a, 4-101b and 4-101c in a ratio of IsoP:PG:12-epi-IsoP = 
9:4:1. 
IR (Film): v~  = 3463 (br. w), 2954 (w), 2931 (w), 2870 (w), 1740 (s), 1669 (m), 1628 (w), 
1436 (w), 1373 (w), 1341 (w), 1319 (w), 1226 (w), 1161 (m), 1079 (w), 984 (w) cm-1. - 
MS(ESI) m/z (%): 747 (15) [2M+Na+], 385 (100) [M+Na+]. - HRMS: C21H30O5Na+: calc. 
385.1991; found 385.1988. 
4-101a: 1H NMR (600 MHz, C6D6): δ = 0.86 (m, 3H, CH2CH3), 1.13-1.26 (m, 4H, 
CH2CH2CH2CH3), 1.32 (m, 1H, OH), 1.53-1.68 (m, 4H, CH2CH2COOMe, CH2CH2CO), 
1.92-1.98 (m, 3H, COCH2CHO, ≡CCH2CH2), 2.01-2.16 (m, 2H, CHCH2C≡, COCH2CHO), 
2.20 (t, J = 7.4 Hz, 2H, CH2CH2CO), 2.26 (t, J = 7.4 Hz, 2H, CH2COOMe), 2.48 (ddt, J = 
17.0, 4.4, 2.3 Hz, 1H, CHCH2C≡), 2.68 (dt, J = 4.1, 8.9 Hz, 1H, CHCH2C≡), 2.84 (ddd, J = 
11.5, 8.3, 3.2 Hz, 1H, CHCHCH=), 3.31 (s, 3H, COOCH3), 3.86 (dt, J = 5.9, 3.1 Hz, 1H, 
CHOH), 6.18 (dd, J = 15.6, 0.6 Hz, 1H, =CHCO), 6.54 (dd, J = 15.6, 9.9 Hz, 1H, 
CH=CHCO). - 13C NMR (150 MHz, C6D6): δ = 14.2 (q, CH2CH3), 16.3 (t, CHCH2C≡), 18.4 
(t, CH2CH2C≡), 23.0 (t, CH2CH3), 24.1 (t, CH2CH2COOMe or CH2CH2CH2CH3), 24.5 (t, 
CH2CH2COOMe or CH2CH2CH2CH3), 31.8 (t, CH2CH2CH3), 32.9 (t, CH2COOMe), 41.0 (t, 
CH2CH2C=O), 45.4 (t, COCH2CHO), 50.2 (d, CHCH2C≡), 51.18 (q, COOCH3), 51.5 (d, 
CHCHCH=), 71.2 (d, CHOH), 78.7 (s, C≡C), 81.0 (s, C≡C), 133.3 (d, =CHCO), 140.8 (d, 
CH=CHCO), 173.1 (s, COOMe), 198.4 (s, =CHC=O), 212.8 (s, C=O). - Significant NOESY-
Cross-Peaks: 
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4-101b: 1H NMR (600 MHz, C6D6): δ = 0.86 (m, 3H, CH2CH3), 0.96 (br. s, 1H, OH), 1.13-
1.26 (m, 4H, CH2CH2CH2CH3), 1.53-1.68 (m, 5H, CH2CH2COOMe, CH2CH2CO, 
CHCH2C≡), 1.92-1.98 (m, 2H, ≡CCH2CH2), 2.01-2.16 (m, 2H, CHCH2C≡, COCH2CHO), 
2.17 (t, J = 7.3 Hz, 2H, CH2CH2CO), 2.24 (t, J = 7.4 Hz, 2H, CH2COOMe), 2.37 (dd, J = 
18.3, 7.5 Hz, 1H, COCH2CHO), 2.58 (ddt, J = 17.0, 4.9, 2.4 Hz, 1H, CHCH2C≡), 2.78 (dt, J = 
11.8, 8.7 Hz, 1H, CHCHCH=), 3.28 (s, 3H, COOCH3), 3.48 (m, 1H, CHOH), 6.24 (dd, J = 
15.6, 0.7 Hz, 1H, =CHCO), 6.63 (dd, J = 15.6, 8.5 Hz, 1H, CH=CHCO). - 13C NMR (150 
MHz, C6D6): δ = 14.2 (q, CH2CH3), 17.3 (t, CHCH2C≡), 18.2 (t, CH2CH2C≡), 23.0 (t, 
CH2CH3), 24.0 (t, CH2CH2COOMe or CH2CH2CH2CH3), 24.4 (t, CH2CH2COOMe or 
CH2CH2CH2CH3), 31.9 (t, CH2CH2CH3), 32.9 (t, CH2COOMe), 41.4 (t, CH2CH2CO), 46.7 (t, 
COCH2CH), 51.22 (q, COOCH3), 52.6 (d, CHCHCH=), 53.1 (d, CHCH2C≡), 71.6 (d, 
CHOH), 77.8 (s, C≡C), 81.9 (s, C≡C), 132.2 (d, =CHCO), 144.2 (d, CH=CHCO), 173.3 (s, 
COOMe), 198.4 (s, =CHC=O), 210.3 (s, C=O). - Significant NOESY cross peaks: 
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4-101c (12-epi-IsoP Isomer, detectable resonances): 1H NMR (600 MHz, C6D6): 2.01-2.16 
(m, 3H, CHCH2C≡, COCH2CHO), 2.25 (m, 1H, CHCH2C≡), 2.64 (ddt, J = 16.9, 4.5, 2.3 Hz, 
1H, CHCH2C≡), 2.73 (ddd, J = 12.0, 8.7, 3.7 Hz, 1H, CHCHCH=), 3.30 (s, 3H, COOCH3), 
3.79 (t, J = 4.1 Hz, 1H, CHOH), 6.91 (dd, J = 16.0, 8.5 Hz, 1H, CH=CHCO). 
 
13,14-Dihydro-15-oxo-15-E2-IsoP methyl ester 4-3 and 13,14-dihydro-15-oxo-PGE2 
methyl ester 4-4: 
O
HO
C5H11
CO2Me
4-3
O
O
HO
C5H11
CO2Me
4-4
O
 
In a Schlenk flask 5 mg of the Lindlar catalyst (~5% Pd on calcium carbonate, poisoned with 
lead, FLUKA, filling code 1308421 11607082) was evacuated and flushed with nitrogen three 
times. In a separate Schlenk flask, a 10:6:1 mixture of HPLC grade ethyl acetate/HPLC grade 
ethanol/distilled pyridine was deoxygenated by five freeze-pump-thaw cycles and 2 mL of 
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this solvent mixture was added to the catalyst. The suspension was subsequently evacuated 
and flushed three times with hydrogen and stirred under a positive pressure of H2 at r.t. for 50 
min. Hydrogenation was started by addition of a carefully deoxygenated solution of 5 mg 
(0.014 mmol) 15-oxo-5,6-dehydro-E2-IsoP, 15-oxo-5,6-dehydro-PGE and 12-epi-15-oxo-5,6-
dehydro-E2-IsoP 4-101a/4-101b/4-101c (9:4:1) in 1.7 mL of the same solvent mixture. The 
reaction mixture was stirred at r.t. for 24 hours under a slightly positive pressure of hydrogen 
(2 balloons of 26 cm diameter). The reaction mixture was diluted with ethyl acetate and 
filtered through a pad of Celite, which was washed with ethyl acetate and diethyl ether. The 
crude product was purified by flash chromatography (hexane/ethyl acetate 5:1, gradient to 
ethyl acetate). The products 4-3 and 4-4 were obtained as a partly separable mixture with 
hexane/ethyl acetate 1:1 and ethyl acetate (Rf(hexane/ethyl acetate 1:1) = 0.23, 0.30). Yield 
4.6 mg (90%) in a ratio of 1.5:1. 
IR (Film): v~  = 3464 (br. w), 3007 (w), 2953 (w), 2931 (w), 2869 (w), 1738 (s), 1715 (m), 
1438 (w), 1372 (w), 1243 (w), 1163 (w), 1079 (w), 1016 (w) cm-1. - MS (ESI) m/z (%): 389 
(100) [M+Na+]. - HRMS: C21H34O5Na+: calc. 389.2304; found 389.2302. 
 
4-3: 1H NMR (600 MHz, C6D6): δ = 0.87 (m, 3H, CH2CH3), 1.06 (m, 1H, CHCH2CH2CO), 
1.12-1.18 (m, 2H, CH2CH2CH2CH3), 1.21-1.30 (m, 2H, CH2CH2CH3), 1.30 (br. s, 1H, OH), 
1.43-1.66 (m, 5H, CH2CH2COOMe, CHCH2CH2CO, CH2CH2CH2C=O), 1.99 (t, J = 7.4 Hz, 
2H, CH2CH2CH2CO), 1.87-2.00 (m, 6H, COCH2CHO, CHCH2CH2CO, =CHCH2CH2, 
CHCH2CH2CO), 2.01-2.12 (m, 3H, CHCH2CH=, CH2COOMe), 2.18 (m, 1H, COCH2CHO), 
2.50 (m, 1H, CHCH2CH=), 2.63 (m, 1H, CHCH2CH=), 3.36 (s, 3H, COOCH3), 3.73 (dt, J = 
5.9, 2.7 Hz, CHOH), 5.32 (m, 1H, =CHCH2CH2), 5.43 (m, 1H, CHCH2CH=). - 13C NMR 
(150 MHz, C6D6): δ = 14.2 (q, CH2CH3), 21.1 (t, CH(OH)CHCH2), 22.9 (t, CH2CH3), 23.1 (t, 
CHCH2CH=), 23.7 (t, CH2CH2CH2CH3), 24.97 (t, CH2CH2COOMe), 26.9 (t, =CHCH2CH2), 
31.7 (t, CH2CH2CH3), 33.30 (t, CH2COOMe), 40.4 (t, CHCH2CH2CO), 42.6 (t, 
CH2CH2CH2CO), 44.9 (t, COCH2CHO), 46.7 (d, CH(OH)CHCH2), 50.6 (d, CHCH2CH=), 
51.02 (q, COOCH3), 70.5 (d, CHOH), 128.4 (d, CHCH2CH=), 130.4 (d, =CHCH2CH2), 173.6 
(s, COOMe), 208.4 (s, C=O), 215.0 (s, C=O). 
 
4-4 methyl ester: 1H NMR (600 MHz, C6D6): δ = 0.87 (m, 3H, CH2CH3), 1.12-1.18 (m, 2H, 
CH2CH2CH3), 1.21-1.30 (m, 2H, CH2CH3), 1.43-1.66 (m, 7H, CHCH2CH2CO, 
CH2CH2CH2CO, CH2CH2COOMe, CHCH2CH=), 1.68 (m, 1H, CHCH2CH2CO), 1.88 (br. s, 
1H, OH), 1.93 (dd, J = 18.3, 7.2 Hz, 1H, COCH2CHO), 2.04 (t, J = 7.4 Hz, 2H, 
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CH2CH2CH2CO), 2.01-2.12 (m, 4H, =CHCH2CH2, CH2COOMe), 2.18 (dt, J = 7.0, 3.1 Hz, 
2H, CHCH2CH2CO), 2.29 (ddd, J = 18.1, 6.8, 1.1 Hz, 1H, COCH2CHO), 2.35 (m, 1H, 
CHCH2CH=), 2.48 (m, 1H, CHCH2CH=), 3.33 (s, 3H, COOCH3), 3.53 (q, J = 6.9 Hz, 1H, 
CHOH), 5.32 (m, 1H, =CHCH2CH2), 5.38 (m, 1H, CHCH2CH=). - 13C NMR (150 MHz, 
C6D6): δ = 14.2 (q, CH2CH3), 22.9 (t, CH2CH3), 23.7 (t, CH2CH2CH2CH3), 25.05 (t, 
CH2CH2COOMe), 26.0 (t, CH(OH)CHCH2), 26.7 (t, CHCH2CH=), 26.8 (t, =CHCH2CH2), 
31.7 (t, CH2CH2CH3), 33.32 (t, CH2COOMe), 39.9 (t, CHCH2CH2CO), 42.7 (t, 
CH2CH2CH2CO), 47.1 (t, COCH2CHO), 47.9 (d, CH(OH)CHCH2), 51.08 (q, COOCH3), 53.9 
(d, CHCH2CH=), 73.1 (d, CHOH), 127.7 (d, CHCH2CH=), 131.1 (d, =CHCH2CH2), 173.4 (s, 
COOMe), 209.4 (s, C=O), 214.1 (s, C=O). - The NMR data of 4-4 methyl ester are in 
agreement with those of the methyl ester synthesised from commercially available 13,14-
dihydro-15-oxo-PGE2 obtained from Cayman Chemical. 
 
Commercially available 13,14-dihydro-15-oxo-PGE2 (Cayman Chemical): 
O
HO
C5H11
CO2H
O  
1H NMR (600 MHz, C6D6): δ = 0.87 (t, J = 7.2 Hz, 3H, CH2CH3), 1.16 (m, 2H, 
CH2CH2CH3), 1.23 (m, 2H, CH2CH3), 1.50-1.56 (m, 6H, CH2CH2CH2CO, CHCH2CH2CO, 
CH2CH2COOH, CHCH2CH=), 1.64 (m, 2H, CHCH2CH2CO, CHCH2CH2CO), 1.93 (dd + br. 
s, J = 18.2, 7.1 Hz, 2H, COCH2CHOH, OH), 2.05 (t, J = 7.4 Hz, 2H, CH2CH2CH2CO), 2.04-
2.24 (m, 6H, =CHCH2CH2, CH2COOH, CHCH2CH2CO), 2.24-2.33 (m, 2H, COCH2CHO, 
CHCH2CH=), 2.45 (m, 1H, CHCH2CH=), 3.51 (q, J = 6.9 Hz, 1H, CHOH), 5.30 (m, 1H, 
=CHCH2CH2), 5.44 (m, 1H, CHCH2CH=). - 13C NMR (150 MHz, C6D6): δ = 14.2 (q, 
CH2CH3), 22.8 (t, CH2CH3), 23.7 (t, CH2CH2CH2CH3), 24.8 (t, CH2CH2COOH), 26.2 (t, 
CH(OH)CHCH2), 26.6 (t, CHCH2CH=), 26.7 (t, =CHCH2CH2), 31.7 (t, CH2CH2CH3), 33.0 (t, 
CH2COOH), 40.1 (t, CHCH2CH2CO), 42.8 (t, CH2CH2CH2CO), 47.1 (t, COCH2CHOH), 48.0 
(d, CH(OH)CHCH2), 54.1 (d, CHCH2CH=), 73.1 (d, CHOH), 127.6 (d, CHCH2CH=), 130.9 
(d, =CHCH2CH2), 177.1 (s, COOH), 210.5 (s, C=O), 214.1 (s, C=O). 
 
Methylation of 13,14-dihydro-15-oxo-PGE2: 
To a solution of 1 mg (0.0028 mmol) of 13,14-dihydro-15-oxo-PGE2 in 1.8 mL dry 
THF/MeOH 8:1 40 µL of a 2M solution of trimethylsilyldiazomethane (0.08 mmol, 28 equiv.) 
in diethyl ether was added at room temperature. After 30 minutes of stirring at the same 
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temperature the reaction mixture was evaporated in vacuum. A 600 MHz NMR spectrum of 
the crude product was recorded. The NMR data are in agreement with those of synthesised 4-
4. 
 
Table 6.10 Significant NMR data and multiplicities of compounds 4-99, 4-100, 4-101, 4-3 
and 4-4 
Product H8 H9 H11 H12 H13 H14 H15 
15α-4-99 2.98 (ddd) - 4.25 (m) 3.22 (m) 4.96 (dd) 5.75 (dd) 4.13 (dt) 
15β-4-99 2.95 (dt) - 4.33 (dt) 3.16 (t) 5.30 (dd) 5.72 (dd) 4.25 (m) 
4-100a 
major 
2.87 (m) - 4.03 (m) 2.93 (m) 5.17 (dd) 5.65 (dd) 4.19 (m) 
4-100a 
minor 
2.79 (m) - 4.09 (m) 2.93 (m) 5.13 (dd) 5.69 (dd) 4.19 (m) 
4-100b 1.63 (m) - 3.59 (dt) 2.85 (m) 5.24 (dd) 5.73 (dd) 4.25 (m) 
4-101a 2.68 (dt) - 3.86 (dt) 2.84 (ddd) 6.54 (dd) 6.18 (dd) - 
4-101b 1.61 (m) - 3.48 (m) 2.78 (dt) 6.63 (dd) 6.24 (dd) - 
4-101c 2.25 (m) - 3.79 (t) 2.73 (ddd) 6.91 (dd) Not 
assigned 
- 
4-3 2.63 (m) - 3.73 (dt) 1.87-2.00 
(m) 
1.06 (m), 
1.43-1.66 
(m) 
1.87-2.00 
(m) 
- 
4-4 1.43-1.66 
(m) 
- 3.53 (q) 1.69 (m) 1.43-1.66 
(m) 
2.18 (dt) - 
 C8 C9 C11 C12 C13 C14 C15 
15α-4-99 49.9 (d) 213.9 (s) 72.6 (d) 52.9 (d) 127.2 (d) 138.6 (d) 85.8 (d) 
15β-4-99 50.8 (d) 213.6 (s) 73.1 (d) 52.1 (d) 128.6 (d) 137.5 (d) 85.2 (d) 
4-100a 
major 
50.7 (d) 213.6 (s) 71.9 (d) 51.4 (d) 128.3 (d) 137.5 (d) 85.2 (d) 
4-100a 
minor 
49.9 (d) 213.9 (s) 71.6 (d) 52.1 (d) 127.8 (d) 137.9 (d) 85.6 (d) 
4-100b 53.6 (d) 211.3 (d) 72.1 (d) 52.5 (d) 131.0 (d) 137.2 (d) 85.5 (d) 
4-101a 50.2 (d) 212.8 (s) 71.2 (d) 51.5 (d) 140.8 (d) 133.3 (d) 198.4 (s) 
4-101b 52.6 (d) 210.3 (d) 71.6 (d) 52.6 (d) 144.2 (d) 132.2 (d) 198.4 (d) 
4-3 50.6 (d) 215.0 (s) 70.5 (d) 46.7 (d) 21.1 (t) 40.4 (t) 208.4 (s) 
4-4 53.9 (d) 214.1 (s) 73.1 (d) 47.9 (d) 26.0 (t) 39.9 (t) 209.4 (d) 
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